Citrus Sinensis ID: 010091
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.498 | 0.661 | 0.437 | 8e-65 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.5 | 0.282 | 0.419 | 8e-60 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.503 | 0.406 | 0.420 | 1e-56 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.509 | 0.382 | 0.404 | 6e-56 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.5 | 0.277 | 0.419 | 3e-55 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.488 | 0.308 | 0.422 | 8e-54 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.544 | 0.218 | 0.382 | 3e-52 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.503 | 0.348 | 0.412 | 8e-52 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.501 | 0.160 | 0.396 | 1e-51 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.501 | 0.398 | 0.423 | 6e-51 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 248 bits (633), Expect = 8e-65, Method: Compositional matrix adjust.
Identities = 115/263 (43%), Positives = 169/263 (64%), Gaps = 5/263 (1%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLT----NEHLNENIRREFAQEVHI 295
W D S L +K SG++ +Y+G + + VA+K++ E + ++F EV +
Sbjct: 79 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSK 354
+ ++ H N+VQFI AC +PP I+TE+MS G++ YL+K++ L + +LR+A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVI 414
GM YLH +IHRDLK+ NLL+N+ VKVADFG + ++ Q GTYRWMAPE+I
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI 258
Query: 415 EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
+ +PY + DV+SFGIVLWEL T LP+ +TP+QAA V +K RP +P P L L
Sbjct: 259 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHL 318
Query: 475 LERCWQRDPSLRPDFSEITELLQ 497
++RCW +PS RPDFS I +L+
Sbjct: 319 IKRCWSENPSKRPDFSNIVAVLE 341
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (590), Expect = 8e-60, Method: Compositional matrix adjust.
Identities = 109/260 (41%), Positives = 168/260 (64%), Gaps = 1/260 (0%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIK-VLTNEHLNENIRREFAQEVHIMRKV 299
EI S LK K+ G++ +YKG + VAIK + NE +N + EF +E+ I+ ++
Sbjct: 656 EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRL 715
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
RH N+V + ACT PP L +TE++ GGS+YD LH +K + + L ++AI +++GMNYL
Sbjct: 716 RHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775
Query: 360 HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPY 419
H + +IHRD+K+ NLL++E+ VK+ DFG+++++++ MT G+ WM+PE++ + Y
Sbjct: 776 HLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLMGEDY 835
Query: 420 NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479
+ DV++FGI+LWEL TG+LPY L +Q A+ V K LRP IP L L++ CW
Sbjct: 836 TEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACW 895
Query: 480 QRDPSLRPDFSEITELLQHL 499
+DP RP F+EI LL +
Sbjct: 896 HQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 111/264 (42%), Positives = 166/264 (62%), Gaps = 3/264 (1%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
D +ID +K +I G+Y ++Y G + VA+K L ++NENI +EF +E+++M+
Sbjct: 365 DGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMK 424
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
+RH NV+QF+G+C PP + I TE+M GS+Y LH Q L+ LL+++ ID +KG+
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484
Query: 358 YLHRNN--IIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE 415
YLH + I+HRDLK+ NLL++EN VKVADFG++ ++ Q MTA GT W +PEV+
Sbjct: 485 YLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPEVLR 543
Query: 416 HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475
Q Y +ADV+SFGI+LWE T + PY + P Q V ++G+RP +P + P + LL
Sbjct: 544 SQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLL 603
Query: 476 ERCWQRDPSLRPDFSEITELLQHL 499
C +PS RP + E L+ +
Sbjct: 604 IDCLNENPSHRPTMEQCLERLESI 627
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (557), Expect = 6e-56, Method: Compositional matrix adjust.
Identities = 108/267 (40%), Positives = 166/267 (62%), Gaps = 3/267 (1%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
D +ID +K +I G++ ++Y G + VA+K L ++NENI +EF +E+++M+
Sbjct: 382 DGKDIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMK 441
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
+RH NV+QF+G+C P + I TE+M GS+Y LH +K + L+ R+ ID +KG+
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGII 501
Query: 358 YLHRNN--IIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE 415
YLH + I+HRDLK+ NLL++EN VKVADFG++ ++ Q MTA GT W +PEV+
Sbjct: 502 YLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPEVLR 560
Query: 416 HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475
Q Y +ADV+SFGI+LWE T + PY + P Q V ++G+RP P + P + LL
Sbjct: 561 SQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLL 620
Query: 476 ERCWQRDPSLRPDFSEITELLQHLAQR 502
+ C +PS RP + E+L+ + +
Sbjct: 621 KDCLNENPSQRPTMEQCLEILESIETK 647
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (550), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 110/262 (41%), Positives = 164/262 (62%), Gaps = 3/262 (1%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
EI + L +I GSY ++Y + +VA+K ++ + EF EV IMR++R
Sbjct: 663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLR 722
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H NVV F+GA TRPP L IVTEF+ GS+Y LH+ K + +++A+DV+ GMN LH
Sbjct: 723 HPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLH 782
Query: 361 RNN--IIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET-GTYRWMAPEVIEHQ 417
+ I+HRDLK NLL++ N VKV DFG++R++ + + T GT WMAPEV+ ++
Sbjct: 783 TSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 842
Query: 418 PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477
P N + DV+SFG++LWEL T +LP+ + P+Q V + R IP P++ ++
Sbjct: 843 PSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRIILE 902
Query: 478 CWQRDPSLRPDFSEITELLQHL 499
CWQ DP+LRP F+++TE+L+ L
Sbjct: 903 CWQTDPNLRPSFAQLTEVLKPL 924
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 8e-54, Method: Compositional matrix adjust.
Identities = 109/258 (42%), Positives = 164/258 (63%), Gaps = 5/258 (1%)
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
L + KI +GS+ +++ + DVA+K+L + + EF +EV IM+++RH N+V
Sbjct: 551 LNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 610
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNN- 363
F+GA T+PP L IVTE++S GS+Y LHK +L L +A DV+KGMNYLH N
Sbjct: 611 FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 670
Query: 364 -IIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT-AETGTYRWMAPEVIEHQPYNH 421
I+HRDLK+ NLL+++ VKV DFG++R++A + + + GT WMAPEV+ +P N
Sbjct: 671 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 730
Query: 422 RADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481
++DV+SFG++LWEL T + P+ +L P Q V K R IP + +P + ++E CW
Sbjct: 731 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTN 790
Query: 482 DPSLRPDFSEITELLQHL 499
+P RP F+ I +LL+ L
Sbjct: 791 EPWKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (525), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 112/293 (38%), Positives = 173/293 (59%), Gaps = 11/293 (3%)
Query: 232 IPAEGIDV-----WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIR 286
IPA+ I+V WE+ S + +I G Y +++G++ +VA+K+L N+++N +
Sbjct: 831 IPAKIIEVEKPFEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLI 890
Query: 287 REFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLL 346
+ +EV ++ K+RH N+V F+GACT P IVTE++S GS+ + L + + L L
Sbjct: 891 SDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRL 950
Query: 347 RVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETG 404
++ D ++GM YLH N IIHRDLK NLL++++ VKVADFG+A V++ T G
Sbjct: 951 QLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKTM-CG 1009
Query: 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP 464
T W+APEV+ + Y +ADV+S+ IVLWEL+T +PY +Q V + +G R +P
Sbjct: 1010 TTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ-VVRSIDRGERLPMP 1068
Query: 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ--TKRGLAQGNAI 515
P L+ RCW+ DP+ RP F EI +++ + Q K +AQG I
Sbjct: 1069 AWCPPKYAALMNRCWETDPTHRPSFPEILPIMEGMISEFQKEKKESIAQGRPI 1121
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 205 bits (521), Expect = 8e-52, Method: Compositional matrix adjust.
Identities = 111/269 (41%), Positives = 158/269 (58%), Gaps = 8/269 (2%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKV--LTNEHLNENIRREFAQEVHI 295
++ ID S + +++I GS +++ G + VAIK L NE +E+ E AQE I
Sbjct: 482 EIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNED-DEDFLNELAQEATI 540
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
M ++RH N+ QF+G C PP + IV E+M GS+Y LH L P + +A+D++KG
Sbjct: 541 MSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKG 600
Query: 356 MNYLHRNN--IIHRDLKAANLLMNENGVVKVADFGVA-RVQAQYGVMTAET--GTYRWMA 410
MNYLH + +IHRDLK+ NLL++E+ VK++DFG++ R + TA T GT W A
Sbjct: 601 MNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWTA 660
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470
PEV+ + PY +ADVFSF IVLWE+VT + PY + Q + V Q LRP +P
Sbjct: 661 PEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAP 720
Query: 471 LVDLLERCWQRDPSLRPDFSEITELLQHL 499
L+ CW DP RP F EI + L+ +
Sbjct: 721 FTRLITECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 204 bits (519), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 107/270 (39%), Positives = 167/270 (61%), Gaps = 10/270 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
WEID S L+ + +G Y ++YK + +VA+K+++++H+++++ R F +EV IM +
Sbjct: 779 WEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEVKIMTSL 838
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNY 358
RH NVV F+ A T+ P + IV EFMS GS+YD L + + L +++A SKGM++
Sbjct: 839 RHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIKMAYQASKGMHF 898
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE---TGTYRWMAPEVIE 415
LH + I+HRDLK+ NLL++ VKV+DFG+ +V+++ GT W+APE++
Sbjct: 899 LHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHWIAPEILN 958
Query: 416 HQPYNHR--ADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI---PVHTHPI 470
ADV+SFGI+LWEL+T + PY +TP AV V++ G+RP I V H I
Sbjct: 959 DSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVIRDGMRPPISDEAVTAHSI 1018
Query: 471 -LVDLLERCWQRDPSLRPDFSEITELLQHL 499
+DL+++CW D +RP F EI L ++
Sbjct: 1019 EYIDLIKQCWHSDTIIRPTFLEIMTRLSNI 1048
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (513), Expect = 6e-51, Method: Compositional matrix adjust.
Identities = 114/269 (42%), Positives = 163/269 (60%), Gaps = 9/269 (3%)
Query: 235 EGIDVWEIDASLLKF--EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQE 292
E I WEID + + + E K+ SG++ +YKG ++VAIK LT EN EF +E
Sbjct: 160 EEIIRWEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVFEENTMNEFKKE 219
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLR---VA 349
V +M K+R+ +++ F+GACT P L IVTE M GS++ L ++ R +A
Sbjct: 220 VSLMAKLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIA 279
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA--QYGVMTAETGTYR 407
D GM +LH +NI+H DLK ANLL+++N VVKVADFG+++ + + G+
Sbjct: 280 RDTVLGMTWLHASNILHLDLKPANLLVDQNWVVKVADFGLSKYMKPDSKDKLLGQAGSPL 339
Query: 408 WMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL--TPLQAAVGVVQKGLRPTIPV 465
+MAPE++ +QPY+ + DVFSF I+LWEL+T + PY+ L + Q GVV K RP IP
Sbjct: 340 YMAPEMLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPIIPD 399
Query: 466 HTHPILVDLLERCWQRDPSLRPDFSEITE 494
+ L DLL RCW PS RP F+EI++
Sbjct: 400 YFPTRLKDLLARCWDHYPSRRPSFAEISK 428
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | ||||||
| 297744550 | 580 | unnamed protein product [Vitis vinifera] | 0.969 | 0.865 | 0.648 | 0.0 | |
| 359474826 | 1515 | PREDICTED: uncharacterized mscS family p | 0.969 | 0.331 | 0.622 | 0.0 | |
| 255539096 | 749 | protein kinase, putative [Ricinus commun | 0.972 | 0.672 | 0.681 | 0.0 | |
| 449454245 | 573 | PREDICTED: protein-tyrosine kinase 2-bet | 0.969 | 0.876 | 0.638 | 0.0 | |
| 224080668 | 494 | predicted protein [Populus trichocarpa] | 0.889 | 0.933 | 0.681 | 0.0 | |
| 255560441 | 558 | protein kinase, putative [Ricinus commun | 0.944 | 0.876 | 0.625 | 0.0 | |
| 224143785 | 539 | predicted protein [Populus trichocarpa] | 0.947 | 0.910 | 0.665 | 0.0 | |
| 283132359 | 578 | ACT-domain-containing protein kinase [Lo | 0.971 | 0.870 | 0.609 | 0.0 | |
| 224083191 | 556 | predicted protein [Populus trichocarpa] | 0.949 | 0.884 | 0.649 | 0.0 | |
| 224065733 | 565 | predicted protein [Populus trichocarpa] | 0.965 | 0.884 | 0.628 | 0.0 |
| >gi|297744550|emb|CBI37812.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/557 (64%), Positives = 419/557 (75%), Gaps = 55/557 (9%)
Query: 1 MVMGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAH 60
MVM D ES SSR D S ++SR+QR K++VYNE+L RLK S+ EE +P F+++LWAH
Sbjct: 1 MVMEDNESCSSRVHDSS-SPAQSRQQRQKLEVYNEVLRRLKDSDNEEAFEPGFDEELWAH 59
Query: 61 FYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNL--- 117
F RLP+RYALDVN+ERAEDVL HKRLLH+A DP PAIEVRLV V S N+
Sbjct: 60 FVRLPTRYALDVNVERAEDVLTHKRLLHLAHDPTNRPAIEVRLVQVHPISDGIHGNIADS 119
Query: 118 VHS---------GSPRYLYTQ-------FSCYP--------------------------- 134
+HS GSP+Y Q F P
Sbjct: 120 IHSNSPTIGPAHGSPKYSSKQSILPPPAFGSSPNLEALAIEANNSHVQDGDGDDSVHASS 179
Query: 135 YKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQE 194
R MHEIT S++DKPKLLSQLT LLSE+ LNIQEAHAFSTVDGYSLDVFVVDGWP +E
Sbjct: 180 QYSRPMHEITFSSDDKPKLLSQLTCLLSELELNIQEAHAFSTVDGYSLDVFVVDGWPYEE 239
Query: 195 TEQLRNVLAKEIPKVEN----HHHVVYPVGEQEQSGI----NHVNIPAEGIDVWEIDASL 246
TEQLR L KE+ K+E +HH + P GEQE++GI + V IP +G DVWEID
Sbjct: 240 TEQLRTALEKEVFKIEKQSWPNHHSLSPTGEQEETGIKCESDFVTIPNDGTDVWEIDVRQ 299
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
LKFE+K+ SGSY DLYKG + SQ+VAIKVL E LN ++++EFAQEV IMRKVRH NVVQ
Sbjct: 300 LKFENKVASGSYGDLYKGTYCSQEVAIKVLKPERLNSDMQKEFAQEVFIMRKVRHKNVVQ 359
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
FIGACTRPP L+IVTEFMSGGS+YDYLHKQK KLP LL+V+IDVSKGMNYLH+NNIIH
Sbjct: 360 FIGACTRPPSLYIVTEFMSGGSVYDYLHKQKGVFKLPALLKVSIDVSKGMNYLHQNNIIH 419
Query: 367 RDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVF 426
RDLKAANLLM+EN VVKVADFGVARV+AQ GVMTAETGTYRWMAPEVIEH+PY+H+ADVF
Sbjct: 420 RDLKAANLLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVF 479
Query: 427 SFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
SFGIVLWEL+TGKLPY+ LTPLQAAVGVVQKGLRPT+P +THP L +LLERCWQ+DP+LR
Sbjct: 480 SFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLRPTMPKNTHPKLAELLERCWQQDPTLR 539
Query: 487 PDFSEITELLQHLAQRL 503
PDFSEI E+LQ +A+ +
Sbjct: 540 PDFSEIIEILQQIAKEV 556
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474826|ref|XP_002280985.2| PREDICTED: uncharacterized mscS family protein At1g78610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/583 (62%), Positives = 424/583 (72%), Gaps = 81/583 (13%)
Query: 1 MVMGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAH 60
MVM D ES SSR D S ++SR+QR K++VYNE+L RLK S+ EE +P F+++LWAH
Sbjct: 1 MVMEDNESCSSRVHDSS-SPAQSRQQRQKLEVYNEVLRRLKDSDNEEAFEPGFDEELWAH 59
Query: 61 FYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLV---------------- 104
F RLP+RYALDVN+ERAEDVL HKRLLH+A DP PAIEVRLV
Sbjct: 60 FVRLPTRYALDVNVERAEDVLTHKRLLHLAHDPTNRPAIEVRLVQFGKFDVSHKRYVRCG 119
Query: 105 --LVQG-----ASTRH---------FSNLVHS---------GSPRYLYTQ-------FSC 132
L QG + T H ++ +HS GSP+Y Q F
Sbjct: 120 WALRQGKRNIISLTVHPISDGIHGNIADSIHSNSPTIGPAHGSPKYSSKQSILPPPAFGS 179
Query: 133 YPYKKRL------------------------MHEITISTNDKPKLLSQLTSLLSEIGLNI 168
P + L MHEIT S++DKPKLLSQLT LLSE+ LNI
Sbjct: 180 SPNLEALAIEANNSHVQDGDGDDSVHASSQPMHEITFSSDDKPKLLSQLTCLLSELELNI 239
Query: 169 QEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPKVEN----HHHVVYPVGEQEQ 224
QEAHAFSTVDGYSLDVFVVDGWP +ETEQLR L KE+ K+E +HH + P GEQE+
Sbjct: 240 QEAHAFSTVDGYSLDVFVVDGWPYEETEQLRTALEKEVFKIEKQSWPNHHSLSPTGEQEE 299
Query: 225 SGI----NHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEH 280
+GI + V IP +G DVWEID LKFE+K+ SGSY DLYKG + SQ+VAIKVL E
Sbjct: 300 TGIKCESDFVTIPNDGTDVWEIDVRQLKFENKVASGSYGDLYKGTYCSQEVAIKVLKPER 359
Query: 281 LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGL 340
LN ++++EFAQEV IMRKVRH NVVQFIGACTRPP L+IVTEFMSGGS+YDYLHKQK
Sbjct: 360 LNSDMQKEFAQEVFIMRKVRHKNVVQFIGACTRPPSLYIVTEFMSGGSVYDYLHKQKGVF 419
Query: 341 KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT 400
KLP LL+V+IDVSKGMNYLH+NNIIHRDLKAANLLM+EN VVKVADFGVARV+AQ GVMT
Sbjct: 420 KLPALLKVSIDVSKGMNYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQSGVMT 479
Query: 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR 460
AETGTYRWMAPEVIEH+PY+H+ADVFSFGIVLWEL+TGKLPY+ LTPLQAAVGVVQKGLR
Sbjct: 480 AETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEYLTPLQAAVGVVQKGLR 539
Query: 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503
PT+P +THP L +LLERCWQ+DP+LRPDFSEI E+LQ +A+ +
Sbjct: 540 PTMPKNTHPKLAELLERCWQQDPTLRPDFSEIIEILQQIAKEV 582
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255539096|ref|XP_002510613.1| protein kinase, putative [Ricinus communis] gi|223551314|gb|EEF52800.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 688 bits (1776), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/533 (68%), Positives = 417/533 (78%), Gaps = 29/533 (5%)
Query: 3 MGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFY 62
MGD ES SSRAVDFV S+SRKQR V VYNE+L RLK SN+E T+ P FED+LW HF+
Sbjct: 1 MGDAESCSSRAVDFV--PSQSRKQRQTVDVYNEVLCRLKDSNDEATKLPGFEDELWTHFH 58
Query: 63 RLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFS------- 115
RLP+RYA+DVN ERA+DVLMHKRLL +A DP+ PAI+VRLV V+ + S
Sbjct: 59 RLPTRYAMDVNAERAQDVLMHKRLLQLAHDPSTRPAIDVRLVQVRIQDSGIDSLEALLPP 118
Query: 116 ---------NLVHSGSPRYLYTQFSCYPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGL 166
LV G + + T S P RLMHEITISTNDKPKLLSQLTSLLSEIGL
Sbjct: 119 PAFGSLPQRKLVRDGRDKDI-TMISS-PLYSRLMHEITISTNDKPKLLSQLTSLLSEIGL 176
Query: 167 NIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPKVENHHHV----VYPVGEQ 222
NI EAHAFST+DGYSLDVFVVD W +ETE+LR +L KEI + E + +YP +Q
Sbjct: 177 NITEAHAFSTIDGYSLDVFVVDNWAHEETERLRTMLLKEIKEFEKSTQLKTNAIYPAVKQ 236
Query: 223 EQSGIN----HVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTN 278
EQ GIN HVNIPA+ +DVWEID SLLK+E KI SGS+ DLYKG F++QDVAIKVL
Sbjct: 237 EQKGINLMCDHVNIPADRMDVWEIDPSLLKYEIKIASGSHGDLYKGTFYTQDVAIKVLRT 296
Query: 279 EHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC 338
EHLN+ +R+EFAQEV+IMRKVRH NVVQFIGACTRPP L IVTEFM GGS++D+LHKQK
Sbjct: 297 EHLNDKLRKEFAQEVYIMRKVRHKNVVQFIGACTRPPSLCIVTEFMCGGSMFDFLHKQKQ 356
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398
L L LLRVAIDVSKGMNYLH+NNIIHRDLKAANLLM+EN VVKVADFGVARV+ Q GV
Sbjct: 357 SLDLQSLLRVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENKVVKVADFGVARVEDQSGV 416
Query: 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG 458
MTAETGTYRWMAPEVIEH+PY + DVFSF IVLWEL+TGKLPY+ L+PLQAA+ VVQ+G
Sbjct: 417 MTAETGTYRWMAPEVIEHKPYGRKVDVFSFSIVLWELLTGKLPYEHLSPLQAAISVVQQG 476
Query: 459 LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKRGLAQ 511
LRP+IP THP LV+LLERCWQ+DPSLRP+F EI ELLQ+LA R+Q +R Q
Sbjct: 477 LRPSIPKRTHPKLVELLERCWQQDPSLRPEFYEILELLQNLA-RMQNRRQRMQ 528
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454245|ref|XP_004144866.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] gi|449528766|ref|XP_004171374.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1757), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/550 (63%), Positives = 405/550 (73%), Gaps = 48/550 (8%)
Query: 1 MVMGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAH 60
MVM D ES SRA D + S ++SR+QR K +VYNE+L RLK SN EE QP F+D+LW H
Sbjct: 1 MVMEDNESCGSRAYDLL-SPAQSRQQRQKFEVYNEVLRRLKDSNNEEAIQPGFDDELWVH 59
Query: 61 FYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHS 120
F RLP+RYALDVN+ERAEDVLMHKRLL A DPA PAIEVRLV VQ S H ++ S
Sbjct: 60 FNRLPTRYALDVNVERAEDVLMHKRLLQFAHDPANRPAIEVRLVQVQAVSDEHSADFADS 119
Query: 121 --------GSPRYLYTQ-------FSCYPYKK-------------------------RLM 140
S L Q F P + R M
Sbjct: 120 CPVKDTDHNSSNCLSRQSMHPPPAFGSSPNLEALALEANNTQDLEVDQSVHARTQFFRPM 179
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRN 200
HEIT ST+DKPKLLSQLTSLL+EIGLNIQEAHAFSTVDGYSLDVFVVDGWP +ETE+L+
Sbjct: 180 HEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETERLKT 239
Query: 201 VLAKEIPKVEN----HHHVVYPVGEQE---QSGINHVNIPAEGIDVWEIDASLLKFEHKI 253
L E+ VE + PVGE + + + V IP +G DVWEI+ LKFEHK+
Sbjct: 240 ALESEVLLVERRGWPNQKSSSPVGELDITAKCESDRVEIPTDGTDVWEINPRHLKFEHKV 299
Query: 254 VSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313
SGSY DLYKG + SQ+VAIKVL E +N +++ EFAQEV+IMRKVRH NVVQFIGACT+
Sbjct: 300 ASGSYGDLYKGTYCSQEVAIKVLKTERVNTDMQSEFAQEVYIMRKVRHKNVVQFIGACTK 359
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
PP L IVTEFMSGGS+YDYLHKQK +LP LL+VAIDVSKGMNYLH+NNIIHRDLKAAN
Sbjct: 360 PPSLCIVTEFMSGGSVYDYLHKQKGTFRLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 419
Query: 374 LLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
LLM+EN VVKVADFGVARV+AQ GVMTAETGTYRWMAPEVIEH+PY+H+ADVFSFGIVLW
Sbjct: 420 LLMDENEVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLW 479
Query: 434 ELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEIT 493
EL+TGKLPY+ LTPLQAAVGVVQKGLRPT+P HT+P L DLLE+CWQ+DPS RPDF EI
Sbjct: 480 ELLTGKLPYEFLTPLQAAVGVVQKGLRPTMPKHTNPKLADLLEKCWQQDPSCRPDFCEII 539
Query: 494 ELLQHLAQRL 503
++L + + +
Sbjct: 540 DILLQITKEV 549
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224080668|ref|XP_002306203.1| predicted protein [Populus trichocarpa] gi|222849167|gb|EEE86714.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1727), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/483 (68%), Positives = 391/483 (80%), Gaps = 22/483 (4%)
Query: 29 KVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLH 88
K++VYNEIL RL++SN EE P F+D LW HF LP+RYALDVN+ERAEDVL HKRLL
Sbjct: 4 KLEVYNEILRRLQESNHEEANLPGFDDQLWTHFNSLPTRYALDVNVERAEDVLTHKRLLR 63
Query: 89 VARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSCYPYKKRLMHEITISTN 148
+A DPA PAIE+RLV +TR F VH S R ++ F Y MHEIT ST+
Sbjct: 64 LAHDPANRPAIEIRLV----QTTRGF---VHDTSFRQVFLGFEGY------MHEITFSTD 110
Query: 149 DKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPK 208
DKPKLLSQLTSL+++IGLNIQEAHAFSTVDGYSLDVFVVDGWP +ETEQLR+ LAKE+ K
Sbjct: 111 DKPKLLSQLTSLVADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRDALAKEVSK 170
Query: 209 VENHHHVVYPV--------GEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCD 260
+E + + P+ G++ + NHV IP +G DVWEID LKFE+K+ SGSY D
Sbjct: 171 IEEFNSGI-PISNSYSTGNGQEIKCDTNHVAIPNDGTDVWEIDPKYLKFENKVASGSYGD 229
Query: 261 LYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320
LYKG + SQ+VAIK+L E +N ++++EFAQEV+IMRKVRH NVVQFIGACT+PP L IV
Sbjct: 230 LYKGTYCSQEVAIKILKPERVNSDLQKEFAQEVYIMRKVRHKNVVQFIGACTKPPSLCIV 289
Query: 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
TEFM GGS+YDYLHKQ+ KLP LL+VAIDVSKGM+YLH+NNIIHRDLK ANLLM+EN
Sbjct: 290 TEFMHGGSVYDYLHKQRGVFKLPNLLKVAIDVSKGMDYLHQNNIIHRDLKGANLLMDENE 349
Query: 381 VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKL 440
VVKVADFGVARV+AQ G+MTAETGTYRWMAPEVIEH+PY+H+ADVFSFGIVLWEL+TGK+
Sbjct: 350 VVKVADFGVARVKAQTGIMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKI 409
Query: 441 PYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500
PY+ LTPLQAAVGVVQKGLRPTIP +T P L +LLE+CWQ+DP+LRPDFSEI E+LQ +A
Sbjct: 410 PYEYLTPLQAAVGVVQKGLRPTIPKNTQPKLAELLEKCWQQDPALRPDFSEIIEILQQIA 469
Query: 501 QRL 503
+ +
Sbjct: 470 KEV 472
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560441|ref|XP_002521235.1| protein kinase, putative [Ricinus communis] gi|223539503|gb|EEF41091.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/545 (62%), Positives = 398/545 (73%), Gaps = 56/545 (10%)
Query: 1 MVMGDTESSSSRAVDFVWSESK----SRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDD 56
++M + ES SR D S R QR K++VYNE+L RLK+SN EE QP F+D+
Sbjct: 3 VMMEENESCGSRVQDSTTSSPSPSHAGRNQRQKLEVYNEVLRRLKESNNEEANQPGFDDE 62
Query: 57 LWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSN 116
LW+HF+RLP+RYALDVN+ERAEDVLMHKRLL +A DP PAIE+RLV V S + ++
Sbjct: 63 LWSHFHRLPTRYALDVNVERAEDVLMHKRLLQLAHDPDNRPAIEIRLVQVPPVSDGNSAD 122
Query: 117 LVHSGSPRYLYTQ-----------FSCYP-----------------------YKKRLMHE 142
SGSPR TQ F P Y + MHE
Sbjct: 123 SDLSGSPRKGDTQSNRKSIHPPPAFGSSPNLEALALEAINPKMXXLGNSDLLYHLQPMHE 182
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVL 202
IT ST+DKPKLLSQLTSLL+EIGLNIQEAHAFSTVDGYSLDVFVVDGWP ++ L
Sbjct: 183 ITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEKHTWPTLSL 242
Query: 203 AKEIPKVENHHHVVYPVGEQEQSGI----NHVNIPAEGIDVWEIDASLLKFEHKIVSGSY 258
+ P E +Q+ I +HV IP +G DVWEID LKFE+K+ SGSY
Sbjct: 243 S--------------PSSEHKQTKIKCDPDHVTIPNDGTDVWEIDPKNLKFENKVASGSY 288
Query: 259 CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318
DLYKG + SQ+VAIK+L E +N ++ +EFAQEV IMRKVRH NVVQFIGACT+PP L
Sbjct: 289 GDLYKGTYCSQEVAIKILKPERINSDLEKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 348
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE 378
IVTEFMSGGS+YDYLHKQK KLP LL+VAIDVSKGMNYLH+NNIIHRDLKAANLLM+E
Sbjct: 349 IVTEFMSGGSVYDYLHKQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 408
Query: 379 NGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTG 438
N VVKVADFGVARV+AQ GVMTAETGTYRWMAPEVIEH+PY+H+AD+FSF IVLWEL+TG
Sbjct: 409 NEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADIFSFAIVLWELLTG 468
Query: 439 KLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
KLPY+ LTPLQAAVGVVQKGLRPTIP HTHP L +LLE+CWQ+DP+LRPDFSEI E+LQ
Sbjct: 469 KLPYEYLTPLQAAVGVVQKGLRPTIPKHTHPKLAELLEKCWQQDPALRPDFSEIIEMLQQ 528
Query: 499 LAQRL 503
+ + +
Sbjct: 529 IVKEV 533
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143785|ref|XP_002336079.1| predicted protein [Populus trichocarpa] gi|222871184|gb|EEF08315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/526 (66%), Positives = 404/526 (76%), Gaps = 35/526 (6%)
Query: 3 MGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFY 62
MGDTES SSRAVDFV R QR K+ V+N++ +RLK+SN+EE + FE++LWAHF
Sbjct: 1 MGDTESCSSRAVDFV-----PRNQRQKLDVFNDVFYRLKESNDEEASRLGFEEELWAHFL 55
Query: 63 RLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVH--- 119
R P RYA+DVN ERAEDV+MHKRLL +A +PA PAIEVRLV + AS L+H
Sbjct: 56 RFPPRYAMDVNAERAEDVIMHKRLLQMAHNPATRPAIEVRLVQL-NASRLILGLLMHVMH 114
Query: 120 --SGSPRYLYTQFS----------------CYPYKKRLMHEITISTNDKPKLLSQLTSLL 161
S P + S P RL+HEITIST D+PKLLSQLTSLL
Sbjct: 115 HKSIHPPPAFGSLSDSELLHKYQDKDITVITGPLCFRLVHEITISTIDQPKLLSQLTSLL 174
Query: 162 SEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPKVE----NHHHVVY 217
SEIGLNIQEAHAFST DGYSLDVFVVD PL++TE+LR+++ KEIPK+E + H VY
Sbjct: 175 SEIGLNIQEAHAFSTTDGYSLDVFVVDNMPLEDTERLRSMVFKEIPKIEEDADSKSHAVY 234
Query: 218 PVGEQEQSGI----NHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAI 273
V EQ+Q GI N +N+PA+ IDVWEIDA L E KI +GS DLYKG F SQDVAI
Sbjct: 235 RVTEQDQIGISLVSNLMNVPADSIDVWEIDARQLIREKKIANGSSGDLYKGTFCSQDVAI 294
Query: 274 KVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL 333
KVL EHLN ++ EF QEV IMRKVRH NVV+FIGACTRPP L I+TEFMSGGS+YD+L
Sbjct: 295 KVLRGEHLNNKLQSEFYQEVSIMRKVRHKNVVKFIGACTRPPSLCIITEFMSGGSMYDFL 354
Query: 334 HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393
HKQK L L LLRVAIDVSKGM+ LH+NNI+HRDLK+ANLLM+ENGV KVADFGVARVQ
Sbjct: 355 HKQKGSLSLQSLLRVAIDVSKGMHCLHQNNIVHRDLKSANLLMDENGVAKVADFGVARVQ 414
Query: 394 AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVG 453
Q GVMTAETGTYRWMAPEVIEH+PY+H+ADVFSFGIVLWEL+TGKLPY+ L+PLQAAVG
Sbjct: 415 DQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLTGKLPYEHLSPLQAAVG 474
Query: 454 VVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
VVQ+GLRP+IP H+HP L +LLERCWQ+DPSLRPDFSEI ELLQ L
Sbjct: 475 VVQQGLRPSIPSHSHPKLAELLERCWQQDPSLRPDFSEIVELLQQL 520
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|283132359|dbj|BAI63585.1| ACT-domain-containing protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1693), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/551 (60%), Positives = 401/551 (72%), Gaps = 48/551 (8%)
Query: 1 MVMGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAH 60
+V+ D ++S + S S++R+ R KV+VYNEIL RL S E QP F D LWAH
Sbjct: 4 VVVDDNDTSGTSNHRATPSPSQTRQHRHKVEVYNEILRRLNDSGNPEALQPGFHDQLWAH 63
Query: 61 FYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHS 120
F RLP+RYALDVN+ERA DVLMHKRLLH+A DPA P+IEVRLV V S + ++ HS
Sbjct: 64 FNRLPARYALDVNVERAADVLMHKRLLHLAHDPANRPSIEVRLVQVHPTSDGNSADSFHS 123
Query: 121 GSPR----------------YLYTQFSCYP------------------------YKKRLM 140
SP + F P R M
Sbjct: 124 DSPGTESGQSSSKYSSRQSIHPPPAFGSSPNLEALALEENNSEDIDERSVHASVQYSRPM 183
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRN 200
HEIT ST DKPKLLSQLT+LL+EIGLNIQEAHAFST DGYSLDVFVVDGWP +ETE+L+
Sbjct: 184 HEITFSTEDKPKLLSQLTALLAEIGLNIQEAHAFSTSDGYSLDVFVVDGWPYEETEKLKV 243
Query: 201 VLAKEIPKVE----NHHHVVYPVGEQEQSGI----NHVNIPAEGIDVWEIDASLLKFEHK 252
L KEI K+E ++ V E +Q+ + +H+ IP +G DVWEIDA L + ++
Sbjct: 244 ALEKEILKIERQARSNQQSVSSADEPDQARMKHEQDHLTIPNDGTDVWEIDAKHLTYGNQ 303
Query: 253 IVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312
I SGSY +L+KG + SQ+VAIKVL EH+N ++REF QEV+IMRKVRH NVVQFIGACT
Sbjct: 304 IASGSYGELFKGTYCSQEVAIKVLKGEHVNAEMQREFVQEVYIMRKVRHKNVVQFIGACT 363
Query: 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
+PPRL I+TEFMSGGS+YDYLHKQK K P LL+VAIDVSKGMNYLH++NIIHRDLK A
Sbjct: 364 KPPRLCIITEFMSGGSVYDYLHKQKGFFKFPSLLKVAIDVSKGMNYLHQHNIIHRDLKGA 423
Query: 373 NLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVL 432
NLLM+ENGVVKVADFGVARV+AQ GVMTAETGTYRWMAPEVIEH+PY+H+ADVFSFG+VL
Sbjct: 424 NLLMDENGVVKVADFGVARVKAQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGVVL 483
Query: 433 WELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
WEL+TGKLPY+ LTPLQAA+GVVQKGLRPTIP +THP V+LLER WQ+D +LRPDFSEI
Sbjct: 484 WELLTGKLPYEYLTPLQAAIGVVQKGLRPTIPKNTHPKFVELLERSWQQDSTLRPDFSEI 543
Query: 493 TELLQHLAQRL 503
++LQ LA+ +
Sbjct: 544 IDILQKLAKEV 554
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224083191|ref|XP_002306961.1| predicted protein [Populus trichocarpa] gi|222856410|gb|EEE93957.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/542 (64%), Positives = 406/542 (74%), Gaps = 50/542 (9%)
Query: 3 MGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFY 62
MGDTES SS AVDFV R QR K+ V+N++L+RLK+SN+EE + FED+LWAHF
Sbjct: 1 MGDTESGSSGAVDFV-----PRNQRQKLDVFNDVLYRLKESNDEEASRLGFEDELWAHFC 55
Query: 63 RLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHS-- 120
R P+RYA+DV ERAEDV+MHKRLL +A +PA PAIEVRLV V S H + V S
Sbjct: 56 RFPTRYAMDVIAERAEDVIMHKRLLQMAHNPATRPAIEVRLVQVPFQSDGHPGDSVDSEL 115
Query: 121 --------GSPRYLYTQFSCYP---------------YKK------------RLMHEITI 145
G R+ +P Y+ RL+HEITI
Sbjct: 116 QLQYFDYLGKHRHGCANIFIHPPPAFGSLSDSELLHKYQDKDITVITGPLCFRLVHEITI 175
Query: 146 STNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKE 205
ST DKPKLLSQLTSLLSEIGLNIQEAHAFST DGYSLDVFVVD PL++TE+LR+++ KE
Sbjct: 176 STIDKPKLLSQLTSLLSEIGLNIQEAHAFSTTDGYSLDVFVVDNMPLEDTERLRSMVFKE 235
Query: 206 IPKVE----NHHHVVYPVGEQEQSGI----NHVNIPAEGIDVWEIDASLLKFEHKIVSGS 257
IPK+E + H VY V EQ+Q GI N +N+PA+ IDVWEIDA L E KI +GS
Sbjct: 236 IPKIEEDADSKSHAVYRVTEQDQIGISLVSNLMNVPADSIDVWEIDARQLIREKKIANGS 295
Query: 258 YCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317
DLYKG F SQDVAIKVL EHLN ++ EF QEV IMRKVRH NVV+FIGACTRPP L
Sbjct: 296 SGDLYKGTFCSQDVAIKVLRGEHLNNKLQSEFYQEVSIMRKVRHKNVVKFIGACTRPPSL 355
Query: 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
I+TEFMSGGS+YD+LHKQK L L LLRVAIDVSKGM+ LH+NNI+HRDLK+ANLLM+
Sbjct: 356 CIITEFMSGGSMYDFLHKQKGSLSLQSLLRVAIDVSKGMHCLHQNNIVHRDLKSANLLMD 415
Query: 378 ENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT 437
ENGV KVADFGVARVQ Q GVMTAETGTYRWMAPEVIEH+PY+H+ADVFSFGIVLWEL+T
Sbjct: 416 ENGVAKVADFGVARVQDQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVLWELLT 475
Query: 438 GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
GKLPY+ L+PLQAAVGVVQ+GLRP+IP H+HP L +LLERCWQ+DPSLRPDFSEI ELLQ
Sbjct: 476 GKLPYEHLSPLQAAVGVVQQGLRPSIPSHSHPKLAELLERCWQQDPSLRPDFSEIVELLQ 535
Query: 498 HL 499
L
Sbjct: 536 QL 537
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065733|ref|XP_002301944.1| predicted protein [Populus trichocarpa] gi|222843670|gb|EEE81217.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/562 (62%), Positives = 415/562 (73%), Gaps = 62/562 (11%)
Query: 3 MGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFY 62
MGDTES SSRAVDFV R QR K+ V+N++L LK+SN++E +P FE++LW HF
Sbjct: 1 MGDTESCSSRAVDFV-----PRNQRQKLDVFNDVLCHLKESNDKEATRPGFENELWTHFC 55
Query: 63 RLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLV----------------LV 106
RLP+RYA+DVN ERA+DV+MHKRLL +AR+PA PAIEVRLV +
Sbjct: 56 RLPARYAMDVNAERAQDVIMHKRLLQMARNPATRPAIEVRLVQHYYIAVAALITICQPFI 115
Query: 107 QG------------------ASTRHFSNLVHSGSPRYLYT---QFSCYPYKKRLMHEITI 145
G S F L+H + Q S Y + LMHEITI
Sbjct: 116 AGKWHLVLFFICSIHPPPAFGSLTDFE-LLHKNQNDDITAFTRQNSAY---QELMHEITI 171
Query: 146 STNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKE 205
STNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV+ W ++TE+LR++L KE
Sbjct: 172 STNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVNNWEPEDTERLRSMLVKE 231
Query: 206 IPKVENH------------HHVVYPVGEQEQSGI----NHVNIPAEGIDVWEIDASLLKF 249
IPK+E + VYPV EQ+Q GI +H+N+PA+ IDVWEIDA L F
Sbjct: 232 IPKIEVALLNVTFILNWMLKNAVYPVAEQDQRGIRLVSSHMNVPADSIDVWEIDAHRLLF 291
Query: 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
E KI +GS DLYKG F SQDVAIKVL EHL++ ++ EF QEV IMRKVRH NVVQFIG
Sbjct: 292 ERKIATGSSGDLYKGTFCSQDVAIKVLRGEHLDDKLQSEFVQEVSIMRKVRHKNVVQFIG 351
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+CTRPP L IVTEFMSGGS+YD+LHKQK L L LLRVAIDVSKGM+ L++N+IIHRDL
Sbjct: 352 SCTRPPSLCIVTEFMSGGSMYDFLHKQKGSLNLQSLLRVAIDVSKGMHCLNQNHIIHRDL 411
Query: 370 KAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFG 429
K+AN+LM+ENGVVKVADFGVARVQ Q GVMTAETGTYRWMAPEVIEH+PY+H+ADVFSFG
Sbjct: 412 KSANILMDENGVVKVADFGVARVQDQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFG 471
Query: 430 IVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDF 489
IVLWEL+TGKLPY+ L+PLQAAVGVVQ+GLRP+IP H+HP LV LL+RCWQRDP LRP+F
Sbjct: 472 IVLWELLTGKLPYEQLSPLQAAVGVVQQGLRPSIPSHSHPKLVGLLKRCWQRDPFLRPEF 531
Query: 490 SEITELLQHLAQRLQTKRGLAQ 511
SEI ELLQ L + + +R Q
Sbjct: 532 SEILELLQQLERTVADERDDKQ 553
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 518 | ||||||
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.706 | 0.636 | 0.705 | 2.7e-167 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.704 | 0.668 | 0.660 | 1e-154 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.704 | 0.640 | 0.660 | 7.1e-154 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.527 | 0.664 | 0.455 | 2e-65 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.527 | 0.662 | 0.451 | 2.5e-65 | |
| DICTYBASE|DDB_G0267514 | 916 | DDB_G0267514 "protein kinase, | 0.498 | 0.281 | 0.421 | 7.7e-56 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.530 | 0.523 | 0.390 | 1.8e-55 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.567 | 0.384 | 0.392 | 2.1e-54 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.478 | 0.240 | 0.434 | 5.5e-54 | |
| DICTYBASE|DDB_G0289791 | 642 | drkA "DRK subfamily protein ki | 0.498 | 0.401 | 0.421 | 8.9e-54 |
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1334 (474.7 bits), Expect = 2.7e-167, Sum P(2) = 2.7e-167
Identities = 263/373 (70%), Positives = 301/373 (80%)
Query: 138 RLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQ 197
R +HEIT ST DKPKLL QLT+LL+E+GLNIQEAHAFST DGYSLDVFVVDGWP +ETE+
Sbjct: 174 RPLHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETER 233
Query: 198 LRNVLAKEIPKVENH------HHVVYPVGEQEQSGIN-HVNIPAEGIDVWEIDASLLKFE 250
LR L KE K+E P E Q+G HV IP +G DVWEI+ LKF
Sbjct: 234 LRISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTHVPIPNDGTDVWEINLKHLKFG 293
Query: 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
HKI SGSY DLYKG + SQ+VAIKVL E L+ ++ +EFAQEV IMRKVRH NVVQFIGA
Sbjct: 294 HKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVVQFIGA 353
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
CT+PP L IVTEFM GGS+YDYLHKQK KLP L +VAID+ KGM+YLH+NNIIHRDLK
Sbjct: 354 CTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDLK 413
Query: 371 AANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGI 430
AANLLM+EN VVKVADFGVARV+AQ GVMTAETGTYRWMAPEVIEH+PY+H+ADVFS+GI
Sbjct: 414 AANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSYGI 473
Query: 431 VLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
VLWEL+TGKLPY+ +TPLQAAVGVVQKGLRPTIP +THP L +LLER W+ D + RPDFS
Sbjct: 474 VLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELLERLWEHDSTQRPDFS 533
Query: 491 EITELLQHLAQRL 503
EI E LQ +A+ +
Sbjct: 534 EIIEQLQEIAKEV 546
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 1.0e-154, Sum P(2) = 1.0e-154
Identities = 247/374 (66%), Positives = 293/374 (78%)
Query: 138 RLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQ 197
R MHEIT ST DKPKLLSQLTSLL E+GLNIQEAHAFSTVDG+SLDVFVVDGW +ET+
Sbjct: 170 RPMHEITFSTIDKPKLLSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDGWSQEETDG 229
Query: 198 LRNVLAKEIPKVENH---HHVVYPVGEQEQSGINH-----VNIPAEGIDVWEIDASLLKF 249
LR+ L+KEI K+++ E ++S N + IP +G D WEID + LK
Sbjct: 230 LRDALSKEILKLKDQPGSKQKSISFFEHDKSS-NELIPACIEIPTDGTDEWEIDVTQLKI 288
Query: 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
E K+ SGSY DL++G + SQ+VAIK L + +N + REF+QEV IMRKVRH NVVQF+G
Sbjct: 289 EKKVASGSYGDLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRHKNVVQFLG 348
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
ACTR P L IVTEFM+ GSIYD+LHKQKC KL LL+VA+DV+KGM+YLH+NNIIHRDL
Sbjct: 349 ACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDL 408
Query: 370 KAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFG 429
K ANLLM+E+G+VKVADFGVARVQ + GVMTAETGTYRWMAPEVIEH+PYNH+ADVFS+
Sbjct: 409 KTANLLMDEHGLVKVADFGVARVQIESGVMTAETGTYRWMAPEVIEHKPYNHKADVFSYA 468
Query: 430 IVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDF 489
IVLWEL+TG +PY LTPLQAAVGVVQKGLRP IP THP + LLERCW +DP RP F
Sbjct: 469 IVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKGLLERCWHQDPEQRPLF 528
Query: 490 SEITELLQHLAQRL 503
EI E+LQ + + +
Sbjct: 529 EEIIEMLQQIMKEV 542
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1247 (444.0 bits), Expect = 7.1e-154, Sum P(2) = 7.1e-154
Identities = 247/374 (66%), Positives = 293/374 (78%)
Query: 138 RLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQ 197
R MHEIT ST D+PKLLSQLTS+L E+GLNIQEAHAFST DG+SLDVFVVDGW +ETE
Sbjct: 176 RPMHEITFSTIDRPKLLSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEG 235
Query: 198 LRNVLAKEIPKVENH---HHVVYPVGEQEQSGINH-----VNIPAEGIDVWEIDASLLKF 249
L++ L KEI K ++ E ++S N V IP +G D WEID LK
Sbjct: 236 LKDALKKEIRKFKDQPCSKQKSITFFEHDKS-TNELLPACVEIPTDGTDEWEIDMKQLKI 294
Query: 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
E K+ GSY +L++G + SQ+VAIK+L E +N + REF+QEV+IMRKVRH NVVQFIG
Sbjct: 295 EKKVACGSYGELFRGTYCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIG 354
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
ACTR P L IVTEFM+ GSIYD+LHK K K+ LL+VA+DVSKGMNYLH+NNIIHRDL
Sbjct: 355 ACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDL 414
Query: 370 KAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFG 429
K ANLLM+E+ VVKVADFGVARVQ + GVMTAETGTYRWMAPEVIEH+PY+HRADVFS+
Sbjct: 415 KTANLLMDEHEVVKVADFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYA 474
Query: 430 IVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDF 489
IVLWEL+TG+LPY LTPLQAAVGVVQKGLRP IP THP L +LLE+CWQ+DP+LRP+F
Sbjct: 475 IVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNF 534
Query: 490 SEITELLQHLAQRL 503
+EI E+L L + +
Sbjct: 535 AEIIEMLNQLIREV 548
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
Identities = 128/281 (45%), Positives = 186/281 (66%)
Query: 233 PAEGI---DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTN-EHLNEN---I 285
P EG+ D W ID L G++ LYKG + +DVAIK+L E+ E +
Sbjct: 113 PTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFM 172
Query: 286 RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL-HKQKCGLKLPL 344
++F QEV ++ ++H N+V+FIGAC +P IVTE+ GGS+ +L +Q + L L
Sbjct: 173 EQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 232
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETG 404
++ A+DV++GM Y+H N IHRDLK+ NLL++ + +K+ADFGVAR++ Q MT ETG
Sbjct: 233 AVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 292
Query: 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP 464
TYRWMAPE+I+H+ YN + DV+SFGIVLWEL+TG LP+ ++T +QAA VV +G+RPT+P
Sbjct: 293 TYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVP 352
Query: 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505
P+L D++ RCW +P +RP F E+ +LL+ + T
Sbjct: 353 NDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLEAAETEIMT 393
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 665 (239.2 bits), Expect = 2.5e-65, P = 2.5e-65
Identities = 127/281 (45%), Positives = 184/281 (65%)
Query: 233 PAEGI---DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLN----ENI 285
P EG+ + W ID L G++ LY+G + +DVAIK+L N + +
Sbjct: 114 PTEGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQAL 173
Query: 286 RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPL 344
++F QEV ++ ++H N+V+FIGAC +P IVTE+ GGS+ +L K Q + L L
Sbjct: 174 EQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKL 233
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETG 404
+ A+DV++GM Y+H N IHRDLK+ NLL++ + +K+ADFGVAR++ Q MT ETG
Sbjct: 234 AVMQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETG 293
Query: 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP 464
TYRWMAPE+I+H+PY + DV+SFGIVLWEL+TG LP+ ++T +QAA VV +G+RPT+P
Sbjct: 294 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVP 353
Query: 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505
P+L +++ RCW DP +RP F+EI LL+ + T
Sbjct: 354 ADCLPVLGEIMTRCWDADPEVRPCFAEIVNLLEAAETEIMT 394
|
|
| DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 7.7e-56, P = 7.7e-56
Identities = 110/261 (42%), Positives = 170/261 (65%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIK-VLTNEHLNENIRREFAQEVHIMRKV 299
EI S LK K+ G++ +YKG + VAIK + NE +N + EF +E+ I+ ++
Sbjct: 656 EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRL 715
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
RH N+V + ACT PP L +TE++ GGS+YD LH +K + + L ++AI +++GMNYL
Sbjct: 716 RHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775
Query: 360 HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPY 419
H + +IHRD+K+ NLL++E+ VK+ DFG+++++++ MT G+ WM+PE++ + Y
Sbjct: 776 HLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLMGEDY 835
Query: 420 NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI-LVDLLERC 478
+ DV++FGI+LWEL TG+LPY L +Q A+ V K LRP IP + P L L++ C
Sbjct: 836 TEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIP-NAWPYQLSHLIQAC 894
Query: 479 WQRDPSLRPDFSEITELLQHL 499
W +DP RP F+EI LL +
Sbjct: 895 WHQDPLKRPSFTEILNLLNEI 915
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 1.8e-55, P = 1.8e-55
Identities = 110/282 (39%), Positives = 175/282 (62%)
Query: 235 EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLT------NEHLNENIRRE 288
E + + +D S L F K G Y LY G + + VA+K++T N L + ++
Sbjct: 195 EASEEFRVDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQ 254
Query: 289 FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLR 347
F +EV ++ ++ H NV++F+GA PP ++T+++ GS+ +LHK + L L L+
Sbjct: 255 FTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIE 314
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYR 407
AID+++GM Y+H IIHRDLK N+L++E +K+ADFG+A + ++ + GTYR
Sbjct: 315 FAIDIARGMEYIHSRRIIHRDLKPENVLIDEEFHLKIADFGIACEEEYCDMLADDPGTYR 374
Query: 408 WMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467
WMAPE+I+ +P+ +ADV+SFG+VLWE+V G +PY+D+ P+QAA VV K +RP IP
Sbjct: 375 WMAPEMIKRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDC 434
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKRGL 509
+ L+E+CW P RP+F +I ++L+ A L+ + L
Sbjct: 435 PVAMKALIEQCWSVAPDKRPEFWQIVKVLEQFAISLEREGNL 476
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 2.1e-54, P = 2.1e-54
Identities = 118/301 (39%), Positives = 187/301 (62%)
Query: 220 GEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNE 279
G S +N V++ ++ +D +EI L +I GS +Y G +F DVA+KV + +
Sbjct: 461 GSTSSSVMNKVDMDSDCLD-YEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQ 519
Query: 280 HLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG 339
+E I F QEV +M+++RH NV+ F+GA P RL IVTEF+ GS++ L + K
Sbjct: 520 EYSEEIITSFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSK 579
Query: 340 LKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397
L L + +A D+++GMNYLH + IIHRDLK++NLL++ N VKVADFG++R++ +
Sbjct: 580 LDLRRRIHMASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETY 639
Query: 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQA--AVGVV 455
+ T GT +WMAPEV+ ++ + ++DV+SFG+VLWELVT K+P+++L +Q AVG +
Sbjct: 640 LTTNGRGTPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFM 699
Query: 456 QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKRGLAQGNAI 515
+ L +P P + L+E CW +P RP F E+ + L+ L ++ + A+ +I
Sbjct: 700 NQRLE--VPKDVDPQWIALMESCWHSEPQCRPSFQELMDKLRELQRKYTIQFQAARAASI 757
Query: 516 E 516
+
Sbjct: 758 D 758
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 5.5e-54, Sum P(2) = 5.5e-54
Identities = 109/251 (43%), Positives = 160/251 (63%)
Query: 252 KIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311
+I GSY ++Y+G + +VA+K ++ L EF EV IM+K+RH N+V F+GA
Sbjct: 753 RIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKKLRHPNIVLFMGAV 812
Query: 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDL 369
TRPP L IVTEF+ GS+Y +H+ L LR+A+D ++GMNYLH N I+HRDL
Sbjct: 813 TRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAARGMNYLHSCNPMIVHRDL 872
Query: 370 KAANLLMNENGVVKVADFGVARVQ-AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSF 428
K+ NLL+++N VVKV DFG++R++ + Y + GT WMAPEV+ ++P + + DV+S+
Sbjct: 873 KSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVLRNEPADEKCDVYSY 932
Query: 429 GIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPD 488
G++LWEL T + P+ + P+Q V + R IP P + DL+ +CWQ D LRP
Sbjct: 933 GVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAIADLISKCWQTDSKLRPS 992
Query: 489 FSEITELLQHL 499
F+EI L+ L
Sbjct: 993 FAEIMASLKRL 1003
|
|
| DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 8.9e-54, P = 8.9e-54
Identities = 110/261 (42%), Positives = 165/261 (63%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
+ID +K +I G+Y ++Y G + VA+K L ++NENI +EF +E+++M+ +R
Sbjct: 368 DIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 427
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H NV+QF+G+C PP + I TE+M GS+Y LH Q L+ LL+++ ID +KG+ YLH
Sbjct: 428 HPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLH 487
Query: 361 RNN--IIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQP 418
+ I+HRDLK+ NLL++EN VKVADFG++ ++ Q MTA GT W +PEV+ Q
Sbjct: 488 NSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPEVLRSQR 546
Query: 419 YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478
Y +ADV+SFGI+LWE T + PY + P Q V ++G+RP +P + P + LL C
Sbjct: 547 YTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLIDC 606
Query: 479 WQRDPSLRPDFSEITELLQHL 499
+PS RP + E L+ +
Sbjct: 607 LNENPSHRPTMEQCLERLESI 627
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 4.6.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00036186001 | SubName- Full=Chromosome chr3 scaffold_8, whole genome shotgun sequence; (580 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 518 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-86 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-85 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-85 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-79 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-70 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-69 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-62 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-59 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-59 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-59 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-56 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-55 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-55 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-55 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-54 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-51 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-51 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-51 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-51 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-50 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-50 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-50 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-50 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-49 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-49 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-49 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-47 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-46 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-46 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-46 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-46 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-46 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-45 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-45 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-45 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-45 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-45 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-44 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-44 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-44 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-43 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-43 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-42 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-42 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-42 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-42 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-42 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-41 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-40 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-40 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-39 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-39 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-39 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-39 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-38 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-38 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-38 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-37 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-37 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-37 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-37 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-36 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-36 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-36 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-36 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-36 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-36 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-35 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-35 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-35 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-35 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-35 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-35 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-35 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-35 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-35 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-34 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-34 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-34 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-33 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-33 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-33 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-33 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-32 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-32 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-32 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-32 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-32 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-32 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-31 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-31 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-31 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-31 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-31 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-31 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-31 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-31 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-30 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-30 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-30 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-30 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-30 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-30 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-30 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-30 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-30 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-30 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-29 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-29 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-29 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-29 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-29 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-29 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-29 | |
| cd04928 | 68 | cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC | 5e-29 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-28 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-28 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-28 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-27 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-27 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-27 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-27 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-26 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-26 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-26 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-26 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-26 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-26 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-25 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-25 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-25 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-24 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-23 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-23 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-23 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-23 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-22 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-22 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-22 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-21 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-20 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-18 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-18 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-18 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-16 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-16 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-16 | |
| cd04900 | 73 | cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU | 5e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-15 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-13 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 8e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-10 | |
| cd04873 | 70 | cd04873, ACT_UUR-ACR-like, ACT domains of the bact | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| PRK05092 | 931 | PRK05092, PRK05092, PII uridylyl-transferase; Prov | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-07 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-07 | |
| cd02116 | 60 | cd02116, ACT, ACT domains are commonly involved in | 6e-06 | |
| TIGR01693 | 850 | TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd04899 | 70 | cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domain | 2e-05 | |
| PRK00275 | 895 | PRK00275, glnD, PII uridylyl-transferase; Provisio | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-05 | |
| COG2844 | 867 | COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran | 7e-05 | |
| pfam01842 | 66 | pfam01842, ACT, ACT domain | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-04 | |
| PRK05007 | 884 | PRK05007, PRK05007, PII uridylyl-transferase; Prov | 5e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 8e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.003 | |
| PRK05092 | 931 | PRK05092, PRK05092, PII uridylyl-transferase; Prov | 0.004 | |
| cd04876 | 71 | cd04876, ACT_RelA-SpoT, ACT domain found C-termina | 0.004 | |
| cd04926 | 72 | cd04926, ACT_ACR_4, C-terminal ACT domain, of a no | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 1e-86
Identities = 99/259 (38%), Positives = 146/259 (56%), Gaps = 11/259 (4%)
Query: 247 LKFEHKIVSGSYCDLYKG------AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
L K+ G++ ++YKG +VA+K L + +E EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H NVV+ +G CT L+IV E+M GG + YL K + L L LL A+ +++GM YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETG--TYRWMAPEVIEHQP 418
N IHRDL A N L+ EN VVK++DFG++R G RWMAPE ++
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 419 YNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477
+ ++DV+SFG++LWE+ T G+ PY ++ + + ++ G R P + P L DL+ +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLEYLKNGYRLPQPPNCPPELYDLMLQ 238
Query: 478 CWQRDPSLRPDFSEITELL 496
CW DP RP FSE+ E+L
Sbjct: 239 CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 263 bits (676), Expect = 2e-85
Identities = 97/260 (37%), Positives = 151/260 (58%), Gaps = 12/260 (4%)
Query: 247 LKFEHKIVSGSYCDLYKG------AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
L+ K+ G++ ++YKG VA+K L E +E R EF +E IM+K+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLS 59
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H N+V+ +G CT+ L+IVTE+M GG + D+L K L L LL++A+ ++KGM YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY---RWMAPEVIEHQ 417
N +HRDL A N L+ EN VVK++DFG++R + G +WMAPE ++
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 418 PYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476
+ ++DV+SFG++LWE+ T G+ PY ++ + + +++ G R P + L +L+
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLELLEDGYRLPRPENCPDELYELML 238
Query: 477 RCWQRDPSLRPDFSEITELL 496
+CW DP RP FSE+ E L
Sbjct: 239 QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 263 bits (674), Expect = 5e-85
Identities = 99/260 (38%), Positives = 147/260 (56%), Gaps = 12/260 (4%)
Query: 247 LKFEHKIVSGSYCDLYKG------AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
L K+ G++ ++YKG +VA+K L + + I EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE-EFLREARIMRKLD 59
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYL 359
H N+V+ +G CT L IV E+M GG + DYL K + L L LL A+ +++GM YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 360 HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETG--TYRWMAPEVIEHQ 417
N IHRDL A N L+ EN VVK++DFG++R + G RWMAPE ++
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 418 PYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476
+ ++DV+SFG++LWE+ T G+ PY ++ + + ++KG R P + P L L+
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-VLEYLKKGYRLPKPPNCPPELYKLML 238
Query: 477 RCWQRDPSLRPDFSEITELL 496
+CW DP RP FSE+ E+L
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 2e-79
Identities = 97/263 (36%), Positives = 148/263 (56%), Gaps = 19/263 (7%)
Query: 252 KIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
K+ G++ ++YKG + +VA+K L + E R++F +E +M+K+ H NVV+
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-RKDFLKEARVMKKLGHPNVVR 60
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG--------LKLPLLLRVAIDVSKGMNY 358
+G CT L++V E+M GG + DYL K + L L LL AI ++KGM Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY---RWMAPEVIE 415
L +HRDL A N L+ E+ VVK++DFG++R +TG RWMAPE ++
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 416 HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
+ ++DV+SFG++LWE+ T G PY L+ + + ++KG R P + L +L
Sbjct: 181 DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYLRKGYRLPKPEYCPDELYEL 239
Query: 475 LERCWQRDPSLRPDFSEITELLQ 497
+ CWQ DP RP FSE+ E L+
Sbjct: 240 MLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 7e-70
Identities = 75/233 (32%), Positives = 121/233 (51%), Gaps = 9/233 (3%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ VAIKV+ + + ++ R +E+ I++K++H N+V+ +L++V E+ GG
Sbjct: 25 KLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGD 83
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
++D L K+ L + + YLH I+HRDLK N+L++E+G VK+ADFG
Sbjct: 84 LFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFG 142
Query: 389 VARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL 448
+AR +T GT +MAPEV+ + Y D++S G++L+EL+TGK P+ L
Sbjct: 143 LARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQL 202
Query: 449 QAAVGVVQKGLRPTIPVHTHPI---LVDLLERCWQRDPSLRPDFSEITELLQH 498
+ K +P P I DL+ + +DP R E LQH
Sbjct: 203 LELFKKIGKP-KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLT---AEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 3e-69
Identities = 87/261 (33%), Positives = 138/261 (52%), Gaps = 13/261 (4%)
Query: 247 LKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
+ K+ SGS+ +YK + VA+K+L + +E+ I+R++ H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
V+ I A L++V E+ GG ++DYL + L ++A+ + +G+ YLH N I
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLHSNGI 119
Query: 365 IHRDLKAANLLMNENGVVKVADFGVARVQAQ-YGVMTAETGTYRWMAPEVI-EHQPYNHR 422
IHRDLK N+L++ENGVVK+ADFG+A+ + +T GT +MAPEV+ Y +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 423 ADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV-----DLLER 477
DV+S G++L+EL+TGK P+ L + + P DL+++
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 478 CWQRDPSLRPDFSEITELLQH 498
C +DPS RP E+LQH
Sbjct: 240 CLNKDPSKRPT---AEEILQH 257
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 3e-62
Identities = 93/260 (35%), Positives = 142/260 (54%), Gaps = 16/260 (6%)
Query: 246 LLKFEHKIVSGSYCDLYKG--AFFSQDVAIKVL---TNEHLNENIRREFAQEVHIMRKVR 300
L + KI G + ++YK ++VAIKV+ + E + I E+ I++K +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-----EIQILKKCK 55
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H N+V++ G+ + L+IV EF SGGS+ D L L + V ++ KG+ YLH
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYN 420
N IIHRD+KAAN+L+ +G VK+ DFG++ + GT WMAPEVI +PY+
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 421 HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERC 478
++AD++S GI EL GK PY +L P++A + G P + P D L++C
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKC 234
Query: 479 WQRDPSLRPDFSEITELLQH 498
Q++P RP +LL+H
Sbjct: 235 LQKNPEKRPT---AEQLLKH 251
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 5e-61
Identities = 94/262 (35%), Positives = 149/262 (56%), Gaps = 14/262 (5%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
ID S L F ++ SG + ++ G + + DVAIK++ ++E+ +F +E +M K+
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H N+VQ G CT+ +FIVTE+M+ G + +YL ++K L LL + DV + M YL
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVAR--VQAQYGVMTAETGT---YRWMAPEVIE 415
N IHRDL A N L+ E+ VVKV+DFG+AR + QY T+ GT +W PEV +
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFD 174
Query: 416 HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
+ ++ ++DV+SFG+++WE+ + GK+PY+ + + V V G R P + +
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRLYRPKLAPTEVYTI 233
Query: 475 LERCWQRDPSLRPDFSEITELL 496
+ CW P RP F ++ L
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 4e-60
Identities = 76/250 (30%), Positives = 127/250 (50%), Gaps = 42/250 (16%)
Query: 255 SGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312
G + +Y + VAIK++ E + E +E+ I++K+ H N+V+ G
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL-LEELLREIEILKKLNHPNIVKLYGVFE 61
Query: 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
L++V E+ GGS+ D L + + L +LR+ + + +G+ YLH N IIHRDLK
Sbjct: 62 DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121
Query: 373 NLLMNE-NGVVKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVIEHQP-YNHRADVFSFG 429
N+L++ NG VK+ADFG+++ + + ++ GT +MAPEV+ + Y+ ++D++S G
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181
Query: 430 IVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDF 489
++L+EL P L DL+ + Q+DP RP
Sbjct: 182 VILYEL---------------------------------PELKDLIRKMLQKDPEKRPSA 208
Query: 490 SEITELLQHL 499
EI L+HL
Sbjct: 209 KEI---LEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-59
Identities = 86/258 (33%), Positives = 132/258 (51%), Gaps = 16/258 (6%)
Query: 251 HKIVSGSYCDLYKGAFFSQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
+ GS+ +Y +D +A+K + +E +E+ I+ ++H N+V+
Sbjct: 6 ELLGRGSFGSVYLA--LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 307 FIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
+ G+ + L I E++SGGS+ L K L P++ + + +G+ YLH N I
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGI 122
Query: 365 IHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET---GTYRWMAPEVIEHQPYNH 421
+HRD+K AN+L++ +GVVK+ADFG A+ GT WMAPEVI + Y
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182
Query: 422 RADVFSFGIVLWELVTGKLPYDDLTPLQAAVG-VVQKGLRPTIPVHTHPILVDLLERCWQ 480
AD++S G + E+ TGK P+ +L AA+ + G P IP H D L +C +
Sbjct: 183 AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLR 242
Query: 481 RDPSLRPDFSEITELLQH 498
RDP RP ELLQH
Sbjct: 243 RDPKKRP---TADELLQH 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 2e-59
Identities = 97/264 (36%), Positives = 148/264 (56%), Gaps = 15/264 (5%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEID + ++ K+ +G + ++++G + + VA+K L ++ +F E IM+K
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKK 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
+RH ++Q CT ++IVTE M GS+ +YL LKLP L+ +A V+ GM
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPEVI 414
YL N IHRDL A N+L+ EN + KVADFG+ARV + + A G +W APE
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAA 176
Query: 415 EHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473
+ ++ ++DV+SFGI+L E+VT G++PY +T + + V +G R P L D
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYRMPCPPGCPKELYD 235
Query: 474 LLERCWQRDPSLRPDFSEITELLQ 497
++ CW+ DP RP F E LQ
Sbjct: 236 IMLDCWKEDPDDRPTF----ETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 4e-59
Identities = 96/267 (35%), Positives = 159/267 (59%), Gaps = 12/267 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
WE++ + + +HK+ G Y ++Y+G + +S VA+K L + + EF +E +M+
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK 57
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGM 356
+++H N+VQ +G CTR P +I+TEFM+ G++ DYL + + + +LL +A +S M
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPEV 413
YL + N IHRDL A N L+ EN +VKVADFG++R+ TA G +W APE
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 176
Query: 414 IEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV 472
+ + ++ ++DV++FG++LWE+ T G PY + L +++KG R P P +
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGYRMERPEGCPPKVY 235
Query: 473 DLLERCWQRDPSLRPDFSEITELLQHL 499
+L+ CWQ +PS RP F+EI + + +
Sbjct: 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 7e-56
Identities = 99/266 (37%), Positives = 153/266 (57%), Gaps = 15/266 (5%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI LK E K+ +G + +++ G + + VA+K L ++ F QE IM+K
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
+RH +VQ C+ ++IVTE+MS GS+ D+L + L+LP L+ +A +++GM
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGT---YRWMAPE 412
YL N IHRDL A N+L+ EN V K+ADFG+AR+ +Y TA G +W APE
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY---TAREGAKFPIKWTAPE 174
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
+ + ++DV+SFGI+L E+VT G++PY +T + + V++G R P + L
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPEEL 233
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQ 497
DL+ +CW +DP RP F + L+
Sbjct: 234 YDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 1e-55
Identities = 90/267 (33%), Positives = 141/267 (52%), Gaps = 26/267 (9%)
Query: 244 ASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH 301
L K KI G+ ++YK + ++VAIK + L + + E+ IM+ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKH 74
Query: 302 MNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR 361
N+V + + L++V E+M GGS+ D + + + P + V +V +G+ YLH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 362 NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET-------GTYRWMAPEVI 414
N+IHRD+K+ N+L++++G VK+ADFG A AQ +T E GT WMAPEVI
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFA---AQ---LTKEKSKRNSVVGTPYWMAPEVI 188
Query: 415 EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH---PIL 471
+ + Y + D++S GI+ E+ G+ PY PL+A + KG+ P + + P
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLK-NPEKWSPEF 246
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQH 498
D L +C +DP RP ELLQH
Sbjct: 247 KDFLNKCLVKDPEKRPSA---EELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 2e-55
Identities = 92/252 (36%), Positives = 143/252 (56%), Gaps = 9/252 (3%)
Query: 252 KIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
KI G++ D+YKG +VA+K L +++R+F QE I+++ H N+V+ IG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
C + ++IV E + GGS+ +L K+K L + LL++++D + GM YL N IHRDL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 371 AANLLMNENGVVKVADFGVARVQAQYGVMTAETGT----YRWMAPEVIEHQPYNHRADVF 426
A N L+ EN V+K++DFG++R + + G+ T G +W APE + + Y +DV+
Sbjct: 121 ARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 427 SFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485
S+GI+LWE + G PY ++ Q ++ G R P + L+ +CW DP
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTR-ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238
Query: 486 RPDFSEITELLQ 497
RP FSEI LQ
Sbjct: 239 RPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 2e-55
Identities = 95/264 (35%), Positives = 154/264 (58%), Gaps = 12/264 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
W I++ LK I G + D+ G + Q VA+K L + + + F E +M +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLH-KQKCGLKLPLLLRVAIDVSKGMNY 358
RH N+VQ +G + L+IVTE+M+ GS+ DYL + + + L L A+DV +GM Y
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY--RWMAPEVIEH 416
L N +HRDL A N+L++E+ V KV+DFG+A+ +A G ++G +W APE +
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQ---DSGKLPVKWTAPEALRE 173
Query: 417 QPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475
+ ++ ++DV+SFGI+LWE+ + G++PY + PL+ V V+KG R P P + ++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232
Query: 476 ERCWQRDPSLRPDFSEITELLQHL 499
+ CW+ DP+ RP F ++ E L +
Sbjct: 233 KDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 5e-54
Identities = 93/253 (36%), Positives = 142/253 (56%), Gaps = 14/253 (5%)
Query: 252 KIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
I G++ +YKG VAIK ++ E + E + QE+ +++ ++H N+V++IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS---KGMNYLHRNNIIH 366
+ L+I+ E+ GS+ + K P L VA+ V +G+ YLH +IH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFG---PFPESL-VAVYVYQVLQGLAYLHEQGVIH 122
Query: 367 RDLKAANLLMNENGVVKVADFGVA-RVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADV 425
RD+KAAN+L ++GVVK+ADFGVA ++ + GT WMAPEVIE + +D+
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDI 182
Query: 426 FSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485
+S G + EL+TG PY DL P+ A +VQ P +P P L D L +C+Q+DP+L
Sbjct: 183 WSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKDPNL 241
Query: 486 RPDFSEITELLQH 498
RP +LL+H
Sbjct: 242 RPT---AKQLLKH 251
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-51
Identities = 92/265 (34%), Positives = 154/265 (58%), Gaps = 14/265 (5%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
W ++ LK I G + D+ G + VA+K + N+ + F E +M ++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ----AFLAEASVMTQL 56
Query: 300 RHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMN 357
RH N+VQ +G L+IVTE+M+ GS+ DYL + + L LL+ ++DV + M
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY--RWMAPEVIE 415
YL NN +HRDL A N+L++E+ V KV+DFG+ + + T +TG +W APE +
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALR 172
Query: 416 HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
+ ++ ++DV+SFGI+LWE+ + G++PY + PL+ V V+KG + P P++ D+
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPVVYDV 231
Query: 475 LERCWQRDPSLRPDFSEITELLQHL 499
+++CW D + RP F ++ E L+H+
Sbjct: 232 MKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 89/259 (34%), Positives = 147/259 (56%), Gaps = 8/259 (3%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
I+ S L F ++ SG + ++ G + +Q VAIK + ++E +F +E +M K+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H +VQ G CT+ L+IVTEFM G + +YL +++ L +LL + DV +GM YL
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVAR--VQAQYGVMTAETGTYRWMAPEVIEHQP 418
RN+ IHRDL A N L++ GVVKV+DFG+ R + +Y + +W PEV
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 419 YNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477
Y+ ++DV+SFG+++WE+ T GK+P++ + + V ++ +G R P + +++
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-VVEMISRGFRLYRPKLASMTVYEVMYS 236
Query: 478 CWQRDPSLRPDFSEITELL 496
CW P RP F+E+ +
Sbjct: 237 CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 88/257 (34%), Positives = 136/257 (52%), Gaps = 20/257 (7%)
Query: 253 IVSGSYCDLY------KGAFFSQDVAIK---VLTNEHLNENIRREFAQEVHIMRKVRHMN 303
+ SGS+ +Y G FF A+K + + + ++ QE+ ++ K++H N
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFF----AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRN 362
+VQ++G L+I E + GGS+ L +K G P++ + G+ YLH
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 363 NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ-PYNH 421
N +HRD+K AN+L++ NGVVK+ADFG+A+ ++ + G+ WMAPEVI Q Y
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181
Query: 422 RADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481
AD++S G + E+ TGK P+ L + A + + P IP H D + +C QR
Sbjct: 182 AADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQR 241
Query: 482 DPSLRPDFSEITELLQH 498
DPSLRP ELL+H
Sbjct: 242 DPSLRP---TAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 91/256 (35%), Positives = 132/256 (51%), Gaps = 21/256 (8%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
K+ GSY +YK Q VAIKV+ E + I +E + I+++ +V++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI--DVSKGMNYLHRNNIIHR 367
+ + L+IV E+ GS+ D + + L AI KG+ YLH N IHR
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR 123
Query: 368 DLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADV 425
D+KA N+L+NE G K+ADFGV+ Q + T GT WMAPEVI+ YN++AD+
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADI 182
Query: 426 FSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK---GLRPTIPVHTHPILVDLLERCWQRD 482
+S GI E+ GK PY D+ P++A + K L P P D +++C +D
Sbjct: 183 WSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS--DPEKWSPEFNDFVKKCLVKD 240
Query: 483 PSLRPDFSEITELLQH 498
P RP +LLQH
Sbjct: 241 PEERP---SAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 71/232 (30%), Positives = 130/232 (56%), Gaps = 10/232 (4%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
+K + +++E R + EV I++K+ H N++++ + +L IV E+ GG +
Sbjct: 28 YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLS 87
Query: 331 DYLHKQKCGLKL---PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
+ KQK K +L + + + YLH I+HRD+K N+ + NG+VK+ DF
Sbjct: 88 QKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDF 147
Query: 388 GVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL 445
G+++V + + A+T GT +++PE+ +++PYN+++D++S G VL+EL T K P++
Sbjct: 148 GISKVLSSTVDL-AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206
Query: 446 TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
L+ A+ +++ P IP L +L+ Q+DP RP I ++LQ
Sbjct: 207 NLLELALKILKGQYPP-IPSQYSSELRNLVSSLLQKDPEERPS---IAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 89/268 (33%), Positives = 141/268 (52%), Gaps = 13/268 (4%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIM 296
ID S + E I G + ++ +G DVAIK L ++ R +F E IM
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIM 59
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+ H N+++ G T+ + I+TE+M GS+ +L + + L+ + ++ GM
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV----QAQYGVMTAETGTYRWMAPE 412
YL N +HRDL A N+L+N N V KV+DFG++R +A Y + RW APE
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI-PIRWTAPE 178
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
I ++ + +DV+SFGIV+WE+++ G+ PY D++ Q + V+ G R P+ L
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSAL 237
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQHL 499
L+ CWQ+D + RP FS+I L +
Sbjct: 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 3e-50
Identities = 91/269 (33%), Positives = 137/269 (50%), Gaps = 33/269 (12%)
Query: 245 SLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM 302
L I GS+ ++YK Q VAIKV+ E + I + QE+ + + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSP 59
Query: 303 NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP-----LLLRVAIDVSKGMN 357
+ ++ G+ + +L+I+ E+ GGS D L K G KL +LR +V G+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPG-KLDETYIAFILR---EVLLGLE 112
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET-------GTYRWMA 410
YLH IHRD+KAAN+L++E G VK+ADFGV+ G +T+ GT WMA
Sbjct: 113 YLHEEGKIHRDIKAANILLSEEGDVKLADFGVS------GQLTSTMSKRNTFVGTPFWMA 166
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH-P 469
PEVI+ Y+ +AD++S GI EL G+ P DL P++ + ++ K P++ +
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-VLFLIPKNNPPSLEGNKFSK 225
Query: 470 ILVDLLERCWQRDPSLRPDFSEITELLQH 498
D + C +DP RP ELL+H
Sbjct: 226 PFKDFVSLCLNKDPKERP---SAKELLKH 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 3e-50
Identities = 81/261 (31%), Positives = 143/261 (54%), Gaps = 7/261 (2%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WE E K+ SG + ++++G + VAIK+L ++ + +++F +EV +++
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMN 357
+RH +++ C+ ++I+TE M GS+ +L + L + L+ +A V++GM
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT-YRWMAPEVIEH 416
YL N IHRDL A N+L+ E+ V KVADFG+AR+ + ++++ Y+W APE H
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178
Query: 417 QPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475
++ ++DV+SFGI+L+E+ T G++PY + + G R P + ++
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIYKIM 237
Query: 476 ERCWQRDPSLRPDFSEITELL 496
CW +P RP F + E L
Sbjct: 238 LECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 96/266 (36%), Positives = 145/266 (54%), Gaps = 17/266 (6%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD-VAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
I S L +I SG + ++ G + + VAIK + ++E +F +E +M K+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLS 57
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H +VQ G CT + +V EFM G + DYL Q+ LL + +DV +GM YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVAR--VQAQYGVMTAETGT---YRWMAPEVIE 415
+N+IHRDL A N L+ EN VVKV+DFG+ R + QY T+ TGT +W +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY---TSSTGTKFPVKWSSPEVFS 174
Query: 416 HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
Y+ ++DV+SFG+++WE+ + GK PY++ + + V + G R P + +L
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-VVETINAGFRLYKPRLASQSVYEL 233
Query: 475 LERCWQRDPSLRPDFSEITELLQHLA 500
++ CW+ P RP FS LL LA
Sbjct: 234 MQHCWKERPEDRPSFS---LLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-49
Identities = 83/283 (29%), Positives = 141/283 (49%), Gaps = 32/283 (11%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKG---AFFSQD----VAIKVLTNEHLNENIRREFAQE 292
WE+ + ++ GS+ +Y+G + VAIK + NE+ + R EF E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-NENASMRERIEFLNE 59
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK------CGLKLP--- 343
+M++ +VV+ +G + +V E M+ G + YL ++ GL P
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR--VQAQY----- 396
+++A +++ GM YL +HRDL A N ++ E+ VK+ DFG+ R + Y
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
Query: 397 -GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGV 454
G++ RWMAPE ++ + ++DV+SFG+VLWE+ T + PY L+ + V
Sbjct: 180 KGLLPV-----RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234
Query: 455 VQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
+ G +P + L++L+ CWQ +P +RP F EI L+
Sbjct: 235 IDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 7e-49
Identities = 88/246 (35%), Positives = 142/246 (57%), Gaps = 8/246 (3%)
Query: 256 GSYCDLYKGAFFSQD-VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314
G++ +++KG + VA+K E L + ++ +F E I+++ H N+V+ IG CT+
Sbjct: 6 GNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR 64
Query: 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
++IV E + GG +L K+K LK L++ A+D + GM YL N IHRDL A N
Sbjct: 65 QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNC 124
Query: 375 LMNENGVVKVADFGVARVQAQYGVMTA---ETGTYRWMAPEVIEHQPYNHRADVFSFGIV 431
L+ EN V+K++DFG++R Q G+ ++ + +W APE + + Y+ +DV+S+GI+
Sbjct: 125 LVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGIL 183
Query: 432 LWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
LWE + G PY +T Q A V+KG R + P + +++RCW P RP FS
Sbjct: 184 LWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFS 242
Query: 491 EITELL 496
E+ + L
Sbjct: 243 ELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 86/258 (33%), Positives = 142/258 (55%), Gaps = 14/258 (5%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
ID L F ++ +G + + G + Q DVAIK++ ++E+ EF +E +M K+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H +VQ G CT+ ++IVTE+MS G + +YL + + LL + DV +GM YL
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVAR--VQAQYGVMTAETGT---YRWMAPEVIE 415
IHRDL A N L+++ G VKV+DFG++R + +Y T+ G+ RW PEV+
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLL 174
Query: 416 HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
+ ++ ++DV++FG+++WE+ + GK+PY+ + V Q GLR P + +
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAI 233
Query: 475 LERCWQRDPSLRPDFSEI 492
+ CW RP F ++
Sbjct: 234 MYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 86/241 (35%), Positives = 126/241 (52%), Gaps = 18/241 (7%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VAIK + E ++ E +EV M + H NVV++ + L++V ++SGGS+
Sbjct: 29 VAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87
Query: 331 DYL-HKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
D + G L ++ V +V KG+ YLH N IHRD+KA N+L+ E+G VK+ADFG
Sbjct: 88 DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFG 147
Query: 389 VARVQAQYGVMTAET-----GTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPY 442
V+ A G T + GT WMAPEV+E Y+ +AD++SFGI EL TG PY
Sbjct: 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207
Query: 443 DDLTPLQAAVGVVQKGLRPTIPVHTHP-----ILVDLLERCWQRDPSLRPDFSEITELLQ 497
P++ + +Q P++ ++ C Q+DPS RP ELL+
Sbjct: 208 SKYPPMKVLMLTLQND-PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAE---ELLK 263
Query: 498 H 498
H
Sbjct: 264 H 264
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 83/260 (31%), Positives = 150/260 (57%), Gaps = 10/260 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
W ++ L I G + + +G + Q VA+K + + + F +E +M K+
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQ----AFLEETAVMTKL 56
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNY 358
H N+V+ +G L+IV E MS G++ ++L + + + + LL+ ++DV++GM Y
Sbjct: 57 HHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQP 418
L ++HRDL A N+L++E+GV KV+DFG+ARV + GV ++ +W APE ++H+
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-GVDNSKLPV-KWTAPEALKHKK 173
Query: 419 YNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477
++ ++DV+S+G++LWE+ + G+ PY ++ L+ V+KG R P + L+
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYVLMTS 232
Query: 478 CWQRDPSLRPDFSEITELLQ 497
CW+ +P RP F ++ E L+
Sbjct: 233 CWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-46
Identities = 78/233 (33%), Positives = 123/233 (52%), Gaps = 10/233 (4%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+K + + +E R++ +E+ +R VV+ GA + + IV E+M GGS+
Sbjct: 29 YALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLA 87
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGV 389
D L K+ + P+L +A + KG++YLH +IIHRD+K +NLL+N G VK+ADFG+
Sbjct: 88 D-LLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGI 146
Query: 390 ARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL 448
++V GT +M+PE I+ + Y++ AD++S G+ L E GK P+
Sbjct: 147 SKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP 206
Query: 449 Q--AAVGVVQKGLRPTIPVHTH-PILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ + G P++P P D + C Q+DP RP ELLQH
Sbjct: 207 SFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPS---AAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 7e-46
Identities = 92/263 (34%), Positives = 149/263 (56%), Gaps = 10/263 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI L+ K+ +G + +++ G + + VA+K L ++ F +E IM+K
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKK 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMN 357
+RH +VQ + P ++IVTE+MS GS+ D+L + LKLP L+ +A V+ GM
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWMAPEVIE 415
Y+ R N IHRDL++AN+L+ + V K+ADFG+AR+ +Y +W APE
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 416 HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
+ + ++DV+SFGI+L ELVT G++PY + + + V++G R P L +L
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHEL 235
Query: 475 LERCWQRDPSLRPDFSEITELLQ 497
+ +CW++DP RP F + L+
Sbjct: 236 MLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 9e-46
Identities = 88/265 (33%), Positives = 135/265 (50%), Gaps = 22/265 (8%)
Query: 248 KFE--HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
+E +I SG+Y D+YK + VAIKV+ E ++ QE+ ++++ RH N
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD--FEIIQQEISMLKECRHPN 61
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363
+V + G+ R +L+IV E+ GGS+ D + L + V + KG+ YLH
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 364 IIHRDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETGTYRWMAPEVIE---HQPY 419
IHRD+K AN+L+ E+G VK+ADFGV A++ A + GT WMAPEV Y
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 420 NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH------PILVD 473
+ + D+++ GI EL + P DL P++A + P P+ D
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFDLHPMRA---LFLISKSNFPPPKLKDKEKWSPVFHD 238
Query: 474 LLERCWQRDPSLRPDFSEITELLQH 498
+++C +DP RP T+LLQH
Sbjct: 239 FIKKCLTKDPKKRPT---ATKLLQH 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 85/270 (31%), Positives = 137/270 (50%), Gaps = 11/270 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVH 294
+EI + I G + D+Y+G + S + VA+K N + ++R +F QE +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAY 59
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
IMR+ H ++V+ IG T P ++IV E G + YL K L L L+ + +S
Sbjct: 60 IMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY--RWMAPE 412
+ YL +HRD+ A N+L++ VK+ DFG++R A G +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 413 VIEHQPYNHRADVFSFGIVLWE-LVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
I + + +DV+ FG+ +WE L+ G P+ + +G ++ G R +P + P L
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTL 237
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
L+ +CW DPS RP F+E+ L + Q
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 83/256 (32%), Positives = 134/256 (52%), Gaps = 13/256 (5%)
Query: 255 SGSYCDLYKGAFFSQ------DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
SG++ +YKG + + VAIKVL E + + E E ++M V H +VV+ +
Sbjct: 17 SGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-EILDEAYVMASVDHPHVVRLL 75
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G C ++ ++T+ M G + DY+ K + LL + ++KGM+YL ++HRD
Sbjct: 76 GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134
Query: 369 LKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGTY--RWMAPEVIEHQPYNHRADV 425
L A N+L+ VK+ DFG+A+ + AE G +WMA E I H+ Y H++DV
Sbjct: 135 LAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDV 194
Query: 426 FSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPS 484
+S+G+ +WEL+T G PY+ + P +++KG R P + +L +CW D
Sbjct: 195 WSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAE 253
Query: 485 LRPDFSEITELLQHLA 500
RP F E+ +A
Sbjct: 254 SRPTFKELINEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 83/252 (32%), Positives = 143/252 (56%), Gaps = 8/252 (3%)
Query: 252 KIVSGSYCDLYKGAFFSQDVAIKVLT-NEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
+I G++ +++ G + + + V + E L +++ +F QE I+++ H N+V+ IG
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
CT+ ++IV E + GG +L + LK+ L+++ + + GM YL + IHRDL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121
Query: 371 AANLLMNENGVVKVADFGVARVQAQYGVMTAETGT----YRWMAPEVIEHQPYNHRADVF 426
A N L+ E V+K++DFG++R + GV + G +W APE + + Y+ +DV+
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEED-GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVW 180
Query: 427 SFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485
SFGI+LWE + G +PY +L+ Q +++G+R P + L+ERCW+ DP
Sbjct: 181 SFGILLWEAFSLGAVPYANLSN-QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239
Query: 486 RPDFSEITELLQ 497
RP FS + + LQ
Sbjct: 240 RPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 159 bits (402), Expect = 4e-45
Identities = 94/263 (35%), Positives = 149/263 (56%), Gaps = 10/263 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI L+ E K+ G + +++ G + + VAIK L ++ F QE +M+K
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
+RH +VQ + P ++IVTE+MS GS+ D+L + L+LP L+ +A ++ GM
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWMAPEVIE 415
Y+ R N +HRDL+AAN+L+ EN V KVADFG+AR+ +Y +W APE
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 416 HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
+ + ++DV+SFGI+L EL T G++PY + + + V++G R P L DL
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPESLHDL 235
Query: 475 LERCWQRDPSLRPDFSEITELLQ 497
+ +CW+++P RP F + L+
Sbjct: 236 MCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 8e-45
Identities = 73/237 (30%), Positives = 122/237 (51%), Gaps = 11/237 (4%)
Query: 269 QDVAIKVLTNEHLNENIRRE---FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
+++A+K + + + ++E E+ +++ ++H +VQ+ G L I E+M
Sbjct: 28 RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMP 87
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVA 385
GGS+ D L K L + + + +G+ YLH N I+HRD+K AN+L + G VK+
Sbjct: 88 GGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLG 146
Query: 386 DFGVA-RVQA---QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
DFG + R+Q M + TGT WM+PEVI + Y +ADV+S G + E++T K P
Sbjct: 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
Query: 442 YDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ + + A + + P +P H P + L R + + RP ELL+H
Sbjct: 207 WAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRP---SAEELLRH 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 1e-44
Identities = 89/267 (33%), Positives = 154/267 (57%), Gaps = 18/267 (6%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WE+ LK K+ +G + +++ G + VAIK L ++ F E ++M++
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL--LLRVAIDVSKGM 356
++H +V+ T+ P ++I+TE+M GS+ D+L K G+KL + L+ +A +++GM
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGM 115
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGT---YRWMAP 411
++ R N IHRDL+AAN+L++E K+ADFG+AR+ +Y TA G +W AP
Sbjct: 116 AFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 172
Query: 412 EVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470
E I + + ++DV+SFGI+L E+VT G++PY +T + + +++G R P +
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQNLERGYRMPRPDNCPEE 231
Query: 471 LVDLLERCWQRDPSLRPDFSEITELLQ 497
L +L+ CW+ P RP F + +L+
Sbjct: 232 LYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 97/264 (36%), Positives = 149/264 (56%), Gaps = 12/264 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI L+ + K+ G + +++ G + + VAIK L + F QE IM+K
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP---EAFLQEAQIMKK 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG--LKLPLLLRVAIDVSKGM 356
+RH +V + P ++IVTEFM GS+ D+L K+ G LKLP L+ +A ++ GM
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGM 115
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWMAPEVI 414
Y+ R N IHRDL+AAN+L+ +N V K+ADFG+AR+ +Y +W APE
Sbjct: 116 AYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 415 EHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473
+ + ++DV+SFGI+L ELVT G++PY + + + V++G R P L +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRMPCPQGCPESLHE 234
Query: 474 LLERCWQRDPSLRPDFSEITELLQ 497
L++ CW++DP RP F I L+
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 7e-44
Identities = 84/262 (32%), Positives = 149/262 (56%), Gaps = 9/262 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI +K K+ +G + +++ G + S VA+K L ++ + F +E ++M+
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKT 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
++H +V+ T+ ++I+TE+M+ GS+ D+L + G + LP L+ + +++GM
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWMAPEVIE 415
Y+ R N IHRDL+AAN+L++E+ + K+ADFG+ARV +Y +W APE I
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177
Query: 416 HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
+ ++DV+SFGI+L+E+VT GK+PY ++ +Q+G R + L D+
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPRMENCPDELYDI 236
Query: 475 LERCWQRDPSLRPDFSEITELL 496
++ CW+ RP F + +L
Sbjct: 237 MKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 3e-43
Identities = 73/232 (31%), Positives = 121/232 (52%), Gaps = 8/232 (3%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K L ++ L++ + +F +E IM + H N+++ G P L +VTE GS+
Sbjct: 26 VAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLL 83
Query: 331 DYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
D L K G + L A+ ++ GM YL IHRDL A N+L+ + VK+ DFG+
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGL 143
Query: 390 AR---VQAQYGVMTAETGT-YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDD 444
R + VM + W APE + + ++H +DV+ FG+ LWE+ T G+ P+
Sbjct: 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203
Query: 445 LTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELL 496
L+ Q + ++G R P + +++ +CW +P+ RP F+ + E L
Sbjct: 204 LSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 6e-43
Identities = 93/271 (34%), Positives = 144/271 (53%), Gaps = 18/271 (6%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVHIM 296
IDAS +K E I +G + ++ G VAIK L + E RR+F E IM
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIM 59
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+ H N++ G T+ + IVTE+M GS+ +L K + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV-----QAQYGVMTAETGT--YRWM 409
YL +HRDL A N+L+N N V KV+DFG++RV +A Y T G RW
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY---TTRGGKIPIRWT 176
Query: 410 APEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468
APE I ++ + +DV+S+GIV+WE+++ G+ PY +++ Q + +++G R P+
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCP 235
Query: 469 PILVDLLERCWQRDPSLRPDFSEITELLQHL 499
L L+ CWQ+D + RP F +I +L L
Sbjct: 236 AALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 86/274 (31%), Positives = 141/274 (51%), Gaps = 22/274 (8%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHIM 296
ID S +K E I +G + ++ +G VAIK L + + E RR+F E IM
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIM 59
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+ H N++ G T+ + I+TEFM G++ +L + + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY------RWMA 410
YL N +HRDL A N+L+N N V KV+DFG++R T + RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR----PTIPV 465
PE I ++ + +DV+S+GIV+WE+++ G+ PY D++ Q + +++ R P
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPT 238
Query: 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
H +++D CWQ+D + RP F +I L +
Sbjct: 239 ALHQLMLD----CWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 4e-42
Identities = 85/275 (30%), Positives = 139/275 (50%), Gaps = 16/275 (5%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVL-TNEHLNENIRREFAQ 291
WE + L F + +G++ + + + VA+K+L H +E R
Sbjct: 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE--REALMS 87
Query: 292 EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVA 349
E+ IM + H N+V +GACT + ++TE+ G + ++L +++ L L LL +
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR---VQAQYGVMTAETGTY 406
V+KGM +L N IHRDL A N+L+ +VK+ DFG+AR + Y V
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPV 465
+WMAPE I + Y +DV+S+GI+LWE+ + G PY + ++++G R P
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267
Query: 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500
H + D+++ CW DP RP F +I +L+
Sbjct: 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 6e-42
Identities = 76/243 (31%), Positives = 122/243 (50%), Gaps = 23/243 (9%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ +A+K + E +NE I+++ +E+ I+ K +V F GA + I E+M GG
Sbjct: 26 GKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVAD 386
S+ L + + + +L ++A+ V KG+ YLH IIHRD+K +N+L+N G +K+ D
Sbjct: 85 SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCD 144
Query: 387 FGVARVQAQYGVMT-----AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
FGV+ G + GT +MAPE I+ Y+ ++D++S G+ L EL TG+ P
Sbjct: 145 FGVS------GQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
Query: 442 Y-----DDLTPLQAAVGVVQKGLRPTIPVHTH-PILVDLLERCWQRDPSLRPDFSEITEL 495
Y + +V P +P P D + C +DP RP EL
Sbjct: 199 YPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQDFVNLCLIKDPRERPS---YKEL 254
Query: 496 LQH 498
L+H
Sbjct: 255 LEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 6e-42
Identities = 71/232 (30%), Positives = 120/232 (51%), Gaps = 9/232 (3%)
Query: 270 DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
+VA+K L EH+ ++EF +E +M ++ H +V+ IG C P L +V E G +
Sbjct: 25 EVAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPL 82
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
YL K++ + + L +A V+ GM YL + +HRDL A N+L+ K++DFG+
Sbjct: 83 LKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM 141
Query: 390 AR-VQAQYGVMTAETG---TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDD 444
+R + A A T +W APE I + ++ ++DV+S+G+ LWE + G PY +
Sbjct: 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201
Query: 445 LTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELL 496
+ + +++ G R P + ++ CW+ P RP FSE+
Sbjct: 202 MKG-AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 9e-42
Identities = 86/272 (31%), Positives = 140/272 (51%), Gaps = 23/272 (8%)
Query: 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDV--AIKVLTNEHLNENIRREFAQEVH 294
D+WEI L G++ +YK + A K++ E +E +F E+
Sbjct: 4 NDIWEIIGEL-------GDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEID 54
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
I+ + +H N+V A +L+I+ EF GG++ + + + GL P + V + +
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETGTYRWMAPEV 413
+N+LH + +IHRDLKA N+L+ +G VK+ADFGV A+ ++ GT WMAPEV
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174
Query: 414 I-----EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVH 466
+ + PY+++AD++S GI L EL + P+ +L P++ + + K PT+ P
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK-ILKSEPPTLDQPSK 233
Query: 467 THPILVDLLERCWQRDPSLRPDFSEITELLQH 498
D L+ C +DP RP ELL+H
Sbjct: 234 WSSSFNDFLKSCLVKDPDDRP---TAAELLKH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 81/286 (28%), Positives = 135/286 (47%), Gaps = 39/286 (13%)
Query: 247 LKFEHKIVSGSYCDLYKGAF-FSQD-----VAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
LKF ++ G + + + D VA+K L N E R +F +E+ I+R +
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLD 64
Query: 301 HMNVVQFIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNY 358
H N+V++ G C +P L ++ E++ GS+ DYL + + + L LL + + KGM+Y
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ----YGVMTAETGTYRWMAPEVI 414
L IHRDL A N+L+ +VK++DFG+A+V + Y V W APE +
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 415 EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
++ +DV+SFG+ L+EL T Y D P Q+ + + L++L
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT----YGD--PSQSPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 475 LE--------------------RCWQRDPSLRPDFSEITELLQHLA 500
L+ CW+ +P RP F+++ ++ L
Sbjct: 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-40
Identities = 84/285 (29%), Positives = 140/285 (49%), Gaps = 29/285 (10%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFAQ 291
WE+ L + G++ + K D VA+K+L + E +
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS 64
Query: 292 EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-----QKCG------ 339
E+ +M+ + +H N++ +G CT+ L++V E+ + G++ D+L +
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 340 ----LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR---V 392
L L+ A V++GM +L IHRDL A N+L+ E+ V+K+ADFG+AR
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 393 QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAA 451
Y T +WMAPE + + Y H++DV+SFG++LWE+ T G PY + P++
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEEL 243
Query: 452 VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELL 496
++++G R P + L L+ CW PS RP F ++ E L
Sbjct: 244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 89/266 (33%), Positives = 135/266 (50%), Gaps = 25/266 (9%)
Query: 255 SGSYCDLYKGAFFSQD--------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
SG++ ++Y+G VA+K L ++ ++EF +E H+M H N+V+
Sbjct: 5 SGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHPNIVK 63
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC------GLKLPLLLRVAIDVSKGMNYLH 360
+G C +I+ E M GG + YL + L L LL + +DV+KG YL
Sbjct: 64 LLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123
Query: 361 RNNIIHRDLKAANLLMNENG-----VVKVADFGVAR---VQAQYGVMTAETGTYRWMAPE 412
+ + IHRDL A N L++E G VVK+ DFG+AR Y RWMAPE
Sbjct: 124 QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPE 183
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
+ + ++DV+SFG+++WE++T G+ PY L + + V G R P + +
Sbjct: 184 SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAGGRLQKPENCPDKI 242
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQ 497
L+ CW +DPS RP F I E+LQ
Sbjct: 243 YQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-39
Identities = 87/269 (32%), Positives = 138/269 (51%), Gaps = 12/269 (4%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
EI S + + I +G + ++++G VAIK L + E R++F E I
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASI 59
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
M + H N+++ G T+ I+TE+M G++ YL L+ + ++ G
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY--GVMTAETGT--YRWMAP 411
M YL N +HRDL A N+L+N N KV+DFG++RV G T G RW AP
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 412 EVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470
E I ++ + +DV+SFGIV+WE+++ G+ PY D++ + + G R P+
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPSA 238
Query: 471 LVDLLERCWQRDPSLRPDFSEITELLQHL 499
+ L+ +CWQ+D + RP F +I LL L
Sbjct: 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 91/277 (32%), Positives = 144/277 (51%), Gaps = 25/277 (9%)
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVHIMRKV-R 300
+KFE I G++ + + A +D AIK+L E +EN R+FA E+ ++ K+
Sbjct: 4 IKFEDVIGEGNFGQVIR-AMIKKDGLKMNAAIKML-KEFASENDHRDFAGELEVLCKLGH 61
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC---------------GLKLPLL 345
H N++ +GAC L+I E+ G++ D+L K + L L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 346 LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT 405
L+ A DV+ GM YL IHRDL A N+L+ EN K+ADFG++R + Y T
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIP 464
RWMA E + + Y ++DV+SFG++LWE+V+ G PY +T + + Q G R P
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRMEKP 240
Query: 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+ + +L+ +CW+ P RP F++I+ L + +
Sbjct: 241 RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 5e-39
Identities = 83/263 (31%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI LK E K+ +G + +++ + VA+K + ++ F E ++M+
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
++H +V+ T+ P ++I+TEFM+ GS+ D+L + LP L+ + +++GM
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWMAPEVIE 415
++ + N IHRDL+AAN+L++ + V K+ADFG+ARV +Y +W APE I
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 416 HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
+ ++DV+SFGI+L E+VT G++PY ++ + + +++G R P + L ++
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNI 235
Query: 475 LERCWQRDPSLRPDFSEITELLQ 497
+ RCW+ P RP F I +L
Sbjct: 236 MMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 6e-39
Identities = 73/255 (28%), Positives = 129/255 (50%), Gaps = 18/255 (7%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI GS+ ++K + + A+K + +N R E E ++ K+ ++++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHR 367
+ +L IV E+ G ++ L Q+ G LP + R I + G+ +LH I+HR
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 368 DLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADV 425
D+K+ NL ++ VK+ D GVA++ + A T GT +++PE+ E +PYN ++DV
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDV 184
Query: 426 FSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR---PTIPVHTHPILVDLLERCWQRD 482
++ G+VL+E TGK P+D ++ K +R P + L L+++C +D
Sbjct: 185 WALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 483 PSLRPDFSEITELLQ 497
RPD +LL+
Sbjct: 241 YRQRPD---TFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 89/285 (31%), Positives = 149/285 (52%), Gaps = 23/285 (8%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
++ + +KF+ I G++ + K D AIK + E+ +++ R+FA E+ ++
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLC 62
Query: 298 KV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC---------------GLK 341
K+ H N++ +GAC L++ E+ G++ D+L K + L
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 342 LPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401
LL A DV++GM+YL + IHRDL A N+L+ EN V K+ADFG++R Q Y T
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182
Query: 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR 460
RWMA E + + Y +DV+S+G++LWE+V+ G PY +T + + Q G R
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 241
Query: 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505
P++ + DL+ +CW+ P RP F++I L + + +T
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-38
Identities = 81/260 (31%), Positives = 132/260 (50%), Gaps = 27/260 (10%)
Query: 261 LYKGAFFS---------QDVAIKVL----TNEHLNENIRREFAQEVHIMRKVRHMNVVQF 307
L KGA+ + Q +A+K + +N E + +EV +++ ++H+N+VQ+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
+G C + I EF+ GGSI L + L P+ + + G+ YLH N ++HR
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 368 DLKAANLLMNENGVVKVADFGVARVQAQYG-------VMTAETGTYRWMAPEVIEHQPYN 420
D+K N+++ NG++K+ DFG AR A G ++ + GT WMAPEVI Y
Sbjct: 127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG 186
Query: 421 HRADVFSFGIVLWELVTGKLPYDDLTPLQA--AVGVVQKGLRPTIPVHTHPILVDLLERC 478
++D++S G ++E+ TGK P + L A +G +GL P +P +D + C
Sbjct: 187 RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAAAIDFVTSC 245
Query: 479 WQRDPSLRPDFSEITELLQH 498
RD RP +LL+H
Sbjct: 246 LTRDQHERP---SALQLLRH 262
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 12/265 (4%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
E+D +K E + +G + +L +G VAI L ++ RR F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALT 59
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
+ + H N+V+ G TR + IVTE+MS G++ +L K + L L+ + ++ G
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA---RVQAQYGVMTAETGTYRWMAPE 412
M YL +H+ L A +L+N + V K++ F + +A Y M+ ++ W APE
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-WAAPE 178
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
I++ ++ +DV+SFGIV+WE+++ G+ PY D++ Q + V+ G R P + +L
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLL 237
Query: 472 VDLLERCWQRDPSLRPDFSEITELL 496
L+ CWQ++ RP FS+I +L
Sbjct: 238 HQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 9e-38
Identities = 88/261 (33%), Positives = 143/261 (54%), Gaps = 15/261 (5%)
Query: 255 SGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
SG++ +YKG + + VAIK+L NE EF E IM + H ++V+ +
Sbjct: 17 SGAFGTVYKGIWVPEGETVKIPVAIKIL-NETTGPKANVEFMDEALIMASMDHPHLVRLL 75
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G C P + +VT+ M G + DY+H+ K + LLL + ++KGM YL ++HRD
Sbjct: 76 GVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRD 134
Query: 369 LKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGTY--RWMAPEVIEHQPYNHRADV 425
L A N+L+ VK+ DFG+AR ++ A+ G +WMA E I ++ + H++DV
Sbjct: 135 LAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDV 194
Query: 426 FSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR-PTIPVHTHPILVDLLERCWQRDP 483
+S+G+ +WEL+T G PYD + P + +++KG R P P+ T + + ++ +CW D
Sbjct: 195 WSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYM-VMVKCWMIDA 252
Query: 484 SLRPDFSEITELLQHLAQRLQ 504
RP F E+ +A+ Q
Sbjct: 253 DSRPKFKELAAEFSRMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 80/262 (30%), Positives = 132/262 (50%), Gaps = 20/262 (7%)
Query: 251 HKIVSGSYCDLYKGAFFSQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
+KI G++ +Y + D +A+K + + + +E A E+ ++ ++H N+V+
Sbjct: 6 NKIGGGTFGKVYTA--VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+ G +++I E+ SGG++ + L + L ++ + + +G+ YLH + I+H
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 367 RDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE-----TGTYRWMAPEVIEHQPYNH 421
RD+K AN+ ++ NGV+K+ DFG A E GT +MAPEVI
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 422 R---ADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH--PILVDLLE 476
AD++S G V+ E+ TGK P+ +L + V G +P IP P D L+
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLD 242
Query: 477 RCWQRDPSLRPDFSEITELLQH 498
RC + DP RP S ELLQH
Sbjct: 243 RCLESDPKKRPTAS---ELLQH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 76/250 (30%), Positives = 132/250 (52%), Gaps = 10/250 (4%)
Query: 256 GSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313
GSY +YK S Q A+K + +++ R + E+ I+ V H N++ + A
Sbjct: 11 GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKL---PLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
+L IV E+ G + + K+K KL + R+ I + +G+ LH I+HRDLK
Sbjct: 71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLK 130
Query: 371 AANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGI 430
+AN+L+ N +VK+ D G+++V + + + GT +MAPEV + +PY++++D++S G
Sbjct: 131 SANILLVANDLVKIGDLGISKVLKK-NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGC 189
Query: 431 VLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
+L+E+ T P++ + +Q VQ+G P IP L + + Q P LRP+
Sbjct: 190 LLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPN-- 246
Query: 491 EITELLQHLA 500
++L A
Sbjct: 247 -CDKILASPA 255
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 87/270 (32%), Positives = 143/270 (52%), Gaps = 16/270 (5%)
Query: 255 SGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
SG++ +YKG + + VAIK L E + +E E ++M V + +V + +
Sbjct: 17 SGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLL 75
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G C + ++T+ M G + DY+ + K + LL + ++KGMNYL ++HRD
Sbjct: 76 GICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRD 134
Query: 369 LKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGTY--RWMAPEVIEHQPYNHRADV 425
L A N+L+ VK+ DFG+A+ + A AE G +WMA E I H+ Y H++DV
Sbjct: 135 LAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 194
Query: 426 FSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR-PTIPVHTHPILVDLLERCWQRDP 483
+S+G+ +WEL+T G PYD + P +++KG R P P+ T + + ++ +CW D
Sbjct: 195 WSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMV-KCWMIDA 252
Query: 484 SLRPDFSEITELLQHLAQRLQTKRGLAQGN 513
RP F E+ +A R + + QG+
Sbjct: 253 DSRPKFRELIIEFSKMA-RDPQRYLVIQGD 281
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 83/250 (33%), Positives = 135/250 (54%), Gaps = 10/250 (4%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
+I GS+ ++YKG + VAIK++ E + I + QE+ ++ + + ++ G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYYG 69
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+ + +L+I+ E++ GGS D L + L+ + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 370 KAANLLMNENGVVKVADFGVARVQAQYGVM-TAETGTYRWMAPEVIEHQPYNHRADVFSF 428
KAAN+L++E G VK+ADFGVA + GT WMAPEVI+ Y+ +AD++S
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187
Query: 429 GIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPD 488
GI EL G+ P DL P++ ++ K PT+ + +E C +DP RP
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLF-LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP- 245
Query: 489 FSEITELLQH 498
ELL+H
Sbjct: 246 --TAKELLKH 253
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-36
Identities = 82/240 (34%), Positives = 131/240 (54%), Gaps = 19/240 (7%)
Query: 270 DVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
D AIK + E+ +++ R+FA E+ ++ K+ H N++ +GAC L++ E+ G+
Sbjct: 24 DAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 82
Query: 329 IYDYLHKQKC---------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
+ D+L K + L LL A DV++GM+YL + IHRDL A N
Sbjct: 83 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 142
Query: 374 LLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
+L+ EN V K+ADFG++R Q Y T RWMA E + + Y +DV+S+G++LW
Sbjct: 143 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202
Query: 434 ELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
E+V+ G PY +T + + Q G R P++ + DL+ +CW+ P RP F++I
Sbjct: 203 EIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 81/245 (33%), Positives = 125/245 (51%), Gaps = 21/245 (8%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K L N+ R++F +E ++ +H N+V+F G CT +V E+M G +
Sbjct: 38 VAVKTLKETASND-ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLN 96
Query: 331 DYLH------------KQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
+L G L L LL++A+ ++ GM YL + +HRDL N L+
Sbjct: 97 KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156
Query: 378 ENGVVKVADFGVAR---VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWE 434
+ VVK+ DFG++R Y V RWM PE I ++ + +DV+SFG+VLWE
Sbjct: 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216
Query: 435 LVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV-DLLERCWQRDPSLRPDFSEI 492
+ T GK P+ L+ + + + +G R T P V D++ CW+RDP R + +I
Sbjct: 217 IFTYGKQPWYGLSN-EEVIECITQG-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274
Query: 493 TELLQ 497
E LQ
Sbjct: 275 HERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 75/252 (29%), Positives = 133/252 (52%), Gaps = 20/252 (7%)
Query: 256 GSYCDLYKGAFFSQD--VAIKVL---TNEHLNENIRREFAQEVHIMRKVRHM---NVVQF 307
G+Y +Y+G VA+K++ T + +I+RE A ++ ++R N+ ++
Sbjct: 12 GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA----LLSQLRQSQPPNITKY 67
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLK-LPLLLRVAIDVSKGMNYLHRNNIIH 366
G+ + PRL+I+ E+ GGS+ + K + +++R +V + Y+H+ +IH
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR---EVLVALKYIHKVGVIH 124
Query: 367 RDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETGTYRWMAPEVI-EHQPYNHRAD 424
RD+KAAN+L+ G VK+ DFGV A + + GT WMAPEVI E + Y+ +AD
Sbjct: 125 RDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKAD 184
Query: 425 VFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV-HTHPILVDLLERCWQRDP 483
++S GI ++E+ TG PY D+ + A+ ++ K P + +L + + C +P
Sbjct: 185 IWSLGITIYEMATGNPPYSDVDAFR-AMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEP 243
Query: 484 SLRPDFSEITEL 495
R E+ +
Sbjct: 244 KERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 92/269 (34%), Positives = 133/269 (49%), Gaps = 33/269 (12%)
Query: 253 IVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG 309
I G+Y +YK Q VAIK++ + E+ E +E +I+RK H N+ F G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 310 A------CTRPPRLFIVTEFMSGGSIYDY---LHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
A +L++V E GGS+ D L K+ LK + + + +G+ YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVI--EHQ 417
N +IHRD+K N+L+ +N VK+ DFGV+ + + G GT WMAPEVI + Q
Sbjct: 131 ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQ 190
Query: 418 P---YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP----- 469
P Y+ R+DV+S GI EL GK P D+ P++A + K R P P
Sbjct: 191 PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKIPRNPPPTLKSPENWSK 246
Query: 470 ILVDLLERCWQRDPSLRPDFSEITELLQH 498
D + C ++ RP F E ELL+H
Sbjct: 247 KFNDFISECLIKNYEQRP-FME--ELLEH 272
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 80/278 (28%), Positives = 134/278 (48%), Gaps = 28/278 (10%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEV 293
EI S ++F ++ G++ +YKG + VAIK L +++EF QE
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEA 59
Query: 294 HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------------HKQKC 338
+M ++H N+V +G CT+ ++ E+++ G ++++L K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV---QAQ 395
L L +AI ++ GM YL ++ +HRDL A N L+ E VK++DFG++R
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGV 454
Y V + RWM PE I + + +D++SFG+VLWE+ + G PY + + +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 455 VQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
+ L P P + L+ CW P+ RP F +I
Sbjct: 240 RSRQLLPC-PEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 9e-36
Identities = 74/253 (29%), Positives = 123/253 (48%), Gaps = 27/253 (10%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L E + +++ +F +E +M + H N+V+ +G C + ++ E+M+ G +
Sbjct: 38 VAVKML-KEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96
Query: 331 DYLHKQ---------------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
++L + L L +A V+ GM YL +HRDL
Sbjct: 97 EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156
Query: 370 KAANLLMNENGVVKVADFGVAR---VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVF 426
N L+ EN VVK+ADFG++R Y + RWM PE I + Y +DV+
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216
Query: 427 SFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485
++G+VLWE+ + G PY + + + V+ G + P + L +L+ CW + PS
Sbjct: 217 AYGVVLWEIFSYGMQPYYGMAHEE-VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSD 275
Query: 486 RPDFSEITELLQH 498
RP F+ I +LQ
Sbjct: 276 RPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 80/259 (30%), Positives = 122/259 (47%), Gaps = 44/259 (16%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+KVL ++N R +F +EV I+ ++ N+ + +G CT P L ++ E+M G +
Sbjct: 49 VAVKVL-RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 331 DYLHK-------QKCGLKLP---LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+L K C K LL +A ++ GM YL N +HRDL N L+ +N
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167
Query: 381 VVKVADFGVARVQAQYGVMTAETGTY-----------RWMAPEVIEHQPYNHRADVFSFG 429
+K+ADFG++R + Y RWMA E + + ++DV++FG
Sbjct: 168 TIKIADFGMSR--------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219
Query: 430 IVLWELVT--GKLPYDDLTPLQ----AAVGVVQKGL-----RPTIPVHTHPILVDLLERC 478
+ LWE++T + PY+ LT Q A G RP + +L+ C
Sbjct: 220 VTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD---IYELMLEC 276
Query: 479 WQRDPSLRPDFSEITELLQ 497
W+RD RP F EI LQ
Sbjct: 277 WRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 85/251 (33%), Positives = 141/251 (56%), Gaps = 12/251 (4%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI GS+ +++KG + VAIK++ E + I + QE+ ++ + V ++ G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+ + +L+I+ E++ GGS D L ++ +LR ++ KG++YLH IHRD
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHSEKKIHRD 126
Query: 369 LKAANLLMNENGVVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFS 427
+KAAN+L++E+G VK+ADFGVA + GT WMAPEVI+ Y+ +AD++S
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 186
Query: 428 FGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRP 487
GI EL G+ P+ +L P++ + ++ K PT+ + L + +E C ++PS RP
Sbjct: 187 LGITAIELAKGEPPHSELHPMK-VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
Query: 488 DFSEITELLQH 498
ELL+H
Sbjct: 246 ---TAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 2e-35
Identities = 80/246 (32%), Positives = 137/246 (55%), Gaps = 26/246 (10%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K+L ++ ++++ + E+ +M+ + +H N++ +GACT+ L+++ E+ S G++
Sbjct: 47 VAVKMLKDDATDKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 330 YDYLHKQK----------CGLKLPL-------LLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
+YL ++ C KLP L+ A V++GM YL IHRDL A
Sbjct: 106 REYLRARRPPGMDYSFDTC--KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163
Query: 373 NLLMNENGVVKVADFGVARVQAQ---YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFG 429
N+L+ E+ V+K+ADFG+AR Y T +WMAPE + + Y H++DV+SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 430 IVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPD 488
++LWE+ T G PY + P++ ++++G R P + L ++ CW PS RP
Sbjct: 224 VLLWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPT 282
Query: 489 FSEITE 494
F ++ E
Sbjct: 283 FKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 94/276 (34%), Positives = 134/276 (48%), Gaps = 50/276 (18%)
Query: 256 GSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
G++ ++Y+G + +D VA+K L E +E +F E IM K H N+V+ I
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLP-ESCSEQDESDFLMEALIMSKFNHQNIVRLI 75
Query: 309 GAC-TRPPRLFIVTEFMSGGSIYDYLHK------QKCGLKLPLLLRVAIDVSKGMNYLHR 361
G R PR FI+ E M+GG + +L + + L + LL A DV+KG YL
Sbjct: 76 GVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE 134
Query: 362 NNIIHRDLKAANLLMNENG---VVKVADFGVAR--VQAQYGVMTAETGTYR--------- 407
N+ IHRD+ A N L+ G V K+ADFG+AR +A Y YR
Sbjct: 135 NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY---------YRKGGRAMLPI 185
Query: 408 -WMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR----P 461
WM PE + + DV+SFG++LWE+ + G +PY T Q + V G R
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGGGRLDPPK 244
Query: 462 TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
P + I+ D CWQ P RP+F+ I E +Q
Sbjct: 245 GCPGPVYRIMTD----CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 74/249 (29%), Positives = 134/249 (53%), Gaps = 22/249 (8%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K+L + ++++ + E+ +M+ + +H N++ +G CT+ L+++ E+ + G++
Sbjct: 47 VAVKMLKDNATDKDLA-DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 330 YDYLHKQKCG---------------LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
++L ++ L L+ A V++GM YL IHRDL A N+
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165
Query: 375 LMNENGVVKVADFGVARVQAQ---YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIV 431
L+ E+ V+K+ADFG+AR Y + +WMAPE + + Y H++DV+SFGI+
Sbjct: 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGIL 225
Query: 432 LWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
+WE+ T G PY + P++ ++++G R P + L L+ CW P+ RP F
Sbjct: 226 MWEIFTLGGSPYPGI-PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK 284
Query: 491 EITELLQHL 499
++ E L +
Sbjct: 285 QLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 71/216 (32%), Positives = 124/216 (57%), Gaps = 12/216 (5%)
Query: 290 AQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVA 349
A+E+ ++++++H N+VQ++G+ L I E++ GGS+ L+ + L+
Sbjct: 54 AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFV 112
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA-RVQAQYGVMTAET----- 403
+ KG+NYLH IIHRD+K AN+L++ G +K++DFG++ +++A
Sbjct: 113 RQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 404 -GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT 462
G+ WMAPEV++ Y +AD++S G ++ E++TGK P+ D T LQA + + P
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPE 231
Query: 463 IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
IP + +D LE+ ++ D + RP + ELL+H
Sbjct: 232 IPSNISSEAIDFLEKTFEIDHNKRPTAA---ELLKH 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 64/232 (27%), Positives = 114/232 (49%), Gaps = 11/232 (4%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+KVL + + + E E +I+ ++ H +V+ A +L++V E+ GG ++
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390
+L K+ A ++ + YLH II+RDLK N+L++ +G +K+ DFG+A
Sbjct: 82 SHLSKEGR-FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLA 140
Query: 391 RVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL 448
+ + T GT ++APEV+ + Y D +S G++L+E++TGK P+
Sbjct: 141 K-ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199
Query: 449 QAAVGVVQKGLR--PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ + +K L+ P P DL+ Q+DP+ R E+ H
Sbjct: 200 E----IYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 81/238 (34%), Positives = 127/238 (53%), Gaps = 21/238 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ VA+K + L + RRE EV IMR +H N+V+ + L++V EF+ GG
Sbjct: 45 RQVAVKKM---DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
++ D + + + + V + V K +++LH +IHRD+K+ ++L+ +G VK++DF
Sbjct: 102 ALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDF 159
Query: 388 G-VARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
G A+V + + GT WMAPEVI PY D++S GI++ E+V G+ PY +
Sbjct: 160 GFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219
Query: 447 PLQAAVGVVQKGLRPTIPV---HTH---PILVDLLERCWQRDPSLRPDFSEITELLQH 498
PLQA K +R +P + H P L L+R RDP+ R + ELL H
Sbjct: 220 PLQA-----MKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR---ATAAELLNH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 85/252 (33%), Positives = 139/252 (55%), Gaps = 14/252 (5%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
+I GS+ +++KG Q VAIK++ E + I + QE+ ++ + V ++ G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+ + +L+I+ E++ GGS D L ++ +L+ ++ KG++YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126
Query: 369 LKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVF 426
+KAAN+L++E G VK+ADFGVA Q + T GT WMAPEVI+ Y+ +AD++
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 427 SFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
S GI EL G+ P D+ P++ + ++ K PT+ + ++ C +DPS R
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMR-VLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFR 244
Query: 487 PDFSEITELLQH 498
P ELL+H
Sbjct: 245 P---TAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 7e-35
Identities = 79/246 (32%), Positives = 135/246 (54%), Gaps = 22/246 (8%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K+L ++ +++ + E+ +M+ + +H N++ +GACT+ L+++ E+ S G++
Sbjct: 53 VAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 330 YDYLHKQK------C---------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
+YL ++ C L L+ A V++GM YL IHRDL A N+
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171
Query: 375 LMNENGVVKVADFGVARVQAQ---YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIV 431
L+ E+ V+K+ADFG+AR Y T +WMAPE + + Y H++DV+SFG++
Sbjct: 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 231
Query: 432 LWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
LWE+ T G PY + P++ ++++G R P + L ++ CW PS RP F
Sbjct: 232 LWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 290
Query: 491 EITELL 496
++ E L
Sbjct: 291 QLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 8e-35
Identities = 81/264 (30%), Positives = 127/264 (48%), Gaps = 39/264 (14%)
Query: 264 GAFFS----QDV------AIKVLT----NEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
GAF S +DV A+K +T E + +E+ +M ++ H ++++ +G
Sbjct: 11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
A + E+M+GGS+ L K K +++ + +G++YLH N IIHRD+
Sbjct: 71 ATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDV 129
Query: 370 KAANLLMNENG-VVKVADFGVARVQAQYGVMTAE-----TGTYRWMAPEVIEHQPYNHRA 423
K ANLL++ G +++ADFG A A G E GT +MAPEV+ + Y
Sbjct: 130 KGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSC 189
Query: 424 DVFSFGIVLWELVTGKLPYDD---------LTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
DV+S G V+ E+ T K P++ + + +A P+IP H P L D+
Sbjct: 190 DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA------PSIPEHLSPGLRDV 243
Query: 475 LERCWQRDPSLRPDFSEITELLQH 498
RC + P RP ELL+H
Sbjct: 244 TLRCLELQPEDRP---PSRELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 8e-35
Identities = 72/217 (33%), Positives = 112/217 (51%), Gaps = 13/217 (5%)
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
E+ ++ + H+N+VQ++G T L I E++ GGSI L + L+
Sbjct: 57 SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTE 115
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ-YGVMTAET--GTYR 407
V +G+ YLH I+HRDLKA NLL++ +G+ K++DFG+++ Y + G+
Sbjct: 116 QVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 408 WMAPEVIE--HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV 465
WMAPEVI Q Y+ + D++S G V+ E+ G+ P+ D + A + K P IP
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235
Query: 466 HTH----PILVDLLERCWQRDPSLRPDFSEITELLQH 498
P+ +D L C+ +P RP ELLQH
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRP---TARELLQH 269
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 80/259 (30%), Positives = 130/259 (50%), Gaps = 14/259 (5%)
Query: 253 IVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQF 307
I G + +Y G D A+K L E + +F +E IM+ H NV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVLSL 61
Query: 308 IGACTRPPRL-FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+G C +V +M G + +++ + + L+ + V+KGM YL +H
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121
Query: 367 RDLKAANLLMNENGVVKVADFGVAR--VQAQYGVMTAETGT---YRWMAPEVIEHQPYNH 421
RDL A N +++E+ VKVADFG+AR +Y + TG +WMA E ++ Q +
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTT 181
Query: 422 RADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480
++DV+SFG++LWEL+T G PY D+ V ++Q G R P + L +++ CW
Sbjct: 182 KSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCPDPLYEVMLSCWH 240
Query: 481 RDPSLRPDFSEITELLQHL 499
P +RP FSE+ ++ +
Sbjct: 241 PKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 76/249 (30%), Positives = 134/249 (53%), Gaps = 22/249 (8%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K+L ++ +++ + E+ +M+ + +H N++ +GACT+ L+++ E+ S G++
Sbjct: 50 VAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 108
Query: 330 YDYLHKQKC---------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
+YL ++ + L+ V++GM YL IHRDL A N+
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168
Query: 375 LMNENGVVKVADFGVARVQAQ---YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIV 431
L+ EN V+K+ADFG+AR Y T +WMAPE + + Y H++DV+SFG++
Sbjct: 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 228
Query: 432 LWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
+WE+ T G PY + P++ ++++G R P + L ++ CW PS RP F
Sbjct: 229 MWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFK 287
Query: 491 EITELLQHL 499
++ E L +
Sbjct: 288 QLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 76/245 (31%), Positives = 125/245 (51%), Gaps = 21/245 (8%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K L + +E+ R++F +E ++ ++H ++V+F G CT L +V E+M G +
Sbjct: 38 VAVKAL--KEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 331 DYLHK-------------QKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
+L G L L +L +A ++ GM YL + +HRDL N L+
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155
Query: 377 NENGVVKVADFGVAR---VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
+ VVK+ DFG++R Y V RWM PE I ++ + +D++SFG+VLW
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215
Query: 434 ELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
E+ T GK P+ L+ + A+ + +G P P + +++ CWQR+P R +I
Sbjct: 216 EIFTYGKQPWYQLSNTE-AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
Query: 493 TELLQ 497
LQ
Sbjct: 275 HSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 71/236 (30%), Positives = 127/236 (53%), Gaps = 7/236 (2%)
Query: 261 LYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320
LY+ V K + L+E RR+ E+ I+ ++H N++ + L I
Sbjct: 18 LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77
Query: 321 TEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE 378
E+ +GG++YD + +QK G ++L + ++Y+H+ I+HRD+K N+ + +
Sbjct: 78 MEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK 136
Query: 379 NGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
G++K+ DFG++++ M AET GT +M+PE+ + YN ++D+++ G VL+EL+
Sbjct: 137 AGLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195
Query: 437 TGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
T K +D PL V +VQ P + V++ L+ L+ Q+DP RP E+
Sbjct: 196 TLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE-LISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 71/249 (28%), Positives = 126/249 (50%), Gaps = 34/249 (13%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RLFIVTEFMSGGS- 328
A+K +T + N +++++ +E+ I + + +V++ GA + I E+ GGS
Sbjct: 30 ALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL 88
Query: 329 --IYDYLHKQ--KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384
IY + K+ + G K+ L ++A V KG++YLH IIHRD+K +N+L+ G VK+
Sbjct: 89 DSIYKKVKKRGGRIGEKV--LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKL 146
Query: 385 ADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD- 443
DFGV+ T TGT +MAPE I+ +PY+ +DV+S G+ L E+ + P+
Sbjct: 147 CDFGVSGELVNSLAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205
Query: 444 DLTPLQAAVGVVQKGLRPTIPVHTHPILVD--------------LLERCWQRDPSLRPDF 489
+ P + ++ + P L D +++C ++DP+ RP
Sbjct: 206 EGEPPLGPIELLSYIVNMPNPE-----LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTP 260
Query: 490 SEITELLQH 498
++L+H
Sbjct: 261 W---DMLEH 266
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 4e-33
Identities = 84/261 (32%), Positives = 141/261 (54%), Gaps = 21/261 (8%)
Query: 255 SGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
SG++ +YKG + VAIKVL E+ + +E E ++M V V + +
Sbjct: 17 SGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGSPYVCRLL 75
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G C + +VT+ M G + DY+ + K + LL + ++KGM+YL ++HRD
Sbjct: 76 GICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRD 134
Query: 369 LKAANLLMNENGVVKVADFGVARV----QAQYGVMTAETGTY--RWMAPEVIEHQPYNHR 422
L A N+L+ VK+ DFG+AR+ + +Y A+ G +WMA E I H+ + H+
Sbjct: 135 LAARNVLVKSPNHVKITDFGLARLLDIDETEY---HADGGKVPIKWMALESILHRRFTHQ 191
Query: 423 ADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR-PTIPVHTHPILVDLLERCWQ 480
+DV+S+G+ +WEL+T G PYD + P + +++KG R P P+ T + + ++ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYM-IMVKCWM 249
Query: 481 RDPSLRPDFSEITELLQHLAQ 501
D RP F E+ + +A+
Sbjct: 250 IDSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 4e-33
Identities = 73/256 (28%), Positives = 135/256 (52%), Gaps = 29/256 (11%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L E+ + + R+ E +++++V H +V++ GAC++ L ++ E+ GS+
Sbjct: 33 VAVKML-KENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 91
Query: 331 DYLH---KQKCG--------------------LKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
+L K L + L+ A +S+GM YL ++HR
Sbjct: 92 SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151
Query: 368 DLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETG--TYRWMAPEVIEHQPYNHRAD 424
DL A N+L+ E +K++DFG++R V + + G +WMA E + Y ++D
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211
Query: 425 VFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDP 483
V+SFG++LWE+VT G PY + P + +++ G R P + + +L+ CW+++P
Sbjct: 212 VWSFGVLLWEIVTLGGNPYPGIAP-ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEP 270
Query: 484 SLRPDFSEITELLQHL 499
RP F++I++ L+ +
Sbjct: 271 DKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 8e-33
Identities = 77/261 (29%), Positives = 126/261 (48%), Gaps = 44/261 (16%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC------TRPPRLFIVT 321
VA+K + + + EF E M+ H NV++ IG C + P+ ++
Sbjct: 27 QLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVIL 86
Query: 322 EFMSGGSIYDYLHKQKCG---LKLPL--LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
FM G ++ +L + G KLPL LL+ +D++ GM YL N IHRDL A N ++
Sbjct: 87 PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML 146
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTY-----------RWMAPEVIEHQPYNHRADV 425
E+ V VADFG+++ +G Y +W+A E + + Y ++DV
Sbjct: 147 REDMTVCVADFGLSK--------KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDV 198
Query: 426 FSFGIVLWELVT-GKLPYDDLTPLQAAVG------VVQKGLRPTIPVHTHPILVDLLERC 478
++FG+ +WE+ T G+ PY V ++ G R P L DL+ C
Sbjct: 199 WAFGVTMWEIATRGQTPY-------PGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSC 251
Query: 479 WQRDPSLRPDFSEITELLQHL 499
W+ DP RP F+++ E+L+++
Sbjct: 252 WRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 74/213 (34%), Positives = 111/213 (52%), Gaps = 15/213 (7%)
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD-YLHKQKCGLKLP--LLLRVAIDV 352
MR V V F GA R ++I E M S+ Y GL +P +L ++A+ +
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSI 112
Query: 353 SKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAP 411
K + YLH ++IHRD+K +N+L+N NG VK+ DFG++ T + G +MAP
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAP 172
Query: 412 EVI----EHQPYNHRADVFSFGIVLWELVTGKLPYDDL-TPLQAAVGVVQKGLRPTIPVH 466
E I + Y+ ++DV+S GI + EL TG+ PYD TP Q VV + P +P
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAE 231
Query: 467 T-HPILVDLLERCWQRDPSLRPDFSEITELLQH 498
P D + +C +++ RP++ ELLQH
Sbjct: 232 KFSPEFQDFVNKCLKKNYKERPNY---PELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 77/249 (30%), Positives = 133/249 (53%), Gaps = 12/249 (4%)
Query: 255 SGSYCDLYKGAFFSQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
SG++ + KG + + DVAIKVL NE+ +++R E +E IM ++ + +V+ IG
Sbjct: 5 SGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
C L +V E SGG + +L +K + + ++ + VS GM YL N +HRDL
Sbjct: 64 C-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLA 122
Query: 371 AANLLMNENGVVKVADFGVARVQAQ----YGVMTAETGTYRWMAPEVIEHQPYNHRADVF 426
A N+L+ K++DFG+++ Y +A +W APE I + ++ R+DV+
Sbjct: 123 ARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVW 182
Query: 427 SFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485
S+GI +WE + G+ PY + + + +++G R P P + L++ CW
Sbjct: 183 SYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWED 241
Query: 486 RPDFSEITE 494
RP+F+++ E
Sbjct: 242 RPNFAKVEE 250
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 2e-32
Identities = 80/251 (31%), Positives = 126/251 (50%), Gaps = 23/251 (9%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG------ACTRPPRLFIVTE 322
Q VA+K+L + + + EF +E M++ H NV++ IG A R P ++
Sbjct: 28 QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87
Query: 323 FMSGGSIYDYLHKQKCG-----LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
FM G ++ +L + G L L L+R ID++ GM YL N IHRDL A N ++N
Sbjct: 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147
Query: 378 ENGVVKVADFGVAR---VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWE 434
EN V VADFG+++ Y A +W+A E + Y +DV++FG+ +WE
Sbjct: 148 ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWE 207
Query: 435 LVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEIT 493
++T G+ PY + + ++ KG R P + +L+ +CW +P RP F
Sbjct: 208 IMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSF---- 262
Query: 494 ELLQHLAQRLQ 504
QHL +L+
Sbjct: 263 ---QHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 80/250 (32%), Positives = 119/250 (47%), Gaps = 35/250 (14%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR--LFIVTEFMSGGS 328
VA+K L +H R+F +E+ I++ ++H N+V++ G C R L +V E++ GS
Sbjct: 36 VAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
+ DYL K + L LL A + KGM YL +HRDL N+L+ VK+ DFG
Sbjct: 94 LRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153
Query: 389 VARVQAQ----YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444
+ +V Q Y V W APE + ++ +DV+SFG+VL+EL T Y D
Sbjct: 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YSD 209
Query: 445 LTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLER--------------------CWQRDP 483
+ A + G + + H L++LL+ CW DP
Sbjct: 210 KSCSPPAEFMRMMGNDKQGQMIVYH--LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDP 267
Query: 484 SLRPDFSEIT 493
S RP FSE+
Sbjct: 268 SQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 73/259 (28%), Positives = 124/259 (47%), Gaps = 27/259 (10%)
Query: 255 SGSYCDLYKGAFFSQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRH-MNVVQFIGACT 312
GS+ ++Y A + VA+KVL + ++ F +E+ I+ + H N+V+
Sbjct: 10 EGSFGEVYL-ARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ 68
Query: 313 RPPRLFIVTEFMSGGSIYDYLHK--QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
L++V E++ GGS+ D L K +K L L + + + YLH IIHRD+K
Sbjct: 69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIK 128
Query: 371 AANLLMNENG-VVKVADFGVARV-------QAQYGVMTAETGTYRWMAPEVIEH---QPY 419
N+L++ +G VVK+ DFG+A++ + + + GT +MAPEV+
Sbjct: 129 PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYA 188
Query: 420 NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK-----------GLRPTIPVHTH 468
+ +D++S GI L+EL+TG P++ A ++ L P+ P
Sbjct: 189 SSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELIS 248
Query: 469 PILVDLLERCWQRDPSLRP 487
DLL++ +DP R
Sbjct: 249 KAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 66/237 (27%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
V +K L + +EN++ EF +E+ + RK+ H NVV+ +G C +++ E+ G +
Sbjct: 38 VLVKAL-QKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96
Query: 331 DYLHKQKCG--------LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVV 382
+L K L + + ++ GM++L +HRDL A N L++ V
Sbjct: 97 QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV 156
Query: 383 KVADFGVAR--VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GK 439
KV+ +++ ++Y + RW+APE ++ ++ ++DV+SFG+++WE+ T G+
Sbjct: 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
Query: 440 LPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELL 496
LP+ L+ + + L +P L L+ RCW +P RP FSE+ L
Sbjct: 217 LPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 69/265 (26%), Positives = 124/265 (46%), Gaps = 27/265 (10%)
Query: 252 KIVSGSYCDLYK------GAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
I GS+ + K G K + ++ E +++ EV+I+R+++H N+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKIL----VWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 306 QFIGACTRPP--RLFIVTEFMSGGSIYDYLHK-QKCGLKLP--LLLRVAIDVSKGMNYLH 360
++ L+IV E+ GG + + K +K + + R+ + + H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 361 R-----NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEV 413
N ++HRDLK AN+ ++ N VK+ DFG+A++ A+T GT +M+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYVGTPYYMSPEQ 181
Query: 414 IEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473
+ H Y+ ++D++S G +++EL P+ LQ A +++G IP L +
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA-SKIKEGKFRRIPYRYSSELNE 240
Query: 474 LLERCWQRDPSLRPDFSEITELLQH 498
+++ DP RP ELLQ
Sbjct: 241 VIKSMLNVDPDKRPS---TEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 83/280 (29%), Positives = 138/280 (49%), Gaps = 36/280 (12%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQD-----VAIKVLTNEHLNENIRREFAQE 292
WE+ + ++ GS+ +Y+G +D VAIK + NE + R EF E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNE 59
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLH------KQKCGLKLPLL- 345
+M++ +VV+ +G ++ ++ E M+ G + YL + P L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 346 --LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET 403
+++A +++ GM YL+ N +HRDL A N ++ E+ VK+ DFG+ R ET
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYET 172
Query: 404 GTY----------RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAV 452
Y RWM+PE ++ + +DV+SFG+VLWE+ T + PY ++ Q
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
Query: 453 GVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
V++ GL P + +L +L+ CWQ +P +RP F EI
Sbjct: 233 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-32
Identities = 80/257 (31%), Positives = 136/257 (52%), Gaps = 16/257 (6%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNV 304
+FE KI G+ +Y + Q+VAIK + +L + ++E E+ +MR+ +H N+
Sbjct: 23 RFE-KIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPNI 78
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
V ++ + L++V E+++GGS+ D + + + + V + + + +LH N +
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 365 IHRDLKAANLLMNENGVVKVADFG-VARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRA 423
IHRD+K+ N+L+ +G VK+ DFG A++ + + GT WMAPEV+ + Y +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 424 DVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQR 481
D++S GI+ E+V G+ PY + PL+A + G P + P I D L RC +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEM 255
Query: 482 DPSLRPDFSEITELLQH 498
D R ELLQH
Sbjct: 256 DVEKR---GSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 73/253 (28%), Positives = 121/253 (47%), Gaps = 29/253 (11%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RLFIVTEFMSGGS 328
VA+K L E +I + +E+ I+R + H N+V++ G CT + ++ EF+ GS
Sbjct: 36 VAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
+ +YL + K + L L+ A+ + KGM+YL +HRDL A N+L+ VK+ DFG
Sbjct: 95 LKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 154
Query: 389 VARV----QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444
+ + + Y V W APE + + +DV+SFG+ L+EL+T Y D
Sbjct: 155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT----YCD 210
Query: 445 ------------LTPLQAA------VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
+ P V V+++G R P + + L+ +CW+ PS R
Sbjct: 211 SESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKR 270
Query: 487 PDFSEITELLQHL 499
F + E + +
Sbjct: 271 TTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 68/253 (26%), Positives = 129/253 (50%), Gaps = 12/253 (4%)
Query: 255 SGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
SG++ + KG + + VA+K+L N++ + ++ E +E ++M+++ + +V+ IG
Sbjct: 5 SGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGI 64
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
C +V E G + +L K K + + + VS GM YL N +HRDL
Sbjct: 65 C-EAESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLA 122
Query: 371 AANLLMNENGVVKVADFGVARV----QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVF 426
A N+L+ K++DFG+++ + Y T +W APE + + ++ ++DV+
Sbjct: 123 ARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVW 182
Query: 427 SFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485
SFG+++WE + G+ PY + + +++ G R P P + DL++ CW
Sbjct: 183 SFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYGVDE 241
Query: 486 RPDFSEITELLQH 498
RP F+ + L++
Sbjct: 242 RPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 81/238 (34%), Positives = 125/238 (52%), Gaps = 21/238 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ VA+K++ L + RRE EV IMR +H NVV+ + L+++ EF+ GG
Sbjct: 47 RQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
++ D + + + L + V V + + YLH +IHRD+K+ ++L+ +G VK++DF
Sbjct: 104 ALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDF 161
Query: 388 G-VARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
G A++ + GT WMAPEVI PY D++S GI++ E+V G+ PY +
Sbjct: 162 GFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221
Query: 447 PLQAAVGVVQKGLRPTIPV------HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
P+QA K LR + P P+L D LER R+P R + ELL H
Sbjct: 222 PVQA-----MKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER---ATAQELLDH 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 44/262 (16%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L + N+N R +F +EV I+ +++ N+++ +G C L ++TE+M G +
Sbjct: 49 VAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 331 DYLHKQK----------------CGLKL--PLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
+L C + LL VA+ ++ GM YL N +HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167
Query: 373 NLLMNENGVVKVADFGVAR---VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFG 429
N L+ EN +K+ADFG++R Y + RWMA E I + +DV++FG
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 430 IVLWEL--VTGKLPYDDLTPLQAAVGVVQKG-------------LRPTIPVHTHPILVDL 474
+ LWE+ + + PY +LT Q V++ RP P L +L
Sbjct: 228 VTLWEILMLCKEQPYGELTDEQ----VIENAGEFFRDQGRQVYLFRP--PPCPQG-LYEL 280
Query: 475 LERCWQRDPSLRPDFSEITELL 496
+ +CW RD RP FS+I L
Sbjct: 281 MLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 74/225 (32%), Positives = 114/225 (50%), Gaps = 16/225 (7%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
+A+KV+ + + ++++ E+ I+ K ++ F GA R+ I TEFM GGS+
Sbjct: 29 LAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD 87
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390
Y + +L R+A+ V KG+ YL I+HRD+K +N+L+N G VK+ DFGV+
Sbjct: 88 VYRK-----IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS 142
Query: 391 RVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD------ 444
Q + GT +MAPE I + Y +DV+S GI EL G+ PY
Sbjct: 143 T-QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201
Query: 445 -LTPLQAAVGVVQKGLRPTIPVHT-HPILVDLLERCWQRDPSLRP 487
L PLQ +V + P +PV V + +C ++ P RP
Sbjct: 202 SLMPLQLLQCIVDED-PPVLPVGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 76/236 (32%), Positives = 129/236 (54%), Gaps = 13/236 (5%)
Query: 267 FSQDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
Q+VAIK + +L + ++E E+ +M+++++ N+V F+ + LF+V E+++
Sbjct: 43 TGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVA 385
GGS+ D + + C + + V + + + +LH N +IHRD+K+ N+L+ +G VK+
Sbjct: 100 GGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLT 157
Query: 386 DFG-VARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444
DFG A++ + + GT WMAPEV+ + Y + D++S GI+ E+V G+ PY +
Sbjct: 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
Query: 445 LTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
PL+A + G P + P PI D L RC + D R ELLQH
Sbjct: 218 ENPLRALYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMDVEKR---GSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 81/250 (32%), Positives = 129/250 (51%), Gaps = 25/250 (10%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K L + ++N R++F +E ++ ++H ++V+F G C L +V E+M G +
Sbjct: 38 VAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95
Query: 331 DYLHKQ------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE 378
+L L +L +A ++ GM YL + +HRDL N L+ E
Sbjct: 96 KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155
Query: 379 NGVVKVADFGVAR---VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWEL 435
N +VK+ DFG++R Y V RWM PE I ++ + +DV+S G+VLWE+
Sbjct: 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
Query: 436 VT-GKLPYDDLTPLQAAVGVVQKGL--RP-TIPVHTHPILVDLLERCWQRDPSLRPDFSE 491
T GK P+ L+ + + Q + RP T P + DL+ CWQR+P +R + E
Sbjct: 216 FTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVY----DLMLGCWQREPHMRLNIKE 271
Query: 492 ITELLQHLAQ 501
I LLQ+LA+
Sbjct: 272 IHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 81/278 (29%), Positives = 136/278 (48%), Gaps = 28/278 (10%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVH 294
E+ S ++F ++ ++ +YKG + +Q VAIK L + N EF QE
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEAS 59
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL-----HKQ-----------KC 338
+M ++ H N+V +G T+ + ++ E+++ G ++++L H K
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR---VQAQ 395
L L +AI ++ GM YL + +H+DL A N+L+ E VK++D G++R
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY 179
Query: 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGV 454
Y V RWM PE I + ++ +D++SFG+VLWE+ + G PY + + V
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
Query: 455 VQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
++ L P P + L+ CWQ PS RP F +I
Sbjct: 240 RKRQLLPC-SEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 77/253 (30%), Positives = 127/253 (50%), Gaps = 28/253 (11%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K L + L R++F +E ++ ++H ++V+F G C L +V E+M G +
Sbjct: 38 VAVKALKDPTLAA--RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 331 DYLH---------------KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+L + K L L +L +A ++ GM YL + +HRDL N L
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155
Query: 376 MNENGVVKVADFGVAR---VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVL 432
+ N +VK+ DFG++R Y V RWM PE I ++ + +DV+SFG++L
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215
Query: 433 WELVT-GKLPYDDLTPLQAAVGVVQKGL--RPTI-PVHTHPILVDLLERCWQRDPSLRPD 488
WE+ T GK P+ L+ + + Q + RP + P + D++ CWQR+P R +
Sbjct: 216 WEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY----DIMLGCWQREPQQRLN 271
Query: 489 FSEITELLQHLAQ 501
EI ++L L +
Sbjct: 272 IKEIYKILHALGK 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 65/237 (27%), Positives = 121/237 (51%), Gaps = 5/237 (2%)
Query: 259 CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318
L + + V IK + E + ++ R E +++ + H N++++ L
Sbjct: 16 VHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALM 75
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
IV E+ GG++ +Y+ K+ C L +L + + ++++H I+HRDLK N+L+
Sbjct: 76 IVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL 134
Query: 377 NENG-VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWEL 435
+++ VVK+ DFG++++ + GT +++PE+ E +PYN ++D+++ G VL+EL
Sbjct: 135 DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
Query: 436 VTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
+ K ++ L A V + G I P L L+ DPS RP S+I
Sbjct: 195 ASLKRAFEAAN-LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 97/340 (28%), Positives = 147/340 (43%), Gaps = 84/340 (24%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFAQE 292
WE LK + G++ + + + F + VA+K+L E + + E
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTE 60
Query: 293 VHIMRKV-RHMNVVQFIGACTRP--PRLFIVTEFMSGGSIYDYLH--------------- 334
+ I+ + H+NVV +GACT+P P + IV E+ G++ +YL
Sbjct: 61 LKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECFSPYRNKSTR 119
Query: 335 ----KQKCGLK-------------------------------------LPLLLRVAI--- 350
KQK G K PL L I
Sbjct: 120 KREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYS 179
Query: 351 -DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR---VQAQYGVMTAETGTY 406
V++GM +L IHRDL A N+L++EN VVK+ DFG+AR Y G
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGDA 235
Query: 407 R----WMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRP 461
R WMAPE I + Y ++DV+SFG++LWE+ + G PY + + +++G R
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 462 TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
P + P + ++ CW +P RP FSE+ E+L L Q
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 76/248 (30%), Positives = 126/248 (50%), Gaps = 11/248 (4%)
Query: 256 GSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315
G+Y +Y S V I + + + +E+ + ++H N+VQ++G+ +
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCGLKL--PLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
I E + GGS+ L + LK ++ + +G+ YLH N I+HRD+K N
Sbjct: 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN 138
Query: 374 LLMNE-NGVVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQP--YNHRADVFSFG 429
+L+N +GVVK++DFG ++ A T TGT ++MAPEVI+ P Y AD++S G
Sbjct: 139 VLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLG 198
Query: 430 IVLWELVTGKLPYDDLTPLQAA---VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
+ E+ TGK P+ +L QAA VG+ + P IP + + RC++ DP R
Sbjct: 199 CTIVEMATGKPPFIELGEPQAAMFKVGMFKI--HPEIPESLSAEAKNFILRCFEPDPDKR 256
Query: 487 PDFSEITE 494
++ +
Sbjct: 257 ASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-30
Identities = 73/247 (29%), Positives = 126/247 (51%), Gaps = 23/247 (9%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFIVTEFMSGGS 328
VA+K L E +N + +E++I++ + H N+V++ G C+ L ++ E++ GS
Sbjct: 36 VAVKTLKRECGQQN-TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
+ DYL K K L LL A + +GM YLH + IHRDL A N+L++ + +VK+ DFG
Sbjct: 95 LRDYLPKHKLNLAQLLLF--AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG 152
Query: 389 VARV----QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444
+A+ Y V W A E ++ +++ +DV+SFG+ L+EL+T
Sbjct: 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212
Query: 445 --------LTPLQAAVGVV------QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
+ P Q + VV ++G+R P + + L++ CW+ + RP F
Sbjct: 213 PPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
Query: 491 EITELLQ 497
+ +L+
Sbjct: 273 SLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 78/240 (32%), Positives = 118/240 (49%), Gaps = 27/240 (11%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD 331
A+KV+ H + +RR+ +E+ I+R V H NVV+ + ++ EFM GGS+
Sbjct: 103 ALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161
Query: 332 YLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391
+ L VA + G+ YLHR +I+HRD+K +NLL+N VK+ADFGV+R
Sbjct: 162 THIADE-----QFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216
Query: 392 VQAQYGVM---TAETGTYRWMAPEVI----EHQPYNHRA-DVFSFGIVLWELVTGKLPY- 442
+ AQ M + GT +M+PE I H Y+ A D++S G+ + E G+ P+
Sbjct: 217 ILAQ--TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
Query: 443 ----DDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
D L A+ + Q P P + C QR+P+ R +LLQH
Sbjct: 275 VGRQGDWASLMCAICMSQP---PEAPATASREFRHFISCCLQREPAKRW---SAMQLLQH 328
|
Length = 353 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 83/287 (28%), Positives = 137/287 (47%), Gaps = 40/287 (13%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD---------VAIKVLTNEHLNENIRREFA 290
WE+ + ++ GS+ +Y+G ++D VA+K + NE + R EF
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEG--NARDIIKGEAETRVAVKTV-NESASLRERIEFL 57
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLH------KQKCGLKLPL 344
E +M+ +VV+ +G ++ +V E M+ G + YL + G P
Sbjct: 58 NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 345 L---LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401
L +++A +++ GM YL+ +HRDL A N ++ + VK+ DFG+ R
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIY 170
Query: 402 ETGTYR----------WMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQA 450
ET YR WMAPE ++ + +D++SFG+VLWE+ + + PY L+ Q
Sbjct: 171 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230
Query: 451 AVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
V+ G P + + DL+ CWQ +P +RP F EI LL+
Sbjct: 231 LKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 71/248 (28%), Positives = 122/248 (49%), Gaps = 23/248 (9%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L + + + R +F +E+ IM ++++ N+++ +G C L ++TE+M G +
Sbjct: 47 VAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 331 DYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+L +++ LL +A+ ++ GM YL N +HRDL N L+ +
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165
Query: 380 GVVKVADFGVAR---VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
+K+ADFG++R Y + RWMA E I + +DV++FG+ LWE+
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225
Query: 437 T--GKLPYDDLTPLQAA--VGVVQKGLRPTIPVHTHPI----LVDLLERCWQRDPSLRPD 488
T + PY L+ Q G + I + P+ + L+ RCW RD RP
Sbjct: 226 TLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285
Query: 489 FSEITELL 496
F++I L
Sbjct: 286 FNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 70/244 (28%), Positives = 130/244 (53%), Gaps = 18/244 (7%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR---PPRLFIVTEFM 324
++V +K + + H +E QE ++ + H N++ + C PP F++ +M
Sbjct: 35 EEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP--FVLYPYM 91
Query: 325 SGGSIYDYLHKQKCG-------LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
+ G++ +L + + G L L+ +AI ++ GM+YLH+ +IH+D+ A N +++
Sbjct: 92 NWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID 151
Query: 378 ENGVVKVADFGVAR--VQAQYGVM-TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWE 434
E VK+ D ++R Y + E +WMA E + ++ Y+ +DV+SFG++LWE
Sbjct: 152 EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWE 211
Query: 435 LVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEIT 493
L+T G+ PY ++ P + A ++ G R P++ L ++ CW DP RP FS++
Sbjct: 212 LMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLV 270
Query: 494 ELLQ 497
+ L
Sbjct: 271 QCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 56/179 (31%), Positives = 99/179 (55%), Gaps = 19/179 (10%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K + ++ E I +E+ ++++++H N+V+ + +L++V E+
Sbjct: 27 VALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD----M 82
Query: 331 D---YLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
D YL K+ L L+ + + +G+ Y H + I+HRDLK N+L+N +GV+K+ADF
Sbjct: 83 DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADF 142
Query: 388 GVARVQAQYGV----MTAETGT--YRWMAPEVIEHQP-YNHRADVFSFGIVLWELVTGK 439
G+AR +G+ T E T YR APE++ Y+ D++S G + E++TGK
Sbjct: 143 GLAR---AFGIPLRTYTHEVVTLWYR--APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 6e-30
Identities = 69/239 (28%), Positives = 124/239 (51%), Gaps = 15/239 (6%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VAIK + + + + E + M + H +V+ +G C L +VT+ GS+
Sbjct: 39 VAIKTIQDRSGRQTFQ-EITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLL 96
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390
D++ + + L LL + ++KGM YL + ++HR+L A N+L+ + +V++ADFGVA
Sbjct: 97 DHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156
Query: 391 RV----QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDL 445
+ +Y +T +WMA E I Y H++DV+S+G+ +WE+++ G PY +
Sbjct: 157 DLLYPDDKKYFYSEHKT-PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
Query: 446 TPLQAAVGVVQKGLRPTIPVHTHPILVD---LLERCWQRDPSLRPDFSEITELLQHLAQ 501
P +++KG R P +D ++ +CW D ++RP F E+ +A+
Sbjct: 216 RP-HEVPDLLEKGERLAQP---QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 8e-30
Identities = 79/232 (34%), Positives = 128/232 (55%), Gaps = 13/232 (5%)
Query: 271 VAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K + L + RRE EV IMR +H NVV+ + L++V EF+ GG++
Sbjct: 48 VAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG- 388
D + + + + V + V K ++ LH +IHRD+K+ ++L+ +G VK++DFG
Sbjct: 105 TDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 162
Query: 389 VARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL 448
A+V + + GT WMAPE+I PY D++S GI++ E+V G+ PY + PL
Sbjct: 163 CAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222
Query: 449 QAAVGVVQKGLRPTIP-VH-THPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ A+ +++ L P + +H P L L+R RDP+ R + ELL+H
Sbjct: 223 K-AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR---ATAAELLKH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 75/265 (28%), Positives = 123/265 (46%), Gaps = 45/265 (16%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VAIK +E++++ +EV ++R++RH N+V A R RL++V E++ ++
Sbjct: 29 VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLL 87
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390
+ L GL + + + + Y H +NIIHRD+K N+L++E+GV+K+ DFG A
Sbjct: 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFA 147
Query: 391 R-VQAQYGVMTAETGTYRWM-APEV-IEHQPYNHRADVFSFGIVLWELVTGK--LPYD-D 444
R ++A+ + RW APE+ + Y DV++ G ++ EL+ G+ P D D
Sbjct: 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207
Query: 445 LTPLQAAVGVVQKGLRPTIPVHTH-------------------------------PILVD 473
+ L ++QK L P P H +D
Sbjct: 208 IDQLY----LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALD 263
Query: 474 LLERCWQRDPSLRPDFSEITELLQH 498
L+ C + DP R ELLQH
Sbjct: 264 FLKACLRMDPKERLT---CDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 78/275 (28%), Positives = 131/275 (47%), Gaps = 16/275 (5%)
Query: 228 NHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRR 287
HV + +VWEI L G++ +YK E +E
Sbjct: 2 EHVRRDLDPNEVWEIIGEL-------GDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 54
Query: 288 EFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLR 347
++ E+ I+ H +V+ +GA +L+I+ EF GG++ + + GL P +
Sbjct: 55 DYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 114
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETGTY 406
+ + + + YLH IIHRDLKA N+L+ +G +K+ADFGV A+ + GT
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174
Query: 407 RWMAPEVI-----EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP 461
WMAPEV+ + PY+++AD++S GI L E+ + P+ +L P++ + + K P
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPP 233
Query: 462 TI--PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494
T+ P D L+ + P RP +++ E
Sbjct: 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 19/242 (7%)
Query: 271 VAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
AIKV+ + +N + E I+ + + VV+ + L++V E++ GG +
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 330 YDYLHKQKCGLKLP-LLLRVAI-DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
L L + R+ I ++ + YLH N IIHRDLK N+L++ NG +K+ DF
Sbjct: 81 ASLLENVGS---LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDF 137
Query: 388 GVARV-----QAQYGVMTAET----GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTG 438
G+++V Q E GT ++APEVI Q ++ D +S G +L+E + G
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
Query: 439 KLPYDDLTPLQAAVGVVQKGL--RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELL 496
P+ TP + + G P + +DL+ + DP R I E+
Sbjct: 198 IPPFHGETP-EEIFQNILNGKIEWPEDVEVS-DEAIDLISKLLVPDPEKRLGAKSIEEIK 255
Query: 497 QH 498
H
Sbjct: 256 NH 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 71/249 (28%), Positives = 136/249 (54%), Gaps = 9/249 (3%)
Query: 252 KIVSGSYCD--LYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI GS+ L K + IK + ++ R E +EV ++ ++H N+VQ+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHR 367
+ L+IV ++ GG +Y ++ Q+ G+ P +L + + + ++H I+HR
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRKILHR 125
Query: 368 DLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADV 425
D+K+ N+ + ++G +K+ DFG+ARV V A T GT +++PE+ E++PYN+++D+
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184
Query: 426 FSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485
++ G VL+E+ T K + + ++ V + +G P + H L +L+ + ++R+P
Sbjct: 185 WALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRD 243
Query: 486 RPDFSEITE 494
RP + I E
Sbjct: 244 RPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 73/234 (31%), Positives = 128/234 (54%), Gaps = 13/234 (5%)
Query: 269 QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
Q+VAIK + +L + ++E E+ +MR+ ++ N+V ++ + L++V E+++GG
Sbjct: 45 QEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
S+ D + + C + + V + + +++LH N +IHRD+K+ N+L+ +G VK+ DF
Sbjct: 102 SLTDVV-TETC-MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 159
Query: 388 G-VARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
G A++ + + GT WMAPEV+ + Y + D++S GI+ E+V G+ PY +
Sbjct: 160 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219
Query: 447 PLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
PL+A + G P + P + D L RC + D R ELLQH
Sbjct: 220 PLRALYLIATNG-TPELQNPERLSAVFRDFLNRCLEMDVDRR---GSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 71/247 (28%), Positives = 118/247 (47%), Gaps = 26/247 (10%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------PRLFIVTEFM 324
VA+K + + +F E M++ H NV++ IG C + P ++ FM
Sbjct: 29 VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88
Query: 325 SGGSIYDYLHKQKCG---LKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
G ++ +L + G LP +L++ D++ GM YL + IHRDL A N ++NEN
Sbjct: 89 KHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN 148
Query: 380 GVVKVADFGVARV--------QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIV 431
V VADFG+++ Q + M +W+A E + + Y ++DV+SFG+
Sbjct: 149 MNVCVADFGLSKKIYNGDYYRQGRIAKMPV-----KWIAIESLADRVYTTKSDVWSFGVT 203
Query: 432 LWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
+WE+ T G+ PY + + +++G R P L L+ CW +P RP F
Sbjct: 204 MWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFE 262
Query: 491 EITELLQ 497
+ L+
Sbjct: 263 TLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
E I++ +RH +V G+ L++V E++ GG ++ +L +K G R
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSG-------RFPEP 101
Query: 352 VSK--------GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET 403
V++ + YLH +I++RDLK NLL++ +G +K+ DFG A+ + T
Sbjct: 102 VARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRTYTL-C 159
Query: 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--RP 461
GT ++APE+I + Y D ++ GI+++E++ G P+ D P+Q + +K L +
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGKV 215
Query: 462 TIPVHTHPILVDLLERCWQRDPSLR 486
P P DL+ Q D + R
Sbjct: 216 RFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 73/217 (33%), Positives = 112/217 (51%), Gaps = 12/217 (5%)
Query: 292 EVHIMRKVRHMNVVQFIGACTR---PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRV 348
E+ +++ ++H +VQ+ G C R L I E+M GGS+ D L K L + +
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKY 111
Query: 349 AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA-RVQA--QYGV-MTAETG 404
+ +GM+YLH N I+HRD+K AN+L + G VK+ DFG + R+Q G + + TG
Sbjct: 112 TRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP 464
T WM+PEVI + Y +ADV+S G + E++T K P+ + + A + + P +P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231
Query: 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
H D L C + RP E+ L AQ
Sbjct: 232 SHISEHARDFL-GCIFVEARHRPSAEEL--LRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 73/262 (27%), Positives = 129/262 (49%), Gaps = 37/262 (14%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
Q VAIK ++ +++ +E+ +++++RH N+V I R RL++V EF+ +
Sbjct: 27 QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH-T 85
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
+ D L K GL + + + +G+ + H +NIIHRD+K N+L++++GVVK+ DFG
Sbjct: 86 VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFG 145
Query: 389 VARVQAQYGVMTAETGTYRWM-APEVIEHQP-YNHRADVFSFGIVLWELVTGK--LPYD- 443
AR A G + + RW APE++ Y D+++ G ++ E++TG+ P D
Sbjct: 146 FARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
Query: 444 -----------------------DLTPLQAAVGVVQ----KGLRPTIPVHTHPILVDLLE 476
PL A + + + + L P + +++DL +
Sbjct: 206 DIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLS-GLVLDLAK 264
Query: 477 RCWQRDPSLRPDFSEITELLQH 498
+C + DP RP S +LL H
Sbjct: 265 QCLRIDPDDRPSSS---QLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-29
Identities = 69/243 (28%), Positives = 124/243 (51%), Gaps = 8/243 (3%)
Query: 256 GSY--CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT- 312
GSY L + + IK L + + R+ QE ++ +++H N+V + +
Sbjct: 11 GSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG 70
Query: 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLK 370
L+IV F GG +Y L +QK G LP ++ + ++ + YLH +I+HRDLK
Sbjct: 71 EDGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLK 129
Query: 371 AANLLMNENGVVKVADFGVARV-QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFG 429
N+ + ++KV D G+ARV + Q + + GT +M+PE+ ++PYN+++DV++ G
Sbjct: 130 TQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALG 189
Query: 430 IVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDF 489
++E+ T K + + + + V + +G P +P P L +L+ + P RP
Sbjct: 190 CCVYEMATLKHAF-NAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSV 248
Query: 490 SEI 492
I
Sbjct: 249 KSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-29
Identities = 44/67 (65%), Positives = 51/67 (76%)
Query: 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLR 199
MHEIT + DKPKLLSQL+SLL ++GLNI EAHAFST DG +LD+FVV GW ET L
Sbjct: 1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALG 60
Query: 200 NVLAKEI 206
+ L KEI
Sbjct: 61 HALQKEI 67
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 9e-29
Identities = 72/215 (33%), Positives = 115/215 (53%), Gaps = 13/215 (6%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVA 349
E+ +++ + H +VQ+ G P L I E M GGSI D L K L + +
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT 112
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA-RVQ----AQYGVMTAETG 404
+ +G++YLH N I+HRD+K AN+L + G VK+ DFG + R+Q + G+ + TG
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TG 171
Query: 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP 464
T WM+PEVI + Y +AD++S G + E++T K P+ + + A + + P +P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231
Query: 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
H D L+R + + LRP ++ ELL+H
Sbjct: 232 PHVSDHCRDFLKRIFV-EAKLRP-SAD--ELLRHT 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 41/283 (14%)
Query: 248 KFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV----- 299
KF I GS+ + A +++ AIK+L L I+ + + V I ++V
Sbjct: 4 KFGKIIGEGSFSTVVL-AKEKETNKEYAIKILDKRQL---IKEKKVKYVKIEKEVLTRLN 59
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
H +++ L+ V E+ G + Y+ K L A ++ + YL
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEYL 118
Query: 360 HRNNIIHRDLKAANLLMNENGVVKVADFGVARV-------------------QAQYGVMT 400
H IIHRDLK N+L++++ +K+ DFG A+V Q +
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 401 AET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK- 457
+ GT +++PE++ +P +D+++ G ++++++TGK P+ QK
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----TFQKI 234
Query: 458 -GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSE-ITELLQH 498
L + P + P DL+E+ DP R +E EL H
Sbjct: 235 LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 73/264 (27%), Positives = 130/264 (49%), Gaps = 15/264 (5%)
Query: 248 KFEHKIVSGSYCDLYKGA--FFSQDVAIK-VLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
K E KI G + +YK + VA+K V E ++ R++ +E+ +++++ H NV
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV 64
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSI---YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR 361
++++ + L IV E G + + KQK + + + + + + ++H
Sbjct: 65 IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124
Query: 362 NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET----GTYRWMAPEVIEHQ 417
I+HRD+K AN+ + GVVK+ D G+ R + T GT +M+PE I
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGR---FFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 418 PYNHRADVFSFGIVLWELVTGKLP-YDDLTPLQAAVGVVQKGLRPTIPV-HTHPILVDLL 475
YN ++D++S G +L+E+ + P Y D L + ++K P +P H L DL+
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV 241
Query: 476 ERCWQRDPSLRPDFSEITELLQHL 499
RC DP RPD S + ++ + +
Sbjct: 242 SRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 65/180 (36%), Positives = 101/180 (56%), Gaps = 9/180 (5%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPP---RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRV 348
E+ +++ +RH +VQ+ G C R P +L I E+M GGSI D L K L + R
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRY 111
Query: 349 AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA-RVQAQYGVMT---AETG 404
+ +G++YLH N I+HRD+K AN+L + G VK+ DFG + R+Q T + TG
Sbjct: 112 TRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP 464
T WM+PEVI + Y +ADV+S + E++T K P+ + + A + + +P +P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 19/223 (8%)
Query: 244 ASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-R 300
A + + + +G+Y +YKG Q AIKV+ + E+ E E+++++K
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSH 71
Query: 301 HMNVVQFIGACTR--PP----RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVS 353
H N+ + GA + PP +L++V EF GS+ D + K LK + + ++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETGTYRWMAPE 412
+G+ +LH + +IHRD+K N+L+ EN VK+ DFGV A++ G GT WMAPE
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191
Query: 413 VI--EHQP---YNHRADVFSFGIVLWELVTGKLPYDDLTPLQA 450
VI + P Y++R+D++S GI E+ G P D+ P++A
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 75/247 (30%), Positives = 133/247 (53%), Gaps = 8/247 (3%)
Query: 252 KIVSGSYCDLY--KGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI GS+ +Y K S+ IK + + + +EV ++ K++H N+V F
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGL-KLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+ RLFIV E+ GG + +++Q+ L +L + +S G+ ++H I+HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 369 LKAANLLMNENGVV-KVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADV 425
+K+ N+ +++NG+V K+ DFG+AR Q + A T GT +++PE+ +++PYN++ D+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDI 185
Query: 426 FSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485
+S G VL+EL T K P++ Q + + Q P P + L L+ + ++ P
Sbjct: 186 WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD-LRSLISQLFKVSPRD 244
Query: 486 RPDFSEI 492
RP + I
Sbjct: 245 RPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 84/271 (30%), Positives = 137/271 (50%), Gaps = 23/271 (8%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDV--AIKVLTNEHLNENIRREFAQEVHI 295
+ WEI L G++ +YK V A KV+ + +E ++ E+ I
Sbjct: 5 EFWEIIGEL-------GDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDI 55
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
+ H N+V+ + A L+I+ EF +GG++ + + + L P + V +
Sbjct: 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETGTYRWMAPEVI 414
+NYLH N IIHRDLKA N+L +G +K+ADFGV A+ + GT WMAPEV+
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 415 -----EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHT 467
+ +PY+++ADV+S GI L E+ + P+ +L P++ + + K PT+ P
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRW 234
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQH 498
D L++C +++ R T+LLQH
Sbjct: 235 SSEFKDFLKKCLEKNVDAR---WTTTQLLQH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 3e-28
Identities = 72/234 (30%), Positives = 126/234 (53%), Gaps = 13/234 (5%)
Query: 269 QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
Q+VAI+ + +L + ++E E+ +MR+ ++ N+V ++ + L++V E+++GG
Sbjct: 46 QEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
S+ D + + C + + V + + + +LH N +IHRD+K+ N+L+ +G VK+ DF
Sbjct: 103 SLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 160
Query: 388 G-VARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
G A++ + + GT WMAPEV+ + Y + D++S GI+ E++ G+ PY +
Sbjct: 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
Query: 447 PLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
PL+A + G P + P I D L RC D R ELLQH
Sbjct: 221 PLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKR---GSAKELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 68/222 (30%), Positives = 116/222 (52%), Gaps = 24/222 (10%)
Query: 283 ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKL 342
++R++ +E+ IM + R +V F GA + + EFM GS+ D ++K+ + +
Sbjct: 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPV 102
Query: 343 PLLLRVAIDVSKGMNYL---HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM 399
+L ++A+ V +G+ YL HR I+HRD+K +N+L+N G +K+ DFGV+ +
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS---GELINS 157
Query: 400 TAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK 457
A+T GT +M+PE I+ Y ++DV+S GI + EL GK P+ + +
Sbjct: 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPM 216
Query: 458 GL-----------RPTIPVHTHP-ILVDLLERCWQRDPSLRP 487
G+ P +P P L D ++ C +DP+ RP
Sbjct: 217 GILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 77/220 (35%), Positives = 119/220 (54%), Gaps = 15/220 (6%)
Query: 251 HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFA---QEVHIMRKVRHMNVV 305
+I SG+Y D+YK + + AIKV+ E +FA QE+ +M+ +H N+V
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIV 69
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ G+ R +L+I EF GGS+ D H L + V+ + +G+ YLH +
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 366 HRDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETGTYRWMAPEV--IEHQ-PYNH 421
HRD+K AN+L+ +NG VK+ADFGV A++ A + GT WMAPEV +E + YN
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ 188
Query: 422 RADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP 461
D+++ GI EL + P DL P++A + + +P
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 56/159 (35%), Positives = 92/159 (57%), Gaps = 4/159 (2%)
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETG 404
L+ + V+ GM +L N +HRDL A N+L+ E +VK+ DFG+AR + ++
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300
Query: 405 TY---RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR 460
T+ +WMAPE I + Y +DV+SFGI+LWE+ T G PY +L + +++G R
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360
Query: 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
P H + +++++CW+ +RPDFS++ L+ L
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 77/238 (32%), Positives = 123/238 (51%), Gaps = 21/238 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ VA+K + L + RRE EV IMR H NVV + L++V EF+ GG
Sbjct: 48 KQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
++ D + + + + V + V + ++YLH +IHRD+K+ ++L+ +G +K++DF
Sbjct: 105 ALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDF 162
Query: 388 G-VARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
G A+V + + GT WMAPEVI PY D++S GI++ E++ G+ PY +
Sbjct: 163 GFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222
Query: 447 PLQAAVGVVQKGLRPTIPVH------THPILVDLLERCWQRDPSLRPDFSEITELLQH 498
PLQA + +R +P +L L+ R+PS R + ELLQH
Sbjct: 223 PLQA-----MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR---ATAQELLQH 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 58/193 (30%), Positives = 102/193 (52%), Gaps = 7/193 (3%)
Query: 252 KIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y +YK + VAIK + +E I + +E+ +++++ H N+++ +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
L++V EFM +Y + ++ GL L+ + +G+ + H + I+HRDL
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124
Query: 370 KAANLLMNENGVVKVADFGVARVQA-QYGVMTAETGTYRWM-APEVI-EHQPYNHRADVF 426
K NLL+N GV+K+ADFG+AR T T RW APE++ + Y+ D++
Sbjct: 125 KPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYSTPVDIW 183
Query: 427 SFGIVLWELVTGK 439
S G + EL++ +
Sbjct: 184 SVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 72/255 (28%), Positives = 119/255 (46%), Gaps = 36/255 (14%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L E N+N R +F +E+ IM +++ N+++ + C L ++TE+M G +
Sbjct: 49 VAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 331 DYLHK----------QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+L + + L+ +A ++ GM YL N +HRDL N L+ +N
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167
Query: 381 VVKVADFGVARVQAQ---YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT 437
+K+ADFG++R Y + RWM+ E I + +DV++FG+ LWE++T
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
Query: 438 --GKLPYDDLTPLQA-------------AVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482
+ PY L+ Q V + + L P L L+ CW+R+
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPD-------SLYKLMLSCWRRN 280
Query: 483 PSLRPDFSEITELLQ 497
RP F EI L
Sbjct: 281 AKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 89/283 (31%), Positives = 136/283 (48%), Gaps = 39/283 (13%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYK--GAFFSQDVAIKVLTNEHLNENIRREFAQEVHI 295
D WEI ++ K G+Y ++K A+K+L H +I E E +I
Sbjct: 18 DTWEIIETIGK-------GTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNI 67
Query: 296 MRKVR-HMNVVQFIGACTRPP-----RLFIVTEFMSGGSIYDYLH---KQKCGLKLPLLL 346
++ + H NVV+F G + +L++V E +GGS+ D + K+ ++ P++
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 347 RVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETGT 405
+ + G+ +LH N IHRD+K N+L+ G VK+ DFGV A++ + GT
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGT 187
Query: 406 YRWMAPEVI--EHQ---PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR 460
WMAPEVI E Q Y+ R DV+S GI EL G P DL P++A + R
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP----R 243
Query: 461 PTIPVHTHPILV-----DLLERCWQRDPSLRPDFSEITELLQH 498
P P L D + +C +D RP +++LLQH
Sbjct: 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 55/157 (35%), Positives = 86/157 (54%), Gaps = 4/157 (2%)
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR---VQAQYGVMTA 401
LL + V+KGM++L N IHRDL A N+L+ + K+ DFG+AR + Y V
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275
Query: 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR 460
+WMAPE I + Y +DV+S+GI+LWE+ + G PY + ++++G R
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335
Query: 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
P + D+++ CW DP RP F +I +L++
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 85/263 (32%), Positives = 130/263 (49%), Gaps = 31/263 (11%)
Query: 251 HKIVSGSYCDLY--KGAFFSQDVAIKVL------TNEHLNENIRREFAQEVHIMRKVRHM 302
+I GS+ +Y + ++ VAIK + +NE + I+ EV ++++RH
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-----EVRFLQQLRHP 75
Query: 303 NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN 362
N +++ G R ++V E+ G S D L K L+ + + +G+ YLH +
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 363 NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVI----EH 416
IHRD+KA N+L+ E G VK+ADFG A + V A + GT WMAPEVI E
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFVGTPYWMAPEVILAMDEG 189
Query: 417 QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI-PVHTHPILVDLL 475
Q Y+ + DV+S GI EL K P ++ + A + Q PT+ + +
Sbjct: 190 Q-YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLSSNDWSDYFRNFV 247
Query: 476 ERCWQRDPSLRPDFSEITELLQH 498
+ C Q+ P RP SE ELL+H
Sbjct: 248 DSCLQKIPQDRPS-SE--ELLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 63/166 (37%), Positives = 92/166 (55%), Gaps = 4/166 (2%)
Query: 340 LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR---VQAQY 396
L L L+ + V+KGM +L IHRDL A N+L++EN VVK+ DFG+AR Y
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVV 455
+WMAPE I + Y ++DV+SFG++LWE+ + G PY + + +
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295
Query: 456 QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
++G R P +T P + + CW +PS RP FSE+ E L +L Q
Sbjct: 296 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 65/223 (29%), Positives = 120/223 (53%), Gaps = 9/223 (4%)
Query: 273 IKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDY 332
I++ + E+ R+E ++ K++H N+V F + L+IV E+ GG +
Sbjct: 33 IRLPKSSSAVEDSRKEAV----LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQK 88
Query: 333 LHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390
+ Q+ G P +L+ + + G+ ++H ++HRD+K+ N+ + +NG VK+ DFG A
Sbjct: 89 IKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSA 147
Query: 391 RVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQ 449
R+ G GT ++ PE+ E+ PYN+++D++S G +L+EL T K P+ +
Sbjct: 148 RLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207
Query: 450 AAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
+ V Q +P +P H L L+++ ++R+P RP + I
Sbjct: 208 LILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 59/248 (23%), Positives = 118/248 (47%), Gaps = 11/248 (4%)
Query: 253 IVSGSYCDLYKGAFFSQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQ----F 307
I +YKG F +++V I+ H + + E+ +R++ N+++
Sbjct: 28 IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIH 366
I PRL ++ E+ + G + + L K+K L L +AID KG+ L++ N +
Sbjct: 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPY 146
Query: 367 RDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH--QPYNHRAD 424
++L + + L+ EN +K+ G+ ++ + Y + +++ Y + D
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDD 204
Query: 425 VFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPS 484
++S G+VLWE+ TGK+P+++LT + ++ K +P+ + ++E C D
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSI 264
Query: 485 LRPDFSEI 492
RP+ EI
Sbjct: 265 KRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/161 (36%), Positives = 89/161 (55%), Gaps = 4/161 (2%)
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR---VQAQYGVMTA 401
L+ + V++GM +L IHRDL A N+L++EN VVK+ DFG+AR Y +
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR 460
+WMAPE I + Y ++DV+SFG++LWE+ + G PY + + ++ G R
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295
Query: 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
P + P + ++ CWQ DP RP FS + E+L L Q
Sbjct: 296 MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 72/223 (32%), Positives = 121/223 (54%), Gaps = 19/223 (8%)
Query: 244 ASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-R 300
A + + + +G+Y +YKG Q AIKV+ + + E QE+++++K
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSH 61
Query: 301 HMNVVQFIGACTR--PP----RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVS 353
H N+ + GA + PP +L++V EF GS+ D + K LK + + ++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETGTYRWMAPE 412
+G+++LH++ +IHRD+K N+L+ EN VK+ DFGV A++ G GT WMAPE
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 181
Query: 413 VI--EHQP---YNHRADVFSFGIVLWELVTGKLPYDDLTPLQA 450
VI + P Y+ ++D++S GI E+ G P D+ P++A
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 224
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 69/221 (31%), Positives = 117/221 (52%), Gaps = 17/221 (7%)
Query: 251 HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
++ SG+Y D+YK + A+K++ E ++ QE+ ++++ +H N+V +
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD--FSLIQQEIFMVKECKHCNIVAYF 72
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL----LLRVAIDVSKGMNYLHRNNI 364
G+ +L+I E+ GGS+ D H + PL + V + +G+ YLH
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 365 IHRDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETGTYRWMAPEVI---EHQPYN 420
+HRD+K AN+L+ +NG VK+ADFGV A++ A + GT WMAPEV ++ YN
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 421 HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP 461
D+++ GI EL + P DL P++A + + +P
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 11/211 (5%)
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFM--SGGSIYDYLH-KQKCGLKLPLLLRVAID 351
+MR +V+F GA R +I E M S Y Y++ K + +L ++A+
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 352 VSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMA 410
K +NYL IIHRD+K +N+L++ NG +K+ DFG++ T + G +MA
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 175
Query: 411 PEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG----LRPTI 463
PE I+ Y+ R+DV+S GI L+E+ TGK PY + + V KG L +
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235
Query: 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494
P V+ + C +D S RP + E+ E
Sbjct: 236 EREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 59/165 (35%), Positives = 95/165 (57%), Gaps = 4/165 (2%)
Query: 340 LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR---VQAQY 396
L L LLR + V++GM++L N IHRD+ A N+L+ + V K+ DFG+AR + Y
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268
Query: 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVV 455
V +WMAPE I Y ++DV+S+GI+LWE+ + GK PY + +V
Sbjct: 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328
Query: 456 QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500
++G + + P P + +++ CW +P+ RP FS+I++L+Q
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 71/254 (27%), Positives = 122/254 (48%), Gaps = 19/254 (7%)
Query: 256 GSYCDLYKGAFFSQDVAIKVLTNE---HLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312
G+Y +YK + + + E L+E+ + E+ I+ K +V F GA
Sbjct: 12 GNYGSVYK--VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF 69
Query: 313 RPPRLFIVTEFMSGGSIYDYLH---KQKCGLKLPLLLRVAIDVSKGMNYL-HRNNIIHRD 368
+++ E+M GS+ D L+ G+ +L R+ V KG+ +L +NIIHRD
Sbjct: 70 IEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128
Query: 369 LKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ------PYNHR 422
+K N+L+N NG VK+ DFGV+ + G +MAPE I+ Y +
Sbjct: 129 VKPTNVLVNGNGQVKLCDFGVSG-NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ 187
Query: 423 ADVFSFGIVLWELVTGKLPY--DDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480
+DV+S G+ + E+ G+ PY + + A + + G PT+P D + +C
Sbjct: 188 SDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLN 247
Query: 481 RDPSLRPDFSEITE 494
+ P+ RP ++++ E
Sbjct: 248 KIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 6/199 (3%)
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
E I++++ H +V + +++V + + GG + +L ++ + + +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE 108
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET-GTYRWM 409
V + YLH IIHRD+K N+L++E G V + DF +A + +T T GT +M
Sbjct: 109 IVL-ALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIAT-KVTPDTLTTSTSGTPGYM 166
Query: 410 APEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD--DLTPLQAAVGVVQKGLRPTIPVHT 467
APEV+ Q Y+ D +S G+ +E + GK PY T Q+ P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA-KQETADVLYPATW 225
Query: 468 HPILVDLLERCWQRDPSLR 486
+D + + +RDP R
Sbjct: 226 STEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 54/210 (25%), Positives = 111/210 (52%), Gaps = 5/210 (2%)
Query: 292 EVHIMRK-VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDY---LHKQKCGLKLPLLLR 347
EV I+++ +RH N+V++ RL+IV + + G + ++ L ++K +
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 348 VAIDVSKGMNYLHRNN-IIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY 406
+ + + + YLH+ I+HRDL N+++ E+ V + DFG+A+ + +T+ GT
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466
+ PE+++++PY +ADV++FG +L+++ T + P+ L A +V+ P
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 467 THPILVDLLERCWQRDPSLRPDFSEITELL 496
+ D++ C D RPD +++ ++
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 54/165 (32%), Positives = 88/165 (53%), Gaps = 4/165 (2%)
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398
GL LL V++GM +L N +HRDL A N+L+ + +VK+ DFG+AR
Sbjct: 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN 292
Query: 399 MTAETGTY---RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGV 454
++ T+ +WMAPE I Y +DV+S+GI+LWE+ + G PY +
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352
Query: 455 VQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
++ G R P H + D++ +CW +P RP F ++++++ L
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 72/283 (25%), Positives = 135/283 (47%), Gaps = 28/283 (9%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEV 293
EI+ S ++F ++ + +YKG F +Q VAIK L ++ +R EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59
Query: 294 HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL-----HKQ----------KC 338
+ +++H N+V +G T+ L ++ + S ++++L H K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR---VQAQ 395
L+ + + ++ GM +L ++++H+DL N+L+ + VK++D G+ R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGV 454
Y +M RWM+PE I + ++ +D++S+G+VLWE+ + G PY + Q + +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVIEM 238
Query: 455 VQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
++ P + L+ CW PS RP F +I L+
Sbjct: 239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 67/230 (29%), Positives = 115/230 (50%), Gaps = 22/230 (9%)
Query: 289 FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP----L 344
F QEV R++ H NV+Q +G C +V EF G + +YL + + +
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA--RVQAQYGVMTAE 402
L R+A +V+ G+ +LH+ + IH DL N + + VK+ D+G+A + Y +T +
Sbjct: 102 LQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-YITKD 160
Query: 403 TGTY--RWMAPEVIEHQPYN-------HRADVFSFGIVLWELVT-GKLPYDDLTPLQAAV 452
RW+APE++E + + +++++S G+ +WEL T PY DL+ Q
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK 220
Query: 453 GVVQ----KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
VV+ K +P + + ++++ CW DP RP E+ ELL +
Sbjct: 221 QVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 48/171 (28%), Positives = 90/171 (52%), Gaps = 4/171 (2%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K + L I + +E+ ++ +H VV+ + +V E+M +
Sbjct: 28 VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLS 86
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390
+ L ++ L + + KG+ Y+H N I+HRDLK ANLL++ +GV+K+ADFG+A
Sbjct: 87 EVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146
Query: 391 RVQAQYG--VMTAETGTYRWMAPEVIEHQP-YNHRADVFSFGIVLWELVTG 438
R+ ++ + + + T + APE++ Y+ D+++ G + EL+ G
Sbjct: 147 RLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 59/219 (26%), Positives = 110/219 (50%), Gaps = 8/219 (3%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+KVL + + ++ E E ++ +H + Q RLF V E+++GG +
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL 83
Query: 330 YDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
H Q+ G P A ++ G+ +LH II+RDLK N+L++ G +K+ADFG
Sbjct: 84 M--FHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFG 141
Query: 389 VARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP 447
+ + GV T+ GT ++APE++ +QPY D ++ G++L+E++ G+ P++
Sbjct: 142 MCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201
Query: 448 LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
+ +++ +R P +L+ ++P R
Sbjct: 202 DELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 66/262 (25%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIK-VLTNEHLNENIRREFAQEVHIMRKVRHMN 303
+ E KI G + ++Y+ + VA+K V E ++ R++ +E+ +++++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
V++++ + L IV E G + Y KQK + + + + + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVIEHQPY 419
++HRD+K AN+ + GVVK+ D G+ R ++ + GT +M+PE I Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 420 NHRADVFSFGIVLWELVTGKLP-YDDLTPLQAAVGVVQKGLRPTIPV-HTHPILVDLLER 477
N ++D++S G +L+E+ + P Y D L + +++ P +P H L +L+
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243
Query: 478 CWQRDPSLRPDFSEITELLQHL 499
C DP RPD + ++ + +
Sbjct: 244 CIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 64/216 (29%), Positives = 115/216 (53%), Gaps = 6/216 (2%)
Query: 281 LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCG 339
LN N + QE ++ K+ H +V+F + I+TE+ G + L + + G
Sbjct: 41 LNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG 100
Query: 340 LKL--PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQY 396
L + I + G++Y+H+ I+HRDLKA N+ + N ++K+ DFGV+R +
Sbjct: 101 KTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSC 159
Query: 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ 456
+ T TGT +M+PE ++HQ Y+ ++D++S G +L+E+ ++ L + +V+
Sbjct: 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
Query: 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
G P++P L +++ +DPSLRP +EI
Sbjct: 220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 63/262 (24%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQDVAI---KVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
+ E KI G + ++Y+ V + KV + ++ R + +E+ +++++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSI---YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
V+++ + L IV E G + + KQK + + + + + + ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVIEHQPY 419
++HRD+K AN+ + GVVK+ D G+ R ++ + GT +M+PE I Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 420 NHRADVFSFGIVLWELVTGKLP-YDDLTPLQAAVGVVQKGLRPTIPV-HTHPILVDLLER 477
N ++D++S G +L+E+ + P Y D L + +++ P +P H L L+
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243
Query: 478 CWQRDPSLRPDFSEITELLQHL 499
C DP RPD + + ++ + +
Sbjct: 244 CINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 26/191 (13%)
Query: 272 AIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+K + H+ E + E I+ + H +V+ ++++ E+ GG ++
Sbjct: 22 ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKG----------MNYLHRNNIIHRDLKAANLLMNENG 380
L R D YLH II+RDLK NLL++ NG
Sbjct: 82 TILRD-----------RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG 130
Query: 381 VVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK 439
VK+ DFG A+ + + G T GT ++APE+I ++ Y+ D +S GI+L+EL+TG+
Sbjct: 131 YVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
Query: 440 LPY--DDLTPL 448
P+ DD P+
Sbjct: 190 PPFGEDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 36/210 (17%)
Query: 251 HKIVSGSYCDLYK------GAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
+I G+Y +YK G VA+K + E+ E +E+ +++K+RH N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGEL----VALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 305 VQFIGACTRPPR--LFIVTEFMS---GGSIYDYLHK----Q-KCGLKLPLLLRVAIDVSK 354
V+ T + +++V E+M G + K Q KC +K LL +
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-QLL--------E 111
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA--QYGVMTAETGT--YRWMA 410
G+ YLH N I+HRD+K +N+L+N +GV+K+ADFG+AR T T YR
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR--P 169
Query: 411 PEVIEHQP-YNHRADVFSFGIVLWELVTGK 439
PE++ Y D++S G +L EL GK
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 76/278 (27%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
+ D + L+ +I SG+ +YK F +A+K + E +R I+
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR-------ILM 62
Query: 298 KVRHM-------NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRV 348
+ + +V+ G +FI E MS + D L ++ +P +L ++
Sbjct: 63 DLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKL-LKRIQGPIPEDILGKM 119
Query: 349 AIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYR 407
+ + K ++YL +IHRD+K +N+L++ +G VK+ DFG++ T G
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 408 WMAPEVIEHQP----YNHRADVFSFGIVLWELVTGKLPYDDL-TPLQAAVGVVQKGLRPT 462
+MAPE I+ Y+ RADV+S GI L EL TG+ PY + T + ++Q+ P+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-PS 238
Query: 463 IPVHTH--PILVDLLERCWQRDPSLRPDFSEITELLQH 498
+P + P ++ C +D RP + ELLQH
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYR---ELLQH 273
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 76/303 (25%), Positives = 123/303 (40%), Gaps = 75/303 (24%)
Query: 248 KFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHL---NENIRREFAQEVHIMRK 298
+ K+ G+Y +YK +D VAIK + + I +E+ ++++
Sbjct: 3 EKGKKLGEGTYAVVYKA----RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE 58
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSG--------GSIYDYLHKQKCGLKLPLLLRVAI 350
++H N++ + + +V EFM SI K + + L
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTL------ 112
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG----VMTAETGTY 406
+G+ YLH N I+HRDLK NLL+ +GV+K+ADFG+AR +G MT + T
Sbjct: 113 ---RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR---SFGSPNRKMTHQVVT- 165
Query: 407 RWM-APEVI---EHQPYNHRADVFSFGIVLWELVTGKLPY-------DDLTPLQAAVG-- 453
RW APE++ H Y D++S G + EL+ P+ D L + A+G
Sbjct: 166 RWYRAPELLFGARH--YGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTP 222
Query: 454 ------VVQKGLRPTIPVHTHPI------------LVDLLERCWQRDPSLRPDFSEITEL 495
V P +DLL+R +P+ R +
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI---TARQA 279
Query: 496 LQH 498
L+H
Sbjct: 280 LEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 87/284 (30%), Positives = 133/284 (46%), Gaps = 41/284 (14%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD---VAIKVLTNEHLNENIRREFAQEVH 294
D WEI ++ K G+Y +YK +D A+K+L ++ E E +
Sbjct: 22 DTWEIIETIGK-------GTYGKVYKVTN-KKDGSLAAVKILDPI---SDVDEEIEAEYN 70
Query: 295 IMRKV-RHMNVVQFIGACTRPPR-----LFIVTEFMSGGSIYDYLHKQ-KCGLKL--PLL 345
I++ + H NVV+F G + + L++V E +GGS+ + + CG +L ++
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 346 LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV-ARVQAQYGVMTAETG 404
+ G+ +LH N IIHRD+K N+L+ G VK+ DFGV A++ + G
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 190
Query: 405 TYRWMAPEVI--EHQ---PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL 459
T WMAPEVI E Q Y+ R DV+S GI EL G P D+ P++ +
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP---- 246
Query: 460 RPTIPVHTHP-----ILVDLLERCWQRDPSLRPDFSEITELLQH 498
R P HP + +C +D RP +T LL+H
Sbjct: 247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARP---SVTHLLEH 287
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 4e-23
Identities = 74/236 (31%), Positives = 117/236 (49%), Gaps = 14/236 (5%)
Query: 262 YKGAFFSQD------VAIKVLTNEHLNENIR-REFAQEVHIMRKVRHMNVVQFIGACTRP 314
+ +F++D VAIK ++ N + ++ +EV ++K+RH N +Q+ G R
Sbjct: 28 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87
Query: 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
++V E+ G S D L K L+ + V +G+ YLH +N+IHRD+KA N+
Sbjct: 88 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146
Query: 375 LMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVI---EHQPYNHRADVFSFGIV 431
L++E G+VK+ DFG A + A GT WMAPEVI + Y+ + DV+S GI
Sbjct: 147 LLSEPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 432 LWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRP 487
EL K P ++ + A + Q H + ++ C Q+ P RP
Sbjct: 204 CIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 4e-23
Identities = 77/261 (29%), Positives = 133/261 (50%), Gaps = 12/261 (4%)
Query: 252 KIVSGSYCDLY--KGAFFSQDVAIKVLTNEHLNENIR-REFAQEVHIMRKVRHMNVVQFI 308
+I GS+ +Y + ++ VAIK ++ N + ++ +EV +++++H N +++
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G R ++V E+ G S D L K L+ + + +G+ YLH +N+IHRD
Sbjct: 92 GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 369 LKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVI---EHQPYNHRADV 425
+KA N+L+ E G VK+ADFG A + + + GT WMAPEVI + Y+ + DV
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDV 207
Query: 426 FSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHT-HPILVDLLERCWQRDPS 484
+S GI EL K P ++ + A + Q PT+ + + ++ C Q+ P
Sbjct: 208 WSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQSNEWSDYFRNFVDSCLQKIPQ 266
Query: 485 LRPDFSEITELLQHLAQRLQT 505
RP E+ + + L +R +T
Sbjct: 267 DRPTSEELLKHMFVLRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 49/130 (37%), Positives = 83/130 (63%), Gaps = 4/130 (3%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
RL+ V E+++GG + H Q+ G K P + A ++S G+ +LHR II+RDLK N+
Sbjct: 75 RLYFVMEYVNGGDLM--YHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNV 132
Query: 375 LMNENGVVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
+++ G +K+ADFG+ + GV T GT ++APE+I +QPY D +++G++L+
Sbjct: 133 MLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLY 192
Query: 434 ELVTGKLPYD 443
E++ G+ P+D
Sbjct: 193 EMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 57/175 (32%), Positives = 96/175 (54%), Gaps = 12/175 (6%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
LF V E+++GG + H Q G A ++ G+ +LH+ II+RDLK N+L
Sbjct: 71 LFFVMEYLNGGDLM--FHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVL 128
Query: 376 MNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
++++G +K+ADFG+ + G A T GT ++APE+++ Q YN D +SFG++L+
Sbjct: 129 LDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLY 187
Query: 434 ELVTGKLPY--DDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
E++ G+ P+ +D L ++ RP P D L + ++RDP+ R
Sbjct: 188 EMLIGQSPFHGEDEDELFDSILND----RPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 9e-23
Identities = 71/228 (31%), Positives = 120/228 (52%), Gaps = 6/228 (2%)
Query: 272 AIKVLTNEH-LNENIRREFAQEVHIMRK-VRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+KVL + LN ++ E +++ K V+H +V + +L+ V +F++GG +
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
+ +L +++ P A +++ + YLH NI++RDLK N+L++ G V + DFG+
Sbjct: 84 FFHLQRERS-FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL 142
Query: 390 ARVQ-AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL 448
+ AQ T GT ++APEVI QPY++ D + G VL+E++ G P+
Sbjct: 143 CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202
Query: 449 QAAVGVVQKGL--RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494
+ ++ K L RP + IL +LLE+ QR + DF EI E
Sbjct: 203 EMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 47/130 (36%), Positives = 81/130 (62%), Gaps = 4/130 (3%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
RL+ V E+++GG + H Q+ G K P + A +++ G+ +LH II+RDLK N+
Sbjct: 75 RLYFVMEYVNGGDLM--YHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 375 LMNENGVVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
+++ G +K+ADFG+ + G T GT ++APE+I +QPY D ++FG++L+
Sbjct: 133 MLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 192
Query: 434 ELVTGKLPYD 443
E++ G+ P+D
Sbjct: 193 EMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 80/284 (28%), Positives = 135/284 (47%), Gaps = 46/284 (16%)
Query: 252 KIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKVRHMNVVQF 307
K+ G+Y +YKG + VA+K + HL+ E +E+ +M++++H N+V+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 308 IGACTRPPRLFIVTEFMSGG-SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+L +V E+M Y H + L + + KG+ + H N ++H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 367 RDLKAANLLMNENGVVKVADFGVARVQAQYGV----MTAETGTYRWMAPEVI-EHQPYNH 421
RDLK NLL+N+ G +K+ADFG+AR +G+ + E T + AP+V+ + Y+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARA---FGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180
Query: 422 RADVFSFGIVLWELVTGKLPY------DDL--------TPLQAAV-GVVQ-KGLRPTIPV 465
D++S G ++ E++TG+ + D L TP ++ G+ Q +PT P
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPR 240
Query: 466 -----------HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
H P+ +DLL R Q +P LR + LQH
Sbjct: 241 YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS---AHDALQH 281
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 77/256 (30%), Positives = 130/256 (50%), Gaps = 17/256 (6%)
Query: 251 HKIVSGSYCDLY--KGAFFSQDVAIKVLT--NEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
H+I GS+ +Y + ++ VA+K ++ + NE + + +EV +++++H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ-DIIKEVKFLQQLKHPNTIE 85
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+ G + ++V E+ G S D L K L+ + + +G+ YLH +N+IH
Sbjct: 86 YKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 144
Query: 367 RDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVI---EHQPYNHRA 423
RD+KA N+L+ E G VK+ADFG A + + GT WMAPEVI + Y+ +
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 424 DVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHT-HPILVDLLERCWQRD 482
DV+S GI EL K P ++ + A + Q PT+ + ++ C Q+
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLQSNEWTDSFRGFVDYCLQKI 260
Query: 483 PSLRPDFSEITELLQH 498
P RP + ELL+H
Sbjct: 261 PQERPASA---ELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 7e-22
Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 16/189 (8%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
L++V E+++GG L K GL + +V G+ LH+ IIHRD+K NLL+
Sbjct: 72 LYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 377 NENGVVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWEL 435
++ G +K+ DFG++R G+ + GT ++APE I + +D +S G V++E
Sbjct: 131 DQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 436 VTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH------PILVDLLERCWQRDPSLRPDF 489
+ G P+ TP V L I P VDL+ R DP+ R
Sbjct: 187 LFGYPPFHAETPDA----VFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGA 242
Query: 490 SEITELLQH 498
+ E+ H
Sbjct: 243 NGYQEIKSH 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 59/212 (27%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 291 QEVHIM-------RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP 343
+E HIM + V+H +V + +L+ V ++++GG ++ +L +++C L+ P
Sbjct: 38 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-P 96
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAE 402
A +++ + YLH NI++RDLK N+L++ G + + DFG+ + ++ G +
Sbjct: 97 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF 156
Query: 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK--GLR 460
GT ++APEV+ QPY+ D + G VL+E++ G P+ + ++ K L+
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 216
Query: 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
P I +L LL++ + + DF EI
Sbjct: 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 68/238 (28%), Positives = 123/238 (51%), Gaps = 18/238 (7%)
Query: 264 GAFFSQDVAIKVLTNEHLNENIRRE--FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321
G+F+ A+KVL + + + + A+ +++ ++H +V + +L+ V
Sbjct: 20 GSFY----AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75
Query: 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
++++GG ++ +L +++C L+ P A +V+ + YLH NII+RDLK N+L++ G
Sbjct: 76 DYVNGGELFFHLQRERCFLE-PRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH 134
Query: 382 VKVADFGVARVQAQYGVMTAET-----GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
V + DFG+ + GV ET GT ++APEV+ +PY+ D + G VL+E++
Sbjct: 135 VVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
Query: 437 TGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
G P+ Q ++ K L+ V +LV LL + +R + DF EI
Sbjct: 191 YGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 52/172 (30%), Positives = 97/172 (56%), Gaps = 2/172 (1%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD 331
A+KVL L R E I+ +V H +V+ A +L+++ +F+ GG ++
Sbjct: 28 AMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 87
Query: 332 YLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391
L K+ + + +A +++ +++LH II+RDLK N+L++E G +K+ DFG+++
Sbjct: 88 RLSKEVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
Query: 392 VQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
+ GT +MAPEV+ + + AD +SFG++++E++TG LP+
Sbjct: 147 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y +YKG Q VA+K + E E + +E+ ++++++H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLL--RVAIDVSKGMNYLHRNNIIHR 367
+ RL+++ EF+S + YL G + L + +G+ + H ++HR
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125
Query: 368 DLKAANLLMNENGVVKVADFGVARVQAQYG----VMTAETGTYRWMAPEVIEHQP-YNHR 422
DLK NLL++ GV+K+ADFG+AR +G V T E T + APEV+ P Y+
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLARA---FGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 423 ADVFSFGIVLWELVTGK 439
D++S G + E+ T K
Sbjct: 183 VDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 46/130 (35%), Positives = 81/130 (62%), Gaps = 4/130 (3%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
RL+ V E+++GG + Q+ G K P + A +++ G+ +LH II+RDLK N+
Sbjct: 75 RLYFVMEYVNGGDLM--YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 375 LMNENGVVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
+++ G +K+ADFG+ + GV T GT ++APE+I +QPY D ++FG++L+
Sbjct: 133 MLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 192
Query: 434 ELVTGKLPYD 443
E++ G+ P++
Sbjct: 193 EMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 66/240 (27%), Positives = 120/240 (50%), Gaps = 34/240 (14%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIM-------RKVRHMNVVQFIGACTRPPRLFIVTEFM 324
A+KVL + + + ++ HIM + V+H +V + +L+ V +++
Sbjct: 24 AVKVLQKKAI-----LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384
+GG ++ +L +++ + P A +++ + YLH NII+RDLK N+L++ G V +
Sbjct: 79 NGGELFFHLQRERSFPE-PRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVL 137
Query: 385 ADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP-- 441
DFG+ + ++ T+ GT ++APEV+ QPY+ D + G VL+E++ G P
Sbjct: 138 TDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
Query: 442 -------YDDL--TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
YD++ PL+ L+P I V +L LL++ + + DF EI
Sbjct: 198 SRDTAEMYDNILNKPLR---------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 60/234 (25%), Positives = 112/234 (47%), Gaps = 24/234 (10%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
V +KVL ++H F + +M ++ H ++V+ G C R + +V E++ G +
Sbjct: 33 VVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLD 88
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV-------VK 383
+LH++K + L L VA ++ ++YL ++H ++ N+L+ G+ +K
Sbjct: 89 VFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148
Query: 384 VADFGVARVQAQYGVMTAETGTYR--WMAPEVIEHQPYNHR--ADVFSFGIVLWELVT-G 438
++D G+ V++ E R W+APE I + + AD +SFG L E+ + G
Sbjct: 149 LSDPGIPI-----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203
Query: 439 KLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
+ P L+ + + +P+ L +L+ +CW DP+ RP F I
Sbjct: 204 EEPLSTLSSSEKERFYQDQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 80/291 (27%), Positives = 133/291 (45%), Gaps = 49/291 (16%)
Query: 248 KFEH--KIVSGSYCDLYK------GAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
K+E KI GSY ++K G Q VAIK + I++ +E+ +++++
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETG----QIVAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
+H N+V I R +L +V E+ ++ + L K G+ L+ ++ + +N+
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 360 HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWM-APEVI--EH 416
H++N IHRD+K N+L+ + G +K+ DFG AR+ G + RW APE++ +
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 417 QPYNHRADVFSFGIVLWELVT------GKLPYDDLTPLQAAVGVVQ-------------K 457
Q Y DV++ G V EL+T GK D L ++ +G + K
Sbjct: 177 Q-YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 458 GLRPTIPVHTHPI----------LVDLLERCWQRDPSLRPDFSEITELLQH 498
GL P P+ + L+ C Q DP+ R ELL+H
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTER---LSCEELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 58/178 (32%), Positives = 98/178 (55%), Gaps = 18/178 (10%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
LF V EF++GG + H Q G L A ++ G+ +LH II+RDLK N++
Sbjct: 71 LFFVMEFLNGGDLM--FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128
Query: 376 MNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
++ +G +K+ADFG+ + + +G A T GT ++APE+++ Y D +SFG++L+
Sbjct: 129 LDRDGHIKIADFGMCK-ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLY 187
Query: 434 ELVTGKLPY--DDLTPLQAAVGVVQKGLRPTIPVHTHPILV---DLLERCWQRDPSLR 486
E++ G+ P+ DD L ++ R P + I D+LE+ ++RDP+ R
Sbjct: 188 EMLIGQSPFHGDDEDELFESI-------RVDTPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 3/198 (1%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI-YDYLHKQKCGLKLPLLLRVAI 350
E I+ KV +V A L +V M+GG + Y + + G + A
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMA 410
+ G+ +LH+ I++RDLK N+L++++G V+++D G+A + GT +MA
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMA 162
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--TIPVHTH 468
PEV++ + Y+ D F+ G L+E++ G+ P+ + ++ L P
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFS 222
Query: 469 PILVDLLERCWQRDPSLR 486
P DL E Q+DP R
Sbjct: 223 PEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 5e-20
Identities = 76/266 (28%), Positives = 118/266 (44%), Gaps = 50/266 (18%)
Query: 271 VAIKVLTN--EHLNE--NIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMS 325
VAIK + E N+R EV +RK+ H N+V+ L+ V E+M
Sbjct: 27 VAIKKMKKKFYSWEECMNLR-----EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYME 81
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384
G ++Y + +K ++R I + +G+ ++H++ HRDLK NLL++ VVK+
Sbjct: 82 G-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKI 140
Query: 385 ADFGVARVQAQYGVMTAETGTYRWM-APEVIEHQP-YNHRADVFSFGIVLWELVTGKLP- 441
ADFG+AR T T RW APE++ Y+ D+++ G ++ EL T + P
Sbjct: 141 ADFGLAREIRSRPPYTDYVST-RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR-PL 198
Query: 442 ------YDDL--------TP----------LQAAVG-----VVQKGLRPTIPVHTHPILV 472
D L TP L + +G L IP + P +
Sbjct: 199 FPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAI 257
Query: 473 DLLERCWQRDPSLRPDFSEITELLQH 498
DL++ + DP RP S+ LQH
Sbjct: 258 DLIKDMLRWDPKKRPTASQA---LQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 20/232 (8%)
Query: 286 RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKL--- 342
+ +F +E R ++H N++Q +G CT +V EF G + YL + +
Sbjct: 39 QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPD 98
Query: 343 PLLL-RVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401
P L R+A +++ G+ +LH+NN IH DL N L+ + VK+ D+G++ + +
Sbjct: 99 PTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158
Query: 402 ETGTY---RWMAPEVIEHQPYN-------HRADVFSFGIVLWELVT-GKLPYDDLTPLQA 450
+ RW+APE+++ N ++V+S G+ +WEL G PY L+ Q
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218
Query: 451 AVGVVQ----KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
V+ K +P + + ++++ CW + P RP E+ LL +
Sbjct: 219 LTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEVHLLLSY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 88/312 (28%), Positives = 130/312 (41%), Gaps = 86/312 (27%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTN--EHLNENIRREFAQEVHIMRK 298
+ I SG+Y G S + VAIK ++N + L + +R +E+ ++R
Sbjct: 3 ELLKPIGSGAY-----GVVCSAVDKRTGRKVAIKKISNVFDDL-IDAKRIL-REIKLLRH 55
Query: 299 VRHMNVVQFIGACTRPPR------LFIVTEFMSGGSIYDYLHKQ-KCGLKLPL------- 344
+RH N++ + RPP ++IVTE M D LHK K L
Sbjct: 56 LRHENIIGLLDI-LRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQYFL 109
Query: 345 --LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ----AQYGV 398
+LR G+ YLH N+IHRDLK +N+L+N N +K+ DFG+AR + G
Sbjct: 110 YQILR-------GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 399 MTAETGT--YRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGK--LP----YDDLTPLQ 449
+T T YR APE++ Y D++S G + EL+T K P D L +
Sbjct: 163 LTEYVVTRWYR--APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV 220
Query: 450 AAVG------------------VVQKGLRPTIPVHT-----HPILVDLLERCWQRDPSLR 486
+G + +P P+ P +DLLE+ DP R
Sbjct: 221 EVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR 280
Query: 487 PDFSEITELLQH 498
E L H
Sbjct: 281 I---TADEALAH 289
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 53/186 (28%), Positives = 84/186 (45%), Gaps = 21/186 (11%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIMR----------KVRHMNVVQFIGACTRPPRLFIVT 321
AIK L + EV + RH +V + V
Sbjct: 28 AIKALKKGDIIAR------DEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81
Query: 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
E+ +GG + +H P + A V G+ YLH N I++RDLK NLL++ G
Sbjct: 82 EYAAGGDLM--MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF 139
Query: 382 VKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKL 440
VK+ADFG+ + +G T+ GT ++APEV+ Y D + G++++E++ G+
Sbjct: 140 VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
Query: 441 PY--DD 444
P+ DD
Sbjct: 200 PFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 77/275 (28%), Positives = 113/275 (41%), Gaps = 63/275 (22%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR------LFIVTEFM 324
VAIK + N N + +E+ ++R + H NV+ I PP ++IV E M
Sbjct: 33 VAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA-IKDIMPPPHREAFNDVYIVYELM 91
Query: 325 SGGSIYDYLHK----------QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
LH+ C L LLR G+ Y+H N++HRDLK +NL
Sbjct: 92 DTD-----LHQIIRSSQTLSDDHCQYFLYQLLR-------GLKYIHSANVLHRDLKPSNL 139
Query: 375 LMNENGVVKVADFGVARVQ-AQYGVMTAETGTYRWMAPEVI-EHQPYNHRADVFSFGIVL 432
L+N N +K+ DFG+AR + MT T + APE++ Y DV+S G +
Sbjct: 140 LLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIF 199
Query: 433 WELVTGK--LPYDDL------------TPLQAAVG----------VVQKGLRPTIPV--- 465
EL+ K P D +P + +G + P
Sbjct: 200 AELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARL 259
Query: 466 --HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
H +P+ +DLLE+ DPS R + E L H
Sbjct: 260 FPHANPLAIDLLEKMLVFDPSKR---ITVEEALAH 291
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 46/155 (29%), Positives = 90/155 (58%), Gaps = 3/155 (1%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI-YDYLHKQKCGLKLPLLLRVAI 350
E I+ KV +V A L +V M+GG + Y + + GL++ ++ +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTYRWM 409
++ G+ +LH +I++RD+K N+L+++ G +++D G+A V+ + G +T GT +M
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYM 161
Query: 410 APEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444
APE+++ +PY++ D F+ G ++E+V G+ P+ D
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 66/251 (26%), Positives = 115/251 (45%), Gaps = 42/251 (16%)
Query: 285 IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
IR + +E+ ++ + +V F GA + I E M GGS+ D + K+ + +
Sbjct: 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENI 100
Query: 345 LLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET 403
L +++I V +G+ YL I+HRD+K +N+L+N G +K+ DFGV+ Q + +
Sbjct: 101 LGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFV 159
Query: 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK--LPYDDLTPLQAAVGVVQKGL-- 459
GT +M+PE ++ Y ++D++S G+ L E+ G+ +P D L+A G
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEA 219
Query: 460 -RPTIPVHTH----------------------PIL---------VDLLERCWQRDPSLRP 487
PV H P L D +++C +++P R
Sbjct: 220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA 279
Query: 488 DFSEITELLQH 498
D + EL +H
Sbjct: 280 D---LKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 51/177 (28%), Positives = 103/177 (58%), Gaps = 8/177 (4%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRP-PRLFIVTEFMSGGSI 329
A+KV+ E +N++ ++ Q E H+ + + + + +C + RLF V E+++GG +
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 330 YDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
++ +Q+ KLP + ++S +NYLH II+RDLK N+L++ G +K+ D+
Sbjct: 84 MFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 140
Query: 388 GVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD 443
G+ + + G T+ GT ++APE++ + Y D ++ G++++E++ G+ P+D
Sbjct: 141 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-19
Identities = 68/257 (26%), Positives = 130/257 (50%), Gaps = 25/257 (9%)
Query: 263 KGAFFSQDVAIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321
+G+ + V K + LN+ + +A+ E+H + H +V+ +L ++
Sbjct: 88 RGSDPKEKVVAKFVM---LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 322 EFMSGGSIYDYLHKQKCGLKLPL------LLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
E+ SGG + + KQ+ LP LL I ++ ++ +H ++HRDLK+AN+
Sbjct: 145 EYGSGGDLNKQI-KQRLKEHLPFQEYEVGLLFYQIVLA--LDEVHSRKMMHRDLKSANIF 201
Query: 376 MNENGVVKVADFGVARVQAQYG------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFG 429
+ G++K+ DFG ++ QY V ++ GT ++APE+ E + Y+ +AD++S G
Sbjct: 202 LMPTGIIKLGDFGFSK---QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 430 IVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDF 489
++L+EL+T P+ + + V+ P P + LL+ ++P+LRP
Sbjct: 259 VILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTT 317
Query: 490 SEI--TELLQHLAQRLQ 504
++ TE L+++A Q
Sbjct: 318 QQLLHTEFLKYVANLFQ 334
|
Length = 478 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 60/191 (31%), Positives = 96/191 (50%), Gaps = 22/191 (11%)
Query: 269 QDVAIKVL-TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ AIK L E L + AQE I+ ++ H +V + + R++ + EF+ GG
Sbjct: 44 EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGG 103
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
++ +L K R DV+K YLH +II+RDLK NLL++
Sbjct: 104 ELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK 154
Query: 380 GVVKVADFGVA-RVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTG 438
G VKV DFG A +V + + GT ++APEVI+ + + D ++ G++L+E + G
Sbjct: 155 GHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
Query: 439 KLPYDDLTPLQ 449
P+ D TP +
Sbjct: 212 YPPFFDDTPFR 222
|
Length = 329 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 58/271 (21%), Positives = 112/271 (41%), Gaps = 46/271 (16%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K + + ++ + QE+ R+++H N++ ++ + L++V+ M+ GS
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 331 DYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
D L GL + + DV ++Y+H IHR +KA+++L++ +G V ++
Sbjct: 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRY 147
Query: 390 A--------RVQAQYGVMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGK 439
+ R + + + W++PEV++ Q YN ++D++S GI EL G
Sbjct: 148 SVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207
Query: 440 LPYDD-----------------------LTPLQAAVGVVQKGLRPTIPVHTHPILV---- 472
+P+ D + ++ + +
Sbjct: 208 VPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTF 267
Query: 473 -----DLLERCWQRDPSLRPDFSEITELLQH 498
+E C QRDP RP S +LL H
Sbjct: 268 SEHFHQFVELCLQRDPESRPSAS---QLLNH 295
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 46/129 (35%), Positives = 77/129 (59%), Gaps = 6/129 (4%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
LF V E+++GG + H Q C LP A ++ G+ +LH I++RDLK N+L
Sbjct: 71 LFFVMEYLNGGDLM--FHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128
Query: 376 MNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
++ +G +K+ADFG+ + + G T GT ++APE++ Q YN D +SFG++L+
Sbjct: 129 LDTDGHIKIADFGMCK-ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLY 187
Query: 434 ELVTGKLPY 442
E++ G+ P+
Sbjct: 188 EMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 52/160 (32%), Positives = 91/160 (56%), Gaps = 7/160 (4%)
Query: 285 IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP- 343
IR + +E+ ++ + +V F GA + I E M GGS+ L K ++P
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPE 102
Query: 344 -LLLRVAIDVSKGMNYL-HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401
+L +V+I V KG+ YL ++ I+HRD+K +N+L+N G +K+ DFGV+ Q + +
Sbjct: 103 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANS 161
Query: 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
GT +M+PE ++ Y+ ++D++S G+ L E+ G+ P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 47/175 (26%), Positives = 91/175 (52%), Gaps = 7/175 (4%)
Query: 272 AIKVLTNEHLNENIRREFAQ---EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
A+K+L E + + E A E +++ RH + + RL V E+ +GG
Sbjct: 24 AMKILKKEVIIA--KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
++ +L +++ ++ + YLH ++++RDLK NL+++++G +K+ DFG
Sbjct: 82 LFFHLSRERV-FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG 140
Query: 389 VARVQAQYG-VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
+ + G M GT ++APEV+E Y D + G+V++E++ G+LP+
Sbjct: 141 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 57/196 (29%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 252 KIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y +YK + VA+K + + E + +E+ +++++ H N+V+ +
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLH-KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+L++V EF+ + ++ G+ LPL+ + +G+ + H + ++HRD
Sbjct: 67 VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 369 LKAANLLMNENGVVKVADFGVARVQAQYGV----MTAETGTYRWMAPEVIEHQPYNHRA- 423
LK NLL+N G +K+ADFG+AR +GV T E T + APE++ Y A
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182
Query: 424 DVFSFGIVLWELVTGK 439
D++S G + E+VT +
Sbjct: 183 DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 56/174 (32%), Positives = 98/174 (56%), Gaps = 9/174 (5%)
Query: 285 IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP- 343
IR + +E+ ++ + +V F GA + I E M GGS+ L + K ++P
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK---RIPE 102
Query: 344 -LLLRVAIDVSKGMNYL-HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401
+L +V+I V +G+ YL ++ I+HRD+K +N+L+N G +K+ DFGV+ Q + +
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANS 161
Query: 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK--LPYDDLTPLQAAVG 453
GT +M+PE ++ Y+ ++D++S G+ L EL G+ +P D L+A G
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG 215
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 30/194 (15%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG-ACTRPPR-------LFIVTE 322
VA+K + + + +E+ I++K++H NVV I A RP + +++VT
Sbjct: 36 VALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP 95
Query: 323 FM----SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE 378
+M SG + + +K +L + +G+NYLH N+I+HRD+KAAN+L++
Sbjct: 96 YMDHDLSGLLENPSVKLTESQIKCYML-----QLLEGINYLHENHILHRDIKAANILIDN 150
Query: 379 NGVVKVADFGVARV--------QAQYGVMTAE-TG--TYRWM-APEVIEH-QPYNHRADV 425
G++K+ADFG+AR + G T + T RW PE++ + Y D+
Sbjct: 151 QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDI 210
Query: 426 FSFGIVLWELVTGK 439
+ G V E+ T +
Sbjct: 211 WGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 21/233 (9%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
V +KVL H +I F + +MR+V H ++V G C R +V EF+ G +
Sbjct: 35 VILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV-------VK 383
++H++ L P +VA ++ ++YL +++H ++ N+L+ G+ +K
Sbjct: 93 LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152
Query: 384 VADFGVARVQAQYGVMTAETGTYR--WMAPEVIE-HQPYNHRADVFSFGIVLWELV-TGK 439
++D G+ V++ + R W+APE +E + + AD +SFG LWE+ G+
Sbjct: 153 LSDPGIP-----ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE 207
Query: 440 LPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
+P D T L + P L DL+ C DP+ RP F I
Sbjct: 208 IPLKDKT-LAEKERFYEGQCMLVTPSCKE--LADLMTHCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 50/176 (28%), Positives = 90/176 (51%), Gaps = 11/176 (6%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-LFIVTEFMSG 326
Q+VAIK + + + +E+ +++ +RH N++ P ++ VTE +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 327 GSIYDYLHK--QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384
LH+ L+ + + +G+ Y+H ++HRDLK +N+L+NEN +K+
Sbjct: 95 D-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKI 149
Query: 385 ADFGVARVQAQYGVMTAETGTYRWMAPEV-IEHQPYNHRADVFSFGIVLWELVTGK 439
DFG+AR+Q MT T + APE+ + Q Y+ D++S G + E++ GK
Sbjct: 150 CDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 244 ASLLKFE--HKIVSGSYCDLYKGAFFSQD--VAIKVLTNEHLNENIRREFAQEVHIMRKV 299
S+ +FE ++I G+Y +Y+ + VA+K + ++ + I +E+ ++ +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 300 RHMNVVQF--IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
RH N+V+ + +F+V E+ + L + + + + +G+
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----MTAETGTYRWMAPEV 413
YLH N IIHRDLK +NLL+ + G +K+ADFG+AR YG+ MT + T + APE+
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART---YGLPAKPMTPKVVTLWYRAPEL 179
Query: 414 I-EHQPYNHRADVFSFGIVLWELVTGK 439
+ Y D+++ G +L EL+ K
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 60/231 (25%), Positives = 114/231 (49%), Gaps = 24/231 (10%)
Query: 264 GAFFSQDVAIKVLTNEHLNENIRREFAQEVH----IMRKVRHMNVVQFIGACTRPPRLFI 319
++ A+KV+ + E IR + Q VH ++++V H +++ L++
Sbjct: 26 EHYY----ALKVMA---IPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78
Query: 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+ E++ GG ++ YL L A ++ + YLH I++RDLK N+L+++
Sbjct: 79 LMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE 137
Query: 380 GVVKVADFGVAR--VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT 437
G +K+ DFG A+ + + GT ++APEVI+ + +N D ++ GI+++E++
Sbjct: 138 GHIKLTDFGFAKKLRDRTWTL----CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV 193
Query: 438 GKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQRDPSLR 486
G P+ D P G+ +K L + P H DL+++ D + R
Sbjct: 194 GYPPFFDDNPF----GIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 51/183 (27%), Positives = 105/183 (57%), Gaps = 8/183 (4%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRP-PRLFIVTEFMSG 326
Q A+KV+ E ++++ ++ Q E H+ + + + +C + RLF+V E+++G
Sbjct: 21 QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80
Query: 327 GSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384
G + ++ +Q+ KLP A ++ +N+LH II+RDLK N+L++ +G +K+
Sbjct: 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKL 137
Query: 385 ADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD 443
D+G+ + G T+ GT ++APE++ + Y D ++ G++++E++ G+ P+D
Sbjct: 138 TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
Query: 444 DLT 446
+T
Sbjct: 198 IIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 52/181 (28%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTR-PPRLFIVTEFMS 325
+ A+KV+ E +N++ ++ Q E H+ + + + +C + RLF V EF+S
Sbjct: 20 RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79
Query: 326 GGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVK 383
GG + ++ +Q+ KLP + ++S +N+LH II+RDLK N+L++ G +K
Sbjct: 80 GGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIK 136
Query: 384 VADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
+ D+G+ + + G T+ GT ++APE++ + Y D ++ G++++E++ G+ P+
Sbjct: 137 LTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 443 D 443
D
Sbjct: 197 D 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 77/278 (27%), Positives = 116/278 (41%), Gaps = 72/278 (25%)
Query: 271 VAIKVL-----TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL------FI 319
VAIK L + H +R + +E+ +++ + H NV+ + T L ++
Sbjct: 43 VAIKKLSRPFQSAIH----AKRTY-RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97
Query: 320 VTEFMSGGSIYDYLHKQK------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
VT M G + + + QK L +L +G+ Y+H IIHRDLK +N
Sbjct: 98 VTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL--------RGLKYIHSAGIIHRDLKPSN 148
Query: 374 LLMNENGVVKVADFGVARVQAQYGVMTAETGTYRW-MAPEVI---EHQPYNHRADVFSFG 429
+ +NE+ +K+ DFG+AR MT T RW APE++ H YN D++S G
Sbjct: 149 IAVNEDCELKILDFGLARHTDDE--MTGYVAT-RWYRAPEIMLNWMH--YNQTVDIWSVG 203
Query: 430 IVLWELVTGKL------PYDDLTPLQAAVGVVQKGLRPTI------------PVHTH--- 468
++ EL+TGK D L + VG + L I P
Sbjct: 204 CIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDF 263
Query: 469 --------PILVDLLERCWQRDPSLRPDFSEITELLQH 498
P+ +DLLE+ DP R E L H
Sbjct: 264 KEVFSGANPLAIDLLEKMLVLDPDKRIT---AAEALAH 298
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 53/165 (32%), Positives = 88/165 (53%), Gaps = 31/165 (18%)
Query: 292 EVHIMRKVRHMNVVQF--IGACTRPPRLFIVTEFMSGG--SIYDYLHKQ------KCGLK 341
E++I+ K++H N+V + + ++++V E++ S+ + + + KC L
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC-LM 112
Query: 342 LPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--- 398
L LL G+ +LH N I+HRDLK +NLL+N G++K+ DFG+AR +YG
Sbjct: 113 LQLLS--------GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR---EYGSPLK 161
Query: 399 -MTAETGT--YRWMAPEVIEHQP-YNHRADVFSFGIVLWELVTGK 439
T T YR APE++ Y+ D++S G + EL+T K
Sbjct: 162 PYTQLVVTLWYR--APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 30/231 (12%)
Query: 286 RREFAQEVHIMRKVRHMNVVQFIGACT-RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
R A E HI+R + H +++Q G T I+ + + +Y YL ++ + +
Sbjct: 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKR---NIAI 181
Query: 345 --LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402
+L + V + + YLH N IIHRD+KA N+ +N G V + DFG A + V
Sbjct: 182 CDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGA----ACFPVDINA 237
Query: 403 TGTYRWM------APEVIEHQPYNHRADVFSFGIVLWELVTGK--------LPYDDLTPL 448
Y W APE++ PY D++S GIVL+E+ T L D +
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDR 297
Query: 449 QAAVGVVQKGLRPT-IPVHTHPILVDLLERCWQ---RDPSLRPDFSEITEL 495
Q + + + G P P+ L ++ + R P RP ++ + EL
Sbjct: 298 QIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL 348
|
Length = 391 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 46/141 (32%), Positives = 81/141 (57%), Gaps = 4/141 (2%)
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY---GVMTAETGTY 406
I V ++++H ++IHRD+K+AN+L+ NG+VK+ DFG +++ A V GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466
++APE+ +PY+ +AD+FS G++L+EL+T K P+D ++ + G +P
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLPPS 268
Query: 467 THPILVDLLERCWQRDPSLRP 487
P + +++ DP RP
Sbjct: 269 ISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 43/132 (32%), Positives = 73/132 (55%), Gaps = 4/132 (3%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
P RLF V EF++GG + H QK A +++ + +LH II+RDLK
Sbjct: 68 PDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125
Query: 373 NLLMNENGVVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIV 431
N+L++ G K+ADFG+ + G T+ GT ++APE+++ Y D ++ G++
Sbjct: 126 NVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVL 185
Query: 432 LWELVTGKLPYD 443
L+E++ G P++
Sbjct: 186 LYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 54/175 (30%), Positives = 96/175 (54%), Gaps = 11/175 (6%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VAIK + NE ++ +E+ ++R ++ N+V+ A R +L++V E++ ++
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK-NML 87
Query: 331 DYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
+ L + G+ P +R I + K +++ H+N+I+HRD+K NLL++ N V+K+ DFG
Sbjct: 88 ELLEEMPNGV-PPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGF 146
Query: 390 AR-----VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK 439
AR A Y T T + +PE++ PY D++S G +L EL G+
Sbjct: 147 ARNLSEGSNANY---TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 55/196 (28%), Positives = 109/196 (55%), Gaps = 4/196 (2%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
E +I+ V+H +V I A +L+++ E++SGG ++ +L ++ ++ ++ +
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-E 108
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE-TGTYRWMA 410
+S + +LH+ II+RDLK N+L++ G VK+ DFG+ + G +T GT +MA
Sbjct: 109 ISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470
PE++ + D +S G ++++++TG P+ + + + KG + +P + P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKG-KLNLPPYLTPE 226
Query: 471 LVDLLERCWQRDPSLR 486
DLL++ +R+PS R
Sbjct: 227 ARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 44/156 (28%), Positives = 86/156 (55%), Gaps = 10/156 (6%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
E +++ RH + + RL V E+++GG ++ +L +++ + A +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-E 103
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET-----GTY 406
+ ++YLH I++RDLK NL+++++G +K+ DFG+ + G+ A T GT
Sbjct: 104 IVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTP 159
Query: 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
++APEV+E Y D + G+V++E++ G+LP+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 43/152 (28%), Positives = 82/152 (53%), Gaps = 1/152 (0%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI-YDYLHKQKCGLKLPLLLRVAI 350
E I+ KV VV A L +V M+GG + + H + G + + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMA 410
++ G+ LH+ I++RDLK N+L++++G ++++D G+A + + GT +MA
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 169
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
PEV++++ Y D ++ G +L+E++ G+ P+
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G++ +++K Q VA+K + E+ E +E+ I++ ++H NVV I
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 310 ACTRPPR--------LFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNY 358
C ++V EF +D L + L + +V + G+ Y
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCE----HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARV-----QAQYGVMTAETGTYRWMAPEV 413
+HRN I+HRD+KAAN+L+ ++G++K+ADFG+AR ++ T T + PE+
Sbjct: 135 IHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 414 -IEHQPYNHRADVFSFGIVLWELVT 437
+ + Y D++ G ++ E+ T
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 43/138 (31%), Positives = 78/138 (56%), Gaps = 7/138 (5%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
RLF V E+++GG + + + + P A +V+ + +LHR+ +I+RDLK N
Sbjct: 68 KDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDN 126
Query: 374 LLMNENGVVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVL 432
+L++ G K+ADFG+ + GV T GT ++APE+++ Y D ++ G+++
Sbjct: 127 ILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLM 186
Query: 433 WELVTGKLPY-----DDL 445
+E++ G+ P+ DDL
Sbjct: 187 YEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 44/152 (28%), Positives = 83/152 (54%), Gaps = 2/152 (1%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
E +++ RH + A RL V E+ +GG ++ +L +++ + A
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTYRWMA 410
VS + YLH ++++RD+K NL+++++G +K+ DFG+ + G M GT ++A
Sbjct: 105 VS-ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
PEV+E Y D + G+V++E++ G+LP+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y +YK + VA+K + E +E + +E+ +++++ H N+V+ +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYL-HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+L++V EF+ + Y+ GL PL+ + +G+ Y H + ++HRD
Sbjct: 66 VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 369 LKAANLLMNENGVVKVADFGVARVQAQYGV----MTAETGTYRWMAPEVIEHQP-YNHRA 423
LK NLL++ G +K+ADFG+AR +GV T E T + APE++ Y+
Sbjct: 125 LKPQNLLIDREGALKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPV 181
Query: 424 DVFSFGIVLWELVTGK 439
D++S G + E+V +
Sbjct: 182 DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 1/145 (0%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
E +++ V H +V++ +V S +Y YL K+ L + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAP 411
+ +G+ YLH IIHRD+K N+ +N+ V + D G A+ GT AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225
Query: 412 EVIEHQPYNHRADVFSFGIVLWELV 436
EV+ YN +AD++S GIVL+E++
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 62/255 (24%), Positives = 118/255 (46%), Gaps = 21/255 (8%)
Query: 260 DLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319
++Y ++ V ++ N E + EF Q+ R ++H N++Q +G C +
Sbjct: 15 EIYTDTGVARVVVKELKANASSKE--QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLL 72
Query: 320 VTEFMSGGSIYDYLHKQKCGLK---LPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
V E+ G + YL +++ + L LL R+A +++ G+ ++H++N +H DL N +
Sbjct: 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL 132
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTY---RWMAPEVI-EHQ------PYNHRADVF 426
+ VKV D+G+ + + + E RW+APE++ E ++V+
Sbjct: 133 TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVW 192
Query: 427 SFGIVLWELV-TGKLPYDDLTPLQAAVGVVQ----KGLRPTIPVHTHPILVDLLERCWQR 481
+ G+ LWEL PY L+ + V++ K +P + + ++L+ CW
Sbjct: 193 ALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWL- 251
Query: 482 DPSLRPDFSEITELL 496
P R E+ LL
Sbjct: 252 SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 1/152 (0%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAI 350
E I+ KV VV A L +V M+GG + +++ G + L A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMA 410
++ G+ LHR N ++RDLK N+L+++ G ++++D G+A + + GT +MA
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMA 169
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
PEV+ +Q Y D + G +++E++ G+ P+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 51/175 (29%), Positives = 93/175 (53%), Gaps = 4/175 (2%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
P +L + + M+GG ++ +L + + + A ++ G+ ++H +++RDLK AN
Sbjct: 69 PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRFVVYRDLKPAN 127
Query: 374 LLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVL 432
+L++E+G V+++D G+A A GT+ +MAPEV++ Y+ AD FS G +L
Sbjct: 128 ILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 186
Query: 433 WELVTGKLPYDDL-TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
++L+ G P+ T + + + + +P P L LLE QRD + R
Sbjct: 187 FKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 67/263 (25%), Positives = 112/263 (42%), Gaps = 41/263 (15%)
Query: 256 GSYCDLYKG---------AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
G++ ++KG +V +KVL H N F + +M ++ H ++V
Sbjct: 6 GTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVL 63
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
G C +V E++ GS+ YL K K + + L VA ++ +++L + H
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTH 123
Query: 367 RDLKAANLLMNENG--------VVKVADFGVARVQAQYGVMTAETGTYR--WMAPEVIEH 416
++ A N+L+ +K++D G++ V+ E R W+ PE IE+
Sbjct: 124 GNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-----ITVLPKEILLERIPWVPPECIEN 178
Query: 417 -QPYNHRADVFSFGIVLWELVTG-KLPYDDLTPLQAAVGVVQKGL-----RPTIPVHTHP 469
Q + AD +SFG LWE+ +G P L QK L R +P
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQFYEDRHQLPAPKWT 230
Query: 470 ILVDLLERCWQRDPSLRPDFSEI 492
L +L+ +C +P RP F I
Sbjct: 231 ELANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 59/282 (20%)
Query: 253 IVSGSYCDLYKGAFFSQ--DVAIKVLTNEHLNEN------IRREFAQEVHIMRKVR---H 301
I G+Y +YK + VA+K + L+E +R E+ +++++ H
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLR-----EIALLKQLESFEH 60
Query: 302 MNVVQFIGACTRPPR-----LFIVTEFMSGGSIYDYLHKQKC---GLKLPLLLRVAIDVS 353
N+V+ + C P L +V E + + YL KC GL + + +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIKDLMRQLL 117
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT--YRWMAP 411
+G+++LH + I+HRDLK N+L+ +G VK+ADFG+AR+ + +T+ T YR AP
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR--AP 175
Query: 412 EVIEHQPYNHRADVFSFGIVLWEL---------------------VTGKLPYDDLTPLQA 450
EV+ Y D++S G + EL V G LP ++ P
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG-LPSEEEWPRNV 234
Query: 451 AVGVVQKGLRPTIPV-----HTHPILVDLLERCWQRDPSLRP 487
++ +DLL++ +P R
Sbjct: 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 72.1 bits (178), Expect = 5e-16
Identities = 28/65 (43%), Positives = 41/65 (63%), Gaps = 3/65 (4%)
Query: 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPLQETE 196
E+ I T D+P L +++ L ++GLNI +A F+T DGY+LD FVV DG P+ E E
Sbjct: 1 GTEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERE 60
Query: 197 QLRNV 201
+L +
Sbjct: 61 RLARI 65
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS----IYDYLHKQKCGLKLPLLLR 347
E I+ KV +V A L +V M+GG IY+ + ++ G P
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACF 101
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA-RVQAQYGVMTAETGTY 406
+ G+ +LH+ II+RDLK N+L++ +G V+++D G+A ++ GT
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161
Query: 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
+MAPE+++ + Y+ D F+ G+ L+E++ + P+
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 53/189 (28%), Positives = 101/189 (53%), Gaps = 11/189 (5%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH-RNNIIHRDLKAANL 374
RL V E+ +GG ++ +L +++ + A ++ ++YLH N+++RDLK NL
Sbjct: 69 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNVVYRDLKLENL 127
Query: 375 LMNENGVVKVADFGVARVQAQYG-VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
+++++G +K+ DFG+ + + G M GT ++APEV+E Y D + G+V++
Sbjct: 128 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 187
Query: 434 ELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR----PDF 489
E++ G+LP+ + + ++ + +R P P LL ++DP R PD
Sbjct: 188 EMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKSLLSGLLKKDPKQRLGGGPD- 244
Query: 490 SEITELLQH 498
+ E++QH
Sbjct: 245 -DAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 252 KIVSGSYCDLYKGAFFSQD--VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
K+ G+Y +YKG D VA+K + EH E +EV +++ ++H N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYL-------HKQKCGLKLPLLLRVAIDVSKGMNYLHRN 362
L +V E++ + YL + L L LLR G+NY HR
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYCHRR 123
Query: 363 NIIHRDLKAANLLMNENGVVKVADFGVARVQA-QYGVMTAETGTYRWMAPEV-IEHQPYN 420
++HRDLK NLL+NE G +K+ADFG+AR ++ + E T + P++ + Y+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 421 HRADVFSFGIVLWELVTGK 439
+ D++ G + +E+ TG+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 54/192 (28%), Positives = 95/192 (49%), Gaps = 13/192 (6%)
Query: 256 GSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315
G C Y A ++VAIK L+ N+ + +E+ +M+ V H N++ + T P
Sbjct: 38 GIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT-PQ 95
Query: 316 R-------LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+ ++IV E M ++ + + ++ LL + G+ +LH IIHRD
Sbjct: 96 KSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRD 151
Query: 369 LKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSF 428
LK +N+++ + +K+ DFG+AR +MT T + APEVI Y D++S
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 429 GIVLWELVTGKL 440
G ++ E++ G +
Sbjct: 212 GCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 49/190 (25%), Positives = 93/190 (48%), Gaps = 11/190 (5%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
V +++ E+ E + EV + RH N++ T L++++ FM+ GS
Sbjct: 28 VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87
Query: 331 DYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
L G+ L+ + +G+NYLH+N IHR++KA+++L++ +G+V ++
Sbjct: 88 SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSH 147
Query: 390 --------ARVQAQYGVMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGK 439
+ + Y T W++PE++ YN ++D++S GI EL TG+
Sbjct: 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
Query: 440 LPYDDLTPLQ 449
+P+ D+ Q
Sbjct: 208 VPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 62/237 (26%), Positives = 113/237 (47%), Gaps = 24/237 (10%)
Query: 268 SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-RLFIVTEFMS 325
+VAIK+L + E+ R F +E + ++ H N+V + + PP LF V E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV---V 382
G ++ + L L R+ + V + H I+HRDLK N+++++ GV
Sbjct: 63 GRTLREVLAADG-ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 383 KVADFGVARV-----QAQYGVMTAET---GTYRWMAPEVIEHQPYNHRADVFSFGIVLWE 434
KV DFG+ + A +T T GT + APE + +P +D++++G++ E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 435 LVTGKLPYDDLTPLQAAVGVVQKGLRP---TIP--VHTHPILVDLLERCWQRDPSLR 486
+TG+ + + ++ + L P ++P + HP L +L + +DP R
Sbjct: 182 CLTGQRVVQGASVAE----ILYQQLSPVDVSLPPWIAGHP-LGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 44/202 (21%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 250 EHKIVSGSY--CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVH-IMRKVRHMNVVQ 306
+ K++ G + + K + K++ ++ N E VH +M+ +
Sbjct: 21 KLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI---EPM--VHQLMKDNPN----- 70
Query: 307 FIG---ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363
FI + T ++ +++ G ++D L K+ L + ++ + + +N LH++N
Sbjct: 71 FIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLHKHN 129
Query: 364 IIHRDLKAANLLMNENGV-VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHR 422
IIH D+K N+L + + + D+G+ ++ GT + +PE I+ Y+
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD---GTLDYFSPEKIKGHNYDVS 186
Query: 423 ADVFSFGIVLWELVTGKLPYDD 444
D ++ G++ +EL+TGK P+ +
Sbjct: 187 FDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 54/176 (30%), Positives = 95/176 (53%), Gaps = 6/176 (3%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRV-AIDVSKGMNYLHRNNIIHRDLKAA 372
P +L + + M+GG ++ +L + G+ +R A ++ G+ ++H +++RDLK A
Sbjct: 69 PDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPA 126
Query: 373 NLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIV 431
N+L++E+G V+++D G+A A GT+ +MAPEV++ Y+ AD FS G +
Sbjct: 127 NILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCM 185
Query: 432 LWELVTGKLPY-DDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
L++L+ G P+ T + + + + +P P L LLE QRD S R
Sbjct: 186 LFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 45/153 (29%), Positives = 82/153 (53%), Gaps = 3/153 (1%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAI 350
E I+ KV VV A L +V M+GG + +++ G + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTYRWM 409
+++ G+ LHR I++RDLK N+L+++ G ++++D G+A V+ G + GT +M
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYM 168
Query: 410 APEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
APEV++++ Y D + G +++E++ GK P+
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 3/99 (3%)
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA--QYGVMTAETGTYRWMAP 411
+G+ YLH I+HRD+K NLL+N N V+K+ DFG+ARV+ + MT E T + AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 412 EVIEHQP-YNHRADVFSFGIVLWELVTGKLPYDDLTPLQ 449
E++ Y D++S G + EL+ ++ + +P+Q
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 75/276 (27%), Positives = 114/276 (41%), Gaps = 68/276 (24%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-----LFIVT 321
+ VAIK + + EH+++ R +E+ ++R +RH ++V+ P R +++V
Sbjct: 26 EKVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83
Query: 322 EFMSGG-----SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
E M D L + L LLR + Y+H N+ HRDLK N+L
Sbjct: 84 ELMESDLHQVIKANDDLTPEHHQFFLYQLLR-------ALKYIHTANVFHRDLKPKNILA 136
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGT---------YRWM-APEVIE--HQPYNHRAD 424
N + +K+ DFG+AR V +T T RW APE+ Y D
Sbjct: 137 NADCKLKICDFGLAR------VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAID 190
Query: 425 VFSFGIVLWELVTGK-------------LPYDDL-TPLQAAVGVVQ--------KGLRPT 462
++S G + E++TGK L D L TP + V+ +R
Sbjct: 191 IWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKK 250
Query: 463 IPV-------HTHPILVDLLERCWQRDPSLRPDFSE 491
PV + P+ + LLER DP RP E
Sbjct: 251 QPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 21/233 (9%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
V +KVL H +I F + +M +V H+++ G C R +V EF+ G +
Sbjct: 47 VVLKVLDPSH--RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV-------VK 383
L K+K + + + VA ++ ++YL N++H ++ A N+L+ G+ +K
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164
Query: 384 VADFGVARVQAQYGVMTAETGTYR--WMAPEVIEHQPYNHRA-DVFSFGIVLWELV-TGK 439
++D GV+ + ++ E R W+APE + A D +SFG L E+ G+
Sbjct: 165 LSDPGVS-----FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219
Query: 440 LPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
+P + TP + +K R +P + L L+ +C +P+ RP F I
Sbjct: 220 VPLKERTPSEKE-RFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 47/196 (23%), Positives = 94/196 (47%), Gaps = 19/196 (9%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+L ++ ++++GG ++ +L+ Q+ + ++ +++LH+ II+RD+K N+L
Sbjct: 79 KLHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137
Query: 376 MNENGVVKVADFGVARVQAQYGVMTAET--------GTYRWMAPEVIEHQP--YNHRADV 425
++ G V + DFG+++ AE GT +MAPEVI ++ D
Sbjct: 138 LDSEGHVVLTDFGLSK------EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191
Query: 426 FSFGIVLWELVTGKLPY--DDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDP 483
+S G++ +EL+TG P+ D Q+ + +P P D +++ ++DP
Sbjct: 192 WSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDP 251
Query: 484 SLRPDFSEITELLQHL 499
R + E+ H
Sbjct: 252 KKRLGANGADEIKNHP 267
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 248 KFEHKIVSGSYCDLYK------GAFFSQDVAIKVLTN-----EHLNENIRREFAQEVHIM 296
K KI G++ ++ K G + AIK + E +N N+R E+ +
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKY----YAIKCMKKHFKSLEQVN-NLR-----EIQAL 51
Query: 297 RKVR-HMNVVQFIGACTRPP--RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS 353
R++ H N+++ I RL +V E M ++Y+ + +K L + +
Sbjct: 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLL 110
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWM-APE 412
K ++++HRN I HRD+K N+L+ ++ ++K+ADFG R T T RW APE
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIST-RWYRAPE 168
Query: 413 -VIEHQPYNHRADVFSFGIVLWELVT 437
++ Y + D+++ G V +E+++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 36/190 (18%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-------LFIVT 321
Q+VAIK L+ N + +E+ +M+ V H N++ + T P + +++V
Sbjct: 42 QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT-PQKSLEEFQDVYLVM 100
Query: 322 EFMSGG------------SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
E M + L++ CG+K +LH IIHRDL
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIK----------------HLHSAGIIHRDL 144
Query: 370 KAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFG 429
K +N+++ + +K+ DFG+AR +MT T + APEVI Y D++S G
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204
Query: 430 IVLWELVTGK 439
++ E++ G
Sbjct: 205 CIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 70/282 (24%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-----LFIVTEF 323
+ VAIK + + + + +E+ I+R +H N++ I RPP +++V +
Sbjct: 31 KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIA-IRDILRPPGADFKDVYVVMDL 89
Query: 324 MSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
M ++ +H + PL LLR G+ Y+H N+IHRDLK +
Sbjct: 90 M-ESDLHHIIHSDQ-----PLTEEHIRYFLYQLLR-------GLKYIHSANVIHRDLKPS 136
Query: 373 NLLMNENGVVKVADFGVARVQA-----QYGVMTAETGTYRWM-APEVIEHQP-YNHRADV 425
NLL+NE+ +++ DFG+AR + MT T RW APE++ P Y D+
Sbjct: 137 NLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RWYRAPELLLSLPEYTTAIDM 195
Query: 426 FSFGIVLWELV------TGKLPYDDL--------TPLQAAVGVVQK----------GLRP 461
+S G + E++ GK L +P + + + +
Sbjct: 196 WSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQ 255
Query: 462 TIPVHT-----HPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+P P +DLL + Q DP R + + LQH
Sbjct: 256 PVPWSKIFPKASPEALDLLSQMLQFDPEERIT---VEQALQH 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 60/193 (31%), Positives = 94/193 (48%), Gaps = 38/193 (19%)
Query: 269 QDVAIKVLTN-EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPRL------ 317
VAIK ++ EH + F Q E+ I+R+ +H N++ I RPP
Sbjct: 31 VKVAIKKISPFEH------QTFCQRTLREIKILRRFKHENIIG-ILDIIRPPSFESFNDV 83
Query: 318 FIVTEFMSGGSIYDYLHKQK-----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
+IV E M +Y + Q L +LR G+ Y+H N++HRDLK +
Sbjct: 84 YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------GLKYIHSANVLHRDLKPS 135
Query: 373 NLLMNENGVVKVADFGVARVQAQ----YGVMTAETGTYRWM-APEV-IEHQPYNHRADVF 426
NLL+N N +K+ DFG+AR+ G +T T RW APE+ + + Y D++
Sbjct: 136 NLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RWYRAPEIMLNSKGYTKAIDIW 194
Query: 427 SFGIVLWELVTGK 439
S G +L E+++ +
Sbjct: 195 SVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 252 KIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
K+ G+Y ++KG VA+K + EH E +EV +++ ++H N+V
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI---DVSKGMNYLHRNNIIH 366
L +V E++ + YL CG L + V I + +G++Y H+ I+H
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL--DNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 367 RDLKAANLLMNENGVVKVADFGVARVQA-QYGVMTAETGTYRWMAPEV-IEHQPYNHRAD 424
RDLK NLL+NE G +K+ADFG+AR ++ + E T + P+V + Y+ D
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 425 VFSFGIVLWELVTGK 439
++ G +L+E+ TG+
Sbjct: 187 MWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 260 DLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQFIGACT---- 312
DL G F ++V T E E + +EV ++R + H NVV+ CT
Sbjct: 22 DLKNGGRFVALKRVRVQTGE---EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78
Query: 313 -RPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
R +L +V E + + YL K + G+ + + + +G+++LH + ++HRDLK
Sbjct: 79 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137
Query: 371 AANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGI 430
N+L+ +G +K+ADFG+AR+ + +T+ T + APEV+ Y D++S G
Sbjct: 138 PQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197
Query: 431 VLWEL 435
+ E+
Sbjct: 198 IFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 54/193 (27%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 256 GSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315
G C Y A ++VAIK L+ N+ + +E+ +M+ V H N++ + T
Sbjct: 31 GIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89
Query: 316 RL------FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
L ++V E M ++ + + ++ LL + G+ +LH IIHRDL
Sbjct: 90 SLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRDL 145
Query: 370 KAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFG 429
K +N+++ + +K+ DFG+AR +MT T + APEVI Y D++S G
Sbjct: 146 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205
Query: 430 IVLWELVTGKLPY 442
++ E+V K+ +
Sbjct: 206 CIMGEMVRHKILF 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 32/172 (18%)
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG-------GSIYDYLHKQKCGLKLP 343
+E+ IM +++H N++ + + +V + M+ I + KC L
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----- 398
L G+N LH+ +HRDL AN+ +N G+ K+ADFG+AR
Sbjct: 129 L---------NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 399 ----------MTAETGTYRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGK 439
MT++ T + APE++ + Y+ D++S G + EL+TGK
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 12/180 (6%)
Query: 270 DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-------LFIVTE 322
+VA+K L+ N+ + +E+ +++ V H N++ + T P + +++V E
Sbjct: 48 NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT-PQKSLEEFQDVYLVME 106
Query: 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVV 382
M ++ +H + ++ LL + G+ +LH IIHRDLK +N+++ + +
Sbjct: 107 LMDA-NLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 162
Query: 383 KVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
K+ DFG+AR +MT T + APEVI Y D++S G ++ ELV G + +
Sbjct: 163 KILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 39/132 (29%), Positives = 74/132 (56%), Gaps = 5/132 (3%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRDLKAA 372
L++VT++MSGG ++ H QK G + I ++ + +LH+ +I++RDLK
Sbjct: 68 DSDLYLVTDYMSGGELF--WHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPE 125
Query: 373 NLLMNENGVVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEV-IEHQPYNHRADVFSFGI 430
N+L++ G + + DFG+++ T GT ++APEV ++ + Y D +S G+
Sbjct: 126 NILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185
Query: 431 VLWELVTGKLPY 442
+++E+ G P+
Sbjct: 186 LVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 69/239 (28%), Positives = 110/239 (46%), Gaps = 38/239 (15%)
Query: 239 VWEIDASLLKFEHKIVSGSY---C---DLYKGAFFSQDVAIKVLTNEHLNENIRREFAQE 292
VWE+ ++ SG+Y C D G + VAIK L+ +E + +E
Sbjct: 10 VWELPERYTSL-KQVGSGAYGSVCSAIDKRTG----EKVAIKKLSRPFQSEIFAKRAYRE 64
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRL------FIVTEFMSGGSIYDYLHKQKC-GLKLP-- 343
+ +++ ++H NV+ + T ++V +M QK G L
Sbjct: 65 LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-------QTDLQKIMGHPLSED 117
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAE 402
+ + + G+ Y+H IIHRDLK NL +NE+ +K+ DFG+AR A+ MT
Sbjct: 118 KVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGY 174
Query: 403 TGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPY------DDLTPLQAAVGV 454
T + APEVI + YN D++S G ++ E++TGK + D LT + GV
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 53/183 (28%), Positives = 93/183 (50%), Gaps = 10/183 (5%)
Query: 268 SQDV-AIKVLTN-EHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
SQ V A+K+L+ E + + F +E IM VVQ A L++V E+M
Sbjct: 67 SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 126
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVA 385
GG + + + K +V ++ +H +IHRD+K N+L++++G +K+A
Sbjct: 127 GGDLVNLMSNYDVPEKWAKFYTA--EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLA 184
Query: 386 DFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQP----YNHRADVFSFGIVLWELVTGK 439
DFG + G++ +T GT +++PEV++ Q Y D +S G+ L+E++ G
Sbjct: 185 DFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD 244
Query: 440 LPY 442
P+
Sbjct: 245 TPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 52/199 (26%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 252 KIVSGSYCDLYKGAFFSQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQF 307
KI G+Y ++K +++ VA+K + + +E + +E+ ++++++H N+V+
Sbjct: 7 KIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
+L +V E+ + Y + ++ + KG+ + H +N++HR
Sbjct: 65 YDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHR 123
Query: 368 DLKAANLLMNENGVVKVADFGVARVQAQYGV----MTAETGTYRWMAPEVI-EHQPYNHR 422
DLK NLL+N+NG +K+ADFG+AR +G+ +AE T + P+V+ + Y+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR---AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 423 ADVFSFGIVLWELVTGKLP 441
D++S G + EL P
Sbjct: 181 IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 47/176 (26%), Positives = 95/176 (53%), Gaps = 6/176 (3%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+L ++ +++SGG ++ +L+ Q+ + + ++ + +LH+ I++RD+K N+L
Sbjct: 79 KLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137
Query: 376 MNENGVVKVADFGVAR--VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRA-DVFSFGIVL 432
++ G V + DFG+++ + + + GT +MAPE+I + + +A D +S GI++
Sbjct: 138 LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILI 197
Query: 433 WELVTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILVDLLERCWQRDPSLR 486
+EL+TG P+ V ++ L+ P P P DLL + ++DP R
Sbjct: 198 FELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 7/159 (4%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVA 349
E I+ + H V G+ L++V EF+ GG + +L + K + P + A
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYA 137
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWM 409
+ YL NI++RDLK NLL++++G +K+ DFG A+V GT ++
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC--GTPEYI 195
Query: 410 APEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL 448
APE++ + + AD ++ GI ++E++ G P+ PL
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 49/157 (31%), Positives = 86/157 (54%), Gaps = 14/157 (8%)
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPR-------LFIVTEFMSGGSIYDYLHKQKCGLKLP 343
+E+ +++ ++H NV+ + T P R +++VT M G + + + QK L
Sbjct: 65 RELRLLKHMKHENVIGLLDVFT-PARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDD 120
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET 403
+ + + +G+ Y+H +IIHRDLK +NL +NE+ +K+ DFG+AR MT
Sbjct: 121 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYV 178
Query: 404 GTYRWMAPEV-IEHQPYNHRADVFSFGIVLWELVTGK 439
T + APE+ + YN D++S G ++ EL+TG+
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 252 KIVSGSYCDLYK------GAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HM 302
+I G+Y +YK G F + +++V TNE + + +EV +++++ H
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALK-SVRVQTNE---DGLPLSTVREVALLKRLEAFDHP 62
Query: 303 NVVQFIGACT-----RPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGM 356
N+V+ + C R ++ +V E + + YL K GL + + +G+
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH 416
++LH N I+HRDLK N+L+ G VK+ADFG+AR+ + +T T + APEV+
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 417 QPYNHRADVFSFGIVLWELVTGK 439
Y D++S G + E+ K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 38/93 (40%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR------VQAQYGVMTAETGTYRW 408
G+ Y+H N++HRDLK NLL+N + +K+ DFG+AR + G MT T RW
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA-GFMTEYVAT-RW 174
Query: 409 M-APEV-IEHQPYNHRADVFSFGIVLWELVTGK 439
APE+ + Q Y DV+S G +L EL+ K
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 56/176 (31%), Positives = 87/176 (49%), Gaps = 12/176 (6%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL------FIVTEFM 324
VAIK L +E + +E+ +++ ++H NV+ + T L ++V FM
Sbjct: 43 VAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM 102
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384
G + + +K L + KG+ Y+H IIHRDLK NL +NE+ +K+
Sbjct: 103 -GTDLGKLMKHEKLSEDRIQFL--VYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKI 159
Query: 385 ADFGVARVQAQYGVMTAETGTYRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGK 439
DFG+AR Q MT T + APEVI Y D++S G ++ E++TGK
Sbjct: 160 LDFGLAR-QTD-SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 8/180 (4%)
Query: 271 VAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K + L + N R E I+ + +V+ + A L++ E++ GG
Sbjct: 29 VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
L L ++ + ++ LH IHRDLK N L++ +G +K+ DFG+
Sbjct: 89 RTLL-NNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGL 147
Query: 390 AR--VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP 447
++ V V+ G+ +MAPEV+ + Y+ D +S G +L+E + G P+ TP
Sbjct: 148 SKGIVTYANSVV----GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 42/221 (19%)
Query: 254 VSGSYCDLY------KGAFFS-------QDVAIK--VLTNEHLNENIRREFAQEVHIMRK 298
+ Y DL G FS + VA+K VLT+ ++ RE + I+R+
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALRE----IKIIRR 58
Query: 299 VRHMNVVQF--------------IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
+ H N+V+ +G+ T ++IV E+M + + L + +
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHAR 117
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVVKVADFGVAR-VQAQY---GVM 399
L + +G+ Y+H N++HRDLK AN+ +N E+ V+K+ DFG+AR V Y G +
Sbjct: 118 LF--MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175
Query: 400 TAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGK 439
+ T + +P ++ Y D+++ G + E++TGK
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 256 GSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315
GS C Y Q VA+K L+ + R +E+ +++ ++H NV+ + T
Sbjct: 29 GSVCSAYD-TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87
Query: 316 RL------FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+ ++VT M G + + + QK L + + + +G+ Y+H IIHRDL
Sbjct: 88 SIENFNEVYLVTNLM-GADLNNIVKCQK--LSDEHVQFLIYQLLRGLKYIHSAGIIHRDL 144
Query: 370 KAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEV-IEHQPYNHRADVFSF 428
K +N+ +NE+ +++ DFG+AR QA MT T + APE+ + YN D++S
Sbjct: 145 KPSNVAVNEDCELRILDFGLAR-QAD-DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202
Query: 429 GIVLWELVTGK--LPYDD 444
G ++ EL+ GK P +D
Sbjct: 203 GCIMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 42/152 (27%), Positives = 77/152 (50%), Gaps = 1/152 (0%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAI 350
E I+ KV VV A L +V M+GG + +++ G + A
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMA 410
++ G+ L R I++RDLK N+L+++ G ++++D G+A + + GT +MA
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMA 169
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
PEVI ++ Y D + G +++E++ G+ P+
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 53/194 (27%), Positives = 99/194 (51%), Gaps = 10/194 (5%)
Query: 252 KIVSGSYCDLYKGAFFSQD--VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
K+ G+Y ++KG + VA+K + EH E +EV +++ ++H N+V
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCG--LKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
L +V E++ + Y+ CG + + + + +G+ Y HR ++HR
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYM--DDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 368 DLKAANLLMNENGVVKVADFGVARVQA-QYGVMTAETGTYRWMAPEV-IEHQPYNHRADV 425
DLK NLL+NE G +K+ADFG+AR ++ + E T + P+V + Y+ + D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188
Query: 426 FSFGIVLWELVTGK 439
+ G + +E+ +G+
Sbjct: 189 WGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 50/186 (26%), Positives = 95/186 (51%), Gaps = 4/186 (2%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
P +L++V F++GG ++ +L ++ A ++ + LH+ N+I+RDLK N
Sbjct: 65 PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHKFNVIYRDLKPEN 123
Query: 374 LLMNENGVVKVADFGVARVQAQYGVMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVL 432
+L++ G + + DFG+ ++ + T GT ++APE++ Y D ++ G++L
Sbjct: 124 ILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLL 183
Query: 433 WELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
+E++TG P+ D + ++Q+ LR P DLL RDP+ R ++
Sbjct: 184 YEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241
Query: 493 TELLQH 498
E+ H
Sbjct: 242 QEIKNH 247
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 60/227 (26%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLP----------LLLRVAIDVSKGMNYLHRNNII 365
L++V E+M GG + + L ++ P L+L A+D +H+ I
Sbjct: 75 HLYLVMEYMPGGDLMNLLIRKDV---FPEETARFYIAELVL--ALD------SVHKLGFI 123
Query: 366 HRDLKAANLLMNENGVVKVADFGVA-----------------------------RVQAQY 396
HRD+K N+L++ +G +K+ADFG+ R Q
Sbjct: 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183
Query: 397 GVMT-AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV 455
V + GT ++APEV+ PY D +S G++L+E++ G P+ T + ++
Sbjct: 184 RVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKII 243
Query: 456 --QKGLRPTIPVHTH--PILVDLLERCWQRDPSLRPDFSEITELLQH 498
++ LR P P +DL+ R DP R E+ H
Sbjct: 244 NWKESLR--FPPDPPVSPEAIDLICRLLC-DPEDR--LGSFEEIKSH 285
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 53/192 (27%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
K+ GSY +YKG Q VA+KV++ + E + +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMK-TEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
L V E+M + Y+ + GL + + +G+ Y+H +I+HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 370 KAANLLMNENGVVKVADFGVARVQA-QYGVMTAETGTYRWMAPEVI-EHQPYNHRADVFS 427
K NLL++ G +K+ADFG+AR ++ ++E T + P+V+ Y+ D++
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWG 189
Query: 428 FGIVLWELVTGK 439
G + E++ G+
Sbjct: 190 AGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 51/189 (26%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 261 LYKGAFFSQDVAIKVLTN-EHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319
L + + A+K+L+ E + + F +E IM VVQ A L++
Sbjct: 61 LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120
Query: 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
V E+M GG + + + K +V ++ +H IHRD+K N+L++++
Sbjct: 121 VMEYMPGGDLVNLMSNYDVPEKWARFYTA--EVVLALDAIHSMGFIHRDVKPDNMLLDKS 178
Query: 380 GVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQP----YNHRADVFSFGIVLW 433
G +K+ADFG + G++ +T GT +++PEV++ Q Y D +S G+ L+
Sbjct: 179 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 434 ELVTGKLPY 442
E++ G P+
Sbjct: 239 EMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 21/169 (12%)
Query: 289 FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI------YDYLHKQKCGLKL 342
F +E IM +VQ A L++V E+M GG + YD K
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTA 149
Query: 343 PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402
++L A+D +H IHRD+K N+L++++G +K+ADFG G++ +
Sbjct: 150 EVVL--ALDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 403 T--GTYRWMAPEVIEHQ----PYNHRADVFSFGIVLWELVTGKLP-YDD 444
T GT +++PEV++ Q Y D +S G+ L+E++ G P Y D
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 45/177 (25%), Positives = 94/177 (53%), Gaps = 7/177 (3%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+L ++ ++++GG ++ +L +++ + + + ++ + +LH+ II+RD+K N+L
Sbjct: 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLHKLGIIYRDIKLENIL 137
Query: 376 MNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNH--RADVFSFGIV 431
++ NG V + DFG+++ + V A + GT +MAP+++ H D +S G++
Sbjct: 138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197
Query: 432 LWELVTGKLPY--DDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
++EL+TG P+ D QA + P P + D+++R +DP R
Sbjct: 198 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 248 KFEHKIVSGSYCDLYKG----AFFSQDVAIKVL-TNEHLNENIRREFAQEVHIMRKVRHM 302
+ E I G+Y +YK ++ AIK ++ I + +E+ ++R+++H
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 303 NVVQFIGACTRPPR-----LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
NVV + LF E I + ++ + ++ + + G++
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 358 YLHRNNIIHRDLKAANLLM----NENGVVKVADFGVARV-QAQYGVMTAETG---TYRWM 409
YLH N ++HRDLK AN+L+ E GVVK+ D G+AR+ A + T +
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR 182
Query: 410 APEVI---EHQPYNHRADVFSFGIVLWELVT 437
APE++ H Y D+++ G + EL+T
Sbjct: 183 APELLLGARH--YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 253 IVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
I G+Y +YK + VA+K + ++ E +E+ I+R++ H N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 311 CT----------RPPRLFIVTEFM---------SGGSIYDYLHKQKCGLKLPLLLRVAID 351
T ++V E+M SG + + LL
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG--LVHFSEDHIKSFMKQLL------ 126
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWM 409
+G+NY H+ N +HRD+K +N+L+N G +K+ADFG+AR+ + T + T +
Sbjct: 127 --EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 410 APE-VIEHQPYNHRADVFSFGIVLWELVTGK 439
PE ++ + Y DV+S G +L EL T K
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-13
Identities = 44/170 (25%), Positives = 72/170 (42%), Gaps = 20/170 (11%)
Query: 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVAD 386
S+ D L + L + V + + LHR K+ N+L+ +G++K+
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL-- 52
Query: 387 FGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
G A + Y +MAPEVI+ Q Y +AD++S GI L+E + +LPY++
Sbjct: 53 DGSV---AFKTPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108
Query: 447 PLQAAVGVVQKGLRPTIP--------VHTHPILVDLLERCWQRDPSLRPD 488
L A + ++ G+ P V D + C R P R
Sbjct: 109 ELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET------------ 403
+ YLH I+HRDLK NLL+ G +K+ DFG++++ G+M+ T
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTR 169
Query: 404 --------GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV 455
GT ++APEVI Q Y D ++ GI+L+E + G +P+ TP + V+
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229
Query: 456 QKGLR-PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ P DL+ R +++P R E+ QH
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG------VMTAETGTYR 407
K + Y+H N+IHRDLK +N+L+N + VK+ADFG+AR ++ V+T T R
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT-R 176
Query: 408 WM-APEV-IEHQPYNHRADVFSFGIVLWELVTGK 439
W APE+ + Y D++S G +L E++ GK
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFA--QEVHIMRKVRHMNVVQF 307
K+ GSY +YKG + VA+KV+ L E F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
L +V E++ + Y+ K GL + + +G++Y+H+ I+HR
Sbjct: 69 HDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127
Query: 368 DLKAANLLMNENGVVKVADFGVARVQA-QYGVMTAETGTYRWMAPEV-IEHQPYNHRADV 425
DLK NLL+++ G +K+ADFG+AR ++ + E T + P+V + Y+ D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 426 FSFGIVLWELVTGKLPYDDLTPLQ 449
+ G + E++ G + + +Q
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 51/207 (24%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 271 VAIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
+ ++ TNE + F Q E+H+ + H N+V + L++VT FM+ GS
Sbjct: 33 INLEACTNEMVT------FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA 86
Query: 330 YDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVA--- 385
D + G+ + + V K ++Y+H +HR +KA+++L++ +G V ++
Sbjct: 87 KDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 146
Query: 386 -DFGVARVQAQYGVMTAETGTYR-----WMAPEVIEH--QPYNHRADVFSFGIVLWELVT 437
+ + Q + + Y W++PEV++ Q Y+ ++D++S GI EL
Sbjct: 147 SNLSMIN-HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 205
Query: 438 GKLPYDDLTPLQAAVGVVQKGLRPTIP 464
G +P+ D+ Q ++ + L T+P
Sbjct: 206 GHVPFKDMPATQ----MLLEKLNGTVP 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 53/197 (26%), Positives = 104/197 (52%), Gaps = 13/197 (6%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y +YK ++ +A+K + E +E + +E+ ++++++H N+V+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRD 368
RL++V E++ + ++ K P L++ + + +G+ Y H + ++HRD
Sbjct: 69 VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRD 127
Query: 369 LKAANLLMNE-NGVVKVADFGVARVQAQYGV----MTAETGTYRWMAPEV-IEHQPYNHR 422
LK NLL++ +K+ADFG+AR +G+ T E T + APE+ + + Y+
Sbjct: 128 LKPQNLLIDRRTNALKLADFGLARA---FGIPVRTFTHEVVTLWYRAPEILLGSRHYSTP 184
Query: 423 ADVFSFGIVLWELVTGK 439
D++S G + E+V K
Sbjct: 185 VDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 5e-12
Identities = 53/225 (23%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 274 KVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RLFIVTEFMSGGSIYD 331
K ++ L E + + EV++MR+++H N+V++I +L+I+ EF G +
Sbjct: 44 KAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103
Query: 332 YLHKQKCGLKLPLLLRVAI-DVSK----GMNYLHR-------NNIIHRDLKAANLLM--- 376
+ QKC + AI D+++ + Y H ++HRDLK N+ +
Sbjct: 104 NI--QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161
Query: 377 ------------NENG--VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ--PYN 420
N NG + K+ DFG+++ + + GT + +PE++ H+ Y+
Sbjct: 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYD 221
Query: 421 HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV 465
++D+++ G +++EL +GK P+ + +++G P +P+
Sbjct: 222 DKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PDLPI 264
|
Length = 1021 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 31/171 (18%)
Query: 287 REFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGL------ 340
+ +E+ I++ + H ++ I A + +V + K KC L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV------------MPKYKCDLFTYVDR 178
Query: 341 KLPLLLRVAIDVSKGM----NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396
PL L AI + + + YLH IIHRD+K N+ ++E + DFG A +
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA---CKL 235
Query: 397 GVMTAETGTYRWM------APEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
Y W +PE++ PY + D++S G+VL+E+ +
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 49/150 (32%), Positives = 75/150 (50%), Gaps = 18/150 (12%)
Query: 251 HKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
K+ GSY +YKG Q VA+K + EH E +E +++ ++H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEH-EEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGL-----KLPL--LLRVAIDVSKGMNYLHR 361
L +V E++ + Y+ GL +L L LLR G+ Y H+
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCHQ 121
Query: 362 NNIIHRDLKAANLLMNENGVVKVADFGVAR 391
++HRDLK NLL++E G +K+ADFG+AR
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIR----RE------FAQEVHIMRKV 299
KI G+Y +YK + + VA+K E E I RE ++ ++I+R +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGG-SIYDYLHKQKCGLKLP--LLLRVAIDVSKGM 356
+V + G P L++V E++ + + + G LP + + KG+
Sbjct: 68 DVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 357 NYLHRNNIIHRDLKAANLLMN-ENGVVKVADFGVARV-QAQYGVMTAETGTYRWMAPEV- 413
+ H++ ++HRDLK NLL++ + G++K+AD G+ R T E T + APEV
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVL 183
Query: 414 IEHQPYNHRADVFSFGIVLWELVTG 438
+ Y+ D++S G + E+
Sbjct: 184 LGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 11/113 (9%)
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
+Y YL + L L + VA + ++Y+H IIHRD+K N+L+N + + DFG
Sbjct: 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305
Query: 389 VA-------RVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWE 434
A YG+ GT APEV+ PY D++S G+V++E
Sbjct: 306 AACFARGSWSTPFHYGI----AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 3e-10
Identities = 20/69 (28%), Positives = 34/69 (49%), Gaps = 2/69 (2%)
Query: 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV-DGWPLQETEQLRN 200
+ + D+P LL+ +T +L+++GLNI +A ST +LDVF V D +
Sbjct: 2 VVEVYAPDRPGLLADITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIA 60
Query: 201 VLAKEIPKV 209
L + +
Sbjct: 61 RLEEALEDA 69
|
This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 63/280 (22%), Positives = 114/280 (40%), Gaps = 47/280 (16%)
Query: 245 SLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
S LK E+ I G YKG + V +N E A M K++H N+
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNI 745
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-- 362
V+ IG C +++ E++ G ++ + L L ++AI ++K + +LH
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCS 801
Query: 363 -NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYR--WMAPEVIEHQPY 419
++ L E ++ D R+ + T ++APE E +
Sbjct: 802 PAVV------VGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDI 855
Query: 420 NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGV--------------------VQKGL 459
++D++ FG++L EL+TGK P D A GV + +
Sbjct: 856 TEKSDIYGFGLILIELLTGKSPAD------AEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909
Query: 460 RPTIPVHTHPIL--VDLLERCWQRDPSLRPDFSEITELLQ 497
R + V+ + I+ ++L C DP+ RP +++ + L+
Sbjct: 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 68/280 (24%), Positives = 115/280 (41%), Gaps = 57/280 (20%)
Query: 268 SQDVAIKVLTNEHLNEN--IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
S+ VA+K + E L+EN +++ F +E I + H +V C+ ++ ++
Sbjct: 27 SRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85
Query: 326 GGSIYDYLHK--QKCGLKLPL--------LLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
G ++ L QK L L L + + + Y+H ++HRDLK N+L
Sbjct: 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNIL 145
Query: 376 MNENGVVKVADFGVARVQAQ----------------YGVMTAE---TGTYRWMAPEVIEH 416
+ G V + D+G A + Y MT GT +MAPE +
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205
Query: 417 QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG----LRPTIP----VHTH 468
P + D+++ G++L++++T PY +KG R I V +
Sbjct: 206 VPASESTDIYALGVILYQMLTLSFPYRR-----------KKGRKISYRDVILSPIEVAPY 254
Query: 469 ----PILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
P L + + DP+ R +S + EL Q L LQ
Sbjct: 255 REIPPFLSQIAMKALAVDPAER--YSSVQELKQDLEPHLQ 292
|
Length = 932 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 36/134 (26%), Positives = 69/134 (51%), Gaps = 8/134 (5%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
L++V E+ GG + L++ + + ++ ++ +H+ +HRD+K N+L+
Sbjct: 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135
Query: 377 NENGVVKVADFG-VARVQAQYGVM-TAETGTYRWMAPEVIE------HQPYNHRADVFSF 428
+ G +K+ADFG AR+ A V GT ++APEV+ Y D +S
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195
Query: 429 GIVLWELVTGKLPY 442
G++ +E++ G+ P+
Sbjct: 196 GVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 47/211 (22%), Positives = 88/211 (41%), Gaps = 48/211 (22%)
Query: 272 AIKVLT-NEHLNEN-IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+KVL E + N ++R E I+ + H + + L +V ++ GG +
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLT-EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL 88
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNENGV 381
+ L +Q ++ +V++ + YLH I++RDLK N+L++E+G
Sbjct: 89 FRLLQRQPGK-------CLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH 141
Query: 382 VKVADF---------GVARVQA-------------QYGVMTAET--------GTYRWMAP 411
+ ++DF +A + E GT ++AP
Sbjct: 142 IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP 201
Query: 412 EVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
EVI + D ++ GI+L+E++ G P+
Sbjct: 202 EVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 37/167 (22%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
L+++ EF+ GG + L K+ + +A + ++ +H+ IHRD+K NLL+
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLGFIHRDIKPDNLLL 134
Query: 377 NENGVVKVADFGVA-----------------------RVQAQYGVMTAET---------- 403
+ G VK++DFG+ Q AET
Sbjct: 135 DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAF 194
Query: 404 ---GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP 447
GT ++APEV YN D +S G++++E++ G P+ TP
Sbjct: 195 STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 33/133 (24%), Positives = 71/133 (53%), Gaps = 7/133 (5%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
L++V ++ GG + L K + L + ++ ++ +H+ + +HRD+K N+LM
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 135
Query: 377 NENGVVKVADFGVARVQAQYGVM--TAETGTYRWMAPEVIEHQP-----YNHRADVFSFG 429
+ NG +++ADFG + G + + GT +++PE+++ Y D +S G
Sbjct: 136 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLG 195
Query: 430 IVLWELVTGKLPY 442
+ ++E++ G+ P+
Sbjct: 196 VCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 41/178 (23%), Positives = 77/178 (43%), Gaps = 47/178 (26%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRDLKAANLL 375
L+ V +++ GG + L + G+ L R I +++ + +H+ IHRD+K N+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL 133
Query: 376 MNENGVVKVADFGVA------------------------------------------RVQ 393
++ +G +K+ DFG+ R +
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRK 193
Query: 394 AQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQ 449
Q+ A + GT ++APEV+ Y D +S G++L+E++ G+ P+ TP +
Sbjct: 194 RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 37/167 (22%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
L+++ EF+ GG + L K+ + +A V ++ +H+ IHRD+K NLL+
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIHQLGFIHRDIKPDNLLL 134
Query: 377 NENGVVKVADFGV------ARVQAQYGVMT-----------------AET---------- 403
+ G VK++DFG+ A Y +T AET
Sbjct: 135 DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAY 194
Query: 404 ---GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP 447
GT ++APEV YN D +S G++++E++ G P+ TP
Sbjct: 195 STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 27/82 (32%), Positives = 49/82 (59%), Gaps = 13/82 (15%)
Query: 317 LFIVTEFMSGG------SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
+++V E++ GG IY Y + + ++ +V+ ++YLHR+ IIHRDLK
Sbjct: 79 VYLVMEYLIGGDVKSLLHIYGYFDE-------EMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 371 AANLLMNENGVVKVADFGVARV 392
N+L++ G +K+ DFG+++V
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 33/133 (24%), Positives = 71/133 (53%), Gaps = 7/133 (5%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
L++V ++ GG + L K + L + ++ ++ +H+ + +HRD+K N+L+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL 135
Query: 377 NENGVVKVADFGVARVQAQYGVM--TAETGTYRWMAPEVIEHQ-----PYNHRADVFSFG 429
+ NG +++ADFG Q G + + GT +++PE+++ Y D +S G
Sbjct: 136 DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 195
Query: 430 IVLWELVTGKLPY 442
+ ++E++ G+ P+
Sbjct: 196 VCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 61/232 (26%), Positives = 111/232 (47%), Gaps = 26/232 (11%)
Query: 248 KFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
K + I +GS+ +Y+ S+ VAIK + + +N +E+ IM+ + H+N++
Sbjct: 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINII 122
Query: 306 ----QFIGACTRPPR----LFIVTEFMSGGSIYDYL-HKQKCGLKLPLLL--RVAIDVSK 354
+ C + L +V EF+ +++ Y+ H + LPL L + + +
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFGVAR--VQAQYGVMTAETGTYRWMAP 411
+ Y+H I HRDLK NLL++ N +K+ DFG A+ + Q V + YR AP
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR--AP 239
Query: 412 EV-IEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT 462
E+ + Y D++S G ++ E++ G + + + V ++Q PT
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291
|
Length = 440 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 41/182 (22%), Positives = 81/182 (44%), Gaps = 20/182 (10%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLK-LPLLL---R 347
E+ + ++ H N+++ +++T+ +Y +++ + K PLL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRA 271
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA------RVQAQYGVMTA 401
+ + + Y+H +IHRD+K N+ +N +G + + DFG A R YG +
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-- 329
Query: 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP 461
GT +PE++ Y D++S G++L ++++ D P+ G K L
Sbjct: 330 --GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS-----HDFCPIGDGGGKPGKQLLK 382
Query: 462 TI 463
I
Sbjct: 383 II 384
|
Length = 501 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 58/258 (22%), Positives = 106/258 (41%), Gaps = 54/258 (20%)
Query: 272 AIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+K L + LN N E I+ + + VV+ + L+ V +++ GG +
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 331 DYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
L + + +L R I +++ + +H+ IHRD+K N+L++ +G +K+ DFG+
Sbjct: 90 SLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
Query: 390 ------------------------------------------------ARVQAQYGVMTA 401
A Q Q + +
Sbjct: 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHS 207
Query: 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP 461
GT ++APEV+ + Y D +S G++L+E++ G+ P+ TP + + V+
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL 267
Query: 462 TIP--VHTHPILVDLLER 477
IP V P VDL+ +
Sbjct: 268 HIPPQVKLSPEAVDLITK 285
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 43/189 (22%), Positives = 80/189 (42%), Gaps = 51/189 (26%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRDLKAANLL 375
L+ V +++ GG + L + G+ L R I +++ + +H+ IHRD+K N+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133
Query: 376 MNENGVVKVADFGV---------------------------------------------- 389
++ +G +K+ DFG+
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLE 193
Query: 390 --ARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP 447
A Q Q + + GT ++APEV+ Y D +S G++L+E++ G+ P+ TP
Sbjct: 194 RRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP 253
Query: 448 LQAAVGVVQ 456
L+ + V+
Sbjct: 254 LETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 40/217 (18%)
Query: 252 KIVSGSYCDLYKG----AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQF 307
K+ G+Y +YK +D A+K + ++ + RE A ++R+++H NV+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA----LLRELKHPNVISL 63
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDY----------LHKQKCGLKLPLLL------RVAID 351
++F+ ++DY H+ K P+ L +
Sbjct: 64 -------QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLM----NENGVVKVADFGVARV----QAQYGVMTAET 403
+ G++YLH N ++HRDLK AN+L+ E G VK+AD G AR+ +
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 404 GTYRWMAPE-VIEHQPYNHRADVFSFGIVLWELVTGK 439
T+ + APE ++ + Y D+++ G + EL+T +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 13/172 (7%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
+F+V + GG ++ ++ K L +P + R A ++ ++ LHR I+ RDL N+
Sbjct: 60 VFLVLQHAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 375 LMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWE 434
L+++ G +++ F A Y APEV D +S G +L+E
Sbjct: 117 LLDDRGHIQLTYFSRWSEVEDSCDGEAVENMY--CAPEVGGISEETEACDWWSLGAILFE 174
Query: 435 LVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
L+TGK T ++ + IP LL++ Q +P+ R
Sbjct: 175 LLTGK------TLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 46/183 (25%)
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGV------ARVQAQYGVMT------------ 400
+H+ IHRD+K NLL++ G +K++DFG+ + Y +++
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 401 --------AET-------------GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK 439
AET GT ++APEV YN D +S G++++E++ G
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236
Query: 440 LPYDDLTPLQAAVGVV--QKGLRPTIPVHTHPILVDLLER--CWQRDPSLRPDFSEITEL 495
P+ P + ++ ++ L+ V P DL++R C + R + + E+
Sbjct: 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC---EAERRLGNNGVNEI 293
Query: 496 LQH 498
H
Sbjct: 294 KSH 296
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 3e-07
Identities = 40/159 (25%), Positives = 57/159 (35%), Gaps = 38/159 (23%)
Query: 54 EDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRH 113
+ D A+ R Y L V+L+ H R + A D A EVR +G +
Sbjct: 680 KADRDAYLARHYPAYWLAVDLD---TQARHARFIRDADDAGRPLATEVRPDPARGVT--- 733
Query: 114 FSNLVHSGSPRYLYTQFSCYPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHA 173
E+T+ D P L S++ + G NI +A
Sbjct: 734 ----------------------------EVTVLAADHPGLFSRIAGACAAAGANIVDARI 765
Query: 174 FSTVDGYSLDVFVV---DGWPLQETEQLRNVLAKEIPKV 209
F+T DG +LD F + G E +L LAK I
Sbjct: 766 FTTTDGRALDTFWIQDAFGRDEDEPRRLAR-LAKAIEDA 803
|
Length = 931 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 36/135 (26%), Positives = 75/135 (55%), Gaps = 11/135 (8%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPL-LLRVAI-DVSKGMNYLHRNNIIHRDLKAANL 374
L++V ++ GG + L K +LP + R + ++ ++ +H+ +HRD+K N+
Sbjct: 76 LYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133
Query: 375 LMNENGVVKVADFGVA-RVQAQYGVMTA-ETGTYRWMAPEVIEHQP-----YNHRADVFS 427
L+++NG +++ADFG R+ A V + GT +++PE+++ Y D +S
Sbjct: 134 LLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWS 193
Query: 428 FGIVLWELVTGKLPY 442
G+ ++E++ G+ P+
Sbjct: 194 LGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 40/217 (18%)
Query: 252 KIVSGSYCDLYKG----AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQF 307
K+ G+Y +YK ++ A+K + ++ + RE A ++R+++H NV+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIA----LLRELKHPNVIAL 63
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDY----------LHKQKCGLKLPLLLRVAI------D 351
++F+ ++DY H+ K P+ L ++
Sbjct: 64 -------QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLM----NENGVVKVADFGVARV----QAQYGVMTAET 403
+ G++YLH N ++HRDLK AN+L+ E G VK+AD G AR+ +
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 404 GTYRWMAPE-VIEHQPYNHRADVFSFGIVLWELVTGK 439
T+ + APE ++ + Y D+++ G + EL+T +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 38/153 (24%), Positives = 62/153 (40%), Gaps = 23/153 (15%)
Query: 250 EHKIVSGSYCDLYKGAFFSQDVAIKV-----LTNEHLNENIRRE-FAQEVHIMRKVRHMN 303
I G+ +Y F +K + L+E +RRE +E I+ K R
Sbjct: 1 MDLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAG 60
Query: 304 V----VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
V V + P IV E++ G + D L + + LL V V K L
Sbjct: 61 VPVPIVYDV----DPDNGLIVMEYIEGELLKDALEE----ARPDLLREVGRLVGK----L 108
Query: 360 HRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392
H+ I+H DL +N++++ + + DFG+
Sbjct: 109 HKAGIVHGDLTTSNIILSGGRIYFI-DFGLGEF 140
|
Length = 204 |
| >gnl|CDD|153139 cd02116, ACT, ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 6e-06
Identities = 19/62 (30%), Positives = 34/62 (54%), Gaps = 4/62 (6%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVL 202
+T+S D+P LL+++ S+L+E G+NI ++ DG D+F+V + L +L
Sbjct: 1 LTVSGPDRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIV----VDGDGDLEKLL 56
Query: 203 AK 204
Sbjct: 57 EA 58
|
Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-prephenate dehydratase enzyme (P-protein), respectively. Aspartokinases typically consist of two C-terminal ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. ACT domain repeats have been shown to have nonequivalent ligand-binding sites with complex regulatory patterns such as those seen in the bifunctional enzyme, aspartokinase-homoserine dehydrogenase (ThrA). In other enzymes, such as phenylalanine hydroxylases, the ACT domain appears to function as a flexible small module providing allosteric regulation via transmission of conformational changes, these conformational changes are not necessarily initiated by regulatory ligand binding at the ACT domain itself. ACT domains are present either singularly, N- or C-terminal, or in pairs present C-terminal or between two catalytic domains. Unique to cyanobacteria are four ACT domains C-terminal to an aspartokinase domain. A few proteins are composed almost entirely of ACT domain repeats as seen in the four ACT domain protein, the ACR protein, found in higher plants; and the two ACT domain protein, the glycine cleavage system transcriptional repressor (GcvR) protein, found in some bacteria. Also seen are single ACT domain proteins similar to the Streptococcus pneumoniae ACT domain protein (uncharacterized pdb structure 1ZPV) found in both bacteria and archaea. Purportedly, the ACT domain is an evolutionarily mobile ligand binding regulatory module that has been fused to different enzymes at various times. Length = 60 |
| >gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 24/101 (23%), Positives = 39/101 (38%), Gaps = 7/101 (6%)
Query: 106 VQGASTRHFSNLV-HSGSPRYLYTQFSCYPYKKRLMHEITISTNDKPKLLSQLTSLLSEI 164
H +L S L P E+ I D+P L +++ L+ +
Sbjct: 636 THKEIAWHAESLRRALSSGGPLALIDGTRP---SGGTEVFIYAPDQPGLFAKVAGALAML 692
Query: 165 GLNIQEAHAFSTVDGYSLDVFVV---DGWPLQETEQLRNVL 202
L++ +A +T DG +LD FVV G P + +L
Sbjct: 693 SLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVFQELL 733
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 23/71 (32%), Positives = 42/71 (59%), Gaps = 2/71 (2%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326
+ VA+K+L + + ++ E+ IM + H+N+V +GACT+ ++I+TE+
Sbjct: 67 TMKVAVKMLKSTARSSE-KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRY 125
Query: 327 GSIYDYLHKQK 337
G + DYLH+ K
Sbjct: 126 GDLVDYLHRNK 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|153171 cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 2e-05
Identities = 25/65 (38%), Positives = 37/65 (56%), Gaps = 6/65 (9%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPLQET--EQ 197
+ ++ D+P LL+ +T +L+E+GLNI A +T+ + DVF V DG PL E
Sbjct: 3 LELTALDRPGLLADVTRVLAELGLNIHSAKI-ATLGERAEDVFYVTDADGQPLDPERQEA 61
Query: 198 LRNVL 202
LR L
Sbjct: 62 LRAAL 66
|
This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
| >gnl|CDD|234709 PRK00275, glnD, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 17/82 (20%), Positives = 40/82 (48%), Gaps = 7/82 (8%)
Query: 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPL----QE 194
+I I D+ + + + ++ LNI +A ++ ++LD ++V DG P+
Sbjct: 706 QIFIYAPDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEPIGDNPAR 765
Query: 195 TEQLRNVLAKEIPKVENHHHVV 216
EQ+R L + + +++ ++
Sbjct: 766 IEQIREGLTEALRNPDDYPTII 787
|
Length = 895 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 30/106 (28%), Positives = 54/106 (50%), Gaps = 9/106 (8%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF----SQ---DVAIKVLTNEHLNENIRREFAQE 292
WE L + SG++ + +G + SQ VA+K+L + ++ E
Sbjct: 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSE-KQALMSE 90
Query: 293 VHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK 337
+ IM + H+N+V +GACT+ ++I+TE+ G + +YLHK +
Sbjct: 91 LKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNR 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 28/70 (40%), Positives = 40/70 (57%), Gaps = 3/70 (4%)
Query: 322 EFM-SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
EFM +G I D + + K + ++ V V G+ LHR I+HRD+K NLL+ +G
Sbjct: 289 EFMMAGKKIPDNMPQDK--RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG 346
Query: 381 VVKVADFGVA 390
VK+ DFG A
Sbjct: 347 QVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 43/148 (29%), Positives = 63/148 (42%), Gaps = 42/148 (28%)
Query: 57 LWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSN 116
LWA R + Y L + A D+ H R L R P LVL+ S
Sbjct: 640 LWA---RCYANYFLRHS---ARDIAWHARHLV--RHDLGKP-----LVLI--------SV 678
Query: 117 LVHSGSPRYLYTQFSCYPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFST 176
HSG E+ + D+P+L + + + LS GL+I +A F+T
Sbjct: 679 RPHSGGT------------------EVFVYAPDRPRLFAVVCAALSRRGLSIVDAQIFTT 720
Query: 177 VDGYSLDVFVV---DGWPLQETEQLRNV 201
DGY+LD F+V DG+P++E +
Sbjct: 721 RDGYALDTFIVLEPDGFPVEEDRRAALR 748
|
Length = 867 |
| >gnl|CDD|190133 pfam01842, ACT, ACT domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 2e-04
Identities = 14/66 (21%), Positives = 30/66 (45%), Gaps = 1/66 (1%)
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRN 200
+ + D+P LL+++ L++ G+NI+ ++ D + VV ++ E
Sbjct: 1 TVLEVGVPDRPGLLAEVFGALADRGINIESISQSTSGDKAGIVFIVVVV-DEEDLEAALE 59
Query: 201 VLAKEI 206
L K +
Sbjct: 60 ALKKLL 65
|
This family of domains generally have a regulatory role. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. Pairs of ACT domains bind specifically to a particular amino acid leading to regulation of the linked enzyme. The ACT domain is found in: D-3-phosphoglycerate dehydrogenase EC:1.1.1.95, which is inhibited by serine. Aspartokinase EC:2.7.2.4, which is regulated by lysine. Acetolactate synthase small regulatory subunit, which is inhibited by valine. Phenylalanine-4-hydroxylase EC:1.14.16.1, which is regulated by phenylalanine. Prephenate dehydrogenase EC:4.2.1.51. formyltetrahydrofolate deformylase EC:3.5.1.10, which is activated by methionine and inhibited by glycine. GTP pyrophosphokinase EC:2.7.6.5. Length = 66 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 31/108 (28%), Positives = 52/108 (48%), Gaps = 12/108 (11%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFAQE 292
WE LK + G++ + + F D VA+K+L E + R E
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSE 60
Query: 293 VHIMRKV-RHMNVVQFIGACTRP--PRLFIVTEFMSGGSIYDYLHKQK 337
+ I+ + H+NVV +GACT+P P L ++ EF G++ +YL ++
Sbjct: 61 LKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSNYLRSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 35/145 (24%), Positives = 61/145 (42%), Gaps = 28/145 (19%)
Query: 261 LYKGAFFSQDVAIKV-----LTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRP 314
+Y G F IK + L+E IRRE +E IM + R V
Sbjct: 12 IYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV--------NV 63
Query: 315 PRLF--------IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
P ++ IV E++ G + D ++ L ++ ++ + + LH IIH
Sbjct: 64 PAVYFVDPENFIIVMEYIEGEPLKDLINSNG-----MEELELSREIGRLVGKLHSAGIIH 118
Query: 367 RDLKAANLLMNENGVVKVADFGVAR 391
DL +N++++ + + DFG+A
Sbjct: 119 GDLTTSNMILSGGKIY-LIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|235329 PRK05007, PRK05007, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 22/76 (28%), Positives = 39/76 (51%), Gaps = 9/76 (11%)
Query: 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPLQE---- 194
EI I + D+P L + + + L L++ +A F++ DG ++D F+V DG PL +
Sbjct: 703 EIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSPLSQDRHQ 762
Query: 195 --TEQLRNVLAKEIPK 208
+ L L + P+
Sbjct: 763 VIRKALEQALTQSSPQ 778
|
Length = 884 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 36/152 (23%), Positives = 61/152 (40%), Gaps = 27/152 (17%)
Query: 253 IVSGSYCDLYKGAFFSQDVAIKVLT-----NEHLNENIRRE-FAQEVHIMRKVRHMNVVQ 306
I G+ +Y G F IK + L+E IRRE E ++ + R
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKA---- 57
Query: 307 FIGACTRPPRLF------IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
G T IV E++ G + D + + LL + V K LH
Sbjct: 58 --GVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEE----GNDELLREIGRLVGK----LH 107
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARV 392
+ I+H DL +N+++ ++ + + DFG+ +
Sbjct: 108 KAGIVHGDLTTSNIIVRDDKLY-LIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 30/116 (25%), Positives = 51/116 (43%), Gaps = 19/116 (16%)
Query: 345 LLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGV----------------VKVADF 387
L ++ ++Y H +++H DLK N+LM + V++ D
Sbjct: 233 LAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 388 GVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD 443
G + T YR +PEV+ + + D++S G +++EL TGKL YD
Sbjct: 293 GGCCDERHSRTAIVSTRHYR--SPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 36/185 (19%), Positives = 71/185 (38%), Gaps = 71/185 (38%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI---DVSK--------GMNYLHRNNII 365
L+++ EF+ GG + + +L++ DV++ + +H+ I
Sbjct: 76 LYLIMEFLPGGDL------------MTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123
Query: 366 HRDLKAANLLMNENGVVKVADFGVA-----------------------RVQAQYGVMT-- 400
HRD+K N+L++ G +K++DFG++ R+ + V
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 401 -----------------------AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT 437
+ GT ++APE+ Q Y D +S G +++E +
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
Query: 438 GKLPY 442
G P+
Sbjct: 244 GWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 27/107 (25%), Positives = 52/107 (48%), Gaps = 10/107 (9%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFAQE 292
WE L+ + G++ + + + F D VA+K+L E + + E
Sbjct: 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKML-KEGATASEHKALMSE 60
Query: 293 VHIMRKV-RHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQK 337
+ I+ + H+NVV +GACT+P L ++ EF G++ ++L ++
Sbjct: 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 32/157 (20%)
Query: 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLT-----NEHLNENIRRE-FAQEVHIMRKVRHMN 303
+H I G+ D+ KG + +D IK + L+E +R E E ++ + R
Sbjct: 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG 397
Query: 304 VVQFIGACTRPPRLF--------IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
V P ++ IV E++ G + D L L+ +V V+K
Sbjct: 398 V--------PTPVIYDVDPEEKTIVMEYIGGKDLKDVLEGNP-----ELVRKVGEIVAK- 443
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392
LH+ I+H DL +N ++ ++ + + DFG+ +
Sbjct: 444 ---LHKAGIVHGDLTTSNFIVRDDRLY-LIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.004
Identities = 19/48 (39%), Positives = 27/48 (56%), Gaps = 7/48 (14%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGY---SLDVFVV 187
I ++ D+P LL LT LS++ LNI AH + Y ++DVF V
Sbjct: 846 IEVNGRDRPGLLYDLTRALSDLNLNIASAH----IATYGERAVDVFYV 889
|
Length = 931 |
| >gnl|CDD|153148 cd04876, ACT_RelA-SpoT, ACT domain found C-terminal of the RelA/SpoT domains | Back alignment and domain information |
|---|
Score = 35.9 bits (84), Expect = 0.004
Identities = 14/62 (22%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVL 202
I + D+P LL+ +T++++E +NI + + DG + ++ +++ E L ++
Sbjct: 1 IRVEAIDRPGLLADITTVIAEEKINILSVNTRTDDDGLATIRLTLE---VRDLEHLARIM 57
Query: 203 AK 204
K
Sbjct: 58 RK 59
|
ACT_RelA-SpoT: the ACT domain found C-terminal of the RelA/SpoT domains. Enzymes of the Rel/Spo family enable bacteria to survive prolonged periods of nutrient limitation by controlling guanosine-3'-diphosphate-5'-(tri)diphosphate ((p)ppGpp) production and subsequent rRNA repression (stringent response). Both the synthesis of (p)ppGpp from ATP and GDP(GTP), and its hydrolysis to GDP(GTP) and pyrophosphate, are catalyzed by Rel/Spo proteins. In Escherichia coli and its close relatives, the metabolism of (p)ppGpp is governed by two homologous proteins, RelA and SpoT. The RelA protein catalyzes (p)ppGpp synthesis in a reaction requiring its binding to ribosomes bearing codon-specified uncharged tRNA. The major role of the SpoT protein is the breakdown of (p)ppGpp by a manganese-dependent (p)ppGpp pyrophosphohydrolase activity. Although the stringent response appears to be tightly regulated by these two enzymes in E. coli, a bifunctional Rel/Spo protein has been discovered in most gram-positive organisms studied so far. These bifunctional Rel/Spo homologs (rsh) appear to modulate (p)ppGpp levels through two distinct active sites that are controlled by a reciprocal regulatory mechanism ensuring inverse coupling of opposing activities. In studies with the Streptococcus equisimilis Rel/Spo homolog, the C-terminal domain appears to be involved in this reciprocal regulation of the two opposing catalytic activities present in the N-terminal domain, ensuring that both synthesis and degradation activities are not coinduced. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 71 |
| >gnl|CDD|153198 cd04926, ACT_ACR_4, C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Score = 35.8 bits (83), Expect = 0.004
Identities = 15/43 (34%), Positives = 23/43 (53%), Gaps = 1/43 (2%)
Query: 145 ISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV 187
+ T D+ LLS +T + E GL + A ST +++VF V
Sbjct: 6 LRTEDRVGLLSDVTRVFRENGLTVTRAE-ISTQGDMAVNVFYV 47
|
This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 72 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| cd04928 | 68 | ACT_TyrKc Uncharacterized, N-terminal ACT domain o | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.4 | |
| cd04900 | 73 | ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, | 98.29 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.13 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| PRK05092 | 931 | PII uridylyl-transferase; Provisional | 98.06 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.98 | |
| PRK04374 | 869 | PII uridylyl-transferase; Provisional | 97.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.92 | |
| PRK00275 | 895 | glnD PII uridylyl-transferase; Provisional | 97.91 | |
| PRK05007 | 884 | PII uridylyl-transferase; Provisional | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.88 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.86 | |
| cd04927 | 76 | ACT_ACR-like_2 Second ACT domain, of a novel type | 97.82 | |
| PRK03059 | 856 | PII uridylyl-transferase; Provisional | 97.81 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.78 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| TIGR01693 | 850 | UTase_glnD [Protein-PII] uridylyltransferase. This | 97.75 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.71 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.68 | |
| PRK01759 | 854 | glnD PII uridylyl-transferase; Provisional | 97.66 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.65 | |
| cd04925 | 74 | ACT_ACR_2 ACT domain-containing protein which is c | 97.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.45 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.42 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.38 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.3 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.24 | |
| cd04897 | 75 | ACT_ACR_3 ACT domain-containing protein which is c | 96.97 | |
| cd04926 | 72 | ACT_ACR_4 C-terminal ACT domain, of a novel type o | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.91 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.84 | |
| PLN02236 | 344 | choline kinase | 96.81 | |
| PF01842 | 66 | ACT: ACT domain; InterPro: IPR002912 The ACT domai | 96.79 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.75 | |
| cd04896 | 75 | ACT_ACR-like_3 ACT domain-containing protein which | 96.71 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=441.86 Aligned_cols=270 Identities=47% Similarity=0.872 Sum_probs=252.6
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECCcc-EEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~-vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
....|+|+...+.+.+.||+|+||+||+|.|.|+. ||+|++.....++.....|.+|+.+|.+++|||||+|+|+|...
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34679999999999999999999999999999998 99999998877666688999999999999999999999999998
Q ss_pred C-ceeEEEeeccCCcccccccc-ccCCCChHHHHHHHHHhHHHHHHHHHCC-ceecCCCCCcEEeccCC-cEEEeeeccc
Q 010091 315 P-RLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNN-IIHRDLKAANLLMNENG-VVKVADFGVA 390 (518)
Q Consensus 315 ~-~~~lV~Ey~~ggsL~~~l~~-~~~~l~~~~i~~i~~ql~~gL~yLH~~g-IiHrDLkp~NILl~~~~-~vkL~DFG~a 390 (518)
. .+++|||||++|+|.+++++ .+..+++..+++++.||++||+|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 8 79999999999999999988 4678999999999999999999999999 99999999999999997 9999999999
Q ss_pred eecccc-CccccCCCCCcccChhhhc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010091 391 RVQAQY-GVMTAETGTYRWMAPEVIE--HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467 (518)
Q Consensus 391 ~~~~~~-~~~~~~~gt~~y~APE~l~--~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~ 467 (518)
+..... ..++...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+..+.+....++..+.+|.+|..+
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 987765 4556678999999999999 6799999999999999999999999999999988888989899999999999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
++.+..+|.+||+.||..||+|.+|+..|+.+...+..
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999999999887654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-53 Score=438.46 Aligned_cols=262 Identities=35% Similarity=0.689 Sum_probs=239.5
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEECCc-cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~-~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
.+.|+|+.+.+++++.||+|.||.||.|.|++. +||+|.++...+.. +.|.+|+.+|++|+|+|||+++++|+.+.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 789999999999999999999999999999986 99999999876554 57889999999999999999999999999
Q ss_pred ceeEEEeeccCCcccccccc-ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 316 RLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~-~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
.+|||||||+.|+|.+||.. .+..+...+++.++.|||+||+||+++++|||||.++|||+++++.+||+|||+|+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999987 55679999999999999999999999999999999999999999999999999999544
Q ss_pred ccC--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 395 QYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 395 ~~~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
... ......-...|+|||.+....++.|||||||||+||||+| |+.||.+++..+.. ..+.+|+|.+.|..|++.+
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-~~le~GyRlp~P~~CP~~v 433 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-ELLERGYRLPRPEGCPDEV 433 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-HHHhccCcCCCCCCCCHHH
Confidence 332 1222235688999999999999999999999999999999 99999999987765 5577899999999999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
.++|..||+.+|++||||+.+...|+++...
T Consensus 434 Y~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 434 YELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 9999999999999999999999999888653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=388.99 Aligned_cols=250 Identities=30% Similarity=0.525 Sum_probs=224.0
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc-e
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-L 317 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~-~ 317 (518)
.|..+++...+.||+|..|+||+++++ ++-+|+|++. ...+....+++.+|+.++++++|||||.+||+|..... +
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 466667888999999999999999976 7889999994 34566777999999999999999999999999999885 9
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|+||||+||||.+++.. .+.+++..+-+++.++++||.|||. .+||||||||+|||++..|.|||||||++......
T Consensus 154 sI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999999999987 4679999999999999999999995 99999999999999999999999999999876665
Q ss_pred CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCC-CcHH
Q 010091 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL-----TPLQAAVGVVQKGLRPTIPVH-THPI 470 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~-----~~~~~~~~~~~~~~~p~~~~~-~~~~ 470 (518)
...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||... ...+....++ .+..|.+|.. ++++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~fS~e 310 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEFSPE 310 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccCCHH
Confidence 445578999999999999999999999999999999999999999774 4445444444 4678888887 9999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++.++..||++||.+||++.|++.
T Consensus 311 f~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 311 FRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999999976
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=382.82 Aligned_cols=246 Identities=31% Similarity=0.564 Sum_probs=220.4
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|.+.++||.|+||+||+|+.+ +..||||.+.....+....+-...|+++|+.++|||||++++++..++.+|+|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 333788999999999999965 689999999988777888888999999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC------CcEEEeeeccceeccccCc
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN------GVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~------~~vkL~DFG~a~~~~~~~~ 398 (518)
.||+|.+|++. .+.+++..+..++.||+.||++||+++||||||||.|||++.. -.+||+|||+|+.......
T Consensus 92 ~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~ 170 (429)
T KOG0595|consen 92 NGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM 170 (429)
T ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH
Confidence 99999999998 4589999999999999999999999999999999999999865 4699999999998877666
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK-GLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~L~~Li~~ 477 (518)
..+.+|++.|||||++....|+.|+|+||+|+++|+|++|+.||...++.+....+.+. ...+.++...++.+.+++..
T Consensus 171 a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ 250 (429)
T KOG0595|consen 171 AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLIS 250 (429)
T ss_pred HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhH
Confidence 66678999999999999999999999999999999999999999999988877654433 34666777777888899999
Q ss_pred hhhhCCCCCCCHHHHH
Q 010091 478 CWQRDPSLRPDFSEIT 493 (518)
Q Consensus 478 cL~~dP~~RPs~~eil 493 (518)
.++.+|.+|-++.+..
T Consensus 251 ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 251 LLQRNPKDRISFEDFF 266 (429)
T ss_pred HHhcCccccCchHHhh
Confidence 9999999997776653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=394.58 Aligned_cols=266 Identities=36% Similarity=0.703 Sum_probs=235.0
Q ss_pred CCCCceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 235 EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 235 ~~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
+....|+|..+++.+...||+|+||+||+|.|-| +||||++......++..+.|+.|+.++++-+|.||+-|.|+|..+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3457899999999999999999999999999987 799999999999999899999999999999999999999999998
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
+. .||+.+|+|.||+.+++-...+|+....+.|+.||++||.|||.++|||+|||..||++.+++.|||+|||++....
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 77 99999999999999999888889999999999999999999999999999999999999999999999999997654
Q ss_pred cc---CccccCCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCC---CC
Q 010091 395 QY---GVMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG-LRPT---IP 464 (518)
Q Consensus 395 ~~---~~~~~~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~-~~p~---~~ 464 (518)
.- .......|...|||||++. ..+|+..+|||||||++|||++|.+||......+.++. +-+| +.+. +.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-VGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-VGRGYLMPDLSKIR 618 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-ecccccCccchhhh
Confidence 42 2234456889999999994 45799999999999999999999999996555555443 3334 2333 23
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 465 ~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
..++.++++|+..||..++++||.|.+|+..|+.++..+
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 567789999999999999999999999999888887653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=388.48 Aligned_cols=247 Identities=28% Similarity=0.455 Sum_probs=224.5
Q ss_pred ccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
..|+..+.||+|+|+.+|.+++ .|+.||+|++...... ....+...+|+.|.++|+|||||+|+++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5677799999999999999996 4899999999875443 345588899999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-Cccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMT 400 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~ 400 (518)
|+|..++|..+++. ...++++.++.++.||+.||.|||+++|+|||||..|++++++-+|||+|||+|...... +...
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence 99999999999884 678999999999999999999999999999999999999999999999999999876654 4555
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
+.+||+.|.|||++.....+..+||||+||++|-||.|++||+..+-.+.+..+... ...+|...+.+..+||.++|+
T Consensus 177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--EYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--CcccccccCHHHHHHHHHHhc
Confidence 678999999999999999999999999999999999999999998877777766654 456778999999999999999
Q ss_pred hCCCCCCCHHHHHH
Q 010091 481 RDPSLRPDFSEITE 494 (518)
Q Consensus 481 ~dP~~RPs~~eil~ 494 (518)
+||.+|||+++|+.
T Consensus 255 ~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 255 PNPSERPSLDEVLD 268 (592)
T ss_pred CCcccCCCHHHHhc
Confidence 99999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=365.85 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=217.9
Q ss_pred cccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEee-eeecCC-ceeE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG-ACTRPP-RLFI 319 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~-~~~~~~-~~~l 319 (518)
..+|+++++||.|+||.||+++. .|..||.|.+.-+.++....+....|+.+|++|+|||||++++ .+.++. .++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 34566699999999999999984 5889999999988888888899999999999999999999998 454444 4999
Q ss_pred EEeeccCCccccccc---cccCCCChHHHHHHHHHhHHHHHHHHH--CC--ceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 320 VTEFMSGGSIYDYLH---KQKCGLKLPLLLRVAIDVSKGMNYLHR--NN--IIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~---~~~~~l~~~~i~~i~~ql~~gL~yLH~--~g--IiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
|||||.+|+|.+.++ +.+..+++..+|+++.|++.||..+|+ .. |+||||||.||+++.+|+|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999885 445579999999999999999999999 44 99999999999999999999999999998
Q ss_pred ccccCc-cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 393 QAQYGV-MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 393 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
...... .....|||.||+||.+.+.+|+.||||||+||++|||+.-+.||.+..-.+....+.+..+.|-....++.++
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l 257 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDL 257 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHH
Confidence 766543 3345799999999999999999999999999999999999999999877777766666544443337889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEIT 493 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil 493 (518)
.++|..|+..||..||+.-.++
T Consensus 258 ~~li~~ci~vd~~~RP~t~~~v 279 (375)
T KOG0591|consen 258 RELINMCIAVDPEQRPDTVPYV 279 (375)
T ss_pred HHHHHHHccCCcccCCCcchHH
Confidence 9999999999999999853333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=376.16 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=211.2
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHH-----HHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN-----IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~-----~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
.|.+.+.||+|+||.|-+|... |+.||||++........ -.....+|+.+|++|+|||||+++++|+.....|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 3445999999999999999854 79999999987654331 1133568999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC---CcEEEeeeccceeccc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN---GVVKVADFGVARVQAQ 395 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~---~~vkL~DFG~a~~~~~ 395 (518)
+||||++||.|.+++-. ++.+.+.....+++|++.|+.|||++||+||||||+|||+..+ ..+||.|||+|+..+.
T Consensus 253 mVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~ 331 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE 331 (475)
T ss_pred EEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence 99999999999999977 5578888899999999999999999999999999999999766 6899999999999887
Q ss_pred cCccccCCCCCcccChhhhcCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCC--CCCCCCCCcH
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPY---NHRADVFSFGIVLWELVTGKLPYDDLTPLQ-AAVGVVQKGL--RPTIPVHTHP 469 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~---~~ksDV~SlGill~eLltG~~P~~~~~~~~-~~~~~~~~~~--~p~~~~~~~~ 469 (518)
...+.+.+||+.|.|||++.++.+ ..+.|+||+||+||-+|+|.+||++..... ....+.+..+ -|..-..++.
T Consensus 332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISE 411 (475)
T ss_pred ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhH
Confidence 777888899999999999965543 347899999999999999999998865555 3333333333 3333456789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+..+||.+||..||++|||+.|.+.
T Consensus 412 ea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 412 EALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHHHHHhhEeCcccCcCHHHHhc
Confidence 9999999999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=374.35 Aligned_cols=262 Identities=32% Similarity=0.631 Sum_probs=221.2
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC 311 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~ 311 (518)
|+|..++|++.++||+|+||.||+|.+. +..||+|+++... .......+.+|+.+++++ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 8888899999999999999999999742 3579999998543 233446789999999999 899999999988
Q ss_pred ecC-CceeEEEeeccCCcccccccccc-----------------------------------------------------
Q 010091 312 TRP-PRLFIVTEFMSGGSIYDYLHKQK----------------------------------------------------- 337 (518)
Q Consensus 312 ~~~-~~~~lV~Ey~~ggsL~~~l~~~~----------------------------------------------------- 337 (518)
... ..+|+||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 654 46899999999999999986421
Q ss_pred --------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---cccCCCCC
Q 010091 338 --------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTY 406 (518)
Q Consensus 338 --------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~ 406 (518)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....++.
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2367788899999999999999999999999999999999999999999999975432211 11223567
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
.|+|||++.+..++.++||||||+++|||++ |..||......+.....+..+..+..+..+++.+.+++.+||+.||.+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999998999999999999999999997 999998866555555555556666677788999999999999999999
Q ss_pred CCCHHHHHHHHHHHHHH
Q 010091 486 RPDFSEITELLQHLAQR 502 (518)
Q Consensus 486 RPs~~eil~~L~~l~~~ 502 (518)
|||+.++++.|+.++++
T Consensus 321 RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 321 RPTFSALVEILGDLLQE 337 (338)
T ss_pred CcCHHHHHHHHHHHHhc
Confidence 99999999999988763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=385.03 Aligned_cols=270 Identities=34% Similarity=0.657 Sum_probs=245.3
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC--C---cc-EEEEEEec-cccCHHHHHHHHHHHHHHhhcCCCceeeEe
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--S---QD-VAIKVLTN-EHLNENIRREFAQEVHIMRKVRHMNVVQFI 308 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~---~~-vAvKvl~~-~~~~~~~~~~f~~E~~il~~l~HpnIv~l~ 308 (518)
....|++.-++..+.++||+|+||.||+|++. + .. ||+|..+. .........+|.+|+++|++++|||||+||
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 45679999999999999999999999999964 1 13 89999986 346677789999999999999999999999
Q ss_pred eeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeec
Q 010091 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388 (518)
Q Consensus 309 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG 388 (518)
|++.....+|+|||+|.||+|.+||.+.+..++..+.+.++.+.+.||+|||++++|||||..+|+|++.++.+||+|||
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999999999977789999999999999999999999999999999999999999999999999
Q ss_pred cceeccccCccc-cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010091 389 VARVQAQYGVMT-AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466 (518)
Q Consensus 389 ~a~~~~~~~~~~-~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~ 466 (518)
+++......... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+....+....++..+++...+..
T Consensus 308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~ 387 (474)
T KOG0194|consen 308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK 387 (474)
T ss_pred cccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence 998765322222 2235689999999999999999999999999999999 89999999999988888888999999999
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
.+.++..++.+||..+|+.||+|.++.+.|+.+.+....
T Consensus 388 ~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 388 TPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999999999887664
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=358.88 Aligned_cols=259 Identities=23% Similarity=0.380 Sum_probs=224.1
Q ss_pred eeeccccceee--eEEeEecceEEEEEEECCccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeec---
Q 010091 240 WEIDASLLKFE--HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTR--- 313 (518)
Q Consensus 240 ~eI~~~~~~~~--~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--- 313 (518)
+.|+.+++... ..||+|+++.||+|.+.|+.||||+++...... ...+.|.+|+.+|++++||||+++++++..
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 44444555445 679999999999999999999999998654433 334788899999999999999999999866
Q ss_pred -CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 314 -PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 314 -~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
...+++||||+++|+|.+++.+ ...+++...+.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 4578999999999999999987 4578899999999999999999998 499999999999999999999999999997
Q ss_pred eccccCccccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010091 392 VQAQYGVMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+...+.++..+..+++
T Consensus 172 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (283)
T PHA02988 172 ILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPL 249 (283)
T ss_pred hhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcH
Confidence 54332 223568899999999976 68999999999999999999999999998877777666666777777878899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
.+.+++.+||+.||.+|||+.|++..|+.+..
T Consensus 250 ~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 250 EIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=384.78 Aligned_cols=256 Identities=33% Similarity=0.630 Sum_probs=233.4
Q ss_pred CCCCceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 235 EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 235 ~~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
...+.|+|..+...-++=||+|+.|.||+|+..++.||||.++.-. ..++.-|++|+|+||+.|.|+|+..
T Consensus 114 qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 114 QQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCC
Confidence 3567899998888888899999999999999999999999876421 1378889999999999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..+|||||||..|-|+..|+. ...+....+..+..+|+.||.|||.+.|||||||.-||||+.+..|||+|||.++...
T Consensus 185 PcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred ceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 999999999999999999988 5678999999999999999999999999999999999999999999999999998766
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
.-..+....||..|||||+|.+.+.+.|.||||||++|||||||..||.+......++++=...+....|..++..++-|
T Consensus 264 ~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 264 DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHH
Confidence 65555567899999999999999999999999999999999999999999887777777666677888999999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
|++||+..|.+||+|.+|+..|+=..
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 99999999999999999999886543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=361.62 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=219.3
Q ss_pred eccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHH-HHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNEN-IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~-~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+..++|++.++||+|+||.||+++. .++-+|+|+++.....+. ..+....|..||.+++||+||+++-.|.....+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 3445566699999999999999985 478899999998765543 4577889999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
+|+||+.||.|...|.+ .+.++++.+.-++..|+.||.|||++|||||||||+|||+|.+|+++|+|||+++.....+.
T Consensus 102 lVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999999999987 56899999999999999999999999999999999999999999999999999986555443
Q ss_pred c-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 399 M-TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 399 ~-~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
. .+.+||+.|||||++.+..|+..+|.||||+++|||++|..||...+..+....+.+.. .+..|...+++.++++++
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~~ 259 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLKK 259 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHHH
Confidence 3 33579999999999999999999999999999999999999999988777777666543 456677789999999999
Q ss_pred hhhhCCCCCC----CHHHH
Q 010091 478 CWQRDPSLRP----DFSEI 492 (518)
Q Consensus 478 cL~~dP~~RP----s~~ei 492 (518)
+|..||.+|- ++.+|
T Consensus 260 LL~rdp~~RLg~~~d~~~i 278 (357)
T KOG0598|consen 260 LLKRDPRQRLGGPGDAEEI 278 (357)
T ss_pred HhccCHHHhcCCCCChHHh
Confidence 9999999994 45554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=371.07 Aligned_cols=250 Identities=24% Similarity=0.409 Sum_probs=223.3
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHH-HHHHHHHHHHhhc-CCCceeeEeeeeecCCce
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIR-REFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~-~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 317 (518)
-...+|+|++.||+|+|++||+|+.. ++.||||++.......+.+ .....|-.+|.+| .||.|++|+..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34567899999999999999999965 7889999998776544333 5667899999999 899999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+|+||+++|.|.++|++. +.+++...+.++.+|+.||+|||++|||||||||+|||++.++++||.|||.|+......
T Consensus 150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999994 689999999999999999999999999999999999999999999999999998754422
Q ss_pred cc--------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010091 398 VM--------------TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI 463 (518)
Q Consensus 398 ~~--------------~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~ 463 (518)
.. ....||-.|.+||++.....+..+|+|+||||+|.|+.|.+||.+....-.+..++ .+...+
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l~y~f 306 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--ALDYEF 306 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--HhcccC
Confidence 11 33569999999999999999999999999999999999999999998877776665 456778
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 464 ~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
|...++...+|+++.|..||.+|+|.++|.+
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 8999999999999999999999999998876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=361.59 Aligned_cols=248 Identities=29% Similarity=0.497 Sum_probs=214.0
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC--ceeEEEe
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RLFIVTE 322 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lV~E 322 (518)
+...+.||+|+||.||++... |...|||......... .+.+.+|+.+|++++|||||+.+|...... .++++||
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 444899999999999999976 6899999988763222 567889999999999999999999744443 6999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-CCcEEEeeeccceeccc----cC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVVKVADFGVARVQAQ----YG 397 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-~~~vkL~DFG~a~~~~~----~~ 397 (518)
|+++|||.+++.+.++.++++.+..+..||++||.|||++||+||||||+|||++. ++.+||+|||++..... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 99999999999986668999999999999999999999999999999999999999 79999999999986653 11
Q ss_pred ccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDD-LTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li 475 (518)
......||+.|||||++.++ ....++|||||||++.||+||+.||.. ....+....+......|.+|..++++.+++|
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl 256 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFL 256 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence 22335699999999999853 334599999999999999999999998 5666666666666677899999999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~~L 496 (518)
.+|+..+|.+|||+++++..-
T Consensus 257 ~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 257 RKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHhhcCcccCcCHHHHhhCh
Confidence 999999999999999997643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=387.22 Aligned_cols=266 Identities=31% Similarity=0.574 Sum_probs=233.8
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEe
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~ 308 (518)
..+..+|..+...+.++||+|+||.||+|...+ +.||||.++... +..+.++|.+|+.++..++|||||+|+
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 455678999999999999999999999998542 569999998764 444679999999999999999999999
Q ss_pred eeeecCCceeEEEeeccCCcccccccccc-------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEE
Q 010091 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQK-------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375 (518)
Q Consensus 309 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NIL 375 (518)
|.|..++.+|+|+|||..|+|.+||.... .+++..+.+.|+.||+.||.||-++.+|||||.++|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 99999999999999999999999996321 23788999999999999999999999999999999999
Q ss_pred eccCCcEEEeeeccceeccccCcc---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 010091 376 MNENGVVKVADFGVARVQAQYGVM---TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAA 451 (518)
Q Consensus 376 l~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~ 451 (518)
|+++-.|||+|||+++..-...-. ....-..+||+||.|..++|+++|||||||++|||+++ |+.||.+.++.++.
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 999999999999999864322211 12235689999999999999999999999999999999 99999999998887
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 452 VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 452 ~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
..+-...+ -..|..|+.++++||..||+.+|.+||+|+||-..|++..+.=
T Consensus 716 e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 716 ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 76665555 7889999999999999999999999999999999998876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=355.57 Aligned_cols=258 Identities=30% Similarity=0.514 Sum_probs=223.9
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
....|-++...|++.++||.|..+.||+|+.. ++.||||++..+..+.+ ...+.+|+..|+.++||||++++..|..
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 34568888888999999999999999999964 78999999998877666 6889999999999999999999999999
Q ss_pred CCceeEEEeeccCCcccccccc-ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~-~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
+..+|+||.||.+||+.+.+.. ....+++..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||++-.
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 9999999999999999999864 344699999999999999999999999999999999999999999999999999865
Q ss_pred ccccCc-----cccCCCCCcccChhhh--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-----
Q 010091 393 QAQYGV-----MTAETGTYRWMAPEVI--EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR----- 460 (518)
Q Consensus 393 ~~~~~~-----~~~~~gt~~y~APE~l--~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~----- 460 (518)
....+. .....||+.|||||++ ....|+.|+|||||||+..||.+|+.||..+.|.+.+..-++....
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 544331 1334699999999996 3456999999999999999999999999999999988776654321
Q ss_pred ---CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 ---PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 ---p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.......+..+.+++..||++||.+|||++++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0111234556999999999999999999999976
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=346.06 Aligned_cols=256 Identities=30% Similarity=0.556 Sum_probs=220.0
Q ss_pred eccccceeeeEEeEecceEEEEEEEC-----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
|+...|++.+.||+|+||.||+|.+. +..||+|.++.... ......|.+|+.++++++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 56677888999999999999999853 46799999987543 3345789999999999999999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.|+||||+++++|.+++......+++..++.++.||+.||+|||++|++||||||+||+++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999999876667899999999999999999999999999999999999999999999999987653322
Q ss_pred Cccc--cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 397 GVMT--AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 397 ~~~~--~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
.... ...++..|+|||.+.+..++.++|||||||++||+++ |..||...+..+.... +..+..+..+..++..+.+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-VEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HHCCCCCCCCCCCCHHHHH
Confidence 1111 2235678999999999999999999999999999875 9999988876654433 4455666677888999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
++.+||+.+|.+||++.+|++.|.++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=362.98 Aligned_cols=247 Identities=29% Similarity=0.531 Sum_probs=217.5
Q ss_pred cccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccC---HHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCce
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRL 317 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~---~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 317 (518)
...|.+.+.||+|+||.|++|.. .+..||+|++...... ......+.+|+.++++++ ||||++++.++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 44566699999999999999986 4799999987765222 123456668999999999 99999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-CcEEEeeeccceec-cc
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVVKVADFGVARVQ-AQ 395 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-~~vkL~DFG~a~~~-~~ 395 (518)
|+||||+.||.|.+++.+ .+++++..+..++.||+.|++|+|++||+||||||+|||++.+ +.+||+|||++... ..
T Consensus 96 ~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~ 174 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE 174 (370)
T ss_pred EEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence 999999999999999999 7789999999999999999999999999999999999999999 99999999999987 45
Q ss_pred cCccccCCCCCcccChhhhcCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC-cHHHH
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQP-YN-HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHT-HPILV 472 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~-~~-~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~L~ 472 (518)
.......+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||+..+.......+. .....+|..+ ++++.
T Consensus 175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~--~~~~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR--KGEFKIPSYLLSPEAR 252 (370)
T ss_pred CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh--cCCccCCCCcCCHHHH
Confidence 55667788999999999998877 86 78999999999999999999999976665555533 3455677777 99999
Q ss_pred HHHHHhhhhCCCCCCCHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEIT 493 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil 493 (518)
.++.+||..||.+|+++.+|+
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHh
Confidence 999999999999999999998
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.83 Aligned_cols=263 Identities=31% Similarity=0.607 Sum_probs=225.0
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEe
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~ 308 (518)
.+.|.+..++|++.+.||+|+||.||++++. +..||+|+++..... .....+.+|+.+++++ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEe
Confidence 4679999999999999999999999999853 246999999865433 3356788999999999 899999999
Q ss_pred eeeecCCceeEEEeeccCCcccccccccc---------------------------------------------------
Q 010091 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQK--------------------------------------------------- 337 (518)
Q Consensus 309 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~--------------------------------------------------- 337 (518)
++|......|+||||+++|+|.+++....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999885421
Q ss_pred ------------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc
Q 010091 338 ------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 338 ------------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 399 (518)
..+++..+++++.||+.||.|||++||+||||||+|||+++++.+||+|||+++........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 23677889999999999999999999999999999999999999999999999754332211
Q ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010091 400 ---TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475 (518)
Q Consensus 400 ---~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li 475 (518)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||...............+..+..+...++++.+++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 11235678999999988899999999999999999997 99999887665555566666667777777889999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
.+||+.||.+|||+.++++.|++++
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.62 Aligned_cols=261 Identities=29% Similarity=0.586 Sum_probs=223.2
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG 309 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~ 309 (518)
..|++..++|++.++||+|+||.||+|++. +..||||+++.... ......+.+|+.+++.+ +||||+++++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 368888899999999999999999999742 35799999976432 23346788999999999 8999999999
Q ss_pred eeecCCceeEEEeeccCCcccccccccc----------------------------------------------------
Q 010091 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------------------------------------------- 337 (518)
Q Consensus 310 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------------------------------------------- 337 (518)
+|......|+||||++||+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999886422
Q ss_pred ----------------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 338 ----------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 338 ----------------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 1367788999999999999999999999999999999999999999999999976543
Q ss_pred cCcc---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 396 YGVM---TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 396 ~~~~---~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
.... ....++..|+|||++.+..++.++||||||+++|||++ |..||............+..+.++..+...+.++
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 346 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEM 346 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHH
Confidence 2211 11235678999999999999999999999999999998 8999988776666666677677776777788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
.+++.+||+.||.+||++.++++.|++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 9999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=388.82 Aligned_cols=264 Identities=32% Similarity=0.604 Sum_probs=233.5
Q ss_pred eeccccceeeeEEeEecceEEEEEEECC---c----cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS---Q----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~---~----~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
++....+++...||+|.||.||.|++.+ . .||||.++... +.....+|.+|..+|++++|||||+++|+|-.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 4567778889999999999999999753 2 38889887654 45567899999999999999999999999999
Q ss_pred CCceeEEEeeccCCccccccccc------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeee
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQ------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DF 387 (518)
....+|++|||+||+|..||++. ...++...++.++.||++|+.||+++++|||||..+|+|+++...|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999886 557999999999999999999999999999999999999999999999999
Q ss_pred ccceeccccC--ccccC-CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010091 388 GVARVQAQYG--VMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTI 463 (518)
Q Consensus 388 G~a~~~~~~~--~~~~~-~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~ 463 (518)
|+|+..-... ....+ .-..+|||||.+..+.++.|+||||||+++||++| |..||...++.+....+...+ +...
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~ 925 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDP 925 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCC
Confidence 9998322211 11122 34579999999999999999999999999999999 999999999999888777766 8999
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 464 ~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
|..|+..+.++|.+||+.+|.+||+|..|++.+..+.+.....
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 9999999999999999999999999999999999988765443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=365.61 Aligned_cols=260 Identities=36% Similarity=0.711 Sum_probs=236.7
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC--ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
..|.||++..+....++||-|.||.||.|.|+. -.||||.++...+. .++|+.|+.+|+.++|||+|+++|.|+.
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe---veEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh---HHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 458999999999999999999999999999984 67999999875442 4899999999999999999999999999
Q ss_pred CCceeEEEeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
+..+|||+|||..|+|.+||++.+. .++.-.++.++.||..||.||..+++|||||...|.|++++..||++|||++++
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999999987554 467777889999999999999999999999999999999999999999999998
Q ss_pred ccccCccccCC---CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 393 QAQYGVMTAET---GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 393 ~~~~~~~~~~~---gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
+.... .++.. ..+.|.|||-+....++.|+|||+||++|||+.| |..||.+.+..+.+ +.+.++++..-|..|+
T Consensus 415 MtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 415 MTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-GLLEKGYRMDGPEGCP 492 (1157)
T ss_pred hcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-HHHhccccccCCCCCC
Confidence 75432 23333 4688999999999999999999999999999999 99999999877766 6688899999999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
+.+.+||..||+.+|.+||+|.||-..++.++
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 99999999999999999999999999999886
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=341.57 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=212.3
Q ss_pred cceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|....++|+|+||.||+++. .|+-||||.+.....+....+-.++|+++|++++|+|+|.++.+|.....+++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 345588999999999999995 489999999988776666778889999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~ 402 (518)
|+. ++.+-|.....+++...+.+++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+....+ ...|-.
T Consensus 83 ~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY 161 (396)
T KOG0593|consen 83 CDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY 161 (396)
T ss_pred cch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh
Confidence 955 666777777888999999999999999999999999999999999999999999999999999987743 345556
Q ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------CCC-C
Q 010091 403 TGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK-------------------GLR-P 461 (518)
Q Consensus 403 ~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~-------------------~~~-p 461 (518)
.-|..|.|||.+-+ ..|....||||+||++.||++|.+.|.+.+..+.+..+... |.+ |
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 78999999999966 78999999999999999999999999988776655443311 111 1
Q ss_pred CCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 TIP---------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ~~~---------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+ ...+.-+.++++.||+.||.+|++.++++.
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111 234556899999999999999999999875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=341.58 Aligned_cols=247 Identities=36% Similarity=0.694 Sum_probs=209.6
Q ss_pred eeeeEEeEecceEEEEEEEC------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 248 KFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~~------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
++.+.||.|+||.||+|++. +..|+||+++.. ........|.+|+.++++++||||++++|++...+..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 45789999999999999987 577999999663 34445689999999999999999999999999888899999
Q ss_pred eeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--
Q 010091 322 EFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-- 398 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 398 (518)
||+++|+|.++|... ...+++..++.++.||+.||.|||+++++|++|+++||+++.++.+||+|||++........
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 56799999999999999999999999999999999999999999999999999987632211
Q ss_pred -cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 399 -MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 399 -~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
.....+...|+|||.+....++.++||||||+++|||++ |+.||......+..... ..+.++..+..++..+.++|.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQ 239 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHH
Confidence 122346789999999988889999999999999999999 78999998776655554 556677778889999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~~L 496 (518)
+||+.+|.+|||+.++++.|
T Consensus 240 ~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 240 QCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHT-SSGGGS--HHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=362.72 Aligned_cols=245 Identities=31% Similarity=0.538 Sum_probs=218.3
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|+--.+||+|+.|.||.++.. ++.||||.+....... .+-+..|+.+|+..+|+|||++++.|...+.+++||||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4566789999999999999964 6789999988764432 35677899999999999999999999888999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
|+||+|.|.+.... +++.++..+++.+++||+|||.+||+|||||.+|||++.+|.+||+|||+|....... ...+.
T Consensus 352 m~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred cCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence 99999999988744 9999999999999999999999999999999999999999999999999998765544 45567
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhhh
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
.||+.|||||++....|++|.||||||++++||+.|.+||-..++.++...+...+- .-..+...++.+++++.+||+.
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~ 509 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVV 509 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhc
Confidence 799999999999999999999999999999999999999999999988876665443 3344567899999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
|+.+|+++.|+|+
T Consensus 510 dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 510 DVEQRASAKELLE 522 (550)
T ss_pred chhcCCCHHHHhc
Confidence 9999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=359.62 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=217.8
Q ss_pred cccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCC-ceeE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPP-RLFI 319 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~-~~~l 319 (518)
-.+|+..++||.|+||.||+|+. .+..||||.++.....-+ ...=++|+..|++|+ ||||+++.+.+.+.. .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45677899999999999999995 478899999987654422 234468999999999 999999999998877 9999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 399 (518)
||||| ..+|++.++.++..+++..+..|+.||++||+|+|++|+.|||+||+|||+..+..|||+|||+||........
T Consensus 88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence 99999 57999999998889999999999999999999999999999999999999999999999999999998888888
Q ss_pred ccCCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------------C
Q 010091 400 TAETGTYRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG-------------------L 459 (518)
Q Consensus 400 ~~~~gt~~y~APE~l-~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~-------------------~ 459 (518)
|....|..|+|||++ ...-|+.+.|+|++|||++|+.+-++.|.+.+..+.+..+++-- +
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 888999999999987 67789999999999999999999999999988877776655211 1
Q ss_pred -CCC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 -RPT--------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 -~p~--------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.|. +-..++++..++|.+|++.||.+|||+.|.++
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 011 11347889999999999999999999999876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=362.80 Aligned_cols=245 Identities=31% Similarity=0.542 Sum_probs=219.2
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|.+.+.||+|+||.||+|+.+ .+.||+|.+.+....+.....+.+|++|+++++|||||.++++|+...++|+|+||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 4666888999999999999954 68899999988777777778899999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-cccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~ 402 (518)
+.| +|..+|.. ++.++++.+..++.+++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+.+..... .+..
T Consensus 83 a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 83 AVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred hhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 976 99999987 67899999999999999999999999999999999999999999999999999998776543 3445
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.||+.|||||+..+.+|+..+|+||+||++|||++|++||-..+-.+....++... ...|...+..+.++++..|.+|
T Consensus 161 kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~--v~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP--VKPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC--CCCcccccHHHHHHHHHHhhcC
Confidence 69999999999999999999999999999999999999998776666555555433 3445578899999999999999
Q ss_pred CCCCCCHHHHHH
Q 010091 483 PSLRPDFSEITE 494 (518)
Q Consensus 483 P~~RPs~~eil~ 494 (518)
|.+|.+..+++.
T Consensus 239 P~~RltW~~Ll~ 250 (808)
T KOG0597|consen 239 PAQRLTWTDLLG 250 (808)
T ss_pred hhhcccHHHHhc
Confidence 999999888765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=336.84 Aligned_cols=256 Identities=36% Similarity=0.710 Sum_probs=221.9
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
|+++..+|.+.++||+|+||.||+|.+. ++.||+|+++... .....+.+|+.++++++|+||+++++++.....+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 7888888999999999999999999975 6889999987542 2346788999999999999999999999999999
Q ss_pred eEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 318 FIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+++|||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999999987533 35889999999999999999999999999999999999999999999999999765432
Q ss_pred Ccc--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 397 GVM--TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 397 ~~~--~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+. .......+.+..+..+++.+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKGYRMERPEGCPPKVYE 236 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCHHHHH
Confidence 211 11224668999999998999999999999999999998 9999988765443 3445556777788889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
++.+||+.+|.+||++.++++.|+.+
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=347.06 Aligned_cols=244 Identities=22% Similarity=0.376 Sum_probs=212.3
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|++.+.||+|+||.||++... ++.||+|++...... ......+.+|+.++++++||||+++++++......|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5677999999999999999976 788999999764332 2344678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
|+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~ 158 (291)
T cd05612 82 YVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL 158 (291)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccc
Confidence 9999999999976 457899999999999999999999999999999999999999999999999999764332 2235
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...++...++.+.++|.+||+.|
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~d 236 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIKKLLVVD 236 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHHHHcCCC
Confidence 6899999999999999999999999999999999999999988776655554433 34567778899999999999999
Q ss_pred CCCCCC-----HHHHHH
Q 010091 483 PSLRPD-----FSEITE 494 (518)
Q Consensus 483 P~~RPs-----~~eil~ 494 (518)
|.+||+ ++++++
T Consensus 237 p~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 237 RTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHccCCccCCHHHHhc
Confidence 999995 787765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=352.72 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=215.8
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
+.|.+ +.|.+.+.||+|+||.||++++. ++.||+|+++.... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~--~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 13 SSWKL--SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred CCCCc--hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 44544 56777999999999999999975 68899999986532 223446788999999999999999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
...|+||||++|++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999999999977 4578899999999999999999999999999999999999999999999999997654
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..+.+....+... ...++..+++.+.++
T Consensus 170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~l 245 (329)
T PTZ00263 170 DR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDL 245 (329)
T ss_pred CC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHH
Confidence 32 22356899999999999999999999999999999999999999988877666554433 345677788999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHH
Q 010091 475 LERCWQRDPSLRPD-----FSEITE 494 (518)
Q Consensus 475 i~~cL~~dP~~RPs-----~~eil~ 494 (518)
|.+||+.||.+||+ +++++.
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99999999999986 677664
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.01 Aligned_cols=250 Identities=30% Similarity=0.495 Sum_probs=226.8
Q ss_pred CCCCceeeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEecc-ccCHHHHHHHHHHHHHHhhcCCCceeeEeeee
Q 010091 235 EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNE-HLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (518)
Q Consensus 235 ~~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~-~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~ 311 (518)
..+..|++ ++.||.|+.|.|-+|+. +|+.+|||++... ...+.....+.+|+-||+.+.||||+++|+.|
T Consensus 9 ~tiGpwkL-------gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw 81 (786)
T KOG0588|consen 9 NTIGPWKL-------GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW 81 (786)
T ss_pred ccccceec-------cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee
Confidence 35678988 99999999999999996 4899999999876 44555567888999999999999999999999
Q ss_pred ecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 312 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
+...++|+|.||++||-|.+|+-. ++++++....+++.||+.|+.|+|..+||||||||+|+|++..+.+||+|||+|.
T Consensus 82 e~~~~lylvlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 82 ENKQHLYLVLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred ccCceEEEEEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceee
Confidence 999999999999999999999988 6689999999999999999999999999999999999999999999999999999
Q ss_pred eccccCccccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 392 VQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
+........+.+|++.|.|||++.|.+|+ .++||||.|+|||.||||++||++..-...+..+.+ ....+|..++++
T Consensus 161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~--G~f~MPs~Is~e 238 (786)
T KOG0588|consen 161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR--GVFEMPSNISSE 238 (786)
T ss_pred cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc--CcccCCCcCCHH
Confidence 88877777888999999999999999986 689999999999999999999997766665555443 345678999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+||.+|+..||.+|.|.+||++
T Consensus 239 aQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 239 AQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHHHHHHHhccCccccccHHHHhh
Confidence 999999999999999999999976
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=372.83 Aligned_cols=260 Identities=34% Similarity=0.603 Sum_probs=236.8
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--C---ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--S---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~---~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
-||+.+..+++++||.|.||.||+|+.+ | ..||||.+|... .+....+|+.|+.||-+.+||||+++.|..+..
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 4789999999999999999999999965 3 469999999875 456679999999999999999999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
....||+|||++|+|..||+++.+.++..++..+++.|+.||+||-+.|+|||||.+.|||++.+-++|++|||++++..
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999999765
Q ss_pred ccCc--cccCC--CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010091 395 QYGV--MTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 395 ~~~~--~~~~~--gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
.... .++.- -..+|.|||.|...+++.+|||||+||+|||.++ |..||=++++.+.. ..++++++.+.|..|+.
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-kaIe~gyRLPpPmDCP~ 861 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-KAIEQGYRLPPPMDCPA 861 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-HHHHhccCCCCCCCCcH
Confidence 4431 11111 2589999999999999999999999999999998 99999999876655 45677999999999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
.|.+||..||++|-.+||.|.+|+..|++++.
T Consensus 862 aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 99999999999999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.60 Aligned_cols=263 Identities=31% Similarity=0.615 Sum_probs=224.8
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIG 309 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~ 309 (518)
+.|+++...|.+.++||+|+||.||+|++.+ ..||||+++... .....+.|.+|+.+++++. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 5799999999999999999999999998642 359999997643 3344578999999999996 999999999
Q ss_pred eeecCCceeEEEeeccCCcccccccccc----------------------------------------------------
Q 010091 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------------------------------------------- 337 (518)
Q Consensus 310 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------------------------------------------- 337 (518)
+|......|+||||+++|+|.+++.+..
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999886421
Q ss_pred -------------------------------------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcE
Q 010091 338 -------------------------------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374 (518)
Q Consensus 338 -------------------------------------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NI 374 (518)
..+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2367788899999999999999999999999999999
Q ss_pred EeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 010091 375 LMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQA 450 (518)
Q Consensus 375 Ll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~ 450 (518)
|++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999976433221 112336788999999998899999999999999999997 9999988765555
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 451 AVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 451 ~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
....+..+.++..+..++..+.+++.+||+.+|.+||++.++.+.|+++++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 555556666677777889999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.15 Aligned_cols=256 Identities=32% Similarity=0.636 Sum_probs=220.5
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
|+|+.+.|++.++||+|+||.||+|.+. ++.||+|.+..... ..+.+.+|+.++++++|+||+++++.+......|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 7888899999999999999999999965 57799999876432 2468899999999999999999999999999999
Q ss_pred EEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
++|||+++++|.+++... ...+++..++.++.|++.||+|||+++++||||||+||+++.++.++|+|||.+.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999999753 3468889999999999999999999999999999999999999999999999998654322
Q ss_pred c--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 V--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 ~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
. .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.... +....+......++.++.++
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHH
Confidence 1 122335678999999988889999999999999999998 9999988766554433 34455555556788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
+.+||+.+|.+||+++++++.|+++
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=333.22 Aligned_cols=237 Identities=27% Similarity=0.438 Sum_probs=215.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
++|.+.+.||.|+||.|.+++.+ |..+|+|++.....- -...+....|..+|+.+.||+++++++.|.+...+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 34555999999999999999965 688999999876443 244577889999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
||++||.|.+++++ .++++++.++-++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+..... ..+
T Consensus 124 eyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~T 200 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWT 200 (355)
T ss_pred eccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEE
Confidence 99999999999998 668999999999999999999999999999999999999999999999999999865443 345
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
.+||+.|+|||++..++|..++|.||||+++|||+.|..||...++.+.+..++...+ .+|...++++++|+.+.|+.
T Consensus 201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQV 278 (355)
T ss_pred ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhh
Confidence 7899999999999999999999999999999999999999999999999998887654 57888999999999999999
Q ss_pred CCCCC
Q 010091 482 DPSLR 486 (518)
Q Consensus 482 dP~~R 486 (518)
|-.+|
T Consensus 279 D~t~R 283 (355)
T KOG0616|consen 279 DLTKR 283 (355)
T ss_pred hhHhh
Confidence 99999
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=342.73 Aligned_cols=253 Identities=31% Similarity=0.554 Sum_probs=208.1
Q ss_pred cccceeeeEEeEecceEEEEEEEC------------------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCcee
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF------------------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~------------------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv 305 (518)
...|++.++||+|+||.||++.+. +..||+|++.... .......|.+|+.++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 456777999999999999999753 2359999998653 344557899999999999999999
Q ss_pred eEeeeeecCCceeEEEeeccCCcccccccccc------------------CCCChHHHHHHHHHhHHHHHHHHHCCceec
Q 010091 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367 (518)
Q Consensus 306 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~------------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHr 367 (518)
++++++......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999999999999999999999999885421 236778899999999999999999999999
Q ss_pred CCCCCcEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCC
Q 010091 368 DLKAANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT--GKLPY 442 (518)
Q Consensus 368 DLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt--G~~P~ 442 (518)
||||+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|+|++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999975433211 112335788999999988889999999999999999986 67889
Q ss_pred CCCCHHHHHHHHHh---c---CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 443 DDLTPLQAAVGVVQ---K---GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 443 ~~~~~~~~~~~~~~---~---~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
...+..+....... . ...+..+..+++.+.+++.+||+.+|.+|||+.+|...|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 88766554432221 1 1123345567889999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.29 Aligned_cols=248 Identities=20% Similarity=0.305 Sum_probs=207.5
Q ss_pred ceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 247 LKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
|+..+.||+|+||.||++.. .++.||+|++....... .....+.+|+.++++++|+||+++++++.....+|+||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 56689999999999999986 47899999987654322 2335678999999999999999999999999999999999
Q ss_pred ccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR 161 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence 99999988875433 36899999999999999999999999999999999999999999999999999765433333445
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV--QKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
.||..|+|||++.+..++.++|||||||++|+|++|+.||............. ........+...++.+.+++.+||+
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 241 (285)
T cd05631 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241 (285)
T ss_pred CCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhh
Confidence 68999999999999999999999999999999999999998754422111111 1223345566788999999999999
Q ss_pred hCCCCCCC-----HHHHHH
Q 010091 481 RDPSLRPD-----FSEITE 494 (518)
Q Consensus 481 ~dP~~RPs-----~~eil~ 494 (518)
.||.+||+ ++++++
T Consensus 242 ~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 242 KNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCHHHhcCCCCCCHHHHhc
Confidence 99999987 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=332.61 Aligned_cols=250 Identities=34% Similarity=0.654 Sum_probs=214.5
Q ss_pred ccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+.++|++.+.||+|+||.||++++.. ..+|+|.+...... ...|.+|+.++++++||||+++++++......|+||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 45667789999999999999999764 58999998755433 357889999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--c
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--M 399 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--~ 399 (518)
||+++++|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||.++....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999999999986556789999999999999999999999999999999999999999999999999875432221 1
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+. .+.++..+...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence 12235678999999988889999999999999999999 999998887666555443 3455556667788999999999
Q ss_pred hhhCCCCCCCHHHHHHHH
Q 010091 479 WQRDPSLRPDFSEITELL 496 (518)
Q Consensus 479 L~~dP~~RPs~~eil~~L 496 (518)
|+.+|.+||++.+++..|
T Consensus 238 ~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 238 WHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ccCCcccCcCHHHHHHhh
Confidence 999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=353.87 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=215.1
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--CceeE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFI 319 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~~~l 319 (518)
.+.|..+++||+|+||.||+|++. |+.||+|.++.....+....-..+|+.||++|+||||+++.+..+.. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 345666999999999999999964 77899999998877777677788999999999999999999988766 68999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC--
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-- 397 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-- 397 (518)
|+|||+. +|.-++....-.|+++++..++.||+.||+|+|++||+|||||.+|||||.+|++||+|||+|++.....
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 9999964 8888888866789999999999999999999999999999999999999999999999999999765544
Q ss_pred ccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC------------------
Q 010091 398 VMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG------------------ 458 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~------------------ 458 (518)
.+|....|..|.|||++.+ ..|+.+.|+||.||||.||++|++.|.+.+..+.+..+..-.
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence 5777889999999999865 569999999999999999999999999988877776655321
Q ss_pred CCCCCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 LRPTIP---------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 ~~p~~~---------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++..+ ...++...+|+..+|..||.+|.|+.+.+.
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111111 334667889999999999999999988764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.64 Aligned_cols=265 Identities=30% Similarity=0.617 Sum_probs=238.6
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC----c--cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEee
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS----Q--DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~--~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~ 309 (518)
+...|+|.+....+.+.||.|.||.||.|.|.. + .||||+.+.....++ .+.|++|..+|+.++||||++++|
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheee
Confidence 344789999999999999999999999999853 2 499999998655444 689999999999999999999999
Q ss_pred eeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 310 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
+|.+. ..+||||.++-|.|..||..++..++...+..++.||+.||.|||+.+.|||||...|||+.+...|||+|||+
T Consensus 459 v~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 459 VCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence 99875 58999999999999999999888999999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCccccCC--CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010091 390 ARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466 (518)
Q Consensus 390 a~~~~~~~~~~~~~--gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~ 466 (518)
++.........+.. -...|||||-++-..++.++|||.||+.+||++. |..||.+..+.+.. +.++.|-+++.|.+
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRlP~P~n 616 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERLPCPPN 616 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCCCCCCC
Confidence 99877665444444 3578999999999999999999999999999998 99999998876654 45667889999999
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
|++.|..|+.+||+.+|.+||.|.||...|.+++++-
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999998743
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.48 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=211.3
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|++.++||+|+||.||+|++. ++.||+|+++...... .....+.+|+.++++++||||+++++++......|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 4667999999999999999975 6889999998654322 334678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
|++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 82 ~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~ 158 (333)
T cd05600 82 YVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV 158 (333)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence 9999999999976 45789999999999999999999999999999999999999999999999999975443 22345
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C-CCCCC---CCCcHHHHHHHH
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG--L-RPTIP---VHTHPILVDLLE 476 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~--~-~p~~~---~~~~~~L~~Li~ 476 (518)
.||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.... + .+... ..+++++.++|.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~ 238 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence 69999999999998899999999999999999999999999887766554443222 1 11111 245889999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~~ 495 (518)
+||..+|.+||++.+++..
T Consensus 239 ~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 239 KLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHhhChhhhcCCHHHHHhC
Confidence 9999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=337.89 Aligned_cols=254 Identities=30% Similarity=0.579 Sum_probs=216.8
Q ss_pred ccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
+.++|++.+.||+|+||.||+|...+ ..||+|.++... .......|.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 34567789999999999999998643 459999987543 3445578999999999999999999999999999
Q ss_pred ceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~ 380 (518)
..|++|||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||++++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 9999999999999999986532 3578889999999999999999999999999999999999999
Q ss_pred cEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 010091 381 VVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQ 456 (518)
Q Consensus 381 ~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~ 456 (518)
.++|+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..+.+.... +.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-IR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HH
Confidence 99999999997543321 1222346788999999988889999999999999999998 9999988777654433 44
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 457 ~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
.+..+..+..+++++.+++.+||+.||.+||++.+|++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 455566778899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=349.96 Aligned_cols=241 Identities=24% Similarity=0.403 Sum_probs=207.5
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
+.||+|+||.||+++.. ++.||+|+++.... .......+.+|+.++++++||||+++++++.....+|+||||++|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 68899999986533 2334467889999999999999999999999999999999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTY 406 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~ 406 (518)
+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ......||+
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 99999976 4578999999999999999999999999999999999999999999999999987532222 223346999
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~R 486 (518)
.|+|||++.+..++.++|||||||++|||++|..||...+.......+... ...++..+++++.++|.+||+.||.+|
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999999999999999999999999999999887665544443332 345677889999999999999999999
Q ss_pred C-----CHHHHHH
Q 010091 487 P-----DFSEITE 494 (518)
Q Consensus 487 P-----s~~eil~ 494 (518)
| ++.++++
T Consensus 238 ~~~~~~~~~~ll~ 250 (323)
T cd05571 238 LGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCCHHHHHc
Confidence 9 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.60 Aligned_cols=261 Identities=32% Similarity=0.615 Sum_probs=221.1
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC 311 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~ 311 (518)
|++...+|++.+.||.|+||.||+|... ++.||+|+++.... ......+.+|+.+++++ +|+||++++++|
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 8888889999999999999999999743 35799999975432 33346778899999999 899999999987
Q ss_pred ec-CCceeEEEeeccCCcccccccccc-----------------------------------------------------
Q 010091 312 TR-PPRLFIVTEFMSGGSIYDYLHKQK----------------------------------------------------- 337 (518)
Q Consensus 312 ~~-~~~~~lV~Ey~~ggsL~~~l~~~~----------------------------------------------------- 337 (518)
.. ...++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 54 467899999999999999885321
Q ss_pred -------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---cccCCCCCc
Q 010091 338 -------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYR 407 (518)
Q Consensus 338 -------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~ 407 (518)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....... .....++..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578899999999999999999999999999999999999999999999999976432211 112335678
Q ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 010091 408 WMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 408 y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~R 486 (518)
|+|||++.+..++.++|||||||++|||++ |..||.+....+........+.++..+...++++.+++.+||+.+|.+|
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 320 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR 320 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999999999999998 9999987665555555566666667777888999999999999999999
Q ss_pred CCHHHHHHHHHHHHH
Q 010091 487 PDFSEITELLQHLAQ 501 (518)
Q Consensus 487 Ps~~eil~~L~~l~~ 501 (518)
|++.|+++.|+++++
T Consensus 321 Ps~~ell~~l~~~~~ 335 (337)
T cd05054 321 PTFSELVEILGDLLQ 335 (337)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=332.24 Aligned_cols=256 Identities=36% Similarity=0.656 Sum_probs=220.3
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
|++..+.|++.+.||.|++|.||+|.+. ++.||+|.++..... ...|.+|+.++++++|+||+++++++...+..|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 7888889999999999999999999975 467999998765432 356889999999999999999999999999999
Q ss_pred EEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
+||||+++++|.+++.... ..+++..+..++.|++.|+.|||++||+||||||+||+++.++.++|+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997643 468999999999999999999999999999999999999999999999999998755322
Q ss_pred cc--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 VM--TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 ~~--~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
.. .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..+.... +........+..++..+.++
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ-VDQGYRMPCPPGCPKELYDI 236 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCHHHHHH
Confidence 11 11123457999999988889999999999999999999 9999988776655543 34455555667788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
+.+||+.+|.+||++.+++..|+.+
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHhhcCcccCCCHHHHHHHHhcC
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=354.83 Aligned_cols=264 Identities=32% Similarity=0.611 Sum_probs=227.1
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeE
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQF 307 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l 307 (518)
....|++..++|.+.++||+|+||.||+|++.+ ..||+|+++..... .....+.+|+.++.++. ||||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 344699999999999999999999999998643 47999999865433 33467889999999997 9999999
Q ss_pred eeeeecCCceeEEEeeccCCcccccccccc--------------------------------------------------
Q 010091 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQK-------------------------------------------------- 337 (518)
Q Consensus 308 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-------------------------------------------------- 337 (518)
+++|......|+||||+++|+|.++++...
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 999999999999999999999999986432
Q ss_pred -----------------------------------------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCC
Q 010091 338 -----------------------------------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370 (518)
Q Consensus 338 -----------------------------------------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLk 370 (518)
..+++..++.++.||+.||.|||+++++|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 135667788999999999999999999999999
Q ss_pred CCcEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 010091 371 AANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLT 446 (518)
Q Consensus 371 p~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~ 446 (518)
|+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999976432211 112346788999999988889999999999999999998 899998877
Q ss_pred HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 447 PLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 447 ~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
..+.....+..+.++..+..++.++.+++.+||+.+|.+||++++|+..|++++
T Consensus 347 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 666666666677777788888999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=329.87 Aligned_cols=254 Identities=36% Similarity=0.677 Sum_probs=222.0
Q ss_pred eeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
|.++...|++.+.||.|+||.||++...++.||+|.++.... ....+.+|+.++++++|+||+++++++......|+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 566777888899999999999999999999999999986543 45788999999999999999999999998899999
Q ss_pred EEeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 320 VTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
||||+++++|.+++..... .+++..++.++.|++.|+.|||++|++|+||||+||+++.++.+||+|||.++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999999999999976432 68999999999999999999999999999999999999999999999999997653322
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+. ...+..+.++..+..+++.+.+++.+
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPHVEKGYRMEAPEGCPPEVYKVMKD 234 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHhcCCCCCCccCCCHHHHHHHHH
Confidence 22345678999999988889999999999999999997 9999987765443 34445566667777889999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~~L~~l 499 (518)
||..+|.+|||++++++.|+++
T Consensus 235 ~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 235 CWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HhccChhhCcCHHHHHHHHhcC
Confidence 9999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=331.53 Aligned_cols=255 Identities=34% Similarity=0.612 Sum_probs=219.4
Q ss_pred ccccceeeeEEeEecceEEEEEEEC-----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
+.++|++.+.||+|+||.||+|.+. ...||+|+++... .......|.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 4566888999999999999999874 2469999987654 344557899999999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY- 396 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~- 396 (518)
|+||||+++++|.+++....+.+++..++.++.|++.|+.|||++||+|+||||+||++++++.++|+|||+++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999999876667999999999999999999999999999999999999999999999999999876421
Q ss_pred Cccc--cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 397 GVMT--AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 397 ~~~~--~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
.... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... +........+..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA-VEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHH
Confidence 1111 1235678999999998899999999999999999998 9999988776554433 3445555666778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
++.+||+.+|.+||++.++++.|+++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=350.25 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=215.3
Q ss_pred eeeccccceeeeEEeEecceEEEEEEECC---ccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS---QDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~---~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
+.+....|++.++||+|+||.||+|++.+ ..||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 45666677789999999999999998643 5799999875432 2334467889999999999999999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999977 44689999999999999999999999999999999999999999999999999976543
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li 475 (518)
. .....||+.|+|||++.+..++.++|+|||||++|||++|..||...++......+... ...+|...++.+.++|
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG--IIYFPKFLDNNCKHLM 259 (340)
T ss_pred C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Confidence 2 23356999999999999888999999999999999999999999988776655554433 2345677889999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHH
Q 010091 476 ERCWQRDPSLRP-----DFSEITE 494 (518)
Q Consensus 476 ~~cL~~dP~~RP-----s~~eil~ 494 (518)
.+||+.||.+|+ +++++++
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHc
Confidence 999999999994 8888875
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.26 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=213.4
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|.+.+.||+|+||.||+++.. ++.||+|+++...... .....+..|+.+++.++|+||+++++++......|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5677999999999999999976 7899999998654322 345778899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-----
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG----- 397 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~----- 397 (518)
|++|++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999874 679999999999999999999999999999999999999999999999999997644332
Q ss_pred -------------------------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 010091 398 -------------------------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAV 452 (518)
Q Consensus 398 -------------------------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~ 452 (518)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 1223458999999999999999999999999999999999999999888776665
Q ss_pred HHHh--cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 010091 453 GVVQ--KGLRPTIPVHTHPILVDLLERCWQRDPSLRPD-FSEITE 494 (518)
Q Consensus 453 ~~~~--~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs-~~eil~ 494 (518)
.+.. ..+.......+++++.++|.+||. +|.+||+ +++++.
T Consensus 241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 5554 223222223368999999999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=330.40 Aligned_cols=251 Identities=31% Similarity=0.622 Sum_probs=214.0
Q ss_pred ccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+..+|++.+.||+|+||.||++.+.+ ..+|+|.++..... ...|.+|+.++++++||||+++++++......|+||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 34567779999999999999999775 46999998765443 257889999999999999999999999888999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc--
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM-- 399 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 399 (518)
||+++++|.+++......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.++........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999999999775557899999999999999999999999999999999999999999999999998754332211
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..... ..+.++..+...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-SQGLRLYRPHLASEKVYAIMYSC 237 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHH
Confidence 12235678999999988889999999999999999999 99999887765544433 34555556667789999999999
Q ss_pred hhhCCCCCCCHHHHHHHHH
Q 010091 479 WQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 479 L~~dP~~RPs~~eil~~L~ 497 (518)
|+.+|.+||++.+++..|+
T Consensus 238 l~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 238 WHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCCcccCCCHHHHHHhhC
Confidence 9999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=340.52 Aligned_cols=258 Identities=30% Similarity=0.560 Sum_probs=217.8
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--Cc----cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~----~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
..++|+..+.||+|+||.||+|++. ++ .||+|+++... ......+|.+|+.+++.++||||++++++|... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 3455677999999999999999863 33 38999987543 334457899999999999999999999998764 5
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.++++||+++|+|.+++.+....++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 78999999999999999876667899999999999999999999999999999999999999999999999999865433
Q ss_pred Ccc---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010091 397 GVM---TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 397 ~~~---~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~ 472 (518)
... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+. ......+.....+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCCCCHHHH
Confidence 221 11234678999999999999999999999999999998 9999988765543 344555666666677889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 473 DLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
+++.+||+.+|.+||++.+++..|..+.+.-
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 9999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=332.36 Aligned_cols=257 Identities=32% Similarity=0.637 Sum_probs=222.0
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
||....+|++.++||.|+||.||+|++. +..+++|++..... .....+..|+.+++.++|+||+++++++......|
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 5566677888999999999999999976 57899999876532 23467889999999999999999999999999999
Q ss_pred EEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
+||||+++++|.+++.+.. ..+++..++.++.||+.|+.|||++|++|+||||+||+++.++.+||+|||.+.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999999997633 458999999999999999999999999999999999999999999999999997654322
Q ss_pred c-cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010091 398 V-MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475 (518)
Q Consensus 398 ~-~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li 475 (518)
. .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+..... ..+.++..+..+++.+.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI-TAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-HhCCcCCCCCCCCHHHHHHH
Confidence 1 222346778999999988889999999999999999998 89999887766555443 35667777788899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
.+||+.||.+|||+.++++.|+.+
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 238 LECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHcCCCchhCcCHHHHHHHHhcC
Confidence 999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.61 Aligned_cols=265 Identities=31% Similarity=0.595 Sum_probs=224.8
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEECC---------ccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceee
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQ 306 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~---------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~ 306 (518)
.+.|++..+.|.+.+.||+|+||.||++.+.+ ..+|+|.++... .......+..|+.+++++ +|+||++
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34789999999999999999999999998532 459999998653 233456788899999999 7999999
Q ss_pred EeeeeecCCceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCC
Q 010091 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371 (518)
Q Consensus 307 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp 371 (518)
+++++......|+||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 9999999999999999999999999997532 2478889999999999999999999999999999
Q ss_pred CcEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCH
Q 010091 372 ANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTP 447 (518)
Q Consensus 372 ~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~ 447 (518)
+||+++.++.+||+|||.++....... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999999999999999999875432211 112234578999999988889999999999999999998 8899987665
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 448 LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 448 ~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
.+ ....+..+..+..+..++.++.+++.+||..+|.+|||+.++++.|++++...
T Consensus 249 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 EE-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 43 33445556666777788999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=337.59 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=205.3
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.+.||+|+||.||++++. ++.||+|+++.....+.....+.+|+.++++++||||+++++++...+..|+||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 5677999999999999999975 67899999987655555567888999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC--cccc
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG--VMTA 401 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~~ 401 (518)
++++++..+. .....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ....
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 9887665544 335578999999999999999999999999999999999999999999999999997653322 1223
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------CC-CC
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK-------------------GL-RP 461 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~-------------------~~-~p 461 (518)
..|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+..+........ .. .+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence 45899999999999888999999999999999999999999876654433222110 00 00
Q ss_pred C----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 T----------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ~----------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. ....+++.+.++|.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 01235778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=333.79 Aligned_cols=256 Identities=29% Similarity=0.554 Sum_probs=215.5
Q ss_pred eeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
|++..++|++.+.||+|+||.||+|.+.+ ..||+|++.... ......+|.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 78888899999999999999999998643 469999986543 2234467899999999999999999999999
Q ss_pred cCCceeEEEeeccCCcccccccccc---------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEE
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQK---------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVK 383 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vk 383 (518)
.....++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||++|++|+||||+||++++++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999999986532 2356778999999999999999999999999999999999999999
Q ss_pred EeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC
Q 010091 384 VADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGL 459 (518)
Q Consensus 384 L~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~ 459 (518)
|+|||+++....... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.+....+.... +....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~-~~~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF-VMEGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCC
Confidence 999999875432211 112345778999999998899999999999999999999 7899988776554433 33344
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 460 RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 460 ~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
.+..+..+++.+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 45667778899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.48 Aligned_cols=256 Identities=36% Similarity=0.645 Sum_probs=217.5
Q ss_pred eeeccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
|+|....|++.++||+|+||.||+|++.+ ..||+|.++..... ...|.+|+.++++++|+||+++++.+. ....|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 77888889999999999999999998754 57999999865433 257889999999999999999999875 45689
Q ss_pred EEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
+||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||.++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999999997633 357899999999999999999999999999999999999999999999999997654332
Q ss_pred cc--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 VM--TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 ~~--~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
.. ....++..|+|||...+..++.++|+||||+++|+|++ |..||......+..... ..+.....+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-hcCCCCCCccccCHHHHHH
Confidence 21 12335678999999988889999999999999999999 88999887766554433 3344455566788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
+.+||+.+|.+||++.++++.|+.++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHccCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=332.07 Aligned_cols=256 Identities=30% Similarity=0.569 Sum_probs=219.7
Q ss_pred eeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
|+|+.++|.+.+.||+|+||.||+|.+.+ ..||+|.+.... .......|.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 78888899999999999999999998642 569999987543 2334567889999999999999999999999
Q ss_pred cCCceeEEEeeccCCcccccccccc---------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEE
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQK---------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVK 383 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vk 383 (518)
.....|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999986422 2367888999999999999999999999999999999999999999
Q ss_pred EeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC
Q 010091 384 VADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGL 459 (518)
Q Consensus 384 L~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~ 459 (518)
|+|||.++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+...... .+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence 999999875433221 222346789999999988889999999999999999998 999998887766554443 455
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 460 RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 460 ~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
.+..+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 66777888999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.26 Aligned_cols=253 Identities=34% Similarity=0.681 Sum_probs=217.8
Q ss_pred eeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee-ecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC-TRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~-~~~~~~~ 318 (518)
|-++..+|++.+.||+|+||.||++...+..||+|.++... ....|.+|+.++++++|+|++++++++ ......|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 56677788889999999999999999999999999987542 245788999999999999999999975 4556789
Q ss_pred EEEeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
++|||+++++|.+++.+... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999999999976443 47889999999999999999999999999999999999999999999999987543322
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+.. ..+..+..+..+..+++.+.+++.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYKMDAPDGCPPVVYDVMK 233 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcCCCCCCCCCCCHHHHHHHH
Confidence 22345678999999998889999999999999999997 99999877654443 334556677777888999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~~L~~l 499 (518)
+||+.+|.+|||+.++++.|+++
T Consensus 234 ~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 234 QCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHhcCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.98 Aligned_cols=250 Identities=35% Similarity=0.645 Sum_probs=214.6
Q ss_pred ccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+..+|++.+.||+|+||.||++.+.+ ..+|+|++....... ..|.+|+.++++++|+||+++++++......|+||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 34456779999999999999998764 579999987654332 46888999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc--
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM-- 399 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 399 (518)
||++|++|.+++......+++..++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||.++........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999999875567899999999999999999999999999999999999999999999999999765432211
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+.... +..+.++..+..+++.+.+++.+|
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHH
Confidence 11224568999999988889999999999999999999 8999988776655443 445666677778899999999999
Q ss_pred hhhCCCCCCCHHHHHHHH
Q 010091 479 WQRDPSLRPDFSEITELL 496 (518)
Q Consensus 479 L~~dP~~RPs~~eil~~L 496 (518)
|+.+|.+|||+.++++.|
T Consensus 238 l~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred hcCChhhCcCHHHHHHHh
Confidence 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.75 Aligned_cols=245 Identities=27% Similarity=0.555 Sum_probs=211.2
Q ss_pred EEeEecceEEEEEEE----CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 252 KIVSGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~----~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
+||+|+||.||+|.+ .+..+|+|+++....+......|..|+.++++++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 3578999999876655566688999999999999999999999875 45679999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc----cccCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----MTAET 403 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~----~~~~~ 403 (518)
+|.+++.. ...+++..++.++.|++.||.|||++||+||||||.||+++.++.+||+|||++........ .....
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 99999976 34689999999999999999999999999999999999999999999999999976543321 11123
Q ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 404 gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
++..|+|||.+....++.++|+||||+++|||++ |..||......+.. ..+..+..+..+..+++++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4578999999988889999999999999999998 99999887765443 345556667788889999999999999999
Q ss_pred CCCCCCHHHHHHHHHHH
Q 010091 483 PSLRPDFSEITELLQHL 499 (518)
Q Consensus 483 P~~RPs~~eil~~L~~l 499 (518)
|.+||++.+|...|++.
T Consensus 239 p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 239 VDERPGFAVVELRLRNY 255 (257)
T ss_pred chhCcCHHHHHHHHhcc
Confidence 99999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=345.39 Aligned_cols=241 Identities=23% Similarity=0.399 Sum_probs=206.9
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
+.||+|+||.||+++.. |+.||+|+++.... .......+.+|+.++++++||||+++++++.....+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999864 68899999986533 2334467788999999999999999999999999999999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccCCCCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAETGTY 406 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~ 406 (518)
+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......||+
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 99998876 457899999999999999999999999999999999999999999999999998753222 2223356899
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~R 486 (518)
.|+|||++.+..++.++|||||||++|+|++|+.||...+........... ...++..+++++.++|.+||+.||.+|
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999999999999999999999999999999887766555444433 334667889999999999999999999
Q ss_pred C-----CHHHHHH
Q 010091 487 P-----DFSEITE 494 (518)
Q Consensus 487 P-----s~~eil~ 494 (518)
+ ++.++++
T Consensus 238 ~~~~~~~~~~~l~ 250 (323)
T cd05595 238 LGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCCHHHHHc
Confidence 8 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=345.09 Aligned_cols=239 Identities=23% Similarity=0.381 Sum_probs=205.2
Q ss_pred EeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
||+|+||.||+++.. ++.||+|+++.... .......+.+|+.++++++||||+++++++......|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999975 67899999976432 233457788999999999999999999999999999999999999999
Q ss_pred ccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCCCcc
Q 010091 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTYRW 408 (518)
Q Consensus 330 ~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y 408 (518)
.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......||+.|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 999976 4578999999999999999999999999999999999999999999999999997533222 22334689999
Q ss_pred cChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 010091 409 MAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPD 488 (518)
Q Consensus 409 ~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs 488 (518)
+|||++.+..++.++|||||||++|+|++|..||......+........ ...++..+++.+.++|.+||+.||.+||+
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999999999999999999999999999999887766655554432 44567788999999999999999999975
Q ss_pred ---HHHHHH
Q 010091 489 ---FSEITE 494 (518)
Q Consensus 489 ---~~eil~ 494 (518)
+.+++.
T Consensus 238 ~~~~~e~l~ 246 (312)
T cd05585 238 YNGAQEIKN 246 (312)
T ss_pred CCCHHHHHc
Confidence 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.58 Aligned_cols=261 Identities=31% Similarity=0.614 Sum_probs=223.7
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG 309 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~ 309 (518)
..|+++.++|++.+.||+|+||.||++.+.+ ..+|+|.+..... +.....+.+|+.+++++ +|+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4689999999999999999999999998642 5699999886533 33456788999999999 8999999999
Q ss_pred eeecCCceeEEEeeccCCccccccccc---------------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcE
Q 010091 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQ---------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374 (518)
Q Consensus 310 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~---------------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NI 374 (518)
++...+.+|++|||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999998632 24588999999999999999999999999999999999
Q ss_pred EeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 010091 375 LMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQA 450 (518)
Q Consensus 375 Ll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~ 450 (518)
+++.++.+||+|||.++....... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999976543221 122235678999999988899999999999999999998 9999988766554
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 451 AVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 451 ~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
. .....+..+..+..++..+.+++.+||..||.+|||+.++++.|++++
T Consensus 244 ~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 F-KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 4 334445566677788899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.88 Aligned_cols=259 Identities=34% Similarity=0.600 Sum_probs=217.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--Cc--cEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQ--DVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~--~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l 319 (518)
++|++.+.||+|+||.||+|... +. .+++|.++... .......|.+|+.++.++ +||||+++++++......|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 46777999999999999999864 32 47888877432 334457789999999999 79999999999999999999
Q ss_pred EEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEE
Q 010091 320 VTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL 384 (518)
||||+++++|.+++.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 999999999999986532 24788999999999999999999999999999999999999999999
Q ss_pred eeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010091 385 ADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTI 463 (518)
Q Consensus 385 ~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~ 463 (518)
+|||++..............+..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... ...+..+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~-~~~~~~~~~ 239 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRMEK 239 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HhcCCCCCC
Confidence 99999864322211111234567999999988889999999999999999997 9999988877665443 344566667
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 464 ~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
+..+++.+.+++.+||+.+|.+||++.+++..|+.++...+.
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 778899999999999999999999999999999999876644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=350.44 Aligned_cols=255 Identities=32% Similarity=0.568 Sum_probs=208.8
Q ss_pred ccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC-ceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-RLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lV~E 322 (518)
+.|.-.+.||+|+||.||+|...+ +.||||.+....... ..+|..|+.++.+++|||+|+++|||.+.+ ..++|+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 344446799999999999999765 899999888765442 356999999999999999999999999988 5999999
Q ss_pred eccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCC---ceecCCCCCcEEeccCCcEEEeeeccceeccc-cC
Q 010091 323 FMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNN---IIHRDLKAANLLMNENGVVKVADFGVARVQAQ-YG 397 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~g---IiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~-~~ 397 (518)
||++|||.++|+.... .++|...++|+.++++||+|||... ||||||||+|||+|++...||+|||+|+.... ..
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence 9999999999998666 8999999999999999999999854 99999999999999999999999999976554 32
Q ss_pred ccccC-CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--H----HHHHHHHHhcC-----CCCCCC-
Q 010091 398 VMTAE-TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT--P----LQAAVGVVQKG-----LRPTIP- 464 (518)
Q Consensus 398 ~~~~~-~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~--~----~~~~~~~~~~~-----~~p~~~- 464 (518)
..... .||.+|+|||++..+..+.|+||||||+++.||+||+.+.+... . .+.....+..+ ..|.+.
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~ 312 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE 312 (361)
T ss_pred ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC
Confidence 22222 79999999999999999999999999999999999998887532 1 11112222221 234433
Q ss_pred CCCc-----HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 465 VHTH-----PILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 465 ~~~~-----~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
.... ..+..+..+|++.+|..||++.|+++.|+.+..
T Consensus 313 ~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 313 GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 2222 237778889999999999999999888866543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.55 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=208.4
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
+..++|++.+.||+|+||.||++++. +..||+|++.... .......|.+|+.++++++||||+++++++...+..++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 34456777999999999999999975 6789999988653 34455789999999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 158 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence 9999999999999976 44689999999999999999999986 6999999999999999999999999998754332 2
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------------------------
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVG------------------------- 453 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~------------------------- 453 (518)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence 2335689999999999999999999999999999999999999976544322110
Q ss_pred --------------------HHhcCCCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 454 --------------------VVQKGLRPTIP-VHTHPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 454 --------------------~~~~~~~p~~~-~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
.+.....+..+ ..+++++.++|.+||+.||.+|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00011112222 2467889999999999999999999999763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=335.06 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=203.0
Q ss_pred cceeeeEEeEecceEEEEEEEC---CccEEEEEEeccccCHHHHHHHHHHHHHHhhc---CCCceeeEeeeee-----cC
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV---RHMNVVQFIGACT-----RP 314 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~---~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~~~~~-----~~ 314 (518)
+|++.+.||+|+||.||+|++. ++.||+|+++.....+.....+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5777999999999999999863 56799999987654444445666788777766 6999999999875 34
Q ss_pred CceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
..+++||||+. ++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 56899999995 68999886533 35889999999999999999999999999999999999999999999999999875
Q ss_pred cccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC------------
Q 010091 394 AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP------------ 461 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p------------ 461 (518)
..........||..|+|||.+.+..++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 240 (290)
T ss_pred cCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhccc
Confidence 54433444568999999999988899999999999999999999999999877665554443211000
Q ss_pred -------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 -------------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 -------------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+....++.+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 241 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 011245678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=327.93 Aligned_cols=254 Identities=35% Similarity=0.654 Sum_probs=217.3
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
|+|..++|++.++||+|+||.||++... +..+|+|.++...... ..|.+|+.++++++|+|++++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 7788888999999999999999999865 5789999998755432 56889999999999999999999875 45689
Q ss_pred EEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
++|||+++++|.+++.+.. ..+++..++.++.|++.||.|||++|++|+||||+||++++++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999999999987633 358999999999999999999999999999999999999999999999999997654322
Q ss_pred cc--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 VM--TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 ~~--~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.... +..+..+..+...+..+.++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCHHHHHH
Confidence 11 11235678999999988889999999999999999999 8999988776554443 34455666777888999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
+.+||..+|.+|||+.++.+.|++
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.05 Aligned_cols=246 Identities=32% Similarity=0.551 Sum_probs=217.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|+..+.||+|+||.||+|.+. ++.||+|++..+...++ .+.+.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566789999999999999975 68899999998765543 57888999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc-ccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM-TAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~ 402 (518)
|.||++.+.|.. ++.+++..+..++++++.|+.|||..+.+|||||+.|||+..+|.||++|||++-........ ...
T Consensus 93 ~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf 171 (467)
T KOG0201|consen 93 CGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF 171 (467)
T ss_pred hcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence 999999999987 445688889999999999999999999999999999999999999999999999765544322 446
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.||+.|||||++....|+.|+|||||||+.+||++|.+||....|..+.. .+.+...|.+...+++.+++++..||.+|
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-lIpk~~PP~L~~~~S~~~kEFV~~CL~k~ 250 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-LIPKSAPPRLDGDFSPPFKEFVEACLDKN 250 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-eccCCCCCccccccCHHHHHHHHHHhhcC
Confidence 79999999999999899999999999999999999999999988844332 23345677777789999999999999999
Q ss_pred CCCCCCHHHHHH
Q 010091 483 PSLRPDFSEITE 494 (518)
Q Consensus 483 P~~RPs~~eil~ 494 (518)
|+.||++.++++
T Consensus 251 P~~RpsA~~LLK 262 (467)
T KOG0201|consen 251 PEFRPSAKELLK 262 (467)
T ss_pred cccCcCHHHHhh
Confidence 999999999876
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=344.85 Aligned_cols=241 Identities=23% Similarity=0.379 Sum_probs=207.4
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
+.||+|+||.||++... ++.||+|++..... .......+.+|+.++++++||||+++++++.....+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 68899999986543 2334577889999999999999999999999999999999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccCCCCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAETGTY 406 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~ 406 (518)
+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||+
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 99998876 457899999999999999999999999999999999999999999999999998753222 2223356899
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~R 486 (518)
.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ....++..+++++.++|.+||+.||.+|
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--CCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999988999999999999999999999999988776554443332 2345677889999999999999999999
Q ss_pred C-----CHHHHHH
Q 010091 487 P-----DFSEITE 494 (518)
Q Consensus 487 P-----s~~eil~ 494 (518)
+ ++.++++
T Consensus 238 ~~~~~~~~~~il~ 250 (328)
T cd05593 238 LGGGPDDAKEIMR 250 (328)
T ss_pred CCCCCCCHHHHhc
Confidence 7 8898875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=347.81 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=214.9
Q ss_pred ccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
..++|.++++||+|+||.||+++- .|.-+|+|+++...+-. +.......|-.+|...++|+||+++-+|.+..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 334455599999999999999984 58899999999876544 345788899999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc----
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ---- 395 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~---- 395 (518)
||||++||++..+|.+ .+.+++..+..++.+++.|++.||+.|+|||||||+|+|||..|++||.|||++.-...
T Consensus 219 iMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 9999999999999987 56899999999999999999999999999999999999999999999999999852100
Q ss_pred -------------------cCc-------------------------cccCCCCCcccChhhhcCCCCCchhhHHHHHHH
Q 010091 396 -------------------YGV-------------------------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIV 431 (518)
Q Consensus 396 -------------------~~~-------------------------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGil 431 (518)
... .....|||.|+|||++.+..|+...|+||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 000 001249999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCCcHHHHHHHHHhhhhCCCCCC---CHHHHHH
Q 010091 432 LWELVTGKLPYDDLTPLQAAVGVVQKG--LRPTIPVHTHPILVDLLERCWQRDPSLRP---DFSEITE 494 (518)
Q Consensus 432 l~eLltG~~P~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~L~~Li~~cL~~dP~~RP---s~~eil~ 494 (518)
+||||.|.+||...++.+....++... +.-+-...++++..+||.+|+. ||.+|- .++||.+
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 999999999999999999998887655 4433445678999999999999 999994 5676654
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=325.28 Aligned_cols=255 Identities=37% Similarity=0.684 Sum_probs=220.3
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
|+++.++|.+.++||+|+||.||++... ++.||||.+...... ...+.+|+.++++++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 7888899999999999999999999865 467999998865443 357889999999999999999999999888999
Q ss_pred EEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
+||||+++++|.+++.+.. ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999997644 468999999999999999999999999999999999999999999999999987654321
Q ss_pred --ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 --VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 --~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+....... ...++....+...+.++.++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ-VERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHH
Confidence 1112235678999999998889999999999999999998 9999988776554443 33455666667778999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
+.+||+.+|.+||+++++++.|+.
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHcccCcccCCCHHHHHHHHhc
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=347.76 Aligned_cols=247 Identities=21% Similarity=0.327 Sum_probs=209.4
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|++.++||+|+||.||+++.. ++.||||+++.... .......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 5777999999999999999974 68899999986532 22344678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-----
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG----- 397 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~----- 397 (518)
|++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 82 YLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999977 4578999999999999999999999999999999999999999999999999986432110
Q ss_pred ----------------------------------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 010091 398 ----------------------------------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD 443 (518)
Q Consensus 398 ----------------------------------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~ 443 (518)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0012358999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 010091 444 DLTPLQAAVGVVQKGLRPTIPV--HTHPILVDLLERCWQRDPSLRPD---FSEITE 494 (518)
Q Consensus 444 ~~~~~~~~~~~~~~~~~p~~~~--~~~~~L~~Li~~cL~~dP~~RPs---~~eil~ 494 (518)
..++.+....+.........+. .+++++.++|.+|+. +|.+|++ +.+++.
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 8887776665554332223332 468899999999996 9999987 888766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.30 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=203.5
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|.+.++||.|+||.||+|... ++.||+|+++..... .....+.+|+.++++++||||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 34666999999999999999865 688999999754322 223567789999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 9965 9999987756668899999999999999999999999999999999999999999999999997643322 2233
Q ss_pred CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------------------C
Q 010091 402 ETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--------------------R 460 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~--------------------~ 460 (518)
..++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+..... .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 568999999998865 5689999999999999999999999988766554433321100 0
Q ss_pred CC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 PT--------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 p~--------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+. .....++++.++|.+||+.||.+|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 01245678999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=323.29 Aligned_cols=247 Identities=27% Similarity=0.457 Sum_probs=216.4
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|.+.+.||+|++|.||+++.. ++.|++|.+............+.+|+.++++++||||+++++++...+..|+||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 567899999999999999974 688999999876666666788999999999999999999999999999999999999
Q ss_pred cCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-cccC
Q 010091 325 SGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTAE 402 (518)
Q Consensus 325 ~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~ 402 (518)
+|++|.+++... ...++...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ ....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 161 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI 161 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhcc
Confidence 999999999774 35688999999999999999999999999999999999999999999999999876544322 2234
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.|++.|+|||++.+..++.++|+||||+++|+|++|+.||......+..... ..+..+.++..++..+.+++.+||+.+
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08529 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLIDQCLTKD 240 (256)
T ss_pred ccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HcCCCCCCccccCHHHHHHHHHHccCC
Confidence 5889999999999999999999999999999999999999887755544433 335556666678899999999999999
Q ss_pred CCCCCCHHHHHH
Q 010091 483 PSLRPDFSEITE 494 (518)
Q Consensus 483 P~~RPs~~eil~ 494 (518)
|++||++.++++
T Consensus 241 p~~Rp~~~~ll~ 252 (256)
T cd08529 241 YRQRPDTFQLLR 252 (256)
T ss_pred cccCcCHHHHhh
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=326.59 Aligned_cols=254 Identities=32% Similarity=0.628 Sum_probs=218.0
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
|+|....|++.++||+|+||.||+|... ++.||+|.+...... ...|.+|+.++++++|+||+++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 7888889999999999999999999964 688999998865443 357889999999999999999999864 45689
Q ss_pred EEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
++|||+++++|.+++... ...++...++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 3468899999999999999999999999999999999999999999999999997654322
Q ss_pred c--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 V--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 ~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
. .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+... .+..+.+...+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-NLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHHcCCCCCCCCCCCHHHHHH
Confidence 1 112345678999999998889999999999999999999 999998877655443 344456666777788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
+.+||+.+|.+||++++++..|++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=326.10 Aligned_cols=245 Identities=31% Similarity=0.616 Sum_probs=210.0
Q ss_pred EEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 252 KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
.||+|+||.||+|.+. +..||+|++.... .......|.+|+.++++++|+||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999864 3459999987653 3444578999999999999999999999875 45789999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc----cccCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----MTAET 403 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~----~~~~~ 403 (518)
+|.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ .+...
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99999976566799999999999999999999999999999999999999999999999999975433221 11223
Q ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 404 gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..+..+.++..+..+++++.+++.+||+.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~c~~~~ 238 (257)
T cd05115 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFIEQGKRLDCPAECPPEMYALMKDCWIYK 238 (257)
T ss_pred CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 4578999999988889999999999999999996 99999988765544 445556777788889999999999999999
Q ss_pred CCCCCCHHHHHHHHHHH
Q 010091 483 PSLRPDFSEITELLQHL 499 (518)
Q Consensus 483 P~~RPs~~eil~~L~~l 499 (518)
|.+||++.+|.+.|+.+
T Consensus 239 ~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 239 WEDRPNFAKVEERMRTY 255 (257)
T ss_pred hhhCcCHHHHHHHHhhh
Confidence 99999999999998875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=339.46 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=198.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC-----Ccee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PRLF 318 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ 318 (518)
+|++.++||+|+||.||+|+.. ++.||||++............+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3667999999999999999964 68899999876443334446788999999999999999999987433 2479
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG- 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~- 397 (518)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 81 VVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 999999 5689998876 4468999999999999999999999999999999999999999999999999997543221
Q ss_pred ---ccccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----------------
Q 010091 398 ---VMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ---------------- 456 (518)
Q Consensus 398 ---~~~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~---------------- 456 (518)
......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1123468999999999865 6789999999999999999999999977554322111000
Q ss_pred ------cCCCCCC-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 457 ------KGLRPTI-------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 457 ------~~~~p~~-------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+.... -...++.+.+++.+||+.||.+|||++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0011111 1245678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.39 Aligned_cols=248 Identities=22% Similarity=0.359 Sum_probs=207.4
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|+++++||+|+||.||+|+.. ++.||||++..... .......+.+|+.++++++|+||+++++++.....+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5677999999999999999975 67899999986543 33455789999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-----
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG----- 397 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~----- 397 (518)
|++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999999876 4468899999999999999999999999999999999999999999999999875321000
Q ss_pred -------------------------------------------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHH
Q 010091 398 -------------------------------------------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWE 434 (518)
Q Consensus 398 -------------------------------------------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~e 434 (518)
......||..|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 0112358999999999998899999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhh--hhCCCCCCCHHHHHH
Q 010091 435 LVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVDLLERCW--QRDPSLRPDFSEITE 494 (518)
Q Consensus 435 LltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~~cL--~~dP~~RPs~~eil~ 494 (518)
|++|..||...++.+....+........++ ..+++++.++|.+|+ ..++..||++.+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999887766655554332223333 357899999999954 556666999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=325.19 Aligned_cols=254 Identities=37% Similarity=0.654 Sum_probs=215.2
Q ss_pred eeeccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
|+|....|.+.++||+|++|.||++.+.+ ..+|+|.+...... ...|.+|+.++++++|+|++++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 66777778889999999999999999764 57999998764332 357889999999999999999999875 45689
Q ss_pred EEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999999997633 347899999999999999999999999999999999999999999999999997654322
Q ss_pred c--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 V--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 ~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
. .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+..+.+.... ...+..+..+...+..+.++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCcccCHHHHHH
Confidence 1 112345678999999988889999999999999999999 9999988776554433 34455666677788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
+.+||+.||.+||+++++++.|++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=341.17 Aligned_cols=252 Identities=28% Similarity=0.409 Sum_probs=209.6
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH--------H----HHHHHHHHHHHHhhcCCCceeeE
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE--------N----IRREFAQEVHIMRKVRHMNVVQF 307 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~--------~----~~~~f~~E~~il~~l~HpnIv~l 307 (518)
.-.++|++++.||+|.||.|-+|+.. ++.||||++....... . -.+...+|+.||++|+|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44577888999999999999999965 6889999997653321 1 12578899999999999999999
Q ss_pred eeeeec--CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEe
Q 010091 308 IGACTR--PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVA 385 (518)
Q Consensus 308 ~~~~~~--~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~ 385 (518)
+.+..+ ...+|||+|||..|.+... ......+++.+.++++.+++.||+|||.+|||||||||+|+|++++|+|||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 998754 4679999999998877543 3323348999999999999999999999999999999999999999999999
Q ss_pred eeccceecccc------CccccCCCCCcccChhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 010091 386 DFGVARVQAQY------GVMTAETGTYRWMAPEVIEHQP----YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV 455 (518)
Q Consensus 386 DFG~a~~~~~~------~~~~~~~gt~~y~APE~l~~~~----~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~ 455 (518)
|||++...... .......||+.|+|||...++. .+.+.||||+|++||.|+.|+.||-+....+....++
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99999765222 1233356999999999986532 3567899999999999999999999988888888888
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 456 QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 456 ~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
...+.-.....+.+++++||.+||++||++|.+..+|..
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 776644334457899999999999999999999888753
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.46 Aligned_cols=263 Identities=33% Similarity=0.608 Sum_probs=216.7
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--Cc--cEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCc
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQ--DVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~--~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~ 316 (518)
|..+.|++.+.||+|+||.||+|.+. +. .+++|.++... .......|.+|+.++.++ +|+||+++++++.....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 34456777999999999999999864 33 35777765432 334457888999999999 89999999999999999
Q ss_pred eeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~ 381 (518)
.|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999986532 25788999999999999999999999999999999999999999
Q ss_pred EEEeeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCC
Q 010091 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR 460 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~ 460 (518)
+||+|||++.............++..|+|||.+.+..++.++||||||+++|+|+| |..||...+..+.... ......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~ 241 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYR 241 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH-HhcCCc
Confidence 99999999864322111122234678999999988889999999999999999998 9999987766554433 334455
Q ss_pred CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 461 p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
+..+...++.+.+++.+||+.+|.+||++.+++..|++++..-.+.
T Consensus 242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 5566678899999999999999999999999999999887665433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=334.62 Aligned_cols=260 Identities=31% Similarity=0.601 Sum_probs=222.8
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeee
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGA 310 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~ 310 (518)
.|.+..++|.+.+.||+|+||.||++++. +..||+|+++.... ......+.+|+.+++++ +|+||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 47888888999999999999999999852 24699999876532 33446889999999999 79999999999
Q ss_pred eecCCceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
+...+..|+||||+++++|.+++.... ..+++.++..++.|++.||.|||+++|+|+||||+||+++.++.++++|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997533 3489999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010091 390 ARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPV 465 (518)
Q Consensus 390 a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~ 465 (518)
++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...............+..+..+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 975433221 112345778999999998899999999999999999998 9999988776655555566666666667
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 466 ~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
..++.+.+++.+||+.+|++|||+.+++..|+++
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 7889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=320.34 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=216.1
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.+|...++||+|.||.||+|++. |+.||||.++.....+.......+|+..|+.++|+||+.++++|.+.+.+-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35666899999999999999975 7999999999988777777788899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-ccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~ 401 (518)
||+ .+|...++.....++...+..++.++++|++|||++.|+||||||.|+||+++|.+||+|||+|+....... .+.
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 995 599999998788899999999999999999999999999999999999999999999999999998776543 344
Q ss_pred CCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Q 010091 402 ETGTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP------------------- 461 (518)
Q Consensus 402 ~~gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p------------------- 461 (518)
...|..|.|||.+. ...|+...|+||.||++.||+.|.+-|.+.+..+....+...-..|
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 46899999999885 4579999999999999999999999999888877776555321111
Q ss_pred --CCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 --TIP-----VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 --~~~-----~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+ ...+.++-+|+.+||..||.+|.+++|.++
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 111 224567899999999999999999999875
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=325.55 Aligned_cols=254 Identities=23% Similarity=0.452 Sum_probs=211.5
Q ss_pred cceeeeEEeEecceEEEEEEE--CCccEEEEEEeccc-cCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~-~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|++.++||+|+||.||+|+. .++.||||.++... .+......|.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 456699999999999999996 47899999887533 344455788999999999999999999999998899999999
Q ss_pred eccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-
Q 010091 323 FMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV- 398 (518)
Q Consensus 323 y~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~- 398 (518)
|+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~ 162 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence 9999999988753 234578899999999999999999999999999999999999999999999999876543221
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhc-CCCCCCCCCCcHHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP-LQAAVGVVQK-GLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~-~~~~~~~~~~-~~~p~~~~~~~~~L~~Li~ 476 (518)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .......+.. ...+......+..+.+++.
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (267)
T cd08228 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242 (267)
T ss_pred HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence 2234588899999999888899999999999999999999999865432 2222222332 3333334567788999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~~L~~l 499 (518)
+||+.+|.+||++.++++.|+.+
T Consensus 243 ~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 243 MCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHCCCCcccCcCHHHHHHHHHHh
Confidence 99999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.39 Aligned_cols=241 Identities=26% Similarity=0.434 Sum_probs=206.4
Q ss_pred eEEeEecceEEEEEEE-----CCccEEEEEEecccc--CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 251 HKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHL--NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~-----~~~~vAvKvl~~~~~--~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
++||+|+||.||+++. .++.||+|+++.... +......+..|+.++++++||||+++++++...+..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 367899999986432 223345678899999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
++|++|.+++.. .+.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 999999999976 4567888999999999999999999999999999999999999999999999987533222 22234
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+... ...++..+++.+.++|.+||+.+
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHcccC
Confidence 6899999999999888999999999999999999999999988776655544432 34567778999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 010091 483 PSLRP-----DFSEITE 494 (518)
Q Consensus 483 P~~RP-----s~~eil~ 494 (518)
|.+|| ++.+++.
T Consensus 239 p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 239 PSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HhHcCCCCCCCHHHHhc
Confidence 99999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.39 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=207.3
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|++.+.||+|+||.||++... ++.||+|+++..... ......+..|+.++++++|+||+++++.+.....+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 5677999999999999999864 688999999864332 2334678889999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-----
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG----- 397 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~----- 397 (518)
|++||+|.+++.+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 82 FLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999977 4578999999999999999999999999999999999999999999999999986432110
Q ss_pred -------------------------------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 010091 398 -------------------------------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446 (518)
Q Consensus 398 -------------------------------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~ 446 (518)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 0112469999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhh--hCCCCCCCHHHHHHH
Q 010091 447 PLQAAVGVVQKGLRPTIP--VHTHPILVDLLERCWQ--RDPSLRPDFSEITEL 495 (518)
Q Consensus 447 ~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~~cL~--~dP~~RPs~~eil~~ 495 (518)
+.+....+........+| ..+++++.++|.+++. .++..||+++||+..
T Consensus 241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 777666655433223333 2467899999998664 233346899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=323.71 Aligned_cols=245 Identities=33% Similarity=0.650 Sum_probs=208.7
Q ss_pred eEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCc
Q 010091 251 HKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 328 (518)
+.||+|+||.||+|+. .++.||+|.+.... .......|.+|+.++++++||||+++++++......|+||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3689999999999986 47889999887543 34455789999999999999999999999999999999999999999
Q ss_pred cccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc---ccCCCC
Q 010091 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM---TAETGT 405 (518)
Q Consensus 329 L~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt 405 (518)
|.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+......... ....++
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99999775557899999999999999999999999999999999999999999999999998753321111 111234
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPS 484 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~ 484 (518)
..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+.. ..+....+...+..++..+.+++.+||+.+|.
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-EAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-HHHHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence 57999999988889999999999999999998 99999877765443 33444556667777889999999999999999
Q ss_pred CCCCHHHHHHHHH
Q 010091 485 LRPDFSEITELLQ 497 (518)
Q Consensus 485 ~RPs~~eil~~L~ 497 (518)
+|||+.++++.|+
T Consensus 239 ~Rps~~~~~~~l~ 251 (252)
T cd05084 239 QRPSFSTVHQELQ 251 (252)
T ss_pred hCcCHHHHHHHHh
Confidence 9999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=330.57 Aligned_cols=259 Identities=29% Similarity=0.530 Sum_probs=216.3
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
|+++..+|++.++||+|+||.||+|... +..||+|.+..... ......+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 8899999999999999999999999753 24799998875432 233457889999999999999999999999
Q ss_pred cCCceeEEEeeccCCcccccccccc---------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEE
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQK---------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVK 383 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vk 383 (518)
.....|+||||+++++|.+++.+.. ..++...++.++.|++.||.|||++||+||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9899999999999999999996422 2345678899999999999999999999999999999999999999
Q ss_pred EeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC
Q 010091 384 VADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGL 459 (518)
Q Consensus 384 L~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~ 459 (518)
|+|||+++....... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||......+...... .+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~ 238 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DGG 238 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence 999999875432211 111235678999999988889999999999999999998 789998877655443333 344
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 460 RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 460 ~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
.+..+..+++.+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 45566677899999999999999999999999998887753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=328.74 Aligned_cols=256 Identities=28% Similarity=0.548 Sum_probs=214.8
Q ss_pred cccceeeeEEeEecceEEEEEEEC--Cc----cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~----~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
..+|++.+.||+|+||.||+|.+. ++ .+++|++.... ......++..|+.++++++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 345666899999999999999974 44 47778875432 23344678889999999999999999998754 567
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
++++||+++++|.+++......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||.++......
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 89999999999999998766679999999999999999999999999999999999999999999999999997643322
Q ss_pred c---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 398 V---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 398 ~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
. .+...++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+.. ....+..+..+..+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKGERLAQPQICTIDVYM 242 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcCCCCCCCCHHHHH
Confidence 1 122346778999999988899999999999999999998 999998876544 34445566666667778889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
++.+||..+|.+|||+.|+++.|..+.+.
T Consensus 243 li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 243 VMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=329.07 Aligned_cols=254 Identities=30% Similarity=0.557 Sum_probs=212.9
Q ss_pred ccccceeeeEEeEecceEEEEEEE------CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
+.+.+++.++||+|+||.||+|.+ .+..|++|.++... .......|.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 345677799999999999999985 24679999998543 33345788999999999999999999999999999
Q ss_pred eeEEEeeccCCcccccccccc----------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK----------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~----------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~ 380 (518)
.|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 999999999999999985321 2477888999999999999999999999999999999999999
Q ss_pred cEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 010091 381 VVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQ 456 (518)
Q Consensus 381 ~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~ 456 (518)
.+||+|||+++...... ......++..|+|||.+.+..++.++|+||||+++|||++ |..||.+..+.... ..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~-~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI-EMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHH
Confidence 99999999997543221 1222346778999999988889999999999999999998 99999877654433 3344
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 457 ~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
....+..+..+++.+.+++.+||+.||.+||++.+|++.|..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 444555677889999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=334.52 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=200.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.++||+|+||.||+|+.. ++.||+|+++...... ....+.+|+.++++++||||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 45666999999999999999974 6889999997543222 22456789999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+. ++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 995 68888887766678999999999999999999999999999999999999999999999999997543222 2234
Q ss_pred CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----------------CCC-
Q 010091 402 ETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-----------------RPT- 462 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-----------------~p~- 462 (518)
..+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..........+...+ .+.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 568999999999865 4588999999999999999999999987654332222111000 000
Q ss_pred ----CC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 ----IP---------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 ----~~---------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+ ...++.+.+++.+||+.||.+|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=330.01 Aligned_cols=258 Identities=30% Similarity=0.576 Sum_probs=217.6
Q ss_pred eccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
|....|.+.+.||+|+||.||++... +..+|+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45567788999999999999999742 245888988654 344457899999999999999999999999999
Q ss_pred CceeEEEeeccCCcccccccccc------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcE
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVV 382 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~v 382 (518)
...|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999986432 248999999999999999999999999999999999999999999
Q ss_pred EEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC
Q 010091 383 KVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKG 458 (518)
Q Consensus 383 kL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~ 458 (518)
||+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+. .+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~-~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 9999999975432211 112335778999999998899999999999999999998 999998877665544433 34
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 459 LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 459 ~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
..+..+..+++.+.+++.+||+.||.+|||+.++...|+++.+.
T Consensus 239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 44555667889999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=343.44 Aligned_cols=238 Identities=26% Similarity=0.420 Sum_probs=206.0
Q ss_pred eEEeEecceEEEEEEE-----CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeecc
Q 010091 251 HKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~-----~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 325 (518)
+.||+|+||.||++.. .++.||+|+++...........+..|+.++++++||||+++++++.....+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 36889999998755444444667889999999999999999999999999999999999
Q ss_pred CCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCC
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETG 404 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~g 404 (518)
+++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ......|
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 9999999976 4568999999999999999999999999999999999999999999999999997644332 2233568
Q ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCC
Q 010091 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPS 484 (518)
Q Consensus 405 t~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~ 484 (518)
|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+... ...++..+++.+.++|.+||+.||.
T Consensus 161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 99999999999888999999999999999999999999988776665554432 3456677889999999999999999
Q ss_pred CCCCHHH
Q 010091 485 LRPDFSE 491 (518)
Q Consensus 485 ~RPs~~e 491 (518)
+||++.+
T Consensus 239 ~R~~a~~ 245 (318)
T cd05582 239 NRLGAGP 245 (318)
T ss_pred HcCCCCC
Confidence 9999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=329.76 Aligned_cols=253 Identities=30% Similarity=0.575 Sum_probs=214.4
Q ss_pred ccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
...+|.+.+.||+|+||.||+|+.. +..||+|+++.... ......|.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 3456777999999999999999853 36799999876543 334578999999999999999999999999999
Q ss_pred ceeEEEeeccCCcccccccccc-------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcE
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQK-------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVV 382 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~-------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~v 382 (518)
..|+||||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999986532 347888999999999999999999999999999999999999999
Q ss_pred EEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC
Q 010091 383 KVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKG 458 (518)
Q Consensus 383 kL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~ 458 (518)
||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.... ...+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~-~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC-ITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcC
Confidence 9999999975432211 122345788999999999999999999999999999998 9999987766554433 3345
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 459 LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 459 ~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
..+..+..++..+.+++.+||+.||.+||++.|+++.|+
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 555566778899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=327.31 Aligned_cols=258 Identities=31% Similarity=0.561 Sum_probs=216.7
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--Cc----cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~----~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
...+|++.++||+|+||.||+|++. +. .||+|+++... .......+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 3456677999999999999999864 33 48999987653 33445788899999999999999999998875 45
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.++++||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 78999999999999999876667899999999999999999999999999999999999999999999999999865432
Q ss_pred Ccc---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010091 397 GVM---TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 397 ~~~---~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~ 472 (518)
... ....++..|+|||.+.+..++.++|||||||++|||++ |..||......... ..+..+..+..+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCccCCHHHH
Confidence 221 12235678999999988889999999999999999998 99999877654433 34555556666777899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 473 DLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
+++.+||+.||.+||++.++++.|+.+.+..
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 9999999999999999999999988775443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=325.33 Aligned_cols=252 Identities=29% Similarity=0.539 Sum_probs=213.8
Q ss_pred ceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc-----
Q 010091 247 LKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR----- 316 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~----- 316 (518)
|++.+.||+|+||.||+|+... ..||+|.++...........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4568899999999999998642 569999998766566666789999999999999999999998765544
Q ss_pred -eeEEEeeccCCccccccccc-----cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 317 -LFIVTEFMSGGSIYDYLHKQ-----KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 317 -~~lV~Ey~~ggsL~~~l~~~-----~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
.+++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999888432 235889999999999999999999999999999999999999999999999999
Q ss_pred eeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010091 391 RVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466 (518)
Q Consensus 391 ~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~ 466 (518)
+....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+.+.... +..+..+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY-LRHGNRLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCcC
Confidence 86543221 111235678999999988889999999999999999999 9999988776655433 344556667778
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
+++.+.+++.+||+.||.+||++.|+++.|+++
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=325.37 Aligned_cols=251 Identities=27% Similarity=0.499 Sum_probs=209.8
Q ss_pred eeeeEEeEecceEEEEEEECC--c--cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC------Cce
Q 010091 248 KFEHKIVSGSYCDLYKGAFFS--Q--DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------PRL 317 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~~~--~--~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~------~~~ 317 (518)
.+.++||+|+||.||+|.+.. . .||+|.++...........|.+|+.++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 357889999999999999753 2 599999987665666678899999999999999999999987432 356
Q ss_pred eEEEeeccCCcccccccc-----ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 318 FIVTEFMSGGSIYDYLHK-----QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~-----~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
+++|||+++++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 899999999999988742 223578999999999999999999999999999999999999999999999999986
Q ss_pred ccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 393 QAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 393 ~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+.... +..+..+..+..++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-LRQGNRLKQPPDCL 240 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCC
Confidence 543221 112235678999999999999999999999999999999 8999988776554433 44444455566788
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 241 DGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.93 Aligned_cols=261 Identities=34% Similarity=0.613 Sum_probs=218.4
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC 311 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~ 311 (518)
|+...++|++.+.||.|+||.||+|.+. ++.||||+++.... ......+.+|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 7888889999999999999999999742 46799999976543 23346788999999999 689999999987
Q ss_pred ec-CCceeEEEeeccCCcccccccccc-----------------------------------------------------
Q 010091 312 TR-PPRLFIVTEFMSGGSIYDYLHKQK----------------------------------------------------- 337 (518)
Q Consensus 312 ~~-~~~~~lV~Ey~~ggsL~~~l~~~~----------------------------------------------------- 337 (518)
.. ....|+||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 54 456899999999999999886421
Q ss_pred -------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---ccc
Q 010091 338 -------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV---MTA 401 (518)
Q Consensus 338 -------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~ 401 (518)
..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1367788899999999999999999999999999999999999999999999975432211 111
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
..+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+.....+..+.++..+...++++.+++.+||+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 235678999999988899999999999999999997 9999987655455555555666666777788999999999999
Q ss_pred hCCCCCCCHHHHHHHHHHHHH
Q 010091 481 RDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 481 ~dP~~RPs~~eil~~L~~l~~ 501 (518)
.+|.+|||+.+|++.|+.+++
T Consensus 321 ~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 321 GEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=338.52 Aligned_cols=244 Identities=24% Similarity=0.421 Sum_probs=205.2
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHH---hhcCCCceeeEeeeeecCCceeEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIM---RKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il---~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
|++.+.||+|+||.||++.+. ++.||||+++..... ......+.+|+.++ ++++||||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456899999999999999975 688999999865322 22335666676655 566899999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VM 399 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 399 (518)
|||++|++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 999999999988865 358999999999999999999999999999999999999999999999999987533222 22
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+... .+..+..+++.+.++|.+||
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHh
Confidence 3356899999999999999999999999999999999999999988776665554433 34466778999999999999
Q ss_pred hhCCCCCC-----CHHHHHH
Q 010091 480 QRDPSLRP-----DFSEITE 494 (518)
Q Consensus 480 ~~dP~~RP-----s~~eil~ 494 (518)
+.||.+|| ++.++++
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhh
Confidence 99999999 5666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=343.29 Aligned_cols=248 Identities=19% Similarity=0.312 Sum_probs=211.4
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|.+.+.||+|+||.||++... ++.||+|+++.... .......+.+|+.+++.++|+||+++++++......|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 4667999999999999999864 68899999987543 23345678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--cc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--MT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~ 400 (518)
|++|++|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 161 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK 161 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeee
Confidence 9999999999988656899999999999999999999999999999999999999999999999999976543322 12
Q ss_pred cCCCCCcccChhhhc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHH
Q 010091 401 AETGTYRWMAPEVIE------HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILV 472 (518)
Q Consensus 401 ~~~gt~~y~APE~l~------~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~ 472 (518)
...||+.|+|||++. ...++.++|||||||++|+|++|..||...+.......+.........+ ..+++.+.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (330)
T cd05601 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFL 241 (330)
T ss_pred cccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHH
Confidence 346899999999986 4567899999999999999999999999887766665554432222222 35788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.+||+ +|.+||++.+++.
T Consensus 242 ~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 242 DLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHcc-ChhhCCCHHHHhC
Confidence 99999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=338.31 Aligned_cols=241 Identities=23% Similarity=0.379 Sum_probs=206.0
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCC-ceeeEeeeeecCCceeEEE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHM-NVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~Hp-nIv~l~~~~~~~~~~~lV~ 321 (518)
+|++.+.||+|+||.||+|+.. ++.||+|+++.... .+.....+..|..++..++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3677999999999999999976 46899999986533 233456788899999999765 5888999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc-cCccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ-YGVMT 400 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~ 400 (518)
||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 99999999999876 45689999999999999999999999999999999999999999999999999864322 12223
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
...||..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. ..+.++..+++++.+++.+||+
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhh
Confidence 34689999999999999999999999999999999999999998877665554443 3456677889999999999999
Q ss_pred hCCCCCCCH
Q 010091 481 RDPSLRPDF 489 (518)
Q Consensus 481 ~dP~~RPs~ 489 (518)
.||.+|++.
T Consensus 238 ~~P~~R~~~ 246 (324)
T cd05587 238 KHPAKRLGC 246 (324)
T ss_pred cCHHHcCCC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=326.33 Aligned_cols=255 Identities=34% Similarity=0.609 Sum_probs=217.0
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--C---ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--S---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~---~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
+..+|++.+.||+|+||.||+|... + ..+|+|.++.... +.....|..|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3456777999999999999999863 2 3699999876543 34457899999999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||+++++|.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999999998766678999999999999999999999999999999999999999999999999997644322
Q ss_pred c--c--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010091 398 V--M--TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 398 ~--~--~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~ 472 (518)
. . ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+.... ...+.++..+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA-IEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH-HhCCCcCCCCCCCCHHHH
Confidence 1 1 11223568999999998889999999999999999887 9999988776554433 344556666677889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
+++.+||+.+|.+||++.++++.|+++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=331.90 Aligned_cols=263 Identities=30% Similarity=0.605 Sum_probs=222.6
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC---------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEe
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~---------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~ 308 (518)
.|++....|.+.+.||+|+||.||++++. +..||+|.++... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 47888888999999999999999999752 2369999987543 234457889999999999 899999999
Q ss_pred eeeecCCceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCc
Q 010091 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (518)
Q Consensus 309 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~N 373 (518)
+++......|+||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999987532 246778899999999999999999999999999999
Q ss_pred EEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 010091 374 LLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQ 449 (518)
Q Consensus 374 ILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~ 449 (518)
|+++.++.+||+|||.++....... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 9999999999999999976543221 122335678999999988889999999999999999998 889998876655
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 450 AAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 450 ~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
... .+..+.+...+..++..+.+++.+||+.+|.+|||+.++++.|++++.-.
T Consensus 248 ~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 LFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHH-HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 443 34445566667788999999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=331.21 Aligned_cols=255 Identities=27% Similarity=0.512 Sum_probs=214.6
Q ss_pred eccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
|+.+.|.+.++||+|+||.||+|++. ++.||+|+++... .......|.+|+.++.+++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 44566777999999999999999864 3679999998543 334457789999999999999999999999999
Q ss_pred CceeEEEeeccCCccccccccc---------------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQ---------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~---------------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~ 379 (518)
...++++||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999997421 1247888899999999999999999999999999999999999
Q ss_pred CcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 010091 380 GVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVV 455 (518)
Q Consensus 380 ~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~ 455 (518)
+.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432221 122345788999999988889999999999999999998 889998877765554433
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 456 QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 456 ~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
.+.....+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 -NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 344455677899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=322.95 Aligned_cols=247 Identities=27% Similarity=0.477 Sum_probs=214.0
Q ss_pred ceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCH---HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNE---NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~---~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
|+..+.||+|++|.||++.. .++.||+|.+....... .....+.+|+.++++++||||+++++++......|+||
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 44499999999999999985 47899999987654332 22367889999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc--
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM-- 399 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 399 (518)
||++|++|.+++.. ...++...+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.++........
T Consensus 84 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 162 (263)
T cd06625 84 EYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT 162 (263)
T ss_pred EECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccc
Confidence 99999999999876 446889999999999999999999999999999999999999999999999998754332111
Q ss_pred --ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 400 --TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 400 --~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..............+..+..++..+.++|.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (263)
T cd06625 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242 (263)
T ss_pred cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHH
Confidence 224578899999999988899999999999999999999999988777666666555566777888899999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||..+|.+|||+.+++.
T Consensus 243 ~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 243 TFVENAKKRPSAEELLR 259 (263)
T ss_pred HhhcCcccCCCHHHHhh
Confidence 99999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.93 Aligned_cols=241 Identities=23% Similarity=0.392 Sum_probs=206.4
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
+.||+|+||.||+++.. ++.||+|+++..... ......+..|+.+++.++||||+++++++.....+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 688999999865432 234467788999999999999999999999999999999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccCCCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAETGT 405 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt 405 (518)
+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 99998876 4468999999999999999999997 79999999999999999999999999998753322 222335699
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ....++..+++++.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999999999999999999999999999999988776555443332 234567778999999999999999999
Q ss_pred CC-----CHHHHHH
Q 010091 486 RP-----DFSEITE 494 (518)
Q Consensus 486 RP-----s~~eil~ 494 (518)
|+ ++.++++
T Consensus 238 R~~~~~~~~~~il~ 251 (325)
T cd05594 238 RLGGGPDDAKEIMQ 251 (325)
T ss_pred hCCCCCCCHHHHhc
Confidence 96 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=324.98 Aligned_cols=254 Identities=33% Similarity=0.594 Sum_probs=215.5
Q ss_pred cccceeeeEEeEecceEEEEEEEC--C---ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--S---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~---~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
.+.|++.+.||+|+||.||+|... + ..||||+++... ++.....|..|+.++++++||||+++++++......+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 345677999999999999999864 2 259999987653 3445678999999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
+||||+++++|.+++....+.+++..++.++.|++.|+.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999999987666789999999999999999999999999999999999999999999999999875433221
Q ss_pred ---cccCC---CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 399 ---MTAET---GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 399 ---~~~~~---gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
..... .+..|+|||.+.+..++.++||||||+++|||++ |..||...........+ ....+...+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~ 240 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTAL 240 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHHH
Confidence 11111 2457999999998899999999999999999987 99999887765544433 4445555666788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
.+++.+||+.+|.+||++.+++..|+.+
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 241 HQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=330.96 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=208.0
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
|+..++||+|+||.||++... ++.||+|++....... .....+.+|+.++++++||||+++++.+..+..+|+||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 566899999999999999964 6889999997654332 2335678899999999999999999999999999999999
Q ss_pred ccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR 161 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccc
Confidence 99999998886533 46899999999999999999999999999999999999999999999999999765433333345
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV--QKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
.|+..|+|||++.+..++.++||||+|+++|+|++|..||.+........... .....+..+...++.+.+++.+||+
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 241 (285)
T cd05605 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241 (285)
T ss_pred cCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHcc
Confidence 68999999999998899999999999999999999999998765432221111 1133445566788999999999999
Q ss_pred hCCCCCC-----CHHHHHH
Q 010091 481 RDPSLRP-----DFSEITE 494 (518)
Q Consensus 481 ~dP~~RP-----s~~eil~ 494 (518)
.||.+|| ++.+++.
T Consensus 242 ~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 242 KDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred CCHHHhcCCCCCCHHHHhc
Confidence 9999999 7888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=323.99 Aligned_cols=259 Identities=31% Similarity=0.597 Sum_probs=219.4
Q ss_pred eeccccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
++...+|.+.++||.|+||.||+|.+.+ ..|++|...... .....+.|.+|+.++++++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 5666778889999999999999998643 368999886543 24455789999999999999999999998875 4
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..|+||||+++++|.+++......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 57899999999999999987555689999999999999999999999999999999999999999999999999976543
Q ss_pred cCcc--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010091 396 YGVM--TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 396 ~~~~--~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~ 472 (518)
.... +...++..|+|||.+....++.++||||||+++|+|++ |..||...+..+.... +..+.++..+..+++.+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLY 238 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHH
Confidence 3211 11224567999999988889999999999999999996 9999988876555433 444556667778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+++.+||..+|.+|||+.++++.|+.+.++
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.99 Aligned_cols=259 Identities=26% Similarity=0.549 Sum_probs=219.4
Q ss_pred eccccceeeeEEeEecceEEEEEEECC------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec-C
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFFS------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-P 314 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-~ 314 (518)
|+.++|++.+.||+|+||.||+|.+.+ ..|++|+++.. ........+.+|+.++++++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 566778889999999999999999653 77999998754 344456788999999999999999999998765 5
Q ss_pred CceeEEEeeccCCcccccccccc-------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeee
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK-------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~-------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DF 387 (518)
...++++||+++++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 67899999999999999986532 35889999999999999999999999999999999999999999999999
Q ss_pred ccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010091 388 GVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTI 463 (518)
Q Consensus 388 G~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~ 463 (518)
|+++...... ......++..|+|||++.+..++.++||||||+++|++++ |+.||....+.+.. ..+..+.++..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-HHHHcCCCCCC
Confidence 9997543221 1122346778999999988889999999999999999999 99999887765544 33444566666
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 464 ~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+..+++.+.+++.+||..+|.+|||+.+++..|+++.++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 677889999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.57 Aligned_cols=248 Identities=20% Similarity=0.284 Sum_probs=206.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|++.++||+|+||.||++... ++.||||++..... .......+.+|+.++++++||||+++++++......|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 4677999999999999999864 68899999876432 23345778899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-----
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG----- 397 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~----- 397 (518)
|++|++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 82 FLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999976 4568899999999999999999999999999999999999999999999999985321100
Q ss_pred -------c------------------------------------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHH
Q 010091 398 -------V------------------------------------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWE 434 (518)
Q Consensus 398 -------~------------------------------------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~e 434 (518)
. .....||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0 001358999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhhCCCCC---CCHHHHHHH
Q 010091 435 LVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV--HTHPILVDLLERCWQRDPSLR---PDFSEITEL 495 (518)
Q Consensus 435 LltG~~P~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~L~~Li~~cL~~dP~~R---Ps~~eil~~ 495 (518)
|++|..||....+.+....+........++. .+++++.++|.+||. +|.+| +++.+++..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999988877665555443222233333 468899999999997 77765 599888763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=339.73 Aligned_cols=246 Identities=30% Similarity=0.464 Sum_probs=203.6
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
..++|.+.++||+|+||.||++++. ++.||||++.... .+.....|.+|+.++++++|+||+++++++.....+|+|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 3456677999999999999999975 6899999997543 344557889999999999999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VM 399 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 399 (518)
|||+++++|.+.. ..++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 151 ~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 151 LEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 9999999987542 34577788999999999999999999999999999999999999999999998654322 22
Q ss_pred ccCCCCCcccChhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCcHHHH
Q 010091 400 TAETGTYRWMAPEVIEH-----QPYNHRADVFSFGIVLWELVTGKLPYDDLTP--LQAAVGVVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~-----~~~~~ksDV~SlGill~eLltG~~P~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~L~ 472 (518)
....||..|+|||++.. ...+.++|||||||++|||++|+.||..... .............+..+..++.++.
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 305 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR 305 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence 34568999999998743 2345689999999999999999999974322 2222222333445666778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|.+||+.||.+||++.|+++
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999976
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.12 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=213.4
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
.+++..+.|++.++||+|+||.||+++.. ++.||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34566677888999999999999999965 6889999997543222 23356788999999999999999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.+|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999998653 588899999999999999999999999999999999999999999999999976543
Q ss_pred cCc--cccCCCCCcccChhhhcCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CC
Q 010091 396 YGV--MTAETGTYRWMAPEVIEHQ----PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV--HT 467 (518)
Q Consensus 396 ~~~--~~~~~gt~~y~APE~l~~~----~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~--~~ 467 (518)
... .....||+.|+|||++.+. .++.++|||||||++|||++|..||...........+........++. .+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 321 2234699999999998643 478999999999999999999999998877666665554333333443 57
Q ss_pred cHHHHHHHHHhhhhCCCC--CCCHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSL--RPDFSEITE 494 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~--RPs~~eil~ 494 (518)
+.++.++|.+||+.+|.+ |+++.+++.
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 899999999999999987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.30 Aligned_cols=265 Identities=29% Similarity=0.601 Sum_probs=223.1
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC---------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeE
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~---------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l 307 (518)
..|.+...+|++.++||+|+||.||+++.. ...+|+|.++.... ......+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 357888889999999999999999999752 24699999876433 34457788999999999 69999999
Q ss_pred eeeeecCCceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCC
Q 010091 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (518)
Q Consensus 308 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~ 372 (518)
++++......|++|||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 999999899999999999999999986532 34788899999999999999999999999999999
Q ss_pred cEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010091 373 NLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPL 448 (518)
Q Consensus 373 NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~ 448 (518)
||+++.++.+||+|||.++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999975433211 112234567999999988889999999999999999999 89999887665
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 449 QAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 449 ~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
+... ....+..+..+..++.++.+++.+||+.+|.+|||+.++++.|.++...+.
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 244 ELFK-LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHH-HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 5443 344455566677888999999999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.44 Aligned_cols=236 Identities=24% Similarity=0.400 Sum_probs=202.9
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||+++.. ++.||+|+++.... .+.....+..|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999975 67899999986532 233446778888888876 699999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt 405 (518)
++|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... ......||
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 999999876 4578999999999999999999999999999999999999999999999999987533222 23335689
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. .....+..+++++.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999999999999999999999999999999998887666555443 234566678999999999999999999
Q ss_pred CCCH
Q 010091 486 RPDF 489 (518)
Q Consensus 486 RPs~ 489 (518)
||++
T Consensus 238 R~~~ 241 (320)
T cd05590 238 RLGS 241 (320)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=347.62 Aligned_cols=249 Identities=26% Similarity=0.446 Sum_probs=226.9
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc-eeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-LFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~-~~lV~E 322 (518)
.|..++++|.|+||.+++.+.+ +..+++|.+......+.......+|+.++++++|||||.+.+.|...+. +||||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4555999999999999988765 5789999999998888888888999999999999999999999998888 999999
Q ss_pred eccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccc
Q 010091 323 FMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 400 (518)
|++||+|.+.+.+.+ ..+++..++.++.|++.|+.|||++.|+|||||+.||+++.++.|||+|||+|+...... ...
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~ 164 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLAS 164 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhh
Confidence 999999999998766 569999999999999999999999999999999999999999999999999999887765 444
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
+..||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.......+.+ ..-..+|..++.++..+|..|+.
T Consensus 165 tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~-~~~~Plp~~ys~el~~lv~~~l~ 243 (426)
T KOG0589|consen 165 TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR-GLYSPLPSMYSSELRSLVKSMLR 243 (426)
T ss_pred eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh-ccCCCCCccccHHHHHHHHHHhh
Confidence 56799999999999999999999999999999999999999998877666666555 44567888999999999999999
Q ss_pred hCCCCCCCHHHHHHH
Q 010091 481 RDPSLRPDFSEITEL 495 (518)
Q Consensus 481 ~dP~~RPs~~eil~~ 495 (518)
.+|..||++.+++..
T Consensus 244 ~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 244 KNPEHRPSALELLRR 258 (426)
T ss_pred cCCccCCCHHHHhhC
Confidence 999999999999986
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.70 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=214.6
Q ss_pred ccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC-----
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP----- 315 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~----- 315 (518)
...+|.+.+.||+|+||.||+++. .++.||||++.....++.....+.+|+.++..++|+||++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 345777799999999999999986 4789999999887766666788899999999999999999988764322
Q ss_pred ---ceeEEEeeccCCccccccccc---cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 316 ---RLFIVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 316 ---~~~lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
.+++||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 368999999999999998642 24688999999999999999999999999999999999999999999999999
Q ss_pred ceecccc---CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010091 390 ARVQAQY---GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466 (518)
Q Consensus 390 a~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~ 466 (518)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....... +....++..
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~ 268 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPLPPS 268 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCC
Confidence 9764332 112334689999999999999999999999999999999999999998776655544443 344456778
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++++.+++.+||+.||.+||++.+++.
T Consensus 269 ~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 269 ISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 8999999999999999999999999876
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=327.85 Aligned_cols=256 Identities=28% Similarity=0.544 Sum_probs=215.8
Q ss_pred cccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
..+|.+.+.||.|+||.||++.+. +..+++|.++... ......|.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 345666899999999999999853 2458888886543 2334678899999999999999999999999999
Q ss_pred eeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~ 381 (518)
.++||||+++++|.+++.... ..+++..++.++.||+.|+.|||++||+||||||+||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999986532 34788999999999999999999999999999999999999999
Q ss_pred EEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 010091 382 VKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQK 457 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~ 457 (518)
++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... ...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~ 240 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-ITQ 240 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhC
Confidence 99999999975433211 122346788999999998999999999999999999999 9999988776554433 444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 458 GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 458 ~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+..+..+..++..+.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 555556677889999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=338.81 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=203.9
Q ss_pred ceeeeEEeEecceEEEEEEE-----CCccEEEEEEeccccC--HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCcee
Q 010091 247 LKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~-----~~~~vAvKvl~~~~~~--~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 318 (518)
|++.++||+|+||.||+++. .++.||+|++...... ......+..|+.+++++ +|+||+++++++.....+|
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 56699999999999999875 3678999999764322 23346788899999999 5999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG- 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~- 397 (518)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999976 4568999999999999999999999999999999999999999999999999997543222
Q ss_pred -ccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCcHHHH
Q 010091 398 -VMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 398 -~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~L~ 472 (518)
......||..|+|||++.+. .++.++|||||||++|+|++|..||..... .......+ ....+.++..+++.+.
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-LKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCHHHH
Confidence 12234689999999999765 478899999999999999999999964321 11121111 2345667778899999
Q ss_pred HHHHHhhhhCCCCCC-----CHHHHHH
Q 010091 473 DLLERCWQRDPSLRP-----DFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RP-----s~~eil~ 494 (518)
+++.+||+.||.+|| +++++++
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.90 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=206.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|++.++||+|+||.||+++.. ++.||+|++..... .......+.+|+.++++++|+||+++++.+...+.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5777999999999999999965 68899999875432 22334678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc------
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY------ 396 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~------ 396 (518)
|++|++|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 82 YIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999977 456889999999999999999999999999999999999999999999999997421100
Q ss_pred --------------------------------------CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcC
Q 010091 397 --------------------------------------GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTG 438 (518)
Q Consensus 397 --------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG 438 (518)
.......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 001123589999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhhCCCCCC---CHHHHHHH
Q 010091 439 KLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQRDPSLRP---DFSEITEL 495 (518)
Q Consensus 439 ~~P~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~L~~Li~~cL~~dP~~RP---s~~eil~~ 495 (518)
+.||....+.+....+........+ ...+++++.++|.+|+ .+|.+|+ ++.+++..
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999988876655444432222222 2357889999999976 5999998 88888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=336.38 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=206.5
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
+..++|++.++||+|+||.||++++. +..+|+|++.... .+.....+.+|+.++++++|+||+++++++...+..|+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 44567777999999999999999975 6789999987653 34455789999999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~ 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 158 (333)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence 9999999999999976 44688999999999999999999985 7999999999999999999999999998654322 1
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--------------------------
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAV-------------------------- 452 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~-------------------------- 452 (518)
.....|+..|+|||++.+..++.++|+|||||++|+|++|+.||......+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 233468999999999998889999999999999999999999997544322211
Q ss_pred -----------------HHHhcCCCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 453 -----------------GVVQKGLRPTIPV-HTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 453 -----------------~~~~~~~~p~~~~-~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+.....+..+. ..+.++.++|.+||+.||.+|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0011111222222 35678999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.38 Aligned_cols=254 Identities=32% Similarity=0.633 Sum_probs=216.7
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
|+|....|++.++||+|+||.||++.+. +..+|+|.++.. +.....|.+|+.++++++|+||+++++.+.. ...|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 7888899999999999999999999865 567999988754 2234678899999999999999999999877 7789
Q ss_pred EEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
++|||+++++|.+++.+. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999763 3457888999999999999999999999999999999999999999999999997543322
Q ss_pred c--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 V--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 ~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
. .....++..|+|||++.+..++.++|+||||+++|+|++ |..||...+..+... .+..+.....+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-ALERGYRMPRPENCPEELYNI 235 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhCCCCCCCcccCCHHHHHH
Confidence 1 112335678999999988889999999999999999998 999998876554443 334455555667788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
+.+||+.+|.+||++.++.+.|+.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=327.49 Aligned_cols=253 Identities=29% Similarity=0.589 Sum_probs=214.5
Q ss_pred ceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 247 LKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
|++.+.||+|+||.||+|+... ..+++|.+..... ......+.+|+.++++++||||+++++.+......|+
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5568899999999999998642 4589998876543 3334678999999999999999999999999999999
Q ss_pred EEeeccCCccccccccc-----------------------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe
Q 010091 320 VTEFMSGGSIYDYLHKQ-----------------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~-----------------------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl 376 (518)
+|||+.+++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987542 1247788999999999999999999999999999999999
Q ss_pred ccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 010091 377 NENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAV 452 (518)
Q Consensus 377 ~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~ 452 (518)
++++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+.+. .
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL-F 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH-H
Confidence 9999999999999975432211 122335678999999988889999999999999999998 9999988765543 3
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 453 GVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 453 ~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
........+..+..++..+.+++.+||+.+|.+||++.++++.|++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 4455566777788889999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=336.12 Aligned_cols=240 Identities=25% Similarity=0.426 Sum_probs=202.7
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||+|++. ++.||+|+++..... +.....+..|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999975 577999999865432 22335556677777654 899999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt 405 (518)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .......||
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 999999876 457899999999999999999999999999999999999999999999999999754322 222334689
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. ...+.++..++.++.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 99999999999999999999999999999999999999887766554433 3456677888999999999999999999
Q ss_pred CCCHH-HHH
Q 010091 486 RPDFS-EIT 493 (518)
Q Consensus 486 RPs~~-eil 493 (518)
||++. +++
T Consensus 238 R~~~~~~l~ 246 (316)
T cd05592 238 RLGVDGDIR 246 (316)
T ss_pred cCCChHHHH
Confidence 99865 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.39 Aligned_cols=246 Identities=20% Similarity=0.377 Sum_probs=209.9
Q ss_pred cceeeeEEeEecceEEEEEEEC---CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~---~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|.+.+.||.|+||.||++... ++.||+|.+... +......+..|+.++++++||||+++++++...+..|+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3777999999999999999854 467888876543 33344677889999999999999999999999999999999
Q ss_pred eccCCccccccccc---cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-
Q 010091 323 FMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV- 398 (518)
Q Consensus 323 y~~ggsL~~~l~~~---~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~- 398 (518)
|++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999999887542 34688999999999999999999999999999999999999999999999999986543221
Q ss_pred --cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 399 --MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 399 --~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....... +..+..+..+++++.++|.
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~ 304 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKALLD 304 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCccCCHHHHHHHH
Confidence 2334589999999999999999999999999999999999999988776665555444 3334456678899999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
+||+.||.+||++.+++.
T Consensus 305 ~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 305 PLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHhccChhhCcCHHHHHh
Confidence 999999999999999864
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=337.45 Aligned_cols=241 Identities=23% Similarity=0.397 Sum_probs=205.6
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
++||+|+||.||+|+.. ++.||+|+++.... .+.....+..|..+++.+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999975 57899999986533 233446677899998866 799999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt 405 (518)
++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 999999876 4568999999999999999999999999999999999999999999999999987533222 22334589
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ....|..+++++.+++.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999999999999999999999999999999988876666554433 33456668899999999999999999
Q ss_pred CC-------CHHHHHH
Q 010091 486 RP-------DFSEITE 494 (518)
Q Consensus 486 RP-------s~~eil~ 494 (518)
|| +++++++
T Consensus 238 R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 238 RLGCVASQGGEDAIKQ 253 (321)
T ss_pred cCCCCCCCCCHHHHhc
Confidence 99 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.65 Aligned_cols=245 Identities=40% Similarity=0.712 Sum_probs=214.8
Q ss_pred eEEeEecceEEEEEEEC-----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeecc
Q 010091 251 HKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 325 (518)
++||+|+||.||++.+. +..|++|+++...... ....+.+|+.+++.++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46899999999999975 6789999998765443 46788999999999999999999999999999999999999
Q ss_pred CCccccccccc--------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 326 GGSIYDYLHKQ--------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 326 ggsL~~~l~~~--------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
+++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999999875 3679999999999999999999999999999999999999999999999999998765432
Q ss_pred ---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 398 ---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 398 ---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
......++..|+|||.+....++.++||||||+++|+|++ |..||...+..+.... +..+.....+..+++++.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-LRKGYRLPKPEYCPDELYE 238 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCccCChHHHH
Confidence 1223457889999999988889999999999999999999 6999998876655444 3346667777888999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
++.+||+.+|.+|||+.+++..|+
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHhhC
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=321.86 Aligned_cols=256 Identities=32% Similarity=0.592 Sum_probs=216.8
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--Cc---cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQ---DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~---~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
|..+.|+..+.||+|+||.||+|+.. ++ .+|+|.++... .......|.+|+.++++++|+||+++.+++.....
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45567788999999999999999864 32 69999987653 23345789999999999999999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.|+||||+++++|.+++.+....+++..+..++.|++.|++|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999875667899999999999999999999999999999999999999999999999999755332
Q ss_pred Ccc----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 397 GVM----TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 397 ~~~----~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
... .....+..|+|||++.+..++.++||||||+++|||++ |..||...+..+....+ ........+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~ 239 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCPSAV 239 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH-hcCCCCCCCCCCCHHH
Confidence 111 11123467999999988889999999999999999997 99999887765544433 3344555566788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
.+++.+||+.+|.+||++.++++.|+++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.54 Aligned_cols=246 Identities=25% Similarity=0.344 Sum_probs=200.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC------c
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------R 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~------~ 316 (518)
.+|++.+.||+|+||.||++... ++.||+|++............+.+|+.+++.++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45666999999999999999864 688999999876555555678889999999999999999999885443 4
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.|+||||+++ +|.+++.. .++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 101 VYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 7999999965 66666643 4788899999999999999999999999999999999999999999999999765444
Q ss_pred CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC------------------
Q 010091 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG------------------ 458 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~------------------ 458 (518)
.......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+............
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 33444578999999999999999999999999999999999999998765433221111100
Q ss_pred --CCCC--------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 --LRPT--------------------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 --~~p~--------------------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+. .....++.+.++|.+||+.||.+|||+.|++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 11123567999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.63 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=207.1
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|.+.++||+|+||.||+|+.. ++.||+|++..... .......+.+|+.++++++|+||+++++.+.....+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4677999999999999999974 67899999976432 23345778899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc------
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY------ 396 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~------ 396 (518)
|++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999999876 356889999999999999999999999999999999999999999999999997421100
Q ss_pred ------------------------------------------CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHH
Q 010091 397 ------------------------------------------GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWE 434 (518)
Q Consensus 397 ------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~e 434 (518)
.......||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 00012358999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 010091 435 LVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVDLLERCWQRDPSLRPD---FSEITE 494 (518)
Q Consensus 435 LltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~~cL~~dP~~RPs---~~eil~ 494 (518)
|++|+.||...++.+....+.........| ...++++.++|.+|+ .+|.+|++ +.+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999888877666655433333333 457899999999976 59999986 887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=335.02 Aligned_cols=241 Identities=23% Similarity=0.395 Sum_probs=205.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+|.+.+.||+|+||.||+|+.. ++.||+|+++.... .+.....+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3667999999999999999975 57899999986543 223345677788888877 5899999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMT 400 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 400 (518)
||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 99999999999876 4568999999999999999999999999999999999999999999999999997543222 223
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+... ...+|...++++.+++.+||+
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcCCHHHHHHHHHHcc
Confidence 356899999999999999999999999999999999999999988776665554433 345667789999999999999
Q ss_pred hCCCCCCCH
Q 010091 481 RDPSLRPDF 489 (518)
Q Consensus 481 ~dP~~RPs~ 489 (518)
.+|.+|++.
T Consensus 238 ~~p~~R~~~ 246 (323)
T cd05616 238 KHPGKRLGC 246 (323)
T ss_pred cCHHhcCCC
Confidence 999999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=337.93 Aligned_cols=242 Identities=25% Similarity=0.414 Sum_probs=201.8
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||+++.. ++.||+|+++.....+ .....+..|..+++++ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999975 6789999998754433 3346788899999998 799999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc-cCccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ-YGVMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~gt 405 (518)
++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 999998876 45799999999999999999999999999999999999999999999999999874222 1222335689
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT--------PLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~--------~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
..|+|||++.+..++.++|+|||||++|+|++|+.||.... .......... .....+|..+++++.++|.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~ 238 (329)
T cd05588 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKASSVLKG 238 (329)
T ss_pred ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-cCCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999996321 1111222222 23445677889999999999
Q ss_pred hhhhCCCCCCC------HHHHHH
Q 010091 478 CWQRDPSLRPD------FSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs------~~eil~ 494 (518)
||+.||.+|++ +.++++
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 239 FLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HhccCHHHcCCCCCCCCHHHHhc
Confidence 99999999987 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=319.62 Aligned_cols=245 Identities=29% Similarity=0.592 Sum_probs=209.0
Q ss_pred eEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeecc
Q 010091 251 HKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 325 (518)
++||+|+||.||+|.+.. ..+|+|.+...... .....+.+|+.++++++|+||+++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 468999999999998642 56999999876544 44578999999999999999999999876 456899999999
Q ss_pred CCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc----cc
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM----TA 401 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~----~~ 401 (518)
+++|.+++.... .+++..++.++.|++.||.|||..+++|+||||+||+++.++.+||+|||.++........ ..
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999998743 7899999999999999999999999999999999999999999999999999765433211 11
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+.. ..+........+..+++.+.+++.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 223568999999998899999999999999999998 99999888765543 3344455556777888999999999999
Q ss_pred hCCCCCCCHHHHHHHHHHH
Q 010091 481 RDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 481 ~dP~~RPs~~eil~~L~~l 499 (518)
.+|.+||++.++++.|+++
T Consensus 237 ~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 237 YRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CChhhCcCHHHHHHHHHhc
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.91 Aligned_cols=247 Identities=26% Similarity=0.443 Sum_probs=212.6
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|++.++||.|+||.||++.+. ++.+|+|.++.... ....+.+.+|+.++++++|+||+++++.+.....+|+||||+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 566999999999999999865 68899999875432 334577888999999999999999999999999999999999
Q ss_pred cCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-cccC
Q 010091 325 SGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTAE 402 (518)
Q Consensus 325 ~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~ 402 (518)
++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||.+........ ....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 999999988653 34588999999999999999999999999999999999999999999999999976544332 2234
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.|+..|+|||++.+..++.++|+||||+++|+|++|..||...+......... .+.....+..++..+.+++.+||+.|
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (255)
T cd08219 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMFKRN 239 (255)
T ss_pred cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHHhCC
Confidence 58899999999998889999999999999999999999998877655544433 34445566778899999999999999
Q ss_pred CCCCCCHHHHHHH
Q 010091 483 PSLRPDFSEITEL 495 (518)
Q Consensus 483 P~~RPs~~eil~~ 495 (518)
|.+||++.+++..
T Consensus 240 P~~Rp~~~~il~~ 252 (255)
T cd08219 240 PRSRPSATTILSR 252 (255)
T ss_pred cccCCCHHHHhhc
Confidence 9999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=324.25 Aligned_cols=250 Identities=27% Similarity=0.513 Sum_probs=205.7
Q ss_pred eeeeEEeEecceEEEEEEE------CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--CceeE
Q 010091 248 KFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFI 319 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~------~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~~~l 319 (518)
++.+.||.|+||.||++.+ .++.||+|+++.... +.....|.+|+.++++++||||+++++++... ...|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 7789999999999998764 246799999986532 33457788999999999999999999987653 45899
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV- 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~- 398 (518)
+|||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||++++++.++|+|||+++.......
T Consensus 86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 99999999999998763 589999999999999999999999999999999999999999999999999976443221
Q ss_pred ---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------HHHHHHHhcCCCC
Q 010091 399 ---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL--------------QAAVGVVQKGLRP 461 (518)
Q Consensus 399 ---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~--------------~~~~~~~~~~~~p 461 (518)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ............+
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC
Confidence 11223567799999998888999999999999999999999998653211 1111122233444
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 462 TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 462 ~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
..+..++..+.+++.+||+.+|.+|||++++++.|+.+.
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 556778899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=346.79 Aligned_cols=243 Identities=25% Similarity=0.418 Sum_probs=215.2
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCc
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPR 316 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~ 316 (518)
.+...++++.++||+|+||.|+++..+ ++.+|||++++... .++..+..+.|.+|+...+ ||.+++++.+|....+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 566678899999999999999999976 57899999998754 3344577788999988775 9999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc-c
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA-Q 395 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~-~ 395 (518)
+|+||||+.||++..+.+. ..+++..+.-++..++.||.|||++|||+||||.+|||+|.+|.+||+|||+++..- .
T Consensus 444 l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999996655543 469999999999999999999999999999999999999999999999999998644 3
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li 475 (518)
.....+.+||+.|||||++.+..|+.+.|.||||++|||||.|..||.+.+..+....++.. .+..|..++.+..++|
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCcccHHHHHHH
Confidence 33444567999999999999999999999999999999999999999999988888777744 5667888999999999
Q ss_pred HHhhhhCCCCCC
Q 010091 476 ERCWQRDPSLRP 487 (518)
Q Consensus 476 ~~cL~~dP~~RP 487 (518)
+++|.++|.+|-
T Consensus 600 ~~ll~k~p~kRL 611 (694)
T KOG0694|consen 600 RRLLRKNPEKRL 611 (694)
T ss_pred HHHhccCccccc
Confidence 999999999994
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=317.73 Aligned_cols=250 Identities=34% Similarity=0.646 Sum_probs=213.4
Q ss_pred ccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+.++|++.+.||+|+||.||++.+. +..+|+|.++...... ..|.+|+.++++++||||+++++++......|+||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 4456777999999999999999876 7889999987654443 46889999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--c
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--M 399 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--~ 399 (518)
||+++++|.+++......+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||.+........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999999987566789999999999999999999999999999999999999999999999999875433211 1
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......... .....+.++..+...+..+.+++.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV-ETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-HHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 12235678999999988889999999999999999998 99999876654433 33444555556666789999999999
Q ss_pred hhhCCCCCCCHHHHHHHH
Q 010091 479 WQRDPSLRPDFSEITELL 496 (518)
Q Consensus 479 L~~dP~~RPs~~eil~~L 496 (518)
|+.+|.+||++.++++.|
T Consensus 238 l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 238 WKERPEDRPSFSLLLHQL 255 (256)
T ss_pred cccChhhCCCHHHHHHhh
Confidence 999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=318.75 Aligned_cols=255 Identities=26% Similarity=0.484 Sum_probs=213.9
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
..|++.+.||+|+||.||+|... ++.||+|.++.... +......+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 35677999999999999999975 78999999875433 3334578999999999999999999999999999999999
Q ss_pred eeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-
Q 010091 322 EFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG- 397 (518)
Q Consensus 322 Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~- 397 (518)
||+++++|.+++.. ....++...++.++.+++.||.|||+.||+||||+|+||+++.++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999998853 23458899999999999999999999999999999999999999999999999987644322
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCCCCCCCC-CCcHHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT-PLQAAVGVVQKGLRPTIPV-HTHPILVDLL 475 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~-~~~~~~~~~~~~~~p~~~~-~~~~~L~~Li 475 (518)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ...........+..+..+. ..+..+.++|
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 241 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV 241 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence 1223458889999999988889999999999999999999999996533 2222223333344444444 6788999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
.+||..+|.+|||+.+|++.|+++
T Consensus 242 ~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 242 SRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHcCCCcccCCCHHHHHHHHHHh
Confidence 999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=322.59 Aligned_cols=247 Identities=34% Similarity=0.626 Sum_probs=206.5
Q ss_pred EEeEecceEEEEEEECC--c--cEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 252 KIVSGSYCDLYKGAFFS--Q--DVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~~--~--~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
.||+|+||.||+|+..+ . .+++|.++... .......|.+|+.+++++ +||||+++++++...+..|+||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 58999999999999753 2 46888887432 334456888999999999 799999999999999999999999999
Q ss_pred Ccccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 327 GSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 327 gsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999986532 247889999999999999999999999999999999999999999999999986
Q ss_pred eccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 392 VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
.............+..|+|||++.+..++.++|+||||+++|||++ |..||...+..+.. ..+..+.+...+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKLPQGYRLEKPLNCDDE 239 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-HHHhCCCCCCCCCcCCHH
Confidence 3322111111234567999999988889999999999999999997 99999877654443 333445566666778899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
+.+++.+||+.+|.+|||+.+++..|++++
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 240 VYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.76 Aligned_cols=264 Identities=30% Similarity=0.605 Sum_probs=223.2
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEECC---------ccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeE
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~---------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l 307 (518)
..|++...+|++.+.||+|+||.||++++.+ ..||+|+++... .+.....+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 4699999999999999999999999997531 258999887543 334457899999999999 79999999
Q ss_pred eeeeecCCceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCC
Q 010091 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (518)
Q Consensus 308 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~ 372 (518)
++++......|++|||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999986532 24677889999999999999999999999999999
Q ss_pred cEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010091 373 NLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPL 448 (518)
Q Consensus 373 NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~ 448 (518)
||+++.++.+||+|||.++....... .....++..|+|||++.+..++.++||||||+++|||++ |..||...+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999976443221 122234578999999999999999999999999999998 88999887655
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 449 QAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 449 ~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
+.. ..+..+..+..+..++..+.+++.+||+.+|.+||++.|++..|+.+...-
T Consensus 244 ~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 ELF-KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHH-HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 544 334445666677788899999999999999999999999999999987533
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=317.37 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=216.6
Q ss_pred cceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|++.+.||.|+||.||.++. .++.+++|.+.....+......+.+|+.++++++|+||+++++++.....++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 367799999999998888875 478899999887666666677899999999999999999999999999999999999
Q ss_pred ccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 324 MSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 324 ~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+....... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999764 3468999999999999999999999999999999999999999999999999998654433 2233
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+....+ +..+..++.++.+++.+||+.
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY-TPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCccccCHHHHHHHHHHccc
Confidence 5689999999999888889999999999999999999999988777666555544333 334566789999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 010091 482 DPSLRPDFSEITEL 495 (518)
Q Consensus 482 dP~~RPs~~eil~~ 495 (518)
+|.+||+++++++.
T Consensus 240 ~p~~R~s~~~ll~~ 253 (256)
T cd08221 240 DPEKRPTADEVLDQ 253 (256)
T ss_pred CcccCCCHHHHhhC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=316.02 Aligned_cols=245 Identities=34% Similarity=0.648 Sum_probs=210.1
Q ss_pred eEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 251 HKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
++||+|+||.||+|... ++.+|+|++.... .......|.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999864 5789999987654 344456789999999999999999999999999999999999999999
Q ss_pred ccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--cccCCCCCc
Q 010091 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--MTAETGTYR 407 (518)
Q Consensus 330 ~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~gt~~ 407 (518)
.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ .....++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 999976556789999999999999999999999999999999999999999999999999875432211 111234677
Q ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 010091 408 WMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 408 y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~R 486 (518)
|+|||++.+..++.++|+||||+++|+|++ |..||.......... .+..+.+...+..++..+.+++.+||+.+|++|
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-QVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 999999998889999999999999999998 999998877655443 344566667777889999999999999999999
Q ss_pred CCHHHHHHHHH
Q 010091 487 PDFSEITELLQ 497 (518)
Q Consensus 487 Ps~~eil~~L~ 497 (518)
|++.++++.|.
T Consensus 239 p~~~~l~~~l~ 249 (250)
T cd05085 239 PKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHhc
Confidence 99999988774
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=322.71 Aligned_cols=247 Identities=33% Similarity=0.612 Sum_probs=206.5
Q ss_pred ceeeeEEeEecceEEEEEEECC--ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~~--~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|++.+.||+|+||.||+++..+ +.||+|++..............+|+.++++++||||+++++++......|+||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5669999999999999999874 57999999987655554455567999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec-cccCccccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ-AQYGVMTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~-~~~~~~~~~~ 403 (518)
++++|.+++.. ...+++..++.++.||+.||.+||++||+|+||||+||++++++.++|+|||.+... ..........
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred ccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999984 567899999999999999999999999999999999999999999999999999763 2223344466
Q ss_pred CCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCC--CCCCcHHHHHHHHH
Q 010091 404 GTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGLRPTI--PVHTHPILVDLLER 477 (518)
Q Consensus 404 gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~~p~~--~~~~~~~L~~Li~~ 477 (518)
++..|+|||++. +..++.++|+||||+++|+|++|..||..... ................ .......+.++|.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK 239 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence 899999999998 88899999999999999999999999998732 2222222221111111 11224889999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||+.||.+||++.++++
T Consensus 240 ~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 240 MLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HSSSSGGGSTTHHHHHT
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=334.01 Aligned_cols=241 Identities=23% Similarity=0.406 Sum_probs=205.5
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||++.+. ++.||+|+++.... .......+..|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999975 57899999986532 223346677899999888 699999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt 405 (518)
++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ......|+
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 999998876 4579999999999999999999999999999999999999999999999999987532222 12234589
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+.. ..+..+..++..+.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE--DEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 999999999999999999999999999999999999988776665544433 234566778899999999999999999
Q ss_pred CCCH-----HHHHH
Q 010091 486 RPDF-----SEITE 494 (518)
Q Consensus 486 RPs~-----~eil~ 494 (518)
||++ .+++.
T Consensus 238 R~s~~~~~~~~ll~ 251 (318)
T cd05570 238 RLGCLPTGEQDIKG 251 (318)
T ss_pred cCCCCCCCHHHHhc
Confidence 9999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=342.41 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=210.9
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
.+++....|++.+.||+|+||.||+++.. ++.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 35666677888999999999999999975 67899999875332 2233466888999999999999999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.+|+||||++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 999999999999999998653 488889999999999999999999999999999999999999999999999986543
Q ss_pred cCc--cccCCCCCcccChhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCC
Q 010091 396 YGV--MTAETGTYRWMAPEVIEHQP----YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHT 467 (518)
Q Consensus 396 ~~~--~~~~~gt~~y~APE~l~~~~----~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~ 467 (518)
... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+........++ ..+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 274 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCC
Confidence 322 22356999999999996543 7899999999999999999999999887766665555433222333 467
Q ss_pred cHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSL--RPDFSEITEL 495 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~--RPs~~eil~~ 495 (518)
+..+.++|.+||..++.+ |+++.++++.
T Consensus 275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 899999999999844433 6899888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.83 Aligned_cols=252 Identities=33% Similarity=0.575 Sum_probs=210.5
Q ss_pred cccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
...|++.+.||+|++|.||+|.+.+ ..||+|.+.... .......|.+|+.++++++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3456779999999999999999743 568888876443 33345679999999999999999999999988889
Q ss_pred eeEEEeeccCCcccccccccc------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC---cEEEeee
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG---VVKVADF 387 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~---~vkL~DF 387 (518)
.|+||||++|++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+||+++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999999987543 2588899999999999999999999999999999999998655 6999999
Q ss_pred ccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010091 388 GVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTI 463 (518)
Q Consensus 388 G~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~ 463 (518)
|+++....... ......+..|+|||++.+..++.++|||||||++|+|++ |..||...+..... ..+....++..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~~~~ 242 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-EFVTGGGRLDP 242 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcCCcCCC
Confidence 99976532211 111223568999999988889999999999999999997 99999887765443 33444556667
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 464 ~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
+..++..+.+++.+||+.+|.+||++.++++.|+
T Consensus 243 ~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 243 PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 7788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.64 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=198.3
Q ss_pred EeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
||+|+||.||++... |+.||+|++....... .....+..|+.++++++||||+++++++......|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999864 7899999987543322 2234556799999999999999999999999999999999999999
Q ss_pred cccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCCcc
Q 010091 330 YDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRW 408 (518)
Q Consensus 330 ~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y 408 (518)
.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.............|+..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 98886433 35888999999999999999999999999999999999999999999999999765443333445689999
Q ss_pred cChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---CCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 409 MAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL---RPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 409 ~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
+|||++.+..++.++|+|||||++|+|++|..||................. .+.....+++++.+++.+||+.||.+
T Consensus 161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~ 240 (277)
T cd05607 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED 240 (277)
T ss_pred cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhh
Confidence 999999888899999999999999999999999976433211111111111 11222457899999999999999999
Q ss_pred CCCHHHHHH
Q 010091 486 RPDFSEITE 494 (518)
Q Consensus 486 RPs~~eil~ 494 (518)
||++.|+++
T Consensus 241 R~~~~~~~~ 249 (277)
T cd05607 241 RLGSREKND 249 (277)
T ss_pred CCCCccchh
Confidence 999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.36 Aligned_cols=245 Identities=31% Similarity=0.578 Sum_probs=210.9
Q ss_pred eEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeecc
Q 010091 251 HKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 325 (518)
++||+|++|.||+|.+.. ..||+|.+...... .....|.+|+.++++++||||+++++.+.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998642 25899999877654 556889999999999999999999999888 88999999999
Q ss_pred CCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc----cc
Q 010091 326 GGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----MT 400 (518)
Q Consensus 326 ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~----~~ 400 (518)
+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........ ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999999997754 4689999999999999999999999999999999999999999999999999976543211 11
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..............+...+..+.+++.+||
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238 (257)
T ss_pred CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence 2346788999999998899999999999999999998 999998887776555444444455556677899999999999
Q ss_pred hhCCCCCCCHHHHHHHHH
Q 010091 480 QRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 480 ~~dP~~RPs~~eil~~L~ 497 (518)
+.+|.+||++.++++.|.
T Consensus 239 ~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 239 AHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCcccCCCHHHHHHHhc
Confidence 999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=323.93 Aligned_cols=253 Identities=30% Similarity=0.549 Sum_probs=213.2
Q ss_pred eccccceeeeEEeEecceEEEEEEE-------CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAF-------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~-------~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
|+..++.+.++||+|+||.||++.. .+..+|+|.++.. .......|.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4556778899999999999999974 2356889987653 344557899999999999999999999999999
Q ss_pred CceeEEEeeccCCcccccccccc--------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK--------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~--------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~ 380 (518)
...|++|||+++++|.+++.... ..+++..++.++.||+.|+.|||++|++||||||+||++++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999986532 2478899999999999999999999999999999999999999
Q ss_pred cEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 010091 381 VVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQ 456 (518)
Q Consensus 381 ~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~ 456 (518)
.+||+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||............ .
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-T 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH-H
Confidence 999999999875432211 111235678999999998999999999999999999998 99999877765544333 3
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 457 ~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
.+..+..+..+++.+.+++.+||+.||.+||++.+++..|+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 34455666778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.48 Aligned_cols=240 Identities=23% Similarity=0.389 Sum_probs=202.2
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
++||+|+||.||++++. ++.||+|+++..... +.....+..|..++... +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 678999999865321 22335566788888754 899999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc-cCccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ-YGVMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~gt 405 (518)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 999999876 45789999999999999999999999999999999999999999999999999874322 1223345689
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. ...+..+..++.++.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 99999999999999999999999999999999999998877655443332 2345667778999999999999999999
Q ss_pred CCCHH-HHH
Q 010091 486 RPDFS-EIT 493 (518)
Q Consensus 486 RPs~~-eil 493 (518)
||++. +++
T Consensus 238 R~~~~~~~~ 246 (316)
T cd05620 238 RLGVVGNIR 246 (316)
T ss_pred cCCChHHHH
Confidence 99974 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.15 Aligned_cols=242 Identities=23% Similarity=0.345 Sum_probs=199.2
Q ss_pred EeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
||+|+||.||++.+. ++.||+|++....... .....+..|+.++++++|+||+++++++......|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999864 6889999997654332 2346778899999999999999999999999999999999999999
Q ss_pred cccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-cccCCCC
Q 010091 330 YDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTAETGT 405 (518)
Q Consensus 330 ~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~gt 405 (518)
.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ .....||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 887743 234689999999999999999999999999999999999999999999999999975433221 2234689
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCCCCCCCCCcHHHHHHHHHhhhhCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK--GLRPTIPVHTHPILVDLLERCWQRDP 483 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~L~~Li~~cL~~dP 483 (518)
+.|+|||.+.+..++.++|+||||+++|+|++|+.||............... ......+..+++.+.+++.+||+.||
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 240 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence 9999999999999999999999999999999999999765432111111111 12234456788999999999999999
Q ss_pred CCCC-----CHHHHHH
Q 010091 484 SLRP-----DFSEITE 494 (518)
Q Consensus 484 ~~RP-----s~~eil~ 494 (518)
.+|| +++++++
T Consensus 241 ~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 241 EKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHhcCCCCCCHHHHhc
Confidence 9999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=319.30 Aligned_cols=250 Identities=32% Similarity=0.660 Sum_probs=213.8
Q ss_pred eeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
|-+....|++.+.||+|+||.||++...++.||+|.++... ....|.+|+.++++++||||+++++++... ..|+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 44455677789999999999999999999999999987542 235788999999999999999999988654 5799
Q ss_pred EEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 320 VTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
||||+++++|.+++.... ..+++..++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997643 35789999999999999999999999999999999999999999999999998754322
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.. .....+.++..+..+++.+.+++.+
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-ECVEKGYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-HHHhCCCCCCCCCcCCHHHHHHHHH
Confidence 122334678999999988889999999999999999998 99999887765443 3344566666677788999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~~L~ 497 (518)
||+.+|.+||++.++++.|+
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HcCCChhhCcCHHHHHHHHc
Confidence 99999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.60 Aligned_cols=240 Identities=24% Similarity=0.405 Sum_probs=202.0
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||+|++. ++.||+|+++..... +.....+..|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999975 578999999875321 22335566788888764 899999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt 405 (518)
++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .......||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 999999876 456899999999999999999999999999999999999999999999999998753221 122334689
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ..+..+..++.++.+++.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 999999999999999999999999999999999999988776555443322 234566678899999999999999999
Q ss_pred CCCHH-HHH
Q 010091 486 RPDFS-EIT 493 (518)
Q Consensus 486 RPs~~-eil 493 (518)
||++. +++
T Consensus 238 R~~~~~~l~ 246 (316)
T cd05619 238 RLGVKGDIR 246 (316)
T ss_pred cCCChHHHH
Confidence 99996 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.59 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=210.4
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
.+....|++.++||+|+||.||++++. ++.||+|++..... .......+.+|+.+++.++||||+++++++.....+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344556777999999999999999975 67899999975332 223346688999999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 9999999999999998653 58899999999999999999999999999999999999999999999999998654332
Q ss_pred c--cccCCCCCcccChhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CCcH
Q 010091 398 V--MTAETGTYRWMAPEVIEHQP----YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV--HTHP 469 (518)
Q Consensus 398 ~--~~~~~gt~~y~APE~l~~~~----~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~--~~~~ 469 (518)
. .....||+.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+........++. .++.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 2 22356999999999996543 78899999999999999999999998877666666655443344443 4688
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 010091 470 ILVDLLERCWQRDPSL--RPDFSEITEL 495 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~--RPs~~eil~~ 495 (518)
.+.+++.+||..++.+ |+++.|+++.
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 9999999999855543 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=321.02 Aligned_cols=257 Identities=31% Similarity=0.590 Sum_probs=217.7
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--Cc----cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~----~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
...+|++.+.||+|+||.||+|.+. +. .+|+|.+..... .....++.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 3456677999999999999999864 32 589998876543 3345788899999999999999999999877 78
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.++||||+++++|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||.++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999999876667999999999999999999999999999999999999999999999999999765432
Q ss_pred Ccc---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010091 397 GVM---TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 397 ~~~---~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~ 472 (518)
... ....++..|+|||.+....++.++|+||||+++||+++ |..||......+.. ..+..+.....+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-DLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-HHHhCCCCCCCCCCCCHHHH
Confidence 211 11224578999999988889999999999999999998 99999887765543 33444555566667889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+++.+||..+|..||++.++++.|+++.+.
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=320.89 Aligned_cols=254 Identities=23% Similarity=0.435 Sum_probs=211.5
Q ss_pred cceeeeEEeEecceEEEEEEE--CCccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|++.+.||+|+||.||+++. .+..+|||.+..... +......|.+|+.+++.++|+||+++++++......+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 456689999999999999995 478999998875433 33445789999999999999999999999999999999999
Q ss_pred eccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-c
Q 010091 323 FMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-V 398 (518)
Q Consensus 323 y~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 398 (518)
|+++++|.+++.. ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence 9999999998863 23458899999999999999999999999999999999999999999999999987654322 1
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhcC-CCCCCCCCCcHHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL-QAAVGVVQKG-LRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~-~~~~~~~~~~-~~p~~~~~~~~~L~~Li~ 476 (518)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ......+... ..+..+...++.+.+++.
T Consensus 163 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (267)
T cd08229 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN 242 (267)
T ss_pred cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHH
Confidence 22346889999999998888999999999999999999999999754322 2222222222 233334567889999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~~L~~l 499 (518)
+||+.+|.+|||+.+|++.++++
T Consensus 243 ~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 243 MCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HhcCCCcccCCCHHHHHHHHhhh
Confidence 99999999999999999988875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.10 Aligned_cols=237 Identities=24% Similarity=0.409 Sum_probs=199.1
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHH-HHhhcCCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVH-IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||+++.. ++.||+|++...... ......+..|.. +++.++||||+++++++......|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999974 788999999865332 222344555554 56789999999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt 405 (518)
++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 999999876 457899999999999999999999999999999999999999999999999998753222 222334589
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...++...++.+.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999999999999999999999999999999987766655554433 23455567899999999999999999
Q ss_pred CCCHH
Q 010091 486 RPDFS 490 (518)
Q Consensus 486 RPs~~ 490 (518)
||++.
T Consensus 238 R~~~~ 242 (323)
T cd05575 238 RLGAK 242 (323)
T ss_pred CCCCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=317.87 Aligned_cols=248 Identities=32% Similarity=0.530 Sum_probs=211.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.+.||.|+||.||++... ++.+++|++...... ....+.+|+.++++++||||+++++++.....+|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 45666999999999999999964 578999999865433 45788899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+++++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 999999999998755679999999999999999999999999999999999999999999999999987644322 2233
Q ss_pred CCCCCcccChhhhcCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHHHHHH
Q 010091 402 ETGTYRWMAPEVIEHQ---PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI---PVHTHPILVDLL 475 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~---~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~---~~~~~~~L~~Li 475 (518)
..++..|+|||.+.+. .++.++|+||||+++|+|++|..||...++.+.........+.+.. +...+.++.+++
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence 4688899999999776 8899999999999999999999999988766655444443333222 234567899999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~ 494 (518)
.+||..+|.+|||+++++.
T Consensus 241 ~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 241 KKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHcCCChhhCCCHHHHhc
Confidence 9999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=323.47 Aligned_cols=255 Identities=29% Similarity=0.547 Sum_probs=212.9
Q ss_pred eccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
++.++|++.+.||.|+||.||++... +..||+|++.... +......|.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 34566777999999999999999863 4679999987543 344457799999999999999999999999999
Q ss_pred CceeEEEeeccCCcccccccccc---------------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK---------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~---------------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~N 373 (518)
...|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986422 246788899999999999999999999999999999
Q ss_pred EEeccCCcEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 010091 374 LLMNENGVVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQ 449 (518)
Q Consensus 374 ILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~ 449 (518)
|+++.++.++|+|||.+....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987543221 1112335677999999988899999999999999999998 888998777665
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 450 AAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 450 ~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
.... +..+.....+..++.++.+++.+||+.+|.+|||+.|++..|++
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYY-VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHH-HhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 4443 33333344566788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=314.03 Aligned_cols=247 Identities=26% Similarity=0.463 Sum_probs=211.7
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec-CCceeEEEee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PPRLFIVTEF 323 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lV~Ey 323 (518)
|++.+.||.|++|.||+++.. ++.||+|.+............+.+|+.++++++|+|++++++.+.. ...+|++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 566999999999999999864 6789999998766555566788999999999999999999988764 4468999999
Q ss_pred ccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 324 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
+++++|.+++.... ..+++.+++.++.|++.|+.+||++|++||||||+||+++.++.++|+|||++....... ....
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST 161 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcccc
Confidence 99999999997643 358999999999999999999999999999999999999999999999999997654322 2233
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+....... ...+..+..+...++.+.+++.+||+.
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR-IIEGKLPPMPKDYSPELGELIATMLSK 240 (257)
T ss_pred ccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHhcCCCCCccccCHHHHHHHHHHhcc
Confidence 4588999999999999999999999999999999999999987765544333 333455566777889999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
+|.+||++.+++.
T Consensus 241 ~p~~Rp~~~~~l~ 253 (257)
T cd08223 241 RPEKRPSVKSILR 253 (257)
T ss_pred CcccCCCHHHHhc
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=335.08 Aligned_cols=238 Identities=24% Similarity=0.416 Sum_probs=198.7
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHH-HHHhhcCCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEV-HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~-~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||++++. ++.||+|++....... .....+..|. .+++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999975 5779999998643221 2223444444 456788999999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc-cCccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ-YGVMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~gt 405 (518)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 999999976 45688899999999999999999999999999999999999999999999999875322 2223335699
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ....+..+++.+.++|.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999999999999999999999999999999988776655554433 23345578899999999999999999
Q ss_pred CCCHHH
Q 010091 486 RPDFSE 491 (518)
Q Consensus 486 RPs~~e 491 (518)
||++.+
T Consensus 238 R~~~~~ 243 (325)
T cd05602 238 RLGAKD 243 (325)
T ss_pred CCCCCC
Confidence 998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=325.79 Aligned_cols=254 Identities=28% Similarity=0.517 Sum_probs=208.0
Q ss_pred ccccceeeeEEeEecceEEEEEEECC----------------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceee
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFFS----------------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~----------------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~ 306 (518)
...+|++.++||+|+||.||+++..+ ..||+|.++... .......|.+|+.++++++|+||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 34567779999999999999987532 248999987653 3445578999999999999999999
Q ss_pred EeeeeecCCceeEEEeeccCCcccccccccc-----------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEE
Q 010091 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-----------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375 (518)
Q Consensus 307 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NIL 375 (518)
+++++......|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999985422 13678889999999999999999999999999999999
Q ss_pred eccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCHHHH
Q 010091 376 MNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT--GKLPYDDLTPLQA 450 (518)
Q Consensus 376 l~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt--G~~P~~~~~~~~~ 450 (518)
++.++.+||+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999875432211 122335678999999988889999999999999999998 6789987766554
Q ss_pred HHHHHh------cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 451 AVGVVQ------KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 451 ~~~~~~------~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
...... .......+..+++.+.+++.+||+.+|.+||++.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 433221 11123334557889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=322.89 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=207.7
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
|+..+.||+|+||.||++++. ++.||+|++....... .....+.+|+.++++++|+||+.+++++...+..|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 455889999999999999975 6889999997654332 2345678899999999999999999999999999999999
Q ss_pred ccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
+++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 99999998886533 36899999999999999999999999999999999999999999999999999765433333345
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ--KGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
.|+..|+|||++.+..++.++|+||||+++|+|++|..||.............. .......+...++.+.+++.+||+
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 241 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHcc
Confidence 689999999999888999999999999999999999999987665433222221 122334556788899999999999
Q ss_pred hCCCCCCC-----HHHHHH
Q 010091 481 RDPSLRPD-----FSEITE 494 (518)
Q Consensus 481 ~dP~~RPs-----~~eil~ 494 (518)
.||.+||+ +.+++.
T Consensus 242 ~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 242 KDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCHhHcCCCcccChHHHHc
Confidence 99999999 666655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=317.77 Aligned_cols=246 Identities=30% Similarity=0.562 Sum_probs=210.5
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-------HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-------NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-------~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
|.+.+.||.|++|.||+|... ++.||+|.+....... .....+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 344889999999999999864 6889999987653322 2346788999999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.++......
T Consensus 82 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred EEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 999999999999999976 3568899999999999999999999999999999999999999999999999987654211
Q ss_pred -------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 398 -------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 398 -------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..... .....+..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI-GENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH-hccCCCcCCcccCHH
Confidence 111234788999999998888999999999999999999999999887665544433 235567778888999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+.++|.+||+.+|.+||++.++++
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhh
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.23 Aligned_cols=237 Identities=24% Similarity=0.414 Sum_probs=197.5
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||+++.. ++.||+|+++..... ......+..|+.++.++ +||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 678999999875433 23446678899988877 799999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt 405 (518)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ......||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 999988876 4578999999999999999999999999999999999999999999999999987532222 22335689
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT--------PLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~--------~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
+.|+|||++.+..++.++|+|||||++|+|++|..||.... .......... .....+|...+..+.++|.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~ll~~ 238 (329)
T cd05618 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKAASVLKS 238 (329)
T ss_pred ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999995311 1111112121 23455777889999999999
Q ss_pred hhhhCCCCCCCH
Q 010091 478 CWQRDPSLRPDF 489 (518)
Q Consensus 478 cL~~dP~~RPs~ 489 (518)
||+.||.+||++
T Consensus 239 ~L~~dP~~R~~~ 250 (329)
T cd05618 239 FLNKDPKERLGC 250 (329)
T ss_pred HhcCCHHHcCCC
Confidence 999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=324.08 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=207.2
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
|+..+.||+|+||.||++.+. ++.||+|.+....... .....+.+|+.++++++|+||+.+++.+......|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 556889999999999999975 6789999987654332 2345678899999999999999999999999999999999
Q ss_pred ccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
++|++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence 99999999986433 35889999999999999999999999999999999999999999999999999765433333345
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL---QAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
.|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ..... .........+..+++++.+++.+||
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l 240 (285)
T cd05630 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-LVKEVQEEYSEKFSPDARSLCKMLL 240 (285)
T ss_pred CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh-hhhhhhhhcCccCCHHHHHHHHHHh
Confidence 6899999999999999999999999999999999999999865432 11111 1122334456678899999999999
Q ss_pred hhCCCCCCC-----HHHHHH
Q 010091 480 QRDPSLRPD-----FSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs-----~~eil~ 494 (518)
+.||.+||| ++|+++
T Consensus 241 ~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 241 CKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCHHHccCCCCCchHHHHc
Confidence 999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=334.31 Aligned_cols=248 Identities=24% Similarity=0.315 Sum_probs=203.0
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC------C
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------P 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~------~ 315 (518)
..+|++.+.||+|+||.||++... ++.||+|++.....+......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 356777999999999999999864 78899999987665555667888999999999999999999987543 3
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..|+||||+++ +|.+++.. .++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 57999999964 67776643 478889999999999999999999999999999999999999999999999987655
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL---------------- 459 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~---------------- 459 (518)
........||..|+|||++.+..++.++|||||||++|+|++|+.||.+....+.....+..-.
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 4444456789999999999999999999999999999999999999987665443322211000
Q ss_pred ----C--------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 460 ----R--------------------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 460 ----~--------------------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
. ...+...+..+.++|.+||+.||.+|||+.|++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 00111234678999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=320.02 Aligned_cols=253 Identities=29% Similarity=0.517 Sum_probs=206.1
Q ss_pred ccceeeeEEeEecceEEEEEEE------CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--CCc
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPR 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~------~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--~~~ 316 (518)
..|++.+.||+|+||.||++.+ .+..||+|.+... .......|.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 3566799999999999999985 2578999998754 33445788999999999999999999997643 456
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|+||||+++++|.+++.+....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 89999999999999999775567899999999999999999999999999999999999999999999999999865432
Q ss_pred Ccc----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHHhc
Q 010091 397 GVM----TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL---------------QAAVGVVQK 457 (518)
Q Consensus 397 ~~~----~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~---------------~~~~~~~~~ 457 (518)
... ....++..|+|||++.+..++.++|+||||+++|||++|..|+...... ......+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 211 1122345699999998888999999999999999999987765432110 011122333
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 458 GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 458 ~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
......+..++.++.+++.+||+.+|.+|||+.+++..|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 344455567889999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=323.76 Aligned_cols=252 Identities=32% Similarity=0.558 Sum_probs=209.0
Q ss_pred ccceeeeEEeEecceEEEEEEECC------------------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFFS------------------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~~------------------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~ 306 (518)
.+|.+.++||+|+||.||+++..+ ..||+|.+.... .......|.+|+.++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 456669999999999999988642 348999988654 3345678999999999999999999
Q ss_pred EeeeeecCCceeEEEeeccCCcccccccccc----------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe
Q 010091 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQK----------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376 (518)
Q Consensus 307 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl 376 (518)
+++++...+..+++|||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999999987633 258899999999999999999999999999999999999
Q ss_pred ccCCcEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCHHHHH
Q 010091 377 NENGVVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT--GKLPYDDLTPLQAA 451 (518)
Q Consensus 377 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt--G~~P~~~~~~~~~~ 451 (518)
+.++.++|+|||.++...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 999999999999987543322 1122346788999999988889999999999999999998 77899877665544
Q ss_pred HHHHhc------CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 452 VGVVQK------GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 452 ~~~~~~------~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
...... ......+..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 333221 1112234456789999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=316.05 Aligned_cols=249 Identities=30% Similarity=0.564 Sum_probs=205.4
Q ss_pred eEEeEecceEEEEEEEC-----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee-cCCceeEEEeec
Q 010091 251 HKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT-RPPRLFIVTEFM 324 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lV~Ey~ 324 (518)
+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.+++.++||||+++++++. .+...|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 35899999999999853 2469999876432 3334578889999999999999999999765 455689999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-----cc
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-----VM 399 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-----~~ 399 (518)
.+++|.+++.+....+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++...... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 9999999998755567788889999999999999999999999999999999999999999999997543211 11
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
....++..|+|||.+.+..++.++||||||+++|||++ |..||......+... .+..+..+..+..+++.+.+++.+|
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV-YLLQGRRLLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhcCCCCCCCCcCCHHHHHHHHHH
Confidence 12345778999999988889999999999999999999 567787766555443 3334445555667788999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHH
Q 010091 479 WQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 479 L~~dP~~RPs~~eil~~L~~l~~ 501 (518)
|+.+|.+||++.+++..|+++..
T Consensus 239 l~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 239 WHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCCChhhCCCHHHHHHHHHHHhc
Confidence 99999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=335.00 Aligned_cols=247 Identities=25% Similarity=0.327 Sum_probs=203.8
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC------C
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------P 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~------~ 315 (518)
..+|++.+.||+|+||.||++... ++.||||++.....+......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 356777999999999999999864 68899999987655555567888999999999999999999987543 3
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..|+||||++ ++|.+++.. .++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 5799999995 477777643 478889999999999999999999999999999999999999999999999987655
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL---------------- 459 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~---------------- 459 (518)
........+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....++..-.
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 4444456789999999999999999999999999999999999999988766554433322100
Q ss_pred ----CCC--------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 ----RPT--------------------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ----~p~--------------------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++. .....+..+.++|.+||+.||.+|||+.+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 01112457899999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=321.01 Aligned_cols=247 Identities=28% Similarity=0.462 Sum_probs=204.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.+.||+|+||.||+|+.. ++.||+|++...... ....+.+|+.++++++||||+++++++......|+||||
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 4555999999999999999964 678999999765322 235678899999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... .....
T Consensus 88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06646 88 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166 (267)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCcc
Confidence 999999999876 4578999999999999999999999999999999999999999999999999997653321 12334
Q ss_pred CCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHHHHHHH
Q 010091 403 TGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI---PVHTHPILVDLLE 476 (518)
Q Consensus 403 ~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~---~~~~~~~L~~Li~ 476 (518)
.++..|+|||.+. ...++.++|+||||+++|+|++|..||....+.+.........+.+.. ...++..+.++|.
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHH
Confidence 5889999999884 445788999999999999999999999776655443322222232222 2346789999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~~ 495 (518)
+||+.+|.+||+++++++.
T Consensus 247 ~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 247 ISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHhhCChhhCcCHHHHhcC
Confidence 9999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=322.81 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=199.0
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc---CCCceeeEeeeeec-----CCc
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV---RHMNVVQFIGACTR-----PPR 316 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~~~~~~-----~~~ 316 (518)
|.+.+.||+|+||.||+|+.. ++.||+|.++.....+.....+.+|+.+++++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 666999999999999999965 68899999886543333334556677777765 79999999998754 345
Q ss_pred eeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.++||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 899999996 48888887643 3589999999999999999999999999999999999999999999999999986654
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----------------
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG----------------- 458 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~----------------- 458 (518)
........||..|+|||++.+..++.++|||||||++|+|++|..||......+....+....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG 240 (288)
T ss_pred cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccccc
Confidence 433344568999999999988889999999999999999999999998776654443332210
Q ss_pred -CCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 -LRP-------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 -~~p-------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+.+ .....++..+.+++.+||+.||.+|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 241 AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 011245678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=313.90 Aligned_cols=247 Identities=34% Similarity=0.586 Sum_probs=213.7
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc---CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~---~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
|+..+.||+|++|.||+|... ++.|++|.+..... .......+.+|+.++++++|+||+++++++......|++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 445789999999999999974 78899999876432 2345578999999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
||+++++|.+++.+ ...+++..++.++.||+.|+.|||+.|++|+||+|+||+++.++.+||+|||.+...........
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 82 ELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 99999999999976 34688999999999999999999999999999999999999999999999999987554433344
Q ss_pred CCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 402 ETGTYRWMAPEVIEHQP-YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~-~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
..++..|++||.+.+.. ++.++|+||||+++|+|++|..||....+.+...........+.++..+++.+.+++.+||+
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 240 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence 56889999999987766 89999999999999999999999988776555555444345666777889999999999999
Q ss_pred hCCCCCCCHHHHHH
Q 010091 481 RDPSLRPDFSEITE 494 (518)
Q Consensus 481 ~dP~~RPs~~eil~ 494 (518)
.+|.+||++.+++.
T Consensus 241 ~~p~~Rp~~~~~l~ 254 (258)
T cd06632 241 RDPSLRPTAAELLE 254 (258)
T ss_pred cCcccCcCHHHHhc
Confidence 99999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=331.15 Aligned_cols=250 Identities=18% Similarity=0.299 Sum_probs=206.4
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|++.+.||+|+||.||+++.. ++.||+|++..... .......|.+|+.+++.++|+||+++++++.....+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 5677999999999999999965 68899999975322 22334678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--cc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--MT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~ 400 (518)
|++|++|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccc
Confidence 9999999999977566789999999999999999999999999999999999999999999999999876443222 12
Q ss_pred cCCCCCcccChhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHHH
Q 010091 401 AETGTYRWMAPEVIEH-----QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI---PVHTHPILV 472 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~-----~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~---~~~~~~~L~ 472 (518)
...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+........+ ...+++.+.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 241 (331)
T cd05597 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK 241 (331)
T ss_pred ceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHH
Confidence 2458999999999863 45788999999999999999999999887776665555443322222 234688999
Q ss_pred HHHHHhhhhCCC--CCCCHHHHHHH
Q 010091 473 DLLERCWQRDPS--LRPDFSEITEL 495 (518)
Q Consensus 473 ~Li~~cL~~dP~--~RPs~~eil~~ 495 (518)
++|.+|+..++. .|+++++++..
T Consensus 242 ~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 242 DLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHccCcccccCCCCHHHHhcC
Confidence 999998865443 36888888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.11 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=197.1
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec-------
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------- 313 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~------- 313 (518)
....|++.++||+|+||.||+|... ++.||||++.... ....+|+.++++++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3456788999999999999999964 6889999886432 233469999999999999999887632
Q ss_pred -CCceeEEEeeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-cEEEeeec
Q 010091 314 -PPRLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFG 388 (518)
Q Consensus 314 -~~~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-~vkL~DFG 388 (518)
...+++||||+++ +|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 1246799999964 77777642 345689999999999999999999999999999999999998664 79999999
Q ss_pred cceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---------
Q 010091 389 VARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG--------- 458 (518)
Q Consensus 389 ~a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~--------- 458 (518)
+++............||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+++..
T Consensus 217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 9986544333344568999999999865 468999999999999999999999998877655544433211
Q ss_pred ------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 ------------------LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 ------------------~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+...+|...++++.+||.+||+.||.+|||+.|++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 111234456788999999999999999999999974
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=330.14 Aligned_cols=240 Identities=25% Similarity=0.415 Sum_probs=204.6
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEEe
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 322 (518)
|.+.+.||+|+||.||++... ++.||+|+++.... .+.....+..|..+++.+. |++|+++++++.....+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 567899999999999999875 67899999986532 2233467788999998886 5778889999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-ccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~ 401 (518)
|++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 82 y~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 82 YVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 9999999999876 45699999999999999999999999999999999999999999999999999875332221 223
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..||+.|+|||++.+..++.++|+|||||++|+|++|..||......+....+... ....|...+.++.+++.+||+.
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHccc
Confidence 45899999999999999999999999999999999999999988876666555543 3456677889999999999999
Q ss_pred CCCCCCCH
Q 010091 482 DPSLRPDF 489 (518)
Q Consensus 482 dP~~RPs~ 489 (518)
+|.+|++.
T Consensus 239 ~p~~R~~~ 246 (323)
T cd05615 239 HPSKRLGC 246 (323)
T ss_pred CHhhCCCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.16 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=206.0
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|++.+.||+|+||.||+++.. ++.||+|+++.... .......+.+|+.++.+++|+||+++++.+.....+|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4666999999999999999974 68899999986432 23345778889999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-----
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG----- 397 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~----- 397 (518)
|++|++|.+++.+ ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 82 FLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred CCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999976 4568999999999999999999999999999999999999999999999999986432110
Q ss_pred -------------------------------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 010091 398 -------------------------------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446 (518)
Q Consensus 398 -------------------------------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~ 446 (518)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 0112358999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 010091 447 PLQAAVGVVQKGLRPTIPV--HTHPILVDLLERCWQRDPSLRPD---FSEITE 494 (518)
Q Consensus 447 ~~~~~~~~~~~~~~p~~~~--~~~~~L~~Li~~cL~~dP~~RPs---~~eil~ 494 (518)
+......+........+|. .+++++.++|.+|+ .||.+|++ +.+++.
T Consensus 241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 7776655554322222332 36889999999977 49999975 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=314.10 Aligned_cols=248 Identities=25% Similarity=0.423 Sum_probs=214.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|.+.+.||+|+||.||++... ++.+|+|.+.....+......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 3667999999999999998864 68899999987666666678899999999999999999999999999999999999
Q ss_pred ccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-CcEEEeeeccceeccccCcccc
Q 010091 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 324 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
+++++|.+++.... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.+ +.+||+|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 99999999997643 358899999999999999999999999999999999999855 4689999999987654433334
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......... .....++..+++++.+++.+||+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHHHccC
Confidence 5688999999999988899999999999999999999999988766554444333 344556677889999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
+|.+|||+.|++.
T Consensus 240 ~p~~Rpt~~~ll~ 252 (256)
T cd08220 240 DPSKRPQLSQIMA 252 (256)
T ss_pred ChhhCCCHHHHhh
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=335.52 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=202.5
Q ss_pred ceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC-----ceeE
Q 010091 247 LKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-----RLFI 319 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~l 319 (518)
|.+.++||+|+||.||++.. .++.||||.+.....+......+.+|+.+++.++|+||+++++++.... ..|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 55689999999999999996 4789999998765444444577889999999999999999999987766 7899
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC--
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-- 397 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-- 397 (518)
||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 v~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 82 VTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred Eeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 999995 578887765 4578999999999999999999999999999999999999999999999999998654322
Q ss_pred ccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------------------
Q 010091 398 VMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ-------------------- 456 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~-------------------- 456 (518)
..+...++..|+|||++.+. .++.++|||||||++|||++|+.||...++.+....+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 23334678999999998764 579999999999999999999999987766544332221
Q ss_pred ---cCCCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 457 ---KGLRP-------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 457 ---~~~~p-------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....+ ......++++.++|.+||+.||.+|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 01111 122345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.66 Aligned_cols=236 Identities=25% Similarity=0.397 Sum_probs=198.3
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHH-HHhhcCCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVH-IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
++||+|+||.||+++.. ++.||+|++...... ......+..|.. +++.++||||+++++++......|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999974 688999999865332 223345555554 67889999999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt 405 (518)
++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .......||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 999988866 456889999999999999999999999999999999999999999999999998753222 222334589
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...++...+..+.+++.+||+.||.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999889999999999999999999999999887766555444432 34566678889999999999999999
Q ss_pred CCCH
Q 010091 486 RPDF 489 (518)
Q Consensus 486 RPs~ 489 (518)
||++
T Consensus 238 R~~~ 241 (321)
T cd05603 238 RLGA 241 (321)
T ss_pred cCCC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.50 Aligned_cols=256 Identities=30% Similarity=0.526 Sum_probs=227.5
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
+..-|....+++.++||+|+||.|++|.|+. -.||||+++...... ....|++|+.+|.+|+|+|++++||...
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 4556777788889999999999999999973 359999999876654 5589999999999999999999999887
Q ss_pred cCCceeEEEeeccCCcccccccc-ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~-~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
. ..+.+|||++++|||.+.|++ ....|-...+..++.||+.||.||.+++.|||||...|+|+-....|||+|||+.+
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence 7 678999999999999999988 44568888999999999999999999999999999999999999999999999999
Q ss_pred eccccCccccC----CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010091 392 VQAQYGVMTAE----TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466 (518)
Q Consensus 392 ~~~~~~~~~~~----~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~ 466 (518)
-......+... .-.+.|||||.+++..++.++|||+||+++|||+| |..||.+....+.+..+- .+-+...|..
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~ 339 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKY 339 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCC
Confidence 77665543322 24678999999999999999999999999999999 999999999998886644 6778888999
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~~L 496 (518)
|+.++++++.+||..+|.+||||..|.+.+
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 999999999999999999999999997543
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=321.58 Aligned_cols=254 Identities=28% Similarity=0.503 Sum_probs=209.1
Q ss_pred ccceeeeEEeEecceEEEEEEE------CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--Cc
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PR 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~------~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~ 316 (518)
..|++.+.||+|+||.||++++ .+..||+|.++... .......|.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4467799999999999999974 25779999987653 334457899999999999999999999988764 56
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.++||||++|++|.+++.+....+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999999775556899999999999999999999999999999999999999999999999999764432
Q ss_pred Cc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------------CHHHHHHHHHhcC
Q 010091 397 GV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL--------------TPLQAAVGVVQKG 458 (518)
Q Consensus 397 ~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~--------------~~~~~~~~~~~~~ 458 (518)
.. .....++..|+|||.+.+..++.++||||||+++|+|+++..|+... ............+
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 21 11234677899999998888999999999999999999977654221 1112222233334
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 459 LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 459 ~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
.....+..++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 44555667889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=355.30 Aligned_cols=258 Identities=23% Similarity=0.413 Sum_probs=216.0
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC-C-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeee-ec
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-S-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGAC-TR 313 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~-~~ 313 (518)
...+|....+++.+.|++|+|+.||+++.. + ..||+|.+-.. ++...+...+|+.+|++|+ |+|||.+++.. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 357888999999999999999999999975 3 79999998876 6777789999999999996 99999999942 11
Q ss_pred ------CCceeEEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEeccCCcEEE
Q 010091 314 ------PPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVVKV 384 (518)
Q Consensus 314 ------~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~~~~~vkL 384 (518)
....+|+||||.||+|-|+|.++ ...|++.++++|+.|+|+|+.+||... |||||||-+||||+.+|..||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 13568999999999999999853 235999999999999999999999998 999999999999999999999
Q ss_pred eeeccceeccccCccc----------cCCCCCcccChhhh---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010091 385 ADFGVARVQAQYGVMT----------AETGTYRWMAPEVI---EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA 451 (518)
Q Consensus 385 ~DFG~a~~~~~~~~~~----------~~~gt~~y~APE~l---~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~ 451 (518)
||||.+.......... ....|+.|+|||++ .+.++++|+|||+|||+||-||....||++.-.....
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl 267 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL 267 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE
Confidence 9999997533322110 12368999999988 6888999999999999999999999999876443332
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 452 VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 452 ~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
...+.-+....++..+.+||..||+.||.+||++-+++..+-.+..
T Consensus 268 ----ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 268 ----NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ----eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 2233322224678899999999999999999999999998888754
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.73 Aligned_cols=247 Identities=31% Similarity=0.570 Sum_probs=210.4
Q ss_pred ceeeeEEeEecceEEEEEEE-CCccEEEEEEeccccC----HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLN----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~-~~~~vAvKvl~~~~~~----~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
|+..+.||.|+||.||+|.. .++.+|+|.++..... ......+.+|+.++++++|+||+++++++......|++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 44488999999999999986 4788999998765322 233467889999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-----
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY----- 396 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~----- 396 (518)
||++|++|.+++.+ ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||.+......
T Consensus 82 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 82 EFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 99999999999976 346889999999999999999999999999999999999999999999999998754221
Q ss_pred --CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCcHHHHH
Q 010091 397 --GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK-GLRPTIPVHTHPILVD 473 (518)
Q Consensus 397 --~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~L~~ 473 (518)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+........... ...+..+..++.++.+
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAID 240 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHH
Confidence 1122345889999999999888999999999999999999999999887665544333322 3456677788999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~ 494 (518)
+|.+||+.+|.+||++.+++.
T Consensus 241 ~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 241 FVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=312.00 Aligned_cols=252 Identities=21% Similarity=0.419 Sum_probs=222.0
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
..|.| ++|.+++.||.|.||.||+|+.. +--||+|++....... .....+.+|+.|...|+||||+++|++|.+.
T Consensus 17 ~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 44555 45666999999999999999976 4569999998765432 3347788999999999999999999999999
Q ss_pred CceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
...|+++||..+|+|+..|.... ..+++.....++.|++.|+.|+|.++||||||||+|+|++..|.+||+|||.+-..
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999998543 46999999999999999999999999999999999999999999999999999766
Q ss_pred cccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 394 AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
. .+...+.+||..|.+||...+..++.+.|+|++|++.||++.|..||...+..+.+..+.. .+..+|..++.+..+
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--VDLKFPSTISGGAAD 251 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--ccccCCcccChhHHH
Confidence 5 4555668899999999999999999999999999999999999999999887666666554 455677889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~ 494 (518)
+|.+|+..+|.+|.+..|+++
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHHHHhccCccccccHHHHhh
Confidence 999999999999999888865
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.02 Aligned_cols=237 Identities=23% Similarity=0.391 Sum_probs=199.2
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||++... ++.||+|+++..... +.....+..|+.++.++ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 578999999876433 33456788999999988 699999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt 405 (518)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 999998876 446999999999999999999999999999999999999999999999999998753222 223335689
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL------TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~------~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
+.|+|||++.+..++.++||||||+++|+|++|..||... ...+....... .....+|...+..+.+++.+||
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~~L 238 (327)
T cd05617 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIPRFLSVKASHVLKGFL 238 (327)
T ss_pred cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-hCCCCCCCCCCHHHHHHHHHHh
Confidence 9999999999999999999999999999999999999632 22222222222 2344567778999999999999
Q ss_pred hhCCCCCCCH
Q 010091 480 QRDPSLRPDF 489 (518)
Q Consensus 480 ~~dP~~RPs~ 489 (518)
+.||.+|+++
T Consensus 239 ~~dP~~R~~~ 248 (327)
T cd05617 239 NKDPKERLGC 248 (327)
T ss_pred ccCHHHcCCC
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.55 Aligned_cols=247 Identities=25% Similarity=0.454 Sum_probs=213.8
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee--cCCceeEEEe
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT--RPPRLFIVTE 322 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lV~E 322 (518)
|.+.+.||.|+||.||++... ++.||+|++............+..|+.++++++|+||+++++++. .....|++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 566899999999999999864 688999999877666666688999999999999999999999775 3456899999
Q ss_pred eccCCccccccccc---cCCCChHHHHHHHHHhHHHHHHHH-----HCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 323 FMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLH-----RNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 323 y~~ggsL~~~l~~~---~~~l~~~~i~~i~~ql~~gL~yLH-----~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
|+++++|.+++... ...+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999998653 456899999999999999999999 8999999999999999999999999999998765
Q ss_pred ccCc-cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 395 QYGV-MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 395 ~~~~-~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......+ ....+..+..+.++...+..+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd08217 162 HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-LASKIKEGKFRRIPYRYSSELNE 240 (265)
T ss_pred CCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-HHHHHhcCCCCCCccccCHHHHH
Confidence 4332 233468999999999988889999999999999999999999998876433 33445555566777888999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~ 494 (518)
++.+||+.+|.+||++.+|++
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHccCCcccCCCHHHHhh
Confidence 999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.58 Aligned_cols=249 Identities=18% Similarity=0.318 Sum_probs=207.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|++.+.||+|+||.||+++.. ++.||+|++..... .......+.+|..+++.++|+||+++++++...+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5677999999999999999975 57899999875322 22334668889999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc--c
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM--T 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~ 400 (518)
|++||+|.+++.+....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......... .
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 161 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeec
Confidence 99999999999875567899999999999999999999999999999999999999999999999999765443222 2
Q ss_pred cCCCCCcccChhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCcHHHH
Q 010091 401 AETGTYRWMAPEVIEH-----QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP---VHTHPILV 472 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~-----~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~---~~~~~~L~ 472 (518)
...||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||......+....+.....+..++ ..+++++.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~ 241 (331)
T cd05624 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAK 241 (331)
T ss_pred cccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHH
Confidence 2458999999999865 567899999999999999999999999887766665555444333333 34588999
Q ss_pred HHHHHhhhhCCCC--CCCHHHHHH
Q 010091 473 DLLERCWQRDPSL--RPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~--RPs~~eil~ 494 (518)
+++.+||..++.+ |+++++++.
T Consensus 242 ~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 242 DLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHHccCchhhcCCCCHHHHhc
Confidence 9999999876654 367887765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.35 Aligned_cols=237 Identities=24% Similarity=0.394 Sum_probs=199.2
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHH-HHhhcCCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVH-IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||+++.. |+.||+|++...... ......+..|.. +++.++||||+++++++......|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999864 788999999765322 223355556654 56779999999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc-cCccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ-YGVMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~gt 405 (518)
++|..++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 999998876 45789999999999999999999999999999999999999999999999999875322 2223334689
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
+.|+|||++.+..++.++|||||||++|+|++|..||...+..+......... ...+...+..+.++|.+||+.+|.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--LVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhccCHHh
Confidence 99999999999999999999999999999999999999887766555544332 3344567889999999999999999
Q ss_pred CCCHH
Q 010091 486 RPDFS 490 (518)
Q Consensus 486 RPs~~ 490 (518)
||++.
T Consensus 238 R~~~~ 242 (325)
T cd05604 238 RLGAK 242 (325)
T ss_pred cCCCC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=325.34 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=202.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|.+.++||+|+||.||+|+.. ++.||+|+++..... .....+.+|+.++++++||||+++++++......|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 34566999999999999999865 678999999865432 223467789999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+++ +|.+++......++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 9964 8888887766668999999999999999999999999999999999999999999999999997643322 2233
Q ss_pred CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------------------CC
Q 010091 402 ETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK---------------------GL 459 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~---------------------~~ 459 (518)
..++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+........ ..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 457899999998854 56899999999999999999999999876654433222210 00
Q ss_pred CCC-------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 RPT-------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ~p~-------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
... ....+++++.++|.+||+.||.+|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 11246788999999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.92 Aligned_cols=252 Identities=29% Similarity=0.535 Sum_probs=206.1
Q ss_pred ccceeeeEEeEecceEEEEEEEC------------------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF------------------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~------------------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~ 306 (518)
++|++.++||+|+||.||++.+. +..||+|+++... .......|.+|+.++++++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 45677999999999999998643 2358999987543 3444578999999999999999999
Q ss_pred EeeeeecCCceeEEEeeccCCcccccccccc----------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe
Q 010091 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQK----------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376 (518)
Q Consensus 307 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl 376 (518)
+++++......|+||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999986532 236677899999999999999999999999999999999
Q ss_pred ccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCHHHHH
Q 010091 377 NENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT--GKLPYDDLTPLQAA 451 (518)
Q Consensus 377 ~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt--G~~P~~~~~~~~~~ 451 (518)
+.++.++|+|||+++....... .....++..|++||...+..++.++|+|||||++|||++ |..||...+..+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 9999999999999875432211 111234678999999888889999999999999999998 78999877665543
Q ss_pred HHHHh------cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 452 VGVVQ------KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 452 ~~~~~------~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
..... .......+..+++.+.+++.+||+.||.+||++.+|++.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 244 ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 32211 11122334567889999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.60 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=202.6
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|++.+.||+|++|.||+|+.. ++.||+|+++....++.....+.+|+.++++++||||+++++++..+...|+||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 566899999999999999974 788999999765444444567888999999999999999999999999999999999
Q ss_pred cCCcccccccccc--CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 325 SGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 325 ~ggsL~~~l~~~~--~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
+ ++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence 6 58888876433 468999999999999999999999999999999999999999999999999997544322 2233
Q ss_pred CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------------
Q 010091 402 ETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG---------------------- 458 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~---------------------- 458 (518)
..++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+............
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP 240 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcc
Confidence 457889999998865 457899999999999999999999998766544332221110
Q ss_pred -----CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 -----LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 -----~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
........+++++.++|.+||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000112346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=321.98 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=209.7
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee--cCCceeEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT--RPPRLFIV 320 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lV 320 (518)
++|...++|++|+||.||+|+++ ++-||+|.++.+...+...-..++|+.+|.+++|||||.+-.+.. .-+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34555999999999999999976 678999999987655544456789999999999999999988764 34569999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-Ccc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVM 399 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~ 399 (518)
||||+. +|...++..+.++...++..++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+..+.. ..+
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 999965 898999887778999999999999999999999999999999999999999999999999999987665 346
Q ss_pred ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--------------------
Q 010091 400 TAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG-------------------- 458 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~-------------------- 458 (518)
|....|..|.|||++.+ ..|++..|+||+|||+.||+++++.|.+.+.......+++.-
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 76778999999998855 569999999999999999999999999887776666554321
Q ss_pred ---------CCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 ---------LRPTIPVH-THPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 ---------~~p~~~~~-~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++..++.. .+..-.+|+..+|..||.+|.|++|.++
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11112222 4567889999999999999999998764
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=314.37 Aligned_cols=246 Identities=33% Similarity=0.549 Sum_probs=209.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|++.++||+|+||.||+|... ++.+++|.++.... ...+.+|+.++++++|+||+++++++......|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 45666999999999999999975 58899999876422 5789999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+++++|.+++......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 999999999998766678999999999999999999999999999999999999999999999999987654432 2223
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~~cL~ 480 (518)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||....+.+.......... ....+..++..+.+++.+||+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV 238 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHh
Confidence 4588899999999988999999999999999999999999988766554433222111 112234567889999999999
Q ss_pred hCCCCCCCHHHHHH
Q 010091 481 RDPSLRPDFSEITE 494 (518)
Q Consensus 481 ~dP~~RPs~~eil~ 494 (518)
.+|.+|||+++++.
T Consensus 239 ~~P~~Rps~~~il~ 252 (256)
T cd06612 239 KDPEERPSAIQLLQ 252 (256)
T ss_pred cChhhCcCHHHHhc
Confidence 99999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=330.19 Aligned_cols=250 Identities=18% Similarity=0.318 Sum_probs=208.2
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|++.++||+|+||.||+++.. ++.||+|++..... .......|..|+.++..++|+||+++++++.....+|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5677999999999999999975 57799999875322 22233568889999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--cc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--MT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~ 400 (518)
|+++|+|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~ 161 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 161 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceec
Confidence 9999999999987556789999999999999999999999999999999999999999999999999875433222 22
Q ss_pred cCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCcHHHH
Q 010091 401 AETGTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP---VHTHPILV 472 (518)
Q Consensus 401 ~~~gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~---~~~~~~L~ 472 (518)
...||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....+..++ ..+++++.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~ 241 (332)
T cd05623 162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAK 241 (332)
T ss_pred ccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHH
Confidence 346899999999985 3568899999999999999999999999888777766655443333333 45789999
Q ss_pred HHHHHhhhhCCCC--CCCHHHHHHH
Q 010091 473 DLLERCWQRDPSL--RPDFSEITEL 495 (518)
Q Consensus 473 ~Li~~cL~~dP~~--RPs~~eil~~ 495 (518)
+++.+|+..++.+ |+++.++++.
T Consensus 242 ~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 242 DLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHccChhhhcCCCCHHHHhCC
Confidence 9999999665544 5889888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.92 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=209.4
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
...+.|++.++||.|+||.||+|+.. ++.|++|++... +......+.+|+.++++++|+||+++++.+......|+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 33455666999999999999999965 688999998754 34445788899999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-Cc
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GV 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~ 398 (518)
||||+++++|..++.+....+++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 99999999998888765667899999999999999999999999999999999999999999999999998653322 12
Q ss_pred cccCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHH
Q 010091 399 MTAETGTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--TIPVHTHPIL 471 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~L 471 (518)
.....++..|+|||++. ...++.++|+||||+++|+|++|..||...++.+....... ...+ ..+..++.++
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 245 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLSQPSKWSMEF 245 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc-CCCccCCCCcccCHHH
Confidence 23345889999999884 45578899999999999999999999988776555444332 2222 2345677899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.++|.+||+.+|.+||+++++++
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 246 RDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHhcCCcccCcCHHHHhc
Confidence 99999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=311.58 Aligned_cols=245 Identities=36% Similarity=0.668 Sum_probs=209.4
Q ss_pred eEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 251 HKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
++||.|+||.||++.+. ++.||+|.++..... .....|.+|+.++++++|+||+++++++......|+||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36899999999999976 789999998876443 3457899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc---ccCCCCC
Q 010091 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM---TAETGTY 406 (518)
Q Consensus 330 ~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt~ 406 (518)
.+++.+....++...++.++.+++.|+.|||++|++||||||+||+++.++.++|+|||.+......... ....++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 9999775567889999999999999999999999999999999999999999999999999754321111 1122356
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
.|+|||.+.+..++.++|+||||+++|+|++ |..||........... +........+...+..+.+++.+||+.+|.+
T Consensus 160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-HhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence 7999999988889999999999999999999 8999988765443333 3334555566778899999999999999999
Q ss_pred CCCHHHHHHHHH
Q 010091 486 RPDFSEITELLQ 497 (518)
Q Consensus 486 RPs~~eil~~L~ 497 (518)
||++.|+++.|+
T Consensus 239 Rp~~~ell~~l~ 250 (251)
T cd05041 239 RPSFSEIYNELQ 250 (251)
T ss_pred CcCHHHHHHHhh
Confidence 999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.27 Aligned_cols=256 Identities=20% Similarity=0.383 Sum_probs=212.7
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-- 313 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-- 313 (518)
+..++....|.+.++||.|+||.||++++. ++.||+|++......+.....|..|+.++++++|||||+++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 444556667888999999999999999975 5789999998776666667889999999999999999999998844
Q ss_pred CCceeEEEeeccCCccccccccc---cCCCChHHHHHHHHHhHHHHHHHHHC-------CceecCCCCCcEEecc-----
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRN-------NIIHRDLKAANLLMNE----- 378 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~ql~~gL~yLH~~-------gIiHrDLkp~NILl~~----- 378 (518)
...+||||||+++++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 45689999999999999998652 24689999999999999999999985 4999999999999964
Q ss_pred ------------CCcEEEeeeccceeccccCccccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 010091 379 ------------NGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDD 444 (518)
Q Consensus 379 ------------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~~ 444 (518)
.+.+||+|||++.............||+.|+|||++.+ ..++.++||||||||+|+|++|..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23599999999986554433344569999999999854 4588999999999999999999999987
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 445 LTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 445 ~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..........+...... .....++++.+||.+||+.+|.+||++.|++.
T Consensus 246 ~~~~~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFSQLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHHHHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 76655555544433221 22356889999999999999999999999984
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=328.05 Aligned_cols=247 Identities=23% Similarity=0.453 Sum_probs=217.2
Q ss_pred cccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
..+|.+.+.||+|.||.|-+++. .|+.||||.++.....+ ...-.+.+|+.||..|+||||+++|..|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34566699999999999999985 48999999998876544 4457888999999999999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 400 (518)
|||..+|.|+||+.. .+.+++...+.|++||..|+.|+|+++++|||||.+|||+|.++++||+|||++-+.......+
T Consensus 132 MEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 132 MEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 999999999999988 5689999999999999999999999999999999999999999999999999998887777778
Q ss_pred cCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 401 AETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~-~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
+.+|++.|.+||++++.+|. +..|.||||++||-|..|..||++.+......++....++ ....+.+...||++||
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---EP~~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---EPETPSDASGLIRWML 287 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc---CCCCCchHHHHHHHHH
Confidence 88999999999999999984 7899999999999999999999998755544443333332 2233456889999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
-.||.+|.|..+|..
T Consensus 288 mVNP~RRATieDiAs 302 (668)
T KOG0611|consen 288 MVNPERRATIEDIAS 302 (668)
T ss_pred hcCcccchhHHHHhh
Confidence 999999999888765
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=311.76 Aligned_cols=248 Identities=25% Similarity=0.464 Sum_probs=214.8
Q ss_pred cceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.++||+|+||.+|+++. .++.||+|.+............+.+|+.++++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 367799999999999999986 468899999987655555567889999999999999999999999999999999999
Q ss_pred ccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-ccc
Q 010091 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTA 401 (518)
Q Consensus 324 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~ 401 (518)
+.+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 99999999987643 3578999999999999999999999999999999999999999999999999976543221 122
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..|+..|+|||++.+..++.++|+||||+++|+|++|..||......+...... .+..+..+...+.++.++|.+||+.
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhhC
Confidence 357889999999988889999999999999999999999998777665554443 3455566778899999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
+|.+||++.++++
T Consensus 240 ~p~~Rp~~~~vl~ 252 (256)
T cd08218 240 NPRDRPSVNSILE 252 (256)
T ss_pred ChhhCcCHHHHhh
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=325.37 Aligned_cols=241 Identities=27% Similarity=0.395 Sum_probs=201.0
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--C---ceeE
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--P---RLFI 319 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~---~~~l 319 (518)
|.-.+++|+|+||.||+|... ++.||||..-.... .-.+|+.+|++++|||||+++.+|... . .+.+
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 555889999999999999954 58899998766432 123699999999999999999887432 2 4568
Q ss_pred EEeeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-CcEEEeeeccceeccc
Q 010091 320 VTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVVKVADFGVARVQAQ 395 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-~~vkL~DFG~a~~~~~ 395 (518)
|||||+ .+|.++++. .+..++.-.+.-+..||++||.|||+.|||||||||.|+|+|.+ |.+||||||.|+....
T Consensus 100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 999996 599998874 24568888899999999999999999999999999999999976 9999999999999877
Q ss_pred cCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------CC----
Q 010091 396 YGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG----------LR---- 460 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~----------~~---- 460 (518)
........+|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+..+.++.+++-- +.
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 777777789999999999855 569999999999999999999999999988777666554210 00
Q ss_pred -------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 -------------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 -------------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+....++++.+++.++|..+|.+|.++.|++.
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1133567899999999999999999999988864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=318.27 Aligned_cols=254 Identities=29% Similarity=0.568 Sum_probs=213.0
Q ss_pred ccceeeeEEeEecceEEEEEEEC------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--CCc
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPR 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--~~~ 316 (518)
..|++.+.||+|+||.||++++. +..+|+|+++..... .....|.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45677899999999999999864 468999999876543 345789999999999999999999999876 567
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.|+||||+++++|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 89999999999999999876667999999999999999999999999999999999999999999999999999875532
Q ss_pred Cc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH--------------HHHHHHHHhcC
Q 010091 397 GV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP--------------LQAAVGVVQKG 458 (518)
Q Consensus 397 ~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~--------------~~~~~~~~~~~ 458 (518)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+..... .......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 21 1122355679999999888899999999999999999999998865322 11222333344
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 459 LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 459 ~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
.+...+..++.++.+++.+||+.+|.+|||+.|+++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 44555667788999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.43 Aligned_cols=246 Identities=29% Similarity=0.524 Sum_probs=204.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecC------Cc
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRP------PR 316 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~------~~ 316 (518)
.|.+.+.||+|+||.||+|... ++.||+|++...... ...+.+|+.+++++ +|+||+++++++... ..
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 4555889999999999999874 678999998764322 35678899999998 699999999998642 45
Q ss_pred eeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
+|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 899999999999999987633 4688999999999999999999999999999999999999999999999999976433
Q ss_pred c-CccccCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010091 396 Y-GVMTAETGTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 396 ~-~~~~~~~gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
. .......|+..|+|||++. +..++.++|+||||+++|+|++|..||....+............+...+..++.
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 243 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCH
Confidence 2 2233456899999999985 346888999999999999999999999877765555444433334444456788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+.+++.+||+.+|.+|||+.++++
T Consensus 244 ~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 244 KFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhh
Confidence 9999999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=322.26 Aligned_cols=268 Identities=26% Similarity=0.405 Sum_probs=218.4
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-- 313 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-- 313 (518)
..|++. ..|...+.||.|+||.|..+.+. |+.||||.+.....+.-..++-.+|+.+|+.++|+||+.+.+.+..
T Consensus 16 ~~~~i~-~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 16 ELFEIP-RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred eEEecc-ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 345653 34444889999999999999975 7899999998776666677889999999999999999999998855
Q ss_pred ---CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 314 ---PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 314 ---~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
-..+|+|+|+| +.+|.+.++. +..++...+..++.||++||+|+|+.||+||||||.|++++.+..+||+|||+|
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 34689999999 6789999887 446999999999999999999999999999999999999999999999999999
Q ss_pred eeccc---cCccccCCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----------
Q 010091 391 RVQAQ---YGVMTAETGTYRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ---------- 456 (518)
Q Consensus 391 ~~~~~---~~~~~~~~gt~~y~APE~l-~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~---------- 456 (518)
+.... .+.+|...-|..|.|||++ ....|+.+.||||.|||+.||++|+.-|.+.+.......+..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98764 4456777789999999987 567899999999999999999999999987654433322221
Q ss_pred ------------cCC--CCCCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhccccc
Q 010091 457 ------------KGL--RPTIP-----VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKRGLA 510 (518)
Q Consensus 457 ------------~~~--~p~~~-----~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~ 510 (518)
+.+ .|..+ .+.++...+|+++||..||.+|+|++|.+. ...+..+....++.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~--hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA--HPYLAPYHDPEDEP 323 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc--ChhhhhhcCCccCC
Confidence 111 12221 467889999999999999999999999865 23455554444433
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=311.64 Aligned_cols=248 Identities=30% Similarity=0.514 Sum_probs=210.7
Q ss_pred cceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|+..+.||+|+||.||+|.. .++.|++|+++...........+..|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 356689999999999999986 468899999987765555678899999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc----
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM---- 399 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~---- 399 (518)
+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999977 345889999999999999999999999999999999999999999999999999765433221
Q ss_pred -ccCCCCCcccChhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC--cHHHHH
Q 010091 400 -TAETGTYRWMAPEVIEHQP---YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHT--HPILVD 473 (518)
Q Consensus 400 -~~~~gt~~y~APE~l~~~~---~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~--~~~L~~ 473 (518)
....++..|+|||.+.+.. ++.++||||||+++|+|++|..||..................+.++... ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 1245788999999997766 8899999999999999999999998764333332223334455566544 889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~ 494 (518)
++.+||+.+|.+||++.+++.
T Consensus 240 li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHccCCcccCCCHHHHhc
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.58 Aligned_cols=244 Identities=29% Similarity=0.524 Sum_probs=199.0
Q ss_pred EEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 252 KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
+||+|+||.||+|... ...+++|.+.... .......|.+|+.+++.++|+||+++++.+......|+||||++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 5899999999999743 2468888776443 3444577889999999999999999999999999999999999999
Q ss_pred ccccccccccC----CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---cc
Q 010091 328 SIYDYLHKQKC----GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV---MT 400 (518)
Q Consensus 328 sL~~~l~~~~~----~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~ 400 (518)
+|.+++..... ..++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 99999976432 246778889999999999999999999999999999999999999999999865332211 12
Q ss_pred cCCCCCcccChhhhc-------CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCC----CCCCCCCCc
Q 010091 401 AETGTYRWMAPEVIE-------HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGL----RPTIPVHTH 468 (518)
Q Consensus 401 ~~~gt~~y~APE~l~-------~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~----~p~~~~~~~ 468 (518)
...++..|+|||++. ...++.++|||||||++|||++ |..||....+.+.....+.... .+..+..++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 233567899999874 3456889999999999999999 8899998877666555444332 334455678
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
+.+.+++..|| .||.+|||++++++.|.
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 88999999999 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.10 Aligned_cols=245 Identities=33% Similarity=0.548 Sum_probs=212.1
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|.+.+.||.|++|.||+|... ++.||+|++..... ......+.+|+.++++++|+||+++++++.....+|+|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4666899999999999999964 68899999876542 33446788999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~ 402 (518)
+++++|.+++... .+++..++.++.|++.|+.|||+++++|+||+|+||++++++.++|+|||+++..... ......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence 9999999999864 6899999999999999999999999999999999999999999999999999776543 222335
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC-CcHHHHHHHHHhhhh
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVH-THPILVDLLERCWQR 481 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~L~~Li~~cL~~ 481 (518)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||....+.+.... +.....+..+.. +++++.+++.+||..
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 237 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKNNPPSLEGNKFSKPFKDFVSLCLNK 237 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-hhhcCCCCCcccccCHHHHHHHHHHhhC
Confidence 688899999999888899999999999999999999999987765554433 334455555555 789999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
+|.+|||+++++.
T Consensus 238 ~p~~Rpt~~~il~ 250 (274)
T cd06609 238 DPKERPSAKELLK 250 (274)
T ss_pred ChhhCcCHHHHhh
Confidence 9999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=310.50 Aligned_cols=247 Identities=38% Similarity=0.713 Sum_probs=212.3
Q ss_pred eeeeEEeEecceEEEEEEECC------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 248 KFEHKIVSGSYCDLYKGAFFS------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~~~------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
++.+.||.|+||.||++.+.. ..||+|+++..... .....+.+|+.++++++|+||+++++++...+..|++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457899999999999999764 77999999766433 24578899999999999999999999999989999999
Q ss_pred eeccCCccccccccccCC-CChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccc
Q 010091 322 EFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~-l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 400 (518)
||+++++|.+++...... +++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999999999999774444 8999999999999999999999999999999999999999999999999997655432211
Q ss_pred --cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 401 --AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 401 --~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
...+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.... +.....+..+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY-LKKGYRLPKPENCPPEIYKLMLQ 239 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCcCCHHHHHHHHH
Confidence 1236789999999988889999999999999999998 8899987666554443 34455666677789999999999
Q ss_pred hhhhCCCCCCCHHHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~~L 496 (518)
||..+|.+|||+.++++.|
T Consensus 240 ~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 240 CWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HCcCChhhCcCHHHHHhhC
Confidence 9999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.26 Aligned_cols=253 Identities=27% Similarity=0.513 Sum_probs=212.1
Q ss_pred cccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
.+.|+..+.||.|+||.||+|+.. .+.|++|.+.... .......|.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 456777999999999999999853 3569999886543 23355789999999999999999999999999899
Q ss_pred eeEEEeeccCCcccccccccc--------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeec
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK--------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~--------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG 388 (518)
.|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999997533 158999999999999999999999999999999999999999999999999
Q ss_pred cceeccccC--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010091 389 VARVQAQYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPV 465 (518)
Q Consensus 389 ~a~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~ 465 (518)
.+....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..............+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE 242 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCC
Confidence 986432211 1222345778999999988888999999999999999999 8899987766655544443344444556
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 466 ~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
.++..+.+++.+||+.+|.+|||+.+++..|.
T Consensus 243 ~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 243 GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 78899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=315.80 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=204.1
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|++.+.||+|++|.||+|+.. ++.||+|++............+.+|+.++++++|+||+++++++......|+||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 4666999999999999999975 68899999876543333446788999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
+++++|..++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... .....
T Consensus 82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 82 CDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred cCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 999888887655 4468999999999999999999999999999999999999999999999999998654433 22234
Q ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------CC-CC
Q 010091 403 TGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK-------------------GL-RP 461 (518)
Q Consensus 403 ~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~-------------------~~-~p 461 (518)
.++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+........ .. .+
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 57889999999865 56789999999999999999999999887665443322110 00 00
Q ss_pred CC---------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 TI---------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ~~---------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.. -...+..+.+++.+||+.+|.+||++.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 1235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.52 Aligned_cols=245 Identities=31% Similarity=0.533 Sum_probs=208.5
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|++.++||.|+||.||++.+. ++.||+|+++.. .......|.+|+.++++++|+||+++++.+......|+||||+
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 444999999999999999974 688999998754 3344578999999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 403 (518)
++++|.+++.+....+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+....... ......
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI 164 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceee
Confidence 9999999998766679999999999999999999999999999999999999999999999999886543322 222345
Q ss_pred CCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHH
Q 010091 404 GTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--TIPVHTHPILVDLLE 476 (518)
Q Consensus 404 gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~L~~Li~ 476 (518)
++..|+|||.+. ...++.++|+||||+++|+|++|..||....+.+...... .+..+ ..+..++.++.++|.
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~ 243 (280)
T cd06611 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPPTLDQPSKWSSSFNDFLK 243 (280)
T ss_pred cchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh-cCCCCCcCCcccCCHHHHHHHH
Confidence 889999999974 3457889999999999999999999998887666554433 23222 234567889999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
+||+.+|.+||++.+++.
T Consensus 244 ~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 244 SCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHhccChhhCcCHHHHhc
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=321.05 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=211.6
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc-eeeEeeeeecCC-----
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPP----- 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn-Iv~l~~~~~~~~----- 315 (518)
...|...++||+|+||.||+|+.. |+.||+|.++.+..++.......+|+.+++.++|+| |+++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 445667888999999999999964 789999999987655545566789999999999999 999999987766
Q ss_pred -ceeEEEeeccCCcccccccccc---CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 316 -RLFIVTEFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 316 -~~~lV~Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
.+++||||+ ..+|..|+.... ..++...+..++.||+.||+|||+++|+||||||.||||+++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999999 569999998755 357778999999999999999999999999999999999999999999999999
Q ss_pred ecccc-CccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--------
Q 010091 392 VQAQY-GVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP-------- 461 (518)
Q Consensus 392 ~~~~~-~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p-------- 461 (518)
....+ ...+.+.+|..|+|||++.+. .|+...||||+|||+.||++++.-|.+.+..+....+.+.--.|
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 76633 346778899999999999766 79999999999999999999999999988877766655321111
Q ss_pred --------CCC------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 462 --------TIP------------VHTHPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 462 --------~~~------------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
.++ ....+...+++.+||+.+|.+|.|++..+..
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111 1122478999999999999999999988764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.82 Aligned_cols=247 Identities=30% Similarity=0.478 Sum_probs=205.5
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|++.++||+|+||.||+|+.. ++.||+|+++.... .....+.+|+.+++.++||||+++++.+......|+|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 35566899999999999999874 68899999886532 223567889999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+++++|.+++.. .+.+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 87 FCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 9999999999876 4578999999999999999999999999999999999999999999999999987543321 2233
Q ss_pred CCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHHHHHH
Q 010091 402 ETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI---PVHTHPILVDLL 475 (518)
Q Consensus 402 ~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~---~~~~~~~L~~Li 475 (518)
..|+..|+|||++. ...++.++|+|||||++|+|++|..||....+.............+.. ...++..+.+++
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHH
Confidence 46899999999974 456889999999999999999999999766654444333333332221 124678899999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~ 494 (518)
.+||+.+|.+||++++++.
T Consensus 246 ~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 246 KMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHccCCchhCcCHHHHhc
Confidence 9999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=318.10 Aligned_cols=244 Identities=26% Similarity=0.439 Sum_probs=210.8
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|++.+.||+|+||.||++.+. ++.||+|++...... ......+.+|+.++++++||||+++++.+......|+|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5677999999999999999974 688999999765432 2345778899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
|+++++|.+++... ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... ....
T Consensus 82 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 158 (290)
T cd05580 82 YVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL 158 (290)
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence 99999999999774 57899999999999999999999999999999999999999999999999999765433 2334
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+...... ...+.++...++.+.++|.+||+.|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~ 236 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNLLQVD 236 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHHccCC
Confidence 68899999999988888999999999999999999999998877554444333 3345567778999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 010091 483 PSLRP-----DFSEITE 494 (518)
Q Consensus 483 P~~RP-----s~~eil~ 494 (518)
|.+|+ ++.|++.
T Consensus 237 p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 237 LTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHccCcccCCHHHHHc
Confidence 99998 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=320.19 Aligned_cols=257 Identities=32% Similarity=0.596 Sum_probs=214.1
Q ss_pred cccceeeeEEeEecceEEEEEEEC--Cc----cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~----~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
..+|+..+.||+|+||.||+|++. ++ .||+|.+..... .....++.+|+.++++++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 445666899999999999999863 43 478898875432 33345788999999999999999999988654 57
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
++++||+++|+|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++......
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 89999999999999998766678999999999999999999999999999999999999999999999999997644322
Q ss_pred c---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 398 V---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 398 ~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+ ....+..+..+..+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPICTIDVYM 242 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCHHHHH
Confidence 1 112235678999999998999999999999999999997 999998765433 33445555555566678889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
++.+||..+|.+||++.+++..|..+....
T Consensus 243 li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 243 VMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 999999999999999999999999886554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=319.12 Aligned_cols=245 Identities=27% Similarity=0.488 Sum_probs=207.0
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.+.||+|+||.||+|... ++.|++|.+....... ...+.+|+.+++.++|+||+++++.+......|+||||
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4555899999999999999864 6889999988654433 36788999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
++|++|.+++.. ..++...+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||.+....... .....
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 176 (296)
T cd06654 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (296)
T ss_pred cCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence 999999999865 357899999999999999999999999999999999999999999999999987543322 12334
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhhh
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
.+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....+............ ....+...++.+.+++.+||..
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcC
Confidence 688999999999888899999999999999999999999987776544333222221 1223456788899999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
+|.+||++.+++.
T Consensus 257 ~p~~Rpt~~eil~ 269 (296)
T cd06654 257 DVEKRGSAKELLQ 269 (296)
T ss_pred CcccCcCHHHHhh
Confidence 9999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=315.07 Aligned_cols=242 Identities=29% Similarity=0.495 Sum_probs=200.7
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.++||+|+||.||+|.+. ++.||+|++.... .......|.+|+.++++++||||+++++++......++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4667899999999999999864 6889999987653 334457799999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET 403 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 403 (518)
+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~ 154 (279)
T cd06619 81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYV 154 (279)
T ss_pred CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCC
Confidence 999998654 24678889999999999999999999999999999999999999999999999754332 223356
Q ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhcCCCCCC-CCCCcHHHHHHH
Q 010091 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL-------QAAVGVVQKGLRPTI-PVHTHPILVDLL 475 (518)
Q Consensus 404 gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~-------~~~~~~~~~~~~p~~-~~~~~~~L~~Li 475 (518)
|+..|+|||++.+..++.++|+||||+++|+|++|..||...... +.... ......+.. ....++++.+++
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccCCCCCCCCcCCHHHHHHH
Confidence 899999999998888999999999999999999999999653221 11111 111222222 334678999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~~ 495 (518)
.+||+.+|.+||++++++..
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhhCChhhCCCHHHHhcC
Confidence 99999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.34 Aligned_cols=251 Identities=24% Similarity=0.468 Sum_probs=211.7
Q ss_pred ceeeeEEeEecceEEEEEEEC---CccEEEEEEeccc--------cCHHHHHHHHHHHHHHhh-cCCCceeeEeeeeecC
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEH--------LNENIRREFAQEVHIMRK-VRHMNVVQFIGACTRP 314 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~---~~~vAvKvl~~~~--------~~~~~~~~f~~E~~il~~-l~HpnIv~l~~~~~~~ 314 (518)
|++.+.||+|+||.||+|... ++.+|+|.+.... ..+....++.+|+.++.+ ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 566889999999999999975 4779999886432 223344677889998875 7999999999999999
Q ss_pred CceeEEEeeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
+..|++|||++|++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999999998743 34568999999999999999999996 78999999999999999999999999999
Q ss_pred eeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 391 RVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
.............|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..................+.....+++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSED 241 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHH
Confidence 87655443445668999999999998889999999999999999999999998776655554444444444334467899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
+.+++.+||+.||.+||++.|+...++
T Consensus 242 l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 242 VTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 999999999999999999999988775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.22 Aligned_cols=263 Identities=32% Similarity=0.652 Sum_probs=234.0
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC---------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEe
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~---------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~ 308 (518)
.|+++.+.+++.+.||+|.||.|++|... ...||||.++..... .....+..|+.+|+.+ +|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 89999999999999999999999999843 246999999987655 5678999999999999 599999999
Q ss_pred eeeecCCceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCc
Q 010091 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (518)
Q Consensus 309 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~N 373 (518)
|+|+..+.+++|+||++.|+|..|+...+ ..++...++.++.||+.||+||++..++||||..+|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998765 348889999999999999999999999999999999
Q ss_pred EEeccCCcEEEeeeccceeccccCccc--cCC--CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010091 374 LLMNENGVVKVADFGVARVQAQYGVMT--AET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPL 448 (518)
Q Consensus 374 ILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~--gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~ 448 (518)
||++.+..+||+|||+++......... ... -...|||||.+....|+.|+||||||++||||+| |..||.+....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999999998644333221 112 3467999999999999999999999999999999 99999997745
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 449 QAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 449 ~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+.....++.|.+...|..+++++.++|+.||+.+|.+||+|.++.+.|+..+..
T Consensus 529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 555668889999999999999999999999999999999999999999996653
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=311.05 Aligned_cols=247 Identities=28% Similarity=0.487 Sum_probs=206.9
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC---HHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--Ccee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLF 318 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~---~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 318 (518)
.|++.+.||+|+||.||+|... +..||+|.+...... ......+.+|+.++++++||||+++++++... ..+|
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 4566999999999999999864 688999998643222 23346888999999999999999999988653 4688
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc--
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-- 396 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-- 396 (518)
++|||++|++|.+++... ..+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||.++.....
T Consensus 83 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999998763 46888999999999999999999999999999999999999999999999998754321
Q ss_pred --CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 397 --GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 397 --~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
.......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..................+..+...+..+.++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 112234588899999999888899999999999999999999999988766665554444444566677778889999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~ 494 (518)
|.+||. +|.+||++++++.
T Consensus 242 i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 242 LKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHhc-ChhhCCCHHHHhc
Confidence 999995 9999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.57 Aligned_cols=238 Identities=26% Similarity=0.507 Sum_probs=194.9
Q ss_pred eEEeEecceEEEEEEECC--------------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 251 HKIVSGSYCDLYKGAFFS--------------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~~--------------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
+.||+|+||.||+|+... ..|++|++.... ......|.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999998531 248889876642 3344688899999999999999999999999889
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc-------EEEeeecc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV-------VKVADFGV 389 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~-------vkL~DFG~ 389 (518)
.++||||+++++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ++++|||.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999999998775667999999999999999999999999999999999999987664 89999999
Q ss_pred ceeccccCccccCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010091 390 ARVQAQYGVMTAETGTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELV-TGKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467 (518)
Q Consensus 390 a~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLl-tG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~ 467 (518)
+...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+.. ....... ......
T Consensus 159 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~--~~~~~~ 232 (262)
T cd05077 159 PITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQC--MLVTPS 232 (262)
T ss_pred CccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCc--cCCCCC
Confidence 8654321 2345788999999886 567899999999999999998 588998776543322 1122111 122334
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~~L 496 (518)
++++.++|.+||+.||.+||++.+|+..|
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 57899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=312.79 Aligned_cols=247 Identities=28% Similarity=0.471 Sum_probs=208.0
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC---HHHHHHHHHHHHHHhhcCCCceeeEeeeeec--CCcee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLF 318 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~---~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 318 (518)
.|+..+.||+|+||.||++... +..|++|++.....+ ......+.+|+.++++++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 3555899999999999999864 688999998754332 2334678899999999999999999998765 35788
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc--
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-- 396 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-- 396 (518)
++|||+++++|.+++.. ...++...++.++.|++.||.|||+++|+||||+|+||+++.++.++|+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999976 346889999999999999999999999999999999999999999999999998754321
Q ss_pred --CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 397 --GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 397 --~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
.......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+...........+.++...++.+.++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 111224588899999999988899999999999999999999999988776665555444445677777788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~ 494 (518)
+ +||..+|.+||+++|++.
T Consensus 242 i-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred H-HHhcCChhhCcCHHHHhc
Confidence 9 688899999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.75 Aligned_cols=243 Identities=26% Similarity=0.346 Sum_probs=194.9
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
+....|++.++||+|+||.||++.+. ++.||+|.... ..+.+|+.++++++||||+++++++......|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 34456777999999999999999974 68899997532 356789999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc--C
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY--G 397 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~--~ 397 (518)
|+|++ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 161 v~e~~-~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 161 ILPRY-KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEecC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 99999 5688888866 346889999999999999999999999999999999999999999999999999753221 1
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHH---------------
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP-------LQAAVGVV--------------- 455 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~-------~~~~~~~~--------------- 455 (518)
......||+.|+|||++.+..++.++|||||||++|||++|..||-.... ......++
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 22335699999999999999999999999999999999999977643210 00000000
Q ss_pred -----------hcCC-CCC-CC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 456 -----------QKGL-RPT-IP-----VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 456 -----------~~~~-~p~-~~-----~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.... .+. .+ ...+.++.++|.+||+.||.+|||++|++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000 00 123567999999999999999999999985
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=313.02 Aligned_cols=244 Identities=27% Similarity=0.492 Sum_probs=197.1
Q ss_pred EEeEecceEEEEEEECC----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 252 KIVSGSYCDLYKGAFFS----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~~----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
.||+|+||.||+|.+.+ ..+|+|.++..... .....|.+|+.++++++||||+++++++......|+||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999998643 46899988765432 33457889999999999999999999999989999999999999
Q ss_pred cccccccccc----CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---cc
Q 010091 328 SIYDYLHKQK----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV---MT 400 (518)
Q Consensus 328 sL~~~l~~~~----~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~ 400 (518)
+|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 9999997532 2356677889999999999999999999999999999999999999999999975433221 12
Q ss_pred cCCCCCcccChhhhcCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC-C---CCCCCCCCc
Q 010091 401 AETGTYRWMAPEVIEHQ-------PYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKG-L---RPTIPVHTH 468 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~-------~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~-~---~p~~~~~~~ 468 (518)
...++..|+|||++.+. .++.++|+||||+++|||++ |..||....+.+.....+... . .+......+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 23467889999998542 35789999999999999996 999998877665543333221 1 233334567
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
+.+.+++.+|| .+|++|||++||...|+
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 88999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.69 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=200.0
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.++||+|+||.||+|++. |+.||+|.++...........+.+|+.++++++|+||+++++++......|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3667899999999999999974 78899999986544444446778899999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 96 58888887656679999999999999999999999999999999999999999999999999997543322 22334
Q ss_pred CCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhc------------------CCCC-
Q 010091 403 TGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDD-LTPLQAAVGVVQK------------------GLRP- 461 (518)
Q Consensus 403 ~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~-~~~~~~~~~~~~~------------------~~~p- 461 (518)
.++..|+|||++.+. .++.++||||||+++|+|++|..|+.. .+..+....+... ...+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 578999999998664 478999999999999999999888543 3322221111100 0000
Q ss_pred --------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 --------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 --------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
......++++.++|.+||+.||.+|||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 111246788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=335.66 Aligned_cols=259 Identities=29% Similarity=0.520 Sum_probs=220.7
Q ss_pred eeeccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
-|+..+.+.+.++||+|.||.|.++...+ ..||+|++++.. ++....+|.+|+++|.+|+||||++++|+|..++.+|
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 35777889999999999999999999776 899999999875 3445689999999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCC-CChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~-l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
+|||||++|+|.+|+.+...+ .......+|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++-.-...
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999999999875333 3566778899999999999999999999999999999999999999999998432211
Q ss_pred c---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHH---hcC---CCCCCCCC
Q 010091 398 V---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT--GKLPYDDLTPLQAAVGVV---QKG---LRPTIPVH 466 (518)
Q Consensus 398 ~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt--G~~P~~~~~~~~~~~~~~---~~~---~~p~~~~~ 466 (518)
. .....-..+|||||.+..+++++++|+|+||+++||+++ ...||+.++..+.....- ..+ .-+..|.-
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 1 111235689999999999999999999999999999886 789999998877654322 111 13445677
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
|+.++.++|.+||..+..+||+|+++-..|.+.
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 899999999999999999999999998887654
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=314.15 Aligned_cols=246 Identities=33% Similarity=0.558 Sum_probs=211.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|+..++||.|+||.||+|++. ++.||+|++..... ......+.+|+.++++++|+||+++++++......|+||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4566889999999999999864 68899999886533 33457899999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
++|++|.+++.. +.++...+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 999999999865 358889999999999999999999999999999999999999999999999997644322 12224
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||....+...... ......+..+..++..+.+++.+||+.+
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-IPKNNPPTLTGEFSKPFKEFIDACLNKD 240 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-hhcCCCCCCchhhhHHHHHHHHHHcccC
Confidence 578899999999888899999999999999999999999988776654433 2334456666678889999999999999
Q ss_pred CCCCCCHHHHHHH
Q 010091 483 PSLRPDFSEITEL 495 (518)
Q Consensus 483 P~~RPs~~eil~~ 495 (518)
|.+||++.+++..
T Consensus 241 p~~Rp~~~~il~~ 253 (277)
T cd06640 241 PSFRPTAKELLKH 253 (277)
T ss_pred cccCcCHHHHHhC
Confidence 9999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=324.48 Aligned_cols=246 Identities=22% Similarity=0.410 Sum_probs=199.5
Q ss_pred eeeEEeEe--cceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 249 FEHKIVSG--SYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 249 ~~~~Lg~G--~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
++++||+| +|++||+++.. |+.||+|++......+.....+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999864 688999999876655555677888999999999999999999999999999999999
Q ss_pred cCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-----
Q 010091 325 SGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----- 398 (518)
Q Consensus 325 ~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 398 (518)
++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++.++.++++||+........+.
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999998653 34589999999999999999999999999999999999999999999999986543221110
Q ss_pred ---cccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-------------
Q 010091 399 ---MTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR------------- 460 (518)
Q Consensus 399 ---~~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~------------- 460 (518)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+...........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 111246778999999965 46899999999999999999999999876554433322211100
Q ss_pred -------------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 -------------------------------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 -------------------------------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.......++.+.+++.+||+.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0011234678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=314.51 Aligned_cols=244 Identities=36% Similarity=0.653 Sum_probs=205.8
Q ss_pred EEeEecceEEEEEEECC--------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 252 KIVSGSYCDLYKGAFFS--------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~~--------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.||.|+||.||+|+... +.+|+|.+..... ......|.+|+.++++++||||+++++++......|+||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998642 5699998865432 23456888999999999999999999999999999999999
Q ss_pred ccCCccccccccc------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-----cEEEeeecccee
Q 010091 324 MSGGSIYDYLHKQ------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-----VVKVADFGVARV 392 (518)
Q Consensus 324 ~~ggsL~~~l~~~------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-----~vkL~DFG~a~~ 392 (518)
+++++|.+++... ...+++..++.++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999998642 23478899999999999999999999999999999999999887 899999999875
Q ss_pred ccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 393 QAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 393 ~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... +..+..+..+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-VTAGGRLQKPENCP 239 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-HhcCCccCCcccch
Confidence 43221 1112345788999999998999999999999999999998 9999988776654433 33445556677788
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
+.+.+++.+||+.+|.+||++.+|++.|+
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99999999999999999999999998876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=311.92 Aligned_cols=236 Identities=27% Similarity=0.537 Sum_probs=195.4
Q ss_pred eEEeEecceEEEEEEECCc------------cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 251 HKIVSGSYCDLYKGAFFSQ------------DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~~~------------~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+.||+|+||.||+|++.+. .+++|++...... ...|.+|+.++++++||||+++++++.. ...|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3689999999999997643 3788887654322 5788999999999999999999999887 7789
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-------cEEEeeeccce
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-------VVKVADFGVAR 391 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-------~vkL~DFG~a~ 391 (518)
+||||+++++|.+++......++...+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999999999999987555789999999999999999999999999999999999999887 79999999997
Q ss_pred eccccCccccCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 392 VQAQYGVMTAETGTYRWMAPEVIEHQ--PYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
.... .....++..|+|||++.+. .++.++|+||||+++|+|++ |..||...+....... .... ...+....
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-~~~~--~~~~~~~~ 230 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQDQ--HRLPMPDC 230 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-HhcC--CCCCCCCc
Confidence 6443 2224467789999999776 78999999999999999999 6888877654332221 2211 12222234
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L 496 (518)
..+.+++.+||..+|.+|||+.++++.|
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 231 AELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 7899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=314.71 Aligned_cols=245 Identities=29% Similarity=0.482 Sum_probs=205.4
Q ss_pred eeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeecc
Q 010091 248 KFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 325 (518)
++.++||+|+||.||+|.+. +..+++|.+... .......|.+|+.+++.++||||+++++++......|+||||++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 34889999999999999975 567888888654 33445788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCC
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETG 404 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~g 404 (518)
+++|..++.+....+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....... ......+
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 165 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 165 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccc
Confidence 999999887655678999999999999999999999999999999999999999999999999986543221 1223458
Q ss_pred CCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHh
Q 010091 405 TYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 405 t~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~~c 478 (518)
+..|+|||++. +..++.++|+||||+++|+|++|..||...++.+.......... ....+..++.++.++|.+|
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHH
Confidence 89999999983 45578899999999999999999999988776665544433211 2234556788999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.+|.+||++.+++.
T Consensus 246 l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 246 LEKNVDARWTTTQLLQ 261 (282)
T ss_pred ccCChhhCcCHHHHhc
Confidence 9999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.12 Aligned_cols=245 Identities=22% Similarity=0.363 Sum_probs=211.7
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
|++.+.||.|+||.||++... ++.||+|++....... .....+.+|+.++++++||||+++++.+......|+|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 667999999999999999975 7899999998654433 4557899999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET 403 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 403 (518)
++|++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||.+.............
T Consensus 82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 9999999999774 578999999999999999999999999999999999999999999999999997655443334456
Q ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP--LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 404 gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+. ......... ...+..+...+..+.++|.+||+.
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-TADVLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-cccccCcccCcHHHHHHHHHHccC
Confidence 88899999999888899999999999999999999999987663 222222222 255667778889999999999999
Q ss_pred CCCCCCCH--HHHH
Q 010091 482 DPSLRPDF--SEIT 493 (518)
Q Consensus 482 dP~~RPs~--~eil 493 (518)
||.+||++ +|++
T Consensus 240 ~p~~R~~~~~~~l~ 253 (258)
T cd05578 240 DPQKRLGDNLKDLK 253 (258)
T ss_pred ChhHcCCccHHHHh
Confidence 99999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.13 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=203.0
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-- 314 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~-- 314 (518)
.|++ .+.|++.+.||+|+||.||++... ++.||+|++............+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 4655 466888999999999999999864 67899999986544444456788999999999999999999887533
Q ss_pred ----CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 315 ----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 315 ----~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
...|++++++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3578999998 7899888754 35899999999999999999999999999999999999999999999999999
Q ss_pred eeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------
Q 010091 391 RVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL---------- 459 (518)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~---------- 459 (518)
+..... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+..........
T Consensus 166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 865432 334568999999999866 5689999999999999999999999987655443332221100
Q ss_pred -----------CCCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 -----------RPTI--------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 -----------~p~~--------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+.. ....++.+.++|.+||+.||.+|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011 1234667899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=316.09 Aligned_cols=237 Identities=27% Similarity=0.495 Sum_probs=194.9
Q ss_pred EEeEecceEEEEEEEC--------------------------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCcee
Q 010091 252 KIVSGSYCDLYKGAFF--------------------------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~--------------------------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv 305 (518)
.||+|+||.||+|... ...|++|++.... .....+|.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5899999999999742 1248899886542 23346788999999999999999
Q ss_pred eEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-----
Q 010091 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG----- 380 (518)
Q Consensus 306 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~----- 380 (518)
++++++......|+||||+++++|..++.+..+.+++..+..++.||+.||.|||++||+||||||+||+++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999999977566789999999999999999999999999999999999997644
Q ss_pred --cEEEeeeccceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHh
Q 010091 381 --VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELV-TGKLPYDDLTPLQAAVGVVQ 456 (518)
Q Consensus 381 --~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLl-tG~~P~~~~~~~~~~~~~~~ 456 (518)
.+|++|||.+..... .....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....+.+... ...
T Consensus 160 ~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~ 235 (274)
T cd05076 160 SPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE 235 (274)
T ss_pred cceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH
Confidence 489999998854322 122457788999998865 56899999999999999995 6999998876654322 222
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 010091 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 457 ~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L 496 (518)
.. ...+....+.+.++|.+||+.+|.+|||+.++++.|
T Consensus 236 ~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 236 KK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 22 233444567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=310.14 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=205.4
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
++.+.......||+|+||.||+|++. +..|++|.+.... ......+.+|+.++++++|+||+++++++......|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 33344444668999999999999865 5679999887543 3345688999999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCC--ChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-CCcEEEeeeccceecccc
Q 010091 320 VTEFMSGGSIYDYLHKQKCGL--KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVVKVADFGVARVQAQY 396 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l--~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-~~~vkL~DFG~a~~~~~~ 396 (518)
|+||+++++|.+++......+ +...+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||.+......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 999999999999998644445 78889999999999999999999999999999999986 679999999998754322
Q ss_pred C-ccccCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCcHHHH
Q 010091 397 G-VMTAETGTYRWMAPEVIEHQ--PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA-VGVVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 397 ~-~~~~~~gt~~y~APE~l~~~--~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~L~ 472 (518)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......... .........+.++..+++++.
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK 242 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHH
Confidence 2 22234588999999998654 3789999999999999999999999765432222 121122345667778889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.+||+.+|.+|||+.+++.
T Consensus 243 ~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 243 NFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHcCCCchhCCCHHHHHh
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=310.80 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=208.1
Q ss_pred EeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
||.|++|.||+++.. ++.||+|++...... ......+.+|+.++++++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999987 789999999865433 34457899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCCccc
Q 010091 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWM 409 (518)
Q Consensus 330 ~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~ 409 (518)
.+++.+. ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.............++..|+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 9999773 468999999999999999999999999999999999999999999999999998655433223345888999
Q ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 010091 410 APEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT--PLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRP 487 (518)
Q Consensus 410 APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RP 487 (518)
+||.+.+..++.++|+||||+++|+|++|..||.... +.+...........+..|...++++.++|.+||+.+|.+||
T Consensus 160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 9999988889999999999999999999999998776 44444444433456667777789999999999999999999
Q ss_pred C-----HHHHHH
Q 010091 488 D-----FSEITE 494 (518)
Q Consensus 488 s-----~~eil~ 494 (518)
+ +.|+++
T Consensus 240 ~~~~~~~~~l~~ 251 (262)
T cd05572 240 GNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHhc
Confidence 9 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=316.54 Aligned_cols=247 Identities=28% Similarity=0.483 Sum_probs=207.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.+.||+|+||.||++.+. ++.||+|.++... ++.....+.+|+.++++++|+||+++++.+...+.+|+||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4666999999999999999975 7899999987643 344457899999999999999999999999999999999999
Q ss_pred ccCCccccccccc--cCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceeccccCccc
Q 010091 324 MSGGSIYDYLHKQ--KCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 324 ~~ggsL~~~l~~~--~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 400 (518)
+++++|.+++... ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||.+...... ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~ 159 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAK 159 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccc
Confidence 9999999988763 2368999999999999999999997 59999999999999999999999999998754332 223
Q ss_pred cCCCCCcccChhhhcCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHhcCCCCCCCCCCcHHHH
Q 010091 401 AETGTYRWMAPEVIEHQ------PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVG--VVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~------~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~L~ 472 (518)
...++..|+|||.+.+. .++.++|+|||||++|+|++|..||........... ....+..+..+..+++++.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ 239 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHH
Confidence 34588899999998544 357899999999999999999999976544332221 1223445667777899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|.+||+.+|.+||++.+++.
T Consensus 240 ~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 240 DFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHcccCcccCCCHHHHhc
Confidence 9999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=318.55 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=210.1
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|++.+.||+|++|.||++... ++.||+|.+....... .....+..|+.++++++|+||+++++.+......|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 4667999999999999999975 6889999998765443 345778899999999999999999999999999999999
Q ss_pred eccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---
Q 010091 323 FMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--- 398 (518)
Q Consensus 323 y~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 398 (518)
|+.|++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 999999999987643 4689999999999999999999999999999999999999999999999999864322110
Q ss_pred ---------------------------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010091 399 ---------------------------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA 451 (518)
Q Consensus 399 ---------------------------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~ 451 (518)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||...+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 241 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH
Confidence 00124788999999999888999999999999999999999999888776666
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC----HHHHHH
Q 010091 452 VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPD----FSEITE 494 (518)
Q Consensus 452 ~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs----~~eil~ 494 (518)
................++.+.+++.+||+.+|.+||+ +.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 242 SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 5555443332223336889999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=317.43 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=209.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|++.+.||+|+||.||++... ++.|++|.+...... ......+.+|+.+++.++||||+++++.+......|+|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5677999999999999999975 578999998765432 2334678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-----
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG----- 397 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~----- 397 (518)
|++|++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 82 YVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999976 3568999999999999999999999999999999999999999999999999986421100
Q ss_pred -----------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCC
Q 010091 398 -----------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPV 465 (518)
Q Consensus 398 -----------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~ 465 (518)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.++.+.......... .+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence 01113468889999999888899999999999999999999999988777665554444332 233334
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 466 ~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
.+++++.++|.+||+.+|.+||++.++.+.|+.
T Consensus 241 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 678899999999999999999997666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=313.23 Aligned_cols=246 Identities=30% Similarity=0.534 Sum_probs=199.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHH-HhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHI-MRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~i-l~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|++.+.||+|+||.||++++. |+.||+|+++.....+. ...+..|+.+ ++.++||||+++++++......|++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4667999999999999999975 78999999987644333 3445556654 667789999999999999999999999
Q ss_pred eccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 323 FMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 323 y~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
|++ ++|.+++.. ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 996 688777653 234689999999999999999999997 999999999999999999999999999976543322
Q ss_pred cccCCCCCcccChhhhcC----CCCCchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCCCCCC-CCCcHHHH
Q 010091 399 MTAETGTYRWMAPEVIEH----QPYNHRADVFSFGIVLWELVTGKLPYDDL-TPLQAAVGVVQKGLRPTIP-VHTHPILV 472 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~----~~~~~ksDV~SlGill~eLltG~~P~~~~-~~~~~~~~~~~~~~~p~~~-~~~~~~L~ 472 (518)
.+...++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||... ...+....... +..+..+ ..++.++.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 238 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPEFQ 238 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHHHH
Confidence 333568889999998854 45688999999999999999999999753 33344433333 3334443 35788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|.+||..+|.+||++.+++.
T Consensus 239 ~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 239 DFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=313.17 Aligned_cols=246 Identities=30% Similarity=0.499 Sum_probs=209.1
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|.+.+.||.|++|.||++... ++.||+|.+..... +.....+.+|+.++++++||||+++++.+......|+++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 4566889999999999999976 78899999887543 34457889999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
+++++|.+++......+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~ 159 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TF 159 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cc
Confidence 99999999998754678999999999999999999999 99999999999999999999999999998654332222 26
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcCCCCCCCCC-CcHHHHHHHH
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT-----PLQAAVGVVQKGLRPTIPVH-THPILVDLLE 476 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~-----~~~~~~~~~~~~~~p~~~~~-~~~~L~~Li~ 476 (518)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+.. ........+..+.. +++.+.++|.
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL-QYIVNEPPPRLPSGKFSPDFQDFVN 238 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH-HHHhcCCCCCCChhhcCHHHHHHHH
Confidence 68899999999998899999999999999999999999997642 22222 22223344555554 7889999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
+||..+|.+|||+.+++.
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 239 LCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHcCCCchhCcCHHHHhh
Confidence 999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=312.85 Aligned_cols=248 Identities=26% Similarity=0.379 Sum_probs=207.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.+.||+|++|.||+|++. ++.||+|++......+.....+.+|+.++++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3667999999999999999974 68899999987765555567899999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--ccc
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--MTA 401 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~ 401 (518)
+ +++|.+++......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+........ ...
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 9999999877566799999999999999999999999999999999999999999999999999986554331 233
Q ss_pred CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Q 010091 402 ETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP------------------- 461 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p------------------- 461 (518)
..++..|+|||.+.+ ..++.++||||||+++|+|++|..||...............-..+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 468899999999854 446899999999999999999998887766544333322210000
Q ss_pred ---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 ---------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ---------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
......+..+.+++.+||+.+|.+||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011245688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.57 Aligned_cols=247 Identities=33% Similarity=0.557 Sum_probs=215.8
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--CceeEEEe
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFIVTE 322 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV~E 322 (518)
|+..+.||+|++|.||+|... ++.|++|++............+.+|+.++++++|+||+++++.+... ...+++||
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 556899999999999999976 78899999987765555668899999999999999999999999888 88999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---c
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV---M 399 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~ 399 (518)
|+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 82 YVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred ecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 999999999998744 889999999999999999999999999999999999999999999999999987665543 3
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT-PLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..............+.++...+..+.+++.+|
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 240 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHh
Confidence 44568899999999988889999999999999999999999998765 33333333333456667778899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.+|.+||++.+++.
T Consensus 241 l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 241 LRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCChhhCCCHHHHhh
Confidence 9999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.96 Aligned_cols=247 Identities=32% Similarity=0.515 Sum_probs=213.4
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|.+.+.||+|++|.||+++.. ++.|++|++...... .....+..|+.++++++|+||+++++++......|+||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 4566899999999999999975 788999998876433 4457899999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceeccccCccc-c
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT-A 401 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~-~ 401 (518)
+++++|.+++... ..+++..++.++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||.+.......... .
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 9999999999763 578999999999999999999999 999999999999999999999999999998655433221 3
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCCCCCCCCC-CcHHHHHHHHHh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT--PLQAAVGVVQKGLRPTIPVH-THPILVDLLERC 478 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~--~~~~~~~~~~~~~~p~~~~~-~~~~L~~Li~~c 478 (518)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ........+.....+..+.. ++..+.++|.+|
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence 457889999999998899999999999999999999999998774 33333333334445556666 889999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|..+|.+||++.++++
T Consensus 240 l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 240 LQKDPKKRPSAAELLQ 255 (264)
T ss_pred ccCChhhCCCHHHHHh
Confidence 9999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.23 Aligned_cols=245 Identities=29% Similarity=0.501 Sum_probs=208.9
Q ss_pred cceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|++.+.||.|++|.||+|.. .++.|++|.+...... ....+.+|+.+++.++||||+++++++......|+||||
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 466699999999999999985 4789999998764333 246788999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-cccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~ 402 (518)
+++++|..++... .+++..++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||++........ ....
T Consensus 98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 9999999988653 589999999999999999999999999999999999999999999999999875433221 2234
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhhh
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||....+............ ....+..+++.+.++|.+||..
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 255 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEM 255 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhc
Confidence 588899999999988899999999999999999999999988877655544333221 2234556789999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
+|.+||++.+++.
T Consensus 256 dp~~Rpt~~~il~ 268 (296)
T cd06655 256 DVEKRGSAKELLQ 268 (296)
T ss_pred ChhhCCCHHHHhh
Confidence 9999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=352.47 Aligned_cols=257 Identities=20% Similarity=0.335 Sum_probs=209.0
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|.+.++||+|+||.||+|++. ++.||+|++...... +....+|.+|+.++++++||||+++++++...+..|+|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 4556999999999999999974 688999999865433 3445789999999999999999999999999999999999
Q ss_pred eccCCccccccccc----------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 323 FMSGGSIYDYLHKQ----------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 323 y~~ggsL~~~l~~~----------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
|++|++|.+++... ....+...++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCccee
Confidence 99999999988531 12355677899999999999999999999999999999999999999999999976
Q ss_pred ccccC-------------------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010091 393 QAQYG-------------------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVG 453 (518)
Q Consensus 393 ~~~~~-------------------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~ 453 (518)
..... ......||+.|+|||++.+..++.++|||||||++|||+||..||...........
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~ 242 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh
Confidence 52110 01123589999999999999999999999999999999999999987554332221
Q ss_pred HHhcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHHHHH
Q 010091 454 VVQKG-LRPTIPVHTHPILVDLLERCWQRDPSLR-PDFSEITELLQHLAQR 502 (518)
Q Consensus 454 ~~~~~-~~p~~~~~~~~~L~~Li~~cL~~dP~~R-Ps~~eil~~L~~l~~~ 502 (518)
..... ........+++.+.+++.+||+.||.+| ++++++++.|+.+++.
T Consensus 243 ~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 243 DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11101 0111123578899999999999999999 5788888888887653
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.82 Aligned_cols=252 Identities=29% Similarity=0.535 Sum_probs=208.2
Q ss_pred ceeeeEEeEecceEEEEEEEC-----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC------
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------ 315 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~------ 315 (518)
|++.+.||+|+||.||+|.+. ++.||||+++....+....+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455789999999999999853 478999999877666666688999999999999999999999875432
Q ss_pred ceeEEEeeccCCccccccccc-----cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQ-----KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~-----~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
..++++||+.+++|.+++... ...++...++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247899999999998886421 224788899999999999999999999999999999999999999999999998
Q ss_pred eeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 010091 391 RVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466 (518)
Q Consensus 391 ~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~ 466 (518)
+...... ......++..|++||.+....++.++||||||+++|+|++ |..||......+...... .......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCCCC
Confidence 7543321 1122345678999999998889999999999999999999 899998776654443333 3333444556
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
.+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=312.98 Aligned_cols=254 Identities=30% Similarity=0.495 Sum_probs=204.1
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeee--
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACT-- 312 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~-- 312 (518)
+.+.....+|++.+.||+|+||.||++... ++.+|+|++..... ....+..|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 334445556667999999999999999864 68899999875322 225677899999999 6999999999873
Q ss_pred ---cCCceeEEEeeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEee
Q 010091 313 ---RPPRLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVAD 386 (518)
Q Consensus 313 ---~~~~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~D 386 (518)
.....|+||||++|++|.+++.. ....+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 34578999999999999998753 234688899999999999999999999999999999999999999999999
Q ss_pred eccceeccccC-ccccCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Q 010091 387 FGVARVQAQYG-VMTAETGTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR 460 (518)
Q Consensus 387 FG~a~~~~~~~-~~~~~~gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~ 460 (518)
||++....... ......|+..|+|||.+. +..++.++|+||||+++|+|++|..||....+......... ...
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~-~~~ 246 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR-NPP 246 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc-cCC
Confidence 99987654322 222345899999999884 34578899999999999999999999987766544432221 211
Q ss_pred C--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 461 P--TIPVHTHPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 461 p--~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
+ ..+..++..+.++|.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 2 2344567889999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=316.66 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=201.8
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|.+.++||.|+||.||+|++. ++.||+|.++..... .....+.+|+.++++++||||+++++++......|+||||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4555999999999999999865 688999998754322 2234677899999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
++ ++|.+++.+....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .....
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE 164 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccccc
Confidence 96 59999988766678999999999999999999999999999999999999999999999999997543322 22234
Q ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------C-C---C
Q 010091 403 TGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG----------------L-R---P 461 (518)
Q Consensus 403 ~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~----------------~-~---p 461 (518)
.++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+........- + . +
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccC
Confidence 57889999998865 457889999999999999999999998776543332211100 0 0 0
Q ss_pred --------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 --------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 --------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.....+++++.++|.+||+.||.+|||++|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011346788999999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.91 Aligned_cols=238 Identities=26% Similarity=0.479 Sum_probs=197.7
Q ss_pred eEEeEecceEEEEEEEC---------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 251 HKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~---------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+.||+|+||.||+|... ...+++|.+.... ....+.|..|+.+++.++||||+++++++......++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 36899999999999863 2348888876432 233467889999999999999999999999888999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc--------EEEeeeccceec
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV--------VKVADFGVARVQ 393 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~--------vkL~DFG~a~~~ 393 (518)
||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++. ++++|||.+...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999999876667899999999999999999999999999999999999987664 699999988654
Q ss_pred cccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 394 AQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTG-KLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG-~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
.. .....++..|+|||++.+ ..++.++|+||||+++|+|++| ..||...++.... .... .+..++...+.++
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~ 232 (258)
T cd05078 159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYE--DRHQLPAPKWTEL 232 (258)
T ss_pred CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHH--ccccCCCCCcHHH
Confidence 32 223457889999999976 4579999999999999999998 5777766554432 2222 2345666677899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~L 496 (518)
.+++.+||+.+|.+|||++++++.|
T Consensus 233 ~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 233 ANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHhccChhhCCCHHHHHHhc
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=328.04 Aligned_cols=249 Identities=27% Similarity=0.503 Sum_probs=228.4
Q ss_pred cccceeeeEEeEecceEEEEEE--ECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~--~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
...|.+.+.||+|.|+.|-+++ +.|..||||++.....++-....+.+|++.|+.++|||||++|.....+..+|+|.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3467779999999999999998 57999999999999988887888999999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec-cCCcEEEeeeccceeccccCccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~ 400 (518)
|.-.+|+|++|+.+....+.+....+++.||+.|+.|+|+..+|||||||+||.+- .-|.|||.|||++-........+
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 99999999999998888899999999999999999999999999999999998775 45999999999998777777788
Q ss_pred cCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 401 AETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~-~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
+.+|+..|.|||++.+..|+ ++.||||||+|||.|.+|+.||......+.+..++.. .+..|...+.+.++||..||
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC--KYtvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC--KYTVPSHVSKECRDLIQSML 254 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc--cccCchhhhHHHHHHHHHHH
Confidence 88999999999999998887 5789999999999999999999998888877666644 46788999999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
..||.+|.+.+||..
T Consensus 255 vRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 255 VRDPKKRASLEEIVS 269 (864)
T ss_pred hcCchhhccHHHHhc
Confidence 999999999999864
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=307.95 Aligned_cols=247 Identities=34% Similarity=0.568 Sum_probs=209.4
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.+.||.|+||+||+|... +..+++|++....... ....+.+|+.+++.++|+||+++++.+......|+||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4666999999999999999864 6789999997655444 457889999999999999999999999999999999999
Q ss_pred ccCCcccccccccc--CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc--
Q 010091 324 MSGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM-- 399 (518)
Q Consensus 324 ~~ggsL~~~l~~~~--~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 399 (518)
+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999999997632 46899999999999999999999999999999999999999999999999998754432211
Q ss_pred ---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC-----CCCcHH
Q 010091 400 ---TAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP-----VHTHPI 470 (518)
Q Consensus 400 ---~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~-----~~~~~~ 470 (518)
....|+..|+|||.+... .++.++|+||||+++|+|++|+.||...++.+......... .+..+ ..+++.
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYSKS 239 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccccccHH
Confidence 223588999999998766 78999999999999999999999998887766655544432 22222 256788
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+.+++.+||+.||.+||++.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhh
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=304.26 Aligned_cols=247 Identities=28% Similarity=0.524 Sum_probs=217.5
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|.+.+.||.|+||.||++.+. ++.|++|++............+.+|+.++++++|+|++++++.+......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 566899999999999999976 789999999887666666788999999999999999999999999999999999999
Q ss_pred cCCccccccccc---cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccc
Q 010091 325 SGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMT 400 (518)
Q Consensus 325 ~ggsL~~~l~~~---~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 400 (518)
++++|.+++... ...+++..++.++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK 161 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceec
Confidence 999999999764 3679999999999999999999999999999999999999999999999999997654432 222
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
...|++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+....... ...+.++..++..+.+++.+||.
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 240 (258)
T cd08215 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVSSLLQ 240 (258)
T ss_pred ceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcC
Confidence 34588899999999888899999999999999999999999988776665555443 34556677888999999999999
Q ss_pred hCCCCCCCHHHHHH
Q 010091 481 RDPSLRPDFSEITE 494 (518)
Q Consensus 481 ~dP~~RPs~~eil~ 494 (518)
.+|.+|||+.++++
T Consensus 241 ~~p~~Rp~~~~ll~ 254 (258)
T cd08215 241 KDPEERPSIAQILQ 254 (258)
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=306.69 Aligned_cols=262 Identities=20% Similarity=0.326 Sum_probs=213.3
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
.+.-.|+.++|++.+.||+|+|+-||+++. .+..+|+|.+.-.. .+..+..++|+...++++||||++++++...+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 455678999999999999999999999983 46889999988764 34457888999999999999999999987444
Q ss_pred C-----ceeEEEeeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEeccCCcEEE
Q 010091 315 P-----RLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVVKV 384 (518)
Q Consensus 315 ~-----~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~~~~~vkL 384 (518)
. ..|++++|+..|||.+.+.. .+..+++.+++.++.+|++||++||... ++||||||.|||+++.+..+|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 3 48999999999999999864 2346999999999999999999999999 999999999999999999999
Q ss_pred eeeccceecccc----------CccccCCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010091 385 ADFGVARVQAQY----------GVMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA 451 (518)
Q Consensus 385 ~DFG~a~~~~~~----------~~~~~~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~ 451 (518)
.|||.++...-. .....+.+|..|+|||.++ +...+.++|||||||++|.|+.|..||+..-.....
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 999999753221 1123456899999999984 667889999999999999999999999743211100
Q ss_pred --HHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 452 --VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 452 --~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
..+....+.-+....++..+.++|++|++.||.+||+..+++..++++.
T Consensus 251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0111112221222347899999999999999999999999999988764
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=328.01 Aligned_cols=240 Identities=22% Similarity=0.341 Sum_probs=196.1
Q ss_pred EeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhc---CCCceeeEeeeeecCCceeEEEeeccC
Q 010091 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV---RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
||+|+||.||+|+.. ++.||+|++...... ......+..|..++.++ +||||+++++++......|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 689999999999865 688999999754322 22334556677777765 699999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGT 405 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt 405 (518)
++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 999999876 4578999999999999999999999999999999999999999999999999987533222 22335689
Q ss_pred CcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCC
Q 010091 406 YRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPS 484 (518)
Q Consensus 406 ~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~ 484 (518)
..|+|||++.+. .++.++|||||||++|+|++|..||......+....+.....+ ......++++.++|.+||+.||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-FPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCCHH
Confidence 999999998654 4799999999999999999999999887765554443332221 12234688999999999999999
Q ss_pred CCC----CHHHHHH
Q 010091 485 LRP----DFSEITE 494 (518)
Q Consensus 485 ~RP----s~~eil~ 494 (518)
+|| ++.++++
T Consensus 239 ~R~~~~~~~~~ll~ 252 (330)
T cd05586 239 HRLGAHRDAVELKE 252 (330)
T ss_pred HCCCCCCCHHHHhc
Confidence 998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=315.13 Aligned_cols=250 Identities=27% Similarity=0.438 Sum_probs=208.5
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
..++|++.++||+|+||.||++.+. ++.||+|++.... .......|.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 3456777999999999999999975 7889999987643 234457889999999999999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 399 (518)
|||+++++|.+++.+ .+.+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++....... .
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~ 159 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-A 159 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-c
Confidence 999999999999877 4568999999999999999999997 599999999999999999999999999986542221 2
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHHhcCCCCCCCCC-C
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL-----------QAAVGVVQKGLRPTIPVH-T 467 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~-----------~~~~~~~~~~~~p~~~~~-~ 467 (518)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||...... ....... ....+.++.. +
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPSSDF 238 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCCchhc
Confidence 2346899999999998888999999999999999999999999865432 1111111 1223333333 7
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~~L 496 (518)
+.++.+++.+||+.||.+|||+.|++...
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 78899999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.73 Aligned_cols=246 Identities=25% Similarity=0.432 Sum_probs=203.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.++||+|+||.||++.+. +..+|+|.+.... .......+.+|+.++++++||||+++++++...+..|+||||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4667999999999999999875 5778999887543 344456788999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
++|++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...... .....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~ 158 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF 158 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccC
Confidence 9999999999773 568999999999999999999997 59999999999999999999999999998654332 12335
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------------------------
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ-------------------------- 456 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~-------------------------- 456 (518)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..... ....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCccchh
Confidence 6889999999998888999999999999999999999999654422211 1111
Q ss_pred ----------cCCCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 457 ----------KGLRPTIPV-HTHPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 457 ----------~~~~p~~~~-~~~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
....+..+. .+++++.+++.+||..+|.+|||+.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122222 357789999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=316.45 Aligned_cols=246 Identities=28% Similarity=0.487 Sum_probs=206.6
Q ss_pred ccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
..|++.+.||+|+||.||++.. .++.||+|.+....... ...+.+|+.+++.++|+||+++++++......|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 3455599999999999999986 47899999997654332 3668899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-ccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~ 401 (518)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+........ ...
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 9999999999865 3578899999999999999999999999999999999999999999999999876443221 223
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~~cL~ 480 (518)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+..........+. ....+...++.+.+++.+||+
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE 254 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHcc
Confidence 4688999999999988899999999999999999999999987655443322221111 222345678889999999999
Q ss_pred hCCCCCCCHHHHHH
Q 010091 481 RDPSLRPDFSEITE 494 (518)
Q Consensus 481 ~dP~~RPs~~eil~ 494 (518)
.+|.+||++.+++.
T Consensus 255 ~~p~~Rps~~~il~ 268 (297)
T cd06656 255 MDVDRRGSAKELLQ 268 (297)
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=311.99 Aligned_cols=246 Identities=29% Similarity=0.522 Sum_probs=201.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeec------CCc
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR------PPR 316 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~------~~~ 316 (518)
.|++.+.||.|+||.||+|.+. ++.+|+|++.... .....+..|+.+++++ +|+||+++++++.. ...
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 4455899999999999999974 6889999986542 2345688899999998 79999999998842 457
Q ss_pred eeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||.+.....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 899999999999999987533 3588888999999999999999999999999999999999999999999999875432
Q ss_pred c-CccccCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010091 396 Y-GVMTAETGTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 396 ~-~~~~~~~gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
. .......|+..|+|||.+. +..++.++|+||||+++|+|++|..||....+...................++.
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCH
Confidence 2 1223345889999999885 456888999999999999999999999877665554433332222333446788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+.++|.+||+.||.+|||+.|+++
T Consensus 254 ~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 254 KFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHHHHHHHHhCCChhhCcCHHHHhc
Confidence 9999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=300.35 Aligned_cols=245 Identities=35% Similarity=0.624 Sum_probs=211.3
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|...+.||+|++|.||++... ++.+++|++..... .....+.+|+.++++++|+||+++++.+......++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 556899999999999999975 78899999987543 34578899999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETG 404 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~g 404 (518)
++++|.+++......+++..+..++.|++.||.|||++|++||||+|.||+++.++.++|+|||.+.............+
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 159 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence 99999999987656799999999999999999999999999999999999999999999999999976554332234568
Q ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHHHhhhhC
Q 010091 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVH--THPILVDLLERCWQRD 482 (518)
Q Consensus 405 t~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~L~~Li~~cL~~d 482 (518)
+..|++||.+.+..++.++|+||||+++|+|++|..||...+..+....... ...+..+.. ++..+.+++.+||+.|
T Consensus 160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (253)
T cd05122 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKN 238 (253)
T ss_pred CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCC
Confidence 8999999999888899999999999999999999999988765555444333 333333333 3788999999999999
Q ss_pred CCCCCCHHHHHH
Q 010091 483 PSLRPDFSEITE 494 (518)
Q Consensus 483 P~~RPs~~eil~ 494 (518)
|.+|||+.+++.
T Consensus 239 p~~R~t~~~~l~ 250 (253)
T cd05122 239 PEKRPTAEQLLK 250 (253)
T ss_pred hhhCCCHHHHhc
Confidence 999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=313.77 Aligned_cols=245 Identities=33% Similarity=0.579 Sum_probs=209.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|+..+.||+|+||.||+|.+. ++.||+|.+...... .....+.+|+.++++++||||+++++.+......|+||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3555788999999999999864 678999998755433 3457889999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-cccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~ 402 (518)
+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||++++++.++|+|||++........ ....
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 999999999865 3588999999999999999999999999999999999999999999999999875443221 1223
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||....+...... ......+..+...+..+.+++.+||+.+
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPKNSPPTLEGQYSKPFKEFVEACLNKD 240 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence 578899999999988899999999999999999999999987665443332 3334456666678889999999999999
Q ss_pred CCCCCCHHHHHH
Q 010091 483 PSLRPDFSEITE 494 (518)
Q Consensus 483 P~~RPs~~eil~ 494 (518)
|.+||++.+++.
T Consensus 241 p~~Rp~~~~il~ 252 (277)
T cd06642 241 PRFRPTAKELLK 252 (277)
T ss_pred cccCcCHHHHHH
Confidence 999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.82 Aligned_cols=247 Identities=28% Similarity=0.492 Sum_probs=210.7
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|.+.+.||.|+||.||++... +..+|+|.+............+.+|+.++++++|+||+++++.+......|+|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 566999999999999999975 688999999876544444567889999999999999999999999999999999999
Q ss_pred cCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-cEEEeeeccceeccccCc-ccc
Q 010091 325 SGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFGVARVQAQYGV-MTA 401 (518)
Q Consensus 325 ~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-~vkL~DFG~a~~~~~~~~-~~~ 401 (518)
++++|.+++..... .+++..++.++.|++.||.|||+++++|+||||+||++++++ .+||+|||.+........ ...
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccc
Confidence 99999999976433 578999999999999999999999999999999999999885 569999999876543321 122
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....... ...+..+...+..+.+++.+||+.
T Consensus 162 ~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~ 240 (257)
T cd08225 162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRDLRSLISQLFKV 240 (257)
T ss_pred cCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHHhcc
Confidence 4588999999999888899999999999999999999999988776655544443 334445556788999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
+|.+|||+.+++.
T Consensus 241 ~p~~Rpt~~~ll~ 253 (257)
T cd08225 241 SPRDRPSITSILK 253 (257)
T ss_pred ChhhCcCHHHHhh
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.65 Aligned_cols=249 Identities=31% Similarity=0.531 Sum_probs=217.3
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC--ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
..|.|+| +..||.|+||.||++.... -..|-|++... +++..+.|+-|+.||..++||+||+++++|..
T Consensus 30 P~d~WeI-------iGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~ 100 (1187)
T KOG0579|consen 30 PRDHWEI-------IGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYF 100 (1187)
T ss_pred HHHHHHH-------HhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc
Confidence 3578999 9999999999999998663 34566776543 45556889999999999999999999999999
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
.+.++|+.|||.||.+...+-.-...++++++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||++-..
T Consensus 101 enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 101 ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc
Confidence 99999999999999999988877778999999999999999999999999999999999999999999999999998543
Q ss_pred ccc-CccccCCCCCcccChhhh-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCC
Q 010091 394 AQY-GVMTAETGTYRWMAPEVI-----EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--IPV 465 (518)
Q Consensus 394 ~~~-~~~~~~~gt~~y~APE~l-----~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~--~~~ 465 (518)
... .......||++|||||+. ...+|+.++|||||||+|.||..+.+|....++...+..+... -+|+ -|.
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-ePPTLlqPS 259 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLLQPS 259 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-CCCcccCcc
Confidence 322 234557899999999986 5678999999999999999999999999999998888765543 3333 367
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 466 HTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 466 ~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.++..+.+++.+||.+||..||++.++++
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 88999999999999999999999999875
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.81 Aligned_cols=247 Identities=29% Similarity=0.528 Sum_probs=204.9
Q ss_pred ceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccC--------HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 247 LKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLN--------ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~--------~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
|...+.||+|+||.||+|.. .++.||+|.++..... ....+.+.+|+.++++++|+||+++++++.....
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 44488999999999999985 4788999988643211 1223578889999999999999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.++||||+++++|.+++.+. +.++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999874 57899999999999999999999999999999999999999999999999999754322
Q ss_pred C---ccccCCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC----CCC
Q 010091 397 G---VMTAETGTYRWMAPEVIEHQP--YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP----VHT 467 (518)
Q Consensus 397 ~---~~~~~~gt~~y~APE~l~~~~--~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~----~~~ 467 (518)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|..||......+...........+.++ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1 122345889999999987654 7899999999999999999999998766655544433333333333 345
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+..+.+++.+||+.+|.+||++.+++.
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.92 Aligned_cols=247 Identities=29% Similarity=0.508 Sum_probs=206.8
Q ss_pred ceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccC----HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLN----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~----~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
|+..+.||+|++|.||++.. .++.||+|++...... ......+.+|+.++++++|+||+++++++...+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 45588999999999999986 4788999999754322 22457889999999999999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-cEEEeeeccceeccccCc-
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFGVARVQAQYGV- 398 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-~vkL~DFG~a~~~~~~~~- 398 (518)
|||++|++|.+++.+ ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 82 VEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999976 45788999999999999999999999999999999999998775 699999999876543211
Q ss_pred ----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCCcHHH
Q 010091 399 ----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL---QAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 399 ----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ............+..+...++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence 11235788999999998888999999999999999999999999754322 22222222344566777788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+++.+||..+|.+||++.+++.
T Consensus 241 ~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 241 RDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHhc
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=307.93 Aligned_cols=244 Identities=25% Similarity=0.498 Sum_probs=196.9
Q ss_pred EEeEecceEEEEEEEC-Cc---cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 252 KIVSGSYCDLYKGAFF-SQ---DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~-~~---~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
+||+|+||.||+|... +. .+++|.++.... ......|.+|+.+++.++||||+++++.+......|+||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5899999999999743 32 456666655432 234578999999999999999999999999999999999999999
Q ss_pred cccccccccc---CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC---cccc
Q 010091 328 SIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG---VMTA 401 (518)
Q Consensus 328 sL~~~l~~~~---~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~ 401 (518)
+|.+++.+.. ...+...++.++.||+.||+|||+.+++||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 9999997532 235667788999999999999999999999999999999999999999999985422211 1223
Q ss_pred CCCCCcccChhhhcC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC----CCCCCCCCCcH
Q 010091 402 ETGTYRWMAPEVIEH-------QPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKG----LRPTIPVHTHP 469 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-------~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~----~~p~~~~~~~~ 469 (518)
..++..|+|||++.. ..++.++||||||+++|||++ |..||...++.+......... .++.++...++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 457889999998743 245789999999999999997 678998877766555444332 34556666788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
.+.+++..|| .+|.+||+++++++.|.
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 9999999999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.31 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=204.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--CceeEEE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFIVT 321 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 321 (518)
.|++.+.||.|+||.||+|++. ++.+++|.++.....+.....+.+|+.++++++||||+++++++... ...|+||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 5666899999999999999975 67899999987655444445677899999999999999999998776 8899999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-Cccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMT 400 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~ 400 (518)
||++ ++|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ....
T Consensus 86 e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 164 (293)
T cd07843 86 EYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT 164 (293)
T ss_pred hhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccc
Confidence 9996 5999988775557999999999999999999999999999999999999999999999999999865543 2223
Q ss_pred cCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------------------
Q 010091 401 AETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK---------------------- 457 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~---------------------- 457 (518)
...++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+...
T Consensus 165 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (293)
T cd07843 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT 244 (293)
T ss_pred cccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccc
Confidence 34578899999998654 4689999999999999999999999877655443332210
Q ss_pred -------CCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 458 -------GLRPTIPVH-THPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 458 -------~~~p~~~~~-~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+...++.. .++.+.++|.+||+.+|.+|||+.|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 011122222 5788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=310.23 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=205.1
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.++||+|+||.||+|... ++.||+|+++....+......+.+|+.++++++|+||+++++++...+..|+||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 4667999999999999999975 68899999987655555567899999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC--cccc
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG--VMTA 401 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~~ 401 (518)
++++.+..+..+ ...++...++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||.+....... ....
T Consensus 82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 988766655544 4568999999999999999999999999999999999999999999999999987654433 2233
Q ss_pred CCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--C--------------CC----
Q 010091 402 ETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK--G--------------LR---- 460 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~--~--------------~~---- 460 (518)
..++..|+|||++.+. .++.++|+||||+++|+|++|..||............... . +.
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 5578899999999877 8899999999999999999999999876544333221110 0 00
Q ss_pred ----------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 ----------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 ----------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
...+..+++++.++|.+||..+|.+||++++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0112334788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=311.29 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=203.8
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC---HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~---~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
|++.+.||+|++|.||+|.+. ++.||+|.++..... ......+..|+.++++++|+||+++++++......|+||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 667889999999999999974 689999999876544 334466778999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMT 400 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 400 (518)
||+ +++|.+++......+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||+++...... ...
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence 999 899999997744479999999999999999999999999999999999999999999999999998655432 223
Q ss_pred cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------------------
Q 010091 401 AETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-------------------- 459 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-------------------- 459 (518)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....+............
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T cd07841 161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK 240 (298)
T ss_pred ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccc
Confidence 3457888999998854 5678999999999999999999888877665443322221100
Q ss_pred -CCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 -RPT-----IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 -~p~-----~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+. .....+..+.++|.+||+.+|.+|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000 11334678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=325.97 Aligned_cols=241 Identities=23% Similarity=0.352 Sum_probs=193.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
..|++.+.||+|+||.||+|+.. ++.||+|+.... ....|+.++++++|+||+++++++......|+|||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 45777999999999999999976 468999985433 23468999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
|+ .++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.++...........
T Consensus 138 ~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 138 HY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred cc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence 99 56899998776678999999999999999999999999999999999999999999999999999764433333445
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCHH---------HHHHHHHhc-CC-CCCCC------
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKL-PYDDLTPL---------QAAVGVVQK-GL-RPTIP------ 464 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~-P~~~~~~~---------~~~~~~~~~-~~-~p~~~------ 464 (518)
.||..|+|||++.+..++.++|||||||++|||+++.. +|...... ......+.. +. ...++
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 68999999999999999999999999999999998544 44331110 001111110 00 00011
Q ss_pred ------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 465 ------------------------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 465 ------------------------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..++.++.++|.+||+.||.+|||+.|++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 134556778999999999999999999875
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.43 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=203.1
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.++||+|+||.||++.+. ++.||+|++............+.+|+.++++++||||+++++++......|+||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 4666999999999999999975 68899999876544444456788999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
+++++|..+... ...+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++....... .....
T Consensus 82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 82 VDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred CCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 999888887665 4458999999999999999999999999999999999999999999999999987643322 22334
Q ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--C------------------CCC
Q 010091 403 TGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK--G------------------LRP 461 (518)
Q Consensus 403 ~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~--~------------------~~p 461 (518)
.++..|+|||++.+ ..++.++||||||+++|+|++|..||...+..+........ . ..+
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 57889999999865 45788999999999999999999999765543322221110 0 000
Q ss_pred C---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 T---------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ~---------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. ....++..+.+++.+||+.+|.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 12356788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=306.07 Aligned_cols=245 Identities=33% Similarity=0.572 Sum_probs=210.7
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|++.++||+|+||.||+|... ++.||+|++..... ......|.+|+.++++++||||+++++++......|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4666889999999999999864 67899999875433 23446888999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 999999999865 358899999999999999999999999999999999999999999999999987543322 12234
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||....+...... +..+..+..+..++.++.+++.+||+.+
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPPTLEGNYSKPLKEFVEACLNKE 240 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence 578899999999888899999999999999999999999987766544433 3334556667778899999999999999
Q ss_pred CCCCCCHHHHHH
Q 010091 483 PSLRPDFSEITE 494 (518)
Q Consensus 483 P~~RPs~~eil~ 494 (518)
|.+||++.+++.
T Consensus 241 p~~Rp~~~~~l~ 252 (277)
T cd06641 241 PSFRPTAKELLK 252 (277)
T ss_pred hhhCcCHHHHHh
Confidence 999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.76 Aligned_cols=246 Identities=33% Similarity=0.530 Sum_probs=201.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCC------
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP------ 315 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~------ 315 (518)
++|++.+.||+|++|.||+|... ++.+++|++..... ....|.+|+.+++++ +|+||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 34555999999999999999974 57899999876532 336788999999999 7999999999986544
Q ss_pred ceeEEEeeccCCccccccccc---cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
.+|+||||+++++|.+++... +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 489999999999999988653 35789999999999999999999999999999999999999999999999999876
Q ss_pred ccccC-ccccCCCCCcccChhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--C
Q 010091 393 QAQYG-VMTAETGTYRWMAPEVIEH-----QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--P 464 (518)
Q Consensus 393 ~~~~~-~~~~~~gt~~y~APE~l~~-----~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~--~ 464 (518)
..... ......|+..|+|||.+.. ..++.++||||||+++|+|++|..||....+......... ...+.. +
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 241 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR-NPPPTLKSP 241 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc-cCCCCCCch
Confidence 43322 2233458899999998743 3467899999999999999999999987665554444332 222222 2
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 465 VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 465 ~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..++..+.+++.+||..||.+|||+.+++.
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 236778999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=302.70 Aligned_cols=246 Identities=29% Similarity=0.490 Sum_probs=214.4
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|++.++||.|+||.||+++.. ++.+++|.+......+.....+.+|+.++++++|+||+++++++......|+||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 566899999999999999864 678999999876666666678889999999999999999999999889999999999
Q ss_pred cCCccccccccc---cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcccc
Q 010091 325 SGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 325 ~ggsL~~~l~~~---~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.+||+|||++...... ....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~ 160 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKT 160 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cccc
Confidence 999999998652 245889999999999999999999999999999999999999999999999999776543 2233
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..++..|++||.+.+..++.++|+||||+++|+|++|+.||...+....... +..+..+..+..++.++.+++.+||+.
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK-VQRGKYPPIPPIYSQDLQNFIRSMLQV 239 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhcCCCCCCchhhCHHHHHHHHHHcCC
Confidence 5688999999999999999999999999999999999999988876544433 334445556667889999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
+|.+||++.+++.
T Consensus 240 ~p~~Rp~~~~~l~ 252 (256)
T cd08530 240 KPKLRPNCDKILA 252 (256)
T ss_pred CcccCCCHHHHhc
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=299.09 Aligned_cols=246 Identities=35% Similarity=0.617 Sum_probs=215.7
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|++.+.||+|++|.||+++.. ++.|++|.+......+.....+.+|+.++++++|+|++++++++......|++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 566899999999999999864 678999999887665566688999999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-cccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~ 403 (518)
++++|.+++... ..+++..++.++.|++.|+.|||++|++||||+|+||+++.++.++|+|||.+........ .....
T Consensus 82 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 82 ENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 999999998774 5789999999999999999999999999999999999999999999999999986554332 22345
Q ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCC
Q 010091 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDP 483 (518)
Q Consensus 404 gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP 483 (518)
++..|+|||...+..++.++|+||||+++|+|++|..||....+......... ...+.++...+..+.+++.+||..+|
T Consensus 161 ~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p 239 (254)
T cd06627 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQCFQKDP 239 (254)
T ss_pred cchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCCHHHHHHHHHHHhCCh
Confidence 88999999999888889999999999999999999999988776555544433 44556777889999999999999999
Q ss_pred CCCCCHHHHHH
Q 010091 484 SLRPDFSEITE 494 (518)
Q Consensus 484 ~~RPs~~eil~ 494 (518)
++||++.+++.
T Consensus 240 ~~R~~~~~~l~ 250 (254)
T cd06627 240 NLRPTAKQLLK 250 (254)
T ss_pred hhCcCHHHHhc
Confidence 99999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.21 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=219.5
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV 320 (518)
..|.+.+.||.|.||.||+++.. |+.+|+|++....... .....+.+|+.+|+++. |||||.++++++....+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 34666899999999999999965 7889999998765432 34568889999999998 99999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC----CcEEEeeeccceecccc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN----GVVKVADFGVARVQAQY 396 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~----~~vkL~DFG~a~~~~~~ 396 (518)
||++.||.|.+.+.+. .+++..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||++......
T Consensus 115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 9999999999999875 39999999999999999999999999999999999999643 47999999999987775
Q ss_pred CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHH
Q 010091 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILVDL 474 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~L~~L 474 (518)
.......||+.|+|||++...+|+...||||+|+++|.|++|..||.+.+.......+....+. ...-..++..+.++
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~ 272 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDF 272 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence 5666778999999999999999999999999999999999999999999988888777765552 22224568899999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~ 494 (518)
+.+|+..||..|+|+.++++
T Consensus 273 i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 273 IRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHhcccCcccCCCHHHHhc
Confidence 99999999999999999987
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=303.44 Aligned_cols=247 Identities=27% Similarity=0.468 Sum_probs=209.7
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc---CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--Ccee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLF 318 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~---~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 318 (518)
.|.+.+.||+|+||.||+|+.. +..||+|++..... .......|.+|+.++++++|+||+++++++... ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 4566999999999999999864 68899998864321 223447888999999999999999999988653 4588
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc--
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-- 396 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-- 396 (518)
++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999998763 45889999999999999999999999999999999999999999999999999754321
Q ss_pred --CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 397 --GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 397 --~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
...+...++..|+|||.+.+..++.++|+||||+++|+|++|+.||.................++.+|...++.+.++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 241 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence 112234588999999999888899999999999999999999999998877766665555556677888899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~ 494 (518)
+.+||+ +|..||++.+++.
T Consensus 242 i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 242 LKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHhc-CcccCccHHHHhc
Confidence 999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.71 Aligned_cols=247 Identities=23% Similarity=0.351 Sum_probs=193.9
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC------CceeeEeeeee
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACT 312 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H------pnIv~l~~~~~ 312 (518)
++...+|++.++||+|+||.||+|.+. ++.||||+++... .....+..|+.++++++| .+++++++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 344567888999999999999999864 6789999997532 223445667777777654 45888988886
Q ss_pred cC-CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCC----------
Q 010091 313 RP-PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENG---------- 380 (518)
Q Consensus 313 ~~-~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~---------- 380 (518)
.. .++|+|||++ |++|.+++.+ .+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 54 5789999998 7899999876 4579999999999999999999998 5999999999999998765
Q ss_pred ------cEEEeeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 010091 381 ------VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGV 454 (518)
Q Consensus 381 ------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~ 454 (518)
.+||+|||.+..... ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998864322 233467999999999999999999999999999999999999999876654433221
Q ss_pred HhcC-------------------------CCCCC---------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 455 VQKG-------------------------LRPTI---------------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 455 ~~~~-------------------------~~p~~---------------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.... +.+.. .....+.+.+||.+||+.||.+|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 1100 00000 0012356789999999999999999999986
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=312.64 Aligned_cols=244 Identities=30% Similarity=0.477 Sum_probs=204.4
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|++.++||+|+||.||+|+.. ++.||+|++..... .......+.+|+.+++.++||||+++++++......|+|||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3666899999999999999964 78899999875432 33445678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
|+. ++|.+++......+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...... ...
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~ 171 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSF 171 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CCc
Confidence 996 5777777654557899999999999999999999999999999999999999999999999998764332 235
Q ss_pred CCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCCcHHHHHHHHHh
Q 010091 403 TGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI-PVHTHPILVDLLERC 478 (518)
Q Consensus 403 ~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~L~~Li~~c 478 (518)
.+++.|+|||++. ...++.++||||||+++|+|++|..||.............. ...+.. +..++..+.++|.+|
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 250 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTLSSNDWSDYFRNFVDSC 250 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-CCCCCCCchhhCHHHHHHHHHH
Confidence 6888999999873 45688999999999999999999999988776554433332 222332 345678899999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.+|.+||++.+++.
T Consensus 251 l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 251 LQKIPQDRPSSEELLK 266 (307)
T ss_pred hcCChhhCcCHHHHhc
Confidence 9999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.12 Aligned_cols=246 Identities=21% Similarity=0.353 Sum_probs=198.3
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
.+-..+|.+.++||+|+||.||++... +..||+|.+... ..+.+|+.++++++||||+++++++.....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 344556888999999999999999854 367999988653 234579999999999999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.|+|||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 161 ~~lv~e~~-~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEehhc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 99999999 4688888844 567999999999999999999999999999999999999999999999999999754332
Q ss_pred Cc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHh--------------
Q 010091 397 GV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQ-------------- 456 (518)
Q Consensus 397 ~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~-------------- 456 (518)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......++.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 21 1234589999999999999999999999999999999999999965432 111111110
Q ss_pred -----------cCCCCCC--C-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 457 -----------KGLRPTI--P-----VHTHPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 457 -----------~~~~p~~--~-----~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
...++.. + ...+.++.++|.+||..||.+|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011111 1 2346678999999999999999999999763
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=315.38 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=218.6
Q ss_pred eeccccceeeeEEeEecceEEEEEEECC--ccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
.+..+.+++.+.||.|.-|+||++...+ ..+|+|++....... .-..+...|-.||+.++||.++.+|..++.+...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 5666677789999999999999999875 789999998775543 3336777899999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc-
Q 010091 318 FIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ- 395 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~- 395 (518)
|++||||+||+|...++++.+ .++++.++-++..++-||+|||-.|||.|||||+||||-++|+|.|+||.++.....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999999999987665 599999999999999999999999999999999999999999999999999742100
Q ss_pred --------------------------------c-Cc-----------------------cccCCCCCcccChhhhcCCCC
Q 010091 396 --------------------------------Y-GV-----------------------MTAETGTYRWMAPEVIEHQPY 419 (518)
Q Consensus 396 --------------------------------~-~~-----------------------~~~~~gt~~y~APE~l~~~~~ 419 (518)
. .. .....||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 00 001238889999999999999
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC----HHHHHH
Q 010091 420 NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPD----FSEITE 494 (518)
Q Consensus 420 ~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs----~~eil~ 494 (518)
+.+.|+|+|||.+|||+.|.-||.+....+.+..++.+.+.-.-....+..+++||++.|.+||.+|-. +.||.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 999999999999999999999999999999999999776643333467788999999999999999976 666643
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=305.72 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=198.4
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecC--CceeEEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRP--PRLFIVT 321 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~--~~~~lV~ 321 (518)
|++.++||+|+||.||+|+.. ++.||+|+++....+... ....+|+.+++++. |+||+++++++... +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 456899999999999999964 688999998765433322 34457889999885 99999999999877 8899999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
||++ ++|.+++......+++..++.++.|++.||.|||++|++||||+|+||+++. +.+||+|||.+...........
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence 9996 5888888765567899999999999999999999999999999999999999 9999999999986554444344
Q ss_pred CCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------CCCCC-
Q 010091 402 ETGTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG----------------LRPTI- 463 (518)
Q Consensus 402 ~~gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~----------------~~p~~- 463 (518)
..++..|+|||.+. +..++.++|+|||||++|||++|..||...+..+......... .....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 56889999999764 4557889999999999999999999998776544332221100 00001
Q ss_pred ----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 464 ----------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 464 ----------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....+..+.++|.+||+++|.+||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1245788999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=312.44 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=203.0
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--CceeEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFIV 320 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV 320 (518)
+.|++.+.||.|+||.||+|.+. ++.||+|+++.....+.....+.+|+.++++++|+||+++++++... ..+|+|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 44566999999999999999974 78999999986544433334567899999999999999999998654 568999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VM 399 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 399 (518)
|||+. ++|.+++......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||.+....... ..
T Consensus 87 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 165 (309)
T cd07845 87 MEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165 (309)
T ss_pred EecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCC
Confidence 99995 58888887655679999999999999999999999999999999999999999999999999998654432 22
Q ss_pred ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----------------
Q 010091 400 TAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP----------------- 461 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p----------------- 461 (518)
+...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...++.+....+......+
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence 33346788999999865 567999999999999999999999999887766554443311000
Q ss_pred CCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 TIP-----------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ~~~-----------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+ ...++.+.++|.+||+.||.+|||+++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 124778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=308.63 Aligned_cols=245 Identities=33% Similarity=0.574 Sum_probs=209.2
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|.+.+.||+|++|.||++.+. ++.|++|++..... ....+..|+.++++++|+||+++++.+......|+|+||+
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 97 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence 555889999999999999976 78899999986543 3567889999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 403 (518)
+|++|.+++......++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 98 ~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 177 (286)
T cd06614 98 DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177 (286)
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcccc
Confidence 9999999998754479999999999999999999999999999999999999999999999999886543321 122345
Q ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCcHHHHHHHHHhhhhC
Q 010091 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT-IPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 404 gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~L~~Li~~cL~~d 482 (518)
++..|++||.+.+..++.++|+||||+++|+|++|..||....+.............+. .+..++..+.++|.+||+.+
T Consensus 178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (286)
T cd06614 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKD 257 (286)
T ss_pred CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccC
Confidence 78899999999888899999999999999999999999998777655544333333221 22337889999999999999
Q ss_pred CCCCCCHHHHHH
Q 010091 483 PSLRPDFSEITE 494 (518)
Q Consensus 483 P~~RPs~~eil~ 494 (518)
|.+||++.+++.
T Consensus 258 p~~Rpt~~~il~ 269 (286)
T cd06614 258 PEKRPSAEELLQ 269 (286)
T ss_pred hhhCcCHHHHhh
Confidence 999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=306.33 Aligned_cols=249 Identities=21% Similarity=0.352 Sum_probs=217.2
Q ss_pred ccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|.+.+.||+|.|+.||+... .|+.+|+|++..........+++.+|+.|-+.|+||||+++.+........|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4556688999999999999874 48999999998877766667889999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---CCcEEEeeeccceeccccCcc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~~~vkL~DFG~a~~~~~~~~~ 399 (518)
+|.|+.|..-+-++ ..+++..+-..+.||+.+|+|+|.+||||||+||+|+++.+ ...+||+|||+|.........
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 99999987766552 56888889999999999999999999999999999999953 347999999999877744444
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--IPVHTHPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~L~~Li~~ 477 (518)
....||+.|||||++...+|+..+|||+-|++||-|+.|.+||.+.+....+.++.+..+... .-..++++.++|+++
T Consensus 170 ~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvrr 249 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRR 249 (355)
T ss_pred ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHH
Confidence 556799999999999999999999999999999999999999999888888888777655333 335688999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||..||.+|.|+.|.+.
T Consensus 250 ML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 250 MLTVNPKKRITADEALK 266 (355)
T ss_pred HhccChhhhccHHHHhC
Confidence 99999999999988754
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.85 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=202.0
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-C-----CceeeEeeeeecCCce
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-H-----MNVVQFIGACTRPPRL 317 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-H-----pnIv~l~~~~~~~~~~ 317 (518)
+|.+.+.||+|+||.|-++.+. ++.||||++++. ......-..|+.+|..|+ | -|+|+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 6788999999999999999965 689999999975 233455667999999997 4 3899999999999999
Q ss_pred eEEEeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC--CcEEEeeeccceecc
Q 010091 318 FIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN--GVVKVADFGVARVQA 394 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~--~~vkL~DFG~a~~~~ 394 (518)
|||+|.+ +.+|+++++.++. +++...++.|+.||+.||.+||+.||||+||||+|||+... ..|||+|||++....
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 9999999 7799999987553 69999999999999999999999999999999999999754 479999999998766
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-C---------------
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK-G--------------- 458 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~-~--------------- 458 (518)
+.-. ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..+.+..+++- |
T Consensus 343 q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 343 QRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred Ccce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 5422 466788999999999999999999999999999999999999877665554443310 0
Q ss_pred ----------------------------------CCCCCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 010091 459 ----------------------------------LRPTIP-----------VHTHPILVDLLERCWQRDPSLRPDFSEIT 493 (518)
Q Consensus 459 ----------------------------------~~p~~~-----------~~~~~~L~~Li~~cL~~dP~~RPs~~eil 493 (518)
.....| ......+.++|.+||..||.+|+|..+.+
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal 500 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL 500 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence 000011 11234589999999999999999998876
Q ss_pred H
Q 010091 494 E 494 (518)
Q Consensus 494 ~ 494 (518)
.
T Consensus 501 ~ 501 (586)
T KOG0667|consen 501 N 501 (586)
T ss_pred c
Confidence 5
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=309.78 Aligned_cols=254 Identities=27% Similarity=0.470 Sum_probs=205.7
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCC
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPP 315 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~ 315 (518)
.|.++.+.|++.+.||+|+||.||+|.+. ++.||||.++...... ....+..|+.++.+.. |+||+++++++....
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 46667777888999999999999999986 7899999998654333 3456667777676664 999999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..|++|||+. ++|.+++......+++..+..++.|++.||.|||+ .||+||||+|+||++++++.+||+|||.+....
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999999994 57777766545578999999999999999999997 599999999999999999999999999987654
Q ss_pred ccCccccCCCCCcccChhhhcCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCCCCCCC--CCC
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQ----PYNHRADVFSFGIVLWELVTGKLPYDDLTP-LQAAVGVVQKGLRPTIP--VHT 467 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~----~~~~ksDV~SlGill~eLltG~~P~~~~~~-~~~~~~~~~~~~~p~~~--~~~ 467 (518)
.........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... .+........ ..+..+ ..+
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 245 (296)
T cd06618 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLPPNEGF 245 (296)
T ss_pred CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCCCCCCC
Confidence 43333344578899999998654 378999999999999999999999976433 3333333332 223333 246
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
+.++.+++.+||+.||.+||++.+++..
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 8899999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=317.88 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=201.4
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC------C
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------P 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~------~ 315 (518)
...|+..+.||+|+||.||++... ++.||+|++.....+......+.+|+.++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 355777999999999999999964 78899999876554555556788899999999999999999987543 3
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..|+||||+. ++|.+++... ++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 5799999995 5888887652 88999999999999999999999999999999999999999999999999987655
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL---------------- 459 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~---------------- 459 (518)
........++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...-.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 4333445688999999999999999999999999999999999999986654332222111000
Q ss_pred ----CC---------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 ----RP---------------------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ----~p---------------------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++ ..+...++.+.++|.+||+.||.+|||+.|++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 001134567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.83 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=198.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+.|...++||+|+||.||++.+. ++.||+|.+...... .....+.+|+.++.++. |+||+++++++......+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 34556889999999999999975 688999998765433 34567889999999996 999999999999889999999
Q ss_pred eeccCCcccccc---cc-ccCCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 322 EFMSGGSIYDYL---HK-QKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 322 Ey~~ggsL~~~l---~~-~~~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
||+. ++|.++. .. ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||+++.....
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 9985 4554432 22 235689999999999999999999975 9999999999999999999999999999754433
Q ss_pred CccccCCCCCcccChhhhcCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC----CCCCcH
Q 010091 397 GVMTAETGTYRWMAPEVIEHQ---PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI----PVHTHP 469 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~---~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~----~~~~~~ 469 (518)
.......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...............+..+.+ +..+++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 333345688999999999765 6899999999999999999999999765432111111112222222 234788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++.+++.+||+.+|.+|||+.+++.
T Consensus 242 ~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 242 SFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=305.55 Aligned_cols=245 Identities=29% Similarity=0.563 Sum_probs=205.2
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC---CCceeeEeeeeecCCceeEE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lV 320 (518)
.|++.+.||.|+||.||+|.+. ++.||+|++..... ......+.+|+.++++++ |||++++++++......|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 3566889999999999999964 68899999876532 233467888999999996 99999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VM 399 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 399 (518)
|||++|++|.+++... .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 9999999999998653 68999999999999999999999999999999999999999999999999997654432 22
Q ss_pred ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC-CcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVH-THPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~L~~Li~~ 477 (518)
....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||........... ......+.++.. .+.++.+++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-cccCCCCCCCcccCCHHHHHHHHH
Confidence 33458899999998864 4578999999999999999999999988765544322 222233444443 78899999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||+.||.+||++.+++.
T Consensus 238 ~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 238 CLDEEPKERLSAEELLK 254 (277)
T ss_pred HcCCCcccCcCHHHHhh
Confidence 99999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=306.28 Aligned_cols=247 Identities=29% Similarity=0.471 Sum_probs=201.7
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecC-----C
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRP-----P 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~-----~ 315 (518)
.+.|.+.+.||+|+||.||++... ++.+|+|++..... ....+.+|+.+++++ +|||++++++++... .
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 345666999999999999999974 68899999875422 235677899999999 899999999988643 3
Q ss_pred ceeEEEeeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 316 RLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
..|+||||++|++|.++++. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 58999999999999998753 234689999999999999999999999999999999999999999999999999875
Q ss_pred ccccC-ccccCCCCCcccChhhhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCC
Q 010091 393 QAQYG-VMTAETGTYRWMAPEVIEHQ-----PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--TIP 464 (518)
Q Consensus 393 ~~~~~-~~~~~~gt~~y~APE~l~~~-----~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--~~~ 464 (518)
..... ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||....+.+....... ...+ ..+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 256 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR-NPPPTLLHP 256 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-CCCCCCCcc
Confidence 44322 12234588999999998543 368899999999999999999999998876665544332 2222 224
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 465 VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 465 ~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
...+..+.++|.+||+.+|.+||++.+++.
T Consensus 257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 456778999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.67 Aligned_cols=243 Identities=32% Similarity=0.499 Sum_probs=212.7
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
|.-.+.||.|+||.||-+++. .+.||||.+..... ..+-...+..|+..|++++|||++.+-|+|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 333778999999999999964 68899999886433 334458899999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET 403 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 403 (518)
| -||-.|++.-.+.++.+..+..|..+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|.+.... ....
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsFv 183 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSFV 183 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hccc
Confidence 9 56888888766678999999999999999999999999999999999999999999999999999877653 3368
Q ss_pred CCCcccChhhh---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC-CCcHHHHHHHHHhh
Q 010091 404 GTYRWMAPEVI---EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV-HTHPILVDLLERCW 479 (518)
Q Consensus 404 gt~~y~APE~l---~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~-~~~~~L~~Li~~cL 479 (518)
||+.|||||+| ..+.|+-|+|||||||+..||...++|+-.++...++-.+.+ +-.|+++. .++..+..++..||
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ-NesPtLqs~eWS~~F~~Fvd~CL 262 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTLQSNEWSDYFRNFVDSCL 262 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-cCCCCCCCchhHHHHHHHHHHHH
Confidence 99999999998 567899999999999999999999999999988777766555 44566654 57888999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
++-|.+|||.++++.
T Consensus 263 qKipqeRptse~ll~ 277 (948)
T KOG0577|consen 263 QKIPQERPTSEELLK 277 (948)
T ss_pred hhCcccCCcHHHHhh
Confidence 999999999988764
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.14 Aligned_cols=246 Identities=29% Similarity=0.462 Sum_probs=208.5
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
|+..+.||+|+||.||+++.. ++.||+|++..... .......+.+|+.++++++|+|++++++++......|+||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666889999999999999864 68899999875432 334457889999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET 403 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 403 (518)
+. |+|.+++......+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..... .....
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~ 182 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFV 182 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccccc
Confidence 96 478887766566789999999999999999999999999999999999999999999999999865432 23356
Q ss_pred CCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 404 GTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 404 gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
++..|+|||.+. +..++.++|+||||+++|+|++|..||..................+.....+++.+.+++.+||+
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 262 (317)
T cd06635 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262 (317)
T ss_pred CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHcc
Confidence 889999999973 45688999999999999999999999988766665555444444444455678899999999999
Q ss_pred hCCCCCCCHHHHHHHH
Q 010091 481 RDPSLRPDFSEITELL 496 (518)
Q Consensus 481 ~dP~~RPs~~eil~~L 496 (518)
.+|.+||++.+++..+
T Consensus 263 ~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 263 KIPQDRPTSEELLKHM 278 (317)
T ss_pred CCcccCcCHHHHHhCh
Confidence 9999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=307.04 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=200.1
Q ss_pred EeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
||+|+||.||++... ++.||+|++....... .....+..|+.++++++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 7889999987643322 2345677899999999999999999999999999999999999999
Q ss_pred cccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCCcc
Q 010091 330 YDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRW 408 (518)
Q Consensus 330 ~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y 408 (518)
.+++.+.. ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99987643 36899999999999999999999999999999999999999999999999998765433333345678899
Q ss_pred cChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 010091 409 MAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV--QKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 409 ~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~R 486 (518)
+|||.+.+..++.++|+||||+++|+|++|+.||............. ........+..+++.+.++|.+||+.+|.+|
T Consensus 161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 240 (277)
T cd05577 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240 (277)
T ss_pred CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence 99999988889999999999999999999999997654311111111 1123445566778999999999999999999
Q ss_pred C-----CHHHHHH
Q 010091 487 P-----DFSEITE 494 (518)
Q Consensus 487 P-----s~~eil~ 494 (518)
| ++.+++.
T Consensus 241 ~~~~~~~~~~ll~ 253 (277)
T cd05577 241 LGCRGGSADEVRE 253 (277)
T ss_pred cCCCcccHHHHHh
Confidence 9 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=307.32 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=197.3
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|.+.+.||+|++|.||+|... ++.||+|.+....... ....+.+|+.++++++|+||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 34566999999999999999964 6889999987653222 22456789999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+.+ +|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++...... ....
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 9975 9999987766678999999999999999999999999999999999999999999999999987543221 1222
Q ss_pred CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---------------------
Q 010091 402 ETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--------------------- 459 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~--------------------- 459 (518)
..++..|+|||.+.+ ..++.++||||||+++|+|++|..||................+
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 346889999999865 5589999999999999999999999976552111111110000
Q ss_pred ----CCC----CCCCCc--HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 ----RPT----IPVHTH--PILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ----~p~----~~~~~~--~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+. .....+ .++.+++.+||+.+|.+|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 001223 77899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=306.98 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=202.0
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|+..+.||.|++|.||+|+.. ++.||||.++...........+.+|+.++++++||||+++++++......|+||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 566899999999999999974 688999998765544444467889999999999999999999999999999999999
Q ss_pred cCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 325 SGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 325 ~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
. ++|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence 5 6888888653 3468999999999999999999999999999999999999999999999999987543322 22334
Q ss_pred CCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--------------------
Q 010091 403 TGTYRWMAPEVIEHQP-YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP-------------------- 461 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~-~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p-------------------- 461 (518)
.++..|+|||.+.+.. ++.++|+||||+++|+|+||+.||...+..............+
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccc
Confidence 5788999999886544 6889999999999999999999998766544433322211100
Q ss_pred -------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 -------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 -------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
......++++.++|.+||+.||.+|||+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 011245788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=305.95 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=203.3
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|++.++||.|++|.||+|.+. |..||+|++............+.+|+.++++++|||++++++++......|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 455889999999999999864 789999999876544444567888999999999999999999999999999999999
Q ss_pred cCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 325 SGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 325 ~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
+++|.+++.... ..+++..++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 468999987643 368999999999999999999999999999999999999999999999999997543321 12234
Q ss_pred CCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------------------
Q 010091 403 TGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--------------------- 460 (518)
Q Consensus 403 ~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--------------------- 460 (518)
.++..|+|||++.+. .++.++|+||||+++|+|++|+.||...+.........+....
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 568899999987654 5789999999999999999999999877665444333221000
Q ss_pred ------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 ------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 ------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.......++.+.+++.+||+.+|.+|||++|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0112346688999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.66 Aligned_cols=246 Identities=26% Similarity=0.450 Sum_probs=200.7
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--CCceeEEE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLFIVT 321 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~ 321 (518)
.|...++||.|++|.||++... ++.+|+|.+..... ......+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3455999999999999999974 68899999886533 2445778999999999999999999998854 34689999
Q ss_pred eeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 322 EFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 322 Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
||++|++|.+++.. ....++...+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999999988653 23458889999999999999999999999999999999999999999999999986543321
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcCCCCCCC------CCC
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL-----TPLQAAVGVVQKGLRPTIP------VHT 467 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~-----~~~~~~~~~~~~~~~p~~~------~~~ 467 (518)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||... .+.+.... ......+.++ ..+
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKDEPGNGIKW 238 (287)
T ss_pred cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhccCCCCCCch
Confidence 12345788999999999899999999999999999999999999765 22332222 2211122222 234
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++.+.+++.+||..+|.+|||+.|++.
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.25 Aligned_cols=240 Identities=22% Similarity=0.376 Sum_probs=184.6
Q ss_pred eeEEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--CCceeEEEee
Q 010091 250 EHKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLFIVTEF 323 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~Ey 323 (518)
.++||+|+||.||+|+.. ++.||+|.+...... ..+.+|+.++++++||||+++++++.. ....|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 458999999999999854 467999998765432 356789999999999999999998853 4568999999
Q ss_pred ccCCccccccccc--------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe----ccCCcEEEeeeccce
Q 010091 324 MSGGSIYDYLHKQ--------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----NENGVVKVADFGVAR 391 (518)
Q Consensus 324 ~~ggsL~~~l~~~--------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl----~~~~~vkL~DFG~a~ 391 (518)
+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 94 5887776421 2258889999999999999999999999999999999999 456789999999998
Q ss_pred eccccC----ccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHHhc
Q 010091 392 VQAQYG----VMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPL---------QAAVGVVQK 457 (518)
Q Consensus 392 ~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~---------~~~~~~~~~ 457 (518)
...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 654321 1223468999999999876 45899999999999999999999999643210 001000000
Q ss_pred -----------------------CCCC-------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 458 -----------------------GLRP-------------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 458 -----------------------~~~p-------------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+.. ......+..+.++|.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=310.66 Aligned_cols=240 Identities=30% Similarity=0.501 Sum_probs=203.0
Q ss_pred eeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 250 EHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
...||+|+||.||++... +..||||.+.... ......+.+|+.++++++|+||+++++.+...+..|+||||++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 567999999999999864 6889999986542 233467889999999999999999999999999999999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTY 406 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~ 406 (518)
+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......|+.
T Consensus 105 ~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 182 (292)
T cd06658 105 ALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTP 182 (292)
T ss_pred cHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCc
Confidence 99998854 358899999999999999999999999999999999999999999999999986533221 122345889
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhhCCC
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVDLLERCWQRDPS 484 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~~cL~~dP~ 484 (518)
.|+|||.+.+..++.++|+||||+++|||++|..||....+.+..... .....+..+ ...+..+.+++.+||..||.
T Consensus 183 ~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 261 (292)
T cd06658 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-RDNLPPRVKDSHKVSSVLRGFLDLMLVREPS 261 (292)
T ss_pred cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcCCCccccccccCHHHHHHHHHHccCChh
Confidence 999999998888999999999999999999999999887766554332 223333322 34678899999999999999
Q ss_pred CCCCHHHHHH
Q 010091 485 LRPDFSEITE 494 (518)
Q Consensus 485 ~RPs~~eil~ 494 (518)
+|||+++++.
T Consensus 262 ~Rpt~~~il~ 271 (292)
T cd06658 262 QRATAQELLQ 271 (292)
T ss_pred HCcCHHHHhh
Confidence 9999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.65 Aligned_cols=243 Identities=31% Similarity=0.501 Sum_probs=204.3
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|...++||+|++|.||++... ++.+++|++.... ......+.+|+.++++++||||+++++++......|+++||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 333678999999999999864 6789999986432 223466889999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 403 (518)
+|++|.+++.. ..++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+....... ......
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 99999999876 458899999999999999999999999999999999999999999999999886533221 122345
Q ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhh
Q 010091 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQR 481 (518)
Q Consensus 404 gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~L~~Li~~cL~~ 481 (518)
|+..|+|||.+.+..++.++|+||||+++|+|++|..||...++......... ...+.. +..++..+.+++.+||+.
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD-NLPPKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh-cCCCCCcccccCCHHHHHHHHHHccc
Confidence 88999999999888899999999999999999999999988776655544332 222222 233678999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
+|.+||++.++++
T Consensus 256 ~p~~Rpt~~~il~ 268 (285)
T cd06648 256 DPAQRATAAELLN 268 (285)
T ss_pred ChhhCcCHHHHcc
Confidence 9999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=302.11 Aligned_cols=241 Identities=27% Similarity=0.417 Sum_probs=204.0
Q ss_pred EeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
||.|+||.||++++. ++.+++|++...... ......+.+|+.++++++|+||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 588999999999975 789999999765432 24457888999999999999999999999999999999999999999
Q ss_pred ccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC---------ccc
Q 010091 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG---------VMT 400 (518)
Q Consensus 330 ~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~---------~~~ 400 (518)
.+++.+. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 9999774 378999999999999999999999999999999999999999999999999987543321 112
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHHHh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVH--THPILVDLLERC 478 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~L~~Li~~c 478 (518)
...++..|++||.+.+..++.++|+||||+++|+|++|..||....+.+.......... ..+.. .++.+.+++.+|
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI--EWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc--CCCccccCCHHHHHHHHHH
Confidence 23478899999999888899999999999999999999999988877666555444232 23333 389999999999
Q ss_pred hhhCCCCCCCHHHHHHHH
Q 010091 479 WQRDPSLRPDFSEITELL 496 (518)
Q Consensus 479 L~~dP~~RPs~~eil~~L 496 (518)
|+.+|.+|||+..+.+.|
T Consensus 238 l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 238 LVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred hcCCHhhcCCCccHHHHh
Confidence 999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.60 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=196.7
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|++.+.||+|+||.||+|... ++.||+|+++..... .....+.+|+.+++.++|+||+++++++......|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 45666999999999999999864 789999998765322 223466789999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+. ++|.+++......+.+..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++...... ....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 995 67877776545567888899999999999999999999999999999999999999999999987543322 1223
Q ss_pred CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhc----------------CCCCC-
Q 010091 402 ETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA-VGVVQK----------------GLRPT- 462 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~-~~~~~~----------------~~~p~- 462 (518)
..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......... ...+.. .+.+.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence 457889999999865 45788999999999999999999999865542221 111100 00000
Q ss_pred ----CC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 ----IP---------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 ----~~---------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+ ...++.+.+++.+|++.||.+|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 112567999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=327.09 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=192.9
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|+.++++++|+|||++++++......|+|||+
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4666999999999999999975 57899996432 3456899999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---cc
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV---MT 400 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~ 400 (518)
+ .++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 9 5789998877556799999999999999999999999999999999999999999999999999976433211 12
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCC-----H-HHHHHHHHhc-CC-------------
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPY-DDLT-----P-LQAAVGVVQK-GL------------- 459 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~-~~~~-----~-~~~~~~~~~~-~~------------- 459 (518)
...||..|+|||++.+..++.++|||||||++|||++|..|+ .... + ......+++. +.
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 345899999999999999999999999999999999977544 2110 1 1112222211 10
Q ss_pred ------------CCCCC-------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 ------------RPTIP-------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ------------~p~~~-------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++... ...+.++.+||.+||+.||.+|||+.|+++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00000 123457999999999999999999999986
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.22 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=199.4
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCc-----e
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPR-----L 317 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~-----~ 317 (518)
+|++.+.||+|+||.||+|.+. ++.||+|+++...........+.+|+.+++++. |+||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 4666999999999999999974 688999998765433333467888999999995 6999999998876655 8
Q ss_pred eEEEeeccCCcccccccccc----CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-CCcEEEeeecccee
Q 010091 318 FIVTEFMSGGSIYDYLHKQK----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVVKVADFGVARV 392 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~----~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-~~~vkL~DFG~a~~ 392 (518)
|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||.+..
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999999975 8888876432 35799999999999999999999999999999999999998 89999999999875
Q ss_pred cccc-CccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----------
Q 010091 393 QAQY-GVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL----------- 459 (518)
Q Consensus 393 ~~~~-~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~----------- 459 (518)
.... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+........-.
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 4332 22233457889999998854 5579999999999999999999999988776655443322100
Q ss_pred -----------CCC----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 -----------RPT----IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 -----------~p~----~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+. .....++++.++|.+||..||.+||++.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 01246788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.34 Aligned_cols=241 Identities=30% Similarity=0.530 Sum_probs=208.4
Q ss_pred EEeEecceEEEEEEECC--ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~~--~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
+||+|.||+||-|++.. ...|||-+... ++...+-+..|+.+.++|+|.|||+++|.+.+.+++-|.||-++||||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 69999999999999765 45788877654 334446788899999999999999999999999999999999999999
Q ss_pred ccccccccCCC--ChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-CCcEEEeeeccceeccccC-ccccCCCC
Q 010091 330 YDYLHKQKCGL--KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVVKVADFGVARVQAQYG-VMTAETGT 405 (518)
Q Consensus 330 ~~~l~~~~~~l--~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-~~~vkL~DFG~a~~~~~~~-~~~~~~gt 405 (518)
.+.|...=+++ .+..+-.+.+||++||.|||.+.|||||||-+||||+. .|++||+|||.++....-. ...+.+||
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 99998766667 77888899999999999999999999999999999975 5899999999997644333 34456799
Q ss_pred CcccChhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 406 YRWMAPEVIEHQ--PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV-QKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 406 ~~y~APE~l~~~--~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
..|||||++..+ .|..++|||||||++.||.||++||-.+...+++.-.+ .-...|++|...+.+.+.+|.+|+.++
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd 819 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPD 819 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCC
Confidence 999999999765 48899999999999999999999998877666664333 334589999999999999999999999
Q ss_pred CCCCCCHHHHHH
Q 010091 483 PSLRPDFSEITE 494 (518)
Q Consensus 483 P~~RPs~~eil~ 494 (518)
|..||++++++.
T Consensus 820 ~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 820 PCDRPSAKDLLQ 831 (1226)
T ss_pred cccCccHHHhcc
Confidence 999999999875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.21 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=206.5
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|++.+.||.|++|.||++... ++.+++|.++...........+.+|+.++++++|+||+++++++......|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 345788999999999999964 788999999876655455678889999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 403 (518)
++ +|.+++......+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 65 8888887755679999999999999999999999999999999999999999999999999997665433 223345
Q ss_pred CCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---------------------
Q 010091 404 GTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--------------------- 461 (518)
Q Consensus 404 gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--------------------- 461 (518)
++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+...........+
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 78899999998766 78999999999999999999999998777655443332210000
Q ss_pred -------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 -------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 -------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
......+.++.++|.+||+.||.+||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 011235778999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=301.92 Aligned_cols=247 Identities=27% Similarity=0.411 Sum_probs=203.2
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--CceeEEEe
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFIVTE 322 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV~E 322 (518)
|++.++||+|++|.||+|+.. ++.+|+|++......+.....+.+|+.++++++|+|++++++++... +..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456899999999999999975 58899999987653344456788999999999999999999999887 88999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC--ccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG--VMT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~ 400 (518)
|++ ++|.+++......+++..++.++.||+.||.|||+.|++|+||+|+||++++++.++|+|||.+....... ..+
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 996 48998887755679999999999999999999999999999999999999999999999999998655433 123
Q ss_pred cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC------------------
Q 010091 401 AETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP------------------ 461 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p------------------ 461 (518)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..............+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 3457888999997754 457899999999999999999999998776544433322210000
Q ss_pred -----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 -----------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 -----------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+...+++.+.+++.+||+.+|.+||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001113778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.82 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=200.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.+.||.|++|.||+|++. ++.||+|.+......+.....+.+|+.++++++||||+++++++......|+||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 4666999999999999999965 67899999876544444456788999999999999999999999999999999999
Q ss_pred ccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-CCcEEEeeeccceeccccC-ccc
Q 010091 324 MSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVVKVADFGVARVQAQYG-VMT 400 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-~~~vkL~DFG~a~~~~~~~-~~~ 400 (518)
++ ++|.+++..... .+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++....... ..+
T Consensus 83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (294)
T PLN00009 83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (294)
T ss_pred cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence 95 578887754332 3678889999999999999999999999999999999985 5679999999997543321 223
Q ss_pred cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------------------
Q 010091 401 AETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-------------------- 459 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-------------------- 459 (518)
...++..|+|||.+.+ ..++.++||||||+++|+|+||..||...+..+..........
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF 241 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence 3457889999998865 4578999999999999999999999987766554433321100
Q ss_pred ---CCC----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 ---RPT----IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ---~p~----~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++. .....++++.+++.+||+.+|.+||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 11345788999999999999999999999876
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=319.65 Aligned_cols=256 Identities=22% Similarity=0.347 Sum_probs=212.3
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecC
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRP 314 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~ 314 (518)
.....|....|+++++||+|+.+.||++... .+.||+|.+.....++....-|..|+..|.+|+ |.+||++|+|-..+
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 4567888999999999999999999999865 478999988888888888999999999999995 99999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
+.+|+||||- ..+|..+|.+....+..-.+..+..|++.++.++|+.||||.||||+|+|+- .|.+||+|||+|....
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 9999999987 6799999998665555457888899999999999999999999999999995 6799999999998765
Q ss_pred ccCc---cccCCCCCcccChhhhcCC-----------CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCC
Q 010091 395 QYGV---MTAETGTYRWMAPEVIEHQ-----------PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ-KGL 459 (518)
Q Consensus 395 ~~~~---~~~~~gt~~y~APE~l~~~-----------~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~-~~~ 459 (518)
.... .....||..||+||.+... +.+.++||||||||||+|+.|+.||........-...+. .+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~ 590 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH 590 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence 5432 3345699999999998322 256789999999999999999999988664433333232 222
Q ss_pred CCCCCCCCcHH-HHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 RPTIPVHTHPI-LVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ~p~~~~~~~~~-L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.-++|...+.. +.++++.||+.||.+||+..|+|.
T Consensus 591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 22444333333 999999999999999999999875
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.50 Aligned_cols=242 Identities=26% Similarity=0.382 Sum_probs=198.4
Q ss_pred eEEeEecceEEEEEEE--CCccEEEEEEeccccC-HHHHHHHHHHHHHH-hhcCCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLN-ENIRREFAQEVHIM-RKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~-~~~~~~f~~E~~il-~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+.||+|+||.||+|+. .++.||+|+++..... ......+..|..++ ...+|+|++++++++......|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999997 4689999998764332 22234445555544 455899999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY 406 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~ 406 (518)
++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....++.
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP 157 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence 999999976 34689999999999999999999999999999999999999999999999999875433 22345888
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCCcHHHHHHHHHhhhhCCC
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG--LRPTIPVHTHPILVDLLERCWQRDPS 484 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~L~~Li~~cL~~dP~ 484 (518)
.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+......... +.......+++.+.+++.+||+.+|.
T Consensus 158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 237 (260)
T cd05611 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237 (260)
T ss_pred CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence 9999999988888999999999999999999999998877766544433322 23334446789999999999999999
Q ss_pred CCCCHHHHHHHH
Q 010091 485 LRPDFSEITELL 496 (518)
Q Consensus 485 ~RPs~~eil~~L 496 (518)
+||++.++.+.|
T Consensus 238 ~R~~~~~~~~~l 249 (260)
T cd05611 238 KRLGANGYQEIK 249 (260)
T ss_pred HccCCCcHHHHH
Confidence 999776554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.57 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=201.8
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC------
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------ 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~------ 315 (518)
.+.|++.+.||+|+||.||+|+.. ++.||+|+++.....+.....+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 445666999999999999999974 688999999865443334457778999999999999999999886654
Q ss_pred ----ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 316 ----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 316 ----~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
.+|+|+||+++ ++.+++......+++..++.++.|++.||.|||++||+|+||||+||++++++.+||+|||.+.
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 78999999975 7777776655578999999999999999999999999999999999999999999999999997
Q ss_pred eccccC--ccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC------C
Q 010091 392 VQAQYG--VMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP------T 462 (518)
Q Consensus 392 ~~~~~~--~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p------~ 462 (518)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+......+ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 654332 1222346788999998854 457899999999999999999999998766554443332211000 0
Q ss_pred ----------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 ----------------------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 ----------------------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....+++.+.+++.+||+.+|.+||++.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01235788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=308.91 Aligned_cols=241 Identities=31% Similarity=0.475 Sum_probs=202.7
Q ss_pred eeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 250 EHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
..+||+|+||.||++.. .++.||+|++...... ....+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 55799999999999986 4789999998754322 2356889999999999999999999999999999999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTY 406 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~ 406 (518)
+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ......|+.
T Consensus 104 ~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 181 (297)
T cd06659 104 ALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP 181 (297)
T ss_pred CHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCc
Confidence 99988754 358899999999999999999999999999999999999999999999999986433221 123345889
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhhhCCCC
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERCWQRDPSL 485 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~~cL~~dP~~ 485 (518)
.|+|||.+.+..++.++|+||||+++|+|++|+.||....+.+.......... ........++.+.++|.+||+.+|.+
T Consensus 182 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~ 261 (297)
T cd06659 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQE 261 (297)
T ss_pred cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCccc
Confidence 99999999888899999999999999999999999987776655543322111 12223456788999999999999999
Q ss_pred CCCHHHHHH
Q 010091 486 RPDFSEITE 494 (518)
Q Consensus 486 RPs~~eil~ 494 (518)
||++++++.
T Consensus 262 Rps~~~ll~ 270 (297)
T cd06659 262 RATAQELLD 270 (297)
T ss_pred CcCHHHHhh
Confidence 999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.55 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=196.5
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC-------
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------- 315 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~------- 315 (518)
+.|++.++||+|+||.||+++.. ++.||||++......+.....+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 34566999999999999999964 688999998765433333345678999999999999999999876544
Q ss_pred -ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 316 -RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 316 -~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..|+||||+. ++|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+....
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 3599999995 58888887755578999999999999999999999999999999999999999999999999997543
Q ss_pred ccCc-----cccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cCCCCC----
Q 010091 395 QYGV-----MTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ--KGLRPT---- 462 (518)
Q Consensus 395 ~~~~-----~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~--~~~~p~---- 462 (518)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||....+......... ....+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3221 1233477889999988654 478899999999999999999999987665433221111 000000
Q ss_pred -----------C-------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 -----------I-------------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 -----------~-------------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. +...++.+.++|.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 1113466889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.37 Aligned_cols=240 Identities=22% Similarity=0.374 Sum_probs=184.1
Q ss_pred eeEEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee--cCCceeEEEee
Q 010091 250 EHKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT--RPPRLFIVTEF 323 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lV~Ey 323 (518)
..+||+|+||.||+|+.. +..||+|.+...... ..+.+|+.++++++||||+++++++. .....|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 458999999999999964 367999998764332 35778999999999999999999884 45678999999
Q ss_pred ccCCcccccccc--------ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe----ccCCcEEEeeeccce
Q 010091 324 MSGGSIYDYLHK--------QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----NENGVVKVADFGVAR 391 (518)
Q Consensus 324 ~~ggsL~~~l~~--------~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl----~~~~~vkL~DFG~a~ 391 (518)
++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 577777642 12247888899999999999999999999999999999999 456799999999998
Q ss_pred eccccC----ccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHHh-
Q 010091 392 VQAQYG----VMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPL---------QAAVGVVQ- 456 (518)
Q Consensus 392 ~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~---------~~~~~~~~- 456 (518)
...... ......||..|+|||++.+ ..++.++|||||||++|||+||..||...... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 654322 1223457999999999866 45899999999999999999999999643210 00000000
Q ss_pred ----------------------cCC-------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 457 ----------------------KGL-------------RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 457 ----------------------~~~-------------~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
... ........+..+.+++.+||+.||.+|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000 00011123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.78 Aligned_cols=245 Identities=29% Similarity=0.496 Sum_probs=204.1
Q ss_pred ccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.+|++.+.||+|+||.||++.. .++.||+|.+..... .....+.+|+.++++++||||+++++.+......|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 3555699999999999999985 468899999865422 234678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 97 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred cCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 99999999998763 47889999999999999999999999999999999999999999999999886543322 2223
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCW 479 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~L~~Li~~cL 479 (518)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......... ...+.. +...+..+.+++.+||
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l 253 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFRDFLNRCL 253 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCCCCCccccCHHHHHHHHHHc
Confidence 4588899999999888899999999999999999999999987665443322211 122222 2345778999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
+.+|.+||++.+++.
T Consensus 254 ~~~p~~Rp~~~~il~ 268 (293)
T cd06647 254 EMDVEKRGSAKELLQ 268 (293)
T ss_pred cCChhhCcCHHHHhc
Confidence 999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=301.03 Aligned_cols=247 Identities=27% Similarity=0.452 Sum_probs=200.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.++||.|++|.||+|+.. ++.||+|+++..... .....+.+|+.++++++|+||+++++++...+..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 3667999999999999999974 788999999865432 2235677899999999999999999999999999999999
Q ss_pred ccCCcccccccccc--CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccc
Q 010091 324 MSGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMT 400 (518)
Q Consensus 324 ~~ggsL~~~l~~~~--~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 400 (518)
+++ +|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||.+....... ...
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 975 8888876533 458999999999999999999999999999999999999999999999999997543321 122
Q ss_pred cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------CCCCC
Q 010091 401 AETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG----------------LRPTI 463 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~----------------~~p~~ 463 (518)
...++..|++||++.+ ..++.++|+||||+++|+|++|..||.+.+..+......... +....
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 3457889999998855 457899999999999999999999998766544333322110 01111
Q ss_pred -----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 464 -----------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 464 -----------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....++.+.+++.+||+.||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.78 Aligned_cols=241 Identities=26% Similarity=0.368 Sum_probs=194.0
Q ss_pred EEeEecceEEEEEEEC--CccEEEEEEeccccCHHH-HHHHHHHHHHHhh---cCCCceeeEeeeeecCCceeEEEeecc
Q 010091 252 KIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENI-RREFAQEVHIMRK---VRHMNVVQFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~-~~~f~~E~~il~~---l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 325 (518)
.||+|+||.||++... ++.+|+|++......... ...+.+|..+++. .+||||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3799999999999964 688999999765433221 2334445444443 479999999999999999999999999
Q ss_pred CCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCC
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT 405 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt 405 (518)
|++|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||++++++.++|+|||++....... .....|+
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT 158 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCC
Confidence 9999999876 4569999999999999999999999999999999999999999999999999986543322 2234689
Q ss_pred CcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCC
Q 010091 406 YRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL-QAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDP 483 (518)
Q Consensus 406 ~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP 483 (518)
..|+|||.+. +..++.++|+||||+++|+|++|..||...... ..............++..+++++.++|.+||+.||
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 9999999986 456899999999999999999999999754321 11111122234556677789999999999999999
Q ss_pred CCCC-----CHHHHHH
Q 010091 484 SLRP-----DFSEITE 494 (518)
Q Consensus 484 ~~RP-----s~~eil~ 494 (518)
.+|| +++|+++
T Consensus 239 ~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 239 SKRLGCLGRGAQEVKE 254 (279)
T ss_pred HHhcCCCCCCHHHHHh
Confidence 9999 5888866
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=300.09 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=202.1
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc---CCCceeeEeeeeecCCc-----
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV---RHMNVVQFIGACTRPPR----- 316 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~~~~~~~~~----- 316 (518)
|++.+.||+|+||.||+|++. ++.||+|+++.....+.....+.+|+.+++++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456899999999999999975 68999999986554444446677788887766 59999999999987766
Q ss_pred eeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.|++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999999996 48988886643 3589999999999999999999999999999999999999999999999999977654
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--------------- 460 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--------------- 460 (518)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+......
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 43333345788999999999889999999999999999999999999887765554443321100
Q ss_pred ---CC-------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 ---PT-------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 ---p~-------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.. .....++.+.+++.+||+.||.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 00123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=305.67 Aligned_cols=246 Identities=31% Similarity=0.469 Sum_probs=205.0
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccc-cCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~-~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|+..+.||.|+||.||+|+.. ++.+|+|.+.... ........+.+|+.+++.++|+|++++++++......|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3555888999999999999974 6789999987542 233445678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
|+. ++|.+++......+++..+..++.|++.|+.|||+++++||||+|+||+++.++.++|+|||.+..... ....
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~~~ 171 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXF 171 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---cccc
Confidence 996 588887765455689999999999999999999999999999999999999999999999999876543 2335
Q ss_pred CCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 403 TGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 403 ~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
.++..|+|||.+. ...++.++||||||+++|+|++|..||......+..............+..++..+.++|.+||
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 251 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHh
Confidence 6889999999974 4567889999999999999999999998776555444433333323334467888999999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 010091 480 QRDPSLRPDFSEITEL 495 (518)
Q Consensus 480 ~~dP~~RPs~~eil~~ 495 (518)
+.+|.+||++.+++..
T Consensus 252 ~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 252 QKIPQDRPTSEVLLKH 267 (308)
T ss_pred hCCcccCCCHHHHhhC
Confidence 9999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=305.06 Aligned_cols=244 Identities=29% Similarity=0.452 Sum_probs=204.8
Q ss_pred ceeeeEEeEecceEEEEEEE--CCccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 247 LKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
|...++||+|+||.||+|+. .++.|++|++..... .......+.+|+.++++++|||++++++++......|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44577899999999999986 478899999876433 334446788999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET 403 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 403 (518)
+. ++|.+++......+++..++.++.||+.|+.|||++|++|+||+|+||+++.++.+||+|||.+..... .....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~ 178 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFV 178 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCcc
Confidence 95 578888776566789999999999999999999999999999999999999999999999999864322 23356
Q ss_pred CCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 404 GTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 404 gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
|+..|+|||++. ...++.++|+||||+++|+|++|..||........................++..+.+++.+||+
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 258 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ 258 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence 889999999983 45688999999999999999999999988776555544443333333334567889999999999
Q ss_pred hCCCCCCCHHHHHH
Q 010091 481 RDPSLRPDFSEITE 494 (518)
Q Consensus 481 ~dP~~RPs~~eil~ 494 (518)
.+|.+||++.+++.
T Consensus 259 ~~P~~Rp~~~~~l~ 272 (313)
T cd06633 259 KIPQERPASAELLR 272 (313)
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=304.12 Aligned_cols=254 Identities=17% Similarity=0.250 Sum_probs=188.1
Q ss_pred eeccccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHH---------HHHHHHHHHHHhhcCCCceee
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENI---------RREFAQEVHIMRKVRHMNVVQ 306 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~---------~~~f~~E~~il~~l~HpnIv~ 306 (518)
++...+|++.++||+|+||.||+|.+.+ ..+|+|+.......-.. ......+...+..++|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3455667779999999999999999654 35677764432211100 012233445566778999999
Q ss_pred EeeeeecCC----ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcE
Q 010091 307 FIGACTRPP----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVV 382 (518)
Q Consensus 307 l~~~~~~~~----~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~v 382 (518)
+++++.... ..++++|++ ..++.+.+.. ....++..++.++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 998765433 346788877 4466666654 2345788899999999999999999999999999999999999999
Q ss_pred EEeeeccceeccccC--------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 010091 383 KVADFGVARVQAQYG--------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGV 454 (518)
Q Consensus 383 kL~DFG~a~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~ 454 (518)
+|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||............
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 999999997643221 112235999999999999999999999999999999999999999876432221111
Q ss_pred Hh----cCC-C-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 010091 455 VQ----KGL-R-PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 455 ~~----~~~-~-p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L 496 (518)
.. ..+ . ......+++.+.+++..||..+|.+||++.+|++.|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10 111 1 112345678899999999999999999999998876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=299.92 Aligned_cols=246 Identities=24% Similarity=0.447 Sum_probs=210.4
Q ss_pred cceeeeEEeEecceEEEEEEE--CCccEEEEEEecccc-CHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+|.+.+.||+|+||.||+++. .++.||+|++..... .......+..|+.++++++ |+||+++++.+......|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 577799999999999999997 478999999876433 2334477889999999998 999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--- 398 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 398 (518)
||+++++|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 82 EYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999874 4799999999999999999999999999999999999999999999999999875433221
Q ss_pred ------------------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Q 010091 399 ------------------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR 460 (518)
Q Consensus 399 ------------------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~ 460 (518)
.....++..|+|||.+.+..++.++|+||||+++|++++|..||...+..+...... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~ 238 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL--KLE 238 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--hcC
Confidence 112246889999999988889999999999999999999999999887655544433 334
Q ss_pred CCCCCCCcHHHHHHHHHhhhhCCCCCCCH----HHHHH
Q 010091 461 PTIPVHTHPILVDLLERCWQRDPSLRPDF----SEITE 494 (518)
Q Consensus 461 p~~~~~~~~~L~~Li~~cL~~dP~~RPs~----~eil~ 494 (518)
..++..+++.+.+++.+||+.+|.+||++ ++++.
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 45667788999999999999999999999 77653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=308.65 Aligned_cols=252 Identities=25% Similarity=0.462 Sum_probs=201.3
Q ss_pred eEEeEe--cceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccC
Q 010091 251 HKIVSG--SYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 251 ~~Lg~G--~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
..||.| +||+||++.+ .++.||+|++......+...+.+.+|+.+++.++||||+++++++......|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 345655 9999999987 479999999987665666668899999999999999999999999999999999999999
Q ss_pred Ccccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc------
Q 010091 327 GSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM------ 399 (518)
Q Consensus 327 gsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~------ 399 (518)
++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 99999987643 35889999999999999999999999999999999999999999999999865432211110
Q ss_pred --ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----------------
Q 010091 400 --TAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG----------------- 458 (518)
Q Consensus 400 --~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~----------------- 458 (518)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+.........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 11234667999999965 347899999999999999999999998776544433322110
Q ss_pred ----------------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHHHH
Q 010091 459 ----------------------------LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE--LLQHLAQR 502 (518)
Q Consensus 459 ----------------------------~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~--~L~~l~~~ 502 (518)
++...+..+++.+.+++.+||+.||.+|||+.|+++ .+..+.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 011112235677999999999999999999999975 55555554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.29 Aligned_cols=243 Identities=29% Similarity=0.526 Sum_probs=203.9
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEecc--ccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc--eeEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNE--HLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR--LFIV 320 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~--~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~--~~lV 320 (518)
+++..+||+|+|-+||+|.+. |-.||--.++.. ..+....++|..|+.+|+.|+||||++|+.+|..... +-+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 366889999999999999975 445554333322 2234455899999999999999999999999976554 7899
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEeccC-CcEEEeeeccceeccccC
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNEN-GVVKVADFGVARVQAQYG 397 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~~~-~~vkL~DFG~a~~~~~~~ 397 (518)
+|.|.+|+|..|+.+ .+..+...+..|++||++||.|||++. |||||||-+||+|+.+ |.|||+|+|+|.+.....
T Consensus 122 TEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999999988 557899999999999999999999985 9999999999999755 999999999999877765
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCCCCCC-CCCCcHHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT-PLQAAVGVVQKGLRPTI-PVHTHPILVDLL 475 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~-~~~~~~~~~~~~~~p~~-~~~~~~~L~~Li 475 (518)
... ..|||.|||||++. ..|+...||||||+.+.||.|+.+||+..+ +.|.+.. +..|..|.. ..--.|+++++|
T Consensus 201 aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK-V~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 201 AKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK-VTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred cce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH-HHcCCCHHHhhccCCHHHHHHH
Confidence 433 67999999999987 789999999999999999999999998855 5555555 444555443 344478999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~ 494 (518)
.+||.. ...|||+.|+|.
T Consensus 278 ekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 278 EKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhcC-chhccCHHHHhh
Confidence 999999 899999999975
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.24 Aligned_cols=253 Identities=27% Similarity=0.391 Sum_probs=202.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC-----Cce
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PRL 317 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 317 (518)
..|++.+.||+|+||.||+++.. ++.||||.+............+.+|+.++++++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 35777999999999999999964 78999999876543333446677899999999999999999987543 358
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY- 396 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~- 396 (518)
|+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 85 YIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 99999994 689888876 457999999999999999999999999999999999999999999999999999765443
Q ss_pred CccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------------------
Q 010091 397 GVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ------------------- 456 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~------------------- 456 (518)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 22334568899999998864 5689999999999999999999999976543222111110
Q ss_pred ---cCC----CC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHH
Q 010091 457 ---KGL----RP---TIPVHTHPILVDLLERCWQRDPSLRPDFSEITEL--LQHL 499 (518)
Q Consensus 457 ---~~~----~p---~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~--L~~l 499 (518)
+.. .+ .....+++++.++|.+||+.+|.+|||+++++.. +..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 00 1123567889999999999999999999999875 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.32 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=200.2
Q ss_pred eeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCc
Q 010091 249 FEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328 (518)
Q Consensus 249 ~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 328 (518)
+.+.+|.|+++.||+++..++.||+|+++....+......+.+|+.++++++|+||+++++++......|++|||+++++
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 35566777777888887788999999998765555666889999999999999999999999999999999999999999
Q ss_pred cccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--------c
Q 010091 329 IYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--------M 399 (518)
Q Consensus 329 L~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--------~ 399 (518)
|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+........ .
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 99999763 34688999999999999999999999999999999999999999999999998864332111 1
Q ss_pred ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-----------------
Q 010091 400 TAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR----------------- 460 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~----------------- 460 (518)
....++..|+|||++.+ ..++.++|+||||+++|+|++|..||..................
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCc
Confidence 22346788999999865 45889999999999999999999999876655443332211100
Q ss_pred ---------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 ---------------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 ---------------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.......+.++.+++.+||+.||.+|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0011122467889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=304.46 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=193.8
Q ss_pred ceeeeEEeEecceEEEEEEE----CCccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--CceeE
Q 010091 247 LKFEHKIVSGSYCDLYKGAF----FSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFI 319 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~----~~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~~~l 319 (518)
|.+.++||+|+||.||+|.. .++.||+|.+..... .+.....+.+|+.++++++||||+++++++... ..+|+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 66789999999999999997 458899999987431 122235677899999999999999999999877 78999
Q ss_pred EEeeccCCccccccccc----cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc----CCcEEEeeeccce
Q 010091 320 VTEFMSGGSIYDYLHKQ----KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE----NGVVKVADFGVAR 391 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~----~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~----~~~vkL~DFG~a~ 391 (518)
||||+++ +|.+++... ...+++..++.++.|++.||.|||+++|+||||||+||+++. ++.+||+|||++.
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999964 666665421 236889999999999999999999999999999999999999 8999999999997
Q ss_pred eccccCc----cccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHHh-
Q 010091 392 VQAQYGV----MTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQ---------AAVGVVQ- 456 (518)
Q Consensus 392 ~~~~~~~----~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~---------~~~~~~~- 456 (518)
....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... .....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6543221 122347889999998865 457899999999999999999999997543321 0000000
Q ss_pred -----------------------cCCCCCCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 457 -----------------------KGLRPTIP-----------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 457 -----------------------~~~~p~~~-----------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.......+ ...+..+.+++.+||+.||.+|||+.|++.
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00011111 145677999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=311.36 Aligned_cols=243 Identities=33% Similarity=0.526 Sum_probs=210.1
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|.++++||+|+||.||++..+ |+.+|||.+..+ ...+++..|+.||++++.|+||++||.+-....++||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 455899999999999999854 899999998754 23578899999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~ 403 (518)
..||+.+.++.++.+++++.+..++...++||+|||...-||||||..|||++.+|..||+|||+|-..... ....+..
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence 999999999998889999999999999999999999999999999999999999999999999999543321 1233456
Q ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhh
Q 010091 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQR 481 (518)
Q Consensus 404 gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~L~~Li~~cL~~ 481 (518)
||+.|||||++..-.|+.++||||||++..||..|++||.+.-|..+...+- ....|++ |..++.++.+++++||-+
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-T~PPPTF~KPE~WS~~F~DFi~~CLiK 269 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-TKPPPTFKKPEEWSSEFNDFIRSCLIK 269 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-CCCCCCCCChHhhhhHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999999887765543211 1222322 345678899999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
+|++|.|+.++++
T Consensus 270 ~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 270 KPEERKTALRLCE 282 (502)
T ss_pred CHHHHHHHHHHhh
Confidence 9999999988765
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=295.96 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=211.8
Q ss_pred ceeeeEEeEecceEEEEEEE--CCccEEEEEEecccc---C---HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCce
Q 010091 247 LKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHL---N---ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~---~---~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 317 (518)
|...+.||.|..+.|-+... .|+.+|+|++..... + ....++-.+|+.||+++ .||+|+++.+.++.+..+
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 44467799999999988764 378899998865322 2 23446778899999999 599999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
++|+|.|+.|.|.|||.+ ...+++...+++++|++.|++|||.++|+||||||+|||++++..+||.|||++.......
T Consensus 99 FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge 177 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE 177 (411)
T ss_pred hhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCch
Confidence 999999999999999988 5579999999999999999999999999999999999999999999999999999887777
Q ss_pred ccccCCCCCcccChhhh------cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcH
Q 010091 398 VMTAETGTYRWMAPEVI------EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHP 469 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l------~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--p~~~~~~~~ 469 (518)
.....+||++|+|||.+ ++..|+...|+|+.|+++|-|+.|.+||=.....-.+..+.+..+. .+--.+++.
T Consensus 178 kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~ 257 (411)
T KOG0599|consen 178 KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISA 257 (411)
T ss_pred hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccc
Confidence 77778899999999998 4566888999999999999999999999654433333333333332 222245678
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITE--LLQHLAQ 501 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~--~L~~l~~ 501 (518)
..++||.+||+.||.+|.|++|.+. .+..+..
T Consensus 258 ~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 258 TVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred cHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 8999999999999999999999986 3444443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=298.45 Aligned_cols=241 Identities=25% Similarity=0.362 Sum_probs=194.8
Q ss_pred EEeEecceEEEEEEEC--CccEEEEEEeccccCHH-HHHHHHHHHH---HHhhcCCCceeeEeeeeecCCceeEEEeecc
Q 010091 252 KIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN-IRREFAQEVH---IMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~-~~~~f~~E~~---il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 325 (518)
.||+|+||.||++... ++.||+|++........ ....+..|.. +++...||||+++++++...+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3799999999999864 68899999876543321 1223344443 4444579999999999999999999999999
Q ss_pred CCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCC
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT 405 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt 405 (518)
|++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++....... .....|+
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT 158 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCC
Confidence 9999998876 4579999999999999999999999999999999999999999999999999987543322 2235689
Q ss_pred CcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCC
Q 010091 406 YRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQ-AAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDP 483 (518)
Q Consensus 406 ~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP 483 (518)
..|+|||.+.+. .++.++|+||+|+++|+|++|..||....... ...........+.++..+++.+.+++.+||..+|
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p 238 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence 999999998644 68999999999999999999999997653211 1111122234566777788999999999999999
Q ss_pred CCCC-----CHHHHHH
Q 010091 484 SLRP-----DFSEITE 494 (518)
Q Consensus 484 ~~RP-----s~~eil~ 494 (518)
.+|| ++.++++
T Consensus 239 ~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 239 NRRLGCLGRGAQEVKE 254 (278)
T ss_pred HhccCCCCCCHHHHHh
Confidence 9999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=306.98 Aligned_cols=252 Identities=27% Similarity=0.378 Sum_probs=207.7
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC-----cee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-----RLF 318 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~ 318 (518)
+|++.+.||.|++|.||+++.. ++.||+|.+............+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3667999999999999999965 688999999875443445578899999999999999999999987765 789
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG- 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~- 397 (518)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||.||+++.++.++|+|||.+.......
T Consensus 81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 9999996 589998876 3479999999999999999999999999999999999999999999999999998765442
Q ss_pred ---ccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC------------
Q 010091 398 ---VMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP------------ 461 (518)
Q Consensus 398 ---~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p------------ 461 (518)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+....-.+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 23335578899999999877 78999999999999999999999998776554433322211000
Q ss_pred -----------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHH
Q 010091 462 -----------------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE--LLQHL 499 (518)
Q Consensus 462 -----------------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~--~L~~l 499 (518)
......++.+.++|.+||+.+|.+||++.+++. .++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 011235788999999999999999999999986 34444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=308.54 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=199.0
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee----cCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT----RPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~----~~~~~~ 318 (518)
..|.+.+.||.|+||.||+|+.. ++.||+|++............+.+|+.++++++||||+++++++. ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 34556899999999999999864 789999999865433344567788999999999999999998875 335689
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 9999995 689999876 34589999999999999999999999999999999999999999999999999976433221
Q ss_pred -----cccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------------
Q 010091 399 -----MTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK--------------- 457 (518)
Q Consensus 399 -----~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~--------------- 457 (518)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+...........
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 123468899999999855 45889999999999999999999999776543322111110
Q ss_pred -------CC--CCCC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 458 -------GL--RPTI-----PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 458 -------~~--~p~~-----~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+ .... ....++++.++|.+||+.+|.+||++++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01 1111 1345788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=300.24 Aligned_cols=246 Identities=21% Similarity=0.369 Sum_probs=200.9
Q ss_pred ceeeeEEeEecceEEEEEEE-----CCccEEEEEEeccccCH--HHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCcee
Q 010091 247 LKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNE--NIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~-----~~~~vAvKvl~~~~~~~--~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 318 (518)
|++.+.||.|+||.||++.. .|+.||+|+++...... .....+..|+.+++++ +|+||+++++.+......|
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56689999999999999985 46889999998643322 2346788899999999 5999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG- 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~- 397 (518)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 82 LILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999976 4568899999999999999999999999999999999999999999999999997643322
Q ss_pred -ccccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 398 -VMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 398 -~~~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||..... .......+. ...+..+..+++.+
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQEMSALA 239 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh-ccCCCCCccCCHHH
Confidence 1123458899999999865 3467899999999999999999999964322 122222222 22345566788999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHH
Q 010091 472 VDLLERCWQRDPSLRP-----DFSEITE 494 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RP-----s~~eil~ 494 (518)
.+++.+||+.+|.+|| +..+++.
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 9999999999999997 6677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=306.57 Aligned_cols=247 Identities=24% Similarity=0.417 Sum_probs=195.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC-----Cce
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PRL 317 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 317 (518)
++|++.++||+|+||.||+|.+. ++.||+|+++... .......+.+|+.++++++|+||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 35666999999999999999864 7889999987532 223446788999999999999999999876543 357
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+|+||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 99999995 578777754 358999999999999999999999999999999999999999999999999987643322
Q ss_pred c----cccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----------------
Q 010091 398 V----MTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ---------------- 456 (518)
Q Consensus 398 ~----~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~---------------- 456 (518)
. .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+............
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 122457899999998744 5689999999999999999999999976543322211110
Q ss_pred ------cC--CCCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 457 ------KG--LRPT-----IPVHTHPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 457 ------~~--~~p~-----~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
.. ..+. .....++++.++|.+||+.+|.+|||+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0001 112356789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=300.58 Aligned_cols=251 Identities=21% Similarity=0.341 Sum_probs=205.1
Q ss_pred ceeeeEEeEecceEEEEEEEC-----CccEEEEEEeccccC--HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCcee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~--~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 318 (518)
|++.+.||.|++|.||+++.. ++.||||+++..... ......+..|+.+++++ +||||+++++.+......|
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 566899999999999998853 467999999854332 22346788999999999 5999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||+++.......
T Consensus 82 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 82 LILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999876 34688999999999999999999999999999999999999999999999999876433221
Q ss_pred --cccCCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 399 --MTAETGTYRWMAPEVIEHQP--YNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 399 --~~~~~gt~~y~APE~l~~~~--~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
.....|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||..... ......... ...+..+..+++.+
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 239 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-KSKPPFPKTMSAEA 239 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-ccCCCCCcccCHHH
Confidence 12235789999999987654 78899999999999999999999964321 111111122 23345666788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
.+++.+||+.+|.+|||+.++.+.|+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 9999999999999999998887777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=296.58 Aligned_cols=235 Identities=18% Similarity=0.352 Sum_probs=190.8
Q ss_pred eeeE--EeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEee
Q 010091 249 FEHK--IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 249 ~~~~--Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+.+. ||+|+||.||++... +..+|+|++........ |+.....+ +||||+++++.+...+..|+||||
T Consensus 18 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 18 IVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred cccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 3454 599999999999864 67899999876543321 22222222 799999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-cEEEeeeccceeccccCccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
+++++|.+++... ..+++..++.++.|+++||.|||+.|++||||||+||+++.++ .++|+|||.+...... ...
T Consensus 91 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~ 166 (267)
T PHA03390 91 IKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCY 166 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccC
Confidence 9999999999774 4799999999999999999999999999999999999999988 9999999998765432 234
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ--KGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
.++..|+|||++.+..++.++|+||||+++|+|++|..||............+. .......+...++.+.++|.+||+
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 246 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLK 246 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhc
Confidence 689999999999988999999999999999999999999985543221111111 122334455788999999999999
Q ss_pred hCCCCCCC-HHHHHH
Q 010091 481 RDPSLRPD-FSEITE 494 (518)
Q Consensus 481 ~dP~~RPs-~~eil~ 494 (518)
.+|.+||+ ++++++
T Consensus 247 ~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 247 YNINYRLTNYNEIIK 261 (267)
T ss_pred cChhhCCchHHHHhc
Confidence 99999995 688874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=301.60 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=196.7
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--------
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-------- 314 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~-------- 314 (518)
.+|.+.++||+|+||.||+|++. ++.+|+|++......+.....+.+|+.++++++|+||+++++.+...
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 34555999999999999999975 68899999876544433335677899999999999999999877443
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..+|+||||+. ++|.+++......+++..+..++.|++.||.|||++||+|+||||+||++++++.++|+|||++....
T Consensus 88 ~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 88 GSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred ceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 34699999995 47777776656679999999999999999999999999999999999999999999999999997543
Q ss_pred ccCc------------cccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Q 010091 395 QYGV------------MTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP 461 (518)
Q Consensus 395 ~~~~------------~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p 461 (518)
.... .+...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3211 122346788999998754 458899999999999999999999998776654443322211000
Q ss_pred ---------------------CCC-------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 ---------------------TIP-------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ---------------------~~~-------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+ ....+.+.+++.+||+.||.+|||+.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 123467889999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=291.06 Aligned_cols=236 Identities=26% Similarity=0.402 Sum_probs=203.8
Q ss_pred EeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
||.|+||.||++... ++.+|+|++....... .....+..|+.++++++|+||+++++.+......|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 6889999998764433 3457889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCCCcc
Q 010091 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTYRW 408 (518)
Q Consensus 330 ~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y 408 (518)
.+++... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 9999773 468999999999999999999999999999999999999999999999999997654431 23335688999
Q ss_pred cChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 010091 409 MAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPD 488 (518)
Q Consensus 409 ~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs 488 (518)
++||.+.+..++.++|+||||+++|+|++|..||......+....... ....++...+..+.+++.+||..||.+||+
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999888889999999999999999999999987765444433333 345677777899999999999999999999
Q ss_pred HHH
Q 010091 489 FSE 491 (518)
Q Consensus 489 ~~e 491 (518)
+.+
T Consensus 238 ~~~ 240 (250)
T cd05123 238 SGG 240 (250)
T ss_pred ccc
Confidence 944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=294.07 Aligned_cols=247 Identities=27% Similarity=0.463 Sum_probs=205.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc---CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~---~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
+|.+.++||+|+||.||++.+. +..+++|+++.... .......+..|+.++++++||||+++++++......|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3667999999999999999865 35577777664322 222334677899999999999999999999988999999
Q ss_pred EeeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 321 TEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|||+++++|.+++.. ....+++..++.++.|++.|+.|||++|++|+||+|+||+++. +.++|+|||.+.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988863 2356899999999999999999999999999999999999975 679999999987653322
Q ss_pred -ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 398 -VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 398 -~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............. .+..+..+..++.++.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHHHH
Confidence 2223458889999999988889999999999999999999999998776655444433 35566677788899999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
+||..+|.+||++.+++.
T Consensus 239 ~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 239 SMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHhcCChhhCcCHHHHhh
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.31 Aligned_cols=246 Identities=24% Similarity=0.390 Sum_probs=199.8
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEEee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
|++.+.||.|++|.||+|+.. ++.|+||.+....... ......+|+..+++++ |+||+++++++......|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 456889999999999999974 6789999987654322 2234557999999999 99999999999999999999999
Q ss_pred ccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
+ +++|.+++.... ..+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 789999887644 46899999999999999999999999999999999999999999999999999866544444445
Q ss_pred CCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------------CCCC---
Q 010091 403 TGTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK-----------------GLRP--- 461 (518)
Q Consensus 403 ~gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~-----------------~~~p--- 461 (518)
.++..|+|||.+. ...++.++|+||||+++|+|++|+.||...+........... ....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 6889999999874 455789999999999999999999999776544333221110 0000
Q ss_pred --------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 --------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 --------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
......++++.+++.+||+.+|.+|||++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001123578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.61 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=202.7
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC-
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP- 315 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~- 315 (518)
.|++ ..+|++.+.||+|+||.||++... +..||||++............+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3554 455777999999999999999864 688999998765444445567889999999999999999999886543
Q ss_pred -----ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 316 -----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 316 -----~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
..|+||||+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 358999999 7799888764 35899999999999999999999999999999999999999999999999999
Q ss_pred eeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------
Q 010091 391 RVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--------- 460 (518)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--------- 460 (518)
...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..................
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 754332 223457889999999865 45889999999999999999999999876554333222211000
Q ss_pred --------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 --------------------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 --------------------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+....++.+.++|.+|++.||.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112356778999999999999999999999883
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.16 Aligned_cols=240 Identities=31% Similarity=0.492 Sum_probs=202.1
Q ss_pred eeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 250 EHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
..+||+|+||.||++... ++.||+|.+.... ......+.+|+.++++++|+||+++++.+...+..|+||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 467999999999999874 6889999875432 233467889999999999999999999999999999999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCCCCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTY 406 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~ 406 (518)
+|.+++.. ..+++..++.++.|++.|++|||++|++||||+|+||+++.++.++|+|||++....... ......|+.
T Consensus 103 ~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 103 ALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred cHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence 99998754 358899999999999999999999999999999999999999999999999886543221 223345889
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhhCCC
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQRDPS 484 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~L~~Li~~cL~~dP~ 484 (518)
.|+|||.+.+..++.++|+||||+++|+|++|..||......+.... ......+.+ ....++.+.+++.+||+.+|.
T Consensus 181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence 99999999888899999999999999999999999987765544332 222333322 235688999999999999999
Q ss_pred CCCCHHHHHH
Q 010091 485 LRPDFSEITE 494 (518)
Q Consensus 485 ~RPs~~eil~ 494 (518)
+||++.+++.
T Consensus 260 ~R~~~~~ll~ 269 (292)
T cd06657 260 QRATAAELLK 269 (292)
T ss_pred cCcCHHHHhc
Confidence 9999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.43 Aligned_cols=245 Identities=29% Similarity=0.485 Sum_probs=218.8
Q ss_pred ceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|.+..+||+|.|+.|.+++. .+..||||++.....+....+.+.+|+++|+.|+|||||+++.+...+..+|+||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 44499999999999999995 4789999999988888777777999999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETG 404 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~g 404 (518)
.+|.+.+|+.+ .+...+.....++.|+.+|++|||+++|||||||++|||++.+-++||+|||++..........+.+|
T Consensus 138 ~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cg 216 (596)
T KOG0586|consen 138 SGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCG 216 (596)
T ss_pred cCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCC
Confidence 99999999988 45667789999999999999999999999999999999999999999999999999887777777889
Q ss_pred CCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCC
Q 010091 405 TYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDP 483 (518)
Q Consensus 405 t~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP 483 (518)
++.|.|||++.+..| .+..|+||+|+++|-|+.|.+||++.+-......++.. ...+|...+.+..++|.++|-.+|
T Consensus 217 sppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--k~rIp~~ms~dce~lLrk~lvl~P 294 (596)
T KOG0586|consen 217 SPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--KYRIPFYMSCDCEDLLRKFLVLNP 294 (596)
T ss_pred CCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--eecccceeechhHHHHHHhhccCc
Confidence 999999999988877 47899999999999999999999987654444443433 344666778889999999999999
Q ss_pred CCCCCHHHHHH
Q 010091 484 SLRPDFSEITE 494 (518)
Q Consensus 484 ~~RPs~~eil~ 494 (518)
.+|++.++|.+
T Consensus 295 skr~~~dqim~ 305 (596)
T KOG0586|consen 295 SKRGPCDQIMK 305 (596)
T ss_pred cccCCHHHhhh
Confidence 99999999876
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.01 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=203.4
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
..|++ ..+|.+.+.||+|+||.||+|++. ++.||+|++......+.....+.+|+.++++++|+||+++++++....
T Consensus 9 ~~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 9 TVWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred hhhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 35777 457888999999999999999864 789999998765444444567889999999999999999999886543
Q ss_pred ------ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 316 ------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 316 ------~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
..|+|+||+. .+|.+++. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 88 SGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred cCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4699999995 46766542 3588999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---------
Q 010091 390 ARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--------- 459 (518)
Q Consensus 390 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~--------- 459 (518)
++.... ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.+...............
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 875432 2233457889999999865 4688999999999999999999999987765444333221100
Q ss_pred ------------CCCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHH
Q 010091 460 ------------RPTI--------PVHTHPILVDLLERCWQRDPSLRPDFSEITE--LLQHL 499 (518)
Q Consensus 460 ------------~p~~--------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~--~L~~l 499 (518)
.+.. ....++++.++|.+||+.||.+||++++++. .++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0011 1235678999999999999999999999984 35554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=295.23 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=203.9
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|++.+.||+|.+|.||+|+.. ++.||+|++......+.....+..|+.++++++|+||+++++++......|+||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 345788999999999999975 689999999876544444577888999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 403 (518)
+ ++|.+++......+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 6 59999998754579999999999999999999999999999999999999999999999999997654432 223345
Q ss_pred CCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------------CCCC-
Q 010091 404 GTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG-------------------LRPT- 462 (518)
Q Consensus 404 gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~-------------------~~p~- 462 (518)
++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+............ ..+.
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 67889999998766 78999999999999999999999998766544332222100 0000
Q ss_pred -------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 -------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 -------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.....+..+.++|.+||+.+|.+||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00123678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.72 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=202.1
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeec--CCceeEE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR--PPRLFIV 320 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~--~~~~~lV 320 (518)
.|++.+.||+|+||.||+|.+. ++.+|+|.+.....+......+.+|+.+++++ +||||+++++++.. ....|+|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 4566899999999999999874 68899999865443444446777899999999 99999999998754 3468999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC---
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG--- 397 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~--- 397 (518)
|||++ ++|.+++... .+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 88 FEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred ecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 99996 5999888763 68888999999999999999999999999999999999999999999999997543321
Q ss_pred ---ccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------------
Q 010091 398 ---VMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-------------- 459 (518)
Q Consensus 398 ---~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-------------- 459 (518)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....+............
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence 1222357889999998754 5678999999999999999999999987654433222111100
Q ss_pred ---------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 460 ---------------RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 460 ---------------~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
.......++.++.++|.+||+.+|.+|||+.+++.. .+++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~--~~~~~~~~~ 304 (337)
T cd07852 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH--PYVAQFHNP 304 (337)
T ss_pred HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC--hhhhhhccC
Confidence 001112367889999999999999999999999863 345555433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.28 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=204.5
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
..|++ .++|.+.+.||+|++|.||+|+.. ++.||+|++.....+......+.+|+.++++++|+||+++++++....
T Consensus 9 ~~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 9 TVWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred ceecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 34565 446888999999999999999975 688999998765444444567788999999999999999998876554
Q ss_pred c------eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 316 R------LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 316 ~------~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
. .|+|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence 4 89999999 6799998875 3589999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--------
Q 010091 390 ARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR-------- 460 (518)
Q Consensus 390 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~-------- 460 (518)
+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+......
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 9765432 333567889999999854 46789999999999999999999999876655443332221000
Q ss_pred ------------------C---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 ------------------P---TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 ------------------p---~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+ ......++++.++|.+||+.+|.+|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 011235788999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=289.50 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=215.1
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEECC--ccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRP 314 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~ 314 (518)
..+..+.++++++..||+|+.|.|+++++.. .-.|||.+..... .+..++++..+.++.+.+ .|+||+.+|+|...
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 3456777888889999999999999999874 7899999987643 333467777888877765 89999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
...++-||.| +..+..++..-..++++..+-++...+++||.||-. +||+|||+||+|||+|+.|++|+||||++-..
T Consensus 164 ~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 164 TDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred chHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 9999999999 556666666656678999999999999999999975 58999999999999999999999999999877
Q ss_pred cccCccccCCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCCCCCCC--CC
Q 010091 394 AQYGVMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDL-TPLQAAVGVVQKGLRPTIPV--HT 467 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~-~~~~~~~~~~~~~~~p~~~~--~~ 467 (518)
..+...+...|-+.|||||.+. ...|+.++||||||++++||.||..||.+. +.++....+++ ...|.++. ..
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gF 321 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGF 321 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCc
Confidence 6666666677999999999994 457999999999999999999999999884 45666666665 44555553 47
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++.+.+++..||++|+.+||.+.++++
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 999999999999999999999999875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.89 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=197.4
Q ss_pred eeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHH------------HHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 249 FEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN------------IRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 249 ~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~------------~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
+.+.||.|+||.||+|.+. ++.||||+++....... ....+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3577999999999999864 78899999876533221 012577899999999999999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
...|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+....
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYG 170 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecc
Confidence 99999999996 589998866 4568999999999999999999999999999999999999999999999999997654
Q ss_pred cc---------------CccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Q 010091 395 QY---------------GVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG 458 (518)
Q Consensus 395 ~~---------------~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~ 458 (518)
.. .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~ 250 (335)
T PTZ00024 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250 (335)
T ss_pred cccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 11 112223467889999998654 46899999999999999999999998877655443322210
Q ss_pred CCC-------------------C-------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 LRP-------------------T-------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 ~~p-------------------~-------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+ . .....+.++.++|.+||+.+|.+||++++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 000 0 01234678999999999999999999999975
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.12 Aligned_cols=250 Identities=16% Similarity=0.290 Sum_probs=187.6
Q ss_pred cccceeeeEEeEecceEEEEEEECC---ccEEEEEE---------------eccccCHHHHHHHHHHHHHHhhcCCCcee
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFFS---QDVAIKVL---------------TNEHLNENIRREFAQEVHIMRKVRHMNVV 305 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~~---~~vAvKvl---------------~~~~~~~~~~~~f~~E~~il~~l~HpnIv 305 (518)
...|++.++||+|+||.||++.... ..++.|.+ +...........+.+|+.++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3567779999999999999987531 22222211 11111223446788999999999999999
Q ss_pred eEeeeeecCCceeEEEeeccCCcccccccccc----CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc
Q 010091 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381 (518)
Q Consensus 306 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~ 381 (518)
++++++......|+|++++ +++|.+++.... .......++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 557777764322 22345678889999999999999999999999999999999999
Q ss_pred EEEeeeccceeccccCc--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCC-CCCCC--CHHHHHHHHHh
Q 010091 382 VKVADFGVARVQAQYGV--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKL-PYDDL--TPLQAAVGVVQ 456 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~-P~~~~--~~~~~~~~~~~ 456 (518)
+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|.. ||... .+.......+.
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 99999999986543321 223469999999999999999999999999999999999875 45432 22222222111
Q ss_pred c------CCC---------------C----CC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 457 K------GLR---------------P----TI-----PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 457 ~------~~~---------------p----~~-----~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. .+. . .+ ....+.++.++|.+||+.||.+|||+.|++.
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 000 0 00 1134567888999999999999999999986
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=299.11 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=195.2
Q ss_pred ceeeeEEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeec----CCce
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR----PPRL 317 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~----~~~~ 317 (518)
|++.+.||+|+||.||++++. +..||+|++............+.+|+.+++++ +||||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 566899999999999999975 45799999876543444456788899999999 59999999987532 2457
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+++||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 82 YLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 89999984 689998866 4578999999999999999999999999999999999999999999999999997543221
Q ss_pred -----ccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------------
Q 010091 398 -----VMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK-------------- 457 (518)
Q Consensus 398 -----~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~-------------- 457 (518)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||............+..
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1223458899999998755 56899999999999999999999999875543322211110
Q ss_pred ----------CCC--C---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 458 ----------GLR--P---TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 458 ----------~~~--p---~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
... . ......+..+.+++.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 0 111235778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=301.89 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=201.4
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-- 314 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~-- 314 (518)
.|++ .++|.+.+.||+|+||.||++.. .++.||+|+++....+......+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~-~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 12 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred Hhhc-cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 3555 35688899999999999999985 478899999986544444456788999999999999999999987532
Q ss_pred ----CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 315 ----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 315 ----~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
...|++++++ |++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence 3478899887 78998887653 5899999999999999999999999999999999999999999999999998
Q ss_pred eeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----------
Q 010091 391 RVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG----------- 458 (518)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~----------- 458 (518)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+....
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 75432 2233568899999998865 568899999999999999999999997665544332221110
Q ss_pred -------------CCCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 459 -------------LRPT-----IPVHTHPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 459 -------------~~p~-----~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
..+. .....++++.++|.+||+.||.+||++.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 012357789999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.77 Aligned_cols=257 Identities=32% Similarity=0.569 Sum_probs=226.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--C----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--S----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
..++..++||+|+||+||+|.|- + -+||+|++......+ .-.+|+.|+.+|.+++|||+++++++|.... +-
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~-~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK-ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch-hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 35667889999999999999974 3 479999988654433 3478999999999999999999999997765 88
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
||++||++|+|.+|++..+..+-.+..+.+..||++||.|||.++++||||.++|||+.+-..|||.|||+++.....+.
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998665442
Q ss_pred -cccCC--CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 399 -MTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 399 -~~~~~--gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
..+.. -.+.|||-|.+....|+.++||||||+++||++| |..||.++...+ ....++.+.+..-|..++-++..+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhccccCCCCCCccHHHHHH
Confidence 22222 4678999999999999999999999999999999 999999987544 556677888888899999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 475 LERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
|.+||..|++.||+|+++...+.++.+..+
T Consensus 933 mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred HHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 999999999999999999999998876554
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.90 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=199.4
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec-CCc
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PPR 316 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-~~~ 316 (518)
|.+ .+.|++.+.||.|+||.||++... ++.||+|++............+.+|+.++++++||||+++++++.. ...
T Consensus 6 ~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEI-TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred ecc-ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 443 345777999999999999999864 6789999987654444445678889999999999999999998865 567
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.|++|||+ +++|.+++.. ..++...+..++.|++.||.|||++||+||||+|.||+++.++.++|+|||.+.....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP- 160 (328)
T ss_pred EEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence 89999999 6689888764 3578888999999999999999999999999999999999999999999999875432
Q ss_pred CccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------------------
Q 010091 397 GVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK------------------ 457 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~------------------ 457 (518)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....+..........
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2233457889999998765 56899999999999999999999999876543221111100
Q ss_pred ----CC--CCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 458 ----GL--RPT-----IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 458 ----~~--~p~-----~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+ ... ....+++.+.++|.+||+.+|.+||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 001 11246788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=293.49 Aligned_cols=251 Identities=25% Similarity=0.428 Sum_probs=218.9
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
.|.-+++.+.++||+|.||.|-+++.+ ++.+|+|+++.+..-. +....-+.|-++|+..+||.+..+.-.|.....+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 455677888999999999999999865 7889999999876543 3346667899999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||..||.|.-.|.. ...++++..+-+...|+.||.|||+++||.||||.+|+|+|.+|++||.|||+++..-..+
T Consensus 244 CFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 999999999999999877 4579999999999999999999999999999999999999999999999999998654443
Q ss_pred -ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 398 -VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 398 -~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
.+.+.+||+.|+|||++....|..+.|.|.+|+++|||++|++||-..+....+.-++...+ .+|..++++.+.|+.
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--KFPRTLSPEAKTLLS 400 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--cCCccCCHHHHHHHH
Confidence 34556799999999999999999999999999999999999999988877666665555544 478889999999999
Q ss_pred HhhhhCCCCC----C-CHHHHHH
Q 010091 477 RCWQRDPSLR----P-DFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~R----P-s~~eil~ 494 (518)
..|.+||.+| | ++.||..
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHh
Confidence 9999999999 2 4555543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.77 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=195.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--------
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-------- 314 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~-------- 314 (518)
.+|.+.+.||.|+||.||+|... ++.||+|.+..... .....+.+|+.++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 56777999999999999999864 68899999876543 2346788899999999999999999765443
Q ss_pred ------CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec-cCCcEEEeee
Q 010091 315 ------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVVKVADF 387 (518)
Q Consensus 315 ------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~-~~~~vkL~DF 387 (518)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+||
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35799999996 588888754 3588999999999999999999999999999999999997 4567899999
Q ss_pred ccceeccccCc----cccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----
Q 010091 388 GVARVQAQYGV----MTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK----- 457 (518)
Q Consensus 388 G~a~~~~~~~~----~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~----- 457 (518)
|.++....... .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||....+..........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99976433211 122357889999998744 56889999999999999999999999877655443332211
Q ss_pred ------------------CCCCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 458 ------------------GLRPT-----IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 458 ------------------~~~p~-----~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
...+. .....+.++.++|.+||+.||.+|||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00010 11346778999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=340.28 Aligned_cols=244 Identities=29% Similarity=0.458 Sum_probs=211.4
Q ss_pred eeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 250 EHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
..+||.|.||.||-+.. +|+..|+|-++-............+|..++..++|||+|+++|+-.+++..+|.||||+||
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 67899999999999984 5788999988866555444567788999999999999999999999999999999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-----ccccC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-----VMTAE 402 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-----~~~~~ 402 (518)
+|.+.+.. +.-.++.....+..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|....... .....
T Consensus 1320 sLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~ 1398 (1509)
T KOG4645|consen 1320 SLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSM 1398 (1509)
T ss_pred cHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhh
Confidence 99999876 4456677777888999999999999999999999999999999999999999997654432 12234
Q ss_pred CCCCcccChhhhcCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 403 TGTYRWMAPEVIEHQ---PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 403 ~gt~~y~APE~l~~~---~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
.||+-|||||++.+. ....++|||||||++.||+||+.||...+..=+..-.+-.+-.|++|...+++-.++|.+||
T Consensus 1399 ~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl 1478 (1509)
T KOG4645|consen 1399 MGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCL 1478 (1509)
T ss_pred cCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHH
Confidence 599999999999544 34678999999999999999999999988776777777778899999999999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
+.||.+|=++.|+++
T Consensus 1479 ~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1479 EQDPKMRWTASQLLE 1493 (1509)
T ss_pred hcCchhhhHHHHHHH
Confidence 999999977666543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=321.39 Aligned_cols=145 Identities=26% Similarity=0.470 Sum_probs=131.2
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccc-cCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~-~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|.+.++||+|+||.||+|.+. ++.||||+++... .+......+..|+.+++.++|+||+++++.+.....+|+|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 4555999999999999999986 7899999998643 334455788899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
|+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999976 3468899999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.67 Aligned_cols=244 Identities=26% Similarity=0.449 Sum_probs=192.8
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC---------
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--------- 314 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--------- 314 (518)
++...+.||+|+||.||+++.+ |+.||||.+.... ++.......+|+..+.+|+|||||+++.+|.+.
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4455778999999999999964 8999999998876 666678899999999999999999998543110
Q ss_pred --------------------------------------------------------------------------------
Q 010091 315 -------------------------------------------------------------------------------- 314 (518)
Q Consensus 315 -------------------------------------------------------------------------------- 314 (518)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCc
Q 010091 315 ------------------------------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364 (518)
Q Consensus 315 ------------------------------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gI 364 (518)
..+||-||||+..+|+++++.+...-.....|+++++|+.||.|+|+.||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 12689999999988888887744322578899999999999999999999
Q ss_pred eecCCCCCcEEeccCCcEEEeeeccceecc-------------------ccCccccCCCCCcccChhhhcCC---CCCch
Q 010091 365 IHRDLKAANLLMNENGVVKVADFGVARVQA-------------------QYGVMTAETGTYRWMAPEVIEHQ---PYNHR 422 (518)
Q Consensus 365 iHrDLkp~NILl~~~~~vkL~DFG~a~~~~-------------------~~~~~~~~~gt~~y~APE~l~~~---~~~~k 422 (518)
|||||||.||++++++.|||+|||+|.... ..+..|...||.-|+|||++.+. +|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999997611 01124556699999999999554 59999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 423 ADVFSFGIVLWELVTGKLPYDD-LTPLQAAVGVVQKGLRPTI---PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 423 sDV~SlGill~eLltG~~P~~~-~~~~~~~~~~~~~~~~p~~---~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+|+|||||+++||+. ||.. +.....+.. ++.+--|.. ...-.+.-..+|++|++.||.+|||+.|++.
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsMERa~iL~~-LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSMERASILTN-LRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHHHHHHHHh-cccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 999999999999984 5654 333333322 223322222 2334566889999999999999999999874
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=298.31 Aligned_cols=248 Identities=22% Similarity=0.311 Sum_probs=210.0
Q ss_pred eeeccccceeeeEEeEecceEEEEEE--ECCccEEEEEEeccccCHH-HHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNEN-IRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~--~~~~~vAvKvl~~~~~~~~-~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
|-+..+.+..-++||.|+||.||-.+ .+|+-+|.|.+........ .....+.|-.||.+++.+.||.+--+|+....
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 45566667778899999999999876 4588999998876554332 22556789999999999999999999999999
Q ss_pred eeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
+|+|+..|.||+|.-+|...+ ..++++.++-++.+|+.||++||+.+||.|||||+|||+|+.|+|+|+|+|+|.....
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999999887644 3699999999999999999999999999999999999999999999999999988777
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HhcCCCCCCCCCCcHHHHH
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGV--VQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~L~~ 473 (518)
....+...||.+|||||++.++.|+...|.|||||++|||+.|+-||........-..+ ......-..+...+++.++
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks 419 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS 419 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence 66666678999999999999999999999999999999999999999754322111111 1112344566888999999
Q ss_pred HHHHhhhhCCCCCC
Q 010091 474 LLERCWQRDPSLRP 487 (518)
Q Consensus 474 Li~~cL~~dP~~RP 487 (518)
+.+..|++||.+|-
T Consensus 420 lc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRL 433 (591)
T ss_pred HHHHHHccCHHHhc
Confidence 99999999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=295.56 Aligned_cols=250 Identities=33% Similarity=0.662 Sum_probs=202.7
Q ss_pred ccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhc--CCCceeeEeeeeecCC----cee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV--RHMNVVQFIGACTRPP----RLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l--~HpnIv~l~~~~~~~~----~~~ 318 (518)
.+..+.+.||+|.||.||+|.|.|+.||||++.... ...+.+|..|.+.+ +|+||+.|+++-..+. .++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 345679999999999999999999999999998642 25667888888865 9999999999864432 589
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC--------CceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN--------NIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~--------gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
+|++|.+.|||+|||.. ..++....++++..++.||++||-. .|.|||||+.|||+..+|...|+|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999999987 4589999999999999999999953 4999999999999999999999999999
Q ss_pred eeccccC-----ccccCCCCCcccChhhhcCCC----C--CchhhHHHHHHHHHHHHc----C------CCCCCCCCH--
Q 010091 391 RVQAQYG-----VMTAETGTYRWMAPEVIEHQP----Y--NHRADVFSFGIVLWELVT----G------KLPYDDLTP-- 447 (518)
Q Consensus 391 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~~----~--~~ksDV~SlGill~eLlt----G------~~P~~~~~~-- 447 (518)
-...... ......||.+|||||++...- + -..+||||||.++||++. | ++||-+..+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 6544331 123456999999999995432 1 134899999999999984 2 478865432
Q ss_pred --HHHHHH-HHhcCCCCCCCCCCcH-----HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 448 --LQAAVG-VVQKGLRPTIPVHTHP-----ILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 448 --~~~~~~-~~~~~~~p~~~~~~~~-----~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
.+.... +..+.++|.+|..+.. .+.++|+.||..||.-|-|+-.|.+.|.++.+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 233322 2356789999977643 38889999999999999999999988888864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=311.51 Aligned_cols=260 Identities=27% Similarity=0.485 Sum_probs=208.0
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
....|+. .+.||+|+||.||+|+.+ |+.||||+++... .....+.-.+|+.+|++++|+|||++.++-..
T Consensus 11 ~~y~W~~-------~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~ 82 (732)
T KOG4250|consen 11 ENYLWEM-------DERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEET 82 (732)
T ss_pred CCcceee-------hhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCc
Confidence 3467888 788999999999999954 8999999998754 22334677789999999999999999987543
Q ss_pred C------CceeEEEeeccCCccccccccc--cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe--ccCC--c
Q 010091 314 P------PRLFIVTEFMSGGSIYDYLHKQ--KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM--NENG--V 381 (518)
Q Consensus 314 ~------~~~~lV~Ey~~ggsL~~~l~~~--~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl--~~~~--~ 381 (518)
. ....+|||||.||+|...|.+. ..++++..++.++.+++.||.|||++||+||||||.||++ +++| .
T Consensus 83 ~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 83 KFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred cccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Confidence 3 3468999999999999999863 3479999999999999999999999999999999999998 3434 5
Q ss_pred EEEeeeccceeccccCccccCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHh
Q 010091 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLT----PLQAAVGVVQ 456 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~----~~~~~~~~~~ 456 (518)
.||+|||.|+-.......+...||..|.+||++. .+.|+...|.|||||++|++.||..||.... ..+..+....
T Consensus 163 yKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t 242 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT 242 (732)
T ss_pred EeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence 7999999999888877788888999999999998 5889999999999999999999999995322 1223332221
Q ss_pred cC-----------------CCCC--CCCCCcHH----HHHHHHHhhhhCCCCCC--CHHHHHHHHHHHHHHh
Q 010091 457 KG-----------------LRPT--IPVHTHPI----LVDLLERCWQRDPSLRP--DFSEITELLQHLAQRL 503 (518)
Q Consensus 457 ~~-----------------~~p~--~~~~~~~~----L~~Li~~cL~~dP~~RP--s~~eil~~L~~l~~~~ 503 (518)
+. +... .|...++. +...+..+|..+|.+|= .+.++-..+.+|+..-
T Consensus 243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 11 1111 23333333 56677788889999996 8888888888887643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=272.96 Aligned_cols=236 Identities=34% Similarity=0.555 Sum_probs=201.9
Q ss_pred cceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCccccccc
Q 010091 257 SYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLH 334 (518)
Q Consensus 257 ~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~ 334 (518)
+||.||+|.+. ++.+|+|++........ ...+.+|+..+++++|+||+++++++......+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999975 58899999987654332 5789999999999999999999999998899999999999999999987
Q ss_pred cccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCCcccChhhh
Q 010091 335 KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVI 414 (518)
Q Consensus 335 ~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l 414 (518)
... .++...++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.............++..|++||.+
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 643 3889999999999999999999999999999999999999999999999999876654444456689999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHH
Q 010091 415 EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVH--THPILVDLLERCWQRDPSLRPDFSEI 492 (518)
Q Consensus 415 ~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~L~~Li~~cL~~dP~~RPs~~ei 492 (518)
.+..++.++|+||||+++|+|++|..||........................ ++.++.+++.+||..+|.+||++.++
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 8888999999999999999999999999874444444444443333322222 78899999999999999999999999
Q ss_pred HH
Q 010091 493 TE 494 (518)
Q Consensus 493 l~ 494 (518)
++
T Consensus 239 ~~ 240 (244)
T smart00220 239 LQ 240 (244)
T ss_pred hh
Confidence 75
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=305.43 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=224.0
Q ss_pred eccccceeeeEEeEecceEEEEEEECCcc--EEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD--VAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~--vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+..++++.+..||-|+||.|-++..+++. +|+|+++....-+ ...+....|-+||..++.|.||++|-.|.+..+.|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44556667889999999999999988776 8999998765543 45578889999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
++||-|-||.|...|++ ++.++.....-++..++.|++|||++|||.|||||+|+|++.+|.+||.|||+|+.......
T Consensus 497 mLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999999998 66899999999999999999999999999999999999999999999999999999888777
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
..+.+||+.|.|||++.++..+.+.|.|||||++|||++|.+||++.++...+..++..--.-.+|..+.....+||++.
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL 655 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence 77788999999999999999999999999999999999999999999999988877764446678888999999999999
Q ss_pred hhhCCCCCCC
Q 010091 479 WQRDPSLRPD 488 (518)
Q Consensus 479 L~~dP~~RPs 488 (518)
+..+|.+|--
T Consensus 656 Cr~~P~ERLG 665 (732)
T KOG0614|consen 656 CRDNPTERLG 665 (732)
T ss_pred HhcCcHhhhc
Confidence 9999999943
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=280.65 Aligned_cols=218 Identities=22% Similarity=0.259 Sum_probs=181.9
Q ss_pred ecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCcccccc
Q 010091 256 GSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL 333 (518)
Q Consensus 256 G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l 333 (518)
|.+|.||++.+. ++.||+|.++... .+.+|...+....||||+++++++......|+||||++|++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999974 6889999997642 2334555555667999999999999999999999999999999998
Q ss_pred ccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCCcccChhh
Q 010091 334 HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEV 413 (518)
Q Consensus 334 ~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~ 413 (518)
.+. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~ 153 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV 153 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence 763 46899999999999999999999999999999999999999999999999987654332 223446778999999
Q ss_pred hcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 010091 414 IEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDF 489 (518)
Q Consensus 414 l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~ 489 (518)
+.+..++.++|+||+|+++|+|++|..|+...... ........++..+++.+.++|.+||+.||.+||++
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 98888999999999999999999999887643211 11122334566788999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=292.89 Aligned_cols=251 Identities=33% Similarity=0.533 Sum_probs=204.4
Q ss_pred cceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhh--cCCCceeeEeeeeecCC----ceeE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK--VRHMNVVQFIGACTRPP----RLFI 319 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~--l~HpnIv~l~~~~~~~~----~~~l 319 (518)
.+++.+.||+|.||.||+|...++.||||++... .++.|..|-.|... ++|+||++|+++-.... .++|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455889999999999999999999999998754 45788888888875 47999999999875554 7899
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC---------CceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN---------NIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~---------gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
|++|.+.|||.+||..+ .+++....+++..+++||+|||+. .|+|||||+.|||+.+|++..|+|||+|
T Consensus 286 Vt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999999874 599999999999999999999963 5999999999999999999999999999
Q ss_pred eecccc---CccccCCCCCcccChhhhcCCCCC------chhhHHHHHHHHHHHHcCC------------CCCC-----C
Q 010091 391 RVQAQY---GVMTAETGTYRWMAPEVIEHQPYN------HRADVFSFGIVLWELVTGK------------LPYD-----D 444 (518)
Q Consensus 391 ~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~------~ksDV~SlGill~eLltG~------------~P~~-----~ 444 (518)
...... +......||.+|||||++.+...- .+.||||+|.++|||++.. .||+ .
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 875532 223346799999999999654321 3589999999999999742 2332 1
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 445 LTPLQAAVGVVQKGLRPTIPVHT-----HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 445 ~~~~~~~~~~~~~~~~p~~~~~~-----~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
.+-.+....+++++.||.+|..+ ...+++.++.||..||..|-|+.=+-+.+..+..-.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 12233344567778899998654 345999999999999999999988887777765433
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=299.37 Aligned_cols=244 Identities=25% Similarity=0.419 Sum_probs=213.2
Q ss_pred eeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 250 EHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
.++||+|.||+||-|+. .|+.||||++.+..........+..|+.||+++.||.||.+--.|+..+..|.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 67899999999999985 4899999999988776666678889999999999999999999999999999999999887
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC---CcEEEeeeccceeccccCccccCCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN---GVVKVADFGVARVQAQYGVMTAETG 404 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~---~~vkL~DFG~a~~~~~~~~~~~~~g 404 (518)
-|.-.|....+.+++....-++.||+.||+|||-+||+|+||||+|||+.+. -.+||||||.|++.+...-.....|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 7777888878899999888899999999999999999999999999999754 3799999999999888766666789
Q ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCC
Q 010091 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPS 484 (518)
Q Consensus 405 t~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~ 484 (518)
|+.|+|||++.++.|...-|+||.|+|+|--++|..||.+........+...-.+.|..-..+++...+||...|+..-.
T Consensus 729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~ 808 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMR 808 (888)
T ss_pred CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999876554433322222345555567899999999999999999
Q ss_pred CCCCHHHHH
Q 010091 485 LRPDFSEIT 493 (518)
Q Consensus 485 ~RPs~~eil 493 (518)
+|-+...-+
T Consensus 809 kRysvdk~l 817 (888)
T KOG4236|consen 809 KRYSVDKSL 817 (888)
T ss_pred HhcchHhhc
Confidence 998886654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=282.84 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=209.4
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhh-cCCCceeeEeeeee
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRK-VRHMNVVQFIGACT 312 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~-l~HpnIv~l~~~~~ 312 (518)
....|+.....++-+..||.|+||+|++...+ |+..|||.++.... +....+++.|.....+ -+.||||+|+|++-
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 34567888888888999999999999999865 78999999998764 3445677777765554 47999999999999
Q ss_pred cCCceeEEEeeccCCccccccc----cccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeee
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLH----KQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADF 387 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~----~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DF 387 (518)
.++..+|-||.| ..||..+.. .++..+++..+-.+....+.||+||-. ..|||||+||+|||++..|.||||||
T Consensus 134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence 999999999999 557655432 234568999999999999999999975 58999999999999999999999999
Q ss_pred ccceeccccCccccCCCCCcccChhhhc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC-
Q 010091 388 GVARVQAQYGVMTAETGTYRWMAPEVIE--HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP- 464 (518)
Q Consensus 388 G~a~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~- 464 (518)
|++-....+-..+...|-..|||||.+. ...|+.+||+||||++|||+.||..||.+....-.....+..+-.|.+.
T Consensus 213 GIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 213 GICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred cchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 9997655555556677999999999993 4459999999999999999999999998865533333333334444433
Q ss_pred ----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 465 ----VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 465 ----~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+.+..+..+|.-||-+|-..||.+.++++
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 236788999999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=329.41 Aligned_cols=242 Identities=22% Similarity=0.387 Sum_probs=191.4
Q ss_pred cceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.++..+.||+|+||.||+|+. .+..||+|.+...... ...|+.++++++|||||+++++|......|+||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 345577899999999999996 4788999998754321 12468889999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHH---HCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccc
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH---RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH---~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 400 (518)
+++|+|.++++. +++..+.+++.|++.||+||| +.+|+||||||+||+++.++..++. ||....... ..
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~ 836 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT 836 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence 999999999964 789999999999999999999 6799999999999999998887775 665543222 12
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHh---------cCCCCCCCC-----
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL-QAAVGVVQ---------KGLRPTIPV----- 465 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~-~~~~~~~~---------~~~~p~~~~----- 465 (518)
...+|..|+|||++.+..++.++|||||||++|||+||+.||...... ........ ....+.+..
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 346889999999999999999999999999999999999998542110 00110000 001121111
Q ss_pred -CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 466 -HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 466 -~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
....++.+++.+||+.+|.+|||+.|+++.|+.+.+
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 122357789999999999999999999999998865
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=284.34 Aligned_cols=243 Identities=25% Similarity=0.419 Sum_probs=209.9
Q ss_pred eeccccceeeeEEeEecceEEEEEEECC--ccEEEEEEeccccC-HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCc
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~ 316 (518)
.|..+++.|+.+||.|+||.|.++..+| +.+|||+++....- ++..+--+.|-++|... +-|.+++++.+|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 7888999999999999999999999876 67999999986542 22222334466777655 46789999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|+||||+.||+|--.++. -+.+.++.+.-++..|+.||-+||++|||.||||.+|||++.+|++||.|||+++..-..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999888876 568999999999999999999999999999999999999999999999999999754433
Q ss_pred Ccc-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010091 397 GVM-TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475 (518)
Q Consensus 397 ~~~-~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li 475 (518)
+.. .+..||+.|+|||++...+|....|.||+|++||||+.|+.||++.+..+....+.... -..|...+.+..++.
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn--vsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN--VSYPKSLSKEAVAIC 581 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc--CcCcccccHHHHHHH
Confidence 322 23469999999999999999999999999999999999999999998888777766654 456788899999999
Q ss_pred HHhhhhCCCCC
Q 010091 476 ERCWQRDPSLR 486 (518)
Q Consensus 476 ~~cL~~dP~~R 486 (518)
...|.+.|.+|
T Consensus 582 kg~ltK~P~kR 592 (683)
T KOG0696|consen 582 KGLLTKHPGKR 592 (683)
T ss_pred HHHhhcCCccc
Confidence 99999999999
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=318.23 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=213.9
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHH-HHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN-IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~-~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
.+..++|.++++||.|+||.|..++.. ++-||+|++..-.+-.. .-.-|..|-.+|.--+.+-|++++-+|.+..++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 445556666999999999999999975 67899999987433222 225688899999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+|||||+||+|..+|.+.. +++++.++-++..|+.||+.||+.|+|||||||+|||+|..|++||+|||.+-.+...+
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999999999999999976 89999999999999999999999999999999999999999999999999998777655
Q ss_pred c--cccCCCCCcccChhhhc----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCc
Q 010091 398 V--MTAETGTYRWMAPEVIE----H-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTH 468 (518)
Q Consensus 398 ~--~~~~~gt~~y~APE~l~----~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~ 468 (518)
. .....|||.|.+||++. + +.|+...|.||+||++|||+.|.-||-..+-.+.+-.+....-.-.+| ..++
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 3 34467999999999993 3 678999999999999999999999998777777777777664444455 5689
Q ss_pred HHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPD---FSEITE 494 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs---~~eil~ 494 (518)
+..++||.+.+ .+|..|-. +++|..
T Consensus 310 eeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 310 EEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 99999999866 46677755 777654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=258.87 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=209.5
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|+-.++||+|.||+||+|+.. ++-||+|..+....++.......+|+-+++.++|+|||++++....+..+-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 455789999999999999954 578999999987767666678899999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 403 (518)
...|..|+..-++.++...+..++.|+++|+.++|++++.||||||.|+||+.+|.+|++|||+++..+.+- ...++.
T Consensus 84 -dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaev 162 (292)
T KOG0662|consen 84 -DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV 162 (292)
T ss_pred -hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeecee
Confidence 669999999888899999999999999999999999999999999999999999999999999999776653 456678
Q ss_pred CCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC-------C-----------CCCC
Q 010091 404 GTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKG-------L-----------RPTI 463 (518)
Q Consensus 404 gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~-------~-----------~p~~ 463 (518)
.|..|.+|.++.+. -|++..|+||.||++.|+.. |.+.|.+.+-.+....+...- + -|..
T Consensus 163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~y 242 (292)
T KOG0662|consen 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIY 242 (292)
T ss_pred eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCc
Confidence 89999999998654 58999999999999999997 888888877666655544211 1 0111
Q ss_pred C---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 464 P---------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 464 ~---------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
| ...+..-++++++.|..+|.+|.++++.++
T Consensus 243 pattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 243 PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1 122344689999999999999999987653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=279.17 Aligned_cols=236 Identities=24% Similarity=0.387 Sum_probs=195.1
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeec----CCceeEEEee
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR----PPRLFIVTEF 323 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~----~~~~~lV~Ey 323 (518)
++||-|-.|.|.....+ ++++|+|++... ....+|+.+.-.. .|||||++++++.. ...+.+|||.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 57999999999988754 799999998753 3455688776655 59999999998743 4678899999
Q ss_pred ccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---CCcEEEeeeccceeccccCcc
Q 010091 324 MSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~~~vkL~DFG~a~~~~~~~~~ 399 (518)
|+||.|.+.+..++. .+++.++-.|+.||+.|+.|||+.+|.||||||+|+|.+. |..+||+|||+|+.-......
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L 220 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDL 220 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccc
Confidence 999999999987543 5999999999999999999999999999999999999974 457999999999887766777
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHhcCCCCCCC----CCCcHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA---VGVVQKGLRPTIP----VHTHPILV 472 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~---~~~~~~~~~p~~~----~~~~~~L~ 472 (518)
.+...|+.|.|||++...+|+...|+||+|+++|-|++|.+||-.+...... ...+. .-...+| ...+...+
T Consensus 221 ~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~-~gqy~FP~pEWs~VSe~aK 299 (400)
T KOG0604|consen 221 MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR-TGQYEFPEPEWSCVSEAAK 299 (400)
T ss_pred cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh-ccCccCCChhHhHHHHHHH
Confidence 7788999999999999999999999999999999999999999543321111 11111 1223333 24577899
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|+.+|..+|.+|-|..++++
T Consensus 300 dlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 300 DLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HHHHHHhcCCchhheeHHHhhc
Confidence 9999999999999999998865
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=300.74 Aligned_cols=248 Identities=33% Similarity=0.538 Sum_probs=209.2
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEE--ECCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeee
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACT 312 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~--~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~ 312 (518)
-.|.|+| .+.||.|.+|.||+++ ..++.+|+|++......+ ++...|.+|++.. +|||++.++|++.
T Consensus 17 p~d~~ei-------~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 17 PADIFEI-------IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred CCCccEE-------EEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 4567888 9999999999999988 458999999988754333 4566788898877 6999999999983
Q ss_pred -----cCCceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEee
Q 010091 313 -----RPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVAD 386 (518)
Q Consensus 313 -----~~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~D 386 (518)
.++.+++|||||.|||..|.++... ..+++..+..|++.++.|+.+||.+.++|||||-.|||++.++.||++|
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEee
Confidence 3568999999999999999987543 4699999999999999999999999999999999999999999999999
Q ss_pred eccceeccccC-ccccCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Q 010091 387 FGVARVQAQYG-VMTAETGTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR 460 (518)
Q Consensus 387 FG~a~~~~~~~-~~~~~~gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~ 460 (518)
||++....... ...+.+||+.|||||++. ...|+..+|+|||||+..||..|.+|+.++-|..++..+-. ..+
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR-NPP 245 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-NPP 245 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC-CCC
Confidence 99997655432 334467999999999994 34578899999999999999999999999988777754332 222
Q ss_pred CCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 PTI--PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 p~~--~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
|.+ |..++.++.++|..||.+|..+||+..++++
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 222 4567888999999999999999999998875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=274.53 Aligned_cols=241 Identities=24% Similarity=0.431 Sum_probs=198.5
Q ss_pred eeEEeEecceEEEEEE--ECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEEeeccC
Q 010091 250 EHKIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~--~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
.+.||+|+|+.|--+. +.|..+|||++.... .....+..+|+.++.+++ |+||++++++|+++..+|+|||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 5679999999998877 568999999998763 334578889999999995 99999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC---cEEEeeeccceeccccC------
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG---VVKVADFGVARVQAQYG------ 397 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~---~vkL~DFG~a~~~~~~~------ 397 (518)
|+|.+.+.+ ...+++....++..+|+.||++||.+||.||||||+|||....+ -||||||.+..-.....
T Consensus 161 GplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 161 GPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred chHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 999999988 45799999999999999999999999999999999999997554 58999998875432221
Q ss_pred --ccccCCCCCcccChhhh-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------------CHHHHHHHHHh
Q 010091 398 --VMTAETGTYRWMAPEVI-----EHQPYNHRADVFSFGIVLWELVTGKLPYDDL--------------TPLQAAVGVVQ 456 (518)
Q Consensus 398 --~~~~~~gt~~y~APE~l-----~~~~~~~ksDV~SlGill~eLltG~~P~~~~--------------~~~~~~~~~~~ 456 (518)
...+..|+..|||||+. ....|+.+.|.||||+|+|-||+|.+||.+. .-.+.+...++
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 12345688899999987 2345899999999999999999999999653 11233334444
Q ss_pred cCCCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 457 KGLRPTIP----VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 457 ~~~~p~~~----~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+ ..++| ..++.+.++++...|..++.+|-++.+++.
T Consensus 320 EG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 320 EG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 44 34444 346788999999999999999988888765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=293.31 Aligned_cols=238 Identities=23% Similarity=0.377 Sum_probs=197.7
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV 320 (518)
...|.+...+|.|+|+.|-.+... ++..++|++.....+ -.+|+.++... +||||+++.+.+....+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeee
Confidence 445677888999999999998854 788999999876322 12466555544 799999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe-ccCCcEEEeeeccceeccccCcc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM-NENGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl-~~~~~vkL~DFG~a~~~~~~~~~ 399 (518)
||.+.|+-|.+.+.... .+. ..+..|+.+|+.|+.|||++|++||||||+|||+ ++.|.++|+|||.++..... .
T Consensus 395 ~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C 470 (612)
T ss_pred ehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence 99999998887776633 233 6777899999999999999999999999999999 68999999999999866554 3
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
....-|..|+|||++....|+.++|+||||++||+||+|+.||........+.. +-..+.+...++...++||.+||
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~---~i~~~~~s~~vS~~AKdLl~~LL 547 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT---RIQMPKFSECVSDEAKDLLQQLL 547 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH---hhcCCccccccCHHHHHHHHHhc
Confidence 345678899999999999999999999999999999999999987655433322 22344555788999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
+.||.+|+++.++..
T Consensus 548 ~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 548 QVDPALRLGADEIGA 562 (612)
T ss_pred cCChhhCcChhhhcc
Confidence 999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=274.02 Aligned_cols=262 Identities=24% Similarity=0.464 Sum_probs=223.4
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC------C-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee-
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF------S-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT- 312 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~------~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~- 312 (518)
.+...+++....+-+|.||.||+|.|. + +.|-+|+++... ++-....|++|.-++..+.|||+.++.+.+.
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 344555666778899999999999653 2 568888887653 4444588999999999999999999999874
Q ss_pred cCCceeEEEeeccCCccccccc-----ccc--CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEe
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLH-----KQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVA 385 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~-----~~~--~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~ 385 (518)
+....+.++.++.-|+|..||. +.. ..++..++..++.|++.||+|||+.||||.||..+|.+|++.-.|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 4566788999998899999997 222 247778899999999999999999999999999999999999999999
Q ss_pred eeccceecccc---CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCC
Q 010091 386 DFGVARVQAQY---GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRP 461 (518)
Q Consensus 386 DFG~a~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p 461 (518)
|=.+++..-.. .....+.....||+||.+.+..|+.++|+||||+++|||+| |+.||.+.+|.+.... +..|++-
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-lkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-LKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH-Hhcccee
Confidence 99999854332 12344567889999999999999999999999999999999 9999999999987654 5568999
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 462 TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 462 ~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
.-|.+|+++|..+|.-||...|++||+|+++..-|.++-.++.
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999999998877664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-33 Score=279.44 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=197.6
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC--C----ceeeEeeeeecCC
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--M----NVVQFIGACTRPP 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H--p----nIv~l~~~~~~~~ 315 (518)
..+|++...+|+|.||.|-...+. +..||||+++.- +...++.+-|+.+++++.+ | -+|++.+||...+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 567888999999999999998765 578999999864 3344666779999999942 2 3888999999999
Q ss_pred ceeEEEeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc----------------
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---------------- 378 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---------------- 378 (518)
+.|||+|.+ |.|+.++|..++. +++...++.|+.||++++++||+++++|.||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999999 8899999988543 6899999999999999999999999999999999999942
Q ss_pred ----CCcEEEeeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--H
Q 010091 379 ----NGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA--V 452 (518)
Q Consensus 379 ----~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~--~ 452 (518)
+-.|+|+|||.|+...+.. +....|..|.|||++.+-.|+..+||||+||||+|++||...|..-++.+.+ .
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM 321 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM 321 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence 2358999999999876653 4466899999999999999999999999999999999999888765543322 1
Q ss_pred HHHhcCC-----------------CCCCC-------------------------CCCcHHHHHHHHHhhhhCCCCCCCHH
Q 010091 453 GVVQKGL-----------------RPTIP-------------------------VHTHPILVDLLERCWQRDPSLRPDFS 490 (518)
Q Consensus 453 ~~~~~~~-----------------~p~~~-------------------------~~~~~~L~~Li~~cL~~dP~~RPs~~ 490 (518)
..+-..+ +-.++ ......|.+||++||..||.+|+|+.
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 1110000 00000 01123499999999999999999999
Q ss_pred HHHH
Q 010091 491 EITE 494 (518)
Q Consensus 491 eil~ 494 (518)
|++.
T Consensus 402 EAL~ 405 (415)
T KOG0671|consen 402 EALS 405 (415)
T ss_pred HHhc
Confidence 9874
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=266.88 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=190.4
Q ss_pred cceeeeEEeEecceEEEEEEEC------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec-CCcee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PPRLF 318 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ 318 (518)
.|+.++.||+|.||.||++... ...+|||.++.+......-....+|+.+++.++||||+.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 3555999999999999999643 2369999999774333333566789999999999999999998865 88899
Q ss_pred EEEeeccCCcccccccc----ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC----CcEEEeeeccc
Q 010091 319 IVTEFMSGGSIYDYLHK----QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN----GVVKVADFGVA 390 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~----~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~----~~vkL~DFG~a 390 (518)
+++||.+. +|.+.++- ....++...+..++.||+.|+.|||++=|+||||||+|||+..+ |.|||+|||++
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99999965 77777752 22358888999999999999999999999999999999999877 89999999999
Q ss_pred eeccccCc----cccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC-------CHHHH--HHHHH-
Q 010091 391 RVQAQYGV----MTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDL-------TPLQA--AVGVV- 455 (518)
Q Consensus 391 ~~~~~~~~----~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~-------~~~~~--~~~~~- 455 (518)
++....-. ......|..|.|||++.+ ..|+.+.|||+.|||+.||+|-.+.|.+. .|.+. ...+.
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 98665421 122346899999999865 56899999999999999999988777532 12111 11111
Q ss_pred --------------------------hcCCCCC--C------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 456 --------------------------QKGLRPT--I------PVHTHPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 456 --------------------------~~~~~p~--~------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
+...... + ...-++...+|+.++|+.||.+|.|+++.++.
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 0000000 0 01123448899999999999999999987663
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-33 Score=266.06 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=202.7
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec----
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR---- 313 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~---- 313 (518)
+-++.+.|.-..+||+|.||.||+++.. ++.||+|+.-.+...+.......+|+.+|+.++|+|++.++..|..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 3445567777889999999999999854 6789998765543333334566789999999999999999998732
Q ss_pred ----CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 314 ----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 314 ----~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
...+|+||.+|+. +|.-.|......++...+.+++.++..||.|+|++.|+|||+||+|+||+.+|.+||+|||+
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 2358999999965 88888888777899999999999999999999999999999999999999999999999999
Q ss_pred ceeccccC-----ccccCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cCCC-
Q 010091 390 ARVQAQYG-----VMTAETGTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ--KGLR- 460 (518)
Q Consensus 390 a~~~~~~~-----~~~~~~gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~--~~~~- 460 (518)
++...... ..+....|..|.+||.+. ...|+++.|+|..||++.||+|+.+.+.+.+..+.+..+-. ....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98654432 234455699999999885 45789999999999999999999999998887665543321 0000
Q ss_pred -----------------CCCCC-------------CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 -----------------PTIPV-------------HTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 -----------------p~~~~-------------~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++++. .-.++..+|+.+++..||.+|+++.+.+.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11111 11346789999999999999999988764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=251.41 Aligned_cols=223 Identities=27% Similarity=0.447 Sum_probs=186.6
Q ss_pred ceeeccccceeeeEEeEecceEEEEEE--ECCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCC
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP 315 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~--~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~ 315 (518)
.++|..+.+..+..||+|++|.|-+.+ +.|+-.|+|.++....+. ...+.+.|+.+..+. .+|.+|.|+|...+..
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 478888888889999999999886555 678999999998765444 446677788776654 7999999999999999
Q ss_pred ceeEEEeeccCCccccccc---cccCCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 316 RLFIVTEFMSGGSIYDYLH---KQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~---~~~~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
..+|.||.| ..||..+.. +.+..+++..+-+++..++.||.|||++ .+||||+||+||||+.+|.||+||||++-
T Consensus 119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999999 568877654 3466799999999999999999999976 89999999999999999999999999997
Q ss_pred eccccCccccCCCCCcccChhhhc----CCCCCchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCCC
Q 010091 392 VQAQYGVMTAETGTYRWMAPEVIE----HQPYNHRADVFSFGIVLWELVTGKLPYDD-LTPLQAAVGVVQKGLRPTIP 464 (518)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~APE~l~----~~~~~~ksDV~SlGill~eLltG~~P~~~-~~~~~~~~~~~~~~~~p~~~ 464 (518)
....+-..+...|-..|||||.++ ...|+.|+||||||+++.||.+++.||+. .++++.+.+++.. ..|.+|
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~Lp 274 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQLP 274 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCCCc
Confidence 766554455567889999999984 44799999999999999999999999975 6788888777763 344444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=281.25 Aligned_cols=254 Identities=18% Similarity=0.234 Sum_probs=183.4
Q ss_pred eeccccceeeeEEeEecceEEEEEEE------------------CCccEEEEEEeccccCH------------HHHHHHH
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAF------------------FSQDVAIKVLTNEHLNE------------NIRREFA 290 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~------------------~~~~vAvKvl~~~~~~~------------~~~~~f~ 290 (518)
.+..++|.+.++||+|+||.||+|.+ .++.||||.+....... ...+.+.
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34567888899999999999999964 23579999987542110 0112344
Q ss_pred HHHHHHhhcCCCce-----eeEeeeeec--------CCceeEEEeeccCCccccccccccC-------------------
Q 010091 291 QEVHIMRKVRHMNV-----VQFIGACTR--------PPRLFIVTEFMSGGSIYDYLHKQKC------------------- 338 (518)
Q Consensus 291 ~E~~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~ggsL~~~l~~~~~------------------- 338 (518)
.|+.++.+++|.++ ++++++|.. ....++||||+++++|.++++...+
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57788888876654 677777643 3568999999999999998864221
Q ss_pred ----CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccc--cCCCCCcccChh
Q 010091 339 ----GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT--AETGTYRWMAPE 412 (518)
Q Consensus 339 ----~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~gt~~y~APE 412 (518)
.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.......... ...+|+.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 23566788999999999999999999999999999999999999999999997543322111 123578999999
Q ss_pred hhcCCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCCCCCHHHHHHH-----------HHhcC
Q 010091 413 VIEHQPY----------------------NHRADVFSFGIVLWELVTGKL-PYDDLTPLQAAVG-----------VVQKG 458 (518)
Q Consensus 413 ~l~~~~~----------------------~~ksDV~SlGill~eLltG~~-P~~~~~~~~~~~~-----------~~~~~ 458 (518)
.+..... ..+.|+||+||++|+|++|.. ||........... .....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 8753221 234799999999999999875 7764322211111 01111
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCC---CCCCCHHHHHH
Q 010091 459 LRPTIPVHTHPILVDLLERCWQRDP---SLRPDFSEITE 494 (518)
Q Consensus 459 ~~p~~~~~~~~~L~~Li~~cL~~dP---~~RPs~~eil~ 494 (518)
+........++...+++.+||..+| .+|+|++|+++
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 2222234567889999999999876 68999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=286.09 Aligned_cols=244 Identities=17% Similarity=0.228 Sum_probs=165.6
Q ss_pred ccccceeeeEEeEecceEEEEEEEC------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeee------
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA------ 310 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~------ 310 (518)
..+.|.+.++||+|+||.||+|++. +..||+|.+......+ .+..+ . ++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e-~-l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE-R-VRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH-H-HHhhchhhHHHHHHhhhcccc
Confidence 4456677999999999999999974 5689999876432111 11111 1 111122223222221
Q ss_pred eecCCceeEEEeeccCCccccccccccCCC-------------------ChHHHHHHHHHhHHHHHHHHHCCceecCCCC
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGL-------------------KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l-------------------~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp 371 (518)
+......++||||+++++|.+++....... ....+..++.||+.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 245667999999999999999987533211 2334668999999999999999999999999
Q ss_pred CcEEecc-CCcEEEeeeccceecccc--CccccCCCCCcccChhhhcCC----------------------CCCchhhHH
Q 010091 372 ANLLMNE-NGVVKVADFGVARVQAQY--GVMTAETGTYRWMAPEVIEHQ----------------------PYNHRADVF 426 (518)
Q Consensus 372 ~NILl~~-~~~vkL~DFG~a~~~~~~--~~~~~~~gt~~y~APE~l~~~----------------------~~~~ksDV~ 426 (518)
+|||++. ++.+||+|||+++..... .......+++.|+|||.+... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 589999999999754322 122335689999999976322 234567999
Q ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------CCCCCCC----------CCCcHHHHHHHHHhhhhCCCCC
Q 010091 427 SFGIVLWELVTGKLPYDDLTPLQAAVGVVQK----------GLRPTIP----------VHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 427 SlGill~eLltG~~P~~~~~~~~~~~~~~~~----------~~~p~~~----------~~~~~~L~~Li~~cL~~dP~~R 486 (518)
||||++|||+++..|++.. .......+.. ...+... ........+||.+||+.||.+|
T Consensus 364 SlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 9999999999987775432 1111111110 0011100 1112335589999999999999
Q ss_pred CCHHHHHH
Q 010091 487 PDFSEITE 494 (518)
Q Consensus 487 Ps~~eil~ 494 (518)
||+.++++
T Consensus 442 ~ta~e~L~ 449 (566)
T PLN03225 442 ISAKAALA 449 (566)
T ss_pred CCHHHHhC
Confidence 99999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=240.53 Aligned_cols=209 Identities=35% Similarity=0.656 Sum_probs=185.8
Q ss_pred EeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCccc
Q 010091 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 330 (518)
||+|++|.||+++.. ++.+++|++....... ....+.+|+..++.++|++|+++++++......+++|||++|++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 589999999999987 7899999998765432 3467899999999999999999999999989999999999999999
Q ss_pred cccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-CCcEEEeeeccceeccccC-ccccCCCCCcc
Q 010091 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVVKVADFGVARVQAQYG-VMTAETGTYRW 408 (518)
Q Consensus 331 ~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y 408 (518)
+++......++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 999875456899999999999999999999999999999999999999 8999999999998665432 12335578899
Q ss_pred cChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 010091 409 MAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRP 487 (518)
Q Consensus 409 ~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RP 487 (518)
++||.+... .++.++|+|++|+++|+| ..+.+++.+|++.+|.+||
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~ 206 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRP 206 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCc
Confidence 999999877 889999999999999999 5799999999999999999
Q ss_pred CHHHHHHH
Q 010091 488 DFSEITEL 495 (518)
Q Consensus 488 s~~eil~~ 495 (518)
++.++++.
T Consensus 207 ~~~~l~~~ 214 (215)
T cd00180 207 SAKEILEH 214 (215)
T ss_pred CHHHHhhC
Confidence 99998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=269.70 Aligned_cols=254 Identities=19% Similarity=0.336 Sum_probs=202.4
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-----HHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-----NIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-----~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
-..-..+|-++..||.|+|+.||++.+. .+.||+|+-.....+. +..+...+|..|.+.|+||.||++|++|.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 3445667888999999999999999854 6789999976544322 23356678999999999999999999985
Q ss_pred -cCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC--CceecCCCCCcEEec---cCCcEEEee
Q 010091 313 -RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN--NIIHRDLKAANLLMN---ENGVVKVAD 386 (518)
Q Consensus 313 -~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~--gIiHrDLkp~NILl~---~~~~vkL~D 386 (518)
+...+|-|+|||+|-+|.-||+. ...+++..++.|+.||+.||.||... -|||-||||.|||+- .-|.+||.|
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred eccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 45678999999999999888876 56799999999999999999999986 499999999999994 347899999
Q ss_pred eccceeccccCc--------cccCCCCCcccChhhhc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 010091 387 FGVARVQAQYGV--------MTAETGTYRWMAPEVIE----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGV 454 (518)
Q Consensus 387 FG~a~~~~~~~~--------~~~~~gt~~y~APE~l~----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~ 454 (518)
||+++++..... .....||++|++||++. ....+.|.||||.|+|+|.++.|+.||+.....+.+...
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 999998765432 12235999999999983 345789999999999999999999999886655444221
Q ss_pred ---Hhc-CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 455 ---VQK-GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 455 ---~~~-~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+.. ...-+.....+++..++|++||++.-.+|.+..++..
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111 1111122346789999999999999999988877643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=276.46 Aligned_cols=245 Identities=21% Similarity=0.333 Sum_probs=201.7
Q ss_pred eeeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
-..+.+-|..++.||-|+||.|.++.- ....||+|.++.... ..+.....+.|-.||..-+.+-||+||-.|.+...
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 356778888899999999999999984 456799999986532 33445778889999999999999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec---
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ--- 393 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~--- 393 (518)
+|+||+|++||++-.+|-+ .+-|.+..++-++..+..|+++.|..|+|||||||+|||||.+|++||.|||+|.-.
T Consensus 704 LYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999999998877 557888889999999999999999999999999999999999999999999998510
Q ss_pred ------cc------------------cC----------------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHH
Q 010091 394 ------AQ------------------YG----------------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433 (518)
Q Consensus 394 ------~~------------------~~----------------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~ 433 (518)
.. .. ......||+.|+|||++....|+.-.|.||.|+|||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00 00 001134899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 010091 434 ELVTGKLPYDDLTPLQAAVGVVQKG--LRPTIPVHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 434 eLltG~~P~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~L~~Li~~cL~~dP~~R 486 (518)
||+.|+.||-..++.+....++... +.-....+++++..++|.+++ ..++.|
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~R 916 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSR 916 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhh
Confidence 9999999999888877665554333 333334567888888887643 455566
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=256.66 Aligned_cols=246 Identities=23% Similarity=0.384 Sum_probs=207.9
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhc-CCCceeeEeeeeec
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKV-RHMNVVQFIGACTR 313 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~ 313 (518)
..|.+...++.+.++||.|+|+.|.+++.. .+-+|+|+++.+..++ +...-...|-.+..+. +||.+|-++.+|..
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 468888889999999999999999999865 5779999999886654 3345555666666655 79999999999999
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
+..+++|.||++||+|--.+.. ..++++..++-+...|+.||.|||++|||.||||.+|||++..|.+||.|+|+++..
T Consensus 323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999999999888877 457999999999999999999999999999999999999999999999999999876
Q ss_pred cccCcc-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHHH-hcCCCCCCC
Q 010091 394 AQYGVM-TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD-------LTPLQAAVGVV-QKGLRPTIP 464 (518)
Q Consensus 394 ~~~~~~-~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~-------~~~~~~~~~~~-~~~~~p~~~ 464 (518)
-..+.. .+.+||+.|.|||.+.+..|....|.|+||++++||+.|+.||+- ......+.+++ .+. -.+|
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--irip 479 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIP 479 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--cccc
Confidence 555543 345699999999999999999999999999999999999999962 22233333332 333 3467
Q ss_pred CCCcHHHHHHHHHhhhhCCCCC
Q 010091 465 VHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 465 ~~~~~~L~~Li~~cL~~dP~~R 486 (518)
...+-....+++.-|++||.+|
T Consensus 480 rslsvkas~vlkgflnkdp~er 501 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKER 501 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHh
Confidence 7777888899999999999999
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=288.74 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=194.4
Q ss_pred CCCceeec------cccceeeeEEeEecceE-EEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeE
Q 010091 236 GIDVWEID------ASLLKFEHKIVSGSYCD-LYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (518)
Q Consensus 236 ~~d~~eI~------~~~~~~~~~Lg~G~~g~-Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l 307 (518)
..+.|+.. ...+.-.+.+|.|+.|+ ||+|.+.++.||||.+-.+. ..-..+|+..|+.- +|||||++
T Consensus 494 ~~~~~~~~~~~v~~k~~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRy 568 (903)
T KOG1027|consen 494 SLDGPEAGGKVVVGKLFFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRY 568 (903)
T ss_pred cccccccccceeeeeeeeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEE
Confidence 34566665 23344456788998875 69999999999999987653 24556899999988 59999999
Q ss_pred eeeeecCCceeEEEeeccCCccccccccc--cCCC-ChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---C--
Q 010091 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQ--KCGL-KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---N-- 379 (518)
Q Consensus 308 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~--~~~l-~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~-- 379 (518)
++.-.++...||..|.| ..+|.+++... .... .....+.++.|++.|+++||+.+||||||||.||||+. +
T Consensus 569 yc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~ 647 (903)
T KOG1027|consen 569 YCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGT 647 (903)
T ss_pred EeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcc
Confidence 99989999999999999 67999999873 1111 11346788999999999999999999999999999976 3
Q ss_pred CcEEEeeeccceeccccC----ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 010091 380 GVVKVADFGVARVQAQYG----VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGV 454 (518)
Q Consensus 380 ~~vkL~DFG~a~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~ 454 (518)
..++|+|||+++...... ......||.+|+|||++.....+.+.|||||||++|+.++ |..||+..-..+.. +
T Consensus 648 ~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--I 725 (903)
T KOG1027|consen 648 LRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--I 725 (903)
T ss_pred eeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--h
Confidence 468999999998754432 1234569999999999998888889999999999999999 58999876544332 2
Q ss_pred HhcCCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 455 VQKGLRP-TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 455 ~~~~~~p-~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+.....- .+......+..+||.+|++++|..||++.+++.
T Consensus 726 l~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 726 LTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 2222110 111111128999999999999999999999863
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=272.18 Aligned_cols=207 Identities=25% Similarity=0.369 Sum_probs=180.4
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC------CCceeeEeeeeec
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR------HMNVVQFIGACTR 313 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~------HpnIv~l~~~~~~ 313 (518)
+--++|.+....|.|-||+|.+|.+. |+.||||++.+. +-+...=+.|+.||++|+ .-|+++++..|.+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 44567888889999999999999975 789999999974 445566678999999995 3489999999999
Q ss_pred CCceeEEEeeccCCccccccccccC--CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-CcEEEeeeccc
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVVKVADFGVA 390 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-~~vkL~DFG~a 390 (518)
.+++|+|||-+ ..+|.+.|.+.+. ++....+..++.|++.||..|-..||+|.||||+|||+++. ..+||||||.|
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999999988 6799999987554 58889999999999999999999999999999999999976 57899999999
Q ss_pred eeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010091 391 RVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVG 453 (518)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~ 453 (518)
....... .+....+..|.|||++.+.+|+...|+||.||+||||+||+..|.+.++.+.+.-
T Consensus 585 ~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 585 SFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred ccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 8766543 3445567789999999999999999999999999999999999999887776543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=243.84 Aligned_cols=242 Identities=19% Similarity=0.339 Sum_probs=192.8
Q ss_pred cccceeeeEEeEecceEEEEEE--ECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeec--CCcee
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTR--PPRLF 318 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~--~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~ 318 (518)
.+.|++.+++|.|.|+.||.|. .++++++||++++.. .+.+.+|+.||+.|. ||||+++++...+ .....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 3445559999999999999998 457899999999863 367889999999997 9999999998754 45678
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-CcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-~~vkL~DFG~a~~~~~~~ 397 (518)
+|+||+.+.+...... .++.-.+...+.++++||.|+|+.||+|||+||.|+|||.. ..++|+|||+|.+.....
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9999998876655543 37777899999999999999999999999999999999854 689999999998877655
Q ss_pred ccccCCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHh---------------cCCC
Q 010091 398 VMTAETGTYRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGKLPYD-DLTPLQAAVGVVQ---------------KGLR 460 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l-~~~~~~~ksDV~SlGill~eLltG~~P~~-~~~~~~~~~~~~~---------------~~~~ 460 (518)
.......+..|-.||++ .-..|+..-|+|||||++..|+..+.||- +.++.+.++.+.. -.+.
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 55555677888999988 45678999999999999999999888873 3333333333220 0011
Q ss_pred CC--------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 PT--------------------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 p~--------------------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
|. ...-.+++..+++.+.|..|-++|+|++|.+.
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11 11223588999999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=236.93 Aligned_cols=212 Identities=32% Similarity=0.553 Sum_probs=180.7
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|.+.+.||+|++|.||++... ++.+++|.+...... .....+.+|+..+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 345889999999999999975 588999999876443 24578889999999999999999999999889999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC--ccccC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG--VMTAE 402 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~~~ 402 (518)
++++|.+++......+++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 9999999998744338899999999999999999999999999999999999999999999999998765432 22334
Q ss_pred CCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCC
Q 010091 403 TGTYRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGKLPYDD-LTPLQAAVGVVQKGL 459 (518)
Q Consensus 403 ~gt~~y~APE~l-~~~~~~~ksDV~SlGill~eLltG~~P~~~-~~~~~~~~~~~~~~~ 459 (518)
.++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. ..+.......+..+.
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 578899999998 777788899999999999999999999977 555545555454443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-31 Score=253.58 Aligned_cols=243 Identities=27% Similarity=0.439 Sum_probs=196.7
Q ss_pred eeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC-----CceeEEEe
Q 010091 250 EHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PRLFIVTE 322 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~lV~E 322 (518)
.+.||-|+||.||.+++ .|+.||+|.+..-..+-..-+++.+|+.+|.-.+|.|++..+++.... ..+|.++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 67899999999999996 489999999887655555558889999999999999999998875433 24689999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC--ccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG--VMT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~ 400 (518)
.| ..+|...+-. ...++.+.+.-+++||++||+|||+.||.||||||.|+|+++|..+||||||+++...... .++
T Consensus 138 Lm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMT 215 (449)
T KOG0664|consen 138 LM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMT 215 (449)
T ss_pred HH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhH
Confidence 99 5588887766 5679999999999999999999999999999999999999999999999999999865543 467
Q ss_pred cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----------------------h
Q 010091 401 AETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV-----------------------Q 456 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~-----------------------~ 456 (518)
.+..|..|.|||++.+ ..|+.+.||||.||++.||+..+..|....|.+...-+. +
T Consensus 216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR 295 (449)
T KOG0664|consen 216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLR 295 (449)
T ss_pred HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence 7778999999999865 569999999999999999999999898776665544322 1
Q ss_pred cCCC-CCCC--------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 457 KGLR-PTIP--------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 457 ~~~~-p~~~--------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+.+ |.++ .....+...++.+++..||..|.+..+.+.
T Consensus 296 ~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 296 AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 1111 1111 122345777888999999999988776543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=250.21 Aligned_cols=245 Identities=24% Similarity=0.343 Sum_probs=199.0
Q ss_pred ccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC------c
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------R 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~------~ 316 (518)
.+|.-...+|.|.- .|-.+.+ .+++||+|.+..+..+.....+..+|..++..++|+||++++.+++-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 44555677788877 5555554 4789999998877666666678889999999999999999999986654 4
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.|+|||+| ..+|.+.+.. .++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+.....
T Consensus 96 ~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 69999999 6799988873 4677788999999999999999999999999999999999999999999999887776
Q ss_pred CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC------------------
Q 010091 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG------------------ 458 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~------------------ 458 (518)
-.++....|..|.|||++.+-.+.+.+||||+||++.||++|+..|.+.+.......+.+.-
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 56777789999999999988889999999999999999999999998765544433332110
Q ss_pred --------------------CCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 --------------------LRPTIP--VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 --------------------~~p~~~--~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++.... ......+++++.+||-.||++|.+++++|.
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 011111 112345899999999999999999988764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=270.36 Aligned_cols=246 Identities=30% Similarity=0.498 Sum_probs=210.2
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|.....+|+|+||.||++++. ++..|+|+++.+..++ ..-..+|+.+++.++|+|||.++|.+.....+++.|||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3445999999999999999964 7899999999875543 45677899999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-CccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~ 402 (518)
|.||+|.+..+- .+.+++.++..+.+..++|++|||+.|=+|||||-.||++++.|.+|+.|||.+-..... ......
T Consensus 94 cgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 94 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred cCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence 999999998877 568999999999999999999999999999999999999999999999999998543322 233446
Q ss_pred CCCCcccChhhh---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCcHHHHHHHH
Q 010091 403 TGTYRWMAPEVI---EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI---PVHTHPILVDLLE 476 (518)
Q Consensus 403 ~gt~~y~APE~l---~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~---~~~~~~~L~~Li~ 476 (518)
.||+.|||||+- ..+.|..++|+|++|++..|+-.-+.|--..-+.++..-.-..++.|.- +..+++.+.++++
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK 252 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVK 252 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHH
Confidence 799999999987 5677999999999999999998878887777777776554444554332 2457888999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
.||.++|.+||+++.++.
T Consensus 253 ~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 253 GALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHhcCCCccCCChhhhee
Confidence 999999999999987764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=251.61 Aligned_cols=145 Identities=24% Similarity=0.407 Sum_probs=118.0
Q ss_pred cccCCcccccCCCCCCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC
Q 010091 223 EQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300 (518)
Q Consensus 223 ~~~~~~~~~~p~~~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~ 300 (518)
...|+++|.+-... ...+|.+.++||.|.|++||++.+. .+.||+|+.+.. +-..+..+.|+.+|++++
T Consensus 62 ~kGGYHpV~IGD~F------~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~ 132 (590)
T KOG1290|consen 62 RKGGYHPVRIGDVF------NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVR 132 (590)
T ss_pred hcCCCceeeccccc------cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHH
Confidence 34566777664432 2356777999999999999999875 578999999864 223366778999999983
Q ss_pred -----C---CceeeEeeeeec----CCceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHC-Ccee
Q 010091 301 -----H---MNVVQFIGACTR----PPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRN-NIIH 366 (518)
Q Consensus 301 -----H---pnIv~l~~~~~~----~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~-gIiH 366 (518)
| ..||+|++.|.. +.+.|+|+|++ |.+|..+|.... ..++...+..|++||+.||.|||+. ||||
T Consensus 133 ~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIH 211 (590)
T KOG1290|consen 133 EGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIH 211 (590)
T ss_pred hcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 3 369999999854 56899999999 889999987644 3699999999999999999999975 9999
Q ss_pred cCCCCCcEEec
Q 010091 367 RDLKAANLLMN 377 (518)
Q Consensus 367 rDLkp~NILl~ 377 (518)
.||||+|||+.
T Consensus 212 TDlKPENvLl~ 222 (590)
T KOG1290|consen 212 TDLKPENVLLC 222 (590)
T ss_pred cCCCcceeeee
Confidence 99999999994
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=262.63 Aligned_cols=204 Identities=25% Similarity=0.408 Sum_probs=174.2
Q ss_pred Cceeec---cccceeeeEEeEecceEEEEEEECC--ccEEEEEEeccccCHHH------HHHHHHHHHHHhhcC---CCc
Q 010091 238 DVWEID---ASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENI------RREFAQEVHIMRKVR---HMN 303 (518)
Q Consensus 238 d~~eI~---~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~vAvKvl~~~~~~~~~------~~~f~~E~~il~~l~---Hpn 303 (518)
-+|+.. .+.|...+.+|+|+||.|+++.++. ..|+||.++++..-.+. .-..-.|++||.+++ |+|
T Consensus 551 ~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 551 IGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred ccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 356554 3457889999999999999999874 56999998876542211 123456999999997 999
Q ss_pred eeeEeeeeecCCceeEEEeec-cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcE
Q 010091 304 VVQFIGACTRPPRLFIVTEFM-SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVV 382 (518)
Q Consensus 304 Iv~l~~~~~~~~~~~lV~Ey~-~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~v 382 (518)
|++++++|++++++||+||-. +|.+|.+|+.. +..+++....-|+.|++.|+++||+.||||||||-+||.++.+|.+
T Consensus 631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~ 709 (772)
T KOG1152|consen 631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFV 709 (772)
T ss_pred hhhhhheeecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeE
Confidence 999999999999999999976 45689999977 5679999999999999999999999999999999999999999999
Q ss_pred EEeeeccceeccccCccccCCCCCcccChhhhcCCCCCc-hhhHHHHHHHHHHHHcCCCCCC
Q 010091 383 KVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNH-RADVFSFGIVLWELVTGKLPYD 443 (518)
Q Consensus 383 kL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-ksDV~SlGill~eLltG~~P~~ 443 (518)
||+|||.+.... .++.....||..|.|||++.+.+|-- ..|||++|++||-++....||-
T Consensus 710 klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 710 KLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999996543 45666778999999999999998854 4899999999999999888884
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=230.20 Aligned_cols=255 Identities=29% Similarity=0.608 Sum_probs=220.0
Q ss_pred eeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
-|+-+.+.+..+|.+...|.+|+|+|.|..++.|++.........-..|..|.-.|+-..||||+.++++|...+++.++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 36677788899999999999999999999999999998777776668899999999999999999999999999999999
Q ss_pred EeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 321 TEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
..||+-|||+..|+...+ ..+-.+..+++.++++||.|||+.. |.---|....|+||++-+.+|. .+-+++.-+
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfq-- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ-- 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeee--
Confidence 999999999999998554 4778899999999999999999975 4444688889999998776654 222222111
Q ss_pred ccccCCCCCcccChhhhcCCCCC---chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYN---HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~---~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
.....-.+.||+||.+..++-+ .++|+|||++++|||-|...||.+.++.+.-..+.-+++++.+|..+++.+..|
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence 1123346889999999776644 568999999999999999999999999999999888999999999999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
+.-|++.||.+||.|..|+-.|+++
T Consensus 422 m~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHHh
Confidence 9999999999999999999988876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=218.68 Aligned_cols=164 Identities=25% Similarity=0.385 Sum_probs=133.3
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY 406 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~ 406 (518)
|||.+++.+.+..+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ...||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 6899999876667999999999999999999999998 999999999999999 9999865442 236889
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC------CCCCcH--HHHHHHHHh
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI------PVHTHP--ILVDLLERC 478 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~------~~~~~~--~L~~Li~~c 478 (518)
.|+|||++.+..++.++|||||||++|||++|+.||............+.....+.. +..... .+.+++.+|
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 148 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC 148 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence 999999999999999999999999999999999999765543333222222222221 112223 699999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 479 WQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 479 L~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
|+.+|.+||++.|+++.+..+..+
T Consensus 149 l~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 149 ASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999988776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-28 Score=274.45 Aligned_cols=193 Identities=16% Similarity=0.234 Sum_probs=144.4
Q ss_pred hcCC-CceeeEeeee-------ecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCC
Q 010091 298 KVRH-MNVVQFIGAC-------TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369 (518)
Q Consensus 298 ~l~H-pnIv~l~~~~-------~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDL 369 (518)
.++| .||++++++| .....++++|||+ +++|.++|......+++..++.++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4456 5888888877 3335678889988 67999999875667999999999999999999999999999999
Q ss_pred CCCcEEeccCC-------------------cEEEeeeccceeccccC-----------------ccccCCCCCcccChhh
Q 010091 370 KAANLLMNENG-------------------VVKVADFGVARVQAQYG-----------------VMTAETGTYRWMAPEV 413 (518)
Q Consensus 370 kp~NILl~~~~-------------------~vkL~DFG~a~~~~~~~-----------------~~~~~~gt~~y~APE~ 413 (518)
||+|||++..| .+|++|||+++...... ......||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996544 45556666654321100 0011347888999999
Q ss_pred hcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 010091 414 IEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEIT 493 (518)
Q Consensus 414 l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil 493 (518)
+.+..++.++|||||||+||||++|..|+..... .... +.....+.......+....++.+||+++|.+||++.|++
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSS-LRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHH-HHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 9999999999999999999999999888764321 1111 111222222222345678899999999999999999997
Q ss_pred H
Q 010091 494 E 494 (518)
Q Consensus 494 ~ 494 (518)
+
T Consensus 264 ~ 264 (793)
T PLN00181 264 Q 264 (793)
T ss_pred h
Confidence 5
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-25 Score=228.93 Aligned_cols=255 Identities=23% Similarity=0.306 Sum_probs=200.9
Q ss_pred cceeeeEEeEecceEEEEEEECCc---cEEEEEEeccccCHHHHHHHHHHHHHHhhcCC----CceeeEeeee-ecCCce
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFFSQ---DVAIKVLTNEHLNENIRREFAQEVHIMRKVRH----MNVVQFIGAC-TRPPRL 317 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~~~---~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H----pnIv~l~~~~-~~~~~~ 317 (518)
.|++.++||+|+||.||.+..... .+|+|+......... ..+..|..++..+.. +++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 455599999999999999997653 599998876533221 156678888888863 6899999988 577789
Q ss_pred eEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-----CcEEEeeeccce
Q 010091 318 FIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-----GVVKVADFGVAR 391 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-----~~vkL~DFG~a~ 391 (518)
|+||+.+ |.+|.++..... ..++...++.++.|++.+|++||+.|++||||||+|++++.. ..+.|+|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999988 999999886544 679999999999999999999999999999999999999855 469999999998
Q ss_pred --ecc-ccC-------c-cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---c
Q 010091 392 --VQA-QYG-------V-MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ---K 457 (518)
Q Consensus 392 --~~~-~~~-------~-~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~---~ 457 (518)
... ..+ . .....||.+|+++.+..+...+.+.|+||+++++.+++.|..||.............. .
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 311 111 1 1123399999999999999999999999999999999999999977654322222221 1
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 458 GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 458 ~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
..........+..+..++..+-..+...+|.+..+...|+.....-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111133445677888888888899999999999999988877664
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=223.56 Aligned_cols=236 Identities=19% Similarity=0.322 Sum_probs=184.8
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEee-eeecCCceeEEE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG-ACTRPPRLFIVT 321 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~-~~~~~~~~~lV~ 321 (518)
.|.+.+.||+|.||.+-++... ++.+++|.+..+... ..+|.+|...--.| .|.||+.-|+ +|...+.+++++
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4556999999999999999976 478999998876443 46888887766666 4899998876 467777888999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec--cCCcEEEeeeccceeccccCcc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN--ENGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~--~~~~vkL~DFG~a~~~~~~~~~ 399 (518)
||++.|+|.+-+.. .++-+....+++.|+++||.|+|++++||||||.+||||- +...|||||||.++..+..-..
T Consensus 102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 99999999988766 3578888999999999999999999999999999999994 3358999999999765442111
Q ss_pred ccCCCCCcccChhhhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCCCCCCCCC---Cc
Q 010091 400 TAETGTYRWMAPEVIEHQ-----PYNHRADVFSFGIVLWELVTGKLPYDDL---TPLQAAVGVVQKGLRPTIPVH---TH 468 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~-----~~~~ksDV~SlGill~eLltG~~P~~~~---~~~~~~~~~~~~~~~p~~~~~---~~ 468 (518)
..-+..|.+||..... ...+.+|+|.|||++|.++||+.||... .+.-.-...+.++..+..|.. .+
T Consensus 180 --~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs 257 (378)
T KOG1345|consen 180 --LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFS 257 (378)
T ss_pred --hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccC
Confidence 2245678999987332 2467899999999999999999999742 222222333455566666643 57
Q ss_pred HHHHHHHHHhhhhCCCCCCC
Q 010091 469 PILVDLLERCWQRDPSLRPD 488 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs 488 (518)
+.+..+.++-|..+|++|=-
T Consensus 258 ~~a~r~Fkk~lt~~~~drck 277 (378)
T KOG1345|consen 258 EKALRLFKKSLTPRFKDRCK 277 (378)
T ss_pred HHHHHHHHHhcCCcccccch
Confidence 78999999999999999933
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=231.78 Aligned_cols=241 Identities=23% Similarity=0.360 Sum_probs=186.6
Q ss_pred cceeeeEEeEecceEEEEEEE-----CCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~-----~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l 319 (518)
.|+.+++||+|+|+.||+++. ....||+|.+...... .+...|+.+|..+ .+.||+++.+++...+..++
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 355589999999999999984 3467999998876433 4678899999999 59999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-CCcEEEeeeccceecc----
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVVKVADFGVARVQA---- 394 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-~~~vkL~DFG~a~~~~---- 394 (518)
|+||++.....+++.. ++...+..+++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|....
T Consensus 113 vlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred EecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 9999999888888765 678999999999999999999999999999999999984 4788999999997100
Q ss_pred -------------c-cC----------------------c-----cccCCCCCcccChhhhc-CCCCCchhhHHHHHHHH
Q 010091 395 -------------Q-YG----------------------V-----MTAETGTYRWMAPEVIE-HQPYNHRADVFSFGIVL 432 (518)
Q Consensus 395 -------------~-~~----------------------~-----~~~~~gt~~y~APE~l~-~~~~~~ksDV~SlGill 432 (518)
. .+ . .....||++|.|||++. ....++++||||.|+|+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 00 0 01123899999999984 45678999999999999
Q ss_pred HHHHcCCCCCCCCCH-HHHHHHH---------------------Hh-----------cCC----------------CC-C
Q 010091 433 WELVTGKLPYDDLTP-LQAAVGV---------------------VQ-----------KGL----------------RP-T 462 (518)
Q Consensus 433 ~eLltG~~P~~~~~~-~~~~~~~---------------------~~-----------~~~----------------~p-~ 462 (518)
.-++++..||-.... ..+...+ ++ ..+ .. .
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 999999999842110 0000000 00 000 00 0
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 ~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.....+..+.+++.+|+..||.+|.|+++.|+
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 01123457999999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-24 Score=208.63 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=203.0
Q ss_pred ceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHH-HHHHHHHHHHHHhhcCCC-ceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNEN-IRREFAQEVHIMRKVRHM-NVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~-~~~~f~~E~~il~~l~Hp-nIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|.+.+.||.|+|+.||++.+. ..+++|.+........ ....|.+|+.++..+.|+ +++++++.+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 556889999999999999988 8899999988766553 568899999999999988 7999999997777789999999
Q ss_pred cCCcccccccccc--CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-cEEEeeeccceeccccC----
Q 010091 325 SGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFGVARVQAQYG---- 397 (518)
Q Consensus 325 ~ggsL~~~l~~~~--~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-~vkL~DFG~a~~~~~~~---- 397 (518)
.++++.+++.... ..+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999997776643 2688999999999999999999999999999999999999988 79999999998544432
Q ss_pred ---ccccCCCCCcccChhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCC----CCC
Q 010091 398 ---VMTAETGTYRWMAPEVIEH---QPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGLRP----TIP 464 (518)
Q Consensus 398 ---~~~~~~gt~~y~APE~l~~---~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~~p----~~~ 464 (518)
......|+..|++||.+.+ ..+....|+||+|++++++++|..||..... .......+.....+ ...
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence 2344569999999999987 5789999999999999999999999877663 23333333333322 111
Q ss_pred CCC----cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 465 VHT----HPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 465 ~~~----~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
... ...+.+++.+|+..+|..|.+..+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 211 1579999999999999999887766553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=206.12 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=212.0
Q ss_pred eccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC-CceeeEeeeeecCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNVVQFIGACTRPPRLF 318 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~l~~~~~~~~~~~ 318 (518)
|-...|+++++||+|+||.+|.|.. .|..||||+-+..... ..+..|..+.+.|++ ..|..+..+..+..+-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 4466788899999999999999985 4799999997765432 245668889998875 67888888888999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC---CcEEEeeeccceeccc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN---GVVKVADFGVARVQAQ 395 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~---~~vkL~DFG~a~~~~~ 395 (518)
+||+.+ |.||.+.+.-....++...++-++-|++.-++|+|.+++|||||||+|+|++-+ ..+.++|||+|+..-.
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999999 999999998777789999999999999999999999999999999999999743 4799999999976433
Q ss_pred cC--------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCCC
Q 010091 396 YG--------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGLRPTIP 464 (518)
Q Consensus 396 ~~--------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~~p~~~ 464 (518)
.. .....+||.+|.+-....+...+...|+-|+|.+|.+...|.+||.+..+ .|.+..+.+......+.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 21 12334699999998887778889999999999999999999999988644 45556666555543332
Q ss_pred ---CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 465 ---VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 465 ---~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
...|.++.-.+.-|-..--.+-|+..-+...+.-++..++
T Consensus 247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 247 VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 5678899999999999999999999888887777765443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=208.19 Aligned_cols=260 Identities=19% Similarity=0.275 Sum_probs=211.7
Q ss_pred eccccceeeeEEeEecceEEEEEE--ECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~--~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ 318 (518)
|-.-.|++.++||+|+||.++.|+ ++++.||||.-.....- -.+..|....+.|. .++|...+-+...+.+..
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 444567789999999999999999 56999999985543221 34556777788774 789999999888889999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-----CCcEEEeeeccceec
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-----NGVVKVADFGVARVQ 393 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-----~~~vkL~DFG~a~~~ 393 (518)
+|+|.+ |.||.|++.-.+..|+...+..++.|++.-|+|+|++..|.|||||+|+||+. ...|-|+|||+|+..
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999 99999999887788999999999999999999999999999999999999973 347999999999865
Q ss_pred cccCc--------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCCC-
Q 010091 394 AQYGV--------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT---PLQAAVGVVQKGLRP- 461 (518)
Q Consensus 394 ~~~~~--------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~---~~~~~~~~~~~~~~p- 461 (518)
..+.. .....||.+||+-....+...+...|+-|||-++++.|.|.+||.+.. ..+.+..+=+..-..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 44321 233569999999888888999999999999999999999999998753 333333322221111
Q ss_pred --CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 462 --TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 462 --~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
.+-.+++.++...|.-.-..+-.+-|+++-+...+.++++.++-+
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t 306 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGET 306 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCc
Confidence 122457788999999999999999999999999999999887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=219.56 Aligned_cols=162 Identities=21% Similarity=0.241 Sum_probs=126.6
Q ss_pred eccccceeeeEEeEecceEEEEEEEC---CccEEEEEEecccc---CHHHHHHHHHHHHHHhhcCCCceee-EeeeeecC
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQ-FIGACTRP 314 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~---~~~vAvKvl~~~~~---~~~~~~~f~~E~~il~~l~HpnIv~-l~~~~~~~ 314 (518)
+-...|.+.+.||+|+||.||+|.+. ++.||||++..... .+.....|.+|+.+|++++|+|++. ++.+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34456777999999999999999863 56789998764321 3344577999999999999999985 5442
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCC-CCCcEEeccCCcEEEeeeccceec
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL-KAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDL-kp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
+..|+||||++|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 457999999999999632 11 11 1467889999999999999999999 999999999999999999999865
Q ss_pred cccCc---------cccCCCCCcccChhhhc
Q 010091 394 AQYGV---------MTAETGTYRWMAPEVIE 415 (518)
Q Consensus 394 ~~~~~---------~~~~~gt~~y~APE~l~ 415 (518)
...+. .+...++..|+|||.+.
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 44331 12334788899999883
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=223.85 Aligned_cols=245 Identities=22% Similarity=0.277 Sum_probs=186.2
Q ss_pred eeeeEEeEecceEEEEEEEC--CccEEEEEEec---cccCHHHH-HHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 248 KFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTN---EHLNENIR-REFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~---~~~~~~~~-~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+....+|+|++|.|+..... ....+.|..+. ....+... ..+..|.-+-.++.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45778999999988777643 23344443321 11122222 33777888888999999988887776666666669
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--- 398 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 398 (518)
|||++ +|..++... ..+....+..++.|++.|++|+|..||.|||||++|++++.+|.+||+|||.+.+......
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99999 999998773 5688889999999999999999999999999999999999999999999999987554332
Q ss_pred --cccCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHhcCC------CCCCCCCCc
Q 010091 399 --MTAETGTYRWMAPEVIEHQPYNHR-ADVFSFGIVLWELVTGKLPYDDLTPLQAAV-GVVQKGL------RPTIPVHTH 468 (518)
Q Consensus 399 --~~~~~gt~~y~APE~l~~~~~~~k-sDV~SlGill~eLltG~~P~~~~~~~~~~~-~~~~~~~------~p~~~~~~~ 468 (518)
.....|+..|+|||++.+..|++. .||||.|++++.|.+|+.||......+... ....... ...+....+
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp 558 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP 558 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence 334568999999999999998865 799999999999999999997654432210 0000000 111123346
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..-+.+|.+||+.+|.+|.|+++|++
T Consensus 559 ~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 559 RETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hhHHHHHHHHccCChhheecHHHHhh
Confidence 67899999999999999999999875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-22 Score=187.85 Aligned_cols=140 Identities=18% Similarity=0.192 Sum_probs=109.1
Q ss_pred eeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHH------------------------HHHHHHHHHHHhhcCCCce
Q 010091 250 EHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENI------------------------RREFAQEVHIMRKVRHMNV 304 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~------------------------~~~f~~E~~il~~l~HpnI 304 (518)
.+.||+|++|.||+|... |+.||||+++........ ......|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999964 889999999875332111 1122359999999988776
Q ss_pred eeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHH-HHCCceecCCCCCcEEeccCCcEE
Q 010091 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL-HRNNIIHRDLKAANLLMNENGVVK 383 (518)
Q Consensus 305 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yL-H~~gIiHrDLkp~NILl~~~~~vk 383 (518)
......... ..++||||++|+++...+.. ...++...+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 443332222 23899999988777655333 34688999999999999999999 799999999999999998 57899
Q ss_pred Eeeeccceec
Q 010091 384 VADFGVARVQ 393 (518)
Q Consensus 384 L~DFG~a~~~ 393 (518)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-22 Score=191.95 Aligned_cols=172 Identities=13% Similarity=0.167 Sum_probs=135.5
Q ss_pred ccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHH-HHH------HHHHHHHHhhcCCCceeeEeeeeecC-
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENI-RRE------FAQEVHIMRKVRHMNVVQFIGACTRP- 314 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~-~~~------f~~E~~il~~l~HpnIv~l~~~~~~~- 314 (518)
-..+|+..+.+|.|+||.||+....+..+|||++.+....... ... |.+|+..+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 3567888999999999999998877889999999877554432 233 67999999999999999998875432
Q ss_pred -------CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeee
Q 010091 315 -------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387 (518)
Q Consensus 315 -------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DF 387 (518)
...++||||++|.+|.++.. ++. ....+++.+|..+|+.|++|||++|+||+++.+| ++|+||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35789999999999988732 222 2456999999999999999999999999999988 999999
Q ss_pred ccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHH
Q 010091 388 GVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWEL 435 (518)
Q Consensus 388 G~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eL 435 (518)
|........... ..+.....++.++|+||||+++.-+
T Consensus 179 g~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 179 SGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHH
Confidence 988654322111 1133445577899999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=180.02 Aligned_cols=181 Identities=16% Similarity=0.128 Sum_probs=140.8
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHH--HHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEEeeccC
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNEN--IRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~--~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
...|++|+||+||.+...+.+++.+.+........ ....|.+|+.+|++|+ ++++++++++ ...|++|||+.|
T Consensus 7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred ceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 66899999999999888888999888876554221 2246889999999995 5889999886 346999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCC-CCCcEEeccCCcEEEeeeccceeccccCcc------
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL-KAANLLMNENGVVKVADFGVARVQAQYGVM------ 399 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDL-kp~NILl~~~~~vkL~DFG~a~~~~~~~~~------ 399 (518)
.+|.+.+.. ....++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 83 ~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~ 154 (218)
T PRK12274 83 AAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAR 154 (218)
T ss_pred ccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHH
Confidence 998754322 11357789999999999999999999 799999999999999999999865443310
Q ss_pred --------ccCCCCCcccChhhhcCC-CCC-chhhHHHHHHHHHHHHcCCCCC
Q 010091 400 --------TAETGTYRWMAPEVIEHQ-PYN-HRADVFSFGIVLWELVTGKLPY 442 (518)
Q Consensus 400 --------~~~~gt~~y~APE~l~~~-~~~-~ksDV~SlGill~eLltG~~P~ 442 (518)
.-...++.|++|+...-. ..+ ...+.++.|+.+|.++|+..+.
T Consensus 155 rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 155 EDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 011257788888865322 223 5679999999999999988765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=178.74 Aligned_cols=141 Identities=17% Similarity=0.174 Sum_probs=111.3
Q ss_pred eeEEeEecceEEEEEEEC-CccEEEEEEeccccCH-----------------------H-HHHHHHHHHHHHhhcCCCce
Q 010091 250 EHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNE-----------------------N-IRREFAQEVHIMRKVRHMNV 304 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~-----------------------~-~~~~f~~E~~il~~l~HpnI 304 (518)
.+.||+|++|.||+|+.. |+.||||+++...... . ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 568999999999999975 8999999998753210 0 01234679999999999987
Q ss_pred eeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEE
Q 010091 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVK 383 (518)
Q Consensus 305 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vk 383 (518)
.....+... ..|+||||++|+++...... ...++...+..++.|++.++.++|+ +||+||||||+||+++ ++.++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 554443332 24899999988765443222 3457888999999999999999999 9999999999999999 88999
Q ss_pred Eeeeccceecc
Q 010091 384 VADFGVARVQA 394 (518)
Q Consensus 384 L~DFG~a~~~~ 394 (518)
|+|||++....
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=212.19 Aligned_cols=251 Identities=18% Similarity=0.241 Sum_probs=193.9
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEE-CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC---CCceeeEeeeeec
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQFIGACTR 313 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~---HpnIv~l~~~~~~ 313 (518)
...++....|.+.+.||.|+||.||+|+. +|+.||||+-++...++- .-=.+++.+|+ -+.|+.+..++.-
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-----YI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-----YICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-----eehHHHHHhhchhhhcchHHHHHHHcc
Confidence 35688888899999999999999999994 488999999998876642 22234455555 2456666666677
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec-------cCCcEEEee
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-------ENGVVKVAD 386 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~-------~~~~vkL~D 386 (518)
.+..++|+||.+.|||.++++. ...+++..+..++.|++..++.||..+||||||||+|+|+. ....++|+|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 7788999999999999999984 66799999999999999999999999999999999999995 234699999
Q ss_pred eccceecccc---CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---CCC
Q 010091 387 FGVARVQAQY---GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK---GLR 460 (518)
Q Consensus 387 FG~a~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~---~~~ 460 (518)
||.+..+..- .......+|-.+-.+|+..|.+|+..+|.|.|+.+++-||.|+..- .+.. ...
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~ 913 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVK 913 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceecc
Confidence 9999654332 2344556889999999999999999999999999999999987421 1111 112
Q ss_pred CCCCCCCcH-HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 461 PTIPVHTHP-ILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 461 p~~~~~~~~-~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
..++..+.. .+.+++..+|+.|-..=|...++...|+..+.+-.+
T Consensus 914 ~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 914 TNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred ccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 223333332 366778888884444448889988888888766543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=190.35 Aligned_cols=191 Identities=24% Similarity=0.387 Sum_probs=145.1
Q ss_pred CCCceeeEeeeeec---------------------------CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHh
Q 010091 300 RHMNVVQFIGACTR---------------------------PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352 (518)
Q Consensus 300 ~HpnIv~l~~~~~~---------------------------~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql 352 (518)
+|||||++.++|.+ ...+|+||..+ ..+|.+|+..+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999887633 23579999988 569999998744 5666677788999
Q ss_pred HHHHHHHHHCCceecCCCCCcEEec--cCC--cEEEeeeccceeccccCc-------cccCCCCCcccChhhhcCCCC--
Q 010091 353 SKGMNYLHRNNIIHRDLKAANLLMN--ENG--VVKVADFGVARVQAQYGV-------MTAETGTYRWMAPEVIEHQPY-- 419 (518)
Q Consensus 353 ~~gL~yLH~~gIiHrDLkp~NILl~--~~~--~vkL~DFG~a~~~~~~~~-------~~~~~gt~~y~APE~l~~~~~-- 419 (518)
++|+.|||++||.|||+|.+|||+. +|+ .+.|+|||++-.....+. .....|.-..||||+....+-
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999999999999999999993 333 689999999864433221 111236778899999854432
Q ss_pred ----CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 010091 420 ----NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEIT 493 (518)
Q Consensus 420 ----~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil 493 (518)
-.|+|.|+.|.+.||+++...||-..-.........++..-|.+|..+++.+++++...|+.||.+|++..-..
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 35899999999999999998888542111111112344557889999999999999999999999998765433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-22 Score=211.67 Aligned_cols=223 Identities=26% Similarity=0.401 Sum_probs=189.3
Q ss_pred EeEecceEEEEEE-----ECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEEeeccC
Q 010091 253 IVSGSYCDLYKGA-----FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 253 Lg~G~~g~Vy~~~-----~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+|.|+||.|++++ +.+.-+|+|+++..............|..++..++ ||.+|++..++..+..++++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999865 34677999999876554433346667888888887 99999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY 406 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~ 406 (518)
|.|...+.+ ...+++.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||.++....... .+||+
T Consensus 82 g~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---~cgt~ 157 (612)
T KOG0603|consen 82 GDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---ACGTY 157 (612)
T ss_pred chhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---cccch
Confidence 999888877 44677777888888999999999999999999999999999999999999999987655433 28999
Q ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 010091 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 407 ~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~R 486 (518)
.|||||+++ .....+|.||||++++||+||..||.. +....+. +..+.+|......+..++.+++..+|.+|
T Consensus 158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il--~~~~~~p~~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL--KAELEMPRELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh--hhccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence 999999998 568889999999999999999999988 3333333 33566788888999999999999999999
Q ss_pred C
Q 010091 487 P 487 (518)
Q Consensus 487 P 487 (518)
-
T Consensus 230 L 230 (612)
T KOG0603|consen 230 L 230 (612)
T ss_pred h
Confidence 4
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-22 Score=218.38 Aligned_cols=243 Identities=19% Similarity=0.240 Sum_probs=181.1
Q ss_pred cceeeeEEeEecceEEEEEEECCccEEEEEEeccc--cCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEH--LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~--~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
++...+.||++.|=.|.++++....|+||++-... .+-....+-..|++ ...+++||++++.-+.......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 56678999999999999999776669999997653 22222233334444 4556899999999988888889999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec----cccCcc
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ----AQYGVM 399 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~----~~~~~~ 399 (518)
. .-+|+|.+.. +..+...+...++.||+.|+..+|..||+|||||.+||||+.-+.+.|.||..-+-- +.+...
T Consensus 103 v-khnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 103 V-KHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred H-hhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 9 5599999987 456788888899999999999999999999999999999999999999999876421 111111
Q ss_pred c----cCCCCCcccChhhhcCC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-CCCC-
Q 010091 400 T----AETGTYRWMAPEVIEHQ----------P-YNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQK-GLRP- 461 (518)
Q Consensus 400 ~----~~~gt~~y~APE~l~~~----------~-~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~-~~~p- 461 (518)
+ +...-..|.|||.+... + .+++-||||+||++.||++ |.+||.-.. +...... ...+
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~~~~~e 256 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGNADDPE 256 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccCccCHH
Confidence 1 12233569999988431 1 4678999999999999998 889885311 1111110 0000
Q ss_pred -CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 462 -TIPVHTHPILVDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 462 -~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
.+..-.+..++++|..|++.||.+|-++++.++.
T Consensus 257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0111123469999999999999999999998876
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=186.16 Aligned_cols=232 Identities=19% Similarity=0.268 Sum_probs=152.3
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCC----------CceeeEeeee-
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRH----------MNVVQFIGAC- 311 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~H----------pnIv~l~~~~- 311 (518)
+++..+.||.|+++.||.+++. ++.+|||++...... ....+.+.+|......+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3566889999999999999986 599999998765422 2345777777766665432 1222222211
Q ss_pred --------ecC---C-----ceeEEEeeccCCccccccc---cccC---CCChHHHHHHHHHhHHHHHHHHHCCceecCC
Q 010091 312 --------TRP---P-----RLFIVTEFMSGGSIYDYLH---KQKC---GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369 (518)
Q Consensus 312 --------~~~---~-----~~~lV~Ey~~ggsL~~~l~---~~~~---~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDL 369 (518)
... . ..+++|+-+ .++|.+++. .... .+.....+.+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 1 347788888 568877753 2111 1233444566789999999999999999999
Q ss_pred CCCcEEeccCCcEEEeeeccceeccccCccccCCCCCcccChhhhcC--------CCCCchhhHHHHHHHHHHHHcCCCC
Q 010091 370 KAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH--------QPYNHRADVFSFGIVLWELVTGKLP 441 (518)
Q Consensus 370 kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~ksDV~SlGill~eLltG~~P 441 (518)
+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|++|..|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999999999999988765553222 445678999998743 2478899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 010091 442 YDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486 (518)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~R 486 (518)
|+...+...... .+ .... +.+..++.||..+|+.||.+|
T Consensus 250 f~~~~~~~~~~~----~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW----DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG----GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccc----cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 987654322110 11 1233 677889999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.1e-19 Score=169.85 Aligned_cols=136 Identities=24% Similarity=0.423 Sum_probs=116.2
Q ss_pred eEEeEecceEEEEEEECCccEEEEEEeccccCHH------HHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNEN------IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~------~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
+.||+|++|.||+|.+.+..|++|+......... ....+.+|+.++..+.|++|.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5789999999999999999999998775433211 1256888999999999999887777776777889999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
+|++|.+++.... . ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986532 2 7889999999999999999999999999999999 78999999998854
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-19 Score=189.17 Aligned_cols=207 Identities=31% Similarity=0.588 Sum_probs=167.3
Q ss_pred HhhcCCCceeeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCc-eecCCCCCcE
Q 010091 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI-IHRDLKAANL 374 (518)
Q Consensus 296 l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gI-iHrDLkp~NI 374 (518)
|+.+.|.|+.+|+|.+..++..++|.+||..|+|.|.+....-.++.-....+.++|+.||.|||.-.| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 467899999999999999999999999999999999998866678888899999999999999998766 9999999999
Q ss_pred EeccCCcEEEeeeccceecccc---CccccCCCCCcccChhhhcCCC-------CCchhhHHHHHHHHHHHHcCCCCCCC
Q 010091 375 LMNENGVVKVADFGVARVQAQY---GVMTAETGTYRWMAPEVIEHQP-------YNHRADVFSFGIVLWELVTGKLPYDD 444 (518)
Q Consensus 375 Ll~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~APE~l~~~~-------~~~ksDV~SlGill~eLltG~~P~~~ 444 (518)
+++....+||.|||+....... .......-...|.|||.+.... .+.+.|+||||++++|+++.+.||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999999776421 1111122456799999996531 46779999999999999999999976
Q ss_pred C----CHHHHHHHHHhc-C---CCCCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 445 L----TPLQAAVGVVQK-G---LRPTIPV--HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 445 ~----~~~~~~~~~~~~-~---~~p~~~~--~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
. .+.+.... +.+ + ++|.+.. ..++.+..++.+||..+|.+||+++++...++.+.+..
T Consensus 161 ~~~~~~~~eii~~-~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 161 RNLVEDPDEIILR-VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccCChHHHHHH-HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 2 23233333 332 2 3444442 34567999999999999999999999999888876543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=166.23 Aligned_cols=131 Identities=21% Similarity=0.370 Sum_probs=108.8
Q ss_pred EeEecceEEEEEEECCccEEEEEEeccccC-H-----HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccC
Q 010091 253 IVSGSYCDLYKGAFFSQDVAIKVLTNEHLN-E-----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~-~-----~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
||+|+||.||+|.+.+..|++|+....... + ....++.+|+.+++.++|+++.....++......++||||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 799999999999999999999997653221 1 1136778899999999988765555455556677999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
++|.+++..... .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||.+..
T Consensus 82 ~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 82 KPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999988765221 7889999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=167.73 Aligned_cols=134 Identities=16% Similarity=0.265 Sum_probs=104.0
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-----CCCceeeEeeeeecCC---cee-EE
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-----RHMNVVQFIGACTRPP---RLF-IV 320 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-----~HpnIv~l~~~~~~~~---~~~-lV 320 (518)
.+.||+|+||.||.....+.. +||++...... ....+.+|+.+++++ +||||+++++++.... ..+ +|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 567999999999973333344 68888764322 346789999999999 5799999999997763 333 78
Q ss_pred Eee--ccCCccccccccccCCCChHHHHHHHHHhHHHH-HHHHHCCceecCCCCCcEEecc----CCcEEEee-eccc
Q 010091 321 TEF--MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM-NYLHRNNIIHRDLKAANLLMNE----NGVVKVAD-FGVA 390 (518)
Q Consensus 321 ~Ey--~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL-~yLH~~gIiHrDLkp~NILl~~----~~~vkL~D-FG~a 390 (518)
||| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++|+||||||+|||++. ++.++|+| ||..
T Consensus 84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 999 5579999999663 35555 35577888777 9999999999999999999974 33799999 4544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-18 Score=168.19 Aligned_cols=141 Identities=19% Similarity=0.222 Sum_probs=111.1
Q ss_pred ceeeeEEeEecceEEEEEE---ECCccEEEEEEeccccCH----------------------HHHHHHHHHHHHHhhcCC
Q 010091 247 LKFEHKIVSGSYCDLYKGA---FFSQDVAIKVLTNEHLNE----------------------NIRREFAQEVHIMRKVRH 301 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~---~~~~~vAvKvl~~~~~~~----------------------~~~~~f~~E~~il~~l~H 301 (518)
|.+.+.||+|++|.||+|. ..|+.||+|+++...... .....+..|+.+++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4458899999999999998 358999999998653210 012346789999999976
Q ss_pred Cc--eeeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCC-ceecCCCCCcEEecc
Q 010091 302 MN--VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN-IIHRDLKAANLLMNE 378 (518)
Q Consensus 302 pn--Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~g-IiHrDLkp~NILl~~ 378 (518)
.+ +.++++. ...|+||||++|.+|..++.. ...+....+..++.|++.++.+||+.| |+||||||+||+++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 33 4455543 235899999999888776543 234666778899999999999999999 99999999999999
Q ss_pred CCcEEEeeeccceec
Q 010091 379 NGVVKVADFGVARVQ 393 (518)
Q Consensus 379 ~~~vkL~DFG~a~~~ 393 (518)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 889999999998643
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.9e-18 Score=185.59 Aligned_cols=144 Identities=22% Similarity=0.346 Sum_probs=118.6
Q ss_pred ceeeccccc---eeeeEEeEecceEEEEEEECCccEEEEEEeccccC-----H-HHHHHHHHHHHHHhhcCCCceeeEee
Q 010091 239 VWEIDASLL---KFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLN-----E-NIRREFAQEVHIMRKVRHMNVVQFIG 309 (518)
Q Consensus 239 ~~eI~~~~~---~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~-----~-~~~~~f~~E~~il~~l~HpnIv~l~~ 309 (518)
.|+...... ...+.||+|+||.||+|.+.+..+++|+....... . ....++.+|+.++++++|++++..+.
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 466655543 34789999999999999998888777764432211 1 12367889999999999999998877
Q ss_pred eeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 310 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
++......++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 7777777899999999999998875 346789999999999999999999999999999 678999999999
Q ss_pred cee
Q 010091 390 ARV 392 (518)
Q Consensus 390 a~~ 392 (518)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 965
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=182.39 Aligned_cols=168 Identities=26% Similarity=0.485 Sum_probs=133.7
Q ss_pred CceeEEEeeccCCcccccccc--ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 315 PRLFIVTEFMSGGSIYDYLHK--QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~--~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
.++||.|++|...+|.+||.. .....++...+.++.|++.|++| ++.+|+|+||.||++..+..+||+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 368999999999999999964 33457788899999999999999 9999999999999999999999999999976
Q ss_pred ccccC-------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 010091 393 QAQYG-------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIP 464 (518)
Q Consensus 393 ~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~ 464 (518)
..... ..+...||..||+||.+.+..|+.|+||||||++++|++. -..++.. -.....++.+.-|+.-
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCChHH
Confidence 55544 4566679999999999999999999999999999999987 2222221 1222233334333222
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCH
Q 010091 465 VHTHPILVDLLERCWQRDPSLRPDF 489 (518)
Q Consensus 465 ~~~~~~L~~Li~~cL~~dP~~RPs~ 489 (518)
....|+-..|+.+++.+.|.+||++
T Consensus 482 ~~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 482 LQDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hhcCcHHHHHHHHhcCCCcccCchH
Confidence 2334556789999999999999944
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.2e-18 Score=187.60 Aligned_cols=217 Identities=27% Similarity=0.368 Sum_probs=155.3
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|..++.|..|+||.||..+++ .+++|+|+-+.+.. .+ .++.....|.+|
T Consensus 85 f~~IklisngAygavylvrh~~trqrfa~kiNkq~li--------lR--nilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI--------LR--NILTFAGNPFVV------------------- 135 (1205)
T ss_pred cceeEeeccCCCCceeeeeccccccchhhcccccchh--------hh--ccccccCCccee-------------------
Confidence 444899999999999999866 68899966433211 00 023333334333
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-------
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG------- 397 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~------- 397 (518)
|+-...++. .+.++.+. +.+++|||+.||+|||+||+|++|+.-|.+|+.|||+++......
T Consensus 136 --gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 136 --GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred --chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence 222223322 33344332 779999999999999999999999999999999999997533211
Q ss_pred ---------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCC
Q 010091 398 ---------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG-LRPTIPVHT 467 (518)
Q Consensus 398 ---------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~-~~p~~~~~~ 467 (518)
......||+.|.|||++....|..-.|+|++|+|+||.+-|+.||.+.++.+.+-.++... ..|+-..-.
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~ 284 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEAL 284 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCC
Confidence 0112358999999999999999999999999999999999999999999988776555432 234445567
Q ss_pred cHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHHHHHh
Q 010091 468 HPILVDLLERCWQRDPSLR-PDFSEITELLQHLAQRL 503 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~R-Ps~~eil~~L~~l~~~~ 503 (518)
+++.++++.++|+.+|..| -+..++.-.=+.+++.+
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 8999999999999999999 34444433333343333
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=157.05 Aligned_cols=136 Identities=18% Similarity=0.170 Sum_probs=107.3
Q ss_pred ceeeeEEeEecceEEEEEEE-CCccEEEEEEeccccCH--------------------HHHHHHHHHHHHHhhcCCC--c
Q 010091 247 LKFEHKIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLNE--------------------NIRREFAQEVHIMRKVRHM--N 303 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~-~~~~vAvKvl~~~~~~~--------------------~~~~~f~~E~~il~~l~Hp--n 303 (518)
|.+.+.||+|+||.||++.. .|+.||||++....... .....+..|..++.++.++ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 44478899999999999987 48999999987543110 0112467899999999877 4
Q ss_pred eeeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEE
Q 010091 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVK 383 (518)
Q Consensus 304 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vk 383 (518)
++..++. ...++||||++|++|...... .....++.+++.++.++|+.||+||||||+||++++++.++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4555542 345899999999998765431 34567889999999999999999999999999999999999
Q ss_pred Eeeeccceec
Q 010091 384 VADFGVARVQ 393 (518)
Q Consensus 384 L~DFG~a~~~ 393 (518)
|+|||.+...
T Consensus 166 liDfg~~~~~ 175 (198)
T cd05144 166 IIDWPQMVST 175 (198)
T ss_pred EEECCccccC
Confidence 9999999543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=148.02 Aligned_cols=137 Identities=23% Similarity=0.289 Sum_probs=99.9
Q ss_pred eeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHH----------------------HHHHHHHhhcCCCc--e
Q 010091 250 EHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREF----------------------AQEVHIMRKVRHMN--V 304 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f----------------------~~E~~il~~l~Hpn--I 304 (518)
.+.||+|+||.||+|... ++.||||+++...........+ ..|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 567999999999999976 8899999988754322211111 34566666664433 4
Q ss_pred eeEeeeeecCCceeEEEeeccCCccccc-cccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcE
Q 010091 305 VQFIGACTRPPRLFIVTEFMSGGSIYDY-LHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVV 382 (518)
Q Consensus 305 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~-l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~v 382 (518)
.+.++. ...++||||++|+++... +.... . ...+..++.+++.++.++|+ .||+|+||||+||+++ ++.+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 444443 235899999998554322 21111 1 16678899999999999999 9999999999999999 8999
Q ss_pred EEeeeccceecc
Q 010091 383 KVADFGVARVQA 394 (518)
Q Consensus 383 kL~DFG~a~~~~ 394 (518)
+|+|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.7e-16 Score=138.31 Aligned_cols=131 Identities=15% Similarity=0.244 Sum_probs=114.2
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC--CceeeEeeeeecCCceeEEEeeccCC
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
.+.||.|.++.||+++..+..+++|+...... ...+.+|+.+++.+++ .++++++.+....+..+++|||++|+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 57899999999999998888999999876543 3578899999999976 58999999888888899999999988
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHC---CceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN---NIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~---gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
++..+ +......++.+++.++.+||.. +++|+|++|.||+++..+.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77765 4556677889999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=150.92 Aligned_cols=137 Identities=15% Similarity=0.144 Sum_probs=107.5
Q ss_pred eeEEe-EecceEEEEEEECCccEEEEEEecccc-----------CHHHHHHHHHHHHHHhhcCCCce--eeEeeeeecC-
Q 010091 250 EHKIV-SGSYCDLYKGAFFSQDVAIKVLTNEHL-----------NENIRREFAQEVHIMRKVRHMNV--VQFIGACTRP- 314 (518)
Q Consensus 250 ~~~Lg-~G~~g~Vy~~~~~~~~vAvKvl~~~~~-----------~~~~~~~f~~E~~il~~l~HpnI--v~l~~~~~~~- 314 (518)
...|| .|+.|+||.+...+..++||.+..... +......+.+|+.++.+++|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 34677 899999999998899999998864221 11223678899999999998875 6677764332
Q ss_pred Cc---eeEEEeeccC-CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 315 PR---LFIVTEFMSG-GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 315 ~~---~~lV~Ey~~g-gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
.. .++||||++| .+|.+++... .++.. .+.+|+.+|.+||++||+|+||||.|||++.++.++|+|||.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 2599999997 6898887652 34443 3568999999999999999999999999999999999999988
Q ss_pred ee
Q 010091 391 RV 392 (518)
Q Consensus 391 ~~ 392 (518)
+.
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.6e-17 Score=177.30 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=194.8
Q ss_pred cccceeeeEEeEecceEEEEEEEC---CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~---~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 319 (518)
...|.+.+.||+|+|+.|-..... ...+|+|.+...............|..+-+.+. |.|++.+++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 334555888999999999887643 244666666554433334455566888888887 9999999999999999999
Q ss_pred EEeeccCCcccccc-ccccCCCChHHHHHHHHHhHHHHHHHH-HCCceecCCCCCcEEeccCC-cEEEeeeccceeccc-
Q 010091 320 VTEFMSGGSIYDYL-HKQKCGLKLPLLLRVAIDVSKGMNYLH-RNNIIHRDLKAANLLMNENG-VVKVADFGVARVQAQ- 395 (518)
Q Consensus 320 V~Ey~~ggsL~~~l-~~~~~~l~~~~i~~i~~ql~~gL~yLH-~~gIiHrDLkp~NILl~~~~-~vkL~DFG~a~~~~~- 395 (518)
+++|..|+++.+.+ +......+....-.++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999998 543336777778889999999999999 99999999999999999999 999999999987655
Q ss_pred cCc---cccCCC-CCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhc--CCCCCCCCCC
Q 010091 396 YGV---MTAETG-TYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA-VGVVQK--GLRPTIPVHT 467 (518)
Q Consensus 396 ~~~---~~~~~g-t~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~-~~~~~~--~~~p~~~~~~ 467 (518)
.+. .....| ++.|+|||...+. ......|+||.|+++.-+++|..||......... ...... ..........
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 322 233457 9999999998774 4467789999999999999999999865433322 111111 1123444567
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEIT 493 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil 493 (518)
+....+++.+++..+|..|.+.+++.
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ChhhhhcccccccCCchhcccccccc
Confidence 78899999999999999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-13 Score=146.30 Aligned_cols=143 Identities=18% Similarity=0.283 Sum_probs=101.2
Q ss_pred eeEEeEecceEEEEEEE-CCccEEEEEEeccccCH----------------------------HH----------HHHHH
Q 010091 250 EHKIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLNE----------------------------NI----------RREFA 290 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~-~~~~vAvKvl~~~~~~~----------------------------~~----------~~~f~ 290 (518)
.+.||+|++|+||+|+. .|+.||||+.++..... .. .-.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 35799999999999996 48999999998753110 00 01356
Q ss_pred HHHHHHhhcC-----CCceeeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHH-HHHHHHHCCc
Q 010091 291 QEVHIMRKVR-----HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK-GMNYLHRNNI 364 (518)
Q Consensus 291 ~E~~il~~l~-----HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~-gL~yLH~~gI 364 (518)
+|+..+.++. +++|.-..-++......++||||++|++|.++........+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 6777777663 33332211122233456999999999999998754222232 3445666655 4688999999
Q ss_pred eecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 365 IHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 365 iHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
+|+|++|.||+++.+|.++++|||++.....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.1e-14 Score=150.54 Aligned_cols=242 Identities=24% Similarity=0.253 Sum_probs=185.2
Q ss_pred cceeeeEEeE--ecceEEEEEEE----CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCcee
Q 010091 246 LLKFEHKIVS--GSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 246 ~~~~~~~Lg~--G~~g~Vy~~~~----~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ 318 (518)
.+.+.+.+|. |.+|.+|.++. .+..+|+|.-+...........-.+|....++++ |+|.++.+..+...+.+|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3444777899 99999999875 3577999885543332222233345666667774 999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHH----HHHHHHHCCceecCCCCCcEEeccC-CcEEEeeeccceec
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLMNEN-GVVKVADFGVARVQ 393 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~----gL~yLH~~gIiHrDLkp~NILl~~~-~~vkL~DFG~a~~~ 393 (518)
+-+|++ +.+|.++.+.....++...++....+... |+.++|+.+++|-|+||+||++..+ ...+++|||+....
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence 999999 68999999887767888999999999999 9999999999999999999999999 89999999999876
Q ss_pred cccCcc------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhcC-CCCCCC
Q 010091 394 AQYGVM------TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL--TPLQAAVGVVQKG-LRPTIP 464 (518)
Q Consensus 394 ~~~~~~------~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~--~~~~~~~~~~~~~-~~p~~~ 464 (518)
...... ....|...|++||..++. ++.++|+|++|.++.+..++..+.... ...... .+. ...++-
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~----r~~~ip~e~~ 348 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL----RQGYIPLEFC 348 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccc----ccccCchhhh
Confidence 554321 112577889999997654 789999999999999998876655433 211111 111 122233
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 010091 465 VHTHPILVDLLERCWQRDPSLRPDFSEIT 493 (518)
Q Consensus 465 ~~~~~~L~~Li~~cL~~dP~~RPs~~eil 493 (518)
...+.++...+..|++.+|..|++++.++
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 34456788899999999999999987654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.6e-13 Score=124.40 Aligned_cols=128 Identities=15% Similarity=0.180 Sum_probs=98.6
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCcee-eEeeeeecCCceeEEEeeccCCc
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV-QFIGACTRPPRLFIVTEFMSGGS 328 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~ggs 328 (518)
.+.|+.|.++.||+++..++.|++|+....... ...+..|+.+++.+.+.+++ +++.... ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 467889999999999999999999998655321 23456799999988665544 4555433 34589999999988
Q ss_pred cccccccccCCCChHHHHHHHHHhHHHHHHHHHCCc-----eecCCCCCcEEeccCCcEEEeeecccee
Q 010091 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI-----IHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 329 L~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gI-----iHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
+.+. . .. ....+.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~--~----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE--D----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--c----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 8654 1 11 13456789999999999985 9999999999999 67899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.9e-12 Score=119.97 Aligned_cols=137 Identities=19% Similarity=0.235 Sum_probs=99.7
Q ss_pred eeEEeEecceEEEEEEEC--------CccEEEEEEecccc-----------C---------HHHHHHH----HHHHHHHh
Q 010091 250 EHKIVSGSYCDLYKGAFF--------SQDVAIKVLTNEHL-----------N---------ENIRREF----AQEVHIMR 297 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~--------~~~vAvKvl~~~~~-----------~---------~~~~~~f----~~E~~il~ 297 (518)
...||.|.-+.||.|... +..+|||+.+.... + .+....+ .+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 356899999999999844 36899999875321 0 0111223 37999999
Q ss_pred hcCC--CceeeEeeeeecCCceeEEEeeccCCcccc-ccccccCCCChHHHHHHHHHhHHHHHHH-HHCCceecCCCCCc
Q 010091 298 KVRH--MNVVQFIGACTRPPRLFIVTEFMSGGSIYD-YLHKQKCGLKLPLLLRVAIDVSKGMNYL-HRNNIIHRDLKAAN 373 (518)
Q Consensus 298 ~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~-~l~~~~~~l~~~~i~~i~~ql~~gL~yL-H~~gIiHrDLkp~N 373 (518)
++.. -++.+++++ ..-++||||+.+..+.. .+.. ..++...+..+..+++.+|..| |+.|+|||||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 9964 456667764 45689999997654422 1222 2345556778889999999998 89999999999999
Q ss_pred EEeccCCcEEEeeeccceec
Q 010091 374 LLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 374 ILl~~~~~vkL~DFG~a~~~ 393 (518)
||++ ++.+.|+|||.+-..
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9997 468999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.7e-11 Score=133.29 Aligned_cols=142 Identities=17% Similarity=0.251 Sum_probs=89.2
Q ss_pred eEEeEecceEEEEEEEC--CccEEEEEEeccccC----------------------------H----HHH------HHHH
Q 010091 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN----------------------------E----NIR------REFA 290 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~----------------------------~----~~~------~~f~ 290 (518)
+.||+|++|+||+|+.. |+.||||+.++.... . +.. -.|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 68999999999999964 799999999875210 0 111 1244
Q ss_pred HHHHHHhhcC----CCceeeEeeee-ecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCce
Q 010091 291 QEVHIMRKVR----HMNVVQFIGAC-TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365 (518)
Q Consensus 291 ~E~~il~~l~----HpnIv~l~~~~-~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIi 365 (518)
+|+..+.++. +.+.+.+-..+ .-....++||||++|+++.++-.-.....+...+.....+ .-+..+...|++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~--~~~~Qif~~Gff 282 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE--VFFTQVFRDGFF 282 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH--HHHHHHHhCCee
Confidence 5555555552 22222222211 2234568999999999998753211122222222211111 112334569999
Q ss_pred ecCCCCCcEEeccCC----cEEEeeeccceecc
Q 010091 366 HRDLKAANLLMNENG----VVKVADFGVARVQA 394 (518)
Q Consensus 366 HrDLkp~NILl~~~~----~vkL~DFG~a~~~~ 394 (518)
|+|++|.||+++.+| .++++|||++....
T Consensus 283 HaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 283 HADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred eCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 999999999999888 99999999996543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.9e-12 Score=115.50 Aligned_cols=133 Identities=23% Similarity=0.376 Sum_probs=104.4
Q ss_pred EEeEecceEEEEEEECCccEEEEEEecccc-----CHHHH-HHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeecc
Q 010091 252 KIVSGSYCDLYKGAFFSQDVAIKVLTNEHL-----NENIR-REFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~-----~~~~~-~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 325 (518)
.+++|+-+.+|.+.+.|.++++|.=.+... ++... .+-.+|+.++.++.--.|...+=+..+.....|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 478899999999999888888887544332 22222 566789999999977666666556677778899999999
Q ss_pred CCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
|..|.+++... . ..++..+-.-+.-||.+||+|+||.++||++..++ +.++|||++...
T Consensus 83 G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 83 GELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred ChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99999998774 2 34555556666789999999999999999998665 999999999753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.1e-11 Score=130.05 Aligned_cols=220 Identities=18% Similarity=0.277 Sum_probs=145.4
Q ss_pred CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHH
Q 010091 267 FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLL 346 (518)
Q Consensus 267 ~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~ 346 (518)
.+.+|.|.+.+.... .......+-+.-|+.++||||++++..+...+.+|+|+|.+ ..|..++.+.. ...+.
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHH
Confidence 367788888776543 22344556778899999999999999999999999999988 47777777633 55566
Q ss_pred HHHHHhHHHHHHHH-HCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-cccCCCCCcccChhhhcCCCCCchhh
Q 010091 347 RVAIDVSKGMNYLH-RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTAETGTYRWMAPEVIEHQPYNHRAD 424 (518)
Q Consensus 347 ~i~~ql~~gL~yLH-~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~ksD 424 (518)
.-+.||+.||.||| +.+++|++|..+.|+++..|..||++|..+........ .....---.|..|+.+.... -..|
T Consensus 108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D 185 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID 185 (690)
T ss_pred HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence 67899999999997 67899999999999999999999999998865433221 01111223356666543322 3469
Q ss_pred HHHHHHHHHHHHcCCCCCC------CCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 425 VFSFGIVLWELVTGKLPYD------DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 425 V~SlGill~eLltG~~P~~------~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
.|.|||++|+++.|..+-. +..+ +.......+.+-.. + ...+-..+++..|...-+--|-.+-+++.+|+.
T Consensus 186 ~~~Lg~li~el~ng~~~~~~~~~~~~~ip-k~~~~~~~k~~~~~-~-~~r~n~~~~~~~~~~~~gff~n~fvd~~~fLee 262 (690)
T KOG1243|consen 186 SWGLGCLIEELFNGSLLTKTDLSNTGKIP-KALIELYCKKLGAT-E-LKRPNKLRFILECRLLGGFFRNDFVDTLLFLEE 262 (690)
T ss_pred hhhHHHHHHHHhCcccCcchhhhccCccc-hhHHHHHHHHhccc-c-ccccchhhHHHHHHhccccccchHHHHHHHHHh
Confidence 9999999999999832221 1222 11111110111000 0 011115556666666666666566666655555
Q ss_pred H
Q 010091 499 L 499 (518)
Q Consensus 499 l 499 (518)
+
T Consensus 263 l 263 (690)
T KOG1243|consen 263 L 263 (690)
T ss_pred c
Confidence 4
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=8.2e-13 Score=131.21 Aligned_cols=195 Identities=21% Similarity=0.364 Sum_probs=139.0
Q ss_pred HhhcCCCceeeEeeeeecC-----CceeEEEeeccCCcccccccccc---CCCChHHHHHHHHHhHHHHHHHHHCC--ce
Q 010091 296 MRKVRHMNVVQFIGACTRP-----PRLFIVTEFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNN--II 365 (518)
Q Consensus 296 l~~l~HpnIv~l~~~~~~~-----~~~~lV~Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~ql~~gL~yLH~~g--Ii 365 (518)
+-++-|.|||+++.||.+. ....+++|||+.|+|.++|++.. ..+....+.+|+.||..||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4455799999999998654 34789999999999999997533 35788889999999999999999875 99
Q ss_pred ecCCCCCcEEeccCCcEEEeeeccceeccc-----cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCC
Q 010091 366 HRDLKAANLLMNENGVVKVADFGVARVQAQ-----YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKL 440 (518)
Q Consensus 366 HrDLkp~NILl~~~~~vkL~DFG~a~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~ 440 (518)
|+++..+.|++..+|.+|+.--.-...... .......++-++|.+||.=.....+..+|||+||....+|..+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 999999999999999998864322211100 111223457889999997666667788999999999999987765
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 441 PYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 441 P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
--...+..-. ++......+....++.-++++.+|++..|+.||++.+++.
T Consensus 281 q~tnseS~~~----~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 281 QSTNSESKVE----VEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred ccCCCcceee----hhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhc
Confidence 4332211100 0001111111112233456889999999999999988764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2e-11 Score=113.07 Aligned_cols=144 Identities=23% Similarity=0.330 Sum_probs=110.3
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEecccc-----CHH-HHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHL-----NEN-IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~-----~~~-~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
...|-+|+-+.|+++.+.|+...||.-.+... +.. ...+-.+|++++.++.--.|.-.--++.+...-+|+|||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 56788999999999999999998886544332 222 236778999999998755554433345555667899999
Q ss_pred ccC-CccccccccccCCCChHH-HHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC---cEEEeeeccceec
Q 010091 324 MSG-GSIYDYLHKQKCGLKLPL-LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG---VVKVADFGVARVQ 393 (518)
Q Consensus 324 ~~g-gsL~~~l~~~~~~l~~~~-i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~---~vkL~DFG~a~~~ 393 (518)
++| .++.+|+......-..+. ...++.+|-..+.-||.++||||||.++||++..++ .+.++|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 977 488888876444333333 478899999999999999999999999999997655 3589999999754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.2e-10 Score=117.57 Aligned_cols=257 Identities=20% Similarity=0.268 Sum_probs=176.4
Q ss_pred eeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeee------e-ecCCceeEE
Q 010091 249 FEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGA------C-TRPPRLFIV 320 (518)
Q Consensus 249 ~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~------~-~~~~~~~lV 320 (518)
....||+|+-+.+|-.-.-+..| -|+......-- -.+.+..|... .||-+-.=+.| . ..+..+.++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhchh-heeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 36789999999999754333333 45554332211 11223333333 46543331221 1 223337788
Q ss_pred EeeccCC-cccccccc----cc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 321 TEFMSGG-SIYDYLHK----QK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 321 ~Ey~~gg-sL~~~l~~----~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
|..++|. ....+++- +. ....++.++++++.|+.+...||..|.+-||+.++|+|+++++.|.|+|-..-.+..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc
Confidence 8888764 23333321 11 247899999999999999999999999999999999999999999999977665554
Q ss_pred ccCccccCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCC-------CHHHHHH--HH-----
Q 010091 395 QYGVMTAETGTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTG-KLPYDDL-------TPLQAAV--GV----- 454 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG-~~P~~~~-------~~~~~~~--~~----- 454 (518)
.........|...|++||.-+ +..-+...|.|.||+++++++.| +.||++. .+.+... +.
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence 444455677999999999764 44457789999999999999985 9999763 2223111 11
Q ss_pred -HhcCCCCCC---C-CCCcHHHHHHHHHhhhh--CCCCCCCHHHHHHHHHHHHHHhhhcccccc
Q 010091 455 -VQKGLRPTI---P-VHTHPILVDLLERCWQR--DPSLRPDFSEITELLQHLAQRLQTKRGLAQ 511 (518)
Q Consensus 455 -~~~~~~p~~---~-~~~~~~L~~Li~~cL~~--dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 511 (518)
-+.+++|.. | .-.++++..+..+|+.. ++.-|||++.++..|..+.+++.++...++
T Consensus 249 ~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~ 312 (637)
T COG4248 249 DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAM 312 (637)
T ss_pred hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhccc
Confidence 112232221 1 23578899999999954 467899999999999999999998876665
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=6e-11 Score=113.91 Aligned_cols=140 Identities=20% Similarity=0.268 Sum_probs=108.8
Q ss_pred eEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCC--ceeeEeeeeecC---CceeEEEeec
Q 010091 251 HKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM--NVVQFIGACTRP---PRLFIVTEFM 324 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hp--nIv~l~~~~~~~---~~~~lV~Ey~ 324 (518)
+.|+.|.++.+|+++..+ +.+++|+....... .....+.+|+.+++.+.+. ++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998765 89999997764321 1235678899999999764 457777776553 2668999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-------------------------------------------
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR------------------------------------------- 361 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~------------------------------------------- 361 (518)
+|.++.+.+.. ..++......++.+++++|.+||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99999887642 346677777788888888888873
Q ss_pred -------------CCceecCCCCCcEEecc--CCcEEEeeeccceec
Q 010091 362 -------------NNIIHRDLKAANLLMNE--NGVVKVADFGVARVQ 393 (518)
Q Consensus 362 -------------~gIiHrDLkp~NILl~~--~~~vkL~DFG~a~~~ 393 (518)
..++|+|+.|.||+++. ++.+.|+||+.+...
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 677899999988643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.3e-12 Score=139.99 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=185.9
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
|......+.+.+-+-+|+++.++.++-. |...+.|+...... .....+...++-.++-...+|-+++....+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 4444455555888899999999987643 33344444332111 11112333344444445567888877776777888
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
++++++|..|++|...|+.- +..+....+.....+..+.+|||...+.|+|++|.|+++..+|..++.|||........
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred cchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999999999884 45666666777788899999999999999999999999999999999999843211000
Q ss_pred --------------------------------CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 010091 397 --------------------------------GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444 (518)
Q Consensus 397 --------------------------------~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~ 444 (518)
.......||+.|.+||...+......+|+|++|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 001223489999999999999889999999999999999999999999
Q ss_pred CCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 010091 445 LTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERCWQRDPSLRPDF 489 (518)
Q Consensus 445 ~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~ 489 (518)
.++.+.+..+..... .|.-+...++...+++.+.+..+|.+|-.+
T Consensus 1038 ~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence 999888866655433 344556778899999999999999999444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=5e-12 Score=134.77 Aligned_cols=246 Identities=22% Similarity=0.201 Sum_probs=182.9
Q ss_pred cccceeeeEEeEecceEEEEEEEC---CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~---~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l 319 (518)
..++..+..||.|.|+.||..... +..|++|-+............-..|+.+...+ .|.+++..+..|..-...|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 446777899999999999987743 56789988877655444333445677777776 48999998888888888899
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-CcEEEeeeccceeccccCc
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-~~vkL~DFG~a~~~~~~~~ 398 (518)
--|||+++++.... .....+++...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||...-....
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee--
Confidence 99999999887766 224468888999999999999999999999999999999999886 78899999998642221
Q ss_pred cccCCCCCccc--ChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 399 MTAETGTYRWM--APEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 399 ~~~~~gt~~y~--APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
........+++ ++.......+..+.|+||||..+.+.++|..--...... ..++.+..+..+... ..+..+.+
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----~~i~~~~~p~~~~~~-~~~q~~~k 495 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----LTIRSGDTPNLPGLK-LQLQVLLK 495 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc----eeeecccccCCCchH-Hhhhhhhh
Confidence 11122333444 566667778889999999999999999976433222211 112334344444433 77888899
Q ss_pred HhhhhCCCCCCCHHHHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~~L~ 497 (518)
.+..+++..||.+.++....+
T Consensus 496 v~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 496 VMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hhcCCccccchhhhhhcccch
Confidence 999999999999887765443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.7e-10 Score=112.30 Aligned_cols=142 Identities=16% Similarity=0.110 Sum_probs=103.2
Q ss_pred eEEeEecceEEEEEEECCccEEEEEEeccccCHHHH---------HHHHHHHHHHhhcCCCcee--eEeeeeec-----C
Q 010091 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIR---------REFAQEVHIMRKVRHMNVV--QFIGACTR-----P 314 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~---------~~f~~E~~il~~l~HpnIv--~l~~~~~~-----~ 314 (518)
+.+-......|+++.+.|+.|.||.........-.. ..+.+|...+.+|...+|. +++++... .
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 334444455577888888999999775443221111 1478899999988654443 34444432 2
Q ss_pred CceeEEEeeccCC-ccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-------CCcEEEe
Q 010091 315 PRLFIVTEFMSGG-SIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-------NGVVKVA 385 (518)
Q Consensus 315 ~~~~lV~Ey~~gg-sL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-------~~~vkL~ 385 (518)
...++|||++++. +|.+++... ....+......++.+++..+.-||.+||+|+|+++.|||++. +..+.++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 3478999999875 898887532 234556677889999999999999999999999999999975 4689999
Q ss_pred eecccee
Q 010091 386 DFGVARV 392 (518)
Q Consensus 386 DFG~a~~ 392 (518)
||+.++.
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9998853
|
|
| >cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.1e-10 Score=88.93 Aligned_cols=67 Identities=66% Similarity=0.984 Sum_probs=64.3
Q ss_pred eeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcchHHHHHHHHHhhc
Q 010091 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEI 206 (518)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~~~~~l~~~l~~~~ 206 (518)
+|||.+.+.|+|+|+++++..|+..||||..|..|+|.||+.+++|.|..|..+++++|..++++++
T Consensus 1 ~~eI~V~~~Dr~gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~ 67 (68)
T cd04928 1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI 67 (68)
T ss_pred CEEEEEEECCCcchHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence 5899999999999999999999999999999999999999999999999999999999999998654
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.7e-09 Score=99.01 Aligned_cols=126 Identities=22% Similarity=0.291 Sum_probs=83.7
Q ss_pred EEEEEEE-CCccEEEEEEeccccC-----------------------H-HHHHHHHHHHHHHhhcCCC--ceeeEeeeee
Q 010091 260 DLYKGAF-FSQDVAIKVLTNEHLN-----------------------E-NIRREFAQEVHIMRKVRHM--NVVQFIGACT 312 (518)
Q Consensus 260 ~Vy~~~~-~~~~vAvKvl~~~~~~-----------------------~-~~~~~f~~E~~il~~l~Hp--nIv~l~~~~~ 312 (518)
.||.|.. .|..+|||+.+....+ . -......+|...|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899986 4789999998754211 0 1235677899999999866 466677542
Q ss_pred cCCceeEEEeecc--CCccccccccccCCCChHHHHHHHHHhHHHHHH-HHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 313 RPPRLFIVTEFMS--GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNY-LHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 313 ~~~~~~lV~Ey~~--ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~y-LH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
..++||||++ |..+..+... . ++......++.+++..+.. +|+.||+||||.+.||+++++ .+.|+|||.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 6555544322 2 2244566777888885555 689999999999999999877 999999998
Q ss_pred ceec
Q 010091 390 ARVQ 393 (518)
Q Consensus 390 a~~~ 393 (518)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 8643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.9e-08 Score=104.60 Aligned_cols=213 Identities=15% Similarity=0.207 Sum_probs=150.5
Q ss_pred cceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee----cCCceeEEEeeccC-Ccc
Q 010091 257 SYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT----RPPRLFIVTEFMSG-GSI 329 (518)
Q Consensus 257 ~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~----~~~~~~lV~Ey~~g-gsL 329 (518)
-..+.|+++. .|..|++|.+........ .....-+.+++++.|+|||+|..++. ....+++|++|+++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 4567899884 488999999932221111 12234578899999999999988775 34568999999986 577
Q ss_pred ccccc--------------cccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 330 YDYLH--------------KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 330 ~~~l~--------------~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.++.- ..+...++..+|.++.||..||.++|+.|...+-|.+.+|+++.+-.++|...|...+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 76542 1123467789999999999999999999999999999999999888999988887765443
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP-YDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
.. + +-+. -..+.|.=.||.++..|.||..- +......+.... .+....+.+++++
T Consensus 446 d~------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS~D~rn~ 501 (655)
T KOG3741|consen 446 DP------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYSTDLRNV 501 (655)
T ss_pred CC------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------HhhhhhhHHHHHH
Confidence 22 0 1111 13467999999999999998643 222222221111 1233466789999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELL 496 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L 496 (518)
+.-....++.+ -+..+++..+
T Consensus 502 v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 502 VEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHhcCccc-ccHHHHHHHH
Confidence 99998888886 5666666543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.1e-08 Score=96.64 Aligned_cols=106 Identities=19% Similarity=0.298 Sum_probs=83.9
Q ss_pred HHHHHHHHHHhhcCCCc--eeeEeeeeecC----CceeEEEeeccCC-ccccccccccCCCChHHHHHHHHHhHHHHHHH
Q 010091 287 REFAQEVHIMRKVRHMN--VVQFIGACTRP----PRLFIVTEFMSGG-SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359 (518)
Q Consensus 287 ~~f~~E~~il~~l~Hpn--Iv~l~~~~~~~----~~~~lV~Ey~~gg-sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yL 359 (518)
..+.+|...+.+|..-+ +.+.+++.... ...++|||++++. +|.+++.... ..+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHH
Confidence 46778888888885443 34455555432 2358999999884 7999887633 266777888999999999999
Q ss_pred HHCCceecCCCCCcEEeccCC---cEEEeeeccceec
Q 010091 360 HRNNIIHRDLKAANLLMNENG---VVKVADFGVARVQ 393 (518)
Q Consensus 360 H~~gIiHrDLkp~NILl~~~~---~vkL~DFG~a~~~ 393 (518)
|++||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999887 8999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3e-08 Score=97.61 Aligned_cols=134 Identities=22% Similarity=0.251 Sum_probs=100.7
Q ss_pred eeeeEEeEecceEEEEEEEC-CccEEEEEEeccccC--------------------HHHHHHHHHHHHHHhhcCCC--ce
Q 010091 248 KFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN--------------------ENIRREFAQEVHIMRKVRHM--NV 304 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~--------------------~~~~~~f~~E~~il~~l~Hp--nI 304 (518)
.+..+||.|.-|.||.|... |.++|||.-+....+ .-......+|..+|++|... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34778999999999999975 899999986644221 11235567899999999765 77
Q ss_pred eeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEE
Q 010091 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384 (518)
Q Consensus 305 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL 384 (518)
.+.+++ +.-.+||||++|..|...- ++....-.++..|+.-+.-+-..||||||+.+-||+++++|.+.+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 777764 3457999999987766542 123333445556666666666999999999999999999999999
Q ss_pred eeeccce
Q 010091 385 ADFGVAR 391 (518)
Q Consensus 385 ~DFG~a~ 391 (518)
+||-.+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9998764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.8e-07 Score=96.16 Aligned_cols=141 Identities=19% Similarity=0.266 Sum_probs=98.6
Q ss_pred eEEeEecceEEEEEEEC-CccEEEEEEeccccC----------------------------HH----------HHHHHHH
Q 010091 251 HKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN----------------------------EN----------IRREFAQ 291 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~----------------------------~~----------~~~~f~~ 291 (518)
+.|+.++-|+||+|+.. |+.||||+.+++... .. ..-.|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999987 899999998876321 00 0123455
Q ss_pred HHHHHhhcC-----CCceeeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCcee
Q 010091 292 EVHIMRKVR-----HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366 (518)
Q Consensus 292 E~~il~~l~-----HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiH 366 (518)
|+..+.+++ .++|.-..-++.-...-.++|||++|..+.+.........+...+.....++. +..+=..|+.|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffH 288 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFH 288 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccc
Confidence 666666662 34433323333444556899999999999998544344566555444433332 23444589999
Q ss_pred cCCCCCcEEeccCCcEEEeeeccceec
Q 010091 367 RDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 367 rDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
.|..|.||+++.+|.+.+.|||+....
T Consensus 289 aDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 289 ADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cCCCccceEEecCCcEEEEcCcceecC
Confidence 999999999999999999999998543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.4e-07 Score=88.36 Aligned_cols=139 Identities=14% Similarity=0.162 Sum_probs=95.2
Q ss_pred ccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHH-HHHH------HHHHHHHHhhcCC---CceeeEeeeee
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNEN-IRRE------FAQEVHIMRKVRH---MNVVQFIGACT 312 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~-~~~~------f~~E~~il~~l~H---pnIv~l~~~~~ 312 (518)
-..+|+..+++-.....-|.+....|+.+++|..++...... .... ..+.+..+.++.. .....++.+..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 345667788888888888999999999999999987643211 1111 2334444444432 22333333322
Q ss_pred -----cCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeee
Q 010091 313 -----RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387 (518)
Q Consensus 313 -----~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DF 387 (518)
-....+++|||++|..|.++.. +++ .++..+..++.-||+.|+.|||..|.|++++++ .++++||
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 2234568999999998887643 222 245667788999999999999999999999855 4999999
Q ss_pred ccce
Q 010091 388 GVAR 391 (518)
Q Consensus 388 G~a~ 391 (518)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.2e-08 Score=110.93 Aligned_cols=143 Identities=20% Similarity=0.300 Sum_probs=103.5
Q ss_pred HhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-----ccc-----CCCCCcccChhhhcCCCC
Q 010091 351 DVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-----MTA-----ETGTYRWMAPEVIEHQPY 419 (518)
Q Consensus 351 ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-----~~~-----~~gt~~y~APE~l~~~~~ 419 (518)
+.+.|+.|+|+ .++||+.|.|++|.++.+|.+||+.|+.+........ .+. ..-...|.|||++.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 44489999996 5899999999999999999999999998854333111 111 113567999999999889
Q ss_pred CchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 010091 420 NHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVV--QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEIT 493 (518)
Q Consensus 420 ~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil 493 (518)
+.++|+||+|+++|.+.. |+.-+............. ..--.-.....+++++.+-|.+++..++.-||++.++.
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 999999999999999994 555554332111111111 11112233467889999999999999999999776654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.7e-07 Score=89.96 Aligned_cols=139 Identities=16% Similarity=0.144 Sum_probs=102.9
Q ss_pred eEecceEEEEEEECCccEEEEEEeccccC----HHHHHHHHHHHHHHhhcCCCc--eeeEeeeeec----CCceeEEEee
Q 010091 254 VSGSYCDLYKGAFFSQDVAIKVLTNEHLN----ENIRREFAQEVHIMRKVRHMN--VVQFIGACTR----PPRLFIVTEF 323 (518)
Q Consensus 254 g~G~~g~Vy~~~~~~~~vAvKvl~~~~~~----~~~~~~f~~E~~il~~l~Hpn--Iv~l~~~~~~----~~~~~lV~Ey 323 (518)
|.|+-|-|++..+.|+.+=+|.-...... ..-...|.+|...+++|..-+ +.+.+..... .-..+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 55888889998888887888876522111 112468999999999996433 4444422111 1236899998
Q ss_pred ccC-Ccccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc--EEEeeecccee
Q 010091 324 MSG-GSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV--VKVADFGVARV 392 (518)
Q Consensus 324 ~~g-gsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~--vkL~DFG~a~~ 392 (518)
++| .+|.+++.+.. ...+......+..+++..+.-||+.|+.|+|+.+.||+++.+|. ++++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 854 58888885532 24577777899999999999999999999999999999987777 99999998864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.5e-07 Score=89.30 Aligned_cols=138 Identities=20% Similarity=0.176 Sum_probs=93.4
Q ss_pred eeEEeEecceEEEEEEE-CCccEEEEEEeccccCHHHH----------------------HHHHHHHHHHhhcC--CCce
Q 010091 250 EHKIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLNENIR----------------------REFAQEVHIMRKVR--HMNV 304 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~-~~~~vAvKvl~~~~~~~~~~----------------------~~f~~E~~il~~l~--HpnI 304 (518)
...|.+|.-+.||+|.. .+..+|+|+++.....-... .-..+|...|+++. +=.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 44788999999999885 47899999998764321110 11234555555553 2233
Q ss_pred eeEeeeeecCCceeEEEeeccCC-ccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcE
Q 010091 305 VQFIGACTRPPRLFIVTEFMSGG-SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVV 382 (518)
Q Consensus 305 v~l~~~~~~~~~~~lV~Ey~~gg-sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~v 382 (518)
.+.+++. ...+||||+... .-.-.|+. .++.......+..++++.|.-|-. .++||+||+.-|||+. ++.+
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 4444432 347999999543 11111222 123344677788899999988877 9999999999999999 8899
Q ss_pred EEeeeccceecc
Q 010091 383 KVADFGVARVQA 394 (518)
Q Consensus 383 kL~DFG~a~~~~ 394 (518)
.|||||.|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999885443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.4e-06 Score=83.81 Aligned_cols=139 Identities=17% Similarity=0.280 Sum_probs=84.6
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCC--ceeeEeeee---ecCCceeEEEeec
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM--NVVQFIGAC---TRPPRLFIVTEFM 324 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hp--nIv~l~~~~---~~~~~~~lV~Ey~ 324 (518)
++.|+.|..+.||+.+..+..+++|+.... .....+.+|..+++.+... .+.+++... ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999988889999997654 3346777888888888533 345666643 2333478999999
Q ss_pred cCCcccc----------------cc---cccc---CCCCh-H-----HHHHH---------------HHHhHH-HHHHHH
Q 010091 325 SGGSIYD----------------YL---HKQK---CGLKL-P-----LLLRV---------------AIDVSK-GMNYLH 360 (518)
Q Consensus 325 ~ggsL~~----------------~l---~~~~---~~l~~-~-----~i~~i---------------~~ql~~-gL~yLH 360 (518)
+|.++.. .+ +... ..+.. . ....+ ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987777 11 1110 00000 0 00000 011122 233333
Q ss_pred -------HCCceecCCCCCcEEec-cCCcEEEeeecccee
Q 010091 361 -------RNNIIHRDLKAANLLMN-ENGVVKVADFGVARV 392 (518)
Q Consensus 361 -------~~gIiHrDLkp~NILl~-~~~~vkL~DFG~a~~ 392 (518)
...++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 24599999999999999 666678999998854
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=9.9e-07 Score=86.30 Aligned_cols=136 Identities=15% Similarity=0.180 Sum_probs=85.7
Q ss_pred eEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc--eeeEeeeeecCCceeEEEeeccCCc
Q 010091 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--VVQFIGACTRPPRLFIVTEFMSGGS 328 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~ggs 328 (518)
..||.|..+.||+. .+..+++|........ ....+|.++++.+..-+ +.+.+++....+..++|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~----~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDK----ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCH----HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 35899999999984 3667889998764322 34577999999886544 4667777777777889999999863
Q ss_pred -ccccc---------------------cccc-CCCChHHH-HHHHHH----------hHH-HHHHHH----HCCceecCC
Q 010091 329 -IYDYL---------------------HKQK-CGLKLPLL-LRVAID----------VSK-GMNYLH----RNNIIHRDL 369 (518)
Q Consensus 329 -L~~~l---------------------~~~~-~~l~~~~i-~~i~~q----------l~~-gL~yLH----~~gIiHrDL 369 (518)
+...+ +.-. ........ ..+..+ +.. ...+|. ...++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1100 01111110 011000 011 112222 124789999
Q ss_pred CCCcEEeccCCcEEEeeeccceec
Q 010091 370 KAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 370 kp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
.|.||++++++ +.|+||+.+...
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCcC
Confidence 99999999888 999999988643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.40 E-value=2e-06 Score=84.60 Aligned_cols=136 Identities=15% Similarity=0.196 Sum_probs=85.7
Q ss_pred EEeEecc-eEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEEeeccCCcc
Q 010091 252 KIVSGSY-CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 252 ~Lg~G~~-g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 329 (518)
.|..|.+ +.||+....+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 8889998777788999886543 234567888888874 34456778777766678999999999877
Q ss_pred cccc-------------------cccc---CCCChH--HHHHH-HH-------------------HhHHHHHHHH-----
Q 010091 330 YDYL-------------------HKQK---CGLKLP--LLLRV-AI-------------------DVSKGMNYLH----- 360 (518)
Q Consensus 330 ~~~l-------------------~~~~---~~l~~~--~i~~i-~~-------------------ql~~gL~yLH----- 360 (518)
.... +... ..+... ..+.. .. .+......|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 1100 011100 00000 00 0111112221
Q ss_pred --HCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 361 --RNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 361 --~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23489999999999999988889999998854
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.8e-06 Score=69.04 Aligned_cols=53 Identities=42% Similarity=0.649 Sum_probs=49.1
Q ss_pred eEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcc
Q 010091 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ 193 (518)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~ 193 (518)
.||.+.+.|||+|+++++..|+..|+||..|..+++.||+.+|+|.|..+...
T Consensus 2 ~~i~v~~~Dr~gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~~~~~ 54 (73)
T cd04900 2 TEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGE 54 (73)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEECCCCC
Confidence 58999999999999999999999999999999999999999999999765543
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.3e-05 Score=90.62 Aligned_cols=145 Identities=19% Similarity=0.312 Sum_probs=92.6
Q ss_pred eeEEeEecceEEEEEEECC----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCce--eeEeeeeecC---CceeE
Q 010091 250 EHKIVSGSYCDLYKGAFFS----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNV--VQFIGACTRP---PRLFI 319 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnI--v~l~~~~~~~---~~~~l 319 (518)
.+.++.|.+..+|+.+..+ ..+++|+........ ....+.+|..+|+.+. |.+| .+++.+|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 5678999999999988654 468888765432211 1246778999999995 6665 7788887654 46789
Q ss_pred EEeeccCCccccc-----------------------cccccC---CC---------ChHHHHHHHH--------------
Q 010091 320 VTEFMSGGSIYDY-----------------------LHKQKC---GL---------KLPLLLRVAI-------------- 350 (518)
Q Consensus 320 V~Ey~~ggsL~~~-----------------------l~~~~~---~l---------~~~~i~~i~~-------------- 350 (518)
||||++|..+.+- |+.... .+ ...++..+..
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 9999998764431 111000 00 0112222111
Q ss_pred -HhHHHHHHHHH-----------CCceecCCCCCcEEecc--CCcEEEeeeccceeccc
Q 010091 351 -DVSKGMNYLHR-----------NNIIHRDLKAANLLMNE--NGVVKVADFGVARVQAQ 395 (518)
Q Consensus 351 -ql~~gL~yLH~-----------~gIiHrDLkp~NILl~~--~~~vkL~DFG~a~~~~~ 395 (518)
.+...+++|.. ..+||+|+++.||+++. ...+-|+||+.+...+.
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 12233456632 24999999999999974 33468999999876544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.1e-05 Score=75.14 Aligned_cols=133 Identities=23% Similarity=0.302 Sum_probs=96.8
Q ss_pred ceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCcee-eEeeeeecCCceeEEEeecc
Q 010091 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV-QFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~ 325 (518)
....+.|++|.+|.||+|.|.|..+|+|+-+.+.. ...+..|+++|..++-.++- +++.+.. .++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence 34477899999999999999999999999886543 36788899999999876654 4555433 245699999
Q ss_pred CCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCC-CCcEEeccCCcEEEeeeccceeccc
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK-AANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLk-p~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
|.+|.++-... +...++.+ +..---|-..||-|+.|. |...++.+++.+.|+||..|+....
T Consensus 96 G~~L~~~~~~~----~rk~l~~v----lE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 96 GRPLGKLEIGG----DRKHLLRV----LEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKK 158 (201)
T ss_pred Ccchhhhhhcc----cHHHHHHH----HHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccC
Confidence 98888775431 33444443 344445677899999885 4455555566999999999975443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.2e-05 Score=77.00 Aligned_cols=74 Identities=12% Similarity=0.208 Sum_probs=47.0
Q ss_pred eEEeEecce-EEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCC---ceeeEeeeeecC---CceeEEEee
Q 010091 251 HKIVSGSYC-DLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM---NVVQFIGACTRP---PRLFIVTEF 323 (518)
Q Consensus 251 ~~Lg~G~~g-~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hp---nIv~l~~~~~~~---~~~~lV~Ey 323 (518)
+.|+.|+.. .||+. +..+++|+.+... ....+.+|..+++.+... -+.++++..... ...|++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 456666665 48875 4568888765432 234678899999887532 344445443322 245889999
Q ss_pred ccCCcccc
Q 010091 324 MSGGSIYD 331 (518)
Q Consensus 324 ~~ggsL~~ 331 (518)
++|.++.+
T Consensus 76 i~G~~l~~ 83 (235)
T cd05155 76 LEGETATA 83 (235)
T ss_pred ecCCCCCc
Confidence 99987754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.1e-05 Score=87.63 Aligned_cols=141 Identities=18% Similarity=0.289 Sum_probs=95.2
Q ss_pred eeEEeEecceEEEEEEEC-CccEEEEEEeccccC-----------------------------HHH------HHHHHHHH
Q 010091 250 EHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN-----------------------------ENI------RREFAQEV 293 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~-----------------------------~~~------~~~f~~E~ 293 (518)
.+.||.-+.|+||+|+.. |+.||||+-++.... ++. +-.|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 467899999999999965 788999998775321 111 13356666
Q ss_pred HHHhhc----CCCc------eeeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCC
Q 010091 294 HIMRKV----RHMN------VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363 (518)
Q Consensus 294 ~il~~l----~Hpn------Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~g 363 (518)
+...+. .|-+ |.+++- .....-.++||||+|..+.|.-.-...+++...+..-+.+... .-+=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 666555 2444 444443 2334568999999999888764433445676655544444322 2233568
Q ss_pred ceecCCCCCcEEecc----CCcEEEeeeccceecc
Q 010091 364 IIHRDLKAANLLMNE----NGVVKVADFGVARVQA 394 (518)
Q Consensus 364 IiHrDLkp~NILl~~----~~~vkL~DFG~a~~~~ 394 (518)
++|+|=.|.||+++. ++.+.+.|||+.....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999983 6789999999986543
|
|
| >PRK05092 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.8e-05 Score=91.00 Aligned_cols=119 Identities=29% Similarity=0.385 Sum_probs=93.7
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCcccccccccC
Q 010091 54 EDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSCY 133 (518)
Q Consensus 54 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~~l~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (518)
.+++.++|.+||.+|-+-.. ++++.-|-+++....+....|++.++. .+.
T Consensus 680 ~~~~~~~~~~~~~~yf~~~~---~~~i~~h~~~~~~~~~~~~~~~v~~~~---~~~------------------------ 729 (931)
T PRK05092 680 KADRDAYLARHYPAYWLAVD---LDTQARHARFIRDADDAGRPLATEVRP---DPA------------------------ 729 (931)
T ss_pred HHHHHHHHHhCCcHHhcCCC---HHHHHHHHHHHHhccccCCCcEEEEEe---cCC------------------------
Confidence 46788899999999999865 559999999998876655667776652 100
Q ss_pred CCcCCceeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEE---cCCCcc---hHHHHHHHHHhhc
Q 010091 134 PYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPLQ---ETEQLRNVLAKEI 206 (518)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v---~~w~~~---~~~~l~~~l~~~~ 206 (518)
.-..||+|.+.|+|+|++.++..|+..|+||..|..|+|.||+++|+|.| +|.+.. ..+.+...+.+.+
T Consensus 730 ----~~~t~v~I~~~Dr~GLfa~i~~~L~~~glnI~~A~I~t~~dg~alD~F~V~~~~g~~~~~~~~~~~l~~~L~~~l 804 (931)
T PRK05092 730 ----RGVTEVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRLARLAKAIEDAL 804 (931)
T ss_pred ----CCeEEEEEEeCCCCcHHHHHHHHHHHCCCcEEEEEEEEecCCeEEEEEEEECCCCCCCCCHHHHHHHHHHHHHHH
Confidence 11349999999999999999999999999999999999999999999999 554422 3445556665444
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.6e-05 Score=75.64 Aligned_cols=100 Identities=20% Similarity=0.355 Sum_probs=79.6
Q ss_pred HHHHHHhhcCC-CceeeEeeeeecCCceeEEEeeccCCccccc---cccccCCCChHHHHHHHHHhHHHHHHHHH---CC
Q 010091 291 QEVHIMRKVRH-MNVVQFIGACTRPPRLFIVTEFMSGGSIYDY---LHKQKCGLKLPLLLRVAIDVSKGMNYLHR---NN 363 (518)
Q Consensus 291 ~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~---l~~~~~~l~~~~i~~i~~ql~~gL~yLH~---~g 363 (518)
.|.-+++.+++ +++++++|+|-+ ++|+||...+++... +.. -...++....+++.+++..+.+|+. ..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47788888875 699999999854 679999976655421 111 1135799999999999999999987 35
Q ss_pred ceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 364 IIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 364 IiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
+.-.|++++|+-++++|.+|++|.+.+.....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~ 114 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVEDK 114 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhHH
Confidence 77799999999999999999999998865443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.8e-05 Score=71.28 Aligned_cols=127 Identities=20% Similarity=0.260 Sum_probs=91.6
Q ss_pred ccceeeeEEeEecc-eEEEEEEECCccEEEEEEec---ccc-------C--H-------HHHHHHHHHHHHHhhcC---C
Q 010091 245 SLLKFEHKIVSGSY-CDLYKGAFFSQDVAIKVLTN---EHL-------N--E-------NIRREFAQEVHIMRKVR---H 301 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~-g~Vy~~~~~~~~vAvKvl~~---~~~-------~--~-------~~~~~f~~E~~il~~l~---H 301 (518)
..+++++.||.|.- |.||+++..|+.+|||+++. ... . + ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888999999999 99999999999999999332 100 0 0 12256889999988885 4
Q ss_pred Cce--eeEeeeeecC------------------CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH
Q 010091 302 MNV--VQFIGACTRP------------------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR 361 (518)
Q Consensus 302 pnI--v~l~~~~~~~------------------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~ 361 (518)
.++ |+.+||..-. ....||.||++... .+... -+.+|.+-|..+|+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence 455 8999986211 12356777775432 23333 34566677788999
Q ss_pred CCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 362 NNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 362 ~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
.||+-+|+++.|..= -||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~~-----G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYRG-----GKLVDFSSS 206 (207)
T ss_pred CCeeeccCccccccC-----CEEEecccC
Confidence 999999999999862 379999965
|
|
| >PRK04374 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=6e-05 Score=87.13 Aligned_cols=119 Identities=16% Similarity=0.199 Sum_probs=88.9
Q ss_pred hHHHHHHHhccCCcccccccCCCchhhHHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCccccccccc
Q 010091 53 FEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSC 132 (518)
Q Consensus 53 ~~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~~l~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (518)
=.+++.++|++||.||-+--. ++++.-|-+++.... ...|.+-++-. .+
T Consensus 638 ~~~~~~~~~~~l~~~Y~~~~~---~~~I~~h~~~~~~~~--~~~~~v~~~~~--~~------------------------ 686 (869)
T PRK04374 638 DDATIDRQFAGMPDENFLRFR---PEQLAWQAASLIEVE--IGQTLVKARRA--VP------------------------ 686 (869)
T ss_pred CHHHHHHHHHhCCchhhcCCC---HHHHHHHHHHHHhcC--CCCCeEEEeee--cc------------------------
Confidence 456788999999999998765 569999999997653 22333322210 00
Q ss_pred CCCcCCceeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcc---hHHHHHHHHHhhc
Q 010091 133 YPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ---ETEQLRNVLAKEI 206 (518)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~---~~~~l~~~l~~~~ 206 (518)
.+-.-||++.+.|+|+|++.++..|+..|+||..|-.|+|.||+.+|+|.|...... ..+.++..+.+.+
T Consensus 687 ----~~~~~~v~v~~~d~~gLFa~i~g~l~~~~lnI~~A~i~t~~~g~~ld~f~V~~~~~~~~~~~~~i~~~l~~~l 759 (869)
T PRK04374 687 ----DNDALEVFVYSPDRDGLFAAIVATLDRKGYGIHRARVLDAPHDAIFDVFEVLPQDTYADGDPQRLAAALRQVL 759 (869)
T ss_pred ----CCCeEEEEEEeCCCccHHHHHHHHHHHCCCeEEEEEEEEcCCCEEEEEEEEeCCCCCChHHHHHHHHHHHHHH
Confidence 012349999999999999999999999999999999999999999999999765443 2333444554444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=2.9e-06 Score=91.77 Aligned_cols=183 Identities=22% Similarity=0.240 Sum_probs=133.7
Q ss_pred eeeEEeEecceEEEEEEECCcc-EEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc-eeeEeeeeecCCceeEEEeeccC
Q 010091 249 FEHKIVSGSYCDLYKGAFFSQD-VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 249 ~~~~Lg~G~~g~Vy~~~~~~~~-vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
+-+-+++|+++.+|+.+...+. ...+.+... ....-++.+|.+++||| .+..++-+..+....++++++.+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3556678999999988755322 234444332 23345889999999999 77778888888899999999987
Q ss_pred C-ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCC
Q 010091 327 G-SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT 405 (518)
Q Consensus 327 g-sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt 405 (518)
+ +...-+....-.+..-+...+.+.-.++++++|+.-=+|+| ||+..+ +..+..||+........-......++
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~ 393 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGT 393 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccCCCC
Confidence 7 44333332222344455666777788899999998778998 776654 78999999998755543333445689
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD 443 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~ 443 (518)
+.|+|||+.....++.+.|.|++|.-..+|--|..|-.
T Consensus 394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 99999999999999999999999986666666665543
|
|
| >PRK00275 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.5e-05 Score=87.33 Aligned_cols=109 Identities=19% Similarity=0.280 Sum_probs=84.0
Q ss_pred hHHHHHHHhccCCcccccccCCCchhhHHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCccccccccc
Q 010091 53 FEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSC 132 (518)
Q Consensus 53 ~~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~~l~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (518)
=.+++.++|.+||.||-+--. ++++.-|-+++....++.. |.+.++ ..+..+ .
T Consensus 649 ~~~~~~~~~~~~~~~Y~l~~~---~~~I~~h~~~~~~~~~~~~-~~v~~~---~~~~~~--~------------------ 701 (895)
T PRK00275 649 DPDDAEQLWSQLGDDYFLRHT---AGDIAWHTEAILQHPDDGG-PLVLIK---ETTQRE--F------------------ 701 (895)
T ss_pred CHHHHHHHHHhCCcHHhcCCC---HHHHHHHHHHHHhcccCCC-CeEEEE---ecCccC--C------------------
Confidence 356788899999999999865 4599999999987644333 433343 111000 0
Q ss_pred CCCcCCceeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcc
Q 010091 133 YPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ 193 (518)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~ 193 (518)
.-.-||++.+.|+|+|++.++..|+..|+||..|-.|+|.||+.+|+|.|......
T Consensus 702 -----~~~t~V~V~~~DrpgLFa~i~g~L~~~~lnI~~A~I~Tt~dg~alD~F~V~d~~g~ 757 (895)
T PRK00275 702 -----EGGTQIFIYAPDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGE 757 (895)
T ss_pred -----CCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEcCCCeEEEEEEEeCCCCC
Confidence 01239999999999999999999999999999999999999999999999654433
|
|
| >PRK05007 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00012 Score=85.15 Aligned_cols=120 Identities=23% Similarity=0.323 Sum_probs=91.0
Q ss_pred hHHHHHHHhccCCcccccccCCCchhhHHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCccccccccc
Q 010091 53 FEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSC 132 (518)
Q Consensus 53 ~~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~~l~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (518)
=.+.+.++|.++|.+|-+-- .++++.-|-+++..+.. ..|.+.++ ..+.
T Consensus 650 ~~~~~~~~~~~~~~~yf~~~---~~~~I~~h~~~~~~~~~--~~p~V~i~---~~~~----------------------- 698 (884)
T PRK05007 650 DEEALHQIWSRCRADYFLRH---TPNQLAWHARHLLQHDL--DKPLVLLS---KQAT----------------------- 698 (884)
T ss_pred CHHHHHHHHHhCChHHhcCC---CHHHHHHHHHHHHhccC--CCCeEEEE---ecCC-----------------------
Confidence 35678889999999999875 45699999999977642 34554433 1100
Q ss_pred CCCcCCceeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCc-----chHHHHHHHHHhhcc
Q 010091 133 YPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPL-----QETEQLRNVLAKEIP 207 (518)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~-----~~~~~l~~~l~~~~~ 207 (518)
.-.-+|.+.+.|+|+|++.++..|+..|+||..|..|++.||+.+|+|.|..... +..+.++..+.+.+.
T Consensus 699 -----~~~t~V~V~a~DrpGLfa~Ia~~La~~~L~I~~A~I~T~~dg~alD~F~V~d~~g~~~~~~~~~~I~~~L~~aL~ 773 (884)
T PRK05007 699 -----RGGTEIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSPLSQDRHQVIRKALEQALT 773 (884)
T ss_pred -----CCeEEEEEEecCCcCHHHHHHHHHHHCCCEEEEEEEEEcCCCeEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHc
Confidence 1233999999999999999999999999999999999999999999999954432 233445666666554
Q ss_pred c
Q 010091 208 K 208 (518)
Q Consensus 208 ~ 208 (518)
.
T Consensus 774 ~ 774 (884)
T PRK05007 774 Q 774 (884)
T ss_pred C
Confidence 3
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00013 Score=69.86 Aligned_cols=134 Identities=22% Similarity=0.361 Sum_probs=95.0
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccc--------------cCHHHHHHHHHHHHHHhhcC------CCceeeEee
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEH--------------LNENIRREFAQEVHIMRKVR------HMNVVQFIG 309 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~--------------~~~~~~~~f~~E~~il~~l~------HpnIv~l~~ 309 (518)
...||+|+.-.||.-- .+....||+..+.. .......++.+|+.-...+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4568999999999753 24567899988776 11122356666776666665 788999999
Q ss_pred eeecCCceeEEEeeccC------CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC--C-
Q 010091 310 ACTRPPRLFIVTEFMSG------GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN--G- 380 (518)
Q Consensus 310 ~~~~~~~~~lV~Ey~~g------gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~--~- 380 (518)
+........+|+|.+.+ .||.+++... .++. .+... +-.-.+||-+.+|+.+|++|.||++... +
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 99999889999998743 3677777442 3554 33333 3344578889999999999999999633 2
Q ss_pred -cEEEee-eccc
Q 010091 381 -VVKVAD-FGVA 390 (518)
Q Consensus 381 -~vkL~D-FG~a 390 (518)
.+.|+| ||..
T Consensus 159 ~~lvlIDG~G~~ 170 (199)
T PF10707_consen 159 FRLVLIDGLGEK 170 (199)
T ss_pred eEEEEEeCCCCc
Confidence 577777 4544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00023 Score=72.50 Aligned_cols=76 Identities=14% Similarity=0.082 Sum_probs=57.8
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC---CceeeEeeeeec---CCceeEEEee
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH---MNVVQFIGACTR---PPRLFIVTEF 323 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H---pnIv~l~~~~~~---~~~~~lV~Ey 323 (518)
.+.||.|..+.||+....+..+.+|..+... . ...|..|...|+.|.. -.+.++++++.. .+..+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 5679999999999998766678888855421 1 2477889999998853 357788887754 3568999999
Q ss_pred ccCCcc
Q 010091 324 MSGGSI 329 (518)
Q Consensus 324 ~~ggsL 329 (518)
++|.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998766
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.86 E-value=5e-05 Score=87.31 Aligned_cols=231 Identities=17% Similarity=0.183 Sum_probs=157.4
Q ss_pred EeEecceEEEEEEECC------ccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc----eeEEE
Q 010091 253 IVSGSYCDLYKGAFFS------QDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR----LFIVT 321 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~~------~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~----~~lV~ 321 (518)
+..-.+|+++..++.- +++-++.-.-... .........-|...+.++.|+|++.++.+...... ..+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 4556778888877642 2222222111111 11222333447778888899999999998755433 34556
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCC---cEEeccCCcEEEe--eeccceecccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA---NLLMNENGVVKVA--DFGVARVQAQY 396 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~---NILl~~~~~vkL~--DFG~a~~~~~~ 396 (518)
+++.+.++.+.+.. .+..+...++.+..++..|+.|+|+....|.-+..+ +-.++..+.+.+. ||+........
T Consensus 266 ~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~ 344 (1351)
T KOG1035|consen 266 EICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN 344 (1351)
T ss_pred hhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCc
Confidence 88888888888776 557889999999999999999999997777666555 5555667778777 99888766555
Q ss_pred CccccCCCCCcccChhhhcCCCCCch--hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 397 GVMTAETGTYRWMAPEVIEHQPYNHR--ADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~~~~~k--sDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
........+..|.+||......++.+ .|+|++|.+...+..|..+-..... ....++......+.+.
T Consensus 345 ~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~-----------~~~~l~~~~~~~~~d~ 413 (1351)
T KOG1035|consen 345 EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV-----------PVSLLDVLSTSELLDA 413 (1351)
T ss_pred ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-----------hhhhhccccchhhhhh
Confidence 44444556677888888876665544 7999999999998887654322110 1111222222368888
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~ 495 (518)
+.+|+..++.+|.++.+++..
T Consensus 414 ~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 414 LPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred hhhhcchhhhhccchhhhhhc
Confidence 999999999999999888753
|
|
| >cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.82 E-value=3.7e-05 Score=62.00 Aligned_cols=51 Identities=27% Similarity=0.412 Sum_probs=46.4
Q ss_pred EEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcc
Q 010091 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ 193 (518)
Q Consensus 143 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~ 193 (518)
+.+.+.|+|+|++.++..|++.|+||..|..++|.+|+.+|+|.|......
T Consensus 3 ~ei~~~Dr~gLfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d~~~~ 53 (76)
T cd04927 3 LKLFCSDRKGLLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITDAREL 53 (76)
T ss_pred EEEEECCCCCHHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeCCCCC
Confidence 567888999999999999999999999999999999999999999765443
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PRK03059 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00015 Score=84.08 Aligned_cols=119 Identities=26% Similarity=0.345 Sum_probs=88.6
Q ss_pred hHHHHHHHhccCCcccccccCCCchhhHHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCccccccccc
Q 010091 53 FEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSC 132 (518)
Q Consensus 53 ~~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~~l~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (518)
=.+.+.++|.++|.+|-+-- .++++.-|-+++....+. ..|.+-+| ..+.
T Consensus 626 ~~~~~~~~~~~~~~~Yf~~~---~~~~I~~h~~~~~~~~~~-~~~~v~~~---~~~~----------------------- 675 (856)
T PRK03059 626 PDDAHEALWDQLDVGYFLRH---DAADIAWHTRHLYRHVDT-DTPIVRAR---LSPA----------------------- 675 (856)
T ss_pred CHHHHHHHHHhCChHHhccC---CHHHHHHHHHHHHhcccC-CCCeEEEE---ecCC-----------------------
Confidence 45678889999999998875 456999999999775432 23433332 1110
Q ss_pred CCCcCCceeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcc-----hHHHHHHHHHhhc
Q 010091 133 YPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ-----ETEQLRNVLAKEI 206 (518)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~-----~~~~l~~~l~~~~ 206 (518)
+-.-||++.+.|+|+|++.++..|+..|+||..|-.|+|.||+.+|+|.|...... ..+.+++.+.+.+
T Consensus 676 -----~~~~~v~i~~~d~~gLFa~i~g~l~~~~l~I~~A~i~t~~~g~~ld~f~V~~~~~~~~~~~~~~~i~~~l~~~l 749 (856)
T PRK03059 676 -----GEGLQVMVYTPDQPDLFARICGYFDRAGFSILDARVHTTRHGYALDTFQVLDPEEDVHYRDIINLVEHELAERL 749 (856)
T ss_pred -----CCeEEEEEEecCCCcHHHHHHHHHHHCCCceeeeEEEEcCCCeEEEEEEEeCCCCCCChHHHHHHHHHHHHHHH
Confidence 12339999999999999999999999999999999999999999999999542222 2334555555444
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0001 Score=73.22 Aligned_cols=135 Identities=16% Similarity=0.184 Sum_probs=80.3
Q ss_pred EeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCce-eeEeeeeecCCceeEEEeeccCCcccc
Q 010091 253 IVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFIVTEFMSGGSIYD 331 (518)
Q Consensus 253 Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~ggsL~~ 331 (518)
+..|-...+|+.+..+..+++|+....... ......+|..+++.+...++ .+++..+. -++||||++|.++..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456778889998877888999986543211 10134678888888864433 34454432 368999999977653
Q ss_pred c-----------------ccccc---CCCChH-HHHHHHHHh---------HHHHHHHHH--------CCceecCCCCCc
Q 010091 332 Y-----------------LHKQK---CGLKLP-LLLRVAIDV---------SKGMNYLHR--------NNIIHRDLKAAN 373 (518)
Q Consensus 332 ~-----------------l~~~~---~~l~~~-~i~~i~~ql---------~~gL~yLH~--------~gIiHrDLkp~N 373 (518)
. ++... ..++.. .+.....++ ...+..+-. ..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 11111 111111 111211111 111222211 248999999999
Q ss_pred EEeccCCcEEEeeeccceecc
Q 010091 374 LLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 374 ILl~~~~~vkL~DFG~a~~~~ 394 (518)
|++++++ +.|+||+.+....
T Consensus 158 il~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred EEEeCCC-CEEEeccccCcCC
Confidence 9999877 7899999886533
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00027 Score=68.83 Aligned_cols=74 Identities=15% Similarity=0.167 Sum_probs=48.6
Q ss_pred eeEEeEecceEEEEEEEC---CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc-eeeEeeeeecCCceeEEEeecc
Q 010091 250 EHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~---~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey~~ 325 (518)
.+.|..|-...+|+.... ++.|++|+....... .....+|+.+++.+...+ .+++++.+. . .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 456778888999998865 468999987653211 112236888888885433 344554332 2 48999999
Q ss_pred CCccc
Q 010091 326 GGSIY 330 (518)
Q Consensus 326 ggsL~ 330 (518)
|.++.
T Consensus 76 G~~l~ 80 (235)
T cd05157 76 GRTLE 80 (235)
T ss_pred CCcCC
Confidence 97763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR01693 UTase_glnD [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00016 Score=83.98 Aligned_cols=120 Identities=21% Similarity=0.270 Sum_probs=90.3
Q ss_pred HHHHHHHhccCCcccccccCCCchhhHHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCcccccccccC
Q 010091 54 EDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSCY 133 (518)
Q Consensus 54 ~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~~l~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (518)
.+++..++.++|.+|-+-..+ +++.-|-+++..+.+... |.+.+. .-.
T Consensus 617 ~~~~~~~~~~~~~~y~~~~~~---~~I~~h~~~~~~~~~~~~-~~v~~~--~~~-------------------------- 664 (850)
T TIGR01693 617 SNEAEVLWLRAYDDYFLRFTH---KEIAWHAESLRRALSSGG-PLALID--GTR-------------------------- 664 (850)
T ss_pred HHHHHHHHHhCCchhhcCCCH---HHHHHHHHHHHhcccCCC-CEEEEe--ccC--------------------------
Confidence 456788999999999998764 599999999988644222 333222 000
Q ss_pred CCcCCceeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcc------hHHHHHHHHHhhcc
Q 010091 134 PYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ------ETEQLRNVLAKEIP 207 (518)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~------~~~~l~~~l~~~~~ 207 (518)
+....||++.+.|+|+|++.++..|+..|+||..|..++|.||+.+|+|.|...... ..+.++..+.+.+.
T Consensus 665 ---~~~~t~i~V~~~DrpgLla~i~~~L~~~~l~I~~A~I~tt~~g~~lD~F~V~~~~g~~~~~~~~~~~i~~~L~~~L~ 741 (850)
T TIGR01693 665 ---PSGGTEVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVFQELLQGLVDVLA 741 (850)
T ss_pred ---CCCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEecCCEEEEEEEEECCCCCCCCcHHHHHHHHHHHHHHHc
Confidence 012449999999999999999999999999999999999999999999999654432 23445556665554
Q ss_pred c
Q 010091 208 K 208 (518)
Q Consensus 208 ~ 208 (518)
.
T Consensus 742 ~ 742 (850)
T TIGR01693 742 G 742 (850)
T ss_pred C
Confidence 3
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=3.9e-05 Score=77.62 Aligned_cols=132 Identities=20% Similarity=0.204 Sum_probs=95.0
Q ss_pred eeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCH-----------------H---HHHHHHHHHHHHhhcCC-C-ce
Q 010091 248 KFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNE-----------------N---IRREFAQEVHIMRKVRH-M-NV 304 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~-----------------~---~~~~f~~E~~il~~l~H-p-nI 304 (518)
.+.++||-|.-+.+|.+-+. |++.++|.-+....+= . ..-...+|...|+.|.. . -|
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 34789999999999999876 8999999754432210 0 11344668888888853 2 34
Q ss_pred eeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEE
Q 010091 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384 (518)
Q Consensus 305 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL 384 (518)
.+.+++. .-|+|||++.|..|.+.-+- .+.+. +...+..-+--|-..|+||||..--||++++++.+++
T Consensus 175 PkpiD~~----RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 175 PKPIDHN----RHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCccccc----ceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 4555543 45899999999998876433 22333 3344455566788999999999999999999999999
Q ss_pred eeeccc
Q 010091 385 ADFGVA 390 (518)
Q Consensus 385 ~DFG~a 390 (518)
+||-.+
T Consensus 244 IDFPQm 249 (465)
T KOG2268|consen 244 IDFPQM 249 (465)
T ss_pred eechHh
Confidence 999765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00032 Score=71.59 Aligned_cols=138 Identities=19% Similarity=0.210 Sum_probs=83.2
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc--eeeEeeee------ecCCceeEEE
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--VVQFIGAC------TRPPRLFIVT 321 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~~~~------~~~~~~~lV~ 321 (518)
.+.++.|....+|+....+..+++|+....... .....|..++..|...+ +.+++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~----~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVKA----EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCCCH----HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 556777878899998766678999987653211 23344666776664222 44444421 2234578999
Q ss_pred eeccCCccccc--------------cccccCCC--------ChHHHHH---------------HHHHhHHHHHHHHH---
Q 010091 322 EFMSGGSIYDY--------------LHKQKCGL--------KLPLLLR---------------VAIDVSKGMNYLHR--- 361 (518)
Q Consensus 322 Ey~~ggsL~~~--------------l~~~~~~l--------~~~~i~~---------------i~~ql~~gL~yLH~--- 361 (518)
+|++|.++..- ++.....+ ....... ....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99998654321 11111111 0111000 01123334555542
Q ss_pred ----CCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 362 ----NNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 362 ----~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
.++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999998878999999884
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK01759 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00037 Score=80.76 Aligned_cols=118 Identities=25% Similarity=0.345 Sum_probs=88.8
Q ss_pred hHHHHHHHhccCCcccccccCCCchhhHHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCccccccccc
Q 010091 53 FEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSC 132 (518)
Q Consensus 53 ~~~~l~~hf~rlp~~y~~d~~~~~~edvl~h~~~l~~~~~~~~~p~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (518)
=.+.+.++|.++|.+|-+- ..+++++-|-+++..... .|.+.++ -.+.
T Consensus 627 ~~~~~~~~~~~~~~~yf~~---~~~~~I~~h~~~~~~~~~---~~~V~i~---~~~~----------------------- 674 (854)
T PRK01759 627 SETQIEQLWQRCPEDYFLR---NTPKQIAWHALLLLDFRG---DLLVKIS---NRFS----------------------- 674 (854)
T ss_pred CHHHHHHHHHhCCcHHhcC---CCHHHHHHHHHHHHhcCC---CCEEEEE---ecCC-----------------------
Confidence 4567888999999999985 456799999999866432 3444332 1100
Q ss_pred CCCcCCceeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcc-----hHHHHHHHHHhhcc
Q 010091 133 YPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ-----ETEQLRNVLAKEIP 207 (518)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~-----~~~~l~~~l~~~~~ 207 (518)
...-||.+.+.|+|+|++.++..|+..|+||..|..++|.||+.+|+|.|...... ..+.++..+.+.+.
T Consensus 675 -----~~~t~V~V~~~DrpGLfa~Ia~~L~~~~L~I~~A~I~T~~~g~alD~F~V~d~~g~~~~~~~~~~l~~~L~~aL~ 749 (854)
T PRK01759 675 -----RGGTEIFIYCQDQANLFLKVVSTIGAKKLSIHDAQIITSQDGYVLDSFIVTELNGKLLEFDRRRQLEQALTKALN 749 (854)
T ss_pred -----CCeEEEEEEecCCccHHHHHHHHHHHCCCeEEEEEEEEccCCEEEEEEEEeCCCCCCCCHHHHHHHHHHHHHHHc
Confidence 12339999999999999999999999999999999999999999999999643322 23345566665554
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00064 Score=68.73 Aligned_cols=138 Identities=17% Similarity=0.166 Sum_probs=85.3
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc--eeeEeee------eecCCceeEEE
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--VVQFIGA------CTRPPRLFIVT 321 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~~~------~~~~~~~~lV~ 321 (518)
.+.|..|....+|+....+..+++|+.... + ......|+.++..+.+.+ +.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 456777888899998877778999997651 2 134556777777774332 4455442 12334568999
Q ss_pred eeccCCccccc--------------cccccCCCC--------hHHHHH------------HHHHhHHHHHHHHH------
Q 010091 322 EFMSGGSIYDY--------------LHKQKCGLK--------LPLLLR------------VAIDVSKGMNYLHR------ 361 (518)
Q Consensus 322 Ey~~ggsL~~~--------------l~~~~~~l~--------~~~i~~------------i~~ql~~gL~yLH~------ 361 (518)
+|++|.++... ++.....+. ...... ....+..++.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 99999776431 011000000 000000 11112334444443
Q ss_pred -CCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 362 -NNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 362 -~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
.++||+|+.|.||++++++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999988889999998853
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00012 Score=58.69 Aligned_cols=46 Identities=33% Similarity=0.502 Sum_probs=42.1
Q ss_pred EEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcC
Q 010091 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDG 189 (518)
Q Consensus 143 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~ 189 (518)
|.+.+.|+|+|++.++..|++.|+||..|..+ |.+|+..++|.|..
T Consensus 3 ~~v~~~Dr~gLl~~i~~~l~~~~lnI~~A~i~-t~~~~~~d~f~V~d 48 (74)
T cd04925 3 IELTGTDRPGLLSEVFAVLADLHCNVVEARAW-THNGRLACVIYVRD 48 (74)
T ss_pred EEEEECCCCCHHHHHHHHHHHCCCcEEEEEEE-EECCEEEEEEEEEc
Confidence 56778899999999999999999999999999 56999999999953
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0012 Score=67.60 Aligned_cols=138 Identities=14% Similarity=0.157 Sum_probs=76.8
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc--eeeEeee------eecCCceeEEE
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--VVQFIGA------CTRPPRLFIVT 321 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~~~------~~~~~~~~lV~ 321 (518)
.+.|+.|....+|+.+..+..+++|+.. . ... .....|..+++.|...+ +.+.+.. ....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~-~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE-R-LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec-c-CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 4457778888999988777789999876 2 122 12223445555543211 3333321 12245578999
Q ss_pred eeccCCcccc-----c---------cccccCCC--------ChHHHHHH---------------HHH-hHHHHHHHH---
Q 010091 322 EFMSGGSIYD-----Y---------LHKQKCGL--------KLPLLLRV---------------AID-VSKGMNYLH--- 360 (518)
Q Consensus 322 Ey~~ggsL~~-----~---------l~~~~~~l--------~~~~i~~i---------------~~q-l~~gL~yLH--- 360 (518)
+|++|..+.. + ++.....+ .......+ +.+ +...++.+.
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 9999875421 1 11100000 11010011 111 111222222
Q ss_pred ----HCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 361 ----RNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 361 ----~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
..++||+|+.|.||+++.+...-|+||+.+..
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 24899999999999999776678999998853
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0014 Score=67.22 Aligned_cols=140 Identities=18% Similarity=0.268 Sum_probs=88.6
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCC--ceeeEeeeeecCC--ceeEEEeecc
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM--NVVQFIGACTRPP--RLFIVTEFMS 325 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hp--nIv~l~~~~~~~~--~~~lV~Ey~~ 325 (518)
.+.+..|-...+|.....++.++++ .......-.......+|..+++.+.-- -+...++.|..+. ..|.||+|++
T Consensus 30 v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 30 VEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 4444455556667766668889999 332222223345666788888877532 3344566776655 6799999999
Q ss_pred CCccccccccccCCCChHHHHHHHH-HhHHHHHHHH--------------------------------------------
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAI-DVSKGMNYLH-------------------------------------------- 360 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~-ql~~gL~yLH-------------------------------------------- 360 (518)
|..+.+.+.... .. ..++. .++..|..||
T Consensus 109 Ge~~~~~~~~~~--~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 109 GEVVWSALPPES--LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred ceeccCcCCccc--ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 854443332211 00 11122 3444444444
Q ss_pred ------HC--------CceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 361 ------RN--------NIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 361 ------~~--------gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.+ .++|||+.+.|++++.++.+-|+||+.+.+.+..
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 22 4899999999999999999999999999876554
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.42 E-value=2.4e-05 Score=91.57 Aligned_cols=232 Identities=11% Similarity=0.057 Sum_probs=148.7
Q ss_pred eEEEEEEECC---ccEEEEEEecc---ccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee--cCCceeEEEeeccCCccc
Q 010091 259 CDLYKGAFFS---QDVAIKVLTNE---HLNENIRREFAQEVHIMRKVRHMNVVQFIGACT--RPPRLFIVTEFMSGGSIY 330 (518)
Q Consensus 259 g~Vy~~~~~~---~~vAvKvl~~~---~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lV~Ey~~ggsL~ 330 (518)
+..+++.|-+ ..+-+|+.+.- ...+..++....|...++...|+++.....-.. .....|.+++|+.+|.+.
T Consensus 1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 4445555543 23455665542 234455566677777777889999887665442 334568999999999999
Q ss_pred ccccccc---CCCChHHHHHHHHHhHHHHHHHHHCC-----ceecCCCCCcEEeccCCcEEEeeeccceecccc-Ccccc
Q 010091 331 DYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNN-----IIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTA 401 (518)
Q Consensus 331 ~~l~~~~---~~l~~~~i~~i~~ql~~gL~yLH~~g-----IiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 401 (518)
+.+-+.. ..++..-+.....+......-.|+.. .+|++||+.|.+|..+..+|++++|+.++.... .....
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl 1399 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGL 1399 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhh
Confidence 9886532 23444445555555466666666531 689999999999999999999999999844332 22334
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..+++.|+.|+..+.-.++.++|+|..|+.+|....|..+|-... .....+.++.+-.-.++...+.+.......+|-.
T Consensus 1400 ~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~fl-q~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~ 1478 (2724)
T KOG1826|consen 1400 ELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFL-QPALKGIIDNHTFFSIEKLKPGDANVEALHRLLW 1478 (2724)
T ss_pred hhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHH-HHHHcCcccccccccccccCCCcccHHHHHHHHH
Confidence 568889999999999999999999999999999988776663211 1111122222222233333334444444444444
Q ss_pred CCCCCCCHHH
Q 010091 482 DPSLRPDFSE 491 (518)
Q Consensus 482 dP~~RPs~~e 491 (518)
.-..||.-..
T Consensus 1479 K~~~rp~q~i 1488 (2724)
T KOG1826|consen 1479 KYMERPGQYI 1488 (2724)
T ss_pred Hhhhcchhhh
Confidence 5556654433
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0011 Score=67.26 Aligned_cols=75 Identities=16% Similarity=0.219 Sum_probs=48.9
Q ss_pred eeEEeEecceEEEEEEEC--------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCce-eeEeeeeecCCceeEE
Q 010091 250 EHKIVSGSYCDLYKGAFF--------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFIV 320 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~--------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV 320 (518)
++.+..|-...+|+.+.. ++.+++|+....... .....+|..+++.+...++ .++++++.. .+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 345667777788988754 378999997654311 1244568888888854333 355655542 368
Q ss_pred EeeccCCcccc
Q 010091 321 TEFMSGGSIYD 331 (518)
Q Consensus 321 ~Ey~~ggsL~~ 331 (518)
+||++|.++..
T Consensus 76 ~e~i~G~~l~~ 86 (302)
T cd05156 76 EEFIPSRTLTT 86 (302)
T ss_pred hheeCCCcCCH
Confidence 99999877653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0011 Score=68.27 Aligned_cols=138 Identities=17% Similarity=0.225 Sum_probs=94.8
Q ss_pred eeEEeEecceEEEEEEEC-CccEEEEEEecccc----------------------CH-HH-HHHHHHHHHHHhhcCCCce
Q 010091 250 EHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHL----------------------NE-NI-RREFAQEVHIMRKVRHMNV 304 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~----------------------~~-~~-~~~f~~E~~il~~l~HpnI 304 (518)
-..|..|.-+.||.++.. |..+|||+++..-. +. .+ ..-...|++.|++++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 557889999999999954 78899999875421 01 11 1223457888888876655
Q ss_pred eeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHH-HCCceecCCCCCcEEeccCCcEE
Q 010091 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH-RNNIIHRDLKAANLLMNENGVVK 383 (518)
Q Consensus 305 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH-~~gIiHrDLkp~NILl~~~~~vk 383 (518)
.-.--+... .-.|||+|+.+... -.=.-....++...+..+-.+++.-|.-|- ..+.||.||.--|+|+- +|.+.
T Consensus 229 P~PePIlLk--~hVLVM~FlGrdgw-~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ly 304 (520)
T KOG2270|consen 229 PCPEPILLK--NHVLVMEFLGRDGW-AAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLY 304 (520)
T ss_pred CCCCceeee--cceEeeeeccCCCC-cCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEE
Confidence 432222221 24789999943211 111111235777788888899999998874 56899999999999985 67999
Q ss_pred Eeeeccce
Q 010091 384 VADFGVAR 391 (518)
Q Consensus 384 L~DFG~a~ 391 (518)
|+|.+.+-
T Consensus 305 iIDVSQSV 312 (520)
T KOG2270|consen 305 IIDVSQSV 312 (520)
T ss_pred EEEccccc
Confidence 99998774
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0034 Score=66.50 Aligned_cols=76 Identities=12% Similarity=-0.050 Sum_probs=53.5
Q ss_pred eeEEeEecceEEEEEEECC--ccEEEEEEecccc--C---HHHHHHHHHHHHHHhhcC---CCceeeEeeeeecCCceeE
Q 010091 250 EHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHL--N---ENIRREFAQEVHIMRKVR---HMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~--~~vAvKvl~~~~~--~---~~~~~~f~~E~~il~~l~---HpnIv~l~~~~~~~~~~~l 319 (518)
.+.||.|.+..||+++..+ +.++||.-.+... . .-...++..|...|+.+. -.++++++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 4578999999999999764 3899998543211 1 113456777888888763 34677788763 355789
Q ss_pred EEeeccCC
Q 010091 320 VTEFMSGG 327 (518)
Q Consensus 320 V~Ey~~gg 327 (518)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999764
|
|
| >cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0018 Score=52.00 Aligned_cols=63 Identities=24% Similarity=0.401 Sum_probs=48.0
Q ss_pred EEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEE---cCCCcc---hHHHHHHHHHhhc
Q 010091 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPLQ---ETEQLRNVLAKEI 206 (518)
Q Consensus 143 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v---~~w~~~---~~~~l~~~l~~~~ 206 (518)
|.+++.|||+||..+...|+++|++|.-|+. +|..+...|+|.| +|-+-. ..+.+..+|...+
T Consensus 4 veV~~~DRpGLL~~i~~~l~~~~l~I~~A~I-~T~gera~D~FyV~d~~g~kl~~~~~~~~l~~~L~~al 72 (75)
T cd04897 4 VTVQCRDRPKLLFDVVCTLTDMDYVVFHATI-DTDGDDAHQEYYIRHKDGRTLSTEGERQRVIKCLEAAI 72 (75)
T ss_pred EEEEeCCcCcHHHHHHHHHHhCCeEEEEEEE-eecCceEEEEEEEEcCCCCccCCHHHHHHHHHHHHHHH
Confidence 5678999999999999999999999998876 4577799999999 443332 2344555555443
|
This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.002 Score=51.22 Aligned_cols=49 Identities=27% Similarity=0.412 Sum_probs=44.2
Q ss_pred EEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCC
Q 010091 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWP 191 (518)
Q Consensus 142 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~ 191 (518)
+|++.+.|+|.+|+.++..+++.|+||..|..+. .+++..++|.|....
T Consensus 3 ri~V~~~D~~Gll~~i~~~l~~~~lnI~sa~i~t-~~~~~~d~f~v~~~~ 51 (72)
T cd04926 3 RLELRTEDRVGLLSDVTRVFRENGLTVTRAEIST-QGDMAVNVFYVTDAN 51 (72)
T ss_pred EEEEEECCccCHHHHHHHHHHHCCcEEEEEEEec-CCCeEEEEEEEECCC
Confidence 7899999999999999999999999999999975 588999999996544
|
This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0085 Score=60.43 Aligned_cols=32 Identities=25% Similarity=0.503 Sum_probs=26.3
Q ss_pred CceecCCCCCcEEeccCCc-EEEeeeccceecc
Q 010091 363 NIIHRDLKAANLLMNENGV-VKVADFGVARVQA 394 (518)
Q Consensus 363 gIiHrDLkp~NILl~~~~~-vkL~DFG~a~~~~ 394 (518)
.++|+|+.|.||+++.++. .-|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 3799999999999997454 5799999986543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.045 Score=56.62 Aligned_cols=140 Identities=16% Similarity=0.220 Sum_probs=81.0
Q ss_pred ccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCce-eeEeeeeecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~~~~~~~~~~~ 318 (518)
+.++ .+.|..|=...+|+....+ ..|++|+...... . .-.-.+|..+++.+..-++ .++++++.. +
T Consensus 15 ~~i~-i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G--- 86 (330)
T PLN02421 15 SDFS-VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--Y-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G--- 86 (330)
T ss_pred CceE-EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--e-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---
Confidence 3344 3455558888899987553 2799998765421 1 1223468888888865555 356665532 2
Q ss_pred EEEeeccCCccccc-----------------cccccCC----C-ChHHHHHHHHHh----------------------HH
Q 010091 319 IVTEFMSGGSIYDY-----------------LHKQKCG----L-KLPLLLRVAIDV----------------------SK 354 (518)
Q Consensus 319 lV~Ey~~ggsL~~~-----------------l~~~~~~----l-~~~~i~~i~~ql----------------------~~ 354 (518)
+|.+|++|.+|..- +|....+ + -+..+.++..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 58999988766321 1111100 1 112222222221 11
Q ss_pred HHHHHH----HCC----ceecCCCCCcEEecc-CCcEEEeeecccee
Q 010091 355 GMNYLH----RNN----IIHRDLKAANLLMNE-NGVVKVADFGVARV 392 (518)
Q Consensus 355 gL~yLH----~~g----IiHrDLkp~NILl~~-~~~vkL~DFG~a~~ 392 (518)
-+..+. ..+ .+|+|+.+.|||+++ ++.++++||..|..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 122221 112 799999999999975 57899999998843
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0077 Score=62.73 Aligned_cols=137 Identities=13% Similarity=0.208 Sum_probs=81.5
Q ss_pred eeEEeEecceEEEEEEEC------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCcee-eEeeeeecCCceeEEEe
Q 010091 250 EHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV-QFIGACTRPPRLFIVTE 322 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lV~E 322 (518)
...|..|-.-.+|+.+.. ++.|++|+..... +.... -.+|..+++.+..-++. ++++.+... .|++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 345556888899998753 2579999876542 21112 25688888888654443 456655432 5899
Q ss_pred eccCCccccc-----------------cccccCC----CC-hHHHHHHHHHh-----------------HHHHHHH----
Q 010091 323 FMSGGSIYDY-----------------LHKQKCG----LK-LPLLLRVAIDV-----------------SKGMNYL---- 359 (518)
Q Consensus 323 y~~ggsL~~~-----------------l~~~~~~----l~-~~~i~~i~~ql-----------------~~gL~yL---- 359 (518)
|++|.+|... +|....+ .+ ...+.++..++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9988776421 1111100 11 12222322111 1111122
Q ss_pred H----HCCceecCCCCCcEEecc-CCcEEEeeeccceec
Q 010091 360 H----RNNIIHRDLKAANLLMNE-NGVVKVADFGVARVQ 393 (518)
Q Consensus 360 H----~~gIiHrDLkp~NILl~~-~~~vkL~DFG~a~~~ 393 (518)
. ...++|+|+++.|||+++ ++.+.++||..+...
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 1 235899999999999986 478999999988643
|
|
| >PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0017 Score=49.88 Aligned_cols=62 Identities=27% Similarity=0.381 Sum_probs=50.0
Q ss_pred eEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcchHHHHHHHHH
Q 010091 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
|.|.+...|||++|..++..|++.|+||..+..+++.++ .-.++.+......+.+.+..++.
T Consensus 1 ~~v~v~~~drpG~l~~v~~~la~~~inI~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~ 62 (66)
T PF01842_consen 1 YRVRVIVPDRPGILADVTEILADHGINIDSISQSSDKDG-VGIVFIVIVVDEEDLEKLLEELE 62 (66)
T ss_dssp EEEEEEEETSTTHHHHHHHHHHHTTEEEEEEEEEEESST-TEEEEEEEEEEGHGHHHHHHHHH
T ss_pred CEEEEEcCCCCCHHHHHHHHHHHcCCCHHHeEEEecCCC-ceEEEEEEECCCCCHHHHHHHHH
Confidence 678899999999999999999999999999999999995 33344444456667777766665
|
ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.014 Score=59.30 Aligned_cols=29 Identities=28% Similarity=0.457 Sum_probs=25.7
Q ss_pred CCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 362 NNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 362 ~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
.++||||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999774
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.004 Score=49.94 Aligned_cols=63 Identities=19% Similarity=0.191 Sum_probs=48.6
Q ss_pred EEEecCCccchHHHHHhhhcccCCCcccccccc-cCCCceeeEEEEcCCCcc-----hHHHHHHHHHhh
Q 010091 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFS-TVDGYSLDVFVVDGWPLQ-----ETEQLRNVLAKE 205 (518)
Q Consensus 143 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~-t~d~~s~~v~~v~~w~~~-----~~~~l~~~l~~~ 205 (518)
|.+.+.|||+||..+...+.+.|++|.-|+.-+ |..+-..|+|.|+..... ..+.|+.++.+.
T Consensus 3 lev~a~DRpGLL~~i~~~l~~~~l~i~~AkI~~~T~Gerv~D~Fyv~~~g~kl~d~~~~~~L~~~L~~~ 71 (75)
T cd04896 3 LQIRCVDQKGLLYDILRTSKDCNIQISYGRFSSKVKGYREVDLFIVQSDGKKIMDPKKQAALCARLREE 71 (75)
T ss_pred EEEEeCCcccHHHHHHHHHHHCCeEEEEEEEecCcccCEEEEEEEEeCCCCccCCHHHHHHHHHHHHHH
Confidence 567899999999999999999999999998764 666677899999765533 234455555543
|
This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 518 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-55 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-54 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-47 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-46 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-46 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-46 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-45 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-45 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-45 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-45 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-45 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-45 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-45 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-45 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-45 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-45 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-45 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-45 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-45 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-45 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-45 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-45 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-45 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-45 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-45 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-45 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-44 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-44 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-44 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-43 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-43 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-42 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-42 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-42 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-42 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-42 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-42 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-42 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-42 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-42 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-42 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-42 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-42 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-42 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-42 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-41 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-41 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-41 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-41 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-41 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-41 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-41 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-41 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-41 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-41 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-41 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-40 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-40 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-40 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-40 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-40 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-40 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-40 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-40 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-40 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-40 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-40 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-39 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-39 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-39 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-39 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-39 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-39 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-39 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-39 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-39 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-39 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-39 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-39 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-38 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-38 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-37 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-37 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-37 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-37 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-36 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-36 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-36 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-36 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-36 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-36 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-36 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-36 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-36 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-36 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-36 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-35 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-35 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-35 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-35 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-35 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-35 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-35 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-35 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-35 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-35 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-35 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-35 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-35 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-35 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-35 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-35 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-35 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-35 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-35 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-35 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-35 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-35 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-35 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-35 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-35 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-35 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-35 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-35 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-35 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-35 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-35 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-35 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-34 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-34 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-34 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-34 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-34 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-34 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-34 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-34 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-34 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-34 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-34 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-34 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-34 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-34 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-34 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-34 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-34 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-33 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-33 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-33 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-32 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-32 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-32 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-32 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-32 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-32 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-32 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-32 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-32 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-32 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-32 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-32 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-32 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-32 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-32 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-32 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-31 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-31 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-31 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-31 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-31 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-31 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-31 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-31 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-31 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-31 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-31 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-31 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-31 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-31 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-31 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-31 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-31 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-31 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-31 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-31 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-31 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-31 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-31 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-31 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-31 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-31 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-31 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-31 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-31 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-31 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-31 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-31 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-31 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-31 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-31 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-31 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-31 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-31 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-31 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-30 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-30 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-30 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-30 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-30 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-30 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-30 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-30 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-30 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-30 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-30 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-30 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-30 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-30 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-30 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-30 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-30 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-30 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-30 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-30 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-30 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-30 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-30 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-30 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-30 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-30 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-29 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-29 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-29 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-29 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-29 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-29 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-29 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-29 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-29 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-29 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-29 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-29 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-29 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-29 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-29 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-29 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-29 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-29 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-29 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-29 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-29 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-29 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-29 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-29 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-29 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-29 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-29 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-29 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-29 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-28 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-28 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-28 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-28 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-28 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-28 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-28 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-28 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-28 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-28 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-28 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-28 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-28 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-28 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-28 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-28 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-28 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-28 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-28 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-28 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-27 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-27 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-27 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-27 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-27 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-27 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-27 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-27 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-27 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-27 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-27 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-27 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-27 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-27 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-27 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-27 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-27 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-27 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-27 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-27 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-27 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-27 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-26 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-26 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-26 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-26 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-26 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-26 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-26 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-26 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-26 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-26 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-26 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-26 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-26 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-26 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-26 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-25 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-25 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-25 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-25 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-25 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-25 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-25 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-25 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-25 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-25 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-25 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-25 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-25 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-25 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-25 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-25 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-25 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-25 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-25 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-25 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-25 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-25 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-25 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-25 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-25 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-25 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-25 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-25 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-25 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-25 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-25 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-24 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-24 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-24 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-24 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-24 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-24 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-24 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-24 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-24 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-24 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-24 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-24 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-24 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-23 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-23 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-23 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-23 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-23 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-23 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-22 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-22 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-22 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-22 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-22 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-22 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-22 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-21 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-21 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-21 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-21 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-21 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-21 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-20 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-20 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-20 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-20 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-19 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-19 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-18 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-17 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-17 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-17 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-16 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-16 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-16 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-16 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-16 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-16 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-16 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-16 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-16 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-16 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-16 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-15 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-12 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 428 bits (1103), Expect = e-149
Identities = 115/306 (37%), Positives = 179/306 (58%), Gaps = 6/306 (1%)
Query: 212 HHHVVYPVGEQEQSGINHVNI-PAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD 270
HHH +P+ + + ++ A D +I L + KI +GS+ +++ + D
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD 62
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L + + EF +EV IM+++RH N+V F+GA T+PP L IVTE++S GS+Y
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 331 DYLHKQKCGLKLPL--LLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVVKVAD 386
LHK +L L +A DV+KGMNYLH N I+HR+LK+ NLL+++ VKV D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 387 FGVARVQAQ-YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL 445
FG++R++A + + GT WMAPEV+ +P N ++DV+SFG++LWEL T + P+ +L
Sbjct: 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
Query: 446 TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505
P Q V K R IP + +P + ++E CW +P RP F+ I +LL+ L +
Sbjct: 243 NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302
Query: 506 KRGLAQ 511
+
Sbjct: 303 PPNRSD 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 397 bits (1022), Expect = e-137
Identities = 95/289 (32%), Positives = 161/289 (55%), Gaps = 12/289 (4%)
Query: 223 EQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLN 282
++ +H + + D WEI + +I SGS+ +YKG + DVA+K+L
Sbjct: 2 KKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKG-KWHGDVAVKMLNVTAPT 60
Query: 283 ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKL 342
+ F EV ++RK RH+N++ F+G T P L IVT++ G S+Y +LH + ++
Sbjct: 61 PQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEM 119
Query: 343 PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ---YGVM 399
L+ +A ++GM+YLH +IIHRDLK+ N+ ++E+ VK+ DFG+A +++
Sbjct: 120 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 400 TAETGTYRWMAPEVIEHQ---PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ 456
+G+ WMAPEVI Q PY+ ++DV++FGIVL+EL+TG+LPY ++ + +V
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239
Query: 457 KGLR----PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+G + + + L+ C ++ RP F I ++ LA+
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 395 bits (1018), Expect = e-137
Identities = 89/274 (32%), Positives = 144/274 (52%), Gaps = 16/274 (5%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNE--NIRREFAQEVHIM 296
+ EID + L E I G + +Y+ + +VA+K ++ + QE +
Sbjct: 1 LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
++H N++ G C + P L +V EF GG + L ++ + +L+ A+ +++GM
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118
Query: 357 NYLHRNN---IIHRDLKAANLLMNE--------NGVVKVADFGVARVQAQYGVMTAETGT 405
NYLH IIHRDLK++N+L+ + N ++K+ DFG+AR + M+A G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177
Query: 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV 465
Y WMAPEVI ++ +DV+S+G++LWEL+TG++P+ + L A GV L IP
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
L+E CW DP RP F+ I + L +
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 390 bits (1003), Expect = e-134
Identities = 77/271 (28%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
ID L F K+ +L+KG + D+ +KVL + R+F +E +R
Sbjct: 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 300 RHMNVVQFIGACTRPP--RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGM 356
H NV+ +GAC PP ++T +M GS+Y+ LH+ + ++ A+D+++GM
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 357 NYLH--RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVI 414
+LH I L + +++++E+ +++ V W+APE +
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEAL 180
Query: 415 EHQPYN---HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
+ +P + AD++SF ++LWELVT ++P+ DL+ ++ + V +GLRPTIP P +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQR 502
L++ C DP+ RP F I +L+ + +
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 390 bits (1004), Expect = e-134
Identities = 84/281 (29%), Positives = 122/281 (43%), Gaps = 16/281 (5%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
S L + G + K + + +E +R F +EV +MR +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
H NV++FIG + RL +TE++ GG++ + + A D++ GM YL
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 360 HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA---------------QYGVMTAETG 404
H NIIHRDL + N L+ EN V VADFG+AR+ G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGV-VQKGLRPTI 463
WMAPE+I + Y+ + DVFSFGIVL E++ D P G+ V+ L
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
P + P + RC DP RP F ++ L+ L L
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 386 bits (994), Expect = e-132
Identities = 79/291 (27%), Positives = 143/291 (49%), Gaps = 19/291 (6%)
Query: 228 NHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRR 287
+ + + W+I L+ I G + +Y G + +VAI+++ E NE+ +
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHG-RWHGEVAIRLIDIERDNEDQLK 74
Query: 288 EFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLR 347
F +EV R+ RH NVV F+GAC PP L I+T G ++Y + K L + +
Sbjct: 75 AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQ 134
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA------QYGVMTA 401
+A ++ KGM YLH I+H+DLK+ N+ +NG V + DFG+ + + +
Sbjct: 135 IAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 402 ETGTYRWMAPEVI---------EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAV 452
+ G +APE+I + P++ +DVF+ G + +EL + P+ +
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-II 252
Query: 453 GVVQKGLRPTIP-VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502
+ G++P + + + D+L CW + RP F+++ ++L+ L +R
Sbjct: 253 WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-132
Identities = 86/280 (30%), Positives = 145/280 (51%), Gaps = 22/280 (7%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNEN-----IRREFA 290
+ + + +++E +I G + ++KG VAIK L +EF
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
+EV IM + H N+V+ G PP +V EF+ G +Y L + +K + LR+ +
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129
Query: 351 DVSKGMNYLHRNN--IIHRDLKAANLLMNENG-----VVKVADFGVARVQAQYGVMTAET 403
D++ G+ Y+ N I+HRDL++ N+ + KVADFG+++ ++
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLL 187
Query: 404 GTYRWMAPEVI--EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAV--GVVQKGL 459
G ++WMAPE I E + Y +AD +SF ++L+ ++TG+ P+D+ + + + ++GL
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247
Query: 460 RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
RPTIP P L +++E CW DP RP FS I + L L
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-129
Identities = 92/273 (33%), Positives = 147/273 (53%), Gaps = 15/273 (5%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
+ ID ++ E + G++ + K + ++DVAIK + +E+ R+ F E+ + +
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI----ESESERKAFIVELRQLSR 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGM 356
V H N+V+ GAC P + +V E+ GGS+Y+ LH + + + S+G+
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 357 NYLHR---NNIIHRDLKAANLLMNENG-VVKVADFGVARVQAQYGVMTAETGTYRWMAPE 412
YLH +IHRDLK NLL+ G V+K+ DFG A + MT G+ WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173
Query: 413 VIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL-TPLQAAVGVVQKGLRPTIPVHTHPIL 471
V E Y+ + DVFS+GI+LWE++T + P+D++ P + V G RP + + +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
L+ RCW +DPS RP EI +++ HL +
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-112
Identities = 81/311 (26%), Positives = 135/311 (43%), Gaps = 48/311 (15%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
V A ++ +I G Y +++ G + + VA+KV R E++
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIYQTVL 87
Query: 299 VRHMNVVQFIGACTRP----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
+RH N++ FI A + +L+++T++ GS+YDYL L +L++A
Sbjct: 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVS 145
Query: 355 GMNYLH--------RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ-----YGVMTA 401
G+ +LH + I HRDLK+ N+L+ +NG +AD G+A
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 402 ETGTYRWMAPEVIE------HQPYNHRADVFSFGIVLWELVTG----------KLPYDDL 445
GT R+M PEV++ H AD++SFG++LWE+ +LPY DL
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 446 TPLQAAVG-----VVQKGLRPTIPVH-----THPILVDLLERCWQRDPSLRPDFSEITEL 495
P + V K LRP+ P + L+ CW +P+ R + +
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 496 LQHLAQRLQTK 506
L +++ K
Sbjct: 326 LAKMSESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-108
Identities = 79/299 (26%), Positives = 137/299 (45%), Gaps = 48/299 (16%)
Query: 244 ASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
A + + G Y ++++G++ ++VA+K+ ++ RE E++ +RH N
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKS-WFRE--TELYNTVMLRHEN 63
Query: 304 VVQFIGACTR----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
++ FI + +L+++T + GS+YDYL L LR+ + ++ G+ +L
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHL 121
Query: 360 H--------RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM-----TAETGTY 406
H + I HRDLK+ N+L+ +NG +AD G+A + +Q GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 407 RWMAPEVIEHQP------YNHRADVFSFGIVLWELVTG----------KLPYDDLTPLQA 450
R+MAPEV++ R D+++FG+VLWE+ K P+ D+ P
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 451 AV-----GVVQKGLRPTIPVH-----THPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
+ V RP IP T L L++ CW ++PS R I + L +
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-105
Identities = 78/311 (25%), Positives = 146/311 (46%), Gaps = 48/311 (15%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
V A + + I G + ++++G + ++VA+K+ ++ R E++
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVM 92
Query: 299 VRHMNVVQFIGACTR----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
+RH N++ FI A + +L++V+++ GS++DYL++ + + ++++A+ +
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150
Query: 355 GMNYLH--------RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-----VMTA 401
G+ +LH + I HRDLK+ N+L+ +NG +AD G+A
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 402 ETGTYRWMAPEVIE------HQPYNHRADVFSFGIVLWELVTG----------KLPYDDL 445
GT R+MAPEV++ H RAD+++ G+V WE+ +LPY DL
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 446 TPLQAAVG-----VVQKGLRPTIPVHTH-----PILVDLLERCWQRDPSLRPDFSEITEL 495
P +V V ++ LRP IP ++ ++ CW + + R I +
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330
Query: 496 LQHLAQRLQTK 506
L L+Q+ K
Sbjct: 331 LSQLSQQEGIK 341
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-102
Identities = 76/309 (24%), Positives = 132/309 (42%), Gaps = 48/309 (15%)
Query: 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHI 295
G + + L+ G + ++K ++ VA+K+ + + EV+
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS---WQNEYEVYS 71
Query: 296 MRKVRHMNVVQFIGACTRPP----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
+ ++H N++QFIGA R L+++T F GS+ D+L + L +A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAET 129
Query: 352 VSKGMNYLHRN----------NIIHRDLKAANLLMNENGVVKVADFGVARVQ---AQYGV 398
+++G+ YLH + I HRD+K+ N+L+ N +ADFG+A G
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 399 MTAETGTYRWMAPEVIEHQP-----YNHRADVFSFGIVLWELVTGKLPYD-----DLTPL 448
+ GT R+MAPEV+E R D+++ G+VLWEL + D + P
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 449 QAAVG-----------VVQKGLRPTIPVHTHP-----ILVDLLERCWQRDPSLRPDFSEI 492
+ +G VV K RP + + +L + +E CW D R +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 493 TELLQHLAQ 501
E + + +
Sbjct: 310 GERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 284 bits (727), Expect = 3e-92
Identities = 78/328 (23%), Positives = 130/328 (39%), Gaps = 63/328 (19%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR-- 297
+D LK I G Y +YKG+ + VA+KV + + R+ F E +I R
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVP 62
Query: 298 KVRHMNVVQFIGACTRPP-----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
+ H N+ +FI R +V E+ GS+ YL R+A V
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSV 120
Query: 353 SKGMNYLH---------RNNIIHRDLKAANLLMNENGVVKVADFGVARVQA--------- 394
++G+ YLH + I HRDL + N+L+ +G ++DFG++
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 395 QYGVMTAETGTYRWMAPEVIE-------HQPYNHRADVFSFGIVLWELV---TGKLPYDD 444
+ +E GT R+MAPEV+E + + D+++ G++ WE+ T P +
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 445 LTPLQAA---------------VGVVQKGLRPTIPVHTHP------ILVDLLERCWQRDP 483
+ Q A V V ++ RP P L + +E CW +D
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 484 SLRPDFSEITELLQHLAQRLQTKRGLAQ 511
R E + L + + ++
Sbjct: 301 EARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 8e-86
Identities = 93/274 (33%), Positives = 149/274 (54%), Gaps = 10/274 (3%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
D W ++ L +I G++ +++ G + VA+K E L +++ +F QE I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARI 165
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
+++ H N+V+ IG CT+ ++IV E + GG +L + L++ LL++ D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT----YRWMAP 411
M YL IHRDL A N L+ E V+K++DFG++R +A GV A G +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWTAP 284
Query: 412 EVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470
E + + Y+ +DV+SFGI+LWE + G PY +L+ Q V+KG R P
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-TREFVEKGGRLPCPELCPDA 343
Query: 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
+ L+E+CW +P RP FS I + LQ + +R +
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 7e-83
Identities = 87/270 (32%), Positives = 149/270 (55%), Gaps = 16/270 (5%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
W ++ LK I G + D+ G + VA+K + N+ + F E +M
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ----AFLAEASVMT 69
Query: 298 KVRHMNVVQFIGACTR-PPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKG 355
++RH N+VQ +G L+IVTE+M+ GS+ DYL + L LL+ ++DV +
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPE 412
M YL NN +HRDL A N+L++E+ V KV+DFG+ + + + + +W APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE 184
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
+ + ++ ++DV+SFGI+LWE+ + G++PY + L+ V V+KG + P P +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAV 243
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
++++ CW D ++RP F ++ E L+H+
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 3e-82
Identities = 84/271 (30%), Positives = 144/271 (53%), Gaps = 14/271 (5%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIM 296
WEID L F ++ +G + + G + Q DVAIK++ ++E+ EF +E +M
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVM 73
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+ H +VQ G CT+ +FI+TE+M+ G + +YL + + + LL + DV + M
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGT---YRWMAP 411
YL +HRDL A N L+N+ GVVKV+DFG++R +Y T+ G+ RW P
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPP 190
Query: 412 EVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470
EV+ + ++ ++D+++FG+++WE+ + GK+PY+ T + +GLR P
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEK 249
Query: 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+ ++ CW RP F + + +
Sbjct: 250 VYTIMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 4e-82
Identities = 92/267 (34%), Positives = 143/267 (53%), Gaps = 10/267 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRK 298
W ID S L F +I SG + ++ G + ++ VAIK + ++E +F +E +M K
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMK 59
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNY 358
+ H +VQ G C + +VTEFM G + DYL Q+ LL + +DV +GM Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPEVIE 415
L +IHRDL A N L+ EN V+KV+DFG+ R T+ TGT +W +PEV
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 416 HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
Y+ ++DV+SFG+++WE+ + GK+PY++ + V + G R P + +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVYQI 237
Query: 475 LERCWQRDPSLRPDFSEITELLQHLAQ 501
+ CW+ P RP FS + L +A+
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 8e-82
Identities = 88/270 (32%), Positives = 145/270 (53%), Gaps = 14/270 (5%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRK 298
E+ + ++ SG + + G + Q DVA+K++ ++E+ EF QE M K
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMK 59
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNY 358
+ H +V+F G C++ ++IVTE++S G + +YL GL+ LL + DV +GM +
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGT---YRWMAPEV 413
L + IHRDL A N L++ + VKV+DFG+ R QY + GT +W APEV
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEV 176
Query: 414 IEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV 472
+ Y+ ++DV++FGI++WE+ + GK+PYD T V V +G R P +
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVSQGHRLYRPHLASDTIY 235
Query: 473 DLLERCWQRDPSLRPDFSEITELLQHLAQR 502
++ CW P RP F ++ ++ L ++
Sbjct: 236 QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 1e-81
Identities = 78/275 (28%), Positives = 133/275 (48%), Gaps = 11/275 (4%)
Query: 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFA 290
G + I + + G + ++Y+G + + VA+K + + + +F
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFM 61
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
E IM+ + H ++V+ IG P +I+ E G + YL + K LK+ L+ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY--RW 408
+ K M YL N +HRD+ N+L+ VK+ DFG++R A +W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 409 MAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467
M+PE I + + +DV+ F + +WE+++ GK P+ L +GV++KG R P
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEKGDRLPKPDLC 239
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502
P+L L+ RCW DPS RP F+E+ L + Q
Sbjct: 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-81
Identities = 83/268 (30%), Positives = 147/268 (54%), Gaps = 12/268 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIM 296
D WE+ LK ++ +G + +++ G + VA+K L ++ F E ++M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLM 62
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKG 355
++++H +V+ T+ P ++I+TE+M GS+ D+L L + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPE 412
M ++ N IHRDL+AAN+L+++ K+ADFG+AR+ + TA G +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 180
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
I + + ++DV+SFGI+L E+VT G++PY +T + +++G R P + L
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEEL 239
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQHL 499
L+ CW+ P RP F + +L+
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 3e-81
Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 12/274 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLN-ENIRREFAQ 291
I L+ K+ GS+ + +G + + VA+K L + L+ +F +
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
EV+ M + H N+++ G PP + +VTE GS+ D L K + L L R A+
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGT---YR 407
V++GM YL IHRDL A NLL+ +VK+ DFG+ R + + +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 408 WMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466
W APE ++ + ++H +D + FG+ LWE+ T G+ P+ L Q + ++G R P
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249
Query: 467 THPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500
+ +++ +CW P RP F + + L
Sbjct: 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 3e-81
Identities = 89/303 (29%), Positives = 151/303 (49%), Gaps = 15/303 (4%)
Query: 212 HHHVVYPVGEQEQSGINHVNIPAEGI--DVWEIDASLLKFEHKIVSGSYCDLYKGAF--- 266
HH P E + P + + EI S + + I +G + ++YKG
Sbjct: 9 HHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTS 68
Query: 267 ---FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
VAIK L E R +F E IM + H N+++ G ++ + I+TE+
Sbjct: 69 SGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVK 383
M G++ +L ++ + L+ + ++ GM YL N +HRDL A N+L+N N V K
Sbjct: 128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCK 187
Query: 384 VADFGVAR-VQAQYGVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-G 438
V+DFG++R ++ +G RW APE I ++ + +DV+SFGIV+WE++T G
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247
Query: 439 KLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ PY +L+ + + G R P+ + L+ +CWQ++ + RP F++I +L
Sbjct: 248 ERPYWELS-NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306
Query: 499 LAQ 501
L +
Sbjct: 307 LIR 309
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 3e-81
Identities = 81/272 (29%), Positives = 139/272 (51%), Gaps = 11/272 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQE 292
+EI ++ I G + D+++G + S + VAIK ++++R +F QE
Sbjct: 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQE 66
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
MR+ H ++V+ IG T P ++I+ E + G + +L +K L L L+ A +
Sbjct: 67 ALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY--RWMA 410
S + YL +HRD+ A N+L++ N VK+ DFG++R A G +WMA
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469
PE I + + +DV+ FG+ +WE++ G P+ + +G ++ G R +P + P
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNCPP 244
Query: 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
L L+ +CW DPS RP F+E+ L + +
Sbjct: 245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 4e-81
Identities = 88/271 (32%), Positives = 148/271 (54%), Gaps = 16/271 (5%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
W ++ LK I G + D+ G + VA+K + N+ + F E +M
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ----AFLAEASVMT 241
Query: 298 KVRHMNVVQFIGACTR-PPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKG 355
++RH N+VQ +G L+IVTE+M+ GS+ DYL + L LL+ ++DV +
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPE 412
M YL NN +HRDL A N+L++E+ V KV+DFG+ + + + + +W APE
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE 356
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
+ + ++ ++DV+SFGI+LWE+ + G++PY + L+ V V+KG + P P +
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAV 415
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQR 502
D+++ CW D + RP F ++ E L+H+
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 5e-81
Identities = 96/272 (35%), Positives = 158/272 (58%), Gaps = 12/272 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
D WE++ + + +HK+ G Y ++Y+G + +S VA+K L + + EF +E +
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSK 354
M++++H N+VQ +G CTR P +I+TEFM+ G++ DYL + + +LL +A +S
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAP 411
M YL + N IHRDL A N L+ EN +VKVADFG++R+ TA G +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAP 181
Query: 412 EVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470
E + + ++ ++DV++FG++LWE+ T G PY + Q +++K R P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEK 240
Query: 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502
+ +L+ CWQ +PS RP F+EI + + + Q
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-80
Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 13/275 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEV 293
+ L+ + SG + ++KG + + V IKV+ + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHM 66
Query: 294 HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS 353
+ + H ++V+ +G C L +VT+++ GS+ D++ + + L LLL + ++
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMA 410
KGM YL + ++HR+L A N+L+ V+VADFGVA + + +WMA
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469
E I Y H++DV+S+G+ +WEL+T G PY L + +++KG R P
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGERLAQPQICTI 244
Query: 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
+ ++ +CW D ++RP F E+ +A+
Sbjct: 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-80
Identities = 91/274 (33%), Positives = 138/274 (50%), Gaps = 12/274 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQE 292
EI+AS + E I SG ++ G VAIK L E RR+F E
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSE 100
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM + H N+++ G TR IVTE+M GS+ +L + L+ + V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGT---YRW 408
GM YL +HRDL A N+L++ N V KV+DFG++R ++ TG RW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 409 MAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467
APE I + ++ +DV+SFG+V+WE++ G+ PY ++T + + V++G R P+
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-NRDVISSVEEGYRLPAPMGC 279
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
L L+ CW +D + RP FS+I +L L +
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 7e-80
Identities = 81/276 (29%), Positives = 138/276 (50%), Gaps = 25/276 (9%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHI 295
+ + K + SG++ +YKG + + VAIK L E + +E E ++
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYV 70
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
M V + +V + +G C + ++T+ M G + DY+ + K + LL + ++KG
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY--------- 406
MNYL ++HRDL A N+L+ VK+ DFG+A+ ++ AE Y
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPI 183
Query: 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPV 465
+WMA E I H+ Y H++DV+S+G+ +WEL+T G PYD + + +++KG R P
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPP 242
Query: 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+ ++ +CW D RP F E+ +A+
Sbjct: 243 ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 1e-79
Identities = 88/274 (32%), Positives = 140/274 (51%), Gaps = 12/274 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQE 292
E+DA+ + + + +G + ++ G VAIK L E RR+F E
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGE 96
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM + H N+++ G T+ + IVTE+M GS+ +L K + L+ + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA--QYGVMTAETGTY--RW 408
+ GM YL +HRDL A N+L+N N V KV+DFG+ RV T G RW
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 409 MAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467
+PE I ++ + +DV+S+GIVLWE+++ G+ PY +++ Q + V +G R P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDEGYRLPPPMDC 275
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
L L+ CWQ+D + RP F +I +L L +
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 9e-79
Identities = 77/279 (27%), Positives = 141/279 (50%), Gaps = 13/279 (4%)
Query: 238 DVWEIDASLLKFEHKIV-SGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQE 292
+D LL E K + SG++ + KG + + VA+K+L NE + ++ E E
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
++M+++ + +V+ IG C +V E G + YL + + +K ++ + V
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQV 126
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGT---YRW 408
S GM YL +N +HRDL A N+L+ K++DFG+++ ++A A+T +W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 409 MAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467
APE I + ++ ++DV+SFG+++WE + G+ PY + +++KG R P
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAMLEKGERMGCPAGC 245
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506
+ DL+ CW D RP F+ + L++ + +
Sbjct: 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-78
Identities = 95/279 (34%), Positives = 161/279 (57%), Gaps = 12/279 (4%)
Query: 230 VNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRR 287
+ + D WE++ + + +HK+ G Y ++Y+G + +S VA+K L + +
Sbjct: 205 IYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--- 261
Query: 288 EFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLL 346
EF +E +M++++H N+VQ +G CTR P +I+TEFM+ G++ DYL + + + +LL
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 347 RVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT- 405
+A +S M YL + N IHR+L A N L+ EN +VKVADFG++R+ TA G
Sbjct: 322 YMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAK 380
Query: 406 --YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPT 462
+W APE + + ++ ++DV++FG++LWE+ T G PY + L +++K R
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRME 439
Query: 463 IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
P + +L+ CWQ +PS RP F+EI + + + Q
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-77
Identities = 88/297 (29%), Positives = 158/297 (53%), Gaps = 15/297 (5%)
Query: 212 HHHVVYPVGEQEQSGINHVNIPAEGI---DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS 268
H+ G ++ + ++ + D WEI LK E K+ +G + +++ +
Sbjct: 152 DHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK 211
Query: 269 Q-DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
VA+K + ++ F E ++M+ ++H +V+ T+ P ++I+TEFM+ G
Sbjct: 212 HTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKG 267
Query: 328 SIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVAD 386
S+ D+L + LP L+ + +++GM ++ + N IHRDL+AAN+L++ + V K+AD
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIAD 327
Query: 387 FGVARVQAQYGVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPY 442
FG+ARV + TA G +W APE I + ++DV+SFGI+L E+VT G++PY
Sbjct: 328 FGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386
Query: 443 DDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
++ + +++G R P + L +++ RCW+ P RP F I +L
Sbjct: 387 PGMS-NPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 5e-77
Identities = 74/279 (26%), Positives = 134/279 (48%), Gaps = 13/279 (4%)
Query: 238 DVWEIDASLLKF-EHKIVSGSYCDLYKGAFFSQ----DVAIKVLTNEHLNENIRREFAQE 292
+ L + ++ G++ + +G + + DVAIKVL + E +E
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMRE 60
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM ++ + +V+ IG C L +V E GG ++ +L ++ + + + + V
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGT---YRW 408
S GM YL N +HRDL A N+L+ K++DFG+++ + A TA + +W
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 409 MAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467
APE I + ++ R+DV+S+G+ +WE ++ G+ PY + + +++G R P
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPEC 238
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506
P L L+ CW RPDF + + ++ L +K
Sbjct: 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 249 bits (636), Expect = 2e-76
Identities = 97/268 (36%), Positives = 152/268 (56%), Gaps = 12/268 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLNENIRREFAQEVHIM 296
D WEI L+ E K+ G + +++ G + + VAIK L ++ F QE +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVM 316
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKG 355
+K+RH +VQ + P ++IVTE+MS GS+ D+L + L+LP L+ +A ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPE 412
M Y+ R N +HRDL+AAN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
+ + ++DV+SFGI+L EL T G++PY + + + V++G R P L
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESL 493
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQHL 499
DL+ +CW+++P RP F + L+
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 2e-76
Identities = 97/268 (36%), Positives = 151/268 (56%), Gaps = 12/268 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIM 296
D WEI L+ E K+ G + +++ G + VAIK L ++ F QE +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVM 233
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKG 355
+K+RH +VQ + P ++IVTE+MS GS+ D+L + L+LP L+ +A ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPE 412
M Y+ R N +HRDL+AAN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
+ + ++DV+SFGI+L EL T G++PY + + + V++G R P L
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESL 410
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQHL 499
DL+ +CW+++P RP F + L+
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 6e-76
Identities = 79/313 (25%), Positives = 139/313 (44%), Gaps = 24/313 (7%)
Query: 211 NHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD 270
+HHH + G + ++ ID +LL + G + + +G +D
Sbjct: 4 SHHHHHHSSGLVPR----GSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQED 59
Query: 271 -----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-----PPRLFIV 320
VA+K + ++ ++ EF E M+ H NV++ +G C P+ ++
Sbjct: 60 GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 321 TEFMSGGSIYDYL-----HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
FM G ++ YL + L LL+ +D++ GM YL N +HRDL A N +
Sbjct: 120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 376 MNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVL 432
+ ++ V VADFG+++ +W+A E + + Y ++DV++FG+ +
Sbjct: 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239
Query: 433 WELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSE 491
WE+ T G PY + + + G R P L +++ CW+ DP RP FS
Sbjct: 240 WEIATRGMTPYPGVQNHE-MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSV 298
Query: 492 ITELLQHLAQRLQ 504
+ L+ L + L
Sbjct: 299 LRLQLEKLLESLP 311
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-75
Identities = 73/323 (22%), Positives = 134/323 (41%), Gaps = 31/323 (9%)
Query: 210 ENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQ 269
+HHH + + E D + + LKF ++ G++ + +
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPL 65
Query: 270 D------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR--LFIVT 321
VA+K L + R+F +E+ I++ ++H N+V++ G C R L ++
Sbjct: 66 QDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123
Query: 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
E++ GS+ DYL K K + LL+ + KGM YL IHRDL N+L+
Sbjct: 124 EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 183
Query: 382 VKVADFGVAR-VQAQYGVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT 437
VK+ DFG+ + + + W APE + ++ +DV+SFG+VL+EL T
Sbjct: 184 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
Query: 438 ----------------GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481
G + + +++ R P + ++ CW
Sbjct: 244 YIEKSKSPPAEFMRMIGNDKQGQMIVFH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNN 302
Query: 482 DPSLRPDFSEITELLQHLAQRLQ 504
+ + RP F ++ + + ++
Sbjct: 303 NVNQRPSFRDLALRVDQIRDQMA 325
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-75
Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 16/284 (5%)
Query: 235 EGIDVWEI--DASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRR 287
+ I + + + I G + +Y G + Q AIK L +
Sbjct: 9 AEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVE 67
Query: 288 EFAQEVHIMRKVRHMNVVQFIGACTRP-PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLL 346
F +E +MR + H NV+ IG P ++ +M G + ++ + + L+
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127
Query: 347 RVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETG 404
+ V++GM YL +HRDL A N +++E+ VKVADFG+AR +Y +
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 405 T---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR 460
+W A E ++ + ++DV+SFG++LWEL+T G PY + P + +G R
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRR 246
Query: 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
P + L ++++CW+ DP++RP F + ++ + L
Sbjct: 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-75
Identities = 81/276 (29%), Positives = 138/276 (50%), Gaps = 25/276 (9%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHI 295
+ + K + SG++ +YKG + + VAIK L E + +E E ++
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYV 70
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
M V + +V + +G C + ++T+ M G + DY+ + K + LL + ++KG
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY--------- 406
MNYL ++HRDL A N+L+ VK+ DFG+A+ ++ AE Y
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPI 183
Query: 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPV 465
+WMA E I H+ Y H++DV+S+G+ +WEL+T G PYD + + +++KG R P
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPP 242
Query: 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+ ++ +CW D RP F E+ +A+
Sbjct: 243 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 2e-75
Identities = 70/297 (23%), Positives = 127/297 (42%), Gaps = 31/297 (10%)
Query: 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREF 289
G D + + LKF ++ G++ + + VA+K L + R+F
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDF 58
Query: 290 AQEVHIMRKVRHMNVVQFIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLR 347
+E+ I++ ++H N+V++ G C R L ++ E++ GS+ DYL K K + LL+
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGT- 405
+ KGM YL IHRDL N+L+ VK+ DFG+ + + +
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 406 --YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT----------------GKLPYDDLTP 447
W APE + ++ +DV+SFG+VL+EL T G +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 448 LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
+ +++ R P + ++ CW + + RP F ++ + + +
Sbjct: 239 FH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 8e-75
Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 29/296 (9%)
Query: 233 PAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIR 286
PA +D + LK + G + + + + VA+K L N
Sbjct: 9 PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHI 67
Query: 287 REFAQEVHIMRKVRHMNVVQFIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
+ +E+ I+R + H N+V++ G CT + ++ EF+ GS+ +YL K K + L
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAET 403
L+ A+ + KGM+YL +HRDL A N+L+ VK+ DFG+ + ++ T +
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 404 GT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT---------------GKLPYDDL 445
W APE + + +DV+SFG+ L EL+T + +
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247
Query: 446 TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
T + V +++G R P + + L+ +CW+ PS R F + E + L +
Sbjct: 248 TVTR-LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 1e-74
Identities = 74/293 (25%), Positives = 130/293 (44%), Gaps = 21/293 (7%)
Query: 233 PAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRR 287
E ++ I + G + + + +D VA+K+L + + +
Sbjct: 11 LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 288 EFAQEVHIMRKVRHMNVVQFIGACTR------PPRLFIVTEFMSGGSIYDYL-----HKQ 336
EF +E M++ H +V + +G R P ++ FM G ++ +L +
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 337 KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396
L L L+R +D++ GM YL N IHRDL A N ++ E+ V VADFG++R
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 397 GVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAV 452
+ +W+A E + Y +DV++FG+ +WE++T G+ PY + +
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IY 249
Query: 453 GVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505
+ G R P + DL+ +CW DP RP F+ + L+++ L
Sbjct: 250 NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 1e-74
Identities = 81/272 (29%), Positives = 139/272 (51%), Gaps = 11/272 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQE 292
+EI ++ I G + D+++G + S + VAIK ++++R +F QE
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQE 441
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
MR+ H ++V+ IG T P ++I+ E + G + +L +K L L L+ A +
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTY--RWMA 410
S + YL +HRD+ A N+L++ N VK+ DFG++R A G +WMA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469
PE I + + +DV+ FG+ +WE++ G P+ + +G ++ G R +P + P
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGERLPMPPNCPP 619
Query: 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
L L+ +CW DPS RP F+E+ L + +
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-74
Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 14/273 (5%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEV 293
V + ++ F I G + +Y G D A+K L N + +F E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEG 77
Query: 294 HIMRKVRHMNVVQFIGACTRP-PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM+ H NV+ +G C R +V +M G + +++ + + L+ + V
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGT---YR 407
+KGM YL +HRDL A N +++E VKVADFG+AR +Y + +TG +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 408 WMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466
WMA E ++ Q + ++DV+SFG++LWEL+T G PY D+ + +G R P +
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEY 256
Query: 467 THPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
L +++ +CW +RP FSE+ + +
Sbjct: 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 3e-74
Identities = 73/299 (24%), Positives = 129/299 (43%), Gaps = 28/299 (9%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQ 291
D + LK+ ++ G++ + + VA+K L + ++ +R+F +
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQR 73
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVA 349
E+ I++ + +V++ G P R L +V E++ G + D+L + + L LL +
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGT--- 405
+ KGM YL +HRDL A N+L+ VK+ADFG+A+ +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGV---------- 454
W APE + ++ ++DV+SFG+VL+EL T +G
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 455 ---VQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKRGLA 510
+++G R P + +L++ CW P RP FS + L L + A
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 7e-74
Identities = 78/273 (28%), Positives = 132/273 (48%), Gaps = 14/273 (5%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEV 293
V + ++ F I G + +Y G D A+K L N + +F E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEG 141
Query: 294 HIMRKVRHMNVVQFIGACTRP-PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM+ H NV+ +G C R +V +M G + +++ + + L+ + V
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGT---YR 407
+KGM +L +HRDL A N +++E VKVADFG+AR ++ + +TG +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 408 WMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466
WMA E ++ Q + ++DV+SFG++LWEL+T G PY D+ + +G R P +
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEY 320
Query: 467 THPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
L +++ +CW +RP FSE+ + +
Sbjct: 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 4e-73
Identities = 85/311 (27%), Positives = 138/311 (44%), Gaps = 29/311 (9%)
Query: 211 NHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--- 267
+HHH P +G D+ E+ + + G++ ++Y+G
Sbjct: 3 HHHHHHNP--NYCFAGKTS-----SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 55
Query: 268 ----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
VA+K L E +E +F E I+ K H N+V+ IG + FI+ E
Sbjct: 56 NDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114
Query: 324 MSGGSIYDYL------HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
M+GG + +L Q L + LL VA D++ G YL N+ IHRD+ A N L+
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 174
Query: 378 ---ENGVVKVADFGVARVQAQYGVMTAETGTY---RWMAPEVIEHQPYNHRADVFSFGIV 431
V K+ DFG+AR + +WM PE + + D +SFG++
Sbjct: 175 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 432 LWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
LWE+ + G +PY + + + V G R P + + ++ +CWQ P RP+F+
Sbjct: 235 LWEIFSLGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 293
Query: 491 EITELLQHLAQ 501
I E +++ Q
Sbjct: 294 IILERIEYCTQ 304
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-72
Identities = 68/287 (23%), Positives = 113/287 (39%), Gaps = 43/287 (14%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKG---------AFFSQDVAIKVLTNEHLNENIRREFA 290
+I L F + G++ ++KG +V +KVL H N F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY--SESFF 60
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
+ +M K+ H ++V G C +V EF+ GS+ YL K K + + L VA
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMN--------ENGVVKVADFGVARVQAQYGVMTAE 402
++ M++L N +IH ++ A N+L+ +K++D G++
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLP 173
Query: 403 TGTY----RWMAPEVIEH-QPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQ 456
W+ PE IE+ + N D +SFG LWE+ + G P L Q + +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYE 232
Query: 457 KGLR----PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
+ + +L+ C +P RP F I L L
Sbjct: 233 DRHQLPAPKAAELA------NLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-72
Identities = 93/321 (28%), Positives = 157/321 (48%), Gaps = 41/321 (12%)
Query: 209 VENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAF-- 266
++ HHH +H + +D + +KF+ I G++ + K
Sbjct: 1 MKKHHHH------------HHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKK 48
Query: 267 --FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEF 323
D AIK + E+ +++ R+FA E+ ++ K+ H N++ +GAC L++ E+
Sbjct: 49 DGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107
Query: 324 MSGGSIYDYLHKQKCG---------------LKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G++ D+L K + L LL A DV++GM+YL + IHRD
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 167
Query: 369 LKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPEVIEHQPYNHRADV 425
L A N+L+ EN V K+ADFG++R Q Y +T RWMA E + + Y +DV
Sbjct: 168 LAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDV 224
Query: 426 FSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPS 484
+S+G++LWE+V+ G PY +T + +G R P++ + DL+ +CW+ P
Sbjct: 225 WSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPY 283
Query: 485 LRPDFSEITELLQHLAQRLQT 505
RP F++I L + + +T
Sbjct: 284 ERPSFAQILVSLNRMLEERKT 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 3e-72
Identities = 81/325 (24%), Positives = 143/325 (44%), Gaps = 38/325 (11%)
Query: 209 VENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAF-- 266
+HHH G V G D LK + G + + +
Sbjct: 2 AHHHHH------HHHHHGALEVLFQGPG-DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDP 54
Query: 267 ----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR--LFIV 320
+ VA+K L R + QE+ I+R + H +++++ G C L +V
Sbjct: 55 TNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113
Query: 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
E++ GS+ DYL + + L LL A + +GM YLH + IHRDL A N+L++ +
Sbjct: 114 MEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR 171
Query: 381 VVKVADFGVAR-VQAQYGVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
+VK+ DFG+A+ V + W APE ++ + + +DV+SFG+ L+EL+
Sbjct: 172 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
Query: 437 T---------------GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481
T + +T L+ ++++G R P + L++ CW+
Sbjct: 232 THCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLERGERLPRPDKCPAEVYHLMKNCWET 290
Query: 482 DPSLRPDFSEITELLQHLAQRLQTK 506
+ S RP F + +L+ + ++ Q +
Sbjct: 291 EASFRPTFENLIPILKTVHEKYQGQ 315
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-72
Identities = 80/291 (27%), Positives = 133/291 (45%), Gaps = 30/291 (10%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
WE + L F + +G++ + + + + VA+K+L + R
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALM 74
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------------- 333
E+ ++ + HMN+V +GACT ++TE+ G + ++L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 334 -HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392
+ L L LL + V+KGM +L N IHRDL A N+L+ + K+ DFG+AR
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 393 QAQYGVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPL 448
+ +WMAPE I + Y +DV+S+GI LWEL + G PY +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 449 QAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
++++G R P H + D+++ CW DP RP F +I +L++
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 3e-72
Identities = 74/285 (25%), Positives = 132/285 (46%), Gaps = 28/285 (9%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQ 291
+ EI S ++F ++ + +YKG F +Q VAIK L + +R EF
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRH 61
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------------HKQ 336
E + +++H NVV +G T+ L ++ + S G ++++L
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 337 KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396
K L+ P + + ++ GM YL ++++H+DL N+L+ + VK++D G+ R
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 397 GVMTAETGTY---RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAV 452
+ RWMAPE I + ++ +D++S+G+VLWE+ + G PY + V
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VV 240
Query: 453 GVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
+++ P + L+ CW PS RP F +I L+
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 4e-72
Identities = 79/292 (27%), Positives = 138/292 (47%), Gaps = 29/292 (9%)
Query: 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRRE 288
GI V I + + ++ G++ ++ + VA+K L + L R++
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--RKD 63
Query: 289 FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL--------------- 333
F +E ++ ++H ++V+F G C L +V E+M G + +L
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 334 HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393
+ K L L +L +A ++ GM YL + +HRDL N L+ N +VK+ DFG++R
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 394 AQYGVMTAETGTY---RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQ 449
T RWM PE I ++ + +DV+SFG++LWE+ T GK P+ L+ +
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 450 AAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+ + +G P + D++ CWQR+P R + EI ++L L +
Sbjct: 244 -VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 1e-71
Identities = 82/323 (25%), Positives = 144/323 (44%), Gaps = 28/323 (8%)
Query: 204 KEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYK 263
K+ PK + ++ + I+ +P + WE + L+F + +G++ + +
Sbjct: 7 KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 264 GAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP 315
F VA+K+L + + + E+ IM + +H N+V +GACT
Sbjct: 65 ATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123
Query: 316 RLFIVTEFMSGGSIYDYL-------------HKQKCGLKLPLLLRVAIDVSKGMNYLHRN 362
+ ++TE+ G + ++L LL + V++GM +L
Sbjct: 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK 183
Query: 363 NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPEVIEHQPY 419
N IHRD+ A N+L+ V K+ DFG+AR + +WMAPE I Y
Sbjct: 184 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243
Query: 420 NHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478
++DV+S+GI+LWE+ + G PY + +V+ G + P + +++ C
Sbjct: 244 TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC 303
Query: 479 WQRDPSLRPDFSEITELLQHLAQ 501
W +P+ RP F +I LQ AQ
Sbjct: 304 WALEPTHRPTFQQICSFLQEQAQ 326
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-71
Identities = 82/291 (28%), Positives = 139/291 (47%), Gaps = 36/291 (12%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFA 290
D WE+ + ++ GS+ +Y+G VAIK + NE + R EF
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 76
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------HKQKCGLK 341
E +M++ +VV+ +G ++ ++ E M+ G + YL +
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 342 LPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401
L ++++A +++ GM YL+ N +HRDL A N ++ E+ VK+ DFG+ R
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIY 189
Query: 402 ETGTY----------RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQA 450
ET Y RWM+PE ++ + +DV+SFG+VLWE+ T + PY L+ Q
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 248
Query: 451 AVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+ V +G P + +L +L+ CWQ +P +RP F EI ++ +
Sbjct: 249 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 4e-71
Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 22/284 (7%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
D+ E+ + + G++ ++Y+G VA+K L E +E +F
Sbjct: 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL 122
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK------QKCGLKLPL 344
E I+ K H N+V+ IG + FI+ E M+GG + +L + Q L +
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG---VVKVADFGVARVQAQYGVMTA 401
LL VA D++ G YL N+ IHRD+ A N L+ G V K+ DFG+AR + G
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 402 ETGTY---RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQK 457
+WM PE + + D +SFG++LWE+ + G +PY + + + V
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVTS 301
Query: 458 GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
G R P + + ++ +CWQ P RP+F+ I E +++ Q
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 5e-71
Identities = 85/296 (28%), Positives = 138/296 (46%), Gaps = 42/296 (14%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFA 290
V I + + ++ G++ ++ + VA+K L E +E+ R++F
Sbjct: 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEA-SESARQDFQ 91
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL--------------HKQ 336
+E ++ ++H ++V+F G CT L +V E+M G + +L
Sbjct: 92 REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 337 KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396
L L LL VA V+ GM YL + +HRDL N L+ + VVK+ DFG++R
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD---- 207
Query: 397 GVMTAETGTY----------RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDL 445
T Y RWM PE I ++ + +DV+SFG+VLWE+ T GK P+ L
Sbjct: 208 ---IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264
Query: 446 TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+ + A+ + +G P P + ++ CWQR+P R ++ LQ LAQ
Sbjct: 265 SNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 6e-71
Identities = 83/318 (26%), Positives = 149/318 (46%), Gaps = 35/318 (11%)
Query: 211 NHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--- 267
+HHH + + +G++ +P + WE L + G++ +
Sbjct: 5 HHHH--HHSQDPMLAGVSEYELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID 60
Query: 268 ------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320
+ VA+K+L + E + E+ +M+ + +H N++ +GACT+ L+++
Sbjct: 61 KDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119
Query: 321 TEFMSGGSIYDYL---------------HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
E+ S G++ +YL + + L+ +++GM YL I
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 179
Query: 366 HRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT---YRWMAPEVIEHQPYNHR 422
HRDL A N+L+ EN V+K+ADFG+AR T +WMAPE + + Y H+
Sbjct: 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 239
Query: 423 ADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481
+DV+SFG+++WE+ T G PY + + ++++G R P + L ++ CW
Sbjct: 240 SDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRDCWHA 298
Query: 482 DPSLRPDFSEITELLQHL 499
PS RP F ++ E L +
Sbjct: 299 VPSQRPTFKQLVEDLDRI 316
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-70
Identities = 91/292 (31%), Positives = 141/292 (48%), Gaps = 29/292 (9%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
WE LK + G++ + + F + VA+K+L E + R
Sbjct: 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM 78
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPR-LFIVTEFMSGGSIYDYL--------------- 333
E+ I+ + H+NVV +GACT+P L ++ EF G++ YL
Sbjct: 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 334 HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393
K L L L+ + V+KGM +L IHRDL A N+L++E VVK+ DFG+AR
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 394 AQYGVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQ 449
+ + +WMAPE I + Y ++DV+SFG++LWE+ + G PY + +
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 450 AAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+++G R P +T P + + CW +PS RP FSE+ E L +L Q
Sbjct: 259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 4e-70
Identities = 77/301 (25%), Positives = 145/301 (48%), Gaps = 36/301 (11%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
WE L + G + + K F VA+K+L E+ + + R+
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLL 74
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL----------------- 333
E +++++V H +V++ GAC++ L ++ E+ GS+ +L
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 334 ------HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
H + L + L+ A +S+GM YL ++HRDL A N+L+ E +K++DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 388 GVARVQAQYGVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYD 443
G++R + + +WMA E + Y ++DV+SFG++LWE+VT G PY
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 444 DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503
+ P + +++ G R P + + L+ +CW+++P RP F++I++ L+ + +
Sbjct: 255 GIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313
Query: 504 Q 504
+
Sbjct: 314 R 314
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-69
Identities = 82/338 (24%), Positives = 150/338 (44%), Gaps = 33/338 (9%)
Query: 191 PLQETEQLRNVLAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFE 250
+ + + + + P V + +G++ +P + WE L
Sbjct: 29 QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPED--PKWEFPRDKLTLG 86
Query: 251 HKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-R 300
+ G + + + VA+K+L + E + E+ +M+ + +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGK 145
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------------HKQKCGLKLPLL 345
H N++ +GACT+ L+++ E+ S G++ +YL + + L
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 346 LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT 405
+ +++GM YL IHRDL A N+L+ EN V+K+ADFG+AR T
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 406 ---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRP 461
+WMAPE + + Y H++DV+SFG+++WE+ T G PY + + ++++G R
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LFKLLKEGHRM 324
Query: 462 TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
P + L ++ CW PS RP F ++ E L +
Sbjct: 325 DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 3e-69
Identities = 74/262 (28%), Positives = 133/262 (50%), Gaps = 16/262 (6%)
Query: 247 LKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
LKF+ +I GS+ +YKG + +VA L + L ++ R+ F +E +++ ++H N+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 305 VQFIGA----CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
V+F + + +VTE M+ G++ YL + K +K+ +L + KG+ +LH
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH 146
Query: 361 RNN--IIHRDLKAANLLMN-ENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ 417
IIHRDLK N+ + G VK+ D G+A ++ GT +MAPE+ E +
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMYE-E 204
Query: 418 PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP-TIPVHTHPILVDLLE 476
Y+ DV++FG+ + E+ T + PY + V G++P + P + +++E
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 477 RCWQRDPSLRPDFSEITELLQH 498
C +++ R +LL H
Sbjct: 265 GCIRQNKDERYSIK---DLLNH 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 4e-69
Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 35/296 (11%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
WE L+F + SG++ + + S VA+K+L E + + R
Sbjct: 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALM 96
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------------- 333
E+ +M ++ H N+V +GACT ++++ E+ G + +YL
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 334 ------HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
+ L LL A V+KGM +L + +HRDL A N+L+ VVK+ DF
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 388 GVARVQAQYGVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYD 443
G+AR +WMAPE + Y ++DV+S+GI+LWE+ + G PY
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 444 DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
+ ++Q G + P + + +++ CW D RP F +T L
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 8e-69
Identities = 81/327 (24%), Positives = 149/327 (45%), Gaps = 14/327 (4%)
Query: 191 PLQETEQLRNVLAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDV-WEID-ASLLK 248
P + + L + P P+ + + P E D + +LL
Sbjct: 280 PQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI 339
Query: 249 FEHKIVSGSYCDLYKGAFFSQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
+ ++ G++ + +G + + DVAIKVL + E +E IM ++ + +
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYI 398
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
V+ IG C L +V E GG ++ +L ++ + + + + VS GM YL N
Sbjct: 399 VRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 365 IHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGT---YRWMAPEVIEHQPYN 420
+HR+L A N+L+ K++DFG+++ + A TA + +W APE I + ++
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 421 HRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479
R+DV+S+G+ +WE ++ G+ PY + + +++G R P P L L+ CW
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMSDCW 576
Query: 480 QRDPSLRPDFSEITELLQHLAQRLQTK 506
RPDF + + ++ L +K
Sbjct: 577 IYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-68
Identities = 82/291 (28%), Positives = 137/291 (47%), Gaps = 31/291 (10%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRRE 288
WE+ L + G++ + VA+K+L E +
Sbjct: 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSD 120
Query: 289 FAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL-------------- 333
E+ +M+ + +H N++ +GACT+ L+++ E+ S G++ +YL
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 334 -HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392
H + L L+ A V++GM YL IHRDL A N+L+ E+ V+K+ADFG+AR
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 393 QAQYGVMTAETGT---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPL 448
T +WMAPE + + Y H++DV+SFG++LWE+ T G PY +
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 449 QAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
+ ++++G R P + L ++ CW PS RP F ++ E L +
Sbjct: 301 E-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-68
Identities = 76/301 (25%), Positives = 136/301 (45%), Gaps = 36/301 (11%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
E + +++ I G++ +++ VA+K+L E + +++ +F
Sbjct: 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQ 98
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL----------------- 333
+E +M + + N+V+ +G C + ++ E+M+ G + ++L
Sbjct: 99 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 334 ------HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
L L +A V+ GM YL +HRDL N L+ EN VVK+ADF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 388 GVARVQAQYGVMTAETGTY---RWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYD 443
G++R A+ RWM PE I + Y +DV+++G+VLWE+ + G PY
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278
Query: 444 DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503
+ + + V+ G P + L +L+ CW + P+ RP F I +LQ + +R
Sbjct: 279 GMAHEE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337
Query: 504 Q 504
+
Sbjct: 338 E 338
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-62
Identities = 71/296 (23%), Positives = 145/296 (48%), Gaps = 25/296 (8%)
Query: 209 VENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKG--AF 266
+ +HHH + N+ + ++ + KI GS+
Sbjct: 1 MHHHHHH------SSGVDLGTENLYFQSMEKYVR-------LQKIGEGSFGKAILVKSTE 47
Query: 267 FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326
+ IK + ++ R E +EV ++ ++H N+VQ+ + L+IV ++ G
Sbjct: 48 DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 327 GSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384
G ++ ++ QK G+ +L + + + ++H I+HRD+K+ N+ + ++G V++
Sbjct: 108 GDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQL 166
Query: 385 ADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
DFG+ARV V A GT +++PE+ E++PYN+++D+++ G VL+EL T K +
Sbjct: 167 GDFGIARV-LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF 225
Query: 443 DDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ + ++ V + G P + +H L L+ + ++R+P RP + +L+
Sbjct: 226 EAGS-MKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS---VNSILEK 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-62
Identities = 64/320 (20%), Positives = 124/320 (38%), Gaps = 22/320 (6%)
Query: 202 LAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDL 261
LAK + P E + + + + E + + + ++ GS+ ++
Sbjct: 16 LAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSFGEV 74
Query: 262 YKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319
++ A+K + E +E+ + +V GA P + I
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVREGPWVNI 127
Query: 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
E + GGS+ + + C L L +G+ YLH I+H D+KA N+L++ +
Sbjct: 128 FMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD 186
Query: 380 GV-VKVADFGVARVQAQYGVMTAET------GTYRWMAPEVIEHQPYNHRADVFSFGIVL 432
G + DFG A G+ + GT MAPEV+ +P + + D++S ++
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 433 WELVTGKLPYDDLTPLQAAVGVVQKG-LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSE 491
++ G P+ + + + IP P+ ++ +++P R
Sbjct: 247 LHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS--- 303
Query: 492 ITELLQHLAQRLQTKRGLAQ 511
EL + + + LQ GL
Sbjct: 304 AMELRRKVGKALQEVGGLKS 323
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 6e-61
Identities = 87/283 (30%), Positives = 136/283 (48%), Gaps = 28/283 (9%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
W I+ + + I SG+ + + VAIK + E ++ E +E+ M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMS 68
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD-YLHKQKCGLKLPLLLR---VAI--- 350
+ H N+V + + L++V + +SGGS+ D H G +L +A
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET------G 404
+V +G+ YLH+N IHRD+KA N+L+ E+G V++ADFGV+ A G +T G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 405 TYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG---LR 460
T WMAPEV+E + Y+ +AD++SFGI EL TG PY P++ + +Q L
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 461 PTIPVHTH-----PILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ ++ C Q+DP RP ELL+H
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLRH 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 8e-60
Identities = 61/251 (24%), Positives = 96/251 (38%), Gaps = 13/251 (5%)
Query: 252 KIVSGSYCDLYKGAFFSQD---VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307
++ GSY +++K +D A+K + R EV KV +H V+
Sbjct: 64 RLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
A L++ TE G S+ + L + D + +LH ++H
Sbjct: 123 EQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 368 DLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFS 427
D+K AN+ + G K+ DFG+ G + G R+MAPE+++ Y ADVFS
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFS 240
Query: 428 FGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRP 487
G+ + E+ Q + Q L P L +L + DP LR
Sbjct: 241 LGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRA 297
Query: 488 DFSEITELLQH 498
LL
Sbjct: 298 T---AEALLAL 305
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 8e-60
Identities = 89/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 228 NHVNIPAEGIDVWEID-ASLLKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNEN 284
+ V G+ + D L KI GS+ +++KG + VAIK++ E +
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE 63
Query: 285 IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
I + QE+ ++ + V ++ G+ + +L+I+ E++ GGS D L L
Sbjct: 64 IE-DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQ 120
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET- 403
+ + ++ KG++YLH IHRD+KAAN+L++E+G VK+ADFGVA Q + T
Sbjct: 121 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKRNTF 179
Query: 404 -GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT 462
GT WMAPEVI+ Y+ +AD++S GI EL G+ P+ +L P++ + + PT
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPT 238
Query: 463 IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ + L + +E C ++PS RP ELL+H
Sbjct: 239 LEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKH 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-59
Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 14/265 (5%)
Query: 245 SLLKFE--HKIVSGSYCDLYKGAFFS--QDVAIK-VLTNEHLNENIRREFAQEVHIMRKV 299
+L F KI G + ++Y+ A VA+K V + ++ R + +E+ +++++
Sbjct: 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLP--LLLRVAIDVSKGM 356
H NV+++ + L IV E G + + K +P + + + + +
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV-QAQYGVMTAETGTYRWMAPEVIE 415
++H ++HRD+K AN+ + GVVK+ D G+ R ++ + GT +M+PE I
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 416 HQPYNHRADVFSFGIVLWELVTGKLPYD-DLTPLQAAVGVVQKGLRPTIPVHTH-PILVD 473
YN ++D++S G +L+E+ + P+ D L + +++ P +P + L
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 474 LLERCWQRDPSLRPDFSEITELLQH 498
L+ C DP RPD +T +
Sbjct: 270 LVNMCINPDPEKRPD---VTYVYDV 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-58
Identities = 76/265 (28%), Positives = 130/265 (49%), Gaps = 25/265 (9%)
Query: 245 SLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM 302
KI G+ +Y + Q+VAI+ + + + + E+ +MR+ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNP 77
Query: 303 NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN 362
N+V ++ + L++V E+++GGS+ D + + + + V + + + +LH N
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135
Query: 363 NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET-------GTYRWMAPEVIE 415
+IHRD+K+ N+L+ +G VK+ DFG AQ +T E GT WMAPEV+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC---AQ---ITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 416 HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVD 473
+ Y + D++S GI+ E++ G+ PY + PL+A + G P + P I D
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRD 248
Query: 474 LLERCWQRDPSLRPDFSEITELLQH 498
L RC + D R ELLQH
Sbjct: 249 FLNRCLEMDVEKRGS---AKELLQH 270
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-58
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 18/255 (7%)
Query: 255 SGSYCDLYKGAFFSQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
G+Y +Y G +AIK + + + +E+ + + ++H N+VQ++G+
Sbjct: 32 KGTYGIVYAG--RDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKL--PLLLRVAIDVSKGMNYLHRNNIIHRD 368
+ + I E + GGS+ L + LK + + +G+ YLH N I+HRD
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 369 LKAAN-LLMNENGVVKVADFGVA-RVQAQYGVMTAETGTYRWMAPEVIEHQP--YNHRAD 424
+K N L+ +GV+K++DFG + R+ TGT ++MAPE+I+ P Y AD
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 425 VFSFGIVLWELVTGKLPYDDLT-PLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDP 483
++S G + E+ TGK P+ +L P A V + P IP + +C++ DP
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDP 267
Query: 484 SLRPDFSEITELLQH 498
R +LL
Sbjct: 268 DKRAC---ANDLLVD 279
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-58
Identities = 87/259 (33%), Positives = 127/259 (49%), Gaps = 15/259 (5%)
Query: 246 LLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
+ K+ GSY +YK Q VAIK + E + I +E+ IM++ +
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII----KEISIMQQCDSPH 85
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363
VV++ G+ + L+IV E+ GS+ D + + L + + KG+ YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 364 IIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNH 421
IHRD+KA N+L+N G K+ADFGVA Q + T GT WMAPEVI+ YN
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204
Query: 422 RADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCW 479
AD++S GI E+ GK PY D+ P++A + PT P D +++C
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PPTFRKPELWSDNFTDFVKQCL 263
Query: 480 QRDPSLRPDFSEITELLQH 498
+ P R T+LLQH
Sbjct: 264 VKSPEQRAT---ATQLLQH 279
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-58
Identities = 80/258 (31%), Positives = 124/258 (48%), Gaps = 25/258 (9%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI GS + + VA+K++ + R EV IMR +H NVV+
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+ L+++ EF+ GG++ D + + + L + V V + + YLH +IHRD+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 370 KAANLLMNENGVVKVADFGVARVQAQYGVMTAET-------GTYRWMAPEVIEHQPYNHR 422
K+ ++L+ +G VK++DFG AQ ++ + GT WMAPEVI Y
Sbjct: 168 KSDSILLTLDGRVKLSDFGFC---AQ---ISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221
Query: 423 ADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQ 480
D++S GI++ E+V G+ PY +P+QA + P + P+L D LER
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLV 280
Query: 481 RDPSLRPDFSEITELLQH 498
RDP R ELL H
Sbjct: 281 RDPQERAT---AQELLDH 295
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-58
Identities = 55/274 (20%), Positives = 108/274 (39%), Gaps = 38/274 (13%)
Query: 252 KIVSGSYCDLYKGAFFSQD---VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307
KI SG + ++K D AIK + +EV+ + +H +VV++
Sbjct: 18 KIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKL---PLLLRVAIDVSKGMNYLHRNNI 364
A + I E+ +GGS+ D + + + L + + V +G+ Y+H ++
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 365 IHRDLKAANLLMNENGV-------------------VKVADFGVARVQAQYGVMTAETGT 405
+H D+K +N+ ++ + K+ D G + E G
Sbjct: 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEGD 193
Query: 406 YRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP 464
R++A EV+ E+ + +AD+F+ + + + + +++G P IP
Sbjct: 194 SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE----IRQGRLPRIP 249
Query: 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+LL+ DP RP L++H
Sbjct: 250 QVLSQEFTELLKVMIHPDPERRPS---AMALVKH 280
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-57
Identities = 64/305 (20%), Positives = 127/305 (41%), Gaps = 31/305 (10%)
Query: 212 HHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QD 270
HHH + G + + + ++ I +I SG +++ Q
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSI-------LKQIGSGGSSKVFQVLNEKKQI 54
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRPPRLFIVTEFMSGGS 328
AIK + E + + E+ + K++ +++ +++V E
Sbjct: 55 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNID 113
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
+ +L K+K + ++ + ++ +H++ I+H DLK AN L+ +G++K+ DFG
Sbjct: 114 LNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG 171
Query: 389 VAR-VQAQYGVMTAET--GTYRWMAPEVIEHQP-----------YNHRADVFSFGIVLWE 434
+A +Q + ++ GT +M PE I+ + ++DV+S G +L+
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 435 LVTGKLPYDDLT-PLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEIT 493
+ GK P+ + + ++ P L D+L+ C +RDP R I
Sbjct: 232 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS---IP 288
Query: 494 ELLQH 498
ELL H
Sbjct: 289 ELLAH 293
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-57
Identities = 58/262 (22%), Positives = 114/262 (43%), Gaps = 24/262 (9%)
Query: 255 SGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGAC 311
SG +++ Q AIK + E + + E+ + K++ +++
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78
Query: 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371
+++V E + +L K+K + ++ + ++ +H++ I+H DLK
Sbjct: 79 ITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136
Query: 372 ANLLMNENGVVKVADFGVAR-VQAQYGVMTAET--GTYRWMAPEVIEHQP---------- 418
AN L+ +G++K+ DFG+A +Q + ++ GT +M PE I+
Sbjct: 137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 195
Query: 419 -YNHRADVFSFGIVLWELVTGKLPYDDLT-PLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476
+ ++DV+S G +L+ + GK P+ + + ++ P L D+L+
Sbjct: 196 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 255
Query: 477 RCWQRDPSLRPDFSEITELLQH 498
C +RDP R I ELL H
Sbjct: 256 CCLKRDPKQRIS---IPELLAH 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-57
Identities = 64/249 (25%), Positives = 110/249 (44%), Gaps = 34/249 (13%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA----------------CT 312
+ IK + NE RE V + K+ H+N+V + G +
Sbjct: 37 KTYVIKRVKYN--NEKAERE----VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90
Query: 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLK 370
+ LFI EF G++ ++ K++ G KL L L + ++KG++Y+H +I+RDLK
Sbjct: 91 KTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKKLINRDLK 149
Query: 371 AANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGI 430
+N+ + + VK+ DFG+ G T GT R+M+PE I Q Y D+++ G+
Sbjct: 150 PSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 209
Query: 431 VLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
+L EL+ + + I LL++ + P RP+
Sbjct: 210 ILAELLHVCDTAFETSKF------FTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPN-- 261
Query: 491 EITELLQHL 499
+E+L+ L
Sbjct: 262 -TSEILRTL 269
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-57
Identities = 79/289 (27%), Positives = 141/289 (48%), Gaps = 25/289 (8%)
Query: 221 EQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTN 278
++ HV + +VWEI ++ G++ +YK A KV+
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIET 54
Query: 279 EHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC 338
+ E ++ E+ I+ H +V+ +GA +L+I+ EF GG++ + +
Sbjct: 55 KSEEE--LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR 112
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398
GL P + V + + +N+LH IIHRDLKA N+LM G +++ADFGV+ + +
Sbjct: 113 GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTL 171
Query: 399 MTAET--GTYRWMAPEVIEHQ-----PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA 451
++ GT WMAPEV+ + PY+++AD++S GI L E+ + P+ +L P++
Sbjct: 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231
Query: 452 VGVVQKGLRPTIPVHTH--PILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ + + PT+ + D L+ ++P RP +LL+H
Sbjct: 232 LKIAKSD-PPTLLTPSKWSVEFRDFLKIALDKNPETRPS---AAQLLEH 276
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 9e-57
Identities = 57/262 (21%), Positives = 113/262 (43%), Gaps = 24/262 (9%)
Query: 255 SGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGAC 311
SG +++ Q AIK + E + + E+ + K++ +++
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371
+++V E + +L K+K + ++ + ++ +H++ I+H DLK
Sbjct: 126 ITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183
Query: 372 ANLLMNENGVVKVADFGVAR-VQAQYGVMTAET--GTYRWMAPEVIEHQP---------- 418
AN L+ +G++K+ DFG+A +Q + ++ G +M PE I+
Sbjct: 184 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 419 -YNHRADVFSFGIVLWELVTGKLPYDDLT-PLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476
+ ++DV+S G +L+ + GK P+ + + ++ P L D+L+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 302
Query: 477 RCWQRDPSLRPDFSEITELLQH 498
C +RDP R I ELL H
Sbjct: 303 CCLKRDPKQRIS---IPELLAH 321
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 7e-56
Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 19/276 (6%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
W+ A LK +I G+Y + K Q +A+K + + ++E +++ ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDV 73
Query: 296 -MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS--IYDYLHKQKCG-LKLPLLLRVAID 351
MR +VQF GA R +I E MS Y Y++ + +L ++ +
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 352 VSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMA 410
K +N+L N IIHRD+K +N+L++ +G +K+ DFG++ T + G +MA
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193
Query: 411 PEVIE----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVH 466
PE I+ Q Y+ R+DV+S GI L+EL TG+ PY + + V KG P +
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253
Query: 467 TH----PILVDLLERCWQRDPSLRPDFSEITELLQH 498
P ++ + C +D S RP + ELL+H
Sbjct: 254 EEREFSPSFINFVNLCLTKDESKRPKYK---ELLKH 286
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-55
Identities = 70/269 (26%), Positives = 124/269 (46%), Gaps = 15/269 (5%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHI-MR 297
E+ A L+ ++ G+Y + K Q +A+K + +N ++ ++ I MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGG--SIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
V V F GA R ++I E M Y + + + +L ++A+ + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 356 MNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVI 414
+ +LH ++IHRD+K +N+L+N G VK+ DFG++ + G +MAPE I
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 415 E----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH-P 469
+ Y+ ++D++S GI + EL + PYD + V + P +P
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241
Query: 470 ILVDLLERCWQRDPSLRPDFSEITELLQH 498
VD +C +++ RP + EL+QH
Sbjct: 242 EFVDFTSQCLKKNSKERPTYP---ELMQH 267
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-54
Identities = 58/282 (20%), Positives = 116/282 (41%), Gaps = 38/282 (13%)
Query: 248 KFE--HKIVSGSY--CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
FE + G + K + AIK + E R + +EV + K+ H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPG 64
Query: 304 VVQFIGAC------------TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVA 349
+V++ A + L+I + ++ D+++ + + + L +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV-------------QAQY 396
+ +++ + +LH ++HRDLK +N+ + VVKV DFG+ Y
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ 456
T + GT +M+PE I Y+H+ D+FS G++L+EL+ P+ + V+
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR 241
Query: 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
P + +P +++ P RP+ ++++
Sbjct: 242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE---AINIIEN 280
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-54
Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 18/275 (6%)
Query: 237 IDVWEIDASLLKFEH--KIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQE 292
I A + E+ ++ SG+ ++K F +A+K + N+ + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMD 73
Query: 293 VHI-MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
+ + ++ +VQ G +FI E M + Q + +L ++ +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGKMTVA 132
Query: 352 VSKGMNYLH-RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMA 410
+ K + YL ++ +IHRD+K +N+L++E G +K+ DFG++ G +MA
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192
Query: 411 PEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV 465
PE I+ Y+ RADV+S GI L EL TG+ PY + + V + P +P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252
Query: 466 HTH--PILVDLLERCWQRDPSLRPDFSEITELLQH 498
H ++ C +D RP ++ +LL+H
Sbjct: 253 HMGFSGDFQSFVKDCLTKDHRKRPKYN---KLLEH 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-54
Identities = 81/256 (31%), Positives = 125/256 (48%), Gaps = 17/256 (6%)
Query: 251 HKIVSGSYCDLYKG--AFFSQDVAIKV--LTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
+I GS+ +Y S+ VAIK + + NE + + +EV ++K+RH N +Q
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHPNTIQ 118
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+ G R ++V E+ GS D L K L+ + V +G+ YLH +N+IH
Sbjct: 119 YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 367 RDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ---PYNHRA 423
RD+KA N+L++E G+VK+ DFG A + + GT WMAPEVI Y+ +
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKV 234
Query: 424 DVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI-PVHTHPILVDLLERCWQRD 482
DV+S GI EL K P ++ + A + Q P + H + ++ C Q+
Sbjct: 235 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQSGHWSEYFRNFVDSCLQKI 293
Query: 483 PSLRPDFSEITELLQH 498
P RP LL+H
Sbjct: 294 PQDRPT---SEVLLKH 306
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-53
Identities = 67/269 (24%), Positives = 125/269 (46%), Gaps = 21/269 (7%)
Query: 252 KIVSGSY--CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
I +GSY C + + + K L + E ++ EV+++R+++H N+V++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 310 A--CTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLP--LLLRVAIDVSKGMNYLHR--- 361
L+IV E+ GG + + K L +LRV ++ + HR
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 362 --NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQ 417
+ ++HRDLK AN+ ++ VK+ DFG+AR+ A+T GT +M+PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTPYYMSPEQMNRM 191
Query: 418 PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477
YN ++D++S G +L+EL P+ + + G +++G IP L +++ R
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRIPYRYSDELNEIITR 250
Query: 478 CWQRDPSLRPDFSEITELLQH--LAQRLQ 504
RP + E+L++ + +
Sbjct: 251 MLNLKDYHRPS---VEEILENPLILEHHH 276
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-53
Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 26/266 (9%)
Query: 251 HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307
+ +G+Y +YKG Q AIKV+ + + E QE+++++K H N+ +
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 308 IGA------CTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLH 360
GA +L++V EF GS+ D + K LK + + ++ +G+++LH
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVI---- 414
++ +IHRD+K N+L+ EN VK+ DFGV+ Q V T GT WMAPEVI
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACDE 205
Query: 415 -EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI-PVHTHPILV 472
Y+ ++D++S GI E+ G P D+ P++A + + P +
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-APRLKSKKWSKKFQ 264
Query: 473 DLLERCWQRDPSLRPDFSEITELLQH 498
+E C ++ S RP +L++H
Sbjct: 265 SFIESCLVKNHSQRPA---TEQLMKH 287
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 5e-53
Identities = 62/329 (18%), Positives = 121/329 (36%), Gaps = 62/329 (18%)
Query: 229 HVNIPAEGIDVWEIDASLLKFEHKIVSG--SYCDLYKGAF--FSQDVAIKVLTNEHLNEN 284
N+ +G+ + + + I G + + + V ++ + E +
Sbjct: 9 MENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE 68
Query: 285 IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL-HKQKCGLKLP 343
+ E+H+ + H N+V + L++VT FM+ GS D + G+
Sbjct: 69 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL 128
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA--------RVQAQ 395
+ + V K ++Y+H +HR +KA+++L++ +G V ++ R +
Sbjct: 129 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 396 YGVMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQA--- 450
+ W++PEV++ Q Y+ ++D++S GI EL G +P+ D+ Q
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 451 ---------------------------------AVGVVQKGLRPTIPVHTH--------P 469
+ + RP+ P
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 470 ILVDLLERCWQRDPSLRPDFSEITELLQH 498
+E+C QR+P RP S LL H
Sbjct: 309 HFHHFVEQCLQRNPDARPSAS---TLLNH 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-51
Identities = 57/259 (22%), Positives = 105/259 (40%), Gaps = 35/259 (13%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA-------------CTRPP 315
+ AIK + E EV ++ + H VV++ A +
Sbjct: 32 RYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
LFI E+ G++YD +H + + R+ + + ++Y+H IIHRDLK N+
Sbjct: 89 TLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF 148
Query: 376 MNENGVVKVADFGVARV---------------QAQYGVMTAETGTYRWMAPEVIEHQP-Y 419
++E+ VK+ DFG+A+ +T+ GT ++A EV++ Y
Sbjct: 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208
Query: 420 NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479
N + D++S GI+ +E++ + + + V P + + ++
Sbjct: 209 NEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLI 268
Query: 480 QRDPSLRPDFSEITELLQH 498
DP+ RP LL
Sbjct: 269 DHDPNKRPG---ARTLLNS 284
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-50
Identities = 65/289 (22%), Positives = 113/289 (39%), Gaps = 34/289 (11%)
Query: 239 VWEIDASLLKFEHKIVSGSY--CDLYKGAFFSQDVAIKVL--TNEHLNENIRREFAQEVH 294
+ ID F K+ G + DL +G A+K + + E +RE
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE----AD 78
Query: 295 IMRKVRHMNVVQFIGACTRPP----RLFIVTEFMSGGSIYDYL---HKQKCGLKLPLLLR 347
+ R H N+++ + C R +++ F G++++ + + L +L
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ----------AQYG 397
+ + + +G+ +H HRDLK N+L+ + G + D G
Sbjct: 139 LLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 398 VMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGV 454
A+ T + APE+ H + R DV+S G VL+ ++ G+ PYD + +V +
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
Query: 455 VQKGLRPTIPVHTH--PILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+ + +IP L LL DP RP I LL L
Sbjct: 259 AVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPH---IPLLLSQLEA 303
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-50
Identities = 68/307 (22%), Positives = 127/307 (41%), Gaps = 55/307 (17%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIM 296
V E+ + ++ +G+ ++K + +A K++ E IR + +E+ ++
Sbjct: 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVL 85
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+ +V F GA + I E M GGS+ L K + +L +V+I V KG+
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGL 144
Query: 357 NYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEV 413
YL I+HRD+K +N+L+N G +K+ DFGV+ Q A + GT +M+PE
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPER 201
Query: 414 IEHQPYNHRADVFSFGIVLWELVTGKLPY------------------DDLTPLQAAVGVV 455
++ Y+ ++D++S G+ L E+ G+ P D
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 456 QKGLRPTIPVHTHPILVDLLER------------------------CWQRDPSLRPDFSE 491
+ + + + +LL+ C ++P+ R D
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD--- 318
Query: 492 ITELLQH 498
+ +L+ H
Sbjct: 319 LKQLMVH 325
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-47
Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 23/261 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA--CTRPPRLFIVTEFMSG 326
AIKV N + + +E +++K+ H N+V+ T ++ EF
Sbjct: 35 DLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 327 GSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----NENG 380
GS+Y L + LP L V DV GMN+L N I+HR++K N++ +
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS 153
Query: 381 VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE--------HQPYNHRADVFSFGIVL 432
V K+ DFG AR + GT ++ P++ E + Y D++S G+
Sbjct: 154 VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 433 WELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC-WQRDPSLRPDFS- 490
+ TG LP+ + V+ K + + W D + S
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 491 ----EITELLQHLAQRLQTKR 507
+T +L ++ + Q K
Sbjct: 274 GLQVLLTPVLANILEADQEKC 294
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-46
Identities = 57/237 (24%), Positives = 107/237 (45%), Gaps = 17/237 (7%)
Query: 269 QDVAIKV-----LTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
+VAIK+ + + + ++ E V I +++H ++++ +++V E
Sbjct: 37 LEVAIKMIDKKAMYKAGMVQRVQNE----VKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVK 383
G + YL + + GM YLH + I+HRDL +NLL+ N +K
Sbjct: 93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIK 152
Query: 384 VADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
+ADFG+A Q + T GT +++PE+ + +DV+S G + + L+ G+ P
Sbjct: 153 IADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
Query: 442 YDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+D ++ + V +P DL+ + +R+P+ R S + L H
Sbjct: 212 FDT-DTVKNTLNKVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSV---LDH 263
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-46
Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 16/235 (6%)
Query: 269 QDVAIKVLTNEHLN-----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
+A+KVL L +RRE V I +RH N+++ G R++++ E+
Sbjct: 35 FILALKVLFKAQLEKAGVEHQLRRE----VEIQSHLRHPNILRLYGYFHDATRVYLILEY 90
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVK 383
G++Y L K +++ ++Y H +IHRD+K NLL+ G +K
Sbjct: 91 APLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELK 149
Query: 384 VADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD 443
+ADFG + GT ++ PE+IE + ++ + D++S G++ +E + GK P++
Sbjct: 150 IADFGWSVHAPSSRRTDL-CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
Query: 444 DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
T Q + + T P DL+ R + +PS RP E+ L+H
Sbjct: 209 ANTY-QETYKRISRV-EFTFPDFVTEGARDLISRLLKHNPSQRPMLREV---LEH 258
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 2e-45
Identities = 61/262 (23%), Positives = 102/262 (38%), Gaps = 23/262 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA--CTRPPRLFIVTEFMSG 326
AIKV N + + +E +++K+ H N+V+ T ++ EF
Sbjct: 35 DLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 327 GSIYDYL--HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----NENG 380
GS+Y L GL L V DV GMN+L N I+HR++K N++ +
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS 153
Query: 381 VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE--------HQPYNHRADVFSFGIVL 432
V K+ DFG AR + GT ++ P++ E + Y D++S G+
Sbjct: 154 VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 433 WELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC-WQRDPSLRPDFS- 490
+ TG LP+ + V+ K + + W D + S
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 491 ----EITELLQHLAQRLQTKRG 508
+T +L ++ + Q K
Sbjct: 274 GLQVLLTPVLANILEADQEKCW 295
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 47/257 (18%), Positives = 108/257 (42%), Gaps = 21/257 (8%)
Query: 257 SYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316
+ + ++ + + + + + ++ M N V + +
Sbjct: 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVY 135
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
L+I + ++ D+++++ + L + I +++ + +LH ++HRDLK +N+
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 375 LMNENGVVKVADFGVARV-------------QAQYGVMTAETGTYRWMAPEVIEHQPYNH 421
+ VVKV DFG+ Y T + GT +M+PE I Y+H
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 422 RADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481
+ D+FS G++L+EL+ + + + V+ P + +P +++
Sbjct: 256 KVDIFSLGLILFELLYSFSTQMERVRI---ITDVRNLKFPLLFTQKYPQEHMMVQDMLSP 312
Query: 482 DPSLRPDFSEITELLQH 498
P+ RP+ T+++++
Sbjct: 313 SPTERPE---ATDIIEN 326
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-45
Identities = 70/232 (30%), Positives = 119/232 (51%), Gaps = 8/232 (3%)
Query: 269 QDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ A K++ L + R + + E+ I R + H +VV F G +F+V E
Sbjct: 41 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 100
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
S+ + ++K L P + G YLHRN +IHRDLK NL +NE+ VK+ DF
Sbjct: 101 SLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDF 159
Query: 388 GVA-RVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
G+A +V+ GT ++APEV+ + ++ DV+S G +++ L+ GK P++ +
Sbjct: 160 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-S 218
Query: 447 PLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
L+ ++K +IP H +P+ L+++ Q DP+ RP +E+ L
Sbjct: 219 CLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINEL---LND 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-45
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 13/229 (5%)
Query: 271 VAIKVLTNEHLN-----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
+A+KVL L +RRE + I +RH N+++ R++++ EF
Sbjct: 42 MALKVLFKSQLEKEGVEHQLRRE----IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVA 385
G +Y L K +++ ++Y H +IHRD+K NLLM G +K+A
Sbjct: 98 RGELYKELQKHGR-FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIA 156
Query: 386 DFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL 445
DFG + T GT ++ PE+IE + ++ + D++ G++ +E + G P+D
Sbjct: 157 DFGWSVHAPSLRRRTM-CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215
Query: 446 TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494
+ + +V L+ P DL+ + + P R + E
Sbjct: 216 SHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 70/232 (30%), Positives = 119/232 (51%), Gaps = 8/232 (3%)
Query: 269 QDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ A K++ L + R + + E+ I R + H +VV F G +F+V E
Sbjct: 67 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
S+ + ++K L P + G YLHRN +IHRDLK NL +NE+ VK+ DF
Sbjct: 127 SLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDF 185
Query: 388 GVA-RVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
G+A +V+ GT ++APEV+ + ++ DV+S G +++ L+ GK P++ +
Sbjct: 186 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-S 244
Query: 447 PLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
L+ ++K +IP H +P+ L+++ Q DP+ RP +E+ L
Sbjct: 245 CLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINEL---LND 292
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 70/262 (26%), Positives = 128/262 (48%), Gaps = 27/262 (10%)
Query: 262 YKGAFFSQDVAIKVLTNEHLNENI--RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319
YKG + VA+K L +++F QE+ +M K +H N+V+ +G + L +
Sbjct: 48 YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCL 107
Query: 320 VTEFMSGGSIYDYLHKQKCGLKL--PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
V +M GS+ D L L + ++A + G+N+LH N+ IHRD+K+AN+L++
Sbjct: 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD 167
Query: 378 ENGVVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWE 434
E K++DFG+AR ++ + + GT +MAPE + + ++D++SFG+VL E
Sbjct: 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLE 226
Query: 435 LVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD-LLE---------------RC 478
++TG D+ Q + + ++ + +D + +C
Sbjct: 227 IITGLPAVDEHREPQLLLDIKEEIEDEEKTIED---YIDKKMNDADSTSVEAMYSVASQC 283
Query: 479 WQRDPSLRPDFSEITELLQHLA 500
+ RPD ++ +LLQ +
Sbjct: 284 LHEKKNKRPDIKKVQQLLQEMT 305
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 68/231 (29%), Positives = 118/231 (51%), Gaps = 7/231 (3%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
++VAIK++ LN ++ +EV IM+ + H N+V+ L+++ E+ SGG
Sbjct: 41 REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
++DYL +K + + Y H+ I+HRDLKA NLL++ + +K+ADFG
Sbjct: 101 VFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG 159
Query: 389 VARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWELVTGKLPYDDLTP 447
+ G + A G + APE+ + + Y+ DV+S G++L+ LV+G LP+D
Sbjct: 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN- 218
Query: 448 LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
L+ V +G + IP + +LL+R +P R +I ++
Sbjct: 219 LKELRERVLRG-KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI---MKD 265
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 71/278 (25%), Positives = 123/278 (44%), Gaps = 27/278 (9%)
Query: 250 EHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
+ I G + +YKG VA+K T E EF E+ + RH ++V I
Sbjct: 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI--EEFETEIETLSFCRHPHLVSLI 101
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLL----LRVAIDVSKGMNYLHRNNI 364
G C + ++ ++M G++ +L+ + + L + I ++G++YLH I
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 365 IHRDLKAANLLMNENGVVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNH 421
IHRD+K+ N+L++EN V K+ DFG+++ + + T GT ++ PE
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE 220
Query: 422 RADVFSFGIVLWELVTGKLPYDDLTPLQA------AVGVVQKG---------LRPTIPVH 466
++DV+SFG+VL+E++ + P + AV G L I
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 467 THPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
+ D +C RP ++ L++ A RLQ
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY-ALRLQ 317
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-43
Identities = 71/306 (23%), Positives = 127/306 (41%), Gaps = 50/306 (16%)
Query: 247 LKFEHKIVSGSY--CDLYKGAFFSQDVAIKVL--TNEHLNENIRREFAQEVHIMRKVR-H 301
L+ + G + + ++ A+K L E N I +E V M+K+ H
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE----VCFMKKLSGH 85
Query: 302 MNVVQFIGACTRPPR--------LFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAID 351
N+VQF A + ++TE G + ++L K + L +L++
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 352 VSKGMNYLHRNN--IIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET------ 403
+ + ++HR IIHRDLK NLL++ G +K+ DFG A + Y +
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 404 -------GTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVG 453
T + PE+I+ + P + D+++ G +L+ L + P++D L+
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260
Query: 454 VVQKGLRPTIPVHTH--PILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKRGLAQ 511
+ G + +IP H + L+ Q +P R I E++ L Q + R +
Sbjct: 261 -IVNG-KYSIPPHDTQYTVFHSLIRAMLQVNPEERLS---IAEVVHQL-QEIAAARNVNP 314
Query: 512 GNAIEE 517
+ I E
Sbjct: 315 KSPITE 320
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 162 bits (410), Expect = 3e-43
Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 17/254 (6%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI------GACTRPPRLFIVTE 322
+ VAIK E +N R + E+ IM+K+ H NVV + E
Sbjct: 40 EQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 323 FMSGGSIYDYL--HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---N 377
+ GG + YL + CGLK + + D+S + YLH N IIHRDLK N+++
Sbjct: 99 YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP 158
Query: 378 ENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT 437
+ + K+ D G A+ Q + T GT +++APE++E + Y D +SFG + +E +T
Sbjct: 159 QRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
Query: 438 GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ-RDPSLRPDF--SEITE 494
G P+ G V++ I V+ L ++ P+ ++
Sbjct: 219 GFRPFLPNWQPVQWHGKVREKSNEHIVVYD--DLTGAVKFSSVLPTPNHLSGILAGKLER 276
Query: 495 LLQHLAQRLQTKRG 508
LQ + Q +RG
Sbjct: 277 WLQCMLMWHQRQRG 290
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 59/252 (23%), Positives = 111/252 (44%), Gaps = 24/252 (9%)
Query: 262 YKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320
Y+G F ++DVA+K + E RE V ++R+ H NV+++ +I
Sbjct: 42 YRGMFDNRDVAVKRILPECF-SFADRE----VQLLRESDEHPNVIRYFCTEKDRQFQYIA 96
Query: 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
E ++ +Y+ ++ + + + G+ +LH NI+HRDLK N+L++
Sbjct: 97 IELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155
Query: 381 -----VVKVADFGVARV----QAQYGVMTAETGTYRWMAPEVIE---HQPYNHRADVFSF 428
++DFG+ + + + + GT W+APE++ + + D+FS
Sbjct: 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215
Query: 429 GIVLWELVT-GKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERCWQRDPSLR 486
G V + +++ G P+ QA + + L H I +L+E+ DP R
Sbjct: 216 GCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKR 275
Query: 487 PDFSEITELLQH 498
P +L+H
Sbjct: 276 PS---AKHVLKH 284
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 61/248 (24%), Positives = 119/248 (47%), Gaps = 17/248 (6%)
Query: 270 DVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
VAIK + E + F +EVH ++ H N+V I ++V E++ G +
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
+ +Y+ L + + + G+ + H I+HRD+K N+L++ N +K+ DFG
Sbjct: 98 LSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFG 156
Query: 389 VARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
+A+ ++ + GT ++ +PE + + + D++S GIVL+E++ G+ P++ T
Sbjct: 157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216
Query: 447 PLQAAVGVVQ-------KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
+ A+ +Q +R IP L +++ R ++D + R + I E+ L
Sbjct: 217 AVSIAIKHIQDSVPNVTTDVRKDIP----QSLSNVILRATEKDKANR--YKTIQEMKDDL 270
Query: 500 AQRLQTKR 507
+ L R
Sbjct: 271 SSVLHENR 278
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 59/161 (36%), Positives = 90/161 (55%), Gaps = 4/161 (2%)
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETG 404
L+ + V+KGM +L IHRDL A N+L++E VVK+ DFG+AR + +
Sbjct: 195 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 405 T---YRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR 460
+WMAPE I + Y ++DV+SFG++LWE+ + G PY + + +++G R
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314
Query: 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
P +T P + + CW +PS RP FSE+ E L +L Q
Sbjct: 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 36/155 (23%), Positives = 62/155 (40%), Gaps = 15/155 (9%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFA 290
WE LK + G++ + + F D VA+K+L E + R
Sbjct: 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM 73
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPR-LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRV 348
E+ I+ + H+NVV +GACT+P L ++ EF G++ YL ++ +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR--NEFVPYKTK 131
Query: 349 AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVK 383
+G +Y+ I DLK + +
Sbjct: 132 GARFRQGKDYV---GAIPVDLKRRLDSITSSQSSA 163
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 50/277 (18%), Positives = 104/277 (37%), Gaps = 55/277 (19%)
Query: 269 QDVAIKVL-------------------TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
+ A+K + + ++ + E + I+ +++ + G
Sbjct: 55 KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE----LQIITDIKNEYCLTCEG 110
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHK-------QKCGLKLPLLLRVAIDVSKGMNYLH-R 361
T ++I+ E+M SI + C + + ++ + V +Y+H
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 362 NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQP--Y 419
NI HRD+K +N+LM++NG VK++DFG + + GTY +M PE ++
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRGTYEFMPPEFFSNESSYN 229
Query: 420 NHRADVFSFGIVLWELVTGKLPYDDLTPLQA------------------AVGVVQKGLRP 461
+ D++S GI L+ + +P+ L + +
Sbjct: 230 GAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKST 289
Query: 462 TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+D L+ +++P+ R + L+H
Sbjct: 290 CSNNFLSNEDIDFLKLFLRKNPAERITSEDA---LKH 323
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-41
Identities = 62/254 (24%), Positives = 112/254 (44%), Gaps = 22/254 (8%)
Query: 252 KIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQF---I 308
K++ + ++ + E + +E + I++K+ H NVV+ +
Sbjct: 50 KLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE----IAILKKLDHPNVVKLVEVL 105
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
L++V E ++ G + + + L D+ KG+ YLH IIHRD
Sbjct: 106 DDPNED-HLYMVFELVNQGPVMEVPTLKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRD 162
Query: 369 LKAANLLMNENGVVKVADFGVARVQAQYGVMTAET-GTYRWMAPEVI--EHQPYN-HRAD 424
+K +NLL+ E+G +K+ADFGV+ + + T GT +MAPE + + ++ D
Sbjct: 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALD 222
Query: 425 VFSFGIVLWELVTGKLPYDD--LTPLQAAVGVVQKGLRPTIPVHTH--PILVDLLERCWQ 480
V++ G+ L+ V G+ P+ D + L + ++ P L DL+ R
Sbjct: 223 VWAMGVTLYCFVFGQCPFMDERIMCLHSK---IKSQ-ALEFPDQPDIAEDLKDLITRMLD 278
Query: 481 RDPSLRPDFSEITE 494
++P R EI
Sbjct: 279 KNPESRIVVPEIKL 292
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-40
Identities = 64/240 (26%), Positives = 117/240 (48%), Gaps = 29/240 (12%)
Query: 269 QDVAIKVL-----TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
VA+K+L + + I+RE + ++ RH ++++ + P F+V E+
Sbjct: 37 HKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLL 375
+SGG ++DY+ K RV ++ ++Y HR+ ++HRDLK N+L
Sbjct: 93 VSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143
Query: 376 MNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWE 434
++ + K+ADFG++ + + + G+ + APEVI + Y D++S G++L+
Sbjct: 144 LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203
Query: 435 LVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494
L+ G LP+DD + ++ G IP + + + LL Q DP R +I E
Sbjct: 204 LLCGTLPFDDEH-VPTLFKKIRGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 64/255 (25%), Positives = 117/255 (45%), Gaps = 26/255 (10%)
Query: 270 DVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVV------QFIGACTRPPRLFIVTE 322
DVA+KVL + + + F +E + H +V + P +IV E
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP--YIVME 96
Query: 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVV 382
++ G ++ D +H + + + V D + +N+ H+N IIHRD+K AN++++ V
Sbjct: 97 YVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV 155
Query: 383 KVADFGVARVQAQYGVMTAET----GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTG 438
KV DFG+AR A G +T GT ++++PE + R+DV+S G VL+E++TG
Sbjct: 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
Query: 439 KLPYDDLTPLQAAVGVVQ------KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
+ P+ +P+ A V+ + L ++ + ++P R +
Sbjct: 216 EPPFTGDSPVSVAYQHVREDPIPPSARHEGLS----ADLDAVVLKALAKNPENR--YQTA 269
Query: 493 TELLQHLAQRLQTKR 507
E+ L + +
Sbjct: 270 AEMRADLVRVHNGEP 284
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-40
Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 29/242 (11%)
Query: 269 QDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
+ VA+K++ + ENI++E + I + + H NVV+F G ++ E+ S
Sbjct: 33 EAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMN 377
GG ++D + + ++ G+ YLH I HRD+K NLL++
Sbjct: 89 GGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 378 ENGVVKVADFG---VARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLW 433
E +K++DFG V R + ++ GT ++APE+++ + ++ DV+S GIVL
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 434 ELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP-VHTHPILVDLLERCWQRDPSLRPDFSEI 492
++ G+LP+D + ++ P + LL + +PS R +I
Sbjct: 200 AMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259
Query: 493 TE 494
+
Sbjct: 260 KK 261
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 78/271 (28%), Positives = 125/271 (46%), Gaps = 29/271 (10%)
Query: 262 YKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320
YKG VA+K L E + +F EV ++ H N+++ G C P +V
Sbjct: 47 YKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105
Query: 321 TEFMSGGSIYDYLH---KQKCGLKLPLLLRVAIDVSKGMNYLH---RNNIIHRDLKAANL 374
+M+ GS+ L + + L P R+A+ ++G+ YLH IIHRD+KAAN+
Sbjct: 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165
Query: 375 LMNENGVVKVADFGVARVQAQYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVL 432
L++E V DFG+A++ V TA GT +APE + + + DVF +G++L
Sbjct: 166 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 225
Query: 433 WELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD-LLE--------------- 476
EL+TG+ +D ++ ++ + LVD L+
Sbjct: 226 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVA 285
Query: 477 -RCWQRDPSLRPDFSEITELLQ--HLAQRLQ 504
C Q P RP SE+ +L+ LA+R +
Sbjct: 286 LLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-39
Identities = 51/248 (20%), Positives = 96/248 (38%), Gaps = 17/248 (6%)
Query: 270 DVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
VA+K+++ + R +E +++ +VV +L++ ++G
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
+ L +Q L P + + + ++ H HRD+K N+L++ + + DFG
Sbjct: 121 LAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG 179
Query: 389 VARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
+A + GT +MAPE +RAD+++ VL+E +TG PY
Sbjct: 180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-D 238
Query: 447 PLQAAVGVVQ------KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500
L + +RP IP ++ R ++P R + +L
Sbjct: 239 QLSVMGAHINQAIPRPSTVRPGIP----VAFDAVIARGMAKNPEDR--YVTCGDLSAAAH 292
Query: 501 QRLQTKRG 508
L T
Sbjct: 293 AALATADQ 300
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-39
Identities = 68/240 (28%), Positives = 114/240 (47%), Gaps = 30/240 (12%)
Query: 269 QDVAIKV-----LTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
Q VA+K L ++ + RE + ++ +RH ++++ T P + +V E+
Sbjct: 35 QKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLL 375
+GG ++DY+ ++K R+ D + + Y HR+ I+HRDLK NLL
Sbjct: 91 -AGGELFDYIVEKK---------RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL 140
Query: 376 MNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWE 434
+++N VK+ADFG++ + + G+ + APEVI + Y DV+S GIVL+
Sbjct: 141 LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYV 200
Query: 435 LVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494
++ G+LP+DD + V +P P L+ R DP R EI
Sbjct: 201 MLVGRLPFDDEF-IPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 29/242 (11%)
Query: 269 QDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
+ VA+K++ + ENI++E + I + + H NVV+F G ++ E+ S
Sbjct: 33 EAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMN 377
GG ++D + + ++ G+ YLH I HRD+K NLL++
Sbjct: 89 GGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 378 ENGVVKVADFG---VARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLW 433
E +K++DFG V R + ++ GT ++APE+++ + ++ DV+S GIVL
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 434 ELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP-VHTHPILVDLLERCWQRDPSLRPDFSEI 492
++ G+LP+D + ++ P + LL + +PS R +I
Sbjct: 200 AMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259
Query: 493 TE 494
+
Sbjct: 260 KK 261
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 66/240 (27%), Positives = 120/240 (50%), Gaps = 29/240 (12%)
Query: 269 QDVAIKVLTNEHLN-----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
VA+K+L + + IRRE + ++ RH ++++ + P +F+V E+
Sbjct: 42 HKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLL 375
+SGG ++DY+ K R+ S+ G++Y HR+ ++HRDLK N+L
Sbjct: 98 VSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148
Query: 376 MNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWE 434
++ + K+ADFG++ + + + G+ + APEVI + Y D++S G++L+
Sbjct: 149 LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYA 208
Query: 435 LVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494
L+ G LP+DD + + G P + +P ++ LL+ Q DP R +I E
Sbjct: 209 LLCGTLPFDDDH-VPTLFKKICDG-IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 31/243 (12%)
Query: 269 QDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ VA+K + EN++RE + R +RH N+V+F P L I+ E+ SGG
Sbjct: 46 ELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
+Y+ + R + D ++ G++Y H I HRDLK N L++ +
Sbjct: 102 ELYERICNAG---------RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS 152
Query: 380 GV--VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWELV 436
+K+ DFG ++ + + GT ++APEV+ Q Y+ ADV+S G+ L+ ++
Sbjct: 153 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML 212
Query: 437 TGKLPYDD---LTPLQAAVGVVQKGLRPTIPVHTH--PILVDLLERCWQRDPSLRPDFSE 491
G P++D + + + + +IP P L+ R + DP+ R E
Sbjct: 213 VGAYPFEDPEEPRDYRKTIQRILSV-KYSIPDDIRISPECCHLISRIFVADPATRISIPE 271
Query: 492 ITE 494
I
Sbjct: 272 IKT 274
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 20/238 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFA------QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322
++V +K + E + E+ E E+ I+ +V H N+++ + +V E
Sbjct: 50 KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME 109
Query: 323 F-MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
SG ++ ++ + L PL + + + YL +IIHRD+K N+++ E+
Sbjct: 110 KHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT 168
Query: 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWELVTGKL 440
+K+ DFG A + + GT + APEV+ PY +++S G+ L+ LV +
Sbjct: 169 IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228
Query: 441 PYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
P+ +L A P L+ L+ Q P R + +L+
Sbjct: 229 PFCELEETVEA--------AIHPPYLVSKELMSLVSGLLQPVPERRTT---LEKLVTD 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 56/242 (23%), Positives = 111/242 (45%), Gaps = 25/242 (10%)
Query: 269 QDVAIKVLTNEHLN------ENIRREFAQEVHIMRKVRHMNVVQF---IGACTRPPRLFI 319
A+K+L + L N+++E + ++R++RH NV+Q + ++++
Sbjct: 31 CRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLRHKNVIQLVDVLYNEE-KQKMYM 85
Query: 320 VTEFMSGGS--IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
V E+ G + D + +++ + + G+ YLH I+H+D+K NLL+
Sbjct: 86 VMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143
Query: 378 ENGVVKVADFGVARVQAQYGV-MTAET--GTYRWMAPEVIE-HQPYN-HRADVFSFGIVL 432
G +K++ GVA + T T G+ + PE+ ++ + D++S G+ L
Sbjct: 144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
Query: 433 WELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
+ + TG P++ + + KG IP P L DLL+ + +P+ R +I
Sbjct: 204 YNITTGLYPFEGDN-IYKLFENIGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
Query: 493 TE 494
+
Sbjct: 262 RQ 263
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 57/239 (23%), Positives = 105/239 (43%), Gaps = 22/239 (9%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHM--NVVQFIGACTRPPRLFIVTE 322
VAIK + + +++ EV +++KV V++ + RP ++ E
Sbjct: 69 LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128
Query: 323 FMSG-GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-G 380
++D++ ++ L+ L V + + + H ++HRD+K N+L++ N G
Sbjct: 129 RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 187
Query: 381 VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWELVTGK 439
+K+ DFG + + V T GT + PE I + Y+ A V+S GI+L+++V G
Sbjct: 188 ELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
Query: 440 LPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+P++ + +G + L+ C PS RP F EI H
Sbjct: 247 IPFEHDEE-------IIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI---QNH 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 43/272 (15%), Positives = 104/272 (38%), Gaps = 35/272 (12%)
Query: 196 EQLRNVLAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVS 255
++L L + K + YP + Q + + E +++ + L+ H +
Sbjct: 24 DKLIFKLLSGLSKPVSS----YPNTFEWQCKLPAIKPKTE----FQLGSKLVYVHHLLGE 75
Query: 256 GSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
G++ +Y+ Q +KV + E Q + ++ ++F
Sbjct: 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT--QLMERLKPSMQHMFMKFY 133
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKC----GLKLPLLLRVAIDVSKGMNYLHRNNI 364
A +V E S G++ + ++ K + L++ A+ + + +H I
Sbjct: 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEI 193
Query: 365 IHRDLKAANLLMN-----------ENGVVKVADFGVA---RVQAQYGVMTAETGTYRWMA 410
IH D+K N ++ + + + D G + ++ + + TA+ T +
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC 253
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPY 442
E++ ++P+N++ D F ++ ++ G
Sbjct: 254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 24/241 (9%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVR----HMNVVQFIGACTRPPRLFIV 320
VAIKV+ + + EV ++ KV H V++ + +V
Sbjct: 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116
Query: 321 TEF-MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-E 378
E + ++DY+ ++ L V + + H ++HRD+K N+L++
Sbjct: 117 LERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175
Query: 379 NGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWELVT 437
G K+ DFG + T GT + PE I Y+ A V+S GI+L+++V
Sbjct: 176 RGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
Query: 438 GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
G +P++ + + P H P L+ RC PS RP EI L
Sbjct: 235 GDIPFER-------DQEILEA-ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI---LL 283
Query: 498 H 498
Sbjct: 284 D 284
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-36
Identities = 54/249 (21%), Positives = 96/249 (38%), Gaps = 26/249 (10%)
Query: 270 DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI-----GACTRPPRLFIVTEFM 324
V +K L + + + E + +V H ++VQ P +IV E++
Sbjct: 108 PVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV 384
G S+ ++ L + + +++ ++YLH +++ DLK N+++ E +K+
Sbjct: 167 GGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKL 222
Query: 385 ADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444
D G +G + GT + APE++ P D+++ G L L +
Sbjct: 223 IDLGAVSRINSFGYL---YGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN- 277
Query: 445 LTPLQAAVGVVQKGLRPTIPV-HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503
G GL PV T+ LL R DP R F+ E+ L L
Sbjct: 278 --------GRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQR--FTTAEEMSAQLTGVL 327
Query: 504 QTKRGLAQG 512
+ G
Sbjct: 328 REVVAQDTG 336
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 57/273 (20%), Positives = 113/273 (41%), Gaps = 45/273 (16%)
Query: 262 YKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320
++G+F + VA+K + + + E + ++ + H NV+++ + T L+I
Sbjct: 33 FQGSFQGRPVAVKRMLIDFC-DIALME----IKLLTESDDHPNVIRYYCSETTDRFLYIA 87
Query: 321 TEFMSGGSIYDYLHKQKCGLKLPLLL------RVAIDVSKGMNYLHRNNIIHRDLKAANL 374
E ++ D + + + L + ++ G+ +LH IIHRDLK N+
Sbjct: 88 LELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNI 146
Query: 375 L-------------MNENGVVKVADFGVARV-----QAQYGVMTAETGTYRWMAPEVIE- 415
L EN + ++DFG+ + + + +GT W APE++E
Sbjct: 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206
Query: 416 ------HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAV--GVVQ-KGLRPTIPV 465
+ D+FS G V + +++ GK P+ D ++ + G+ ++
Sbjct: 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDR 266
Query: 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
DL+ + DP RP ++L+H
Sbjct: 267 SLIAEATDLISQMIDHDPLKRPT---AMKVLRH 296
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 34/286 (11%), Positives = 75/286 (26%), Gaps = 45/286 (15%)
Query: 269 QDVAIKVLT-NEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC---------------- 311
+D A+KV T + + + ++ + +
Sbjct: 88 EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPP 147
Query: 312 ----------TRPPRLFIVTEFMSG-----GSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
++ S S D+++ + + L + + +
Sbjct: 148 FAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH 416
L ++H NL + +G + + D G ++ TY E +
Sbjct: 208 ANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTY--APREFLNA 265
Query: 417 Q--PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP-------VHT 467
+ H + + G+ ++ + LP+ +TP P
Sbjct: 266 STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL 325
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITE--LLQHLAQRLQTKRGLAQ 511
+ L+ R D R E E L + + Q
Sbjct: 326 PDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 33/232 (14%)
Query: 272 AIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
AIK+L H+ I+ E +M ++ H V+ +L+ + G
Sbjct: 59 AIKILEKRHI---IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 115
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
+ Y+ K ++ + YLH IIHRDLK N+L+NE+
Sbjct: 116 ELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166
Query: 380 GVVKVADFGVA-RVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
+++ DFG A + + A + GT ++++PE++ + +D+++ G ++++LV
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 437 TGKLPYDDLTPLQAAVGVVQK--GLRPTIPVHTHPILVDLLERCWQRDPSLR 486
G P+ + QK L P P DL+E+ D + R
Sbjct: 227 AGLPPFRAGNEYL----IFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 60/287 (20%), Positives = 103/287 (35%), Gaps = 64/287 (22%)
Query: 269 QDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
AIK++ + N EV +M+K+ H N+ + + +V E
Sbjct: 52 AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCH 111
Query: 326 GGSIYDYLHKQKCGLKLPLLL--------------------------------------- 346
GG + D L+ +
Sbjct: 112 GGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171
Query: 347 RVAIDVSKGMNYLHRNNIIHRDLKAANLLM--NENGVVKVADFGVARV-----QAQYGVM 399
+ + ++YLH I HRD+K N L N++ +K+ DFG+++ +Y M
Sbjct: 172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231
Query: 400 TAETGTYRWMAPEVIE--HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK 457
T + GT ++APEV+ ++ Y + D +S G++L L+ G +P+ + V+ K
Sbjct: 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK 291
Query: 458 GLR------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
L + DLL R+ R D LQH
Sbjct: 292 KLCFENPNYNVLSPL----ARDLLSNLLNRNVDERFDAMRA---LQH 331
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 70/290 (24%), Positives = 120/290 (41%), Gaps = 57/290 (19%)
Query: 252 KIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
KI GSY ++K ++ VAIK + I++ +E+ ++++++H N+V
Sbjct: 10 KIGEGSYGVVFKC----RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ R RL +V E+ ++ L + + G+ L+ + + +N+ H++N I
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 366 HRDLKAANLLMNENGVVKVADFGVARVQAQYGV----MTAETGT--YRWMAPEVIEHQP- 418
HRD+K N+L+ ++ V+K+ DFG AR E T YR +PE++
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFAR---LLTGPSDYYDDEVATRWYR--SPELLVGDTQ 179
Query: 419 YNHRADVFSFGIVLWELVTGKLPY-------DDL--------TP----------LQAAVG 453
Y DV++ G V EL++G P D L Q G
Sbjct: 180 YGPPVDVWAIGCVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 454 VVQKGLRPTIPVHTH-----PILVDLLERCWQRDPSLRPDFSEITELLQH 498
V P+ + LL+ C DP+ R +LL H
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT---CEQLLHH 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 62/241 (25%), Positives = 116/241 (48%), Gaps = 22/241 (9%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ AIK++ ++ + + +EV +++ + H N+++ ++V E GG
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---NENGV 381
++D + + A + K G+ YLH++NI+HRDLK NLL+ ++ +
Sbjct: 123 LFDEIIHRMK-----FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDAL 177
Query: 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
+K+ DFG++ V M GT ++APEV+ + Y+ + DV+S G++L+ L+ G P
Sbjct: 178 IKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPP 236
Query: 442 YDDLTPLQAAVGVVQKGL----RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
+ T Q + V+KG P + DL+++ Q D R + L+
Sbjct: 237 FGGQT-DQEILRKVEKGKYTFDSPEWKNVSEGA-KDLIKQMLQFDSQRRIS---AQQALE 291
Query: 498 H 498
H
Sbjct: 292 H 292
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 60/243 (24%), Positives = 109/243 (44%), Gaps = 30/243 (12%)
Query: 272 AIKVLTNEHLNENIRREFA---QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
A+K + + E R E +E+ IM+ + H +V + +F+V + + GG
Sbjct: 44 AMKYMNKQKCVE--RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGD 101
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNENG 380
+ H Q+ + K ++YL IIHRD+K N+L++E+G
Sbjct: 102 LR--YHLQQNV-------HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG 152
Query: 381 VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQP---YNHRADVFSFGIVLWELVT 437
V + DF +A + + +T GT +MAPE+ + Y+ D +S G+ +EL+
Sbjct: 153 HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 438 GKLPYD--DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITEL 495
G+ PY T + V + T P +V LL++ + +P R FS+++++
Sbjct: 213 GRRPYHIRSSTSSKEIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQR--FSQLSDV 269
Query: 496 LQH 498
Sbjct: 270 QNF 272
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 20/245 (8%)
Query: 269 QDVAIKVL------TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322
+ VAI+++ + E+ I++K+ H +++ +IV E
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLE 219
Query: 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NEN 379
M GG ++D + LK + + YLH N IIHRDLK N+L+ E+
Sbjct: 220 LMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 278
Query: 380 GVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELV 436
++K+ DFG +++ + +M GT ++APEV+ YN D +S G++L+ +
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 437 TGKLP-YDDLTPLQAAVGVVQKGLRPTIPV--HTHPILVDLLERCWQRDPSLRPDFSEIT 493
+G P + T + + V +DL+++ DP R
Sbjct: 339 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TE 395
Query: 494 ELLQH 498
E L+H
Sbjct: 396 EALRH 400
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 41/262 (15%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VAIK ++ +++ +E+ +++++RH N+V + C + R ++V EF+ +I
Sbjct: 53 VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TIL 111
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390
D L GL ++ + + G+ + H +NIIHRD+K N+L++++GVVK+ DFG A
Sbjct: 112 DDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
Query: 391 RV-QAQYGVMTAETGT--YRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGKLPY---- 442
R A V E T YR APE++ Y DV++ G ++ E+ G+ P
Sbjct: 172 RTLAAPGEVYDDEVATRWYR--APELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PLFPGD 228
Query: 443 ---DDL--------TP----------LQAAVGVVQKGLRPTIPVHTH-----PILVDLLE 476
D L GV ++ P+ +++DL +
Sbjct: 229 SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAK 288
Query: 477 RCWQRDPSLRPDFSEITELLQH 498
+C DP RP ELL H
Sbjct: 289 KCLHIDPDKRPF---CAELLHH 307
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 64/241 (26%), Positives = 114/241 (47%), Gaps = 22/241 (9%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
Q+ A+KV+ +EV +++K+ H N+++ +IV E +GG
Sbjct: 48 QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---NENGV 381
++D + K+K A + K G+ Y+H++NI+HRDLK N+L+ ++
Sbjct: 108 LFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCD 162
Query: 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
+K+ DFG++ Q M GT ++APEV+ Y+ + DV+S G++L+ L++G P
Sbjct: 163 IKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221
Query: 442 YDDLTPLQAAVGVVQKGL----RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
+ + V+ G P + DL+ + PSLR T+ L+
Sbjct: 222 FYGKN-EYDILKRVETGKYAFDLPQWRTISDDA-KDLIRKMLTFHPSLRIT---ATQCLE 276
Query: 498 H 498
H
Sbjct: 277 H 277
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 46/183 (25%), Positives = 92/183 (50%), Gaps = 12/183 (6%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ A K++ + L+ ++ +E I RK++H N+V+ + ++V + ++GG
Sbjct: 32 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---NENGV 381
+++ + ++ A + + Y H N I+HR+LK NLL+ +
Sbjct: 92 LFEDIVAREF-----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 146
Query: 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
VK+ADFG+A GT +++PEV++ PY+ D+++ G++L+ L+ G P
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
Query: 442 YDD 444
+ D
Sbjct: 207 FWD 209
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 32/229 (13%)
Query: 272 AIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
A+K+L + + ++ + + E I++ V +V+ + L++V E+++GG
Sbjct: 70 AMKILDKQKV---VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
++ +L + R + ++ YLH ++I+RDLK NLL+++
Sbjct: 127 EMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 380 GVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT 437
G ++V DFG A+ T GT +APE+I + YN D ++ G++++E+
Sbjct: 178 GYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 438 GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
G P+ P+Q +V +R P H L DLL Q D + R
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 55/242 (22%), Positives = 105/242 (43%), Gaps = 22/242 (9%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ IK + + + + E+ +++ + H N+++ ++IV E GG
Sbjct: 48 LERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---NENGV 381
+ + + + K L ++ K + Y H +++H+DLK N+L + +
Sbjct: 107 LLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSP 165
Query: 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
+K+ DFG+A + T GT +MAPEV + + D++S G+V++ L+TG LP
Sbjct: 166 IKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
Query: 442 YDDLTPLQAAVGVVQKGLRPTIPVHTHPILV-----DLLERCWQRDPSLRPDFSEITELL 496
+ + V QK + DLL++ +DP RP ++L
Sbjct: 225 FTGTSL----EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS---AAQVL 277
Query: 497 QH 498
H
Sbjct: 278 HH 279
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 61/246 (24%), Positives = 118/246 (47%), Gaps = 31/246 (12%)
Query: 269 QDVAIKV-----LTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
Q+ A+KV + + E++ RE V +++++ H N+++ ++V E
Sbjct: 52 QECAVKVISKRQVKQKTDKESLLRE----VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM--- 376
+GG ++D + +K A + + G+ Y+H+N I+HRDLK NLL+
Sbjct: 108 YTGGELFDEIISRKR-----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 162
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
+++ +++ DFG++ M + GT ++APEV+ H Y+ + DV+S G++L+ L+
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILL 221
Query: 437 TGKLPYDDLTPLQAAVGVVQKG----LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492
+G P++ + V+KG P + DL+ + PS+R
Sbjct: 222 SGCPPFNGAN-EYDILKKVEKGKYTFELPQWKKVSESA-KDLIRKMLTYVPSMRIS---A 276
Query: 493 TELLQH 498
+ L H
Sbjct: 277 RDALDH 282
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-30
Identities = 67/231 (29%), Positives = 112/231 (48%), Gaps = 36/231 (15%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIM------RKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
A+KVL E + +R + Q H V H +++ G ++F++ +++
Sbjct: 35 AMKVLKKEIV---VRLK--QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMN 377
GG ++ L +K R V+K + YLH +II+RDLK N+L++
Sbjct: 90 GGELFSLL--RKSQ-------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 140
Query: 378 ENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWEL 435
+NG +K+ DFG A+ T GT ++APEV+ +PYN D +SFGI+++E+
Sbjct: 141 KNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM 196
Query: 436 VTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
+ G P+ D ++ ++ LR P + + DLL R RD S R
Sbjct: 197 LAGYTPFYDSNTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 13/234 (5%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A K L + + + A E I+ KV VV A L +V M+GG +
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 331 DYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
+++ + G + A ++ G+ LHR I++RDLK N+L++++G ++++D G+
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332
Query: 390 ARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP 447
A V G GT +MAPEV++++ Y D ++ G +L+E++ G+ P+
Sbjct: 333 A-VHVPEGQTIK-GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390
Query: 448 LQAAVGVVQKGLR--PTIPVHTHPILVDLLERCWQRDPSLR-----PDFSEITE 494
V + P L + +DP+ R E+ E
Sbjct: 391 KIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 46/183 (25%), Positives = 92/183 (50%), Gaps = 12/183 (6%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ A K++ + L+ ++ +E I RK++H N+V+ + ++V + ++GG
Sbjct: 55 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 114
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---NENGV 381
+++ + ++ A + + Y H N I+HR+LK NLL+ +
Sbjct: 115 LFEDIVAREF-----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 169
Query: 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
VK+ADFG+A GT +++PEV++ PY+ D+++ G++L+ L+ G P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
Query: 442 YDD 444
+ D
Sbjct: 230 FWD 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-30
Identities = 32/251 (12%), Positives = 73/251 (29%), Gaps = 44/251 (17%)
Query: 270 DVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
VA+ + + L +++ +E + ++ V + + +V E++ GGS
Sbjct: 58 QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
+ + +R ++ + HR + + + ++ +G V +A
Sbjct: 118 LQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA 174
Query: 389 VARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL 448
N + D+ G L+ L+ + P +
Sbjct: 175 TMP--------------------------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208
Query: 449 QAAVGVVQ---------KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499
+ + IP + + R Q D +R S + L+Q
Sbjct: 209 SGLAPAERDTAGQPIEPADIDRDIP----FQISAVAARSVQGDGGIRSA-STLLNLMQQA 263
Query: 500 AQRLQTKRGLA 510
L
Sbjct: 264 TAVADRTEVLG 274
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 62/231 (26%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD 331
A+KVL L R E I+ +V H +V+ A +L+++ +F+ GG ++
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115
Query: 332 YLHKQKCGLKLPLLLRVAI---DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388
L K+ V +++ +++LH II+RDLK N+L++E G +K+ DFG
Sbjct: 116 RLSKEVM-FTEE---DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 389 VARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446
+++ + + GT +MAPEV+ + + AD +SFG++++E++TG LP+
Sbjct: 172 LSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
Query: 447 PLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR-----PDFSEI 492
+ +++ L +P P LL ++R+P+ R EI
Sbjct: 231 RKETMTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 38/278 (13%), Positives = 85/278 (30%), Gaps = 50/278 (17%)
Query: 269 QDVAIKVL-TNEHLNENIRREFAQEVHIMRK----------------------VRHMNVV 305
+ + V E N ++ +EV +R V+
Sbjct: 104 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163
Query: 306 QFIGACTRPPRLFIVTEFMS-----------GGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
+ I +++++ F G + + K L L++ + V +
Sbjct: 164 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-LVHHARLQLTLQVIR 222
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPE 412
+ LH ++H L+ ++++++ G V + F V A
Sbjct: 223 LLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAER 282
Query: 413 VIEHQP-----YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467
++ D ++ G+ ++ + LP D L + + + IP
Sbjct: 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS--CKNIP--- 337
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505
+ LLE + R + E ++L+T
Sbjct: 338 -QPVRALLEGFLRYPKEDRLLPLQAME--TPEYEQLRT 372
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/226 (25%), Positives = 112/226 (49%), Gaps = 13/226 (5%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+KV+ E +N++ ++ Q E H+ + H +V RLF V E+++GG +
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
++ +Q+ L + ++S +NYLH II+RDLK N+L++ G +K+ D+G+
Sbjct: 98 MFHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156
Query: 390 ARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP 447
+ + G T+ T GT ++APE++ + Y D ++ G++++E++ G+ P+D +
Sbjct: 157 CKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215
Query: 448 LQAAVGVVQKGL-------RPTIPVHTHPILVDLLERCWQRDPSLR 486
+ L + IP +L+ +DP R
Sbjct: 216 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 40/185 (21%), Positives = 84/185 (45%), Gaps = 19/185 (10%)
Query: 269 QDVAIKVLTNEHLN--ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326
A K + + + ++E + IM+ + H N+++ +++V E +G
Sbjct: 35 IRRAAKKIPKYFVEDVDRFKQE----IEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90
Query: 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---NEN 379
G +++ + ++ A + K + Y H+ N+ HRDLK N L + +
Sbjct: 91 GELFERVVHKRV-----FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD 145
Query: 380 GVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK 439
+K+ DFG+A +M + GT +++P+V+ Y D +S G++++ L+ G
Sbjct: 146 SPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLYGPECDEWSAGVMMYVLLCGY 204
Query: 440 LPYDD 444
P+
Sbjct: 205 PPFSA 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 52/183 (28%), Positives = 95/183 (51%), Gaps = 13/183 (7%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
Q+ A+KV+ +EV +++K+ H N+++ +IV E +GG
Sbjct: 48 QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---NENGV 381
++D + K+K A + K G+ Y+H++NI+HRDLK N+L+ ++
Sbjct: 108 LFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCD 162
Query: 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
+K+ DFG++ Q M GT ++APEV+ Y+ + DV+S G++L+ L++G P
Sbjct: 163 IKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221
Query: 442 YDD 444
+
Sbjct: 222 FYG 224
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 12/185 (6%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM-NVVQFIGACTRPPRLFIVTEFMSGG 327
Q+ A K L ++ R E E+ ++ + V+ + ++ E+ +GG
Sbjct: 55 QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---NENG 380
I+ + + + I + K G+ YLH+NNI+H DLK N+L+ G
Sbjct: 115 EIFSLCLPELAEM---VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG 171
Query: 381 VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKL 440
+K+ DFG++R + GT ++APE++ + P D+++ GI+ + L+T
Sbjct: 172 DIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS 231
Query: 441 P-YDD 444
P +
Sbjct: 232 PFVGE 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 32/275 (11%), Positives = 81/275 (29%), Gaps = 58/275 (21%)
Query: 269 QDVAIKVLTNEHLN-----ENIRRE---------------------FAQEVHIMRKVRHM 302
+ + V + ++ E F +++ +
Sbjct: 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 303 NVVQFIGACTRP--PRLFIVTEFMS------GGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
+++ F + M G + + K L L++ + V +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-LVHHARLQLTLQVIR 217
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVI 414
+ LH ++H L+ ++++++ G V + F + G + + + PE+
Sbjct: 218 LLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---RDGARVVSSVSRGFEPPELE 274
Query: 415 -----------EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI 463
D ++ G+V++ + LP L + + + I
Sbjct: 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS--CKNI 332
Query: 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
P + LLE + R + ++
Sbjct: 333 P----QPVRALLEGFLRYPKEDRLLPLQA---MET 360
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 20/191 (10%)
Query: 269 QDVAIKV------LTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321
Q A+K+ ++ L+ E+++RE I ++H ++V+ + + L++V
Sbjct: 50 QQFAVKIVDVAKFTSSPGLSTEDLKRE----ASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM- 376
EFM G + + ++ VA + + Y H NNIIHRD+K +L+
Sbjct: 106 EFMDGADLCFEI-VKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA 164
Query: 377 --NENGVVKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLW 433
+ VK+ FGVA + V GT +MAPEV++ +PY DV+ G++L+
Sbjct: 165 SKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224
Query: 434 ELVTGKLPYDD 444
L++G LP+
Sbjct: 225 ILLSGCLPFYG 235
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 269 QDVAIKVL------TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322
+ VAIK++ + E+ I++K+ H +++ +IV E
Sbjct: 36 KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLE 94
Query: 323 FMSGGSIYDYLHKQKCGLKLP-----LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM- 376
M GG ++D + K +L L + + YLH N IIHRDLK N+L+
Sbjct: 95 LMEGGELFDKVVGNK---RLKEATCKLYFY---QMLLAVQYLHENGIIHRDLKPENVLLS 148
Query: 377 --NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIV 431
E+ ++K+ DFG +++ + +M GT ++APEV+ YN D +S G++
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
Query: 432 LWELVTGKLPYDD 444
L+ ++G P+ +
Sbjct: 209 LFICLSGYPPFSE 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 56/231 (24%), Positives = 108/231 (46%), Gaps = 12/231 (5%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+K+L E + E +++ RH + A RL V E+ +GG ++
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390
+L +++ ++ + YLH ++++RD+K NL+++++G +K+ DFG+
Sbjct: 94 FHLSRERV-FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
Query: 391 RVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL 448
+ G T GT ++APEV+E Y D + G+V++E++ G+LP+ +
Sbjct: 153 KEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 449 QAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR-----PDFSEITE 494
+ ++ + +R P P LL ++DP R D E+ E
Sbjct: 212 RLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 13/225 (5%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A K L + L + + A E I+ KV +V A L +V M+GG I
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 331 DYLHKQKCGLKLPLLL--RV---AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVA 385
H P R + G+ +LH+ NII+RDLK N+L++++G V+++
Sbjct: 274 --YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRIS 331
Query: 386 DFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD 443
D G+A T + GT +MAPE++ + Y+ D F+ G+ L+E++ + P+
Sbjct: 332 DLGLAVELKAGQTKT-KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390
Query: 444 DLTPLQAAVGVVQKGLR--PTIPVHTHPILVDLLERCWQRDPSLR 486
+ Q+ L T P P D E Q+DP R
Sbjct: 391 ARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 58/252 (23%), Positives = 111/252 (44%), Gaps = 33/252 (13%)
Query: 269 QDVAIKVL-----------TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317
+ AIKV+ + E E E+ +++ + H N+++
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAAN 373
++VTEF GG +++ + + A ++ K G+ YLH++NI+HRD+K N
Sbjct: 122 YLVTEFYEGGELFEQIINRHK-----FDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176
Query: 374 LLM---NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGI 430
+L+ N +K+ DFG++ ++ + GT ++APEV+ + YN + DV+S G+
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGV 235
Query: 431 VLWELVTGKLPYDDLTPLQAAVGVVQKGL----RPTIPVHTHPILVDLLERCWQRDPSLR 486
+++ L+ G P+ Q + V+KG + +L++ D + R
Sbjct: 236 IMYILLCGYPPFGGQN-DQDIIKKVEKGKYYFDFNDWKNISDEA-KELIKLMLTYDYNKR 293
Query: 487 PDFSEITELLQH 498
E L
Sbjct: 294 CT---AEEALNS 302
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 57/226 (25%), Positives = 112/226 (49%), Gaps = 13/226 (5%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A++V+ E +N++ ++ Q E H+ + H +V RLF V E+++GG +
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
++ +Q+ L + ++S +NYLH II+RDLK N+L++ G +K+ D+G+
Sbjct: 141 MFHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199
Query: 390 ARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP 447
+ + G T+ T GT ++APE++ + Y D ++ G++++E++ G+ P+D +
Sbjct: 200 CKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258
Query: 448 LQAAVGVVQKGL-------RPTIPVHTHPILVDLLERCWQRDPSLR 486
+ L + IP +L+ +DP R
Sbjct: 259 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 49/194 (25%), Positives = 100/194 (51%), Gaps = 24/194 (12%)
Query: 269 QDVAIKVL------TNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVT 321
+ A+K++ + E +R +E HI+R+V H +++ I + +F+V
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 322 EFMSGGSIYDYLHKQKCGLKLP-----LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
+ M G ++DYL ++ L ++R + + +++LH NNI+HRDLK N+L+
Sbjct: 180 DLMRKGELFDYLTEKV---ALSEKETRSIMR---SLLEAVSFLHANNIVHRDLKPENILL 233
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE------HQPYNHRADVFSFGI 430
++N ++++DFG + + GT ++APE+++ H Y D+++ G+
Sbjct: 234 DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
Query: 431 VLWELVTGKLPYDD 444
+L+ L+ G P+
Sbjct: 294 ILFTLLAGSPPFWH 307
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 25/198 (12%)
Query: 269 QDVAIKV-------LTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320
++ A+K+ + + +R +EV I+RKV H N++Q F+V
Sbjct: 43 KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 321 TEFMSGGSIYDYLHKQKCGLKLP-----LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+ M G ++DYL ++ L ++R + + + LH+ NI+HRDLK N+L
Sbjct: 103 FDLMKKGELFDYLTEKV---TLSEKETRKIMR---ALLEVICALHKLNIVHRDLKPENIL 156
Query: 376 MNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE------HQPYNHRADVFSFG 429
++++ +K+ DFG + + GT ++APE+IE H Y D++S G
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216
Query: 430 IVLWELVTGKLPYDDLTP 447
++++ L+ G P+
Sbjct: 217 VIMYTLLAGSPPFWHRKQ 234
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 61/234 (26%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 272 AIKVLTNEHLNENIRREFAQ---EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
A+KVL + N ++ A E +I+ +V+H +V I A +L+++ E++SGG
Sbjct: 49 AMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE 107
Query: 329 IYDYLHKQKCGLKLPLLLRVAI---DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVA 385
++ L ++ ++S + +LH+ II+RDLK N+++N G VK+
Sbjct: 108 LFMQLEREGI-FMED---TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLT 163
Query: 386 DFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD 443
DFG+ + G +T T GT +MAPE++ +N D +S G ++++++TG P+
Sbjct: 164 DFGLCKESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222
Query: 444 DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR-----PDFSEI 492
+ +++ L +P + DLL++ +R+ + R D E+
Sbjct: 223 GENRKKTIDKILKCKLN--LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEV 274
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 44/183 (24%), Positives = 94/183 (51%), Gaps = 15/183 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSGG 327
Q A+K++ ++ + N ++E + ++ H N+V+ F+V E ++GG
Sbjct: 37 QAFAVKII-SKRMEANTQKE----ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91
Query: 328 SIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVV 382
+++ + K+K + ++R + ++++H ++HRDLK NLL N+N +
Sbjct: 92 ELFERIKKKKHFSETEASYIMR---KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI 148
Query: 383 KVADFGVAR-VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
K+ DFG AR + T + APE++ Y+ D++S G++L+ +++G++P
Sbjct: 149 KIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
Query: 442 YDD 444
+
Sbjct: 209 FQS 211
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 48/183 (26%), Positives = 92/183 (50%), Gaps = 15/183 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ A+K + E+ +++K++H N+V ++V + +SGG
Sbjct: 35 KLFALKCIKKSPAFR--DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE 92
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLL---MNENGV 381
++D + ++ + A V + + YLH N I+HRDLK NLL EN
Sbjct: 93 LFDRILERGV-----YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSK 147
Query: 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
+ + DFG+++++ G+M+ GT ++APEV+ +PY+ D +S G++ + L+ G P
Sbjct: 148 IMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
Query: 442 YDD 444
+ +
Sbjct: 207 FYE 209
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 42/184 (22%), Positives = 93/184 (50%), Gaps = 13/184 (7%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
Q+ A ++ + L+ ++ +E I R ++H N+V+ + + +++ + ++GG
Sbjct: 37 QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 96
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---NENGV 381
+++ + ++ A + + + H+ ++HR+LK NLL+ +
Sbjct: 97 LFEDIVAREY-----YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAA 151
Query: 382 VKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKL 440
VK+ADFG+A V+ + GT +++PEV+ PY D+++ G++L+ L+ G
Sbjct: 152 VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
Query: 441 PYDD 444
P+ D
Sbjct: 212 PFWD 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 20/225 (8%)
Query: 272 AIKVLTNEHLNENIRREFAQEV-HIM--RKV-----RHMNVVQFIGACTRPPRLFIVTEF 323
A+KVL + + ++ +V M +++ H + Q P RLF V EF
Sbjct: 52 AVKVLKKDVILQD------DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF 105
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVK 383
++GG + ++ K + A ++ + +LH II+RDLK N+L++ G K
Sbjct: 106 VNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164
Query: 384 VADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
+ADFG+ + GV TA T GT ++APE+++ Y D ++ G++L+E++ G P
Sbjct: 165 LADFGMCKEGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
Query: 442 YDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
++ ++ + P H +L+ ++P++R
Sbjct: 224 FEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMR 266
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 65/237 (27%), Positives = 122/237 (51%), Gaps = 28/237 (11%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIM-------RKVRHMNVVQFIGACTRPPRLFIVTEFM 324
A+KVL + + ++++ +E HIM + V+H +V + +L+ V +++
Sbjct: 67 AVKVLQKKAI---LKKK--EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRV---AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+GG ++ +L +++C P R A +++ + YLH NI++RDLK N+L++ G
Sbjct: 122 NGGELFYHLQRERC-FLEP---RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH 177
Query: 382 VKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK 439
+ + DFG+ + ++ T+ T GT ++APEV+ QPY+ D + G VL+E++ G
Sbjct: 178 IVLTDFGLCKENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
Query: 440 LPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR----PDFSEI 492
P+ + ++ K L+ + + LLE Q+D + R DF EI
Sbjct: 237 PPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 49/182 (26%), Positives = 92/182 (50%), Gaps = 17/182 (9%)
Query: 269 QDVAIKVLTNEHLNENI----RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324
++ A K + L+ + R E +EV+I+R++RH N++ + ++ E +
Sbjct: 31 KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 90
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---- 376
SGG ++D+L +++ L A K G++YLH I H DLK N+++
Sbjct: 91 SGGELFDFLAEKES-----LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN 145
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
N +K+ DFG+A GT ++APE++ ++P AD++S G++ + L+
Sbjct: 146 VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
Query: 437 TG 438
+G
Sbjct: 206 SG 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIM--RKV-----RHMNVVQFIGACTRPPRLFIVTEFM 324
AIK L + + + + M ++V H + LF V E++
Sbjct: 46 AIKALKKDVV---LMDD--DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 100
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRV---AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+GG + ++ L R A ++ G+ +LH I++RDLK N+L++++G
Sbjct: 101 NGGDLMYHIQSCHK-FDLS---RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH 156
Query: 382 VKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK 439
+K+ADFG+ + T T GT ++APE++ Q YNH D +SFG++L+E++ G+
Sbjct: 157 IKIADFGMCKENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
Query: 440 LPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR 486
P+ + + P DLL + + R+P R
Sbjct: 216 SPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 55/230 (23%), Positives = 111/230 (48%), Gaps = 13/230 (5%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+K+L + + ++ E E ++ + + Q RL+ V E+++GG +
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
++ + K P + A +++ G+ +L II+RDLK N++++ G +K+ADFG+
Sbjct: 109 MYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 167
Query: 390 ARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP 447
+ GV T T GT ++APE+I +QPY D ++FG++L+E++ G+ P++
Sbjct: 168 CKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226
Query: 448 LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR-----PDFSEI 492
+ +++ + P V + + + P R +I
Sbjct: 227 DELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 274
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 4/178 (2%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ A K + H ++ + +E+ M +RH +V A + ++ EFMSGG
Sbjct: 183 NNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM--NENGVVKVAD 386
+++ + + + + V KG+ ++H NN +H DLK N++ + +K+ D
Sbjct: 241 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 300
Query: 387 FGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444
FG+ + TGT + APEV E +P + D++S G++ + L++G P+
Sbjct: 301 FGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 37/179 (20%), Positives = 81/179 (45%), Gaps = 7/179 (3%)
Query: 269 QDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ K + + + +++E + I+ RH N++ + L ++ EF+SG
Sbjct: 31 KTYMAKFVKVKGTDQVLVKKE----ISILNIARHRNILHLHESFESMEELVMIFEFISGL 86
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM--NENGVVKVA 385
I++ ++ L ++ V + + +LH +NI H D++ N++ + +K+
Sbjct: 87 DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKII 146
Query: 386 DFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444
+FG AR + APEV +H + D++S G +++ L++G P+
Sbjct: 147 EFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ E ++ G+ +Y+ + A+KVL + +R E + ++ ++ H N++
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTE----IGVLLRLSHPNII 111
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHR 361
+ P + +V E ++GG ++D + ++ R A D K + YLH
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGY-----YSERDAADAVKQILEAVAYLHE 166
Query: 362 NNIIHRDLKAANLLM---NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQP 418
N I+HRDLK NLL + +K+ADFG++++ +M GT + APE++
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 419 YNHRADVFSFGIVLWELVTGKLPYDD 444
Y D++S GI+ + L+ G P+ D
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYD 252
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 55/230 (23%), Positives = 111/230 (48%), Gaps = 13/230 (5%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+K+L + + ++ E E ++ + + Q RL+ V E+++GG +
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
++ + K P + A +++ G+ +L II+RDLK N++++ G +K+ADFG+
Sbjct: 430 MYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488
Query: 390 ARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP 447
+ GV T T GT ++APE+I +QPY D ++FG++L+E++ G+ P++
Sbjct: 489 CKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547
Query: 448 LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR-----PDFSEI 492
+ +++ + P V + + + P R +I
Sbjct: 548 DELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 595
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 269 QDVAIKVLTNEHLNEN----IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324
+ A K + + R E +EV I+R+V H N++ + ++ E +
Sbjct: 38 LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---- 376
SGG ++D+L +++ L A K G+NYLH I H DLK N+++
Sbjct: 98 SGGELFDFLAQKES-----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN 152
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
+K+ DFG+A GT ++APE++ ++P AD++S G++ + L+
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 437 TGKLPYDD 444
+G P+
Sbjct: 213 SGASPFLG 220
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 36/178 (20%), Positives = 86/178 (48%), Gaps = 4/178 (2%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ K + + + + E+ IM ++ H ++ A + ++ EF+SGG
Sbjct: 77 RVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM--NENGVVKVAD 386
++D + + + ++ +G+ ++H ++I+H D+K N++ + VK+ D
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194
Query: 387 FGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444
FG+A ++ T T + APE+++ +P D+++ G++ + L++G P+
Sbjct: 195 FGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 59/232 (25%), Positives = 112/232 (48%), Gaps = 17/232 (7%)
Query: 272 AIKVLTNEHLNENIRREFAQ---EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
A+K+L E + + E A E +++ RH + + RL V E+ +GG
Sbjct: 177 AMKILKKEVIVA--KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 234
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH-RNNIIHRDLKAANLLMNENGVVKVADF 387
++ +L +++ ++ ++YLH N+++RDLK NL+++++G +K+ DF
Sbjct: 235 LFFHLSRERV-FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293
Query: 388 GVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL 445
G+ + + G T GT ++APEV+E Y D + G+V++E++ G+LP+ +
Sbjct: 294 GLCKEGIKDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
Query: 446 TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLR-----PDFSEI 492
+ ++ + +R P P LL ++DP R D EI
Sbjct: 353 DHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEI 402
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 50/188 (26%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 269 QDVAIKVLTNEHLNENI----RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324
+ A K + + R E +EV I+R+V H NV+ + ++ E +
Sbjct: 38 LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELV 97
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---- 376
SGG ++D+L +++ L A K G+NYLH I H DLK N+++
Sbjct: 98 SGGELFDFLAQKES-----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN 152
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
+K+ DFG+A GT ++APE++ ++P AD++S G++ + L+
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 437 TGKLPYDD 444
+G P+
Sbjct: 213 SGASPFLG 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 55/244 (22%), Positives = 106/244 (43%), Gaps = 33/244 (13%)
Query: 272 AIKVLTNEHLNENIRREFAQ---EVHIMRKVRHMN-VVQFIGACTRPPRLFIVTEFMSGG 327
A+KVL + + + E ++ +R +V A +L ++ ++++GG
Sbjct: 86 AMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 144
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
++ H + R + + +LH+ II+RD+K N+L++ N
Sbjct: 145 ELF--THLSQRE-------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 380 GVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQPYNHRADV--FSFGIVLWEL 435
G V + DFG+++ A GT +MAP+++ H V +S G++++EL
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255
Query: 436 VTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILVDLLERCWQRDPSLR-----PD 488
+TG P+ + + ++ L+ P P + DL++R +DP R D
Sbjct: 256 LTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRD 315
Query: 489 FSEI 492
EI
Sbjct: 316 ADEI 319
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 42/178 (23%), Positives = 89/178 (50%), Gaps = 4/178 (2%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+A K++ + + + E E+ +M ++ H N++Q A + +V E++ GG
Sbjct: 115 LKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM--NENGVVKVAD 386
++D + + L + + +G+ ++H+ I+H DLK N+L + +K+ D
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIID 232
Query: 387 FGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD 444
FG+AR + GT ++APEV+ + + D++S G++ + L++G P+
Sbjct: 233 FGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 32/248 (12%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC----TRPPRLFIVTEF 323
Q A+K+L + + QEV + ++V + L I+ E
Sbjct: 55 QKCALKLLYD-------SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107
Query: 324 MSGGSIYDYLHKQKCGL----KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM--- 376
M GG ++ + ++ + ++R D+ + +LH +NI HRD+K NLL
Sbjct: 108 MEGGELFSRIQERGDQAFTEREAAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLYTSK 164
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
++ V+K+ DFG A+ Q + T ++APEV+ + Y+ D++S G++++ L+
Sbjct: 165 EKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 223
Query: 437 TGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP-ILV-----DLLERCWQRDPSLRPDFS 490
G P+ T + G+ ++ V L+ + DP+ R
Sbjct: 224 CGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT-- 281
Query: 491 EITELLQH 498
IT+ + H
Sbjct: 282 -ITQFMNH 288
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 45/188 (23%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 269 QDVAIKVLTNEHLNENI----RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324
A K + + R + +EV I+++++H NV+ + ++ E +
Sbjct: 37 LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM---- 376
+GG ++D+L +++ L A + K G+ YLH I H DLK N+++
Sbjct: 97 AGGELFDFLAEKES-----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 151
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
+K+ DFG+A GT ++APE++ ++P AD++S G++ + L+
Sbjct: 152 VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 437 TGKLPYDD 444
+G P+
Sbjct: 212 SGASPFLG 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 42/210 (20%)
Query: 252 KIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNE-----NIRREFAQEVHIMRKVRH 301
K+ G+Y +YK +D VA+K + + +E IR E+ +++++ H
Sbjct: 28 KVGEGTYGVVYKA----KDSQGRIVALKRIRLDAEDEGIPSTAIR-----EISLLKELHH 78
Query: 302 MNVVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNY 358
N+V I L +V EFM D L + K GL+ + + +G+ +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----MTAETGT--YRWMAPE 412
H++ I+HRDLK NLL+N +G +K+ADFG+AR +G+ T E T YR AP+
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLAR---AFGIPVRSYTHEVVTLWYR--APD 189
Query: 413 VI---EHQPYNHRADVFSFGIVLWELVTGK 439
V+ + Y+ D++S G + E++TGK
Sbjct: 190 VLMGSKK--YSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 1e-26
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 38/208 (18%)
Query: 252 KIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNE-----NIRREFAQEVHIMRKVRH 301
KI G+Y +YK Q+ A+K + E +E IR E+ I+++++H
Sbjct: 9 KIGEGTYGVVYKA----QNNYGETFALKKIRLEKEDEGIPSTTIR-----EISILKELKH 59
Query: 302 MNVVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNY 358
N+V+ RL +V E + D L + GL+ + + G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----MTAETGT--YRWMAPE 412
H ++HRDLK NLL+N G +K+ADFG+AR +G+ T E T YR AP+
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARA---FGIPVRKYTHEIVTLWYR--APD 170
Query: 413 VIEHQP-YNHRADVFSFGIVLWELVTGK 439
V+ Y+ D++S G + E+V G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 53/284 (18%), Positives = 99/284 (34%), Gaps = 67/284 (23%)
Query: 269 QDVAIKVLTNEHLNENIRREF-----AQ----EVHIMRKVRHMNVVQFIGACTRPPR--- 316
VAIK + N + + E+ ++ H N++
Sbjct: 47 IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106
Query: 317 --LFIVTEFMSGGSIYDYLHKQKCGLK-------LPLLLRVAIDVSKGMNYLHRNNIIHR 367
L++VTE M + +H Q+ + + +L G++ LH ++HR
Sbjct: 107 HKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILL-------GLHVLHEAGVVHR 158
Query: 368 DLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT--YRWMAPEVI-EHQPYNHRAD 424
DL N+L+ +N + + DF +AR T YR APE++ + + + D
Sbjct: 159 DLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVD 216
Query: 425 VFSFGIVLWELVTGK--LPYDDL------------TPLQAAVGVVQ--------KGLRPT 462
++S G V+ E+ K TP V + +
Sbjct: 217 MWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSN 276
Query: 463 IPV--------HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+P P+ +DL+ + + +P R + L+H
Sbjct: 277 VPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS---TEQALRH 317
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 43/214 (20%)
Query: 252 KIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNE-----NIRREFAQEVHIMRKVR 300
KI G+Y ++K ++ VA+K + + +E +R E+ ++++++
Sbjct: 9 KIGEGTYGTVFKA----KNRETHEIVALKRVRLDDDDEGVPSSALR-----EICLLKELK 59
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMN 357
H N+V+ +L +V EF D Y L ++ + KG+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----MTAETGT--YRWMAP 411
+ H N++HRDLK NLL+N NG +K+A+FG+AR +G+ +AE T YR P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA---FGIPVRCYSAEVVTLWYR--PP 170
Query: 412 EVI---EHQPYNHRADVFSFGIVLWELVTGKLPY 442
+V+ + Y+ D++S G + EL P
Sbjct: 171 DVLFGAKL--YSTSIDMWSAGCIFAELANAGRPL 202
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 66/274 (24%), Positives = 114/274 (41%), Gaps = 60/274 (21%)
Query: 269 QDVAIKVL--TNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMS 325
Q+ A+K++ H+ + RE V ++ + + H NV++ I R ++V E M
Sbjct: 39 QEYAVKIIEKQPGHIRSRVFRE----VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 326 GGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENG 380
GGSI ++HK++ L+ ++++ DV+ +++LH I HRDLK N+L N+
Sbjct: 95 GGSILSHIHKRRHFNELEASVVVQ---DVASALDFLHNKGIAHRDLKPENILCEHPNQVS 151
Query: 381 VVKVADFGVARV--------QAQYGVMTAETGTYRWMAPEVIE-----HQPYNHRADVFS 427
VK+ DF + + G+ +MAPEV+E Y+ R D++S
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211
Query: 428 FGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV--------------- 472
G++L+ L++G P G R +L
Sbjct: 212 LGVILYILLSGY------PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDW 265
Query: 473 --------DLLERCWQRDPSLRPDFSEITELLQH 498
DL+ + RD R ++LQH
Sbjct: 266 AHISCAAKDLISKLLVRDAKQRLS---AAQVLQH 296
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 46/194 (23%)
Query: 271 VAIKVLTNEHLNEN--------IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322
VAIK + H +E +R E+ +++++ H N++ + A + +V +
Sbjct: 38 VAIKKIKLGHRSEAKDGINRTALR-----EIKLLQELSHPNIIGLLDAFGHKSNISLVFD 92
Query: 323 FMSGGSIYD---YLHKQKCGLKLPL-------LLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
FM D + L L+ G+ YLH++ I+HRDLK
Sbjct: 93 FME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQ-------GLEYLHQHWILHRDLKPN 141
Query: 373 NLLMNENGVVKVADFGVARVQAQYGV----MTAETGT--YRWMAPEVIEHQP-YNHRADV 425
NLL++ENGV+K+ADFG+A+ +G T + T YR APE++ Y D+
Sbjct: 142 NLLLDENGVLKLADFGLAK---SFGSPNRAYTHQVVTRWYR--APELLFGARMYGVGVDM 196
Query: 426 FSFGIVLWELVTGK 439
++ G +L EL+
Sbjct: 197 WAVGCILAELLLRV 210
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 49/185 (26%), Positives = 96/185 (51%), Gaps = 25/185 (13%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRK-VRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ A+K++ + +R+ +E+ I+ + +H N++ +++VTE M GG
Sbjct: 48 MEFAVKII------DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101
Query: 328 SIYDYLHKQKCGLKLPLLL------RVAIDVSKGMNYLHRNNIIHRDLKAANLLM----N 377
+ D + +QK V ++K + YLH ++HRDLK +N+L
Sbjct: 102 ELLDKILRQKF-------FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 154
Query: 378 ENGVVKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
+++ DFG A+ ++A+ G++ T ++APEV+E Q Y+ D++S G++L+ ++
Sbjct: 155 NPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214
Query: 437 TGKLP 441
TG P
Sbjct: 215 TGYTP 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 10/222 (4%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMN---VVQFIGACTRPPRLFIVTEFMSGG 327
A+K L + + A E ++ V + +V A P +L + + M+GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
++ +L + + A ++ G+ ++H +++RDLK AN+L++E+G V+++D
Sbjct: 278 DLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 336
Query: 388 GVARVQAQYGVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLT 446
G+A A GT+ +MAPEV++ Y+ AD FS G +L++L+ G P+
Sbjct: 337 GLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395
Query: 447 PLQAAVGVVQKGLR--PTIPVHTHPILVDLLERCWQRDPSLR 486
+ + L +P P L LLE QRD + R
Sbjct: 396 TKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 34/206 (16%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNEN------IRREFAQEVHIMRKVRHMN 303
K+ G+Y +YKG VA+K + EH E IR EV +++ ++H N
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIR-----EVSLLKDLKHAN 61
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
+V L +V E++ D YL + + + + +G+ Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----MTAETGT--YRWMAPEVI 414
R ++HRDLK NLL+NE G +K+ADFG+AR + E T YR P+++
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARA---KSIPTKTYDNEVVTLWYR--PPDIL 172
Query: 415 EHQP-YNHRADVFSFGIVLWELVTGK 439
Y+ + D++ G + +E+ TG+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 248 KFE--HKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKV 299
K+E KI G++ +++K + VA+K + E+ E +E+ I++ +
Sbjct: 18 KYEKLAKIGQGTFGEVFKA----RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 300 RHMNVVQFIGACT--------RPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRV 348
+H NVV I C +++V +F +D L L + RV
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRV 129
Query: 349 AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR-----VQAQYGVMTAET 403
+ G+ Y+HRN I+HRD+KAAN+L+ +GV+K+ADFG+AR +Q T
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 404 GT--YRWMAPEVIEHQP-YNHRADVFSFGIVLWELVTGK 439
T YR PE++ + Y D++ G ++ E+ T
Sbjct: 190 VTLWYR--PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 55/248 (22%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC----TRPPRLFIVTEF 323
+ A+K+L + RRE V + + + ++V+ + L IV E
Sbjct: 88 EKFALKMLQDC---PKARRE----VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140
Query: 324 MSGGSIYDYLHKQKCGL----KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM--- 376
+ GG ++ + + + +++ + + + YLH NI HRD+K NLL
Sbjct: 141 LDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSINIAHRDVKPENLLYTSK 197
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
N ++K+ DFG A+ + +T T ++APEV+ + Y+ D++S G++++ L+
Sbjct: 198 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257
Query: 437 TGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP-ILV-----DLLERCWQRDPSLRPDFS 490
G P+ L + G+ + V L+ + +P+ R
Sbjct: 258 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT-- 315
Query: 491 EITELLQH 498
ITE + H
Sbjct: 316 -ITEFMNH 322
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 45/226 (19%), Positives = 99/226 (43%), Gaps = 17/226 (7%)
Query: 272 AIKVLTNEHLNENIRRE----FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
A+K+L + ++R F +E ++ + A L++V ++ GG
Sbjct: 103 AMKILNKWEM---LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG 159
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387
+ L K + L + ++ ++ +H+ + +HRD+K N+LM+ NG +++ADF
Sbjct: 160 DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADF 219
Query: 388 GVARVQAQYGVMTAET--GTYRWMAPEVIEHQP-----YNHRADVFSFGIVLWELVTGKL 440
G + G + + GT +++PE+++ Y D +S G+ ++E++ G+
Sbjct: 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
Query: 441 PYDDLTPLQAAVGVVQKGLRPTIPVHTHPI---LVDLLERCWQRDP 483
P+ + ++ ++ R P + DL+ R
Sbjct: 280 PFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSRE 325
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 46/248 (18%), Positives = 98/248 (39%), Gaps = 30/248 (12%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+K++ + + + E ++ + Q A L++V E+ GG +
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNENGVV 382
L K G ++P ++++ ++ +HR +HRD+K N+L++ G +
Sbjct: 150 TLL--SKFGERIPA------EMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI 201
Query: 383 KVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQ-------PYNHRADVFSFGIVLW 433
++ADFG G + + GT +++PE+++ Y D ++ G+ +
Sbjct: 202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261
Query: 434 ELVTGKLPY--DDLTPLQAAVGVVQKGLR-PTIPVHTHPILVDLLERCWQRDPSLRPDFS 490
E+ G+ P+ D + ++ L P + D ++R P R
Sbjct: 262 EMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRG 320
Query: 491 EITELLQH 498
+ H
Sbjct: 321 GAGDFRTH 328
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 72/279 (25%), Positives = 110/279 (39%), Gaps = 68/279 (24%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-------RLFIV 320
S +VAIK + + +N RE + IMR V+H NVV + A L +V
Sbjct: 64 SDEVAIKKVLQDKRFKN--RE----LQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLNLV 116
Query: 321 TEFMSGGSIYDYL-HKQKCGLKLPL---------LLRVAIDVSKGMNYLHRNNIIHRDLK 370
E++ ++Y H K +P+ LLR + Y+H I HRD+K
Sbjct: 117 LEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR-------SLAYIHSIGICHRDIK 168
Query: 371 AANLLMNEN-GVVKVADFGVARVQAQYGVMTAE--TGTYRWMAPEVI-EHQPYNHRADVF 426
NLL++ GV+K+ DFG A++ + + YR APE+I Y D++
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTNIDIW 226
Query: 427 SFGIVLWELVTGK--LPYDDL------------TPLQAAVGVVQ-------------KGL 459
S G V+ EL+ G+ P + TP + + +
Sbjct: 227 STGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPF 286
Query: 460 RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
T P +DL+ R + PS R E L H
Sbjct: 287 SKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA---LCH 322
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 75/284 (26%), Positives = 109/284 (38%), Gaps = 80/284 (28%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR------ 316
VAIK L + FA+ E+ +++ +RH NV+ + T
Sbjct: 51 AKVAIKKLYRPFQSE------LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNII 365
++V FM G + + + L +L+ G+ Y+H II
Sbjct: 105 FYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLK-------GLRYIHAAGII 150
Query: 366 HRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWM-APEVI-EHQPYNHRA 423
HRDLK NL +NE+ +K+ DFG+AR MT T RW APEVI Y
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVT-RWYRAPEVILNWMRYTQTV 207
Query: 424 DVFSFGIVLWELVTGK--LPYDDL------------TPLQAAVGVVQ--------KGLRP 461
D++S G ++ E++TGK D TP V +Q KGL
Sbjct: 208 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 267
Query: 462 TIPV-------HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ P+ V+LLE+ D R E L H
Sbjct: 268 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEALAH 308
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 70/284 (24%), Positives = 110/284 (38%), Gaps = 80/284 (28%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-------LFIVT 321
+ VAIK + + +N RE + IMRK+ H N+V+ + L +V
Sbjct: 80 ELVAIKKVLQDKRFKN--RE----LQIMRKLDHCNIVR-LRYFFYSSGEKKDEVYLNLVL 132
Query: 322 EFMSGGSIYDYL-HKQKCGLKLPL---------LLRVAIDVSKGMNYLHRNNIIHRDLKA 371
+++ ++Y H + LP+ L R + Y+H I HRD+K
Sbjct: 133 DYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFGICHRDIKP 184
Query: 372 ANLLMNEN-GVVKVADFGVARVQAQYGVMTAETGT--YRWMAPEVI-EHQPYNHRADVFS 427
NLL++ + V+K+ DFG A+ + + + YR APE+I Y DV+S
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELIFGATDYTSSIDVWS 242
Query: 428 FGIVLWELVTGK--LPYDDL------------TPLQAAVGVV-----------------Q 456
G VL EL+ G+ P D TP + + +
Sbjct: 243 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT 302
Query: 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEIT--ELLQH 498
K RP T P + L R + P+ R +T E H
Sbjct: 303 KVFRP----RTPPEAIALCSRLLEYTPTAR-----LTPLEACAH 337
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 62/295 (21%), Positives = 103/295 (34%), Gaps = 91/295 (30%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR------ 316
++VAIK L+ ++ A+ E+ +M+ V H N++ + T
Sbjct: 88 RNVAIKKLSRPFQNQ------THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNII 365
+++V E M + L + +++ L +L G+ +LH II
Sbjct: 142 VYLVMELMD----AN-LCQV---IQMELDHERMSYLLYQMLC-------GIKHLHSAGII 186
Query: 366 HRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT--YRWMAPEVIEHQPYNHRA 423
HRDLK +N+++ + +K+ DFG+AR +MT T YR APEVI Y
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVILGMGYKENV 244
Query: 424 DVFSFGIVLWELVTGK----------------------------------------LPYD 443
D++S G ++ E+V K P
Sbjct: 245 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 304
Query: 444 DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
DLL + DP+ R + + LQH
Sbjct: 305 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS---VDDALQH 356
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 71/284 (25%), Positives = 108/284 (38%), Gaps = 81/284 (28%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR------ 316
+ VAIK L+ + FA+ E+ +++ ++H NV+ + T
Sbjct: 50 EKVAIKKLSRPFQSE------IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNII 365
++V FM D L K + L +L+ G+ Y+H ++
Sbjct: 104 FYLVMPFMQ----TD-LQKI---MGLKFSEEKIQYLVYQMLK-------GLKYIHSAGVV 148
Query: 366 HRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRW-MAPEVI-EHQPYNHRA 423
HRDLK NL +NE+ +K+ DFG+AR MT T RW APEVI YN
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVT-RWYRAPEVILSWMHYNQTV 205
Query: 424 DVFSFGIVLWELVTGK--LPYDDL------------TPLQAAVGVVQ--------KGLRP 461
D++S G ++ E++TGK D P V + + L
Sbjct: 206 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ 265
Query: 462 TIPV-------HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
T P DLLE+ + D R + L H
Sbjct: 266 TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQALTH 306
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 66/261 (25%), Positives = 111/261 (42%), Gaps = 73/261 (27%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRV 348
E+ +M++++H N+V+ +L +V EFM D Y+ + G L
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELN 108
Query: 349 AI-----DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----M 399
+ + +G+ + H N I+HRDLK NLL+N+ G +K+ DFG+AR +G+
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR---AFGIPVNTF 165
Query: 400 TAETGT--YRWMAPEVIEHQP-YNHRADVFSFGIVLWELVTGK----------------- 439
++E T YR AP+V+ Y+ D++S G +L E++TGK
Sbjct: 166 SSEVVTLWYR--APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD 223
Query: 440 ---------------LP-YDDLTPLQAAVGVVQKGLRPTIPVHTHPIL----VDLLERCW 479
LP Y+ + + LR + HT L +D L
Sbjct: 224 IMGTPNESLWPSVTKLPKYNPNIQQRPP-----RDLRQVLQPHTKEPLDGNLMDFLHGLL 278
Query: 480 QRDPSLRPDFSEIT--ELLQH 498
Q +P +R ++ + L H
Sbjct: 279 QLNPDMR-----LSAKQALHH 294
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 85/292 (29%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR------LF 318
++VAIK L+ N+ A+ E+ +M+ V H N++ + T ++
Sbjct: 51 RNVAIKKLSRPFQNQ----THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHR 367
IV E M + L + +++ L +L G+ +LH IIHR
Sbjct: 107 IVMELMD----AN-LCQV---IQMELDHERMSYLLYQMLC-------GIKHLHSAGIIHR 151
Query: 368 DLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWM-APEVIEHQPYNHRADVF 426
DLK +N+++ + +K+ DFG+AR +MT T R+ APEVI Y D++
Sbjct: 152 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT-RYYRAPEVILGMGYKENVDIW 210
Query: 427 SFGIVLWELVTGK--LPYDDL------------TPLQAAVGVVQKGLR---------PTI 463
S G ++ E++ G P D TP + +Q +R
Sbjct: 211 SVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGY 270
Query: 464 PVH-----------------THPILVDLLERCWQRDPSLRPDFSEITELLQH 498
DLL + D S R + E LQH
Sbjct: 271 SFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS---VDEALQH 319
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 55/235 (23%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 272 AIKVLTNEHLNENIRRE----FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
A+K+L+ + I+R F +E IM VVQ A L++V E+M GG
Sbjct: 98 AMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
+ + + V ++ ++ +H IHRD+K N+L++++
Sbjct: 155 DLVNLMSNY----------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204
Query: 380 GVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQP----YNHRADVFSFGIVLW 433
G +K+ADFG + G++ +T GT +++PEV++ Q Y D +S G+ L+
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264
Query: 434 ELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH--PILVDLLERCWQRDPSLR 486
E++ G P+ + + ++ T P +L+ + D +R
Sbjct: 265 EMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVR 318
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 26/165 (15%)
Query: 292 EVHIMRKVR---HMNVVQFIGACT-----RPPRLFIVTEFMSGGSIYD---YLHKQKC-G 339
EV ++R++ H NVV+ + C R ++ +V E + D YL K G
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPG 116
Query: 340 LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV- 398
L + + +G+++LH N I+HRDLK N+L+ G VK+ADFG+AR Y
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 173
Query: 399 --MTAETGT--YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK 439
+T T YR APEV+ Y D++S G + E+ K
Sbjct: 174 MALTPVVVTLWYR--APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 39/213 (18%)
Query: 252 KIVSGSYCDLYKG---AFFSQDVAIKVLTNEHLNE-----NIRREFAQEVHIMRKVR--- 300
+I G+Y ++K + VA+K + + E IR EV ++R +
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-----EVAVLRHLETFE 72
Query: 301 HMNVVQFI-----GACTRPPRLFIVTEFMSGGSIYD---YLHKQK-CGLKLPLLLRVAID 351
H NVV+ R +L +V E + D YL K G+ + +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV---MTAETGT--Y 406
+ +G+++LH + ++HRDLK N+L+ +G +K+ADFG+AR Y +T+ T Y
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWY 185
Query: 407 RWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK 439
R APEV+ Y D++S G + E+ K
Sbjct: 186 R--APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 77/353 (21%), Positives = 134/353 (37%), Gaps = 97/353 (27%)
Query: 209 VENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFE--HKIVSGSYCDLYKGAF 266
+ +HHH E + G +++ A S+ ++ K+ G+Y ++YK
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSA-----APSATSIDRYRRITKLGEGTYGEVYKA-- 53
Query: 267 FSQD------VAIKVLTNEHLNE-----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315
D VAIK + EH E IR EV ++++++H N+++
Sbjct: 54 --IDTVTNETVAIKRIRLEHEEEGVPGTAIR-----EVSLLKELQHRNIIELKSVIHHNH 106
Query: 316 RLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
RL ++ E+ D Y+ K + + ++ + G+N+ H +HRDLK
Sbjct: 107 RLHLIFEYAE----NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQ 161
Query: 373 NLLMN-----ENGVVKVADFGVARVQAQYGV----MTAETGT--YRWMAPEVIEHQP-YN 420
NLL++ E V+K+ DFG+AR +G+ T E T YR PE++ Y+
Sbjct: 162 NLLLSVSDASETPVLKIGDFGLAR---AFGIPIRQFTHEIITLWYR--PPEILLGSRHYS 216
Query: 421 HRADVFSFGIVLWELVTGK--------------------------------LP-YDDLTP 447
D++S + E++ LP + P
Sbjct: 217 TSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFP 276
Query: 448 LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEIT--ELLQH 498
K L+ + +DLL + DP R I+ L+H
Sbjct: 277 KFRG-----KTLKRVLGALLDDEGLDLLTAMLEMDPVKR-----ISAKNALEH 319
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 50/222 (22%), Positives = 96/222 (43%), Gaps = 50/222 (22%)
Query: 252 KIVSGSYCDLYKG----AFFSQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQ 306
K+ G+Y +YK +D A+K + ++ R E+ ++R+++H NV+
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-----EIALLRELKHPNVIS 82
Query: 307 FIGACTRP--PRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSK------- 354
+++++ ++ +D + + +++ + K
Sbjct: 83 LQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 355 -GMNYLHRNNIIHRDLKAANLLM----NENGVVKVADFGVARVQAQYGV----MTAETGT 405
G++YLH N ++HRDLK AN+L+ E G VK+AD G AR + +
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPV 195
Query: 406 -----YRWMAPEVI---EHQPYNHRADVFSFGIVLWELVTGK 439
YR APE++ H Y D+++ G + EL+T +
Sbjct: 196 VVTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTSE 233
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 68/287 (23%), Positives = 112/287 (39%), Gaps = 82/287 (28%)
Query: 269 QDVAIKVLTN-EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR-----LF 318
VAIK ++ EH + Q E+ I+ + RH N++ P ++
Sbjct: 53 VRVAIKKISPFEHQ------TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHR 367
IV + M +Y L Q L +LR G+ Y+H N++HR
Sbjct: 107 IVQDLM-ETDLYKLLKTQ------HLSNDHICYFLYQILR-------GLKYIHSANVLHR 152
Query: 368 DLKAANLLMNENGVVKVADFGVARV----QAQYGVMTAETGT--YRWMAPEVI-EHQPYN 420
DLK +NLL+N +K+ DFG+ARV G +T T YR APE++ + Y
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR--APEIMLNSKGYT 210
Query: 421 HRADVFSFGIVLWELVTGK--LPYDDL------------TPLQAAVGVVQ--------KG 458
D++S G +L E+++ + P +P Q + +
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 459 LRPTIPV-------HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
L V + +DLL++ +P R + + + L H
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAH 314
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 60/290 (20%), Positives = 105/290 (36%), Gaps = 83/290 (28%)
Query: 269 QDVAIK-VLTNEHLNENIR---REFAQEVHIMRKVRHMNVVQFIGACTRPPR-------- 316
VAIK V+ ++ R RE Q + + + H N+VQ + +
Sbjct: 49 MSVAIKKVI------QDPRFRNREL-QIMQDLAVLHHPNIVQ-LQSYFYTLGERDRRDIY 100
Query: 317 LFIVTEFMSGGSIYDYL-HKQKCGLKLPL---------LLRVAIDVSKGMNYLHRN--NI 364
L +V E++ +++ + + + P L+R + LH N+
Sbjct: 101 LNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR-------SIGCLHLPSVNV 152
Query: 365 IHRDLKAANLLMN-ENGVVKVADFGVARVQAQYGVMTAETGT--YRWMAPEVI-EHQPYN 420
HRD+K N+L+N +G +K+ DFG A+ + A + YR APE+I +Q Y
Sbjct: 153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR--APELIFGNQHYT 210
Query: 421 HRADVFSFGIVLWELVTGK--LPYDDL------------TPLQAAVGVVQKG-------- 458
D++S G + E++ G+ D+ P + + +
Sbjct: 211 TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYN 270
Query: 459 --------LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEIT--ELLQH 498
+ + DLL Q P R + E L H
Sbjct: 271 SKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER-----MKPYEALCH 315
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 76/282 (26%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR------LF 318
VA+K L+ + A+ E+ +++ ++H NV+ + T ++
Sbjct: 55 LRVAVKKLSRPFQSI----IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHR 367
+VT M G + + + Q L +LR G+ Y+H +IIHR
Sbjct: 111 LVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILR-------GLKYIHSADIIHR 156
Query: 368 DLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRW-MAPEVI-EHQPYNHRADV 425
DLK +NL +NE+ +K+ DFG+AR A MT T RW APE++ YN D+
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVAT-RWYRAPEIMLNWMHYNQTVDI 213
Query: 426 FSFGIVLWELVTGKL---------------------PYDDLTPLQ---AAVGVVQKGLRP 461
+S G ++ EL+TG+ + L + A + P
Sbjct: 214 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP 273
Query: 462 TIPV-----HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ +P+ VDLLE+ D R + L H
Sbjct: 274 KMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQALAH 312
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 43/196 (21%), Positives = 90/196 (45%), Gaps = 33/196 (16%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-----------HMNVVQ------FIGAC 311
VA+K++ ++ E+ ++++V ++++ G
Sbjct: 45 THVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 101
Query: 312 TRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDL 369
+ +V E + G ++ + K + G+ L + +++ + G++Y+HR IIH D+
Sbjct: 102 GVH--VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDI 158
Query: 370 KAANLLMNE------NGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRA 423
K N+LM +K+AD G A ++ + +T YR +PEV+ P+ A
Sbjct: 159 KPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR--SPEVLLGAPWGCGA 216
Query: 424 DVFSFGIVLWELVTGK 439
D++S +++EL+TG
Sbjct: 217 DIWSTACLIFELITGD 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 54/297 (18%), Positives = 113/297 (38%), Gaps = 69/297 (23%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFI 308
K+ G Y ++++ + + V +K+L + R E+ I+ +R N++
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-----EIKILENLRGGPNIITLA 97
Query: 309 GACTRPPRLF----IVTEFMSG--GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN 362
+ P + + +Y L + +L+ ++Y H
Sbjct: 98 -DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCHSM 149
Query: 363 NIIHRDLKAANLLMN-ENGVVKVADFGVARVQAQYGVMTAETGTYRWM-APEVI-EHQPY 419
I+HRD+K N++++ E+ +++ D+G+A + R+ PE++ ++Q Y
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLVDYQMY 208
Query: 420 NHRADVFSFGIVLWELVTGKLP-------YDDL--------TP-LQAAVGVVQKGLRP-- 461
++ D++S G +L ++ K P YD L T L + L P
Sbjct: 209 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268
Query: 462 --TIPVHT----------------HPILVDLLERCWQRDPSLRPDFSEIT--ELLQH 498
+ H+ P +D L++ + D R +T E ++H
Sbjct: 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR-----LTAREAMEH 320
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 67/293 (22%), Positives = 109/293 (37%), Gaps = 86/293 (29%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR-------- 316
+ VAIK + + + E+ I+R++ H N+V+
Sbjct: 37 KRVAIKKIVLTDP------QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90
Query: 317 ------LFIVTEFMSGGSIYDYLHK---------QKCGLKLPLLLRVAIDVSKGMNYLHR 361
++IV E+M D L + L + LLR G+ Y+H
Sbjct: 91 LTELNSVYIVQEYME----TD-LANVLEQGPLLEEHARLFMYQLLR-------GLKYIHS 138
Query: 362 NNIIHRDLKAANLLMN-ENGVVKVADFGVARV----QAQYGVMTAETGT--YRWMAPEVI 414
N++HRDLK ANL +N E+ V+K+ DFG+AR+ + G ++ T YR +P ++
Sbjct: 139 ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR--SPRLL 196
Query: 415 -EHQPYNHRADVFSFGIVLWELVTGK---------------------LPYDDLTPLQ--A 450
Y D+++ G + E++TGK + +D L
Sbjct: 197 LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI 256
Query: 451 AVGVVQKGLRPTIPV-----HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
V + P P+ VD LE+ P R E L H
Sbjct: 257 PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT---AEEALSH 306
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 58/180 (32%), Positives = 95/180 (52%), Gaps = 15/180 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACTRPPRLFIVTE 322
Q VA+K++ N + R+ A+E+ I+ +R MNV+ + T + + E
Sbjct: 123 QHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179
Query: 323 FMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG- 380
+S ++Y+ + K K G LPL+ + A + + ++ LH+N IIH DLK N+L+ + G
Sbjct: 180 LLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR 238
Query: 381 -VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK 439
+KV DFG + + Q ++ YR APEVI Y D++S G +L EL+TG
Sbjct: 239 SGIKVIDFGSSCYEHQRVYTYIQSRFYR--APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 72/298 (24%), Positives = 109/298 (36%), Gaps = 96/298 (32%)
Query: 269 QDVAIKVLTN-EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR-----LF 318
+ VAIK + + FA E+ I++ +H N++ ++
Sbjct: 37 EIVAIKKIEPFDKP------LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90
Query: 319 IVTEFM--------SGGSIYDYLHKQK------CGLKLPLLLRVAIDVSKGMNYLHRNNI 364
I+ E M S + D H Q +K LH +N+
Sbjct: 91 IIQELMQTDLHRVISTQMLSDD-HIQYFIYQTLRAVK----------------VLHGSNV 133
Query: 365 IHRDLKAANLLMNENGVVKVADFGVARV-----------QAQYGVMTAETGT--YRWMAP 411
IHRDLK +NLL+N N +KV DFG+AR+ Q M T YR AP
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR--AP 191
Query: 412 EVI-EHQPYNHRADVFSFGIVLWELVTGK----------------------LPYDDLTPL 448
EV+ Y+ DV+S G +L EL + +DL +
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 449 Q---AAVGVVQKGLRPTIPV-----HTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ A + + P P+ +P +DLL+R DP+ R E L+H
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT---AKEALEH 306
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 50/248 (20%), Positives = 95/248 (38%), Gaps = 52/248 (20%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC----TRPPRLFIVTEF 323
+ A+K+L + RRE V + + + ++V+ + L IV E
Sbjct: 44 EKFALKMLQD---CPKARRE----VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96
Query: 324 MSGGSIYDYLHKQKCGL----KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM--- 376
+ GG ++ + + + +++ + + + YLH NI HRD+K NLL
Sbjct: 97 LDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSINIAHRDVKPENLLYTSK 153
Query: 377 NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELV 436
N ++K+ DFG A E + Y+ D++S G++++ L+
Sbjct: 154 RPNAILKLTDFG--------------------FAKETT-GEKYDKSCDMWSLGVIMYILL 192
Query: 437 TGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP-ILV-----DLLERCWQRDPSLRPDFS 490
G P+ L + G+ + V L+ + +P+ R
Sbjct: 193 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT-- 250
Query: 491 EITELLQH 498
ITE + H
Sbjct: 251 -ITEFMNH 257
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 59/310 (19%), Positives = 110/310 (35%), Gaps = 100/310 (32%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQ--------------------- 306
+ A+K + + + E+ IM+ + H+N+++
Sbjct: 33 KRFALKKVLQD-------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85
Query: 307 -----------FIGACTRPPR------LFIVTEFMSGGSIYDYL-HKQKCGLKLPL---- 344
+ L ++ E++ +++ L + G +P+
Sbjct: 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLIS 144
Query: 345 -----LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVVKVADFGVARVQAQYGV 398
L R + ++H I HRD+K NLL+N ++ +K+ DFG A+
Sbjct: 145 IYIYQLFR-------AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP 197
Query: 399 MTAETGT--YRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGK--LPYDDL-------- 445
A + YR APE++ Y D++S G V EL+ GK +
Sbjct: 198 SVAYICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRII 255
Query: 446 ----TPLQAAVGVVQ-------------KGLRPTIPVHTHPILVDLLERCWQRDPSLRPD 488
TP + + + K R +P T + +DLLE+ + +P LR +
Sbjct: 256 QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315
Query: 489 FSEITELLQH 498
E + H
Sbjct: 316 ---PYEAMAH 322
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 63/299 (21%), Positives = 109/299 (36%), Gaps = 77/299 (25%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACTRPPRLFIVT 321
+ VA+K++ N + E+ ++ + VQ + + IV
Sbjct: 40 GRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96
Query: 322 EFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
E + G S YD++ + +L + ++A + K +N+LH N + H DLK N+L ++
Sbjct: 97 ELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSD 155
Query: 381 V-------------------VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNH 421
+KV DFG A ++ T YR APEVI ++
Sbjct: 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APEVILALGWSQ 213
Query: 422 RADVFSFGIVLWELVTG----------------------------------------KLP 441
DV+S G +L E G +L
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLD 273
Query: 442 YDDLTPLQAAVGVVQKGLRPTIPVHT--HPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+D+ + V K L+ + H L DL+++ + DP+ R + E L+H
Sbjct: 274 WDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT---LREALKH 329
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 53/222 (23%), Positives = 85/222 (38%), Gaps = 71/222 (31%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR-----L 317
++VAIK + E L + E+ I+ +++ +++ L
Sbjct: 52 KNVAIKKVNRMFEDL------IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105
Query: 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS------------KGMNYLHRNNII 365
+IV E D L K L + I ++ G N++H + II
Sbjct: 106 YIVLEIAD----SD-LKK---------LFKTPIFLTEEHIKTILYNLLLGENFIHESGII 151
Query: 366 HRDLKAANLLMNENGVVKVADFGVARV-----------------------QAQYGVMTAE 402
HRDLK AN L+N++ VKV DFG+AR + +T+
Sbjct: 152 HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSH 211
Query: 403 TGT--YRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGKLP 441
T YR APE+I + Y D++S G + EL+
Sbjct: 212 VVTRWYR--APELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACTRPPRLFIVTE 322
+ VAIK++ N + + EV ++ + +V L +V E
Sbjct: 80 EWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136
Query: 323 FMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRN--NIIHRDLKAANLLMNEN 379
+S ++YD L G+ L L + A + + +L +IIH DLK N+L+
Sbjct: 137 MLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195
Query: 380 G--VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT 437
+K+ DFG + Q ++ YR +PEV+ PY+ D++S G +L E+ T
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPEVLLGMPYDLAIDMWSLGCILVEMHT 253
Query: 438 GK 439
G+
Sbjct: 254 GE 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 60/298 (20%), Positives = 103/298 (34%), Gaps = 77/298 (25%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACTRPPRLFIVTE 322
VA+K++ N R E+++++K++ V + I E
Sbjct: 46 SQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102
Query: 323 FMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ G + +++L + LP + +A + + +LH N + H DLK N+L +
Sbjct: 103 LL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161
Query: 382 -------------------VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHR 422
++VADFG A ++ T YR PEVI +
Sbjct: 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR--PPEVILELGWAQP 219
Query: 423 ADVFSFGIVLWELVTGK----------------------------------------LPY 442
DV+S G +L+E G L +
Sbjct: 220 CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVW 279
Query: 443 DDLTPLQAAVGVVQKGLRPTIPVHT--HPILVDLLERCWQRDPSLRPDFSEITELLQH 498
D+ + V K L+ + + H L DL+ R + DP+ R + E L H
Sbjct: 280 DENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT---LAEALLH 334
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 52/221 (23%), Positives = 82/221 (37%), Gaps = 72/221 (32%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR-----LFI 319
+ VAIK + + + E+ I+ ++ H +VV+ + L++
Sbjct: 79 RVVAIKKILRVFEDL----IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS------------KGMNYLHRNNIIHR 367
V E D K L R + ++ G+ Y+H I+HR
Sbjct: 135 VLEIAD----SD-FKK---------LFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHR 180
Query: 368 DLKAANLLMNENGVVKVADFGVARV----------------------------QAQYGVM 399
DLK AN L+N++ VKV DFG+AR + +
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 400 TAETGT--YRWMAPEVI-EHQPYNHRADVFSFGIVLWELVT 437
T T YR APE+I + Y DV+S G + EL+
Sbjct: 241 TGHVVTRWYR--APELILLQENYTEAIDVWSIGCIFAELLN 279
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 61/325 (18%), Positives = 109/325 (33%), Gaps = 125/325 (38%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQ----EVHIMRKVR-HMNVVQFIGACTRPPR---LF 318
+ VA+K + + ++ AQ E+ I+ ++ H N+V + R ++
Sbjct: 35 EVVAVKKIFDAFQN------STDAQRTFREIMILTELSGHENIVNLLNVL-RADNDRDVY 87
Query: 319 IVTEFMSGGSIYDYLHK----QKCGLKLPL-----------LLRVAIDVSKGMNYLHRNN 363
+V ++M D LH L L++ + YLH
Sbjct: 88 LVFDYME----TD-LHAVIRAN------ILEPVHKQYVVYQLIK-------VIKYLHSGG 129
Query: 364 IIHRDLKAANLLMNENGVVKVADFGVARV----------------------QAQYGVMTA 401
++HRD+K +N+L+N VKVADFG++R ++T
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 402 ETGT--YRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGK------------------- 439
T YR APE++ Y D++S G +L E++ GK
Sbjct: 190 YVATRWYR--APEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247
Query: 440 ----------------------LPYDDLTPLQAAVGVVQKGLRPTIPV----HTHPILVD 473
L + K + + + +D
Sbjct: 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307
Query: 474 LLERCWQRDPSLRPDFSEITELLQH 498
LL++ Q +P+ R + L+H
Sbjct: 308 LLDKLLQFNPNKRIS---ANDALKH 329
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM-----NVVQFIGACTRPPRLFIVTEF 323
+ A+KV+ N + R E I++K+++ N+V++ G + ++ E
Sbjct: 61 KYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP 117
Query: 324 MSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV- 381
+ G S+Y+ + + G + + I++ K +NYL + ++ H DLK N+L+++
Sbjct: 118 L-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176
Query: 382 ------------------------VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ 417
+K+ DFG A ++ Y T YR APEVI +
Sbjct: 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR--APEVILNL 234
Query: 418 PYNHRADVFSFGIVLWELVTGK 439
++ +D++SFG VL EL TG
Sbjct: 235 GWDVSSDMWSFGCVLAELYTGS 256
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 53/243 (21%), Positives = 91/243 (37%), Gaps = 83/243 (34%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--------VVQFIGA-----------C 311
VA+KV+ + E+ E+ +++ VR+ + VVQ + C
Sbjct: 65 VAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC 121
Query: 312 TRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDL 369
+V E + G + ++ K GL LP + ++ V +G++YLH IIH D+
Sbjct: 122 -------MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDI 173
Query: 370 KAANLLMN-------------------------------------------------ENG 380
K N+L++ E
Sbjct: 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKL 233
Query: 381 VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKL 440
VK+AD G A ++ +T YR + EV+ YN AD++S + +EL TG
Sbjct: 234 KVKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSGYNTPADIWSTACMAFELATGDY 291
Query: 441 PYD 443
++
Sbjct: 292 LFE 294
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 8e-13
Identities = 71/282 (25%), Positives = 113/282 (40%), Gaps = 35/282 (12%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNV 304
+ KI SGS+ D+Y G + ++VAIK+ + + + E I + ++ + +
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE----SKIYKMMQGGVGI 67
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL--LLRVAIDVSKGMNYLHRN 362
+V E + G S+ D C K L +L +A + + Y+H
Sbjct: 68 PTIRWCGAEGDYNVMVMELL-GPSLEDLF--NFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 363 NIIHRDLKAANLLM---NENGVVKVADFGVAR--------VQAQYGVMTAETGTYRWM-- 409
N IHRD+K N LM + +V + DFG+A+ Y TGT R+
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 410 -APEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL---TPLQAAVGVVQKGLRPTIPV 465
IE R D+ S G VL G LP+ L T Q + +K + I V
Sbjct: 185 NTHLGIEQSR---RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241
Query: 466 --HTHPI-LVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
+P L C +PD+S + +L ++L R
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 40/236 (16%), Positives = 86/236 (36%), Gaps = 47/236 (19%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEH---LNENIRREFAQEVHIMR 297
K I G + +Y S +KV +++ E + A + ++
Sbjct: 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97
Query: 298 KVRHMNVVQFIGACTRPPRL--------------FIVTEFMSGGSIYDYLHKQKCGLKLP 343
K ++++G P+ F++ + G + + +
Sbjct: 98 KWIRTRKLKYLGV----PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY--EANAKRFS 150
Query: 344 L--LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV--ADFGVAR-------- 391
+L++++ + + Y+H + +H D+KA+NLL+N +V D+G+A
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 392 VQAQYGVMTAETGTYRWMAPEVIEHQPYNH--RADVFSFGIVLWELVTGKLPYDDL 445
GT + + + H R D+ G + + +TG LP++D
Sbjct: 211 KAYAADPKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 30/279 (10%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNV 304
+ KI G++ +L G + VAIK+ E + + E +++ +
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSR-APQLHLEYRFYKQLGSGDGI 67
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL--LLRVAIDVSKGMNYLHRN 362
Q +V E + G S+ D C L +L +AI + M Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLF--DLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 363 NIIHRDLKAANLLM-----NENGVVKVADFGVAR--------VQAQYGVMTAETGTYRWM 409
N+I+RD+K N L+ V+ + DF +A+ Y + TGT R+M
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
Query: 410 APEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL---TPLQAAVGVVQKGLRPTIPV- 465
+ + + R D+ + G + + G LP+ L T + + I V
Sbjct: 185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL 244
Query: 466 -HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503
P + L + D +PD+ + +L L R
Sbjct: 245 CENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 52/281 (18%), Positives = 97/281 (34%), Gaps = 31/281 (11%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNV 304
K +I GS+ +++G Q VAIK E + + E + + +
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSD-APQLRDEYRTYKLLAGCTGI 68
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL--LLRVAIDVSKGMNYLHRN 362
+V + + G S+ D L CG K + + A + + +H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLL-GPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 363 NIIHRDLKAANLLMNENG-----VVKVADFGVAR--------VQAQYGVMTAETGTYRWM 409
++++RD+K N L+ ++ V DFG+ + Y +GT R+M
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 410 APEVIEHQPYNHRADVFSFGIVLWELVTGKLP---YDDLTPLQAAVGVVQKGLRPTIPV- 465
+ + + R D+ + G V + G LP T Q + +K +
Sbjct: 186 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245
Query: 466 -HTHPI-LVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
P + PD+ + L + +RL
Sbjct: 246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 51/240 (21%), Positives = 89/240 (37%), Gaps = 44/240 (18%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNE-HLNENIRREF-----AQEVHIMRKV 299
KI SG + +Y + + A V+ E N + E + ++K
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW 99
Query: 300 RHMNVVQFIGACTRPPRL--------------FIVTEFMSGGSIYDYLHKQKCG-LKLPL 344
+ ++G P F+V E + G + + G K
Sbjct: 100 IERKQLDYLGI----PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS--GQNGTFKKST 152
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKV--ADFGVAR--------VQA 394
+L++ I + + Y+H N +H D+KAANLL+ +V AD+G++ Q
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 395 QYGVMTAETGTYRWMAPEVIEHQPYNH--RADVFSFGIVLWELVTGKLPYDDLTPLQAAV 452
Q GT + + + H+ R+DV G + + GKLP++ AV
Sbjct: 213 QENPRKGHNGTIEFTS--LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 23/210 (10%)
Query: 248 KFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNV 304
+ KI SGS+ ++Y G +++VAIK+ + + + E I R ++ +
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE----SKIYRILQGGTGI 65
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL--LLRVAIDVSKGMNYLHRN 362
+V + + G S+ D C KL L +L +A + + ++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 363 NIIHRDLKAANLLMNENG---VVKVADFGVAR--------VQAQYGVMTAETGTYRWMAP 411
+ +HRD+K N LM V + DFG+A+ Y TGT R+ +
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182
Query: 412 EVIEHQPYNHRADVFSFGIVLWELVTGKLP 441
+ R D+ S G VL + G LP
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 38/232 (16%), Positives = 80/232 (34%), Gaps = 39/232 (16%)
Query: 248 KFEHKIVSGSYCDLYKG----------AFFSQDVAIKV------LTNEH--LNENIRREF 289
K + + LY+ Q ++K+ L NE +
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ 104
Query: 290 AQEVHIMRKVRHMNVVQFIGACTRPPRL-FIVTEFMSGGSIYDYLHKQKCGLK---LPLL 345
+ + + + +G + F+V + G S+ L +
Sbjct: 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSAL--DVSPKHVLSERSV 161
Query: 346 LRVAIDVSKGMNYLHRNNIIHRDLKAANLLM--NENGVVKVADFGVAR--------VQAQ 395
L+VA + + +LH N +H ++ A N+ + + V +A +G A V
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 396 YGVMTAETGTYRWMAPEVIEHQPYNH--RADVFSFGIVLWELVTGKLPYDDL 445
G + G +++ + H+ R+D+ S G + + + G LP+ +
Sbjct: 222 EGSRSPHEGDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 3e-08
Identities = 66/457 (14%), Positives = 130/457 (28%), Gaps = 144/457 (31%)
Query: 3 MGDTESSSSRAVDFVWSESKSRKQR-VKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHF 61
+ S S + ++ +R +K + Y L L ++
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL--------------LNVQ--- 254
Query: 62 YRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSG 121
+ A ++ ++L R T + A+T H S L H
Sbjct: 255 ---------NAKAWNAFNL--SCKILLTTRFKQVTDF-------LSAATTTHIS-LDHHS 295
Query: 122 ---SPRYLYTQFSCYPYKKRLMHEITISTNDKPKLLSQLTSL-LSEIGLNIQEAHAFSTV 177
+P + + Y + D P+ + LS I +I++ A
Sbjct: 296 MTLTPDEVKSLLLKY---------LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW-- 344
Query: 178 DGYSLDVFVVDGWPLQETEQLRNVLAKEI----PKVENHHH---VVYPVGEQEQSGINHV 230
D W ++L ++ + P V+P
Sbjct: 345 ----------DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP---------PSA 385
Query: 231 NIPAEGIDV-WE--------------IDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKV 275
+IP + + W SL++ + K + S +Y ++ +K+
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY------LELKVKL 439
Query: 276 LTNEHLNE------NIRREFAQE------------VHIMRKVRHMNVVQFIGACTRPPRL 317
L+ NI + F + HI H+ ++ T +
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH---HLKNIEHPERMTLFRMV 496
Query: 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVA-----IDVSKG---------MNYLHR-N 362
F+ F+ +D G L L ++ I + +++L +
Sbjct: 497 FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIE 556
Query: 363 NIIHRDLKAANL----LMNENGVVKVADFGVARVQAQ 395
+ K +L LM E+ + F A Q Q
Sbjct: 557 ENLICS-KYTDLLRIALMAEDEAI----FEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 4e-05
Identities = 43/320 (13%), Positives = 90/320 (28%), Gaps = 96/320 (30%)
Query: 211 NHHHVVYPVGEQEQS--GINHVNIPA--EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAF 266
+HHH+ + GE + I V A + D ++ D+ K
Sbjct: 3 HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQ----------------DMPKSIL 46
Query: 267 FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326
+++ ++ ++ R F + + V +F+ R F+++
Sbjct: 47 SKEEID-HIIMSKDAVSGTLRLFW----TLLSKQEEMVQKFVEEVLRINYKFLMSPI--- 98
Query: 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVAD 386
K + + P ++ Y+ + + ++ N A
Sbjct: 99 --------KTEQ--RQPSMMTR--------MYIEQRDRLY------------NDNQVFAK 128
Query: 387 FGVARVQA----QYGVMTAETGTY-----------RWMAPEVIEHQPYNHRADVFSFGIV 431
+ V+R+Q + ++ W+A +V F I
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK---VQCKMDFKI- 184
Query: 432 LWELVTGKL--PYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDF 489
W L P L LQ L + I + R +++
Sbjct: 185 FW-LNLKNCNSPETVLEMLQK--------LL-------YQIDPNWTSRS-DHSSNIKLRI 227
Query: 490 SEITELLQHLAQRLQTKRGL 509
I L+ L + + L
Sbjct: 228 HSIQAELRRLLKSKPYENCL 247
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 3e-07
Identities = 29/186 (15%), Positives = 57/186 (30%), Gaps = 48/186 (25%)
Query: 252 KIVSGSYCDLYKGAFFSQDVAIKVLTNEHL------NENIRREFAQEVHIMRKV------ 299
KI G + ++++ VAIK++ E ++ E E+ I +++
Sbjct: 27 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 300 ---RHMNVVQFIGAC------------------------------TRPPRLFIVTEFMSG 326
R + + +LFIV EF G
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVA 385
G D + L + ++ + + HRDL N+L+ + + K+
Sbjct: 147 GI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204
Query: 386 DFGVAR 391
+
Sbjct: 205 YTLNGK 210
|
| >2ko1_A CTR148A, GTP pyrophosphokinase; homodimer, alpha+beta, transferase, structural genomics, PSI-2, protein structure initiative; NMR {Chlorobaculum tepidum} PDB: 3ibw_A Length = 88 | Back alignment and structure |
|---|
Score = 38.0 bits (89), Expect = 6e-04
Identities = 19/84 (22%), Positives = 38/84 (45%), Gaps = 15/84 (17%)
Query: 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNV 201
I I DK + +Q+T ++S+ NI+ + DG ++ ++ T++L +
Sbjct: 7 GIRIVGEDKNGMTNQITGVISKFDTNIRTIV-LNAKDGIFTCNLMIF---VKNTDKLTTL 62
Query: 202 LAK--EIPKV---------ENHHH 214
+ K ++ V E+HHH
Sbjct: 63 MDKLRKVQGVFTVERLSNLEHHHH 86
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.68 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.67 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.54 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.11 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.74 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.49 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.24 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.93 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.63 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.49 | |
| 1u8s_A | 192 | Glycine cleavage system transcriptional repressor, | 95.98 | |
| 1zpv_A | 91 | ACT domain protein; structural genomics, PSI, prot | 95.74 | |
| 2f1f_A | 164 | Acetolactate synthase isozyme III small subunit; f | 95.6 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.5 | |
| 2nyi_A | 195 | Unknown protein; protein structure initiative, PSI | 95.28 | |
| 2ko1_A | 88 | CTR148A, GTP pyrophosphokinase; homodimer, alpha+b | 95.17 | |
| 2pc6_A | 165 | Probable acetolactate synthase isozyme III (small; | 94.85 | |
| 2fgc_A | 193 | Acetolactate synthase, small subunit; regulatory s | 92.38 | |
| 2nyi_A | 195 | Unknown protein; protein structure initiative, PSI | 88.83 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.63 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 87.36 | |
| 1u8s_A | 192 | Glycine cleavage system transcriptional repressor, | 85.36 | |
| 1y7p_A | 223 | Hypothetical protein AF1403; structural genomics, | 85.16 | |
| 3p96_A | 415 | Phosphoserine phosphatase SERB; ssgcid, structural | 81.71 | |
| 3obi_A | 288 | Formyltetrahydrofolate deformylase; structural gen | 81.54 | |
| 3nrb_A | 287 | Formyltetrahydrofolate deformylase; N-terminal ACT | 80.57 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=466.75 Aligned_cols=265 Identities=36% Similarity=0.660 Sum_probs=229.7
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
..+.|||+.+++++.++||+|+||.||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||++++++.. +
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 346799999999999999999999999998765 59999998777777777899999999999999999999998865 5
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.+|||||||+||+|.++|+.....+++..++.++.||+.||.|||+++||||||||+|||+++++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 68999999999999999987777899999999999999999999999999999999999999999999999999986543
Q ss_pred cC---ccccCCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-C---CCCC
Q 010091 396 YG---VMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR-P---TIPV 465 (518)
Q Consensus 396 ~~---~~~~~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~-p---~~~~ 465 (518)
.. ......||+.|||||++. +.+|+.++|||||||++|||+||+.||.+.++.......+..+.. | ..+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 22 234457999999999995 346899999999999999999999999988877666666665543 2 3456
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 466 ~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
.+++.+.++|.+||+.||.+||||.||++.|+.+...
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 7899999999999999999999999999999877543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=457.51 Aligned_cols=260 Identities=29% Similarity=0.565 Sum_probs=229.4
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
+.|+.++|.+.++||+|+||.||+|++. ++.||||+++.. ++...++|.+|+.+|++++|||||+++++|.
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 5788889999999999999999999864 467999999754 4556688999999999999999999999999
Q ss_pred cCCceeEEEeeccCCcccccccccc------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQK------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~ 380 (518)
..+.+|+|||||+||+|.++|++.. ..+++..++.++.||+.||.|||+++||||||||+|||+++++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 9999999999999999999997532 3689999999999999999999999999999999999999999
Q ss_pred cEEEeeeccceeccccCcc---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 010091 381 VVKVADFGVARVQAQYGVM---TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQ 456 (518)
Q Consensus 381 ~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~ 456 (518)
.+||+|||+|+........ ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.++.+....+ .
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i-~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-T 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-H
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-H
Confidence 9999999999865443221 22348999999999999999999999999999999999 99999999887766554 4
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 457 ~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
.+.++..|..+++++.+||.+||+.||.+|||+++|...|+++.+.
T Consensus 245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 4667788899999999999999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-56 Score=457.73 Aligned_cols=261 Identities=32% Similarity=0.556 Sum_probs=226.8
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~ 310 (518)
..++|+.+++.+.++||+|+||.||+|++. ++.||||+++.. +....++|.+|+.+|++++|||||+++++
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 457888899999999999999999999874 467999999754 45566889999999999999999999999
Q ss_pred eecCCceeEEEeeccCCcccccccccc--------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK--------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~--------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl 376 (518)
|.+...+|||||||++|+|.+++++.. ..+++..++.++.||+.||.|||+++||||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 999999999999999999999987532 358999999999999999999999999999999999999
Q ss_pred ccCCcEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 010091 377 NENGVVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAV 452 (518)
Q Consensus 377 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~ 452 (518)
++++.+||+|||+++...... ..+...||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+...
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999998654332 1233469999999999999999999999999999999999 999999998877654
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 453 GVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 453 ~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
. +..+.++..|..+++++.+||.+||+.||.+||||+||++.|+.+.+
T Consensus 272 ~-i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 C-ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp H-HHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred H-HHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 4 44577888899999999999999999999999999999999998865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=454.90 Aligned_cols=260 Identities=28% Similarity=0.533 Sum_probs=228.6
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~ 310 (518)
..++|+.+++++.++||+|+||.||+|++. ++.||||+++... +....++|.+|+.+|++++|||||+++|+
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 456888899999999999999999999973 4679999998653 33445789999999999999999999999
Q ss_pred eecCCceeEEEeeccCCccccccccc---------------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEE
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQ---------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~---------------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NIL 375 (518)
|...+.+|+|||||++|+|.++|... ...+++..++.++.||+.||.|||+++||||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 99999999999999999999999542 235899999999999999999999999999999999999
Q ss_pred eccCCcEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 010091 376 MNENGVVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAA 451 (518)
Q Consensus 376 l~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~ 451 (518)
+++++.+||+|||+++...... ..+...||++|||||++.+..|+.++|||||||++|||+| |..||.+.+..+..
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998654322 2334568999999999999999999999999999999999 89999999877665
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 452 VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 452 ~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
.. +..+.+++.|..+++++.+++.+||+.||.+||||+||++.|+.+
T Consensus 258 ~~-i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EM-IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH-HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 54 455667778899999999999999999999999999999988753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-56 Score=458.15 Aligned_cols=265 Identities=34% Similarity=0.606 Sum_probs=235.1
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC-CceeeEe
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNVVQFI 308 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~l~ 308 (518)
.+.|||+.++|++.++||+|+||.||+|++.+ +.||||+++... .....+.|.+|+.+|++++| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 45799999999999999999999999999754 469999998654 34446789999999999965 8999999
Q ss_pred eeeecC-CceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCC
Q 010091 309 GACTRP-PRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (518)
Q Consensus 309 ~~~~~~-~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~ 372 (518)
++|... ..+|+|||||++|+|.++|++.. ..+++..++.++.||+.||.|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998664 57899999999999999997532 34789999999999999999999999999999999
Q ss_pred cEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010091 373 NLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPL 448 (518)
Q Consensus 373 NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~ 448 (518)
|||+++++.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986544322 223458999999999999999999999999999999998 99999998877
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 449 QAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 449 ~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+.....+..+.++..|..+++++.++|.+||+.||.+||||.||++.|+++++.
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 777777888899999999999999999999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=452.98 Aligned_cols=249 Identities=26% Similarity=0.462 Sum_probs=218.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|+++++||+|+||.||+|++. |+.||||++.....++...+.|.+|+.+|++|+|||||++++++...+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45667999999999999999975 7899999999887777778899999999999999999999999999999999999
Q ss_pred eccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccc
Q 010091 323 FMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 400 (518)
||+||+|.+++...+ ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...... ..+
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 183 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccccc
Confidence 999999999997544 357899999999999999999999999999999999999999999999999998765432 223
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
...||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+.... .+..+..+++++.+||.+||+
T Consensus 184 ~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~~~L~ 262 (350)
T 4b9d_A 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSLVSQLFK 262 (350)
T ss_dssp HHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHHHHHHTC
T ss_pred ccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHHHHHHcc
Confidence 4569999999999999999999999999999999999999999998888777766544 456777899999999999999
Q ss_pred hCCCCCCCHHHHHH
Q 010091 481 RDPSLRPDFSEITE 494 (518)
Q Consensus 481 ~dP~~RPs~~eil~ 494 (518)
.||.+|||+.|+++
T Consensus 263 ~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 263 RNPRDRPSVNSILE 276 (350)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=434.11 Aligned_cols=245 Identities=29% Similarity=0.536 Sum_probs=214.8
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec----CCceeEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----PPRLFIV 320 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV 320 (518)
|++.++||+|+||.||+|++. +..||+|++.....+....+.|.+|+.+|++++|||||+++++|.. ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 477889999999999999986 6789999999877777777899999999999999999999998854 3568999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEecc-CCcEEEeeeccceeccccC
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNE-NGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~~-~~~vkL~DFG~a~~~~~~~ 397 (518)
||||+||+|.+++.+ ...+++..++.++.||+.||+|||++| ||||||||+|||++. +|.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999999999999987 567999999999999999999999999 999999999999974 799999999999864432
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHHHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR-PTIPVHTHPILVDLLE 476 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~L~~Li~ 476 (518)
......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..........+..+.. +.++..+++++.+||.
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 264 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence 3344679999999999875 5999999999999999999999999887666655555555543 3456678899999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
+||+.||.+|||++|+++
T Consensus 265 ~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 265 GCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=443.04 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=223.2
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
+......|++.++||+|+||.||+|++. |+.||||+++..... .+|+.+|++++|||||++++++...+.+
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3444556788999999999999999976 789999999875432 4699999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-cEEEeeeccceecccc
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFGVARVQAQY 396 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-~vkL~DFG~a~~~~~~ 396 (518)
|||||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+.....
T Consensus 126 ~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999999999987 45799999999999999999999999999999999999999987 6999999999875443
Q ss_pred Cc------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcH
Q 010091 397 GV------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR-PTIPVHTHP 469 (518)
Q Consensus 397 ~~------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~-p~~~~~~~~ 469 (518)
.. .....||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+...... ..++..+++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 284 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP 284 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCH
Confidence 21 12235999999999999999999999999999999999999999887766555555544332 346778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
.+.++|.+||++||.+|||+.|+++.|...++++..
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 999999999999999999999999999999888763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=437.69 Aligned_cols=251 Identities=26% Similarity=0.421 Sum_probs=214.2
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC-----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
.++.++|++.+.||+|+||.||+|+.. ++.||||+++...........+.+|+.+|++++|||||++++++...+
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 456678888999999999999999862 567999999875544333356888999999999999999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.+|+|||||+||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999999987 55799999999999999999999999999999999999999999999999999986433
Q ss_pred c-CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 396 Y-GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 396 ~-~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
. .......||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+... .+.+|..+++++.+|
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 256 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSL 256 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCcCCHHHHHH
Confidence 3 3344567999999999999999999999999999999999999999998888777666654 345778899999999
Q ss_pred HHHhhhhCCCCCCCH-----HHHHH
Q 010091 475 LERCWQRDPSLRPDF-----SEITE 494 (518)
Q Consensus 475 i~~cL~~dP~~RPs~-----~eil~ 494 (518)
|.+||+.||.+|||+ +|+++
T Consensus 257 i~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 257 LRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHcccCHHHCCCCCcCCHHHHHc
Confidence 999999999999984 56553
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=439.25 Aligned_cols=245 Identities=31% Similarity=0.480 Sum_probs=216.3
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
..|++.++||+|+||.||+|++. |+.||||++....... .+.+.+|+.+|++++|||||++++++...+.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 34666999999999999999985 7899999997654332 3568899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
||+||+|.+++.+ ..+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...... ..+.
T Consensus 152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9999999999875 469999999999999999999999999999999999999999999999999998765433 3455
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCW 479 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~L~~Li~~cL 479 (518)
..||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.. ...+.+ +..+++++.+||.+||
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-~~~~~~~~~~~~s~~~~dli~~~L 308 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLL 308 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SSCCCCSCGGGSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccccCCHHHHHHHHHHc
Confidence 6799999999999999999999999999999999999999999888776655444 443333 3468999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
+.||.+|||+.|+++
T Consensus 309 ~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 309 VRDPAQRATAAELLK 323 (346)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred CCChhHCcCHHHHhc
Confidence 999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=426.16 Aligned_cols=245 Identities=25% Similarity=0.455 Sum_probs=202.2
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|++.+.||+|+||.||+|++. |+.||||++......+ .....+.+|+.+|++++|||||++++++...+.+|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5667999999999999999964 7899999998765433 335789999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
|+ +|+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...........
T Consensus 94 y~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 171 (275)
T 3hyh_A 94 YA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171 (275)
T ss_dssp CC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred CC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence 99 7899999977 457999999999999999999999999999999999999999999999999999876655555567
Q ss_pred CCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 403 TGTYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
.||+.|||||++.+..+ +.++|||||||++|+|+||+.||.+.+..+....+... .+.+|..+++++.++|.+||+.
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLIKRMLIV 249 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHSCS
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccC
Confidence 89999999999998876 57999999999999999999999988766655544432 4567788999999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
||.+|||++|+++
T Consensus 250 dP~~R~s~~eil~ 262 (275)
T 3hyh_A 250 NPLNRISIHEIMQ 262 (275)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhHCcCHHHHHc
Confidence 9999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=436.51 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=219.6
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
.++|++.++||+|+||.||+|++. ++.||||++...... +.....+.+|+.+|++++|||||++++++...+.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 345777999999999999999975 789999999865332 23347889999999999999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC---
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG--- 397 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~--- 397 (518)
||||+||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 111 mEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 111 LSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999999999999987 5679999999999999999999999999999999999999999999999999998764332
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
......||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+... .+.+|..+++++.+||.+
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--EYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTCCHHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCcccCHHHHHHHHH
Confidence 233457999999999999999999999999999999999999999998887777666654 356778899999999999
Q ss_pred hhhhCCCCCCCHHHHH
Q 010091 478 CWQRDPSLRPDFSEIT 493 (518)
Q Consensus 478 cL~~dP~~RPs~~eil 493 (518)
||+.||.+|||++|++
T Consensus 268 lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 268 LLVLDATKRLGCEEME 283 (311)
T ss_dssp HSCSSGGGSTTSGGGT
T ss_pred HccCCHhHCcChHHHc
Confidence 9999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=440.28 Aligned_cols=245 Identities=31% Similarity=0.473 Sum_probs=216.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
..|++.++||+|+||.||+|++. |+.||||++....... .+.+.+|+.+|++++|||||+++++|...+.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 45677999999999999999986 7899999998654332 3568899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
||+||+|.+++.. ..+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...... ....
T Consensus 229 y~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 229 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9999999999865 359999999999999999999999999999999999999999999999999998765433 3445
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHHhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--TIPVHTHPILVDLLERCW 479 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~L~~Li~~cL 479 (518)
..||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++.+....+.. ...+ ..+..+++++.+||.+||
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-~~~~~~~~~~~~s~~~~dli~~~L 385 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLL 385 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCSCTTSSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCcccccCCHHHHHHHHHHc
Confidence 6799999999999999999999999999999999999999999888777665544 3333 334578999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
+.||.+|||+.|+++
T Consensus 386 ~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 386 VRDPAQRATAAELLK 400 (423)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred CCChhHCcCHHHHhc
Confidence 999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=422.87 Aligned_cols=253 Identities=27% Similarity=0.511 Sum_probs=205.5
Q ss_pred ccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC----ceeEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP----RLFIV 320 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~----~~~lV 320 (518)
.+|.+.++||+|+||.||+|++.|+.||||+++... .....+..|+..+.+++|||||+++++|.... .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 357779999999999999999999999999997542 11223345777778899999999999997653 57999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC--------CceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN--------NIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~--------gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
||||+||+|.++++.. .+++..+++++.|++.||.|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999999763 589999999999999999999987 999999999999999999999999999987
Q ss_pred ccccCc-----cccCCCCCcccChhhhcCC------CCCchhhHHHHHHHHHHHHcCCCCCC----------CCC-----
Q 010091 393 QAQYGV-----MTAETGTYRWMAPEVIEHQ------PYNHRADVFSFGIVLWELVTGKLPYD----------DLT----- 446 (518)
Q Consensus 393 ~~~~~~-----~~~~~gt~~y~APE~l~~~------~~~~ksDV~SlGill~eLltG~~P~~----------~~~----- 446 (518)
...... .....||+.|||||++.+. .++.++|||||||++|||+||..||. ...
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 654332 1224699999999999654 36789999999999999999976553 221
Q ss_pred HHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 447 PLQAAVGVVQKGLRPTIPVHT-----HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 447 ~~~~~~~~~~~~~~p~~~~~~-----~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
..+....+...+++|.+|... +..+.+|+.+||+.||.+||||.||++.|+++.++
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 122333344566778777543 34689999999999999999999999999988654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=414.19 Aligned_cols=245 Identities=23% Similarity=0.403 Sum_probs=192.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC--------
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-------- 315 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~-------- 315 (518)
+|++.+.||+|+||.||+|++. |+.||||+++... .+...+.|.+|+.+|++++|||||+++++|...+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4677999999999999999976 7899999997653 3445678999999999999999999999986443
Q ss_pred ----ceeEEEeeccCCccccccccccC--CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 316 ----RLFIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 316 ----~~~lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
.+|+|||||+||+|.+++..... ..+...++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 37999999999999999976432 245566889999999999999999999999999999999999999999999
Q ss_pred ceeccccC-------------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 010091 390 ARVQAQYG-------------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ 456 (518)
Q Consensus 390 a~~~~~~~-------------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~ 456 (518)
|+...... ..+...||+.|||||++.+..|+.++|||||||++|||++ ||............+.
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~ 241 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR 241 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh
Confidence 98654322 1223469999999999999999999999999999999996 7765332222222222
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 457 ~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....|......++.+.++|.+||+.||.+|||+.|+++
T Consensus 242 ~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22233333345667889999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=412.55 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=211.3
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec------CCc
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------PPR 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~------~~~ 316 (518)
++|+++++||+|+||.||+|++. |+.||||+++...........+.+|+.+|++++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 56888999999999999999975 7899999998776666667889999999999999999999998753 467
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|||||||+ |+|.+++.+ .+.+++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 899999995 689999977 568999999999999999999999999999999999999999999999999999864332
Q ss_pred -----CccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 010091 397 -----GVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT-------- 462 (518)
Q Consensus 397 -----~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~-------- 462 (518)
...+...||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+......+.
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 223456799999999998765 569999999999999999999999999887776655543221111
Q ss_pred --------------C-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 --------------I-------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 --------------~-------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. ....++++.+||.+||+.||.+|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1 1246788999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=394.07 Aligned_cols=270 Identities=41% Similarity=0.699 Sum_probs=231.2
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
..+.|+|...+|++.++||+|+||.||+|++.++.||||++............|.+|+.++++++||||+++++++....
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 45678899999999999999999999999999999999999887777777788999999999999999999999999999
Q ss_pred ceeEEEeeccCCccccccccccC--CCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
..|+||||+++++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999976432 3899999999999999999999999 9999999999999999999999999997
Q ss_pred eccccC-ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 392 VQAQYG-VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 392 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+.............++..+++.
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 654432 2233568999999999999999999999999999999999999999998887776666666778888899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
+.++|.+||+.||.+|||+.++++.|+.+++....
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999999876543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=421.85 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=222.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.+.||+|+||.||+|+.. |+.||+|++.... ......+.+|+.+|++++|||||++++++.....+|+|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 46888999999999999999975 7899999997653 3345778899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC--CcEEEeeeccceeccccCccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN--GVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~--~~vkL~DFG~a~~~~~~~~~~ 400 (518)
||+||+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.........
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 999999999998767789999999999999999999999999999999999999854 899999999999876655555
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHHHh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILVDLLERC 478 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~L~~Li~~c 478 (518)
...||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+....+....+. ......+++++.+||.+|
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~ 394 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 394 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTT
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999999888877666654443 333457899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||+.|+++
T Consensus 395 L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 395 LLADPNTRMTIHQALE 410 (573)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999876
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=372.63 Aligned_cols=260 Identities=33% Similarity=0.638 Sum_probs=231.0
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
+.|.|+.++|++.+.||+|+||.||++++. ++.||+|++....... ..+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 469999999999999999999999999984 6789999998765543 568899999999999999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999999876777999999999999999999999999999999999999999999999999999754332
Q ss_pred C--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 397 G--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 397 ~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
. ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+.... +..+..+..+...++.+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLASTHVYQ 238 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTSCHHHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HhcCccCCCCCcCCHHHHH
Confidence 2 2233457788999999999999999999999999999999 9999998887665544 4445677778888999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
++.+||+.||.+|||+.++++.|+.+.+
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999998865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=396.72 Aligned_cols=264 Identities=33% Similarity=0.627 Sum_probs=233.8
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
.+.|+++.++|++.++||+|+||.||+|++. ++.||||+++.. ........|.+|+.+|++++||||+++++++...
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 4679999999999999999999999999985 788999999854 3445557899999999999999999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
...|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999998766679999999999999999999999999999999999999999999999999998643
Q ss_pred ccCcc---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 395 QYGVM---TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 395 ~~~~~---~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
..... ....++..|+|||++.+..++.++||||||+++|||++ |..||...+..+.. ..+..+.++..+..+++.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-EFVEKGGRLPCPELCPDA 343 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-HHHHTTCCCCCCTTCCHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCCCCCCCHH
Confidence 32111 11224678999999998899999999999999999998 99999998876554 445556777788889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+.++|.+||+.||.+|||+.++++.|+.+.+.
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=372.10 Aligned_cols=259 Identities=30% Similarity=0.571 Sum_probs=233.6
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC--Cc
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PR 316 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~--~~ 316 (518)
.++++.++|++.+.||+|+||.||+|++.++.||+|+++....+......|.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 3567778888899999999999999999999999999998877777778899999999999999999999999876 78
Q ss_pred eeEEEeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
.|+||||+++++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+||+++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 8999999999999999987543 5899999999999999999999999 999999999999999999999999887542
Q ss_pred cccCccccCCCCCcccChhhhcCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 394 AQYGVMTAETGTYRWMAPEVIEHQPYNH---RADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~~~~~~~---ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
.. ....||+.|+|||.+.+..++. ++||||||+++|+|++|+.||......+........+.++..+..+++.
T Consensus 164 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 164 QS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp SC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred cc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 22 2356899999999998765544 8999999999999999999999999888887878888888999999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
+.+++.+||+.||.+|||++++++.|+.+.+
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9999999999999999999999999998743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=392.95 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=196.0
Q ss_pred ccceeeeEEeEecceEEEEEEEC-----CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 318 (518)
+.|++.++||+|+||.||+|+.. ++.||+|++..... ...+.+|+.+|+++ +|||||++++++...+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 34666999999999999999863 46799999876432 35678899999998 6999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-CcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-~~vkL~DFG~a~~~~~~~ 397 (518)
+||||++|++|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999999984 48999999999999999999999999999999999999877 899999999997543211
Q ss_pred -----------------------------ccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC-
Q 010091 398 -----------------------------VMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLT- 446 (518)
Q Consensus 398 -----------------------------~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~- 446 (518)
..+...||+.|+|||++.+. .|+.++||||+||++|||++|+.||...+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 12334699999999999765 58999999999999999999999995433
Q ss_pred HHHHHHHHHh------------------------------------cCC----------------CCCCCCCCcHHHHHH
Q 010091 447 PLQAAVGVVQ------------------------------------KGL----------------RPTIPVHTHPILVDL 474 (518)
Q Consensus 447 ~~~~~~~~~~------------------------------------~~~----------------~p~~~~~~~~~L~~L 474 (518)
..+....+.. ... ........++++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 2222221110 000 001123567889999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~ 494 (518)
|.+||+.||.+|+|++|+++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=389.29 Aligned_cols=265 Identities=29% Similarity=0.595 Sum_probs=231.6
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC---------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeE
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~---------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l 307 (518)
..|++..+.|++.+.||+|+||.||+|++. +..||||+++... .......+.+|+.+++++ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 457888889999999999999999999863 2459999998653 344567899999999999 89999999
Q ss_pred eeeeecCCceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCC
Q 010091 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (518)
Q Consensus 308 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~ 372 (518)
++++...+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 999999999999999999999999997643 24788999999999999999999999999999999
Q ss_pred cEEeccCCcEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010091 373 NLLMNENGVVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPL 448 (518)
Q Consensus 373 NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~ 448 (518)
|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999998654432 1233457889999999999999999999999999999999 99999987765
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 449 QAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 449 ~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
+.. ..+..+.++..+..+++++.++|.+||+.||.+|||+.|+++.|+++++...
T Consensus 313 ~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 313 ELF-KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp GHH-HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHH-HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 544 4455567788888999999999999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=382.42 Aligned_cols=265 Identities=34% Similarity=0.569 Sum_probs=230.9
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC-----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
.+++...+|++.+.||+|+||.||+|++. +..||||+++... .......|.+|+.++++++||||+++++++..
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 46788899999999999999999999974 2359999998653 45556889999999999999999999999999
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
....|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999876678999999999999999999999999999999999999999999999999999875
Q ss_pred cccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 394 AQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 394 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +..+..+..+..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-VEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCCCCCCCCcC
Confidence 44321 222346788999999998999999999999999999999 9999998887665544 44466777888899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
+.+.++|.+||+.||.+|||+.++++.|+.+++....
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 9999999999999999999999999999999875543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=371.48 Aligned_cols=263 Identities=31% Similarity=0.631 Sum_probs=231.2
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
....|+++.++|++.+.||+|+||.||++.+.+ ..||+|+++...... ..+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 456899999999999999999999999999875 579999998765543 5688999999999999999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
...|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999998866789999999999999999999999999999999999999999999999999997543
Q ss_pred ccC--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 395 QYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 395 ~~~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+.... +..+.....+...++.+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKV 250 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCCCCCCTTCCHHH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-HhcccCCCCCCcCCHHH
Confidence 322 1223447788999999998899999999999999999998 9999999887666554 44466777788889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
.+++.+||+.||.+|||+.++++.|++++++
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999999999999865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=399.46 Aligned_cols=258 Identities=33% Similarity=0.654 Sum_probs=228.9
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC-
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP- 315 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~- 315 (518)
.+.|+|+.++|++.++||+|+||.||+|++.++.||||+++... ..+.|.+|+.+|++++||||+++++++....
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 35799999999999999999999999999999999999998654 2367999999999999999999999986655
Q ss_pred ceeEEEeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
.+|+||||+++|+|.+++.+... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 79999999999999999987543 37899999999999999999999999999999999999999999999999998543
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
.. .....++..|+|||++.+..++.++||||||+++|||++ |..||...+..+... .+..+.++..+..+++.+.+
T Consensus 341 ~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-~i~~~~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 341 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RVEKGYKMDAPDGCPPAVYD 417 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-HHHTTCCCCCCTTCCHHHHH
T ss_pred cc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCcCCHHHHH
Confidence 32 222467889999999999999999999999999999998 999999887665543 35567788888999999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
+|.+||+.||.+|||+.++++.|+++.+
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=385.06 Aligned_cols=267 Identities=33% Similarity=0.602 Sum_probs=233.0
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeE
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l 307 (518)
....|++..++|++.++||+|+||.||+|++. ++.||||+++... .......|.+|+.+++++ +||||+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45689999999999999999999999999853 3679999998653 344457899999999999 78999999
Q ss_pred eeeeecCC-ceeEEEeeccCCccccccccccC------------------------------------------------
Q 010091 308 IGACTRPP-RLFIVTEFMSGGSIYDYLHKQKC------------------------------------------------ 338 (518)
Q Consensus 308 ~~~~~~~~-~~~lV~Ey~~ggsL~~~l~~~~~------------------------------------------------ 338 (518)
++++.... .+|+||||++||+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99987754 48999999999999999976432
Q ss_pred -----------------CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---
Q 010091 339 -----------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--- 398 (518)
Q Consensus 339 -----------------~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 398 (518)
.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 188899999999999999999999999999999999999999999999999986533221
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
.....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+.....+..+..+..+..+++++.+++.+
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 223447889999999999999999999999999999998 9999998876666767777777888888899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 478 CWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
||+.||.+|||+.|+++.|+.+++..
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=374.60 Aligned_cols=265 Identities=35% Similarity=0.697 Sum_probs=217.6
Q ss_pred CCCCceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 235 EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 235 ~~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
...+.|+|...+|++.++||+|+||.||+|++.+ .||+|+++...........|.+|+.++++++||||+++++++ ..
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 3567889999999999999999999999998665 599999998777777778999999999999999999999965 55
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
...++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 67899999999999999998767789999999999999999999999999999999999999999999999999997544
Q ss_pred cc---CccccCCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCC---CC
Q 010091 395 QY---GVMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPT---IP 464 (518)
Q Consensus 395 ~~---~~~~~~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~---~~ 464 (518)
.. .......||+.|+|||++. +..++.++||||||+++|+|++|+.||......+.....+..+. .+. ..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 32 1223346899999999986 66788999999999999999999999998776666655554443 222 33
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 465 ~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
..+++.+.++|.+||+.||.+|||+.++++.|+++.+
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 5678999999999999999999999999999988753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=380.83 Aligned_cols=247 Identities=28% Similarity=0.476 Sum_probs=222.3
Q ss_pred ccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
..|++.+.||+|+||.||+|++ .|+.||||++.....+......+.+|+.++++++||||+++++++.....+|+|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4566799999999999999997 47899999999877777777889999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
|++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 95 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 173 (328)
T 3fe3_A 95 YASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF 173 (328)
T ss_dssp CCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTT
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccc
Confidence 9999999999977 457999999999999999999999999999999999999999999999999999876655555667
Q ss_pred CCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 403 TGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~-~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
.||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+... ...+|...++++.++|.+||+.
T Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~ 251 (328)
T 3fe3_A 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFYMSTDCENLLKRFLVL 251 (328)
T ss_dssp SSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHCCS
T ss_pred cCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHCCC
Confidence 799999999999888775 7999999999999999999999998877766555543 3456777899999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
||.+|||++|+++
T Consensus 252 dP~~R~t~~eil~ 264 (328)
T 3fe3_A 252 NPIKRGTLEQIMK 264 (328)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=368.62 Aligned_cols=260 Identities=32% Similarity=0.597 Sum_probs=229.2
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
.|++..++|++.+.||+|+||.||++++.+ ..||+|+++...... ..+.+|+.++++++||||+++++++......
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 478888899999999999999999999875 579999998765543 5688999999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999998866679999999999999999999999999999999999999999999999999998654433
Q ss_pred c--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 V--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 ~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
. .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+..... ..+.....+...++.+.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCCCCCTTSCHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH-HcCCCCCCCCcChHHHHHH
Confidence 2 223346778999999998889999999999999999999 99999988877665543 3455666777789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+.+||+.||.+|||+.++++.|+.+.++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 9999999999999999999999887543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=414.26 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=207.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc----CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL----NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~----~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
++|++.++||+|+||.||+|+.. |+.||||++..... ..........++.+++.++|||||+++++|.....+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 34556999999999999999975 78999999975432 2222233344567778889999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
+|||||+||+|.++|.+ .+.+++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 269 lVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp EEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 99999999999999987 5679999999999999999999999999999999999999999999999999998765433
Q ss_pred cccCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLT---PLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~---~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
..+.+||+.|||||++. +..|+.++|+|||||++|||++|..||.+.+ ..+....+. ...+.+|..+++++.+|
T Consensus 347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~~~~~~p~~~S~~a~dL 424 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPELRSL 424 (689)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--CCCCCCCccCCHHHHHH
Confidence 34467999999999996 4679999999999999999999999997532 222222222 34566788899999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHH
Q 010091 475 LERCWQRDPSLRPD-----FSEITE 494 (518)
Q Consensus 475 i~~cL~~dP~~RPs-----~~eil~ 494 (518)
|.+||+.||.+|++ ++||++
T Consensus 425 I~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 425 LEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHccCCHhHCCCCCCCCHHHHhc
Confidence 99999999999987 677764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=369.39 Aligned_cols=265 Identities=29% Similarity=0.574 Sum_probs=220.0
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~ 311 (518)
...|++..++|++.+.||+|+||.||+|.+.. ..||+|+++... .+.....|.+|+.++++++||||+++++++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 34689999999999999999999999999752 459999987643 445568899999999999999999999998
Q ss_pred ecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 312 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
. .+..|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 5 467899999999999999998766679999999999999999999999999999999999999999999999999998
Q ss_pred eccccCc--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 392 VQAQYGV--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 392 ~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +..+..+..+..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~ 243 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGERLPMPPNCP 243 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCCCCTTCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH-HHcCCCCCCCCCCC
Confidence 6544322 222346789999999998999999999999999999997 9999998776655444 33455666778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
+.+.++|.+||+.||.+|||+.++++.|+.++++..
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999987754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=379.73 Aligned_cols=266 Identities=32% Similarity=0.494 Sum_probs=224.2
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
+.+..++|++.++||+|+||.||++++. ++.||+|++... +......|.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 4566778888999999999999999976 788999998553 455668899999999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999998866789999999999999999999999999999999999999999999999999998654322
Q ss_pred cc---------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHhcCCCC
Q 010091 398 VM---------------TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVG-VVQKGLRP 461 (518)
Q Consensus 398 ~~---------------~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~-~~~~~~~p 461 (518)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|..||....+...... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 11 134689999999999999999999999999999999999999875332110000 00001122
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 010091 462 TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKR 507 (518)
Q Consensus 462 ~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~ 507 (518)
..+..+++.+.+++.+||+.||.+|||+.++++.|+.+...+....
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 3456678889999999999999999999999999999988876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=372.78 Aligned_cols=263 Identities=26% Similarity=0.481 Sum_probs=220.1
Q ss_pred eeeccccceeeeEEeEecceEEEEEEE------CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
.++...+|++.++||+|+||.||++++ .++.||||++... .......|.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456677888899999999999999985 3678999999754 44556789999999999999999999998844
Q ss_pred --CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 314 --PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 314 --~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
...+|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999998866679999999999999999999999999999999999999999999999999998
Q ss_pred eccccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHH
Q 010091 392 VQAQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL---------------QAAV 452 (518)
Q Consensus 392 ~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~---------------~~~~ 452 (518)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 6544321 22334778899999999999999999999999999999999998643211 1222
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 453 GVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 453 ~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
..+..+.+...+..+++++.++|.+||+.||.+|||+.|+++.|+.+.+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 3344556777788899999999999999999999999999999999987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=372.37 Aligned_cols=267 Identities=30% Similarity=0.583 Sum_probs=235.7
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEe
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~ 308 (518)
...|++..++|++.+.||+|+||.||+|++. ++.||+|+++... .......+.+|+.+++++ +||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 4579999999999999999999999999862 4689999998653 334457899999999999 999999999
Q ss_pred eeeecCCceeEEEeeccCCccccccccccC-----------------CCChHHHHHHHHHhHHHHHHHHHCCceecCCCC
Q 010091 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKC-----------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371 (518)
Q Consensus 309 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~-----------------~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp 371 (518)
+++...+..|+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999999976432 489999999999999999999999999999999
Q ss_pred CcEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCH
Q 010091 372 ANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTP 447 (518)
Q Consensus 372 ~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~ 447 (518)
+||+++.++.+||+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999986554332 122346788999999999999999999999999999999 9999998776
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 448 LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 448 ~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
.......+....++..+..+++.+.+++.+||+.||.+|||+.|+++.|++++++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 666666677777777788899999999999999999999999999999999987653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=362.99 Aligned_cols=259 Identities=34% Similarity=0.646 Sum_probs=229.8
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
.|.|+.++|++.+.||+|+||.||++++. ++.||+|++....... +.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 58999999999999999999999999985 6789999998765443 5788999999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999999999998766779999999999999999999999999999999999999999999999999997643321
Q ss_pred --ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 --VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 --~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
......++..|+|||++.+..++.++||||||+++|+|++ |..||......+.... +..+..+..+...++.+.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTSCHHHHHH
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH-HhcCCcCCCCccCcHHHHHH
Confidence 1223457789999999998899999999999999999999 8999998876665544 44466677778889999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
+.+||+.||.+|||+.++++.|+.+.+
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=379.94 Aligned_cols=266 Identities=28% Similarity=0.522 Sum_probs=228.8
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~ 311 (518)
.|++..+.|++.+.||+|+||.||+|++.+ +.||||+++... .......|.+|+.++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 467888889999999999999999999764 679999998653 445568899999999999999999999999
Q ss_pred ecCCceeEEEeeccCCcccccccccc-----------------------CCCChHHHHHHHHHhHHHHHHHHHCCceecC
Q 010091 312 TRPPRLFIVTEFMSGGSIYDYLHKQK-----------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368 (518)
Q Consensus 312 ~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrD 368 (518)
......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999997632 4689999999999999999999999999999
Q ss_pred CCCCcEEeccCCcEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 010091 369 LKAANLLMNENGVVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDD 444 (518)
Q Consensus 369 Lkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~ 444 (518)
|||+||+++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999997643322 1223457889999999998899999999999999999999 9999998
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 445 LTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 445 ~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
....+.... +..+..+..+..+++.+.++|.+||+.||.+|||+.++++.|+++.+....+
T Consensus 280 ~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 280 MAHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp SCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred CChHHHHHH-HhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence 887665544 3445556677889999999999999999999999999999999988766544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=383.30 Aligned_cols=269 Identities=30% Similarity=0.582 Sum_probs=236.2
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC---------ccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCcee
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVV 305 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~---------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv 305 (518)
....|++..++|.+.++||+|+||.||+|++.+ ..||||+++... .......+.+|+.+++++ +||||+
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhh
Confidence 345789999999999999999999999999642 469999998653 455568899999999999 999999
Q ss_pred eEeeeeecCCceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCC
Q 010091 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370 (518)
Q Consensus 306 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLk 370 (518)
++++++...+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 218 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999999999999999999999999997643 358999999999999999999999999999999
Q ss_pred CCcEEeccCCcEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 010091 371 AANLLMNENGVVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLT 446 (518)
Q Consensus 371 p~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~ 446 (518)
|+|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998654432 2233457889999999999999999999999999999999 999999887
Q ss_pred HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 447 PLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 447 ~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
..+.. ..+..+.++..+..+++++.++|.+||+.||.+|||+.|+++.|++++......
T Consensus 299 ~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 299 VEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHHH-HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHHH-HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 65544 445566777888899999999999999999999999999999999998766543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=365.61 Aligned_cols=256 Identities=34% Similarity=0.671 Sum_probs=216.0
Q ss_pred eeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCH--HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNE--NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~--~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+++..+|++.+.||+|+||.||+|++.++.||||+++...... ...+.+.+|+.++++++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 4566778889999999999999999999999999987654322 23478899999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCC---ceecCCCCCcEEecc--------CCcEEEeee
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN---IIHRDLKAANLLMNE--------NGVVKVADF 387 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~g---IiHrDLkp~NILl~~--------~~~vkL~DF 387 (518)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||++| |+||||||+||+++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999864 36899999999999999999999999 999999999999986 778999999
Q ss_pred ccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010091 388 GVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467 (518)
Q Consensus 388 G~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~ 467 (518)
|++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....................+..+
T Consensus 161 g~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 161 GLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred Ccccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 99976544322 23569999999999999999999999999999999999999999998888777777777788888899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
++.+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=380.81 Aligned_cols=266 Identities=29% Similarity=0.544 Sum_probs=229.5
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG 309 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~ 309 (518)
..|++..+.|++.+.||+|+||.||+|++. +..||||+++... .......+.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 469999999999999999999999999962 3579999998543 233447899999999999 8999999999
Q ss_pred eeecCCceeEEEeeccCCccccccccccC----------------------CCChHHHHHHHHHhHHHHHHHHHCCceec
Q 010091 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKC----------------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367 (518)
Q Consensus 310 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~----------------------~l~~~~i~~i~~ql~~gL~yLH~~gIiHr 367 (518)
++...+..|+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999976432 37889999999999999999999999999
Q ss_pred CCCCCcEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 010091 368 DLKAANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYD 443 (518)
Q Consensus 368 DLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~ 443 (518)
||||+||+++.++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986544322 122346789999999998999999999999999999998 999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 444 DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 444 ~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
...........+..+..+..+..+++.+.++|.+||+.||.+|||+.++++.|+.++....
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 8877666767777778888888899999999999999999999999999999999877654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=393.87 Aligned_cols=262 Identities=31% Similarity=0.625 Sum_probs=231.1
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
..+.|+|..++|++.++||+|+||.||+|++. ++.||||+++..... .+.|.+|+.+|++++||||+++++++. .
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 45789999999999999999999999999986 678999999875433 468999999999999999999999987 5
Q ss_pred CceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
..+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 67899999999999999998643 36889999999999999999999999999999999999999999999999999865
Q ss_pred cccC--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 394 AQYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 394 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+.... +..+.+...+..+++.
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEE 413 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHHTCCCCCCTTSCHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHH
Confidence 4321 1223346789999999998999999999999999999999 9999999887766544 4456777788899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+.++|.+||+.||.+|||+++|++.|+++...
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999887543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=364.82 Aligned_cols=270 Identities=27% Similarity=0.511 Sum_probs=235.1
Q ss_pred ceeeccccceeee-EEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 239 VWEIDASLLKFEH-KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 239 ~~eI~~~~~~~~~-~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
.|.+...+|.+.+ .||+|+||.||+|++. ++.||+|+++... .......+.+|+.++++++||||+++++++ .
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4677788888887 9999999999999863 5679999998753 445568899999999999999999999998 4
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
.+..|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 56799999999999999999876677999999999999999999999999999999999999999999999999999875
Q ss_pred cccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 394 AQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 394 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+... .+..+.++..+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~ 239 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRMECPPECP 239 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-HHHTTCCCCCCTTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-HHhcCCcCCCCCCcC
Confidence 43322 222346889999999998889999999999999999998 999999877655443 344566777888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcccccc
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKRGLAQ 511 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 511 (518)
+.+.++|.+||+.||.+||++.++++.|+.++.+...+....+
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~ 282 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCc
Confidence 9999999999999999999999999999999999887765544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=362.27 Aligned_cols=265 Identities=30% Similarity=0.590 Sum_probs=230.9
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
..+.|++..++|++.+.||+|+||.||+|.+.+ +.||+|+++..... ...|.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred chhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 456899999999999999999999999999874 58999999865443 3578899999999999999999998864
Q ss_pred CceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
+..|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 56899999999999999998643 26899999999999999999999999999999999999999999999999999875
Q ss_pred cccCc--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 394 AQYGV--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 394 ~~~~~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+.... +..+..+..+..+++.
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-HhcccCCCCcccccHH
Confidence 54321 223346789999999998889999999999999999999 9999998877655443 4456677778889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
+.+++.+||+.||.+|||+.++++.|+.+++....
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999999887643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=374.17 Aligned_cols=270 Identities=29% Similarity=0.563 Sum_probs=236.5
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEe
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~ 308 (518)
.+.|++..+.|++.+.||+|+||.||+|++.+ ..||+|++.... .......+.+|+.+++++ +||||++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 45799999999999999999999999999753 369999998654 344567899999999999 899999999
Q ss_pred eeeecCCceeEEEeeccCCccccccccc-------------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEE
Q 010091 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQ-------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375 (518)
Q Consensus 309 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~-------------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NIL 375 (518)
+++......|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999999999999753 235789999999999999999999999999999999999
Q ss_pred eccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 010091 376 MNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAA 451 (518)
Q Consensus 376 l~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~ 451 (518)
++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999986544322 122346788999999999999999999999999999999 99999987766666
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 010091 452 VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKR 507 (518)
Q Consensus 452 ~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~ 507 (518)
...+..+..+..+..+++.+.++|.+||+.||.+|||+.++++.|+++.++...++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~r 332 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhccC
Confidence 66677777777888899999999999999999999999999999999988765543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=383.36 Aligned_cols=264 Identities=32% Similarity=0.581 Sum_probs=220.7
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC-----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
..+++...|++.+.||+|+||.||+|++. +..||||+++... .+.....|.+|+.++++++||||+++++++..
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 35778888999999999999999999864 5679999998653 45556889999999999999999999999999
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
....|+||||+++++|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999999886667999999999999999999999999999999999999999999999999999865
Q ss_pred cccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 394 AQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 394 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
..... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+... .+..+.+...+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~-~i~~~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK-AVDEGYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH-HHHTTEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCcccc
Confidence 44321 112235778999999999999999999999999999998 999999887765543 344566666777899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
..+.+++.+||+.||.+||++.++++.|+.+++...
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 999999999999999999999999999999987543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=371.67 Aligned_cols=274 Identities=29% Similarity=0.572 Sum_probs=233.5
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC---------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCcee
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVV 305 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~---------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv 305 (518)
....|++..++|++.+.||+|+||.||+|++. ++.||+|+++... .......+.+|+.+++++ +||||+
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 34579999999999999999999999999964 4579999998653 445567899999999999 899999
Q ss_pred eEeeeeecCCceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCC
Q 010091 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370 (518)
Q Consensus 306 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLk 370 (518)
++++++......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 99999999999999999999999999997643 248899999999999999999999999999999
Q ss_pred CCcEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 010091 371 AANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLT 446 (518)
Q Consensus 371 p~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~ 446 (518)
|+||+++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999999986544321 223457889999999988889999999999999999999 999999887
Q ss_pred HHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcccccc
Q 010091 447 PLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKRGLAQ 511 (518)
Q Consensus 447 ~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~ 511 (518)
..+.. ..+..+..+..+..+++.+.++|.+||+.||.+|||+.++++.|+++++..........
T Consensus 265 ~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~~~~ 328 (334)
T 2pvf_A 265 VEELF-KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDL 328 (334)
T ss_dssp HHHHH-HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-------
T ss_pred HHHHH-HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCcccCC
Confidence 65544 34455667778888999999999999999999999999999999999887765544333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=369.14 Aligned_cols=265 Identities=22% Similarity=0.403 Sum_probs=223.6
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
-.++|++.+.||+|+||.||++++. ++.||+|++..... .......|.+|+.++++++||||+++++++......|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3556777999999999999999975 68899999876443 44556889999999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV- 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~- 398 (518)
||||++|++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 89 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 9999999999999977 45799999999999999999999999999999999999999999999999999976543321
Q ss_pred -cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCCCCCCcHHHHHH
Q 010091 399 -MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR---PTIPVHTHPILVDL 474 (518)
Q Consensus 399 -~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~L~~L 474 (518)
.....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.............. ...+..+++.+.++
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence 22345899999999999999999999999999999999999999998887766665554332 12346688999999
Q ss_pred HHHhhhhCCCCCC-CHHHHHHHHHHHHHHhhhccc
Q 010091 475 LERCWQRDPSLRP-DFSEITELLQHLAQRLQTKRG 508 (518)
Q Consensus 475 i~~cL~~dP~~RP-s~~eil~~L~~l~~~~~~~~~ 508 (518)
|.+||+.||.+|| +++++.+.|+.++.+-.....
T Consensus 248 i~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 248 ILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp HHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred HHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 9999999999997 999999999887655444433
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=365.60 Aligned_cols=267 Identities=28% Similarity=0.527 Sum_probs=227.9
Q ss_pred Cceeeccccceeee-EEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 238 DVWEIDASLLKFEH-KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 238 d~~eI~~~~~~~~~-~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
+.+.++..+|++.+ .||+|+||.||+|.+. ++.||||+++....+......|.+|+.++++++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 45677888888888 9999999999999753 47799999987765556678899999999999999999999998
Q ss_pred cCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
..+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 56678999999999999999987 45699999999999999999999999999999999999999999999999999986
Q ss_pred ccccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010091 393 QAQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467 (518)
Q Consensus 393 ~~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~ 467 (518)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ..+..+.++..+..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 245 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGCPAGC 245 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCCCCCCCCC
Confidence 544322 122346788999999998889999999999999999999 99999988776544 334456677788889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKR 507 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~ 507 (518)
++.+.++|.+||+.||.+||++.++++.|++++....+.+
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 9999999999999999999999999999999998876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=367.91 Aligned_cols=264 Identities=28% Similarity=0.568 Sum_probs=230.8
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEee
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~ 309 (518)
...|++....|++.+.||+|+||.||++++. ++.||+|+++... .......+.+|+.++++++||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 3568899999999999999999999999862 3679999998653 4455688999999999999999999999
Q ss_pred eeecCCceeEEEeeccCCcccccccccc-----------------------CCCChHHHHHHHHHhHHHHHHHHHCCcee
Q 010091 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQK-----------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366 (518)
Q Consensus 310 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiH 366 (518)
++......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 9999999999999999999999997633 23788999999999999999999999999
Q ss_pred cCCCCCcEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 010091 367 RDLKAANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPY 442 (518)
Q Consensus 367 rDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~ 442 (518)
|||||+||+++.++.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986544322 223347788999999998899999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 443 DDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
......+.. ..+..+..+..+..+++.+.+++.+||+.||.+|||+.++++.|++++++
T Consensus 254 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 254 PGIPPERLF-NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TTCCGGGHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCHHHHH-HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 987765544 34455667778888999999999999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=370.35 Aligned_cols=267 Identities=31% Similarity=0.582 Sum_probs=227.5
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEECC------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
.++|..+.|++.+.||+|+||.||+|++.. ..||||+++... .......|.+|+.++++++||||+++++++.
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 358888999999999999999999998653 249999998653 4455678999999999999999999999999
Q ss_pred cCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
.....|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999999999987667899999999999999999999999999999999999999999999999999986
Q ss_pred ccccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010091 393 QAQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467 (518)
Q Consensus 393 ~~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~ 467 (518)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +..+.++..+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~ 275 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTPMDC 275 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHCCCcCCCcccC
Confidence 543321 122346788999999999999999999999999999999 9999998877655443 4456666777889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKR 507 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~ 507 (518)
++.+.+++.+||+.||.+||++.++++.|+++++......
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~ 315 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence 9999999999999999999999999999999987665443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=367.03 Aligned_cols=246 Identities=27% Similarity=0.488 Sum_probs=215.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
..|++.++||+|+||.||+|.+. ++.||||++....... ...+.+|+.++++++||||+++++++...+..|+|||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 34666999999999999999854 7899999998654333 3678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|++|++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 99999999999763 58999999999999999999999999999999999999999999999999997655433 2334
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~~cL~ 480 (518)
..||+.|+|||++.+..++.++||||||+++|+|++|..||....+............ ....+..+++.+.++|.+||+
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 255 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSC
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHcc
Confidence 5699999999999999999999999999999999999999998887776655554433 344566788999999999999
Q ss_pred hCCCCCCCHHHHHH
Q 010091 481 RDPSLRPDFSEITE 494 (518)
Q Consensus 481 ~dP~~RPs~~eil~ 494 (518)
.||.+|||+.|+++
T Consensus 256 ~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 256 MDVEKRGSAKELLQ 269 (297)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhHCcCHHHHhh
Confidence 99999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=371.17 Aligned_cols=268 Identities=27% Similarity=0.491 Sum_probs=213.5
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~ 311 (518)
...+.+...+|++.+.||+|+||.||+|++.. ..||||+++...........|.+|+.++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 34567778889999999999999999998653 2799999987765666678999999999999999999999998
Q ss_pred ecCCce------eEEEeeccCCcccccccccc-----CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC
Q 010091 312 TRPPRL------FIVTEFMSGGSIYDYLHKQK-----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (518)
Q Consensus 312 ~~~~~~------~lV~Ey~~ggsL~~~l~~~~-----~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~ 380 (518)
...... |+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 776654 99999999999999986432 2589999999999999999999999999999999999999999
Q ss_pred cEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 010091 381 VVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQ 456 (518)
Q Consensus 381 ~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~ 456 (518)
.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+......
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~- 253 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI- 253 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-
Confidence 999999999976544321 223346788999999999999999999999999999999 999999887766554443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 457 ~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
.+..+..+..+++.+.+++.+||+.||.+|||+.++++.|+++++....
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 3456667778999999999999999999999999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=365.77 Aligned_cols=266 Identities=35% Similarity=0.662 Sum_probs=234.3
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
..+.|++...+|++.+.||+|+||.||+|++. +..||+|++.... .....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 45789999999999999999999999999986 6789999997643 234788999999999999999999999999
Q ss_pred CCceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
....|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999999997633 4589999999999999999999999999999999999999999999999999976
Q ss_pred ccccCc--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010091 393 QAQYGV--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 393 ~~~~~~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
...... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+... .+.....+..+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCPE 239 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCCCCCTTCCH
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHhccCCCCCCCCCCH
Confidence 544321 222346788999999999999999999999999999999 999998877655443 3455667778888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
.+.+++.+||+.||.+|||+.++++.|+.++++...
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 999999999999999999999999999999887653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=392.27 Aligned_cols=262 Identities=35% Similarity=0.635 Sum_probs=227.0
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
.+.|+|..+.|++.++||+|+||.||+|++.+ ..||||+++..... .+.|.+|+.+|++++||||+++++++.. .
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 57899999999999999999999999999875 67999999876543 3578999999999999999999999876 6
Q ss_pred ceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 7899999999999999998633 458999999999999999999999999999999999999999999999999998654
Q ss_pred ccC--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 395 QYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 395 ~~~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+....+.... +..+.++..+..+++.+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l 410 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL 410 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTSCHHH
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHH
Confidence 322 1222346789999999998999999999999999999999 9999999887665544 45577778888999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
.++|.+||+.||.+|||++++++.|+.+....
T Consensus 411 ~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 99999999999999999999999999886543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=368.48 Aligned_cols=268 Identities=33% Similarity=0.605 Sum_probs=232.3
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeE
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l 307 (518)
....|++..++|++.+.||+|+||.||+|++. ++.||||+++... .......+.+|+.+++++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34578999999999999999999999999853 3679999998653 344557899999999999 79999999
Q ss_pred eeeeecCC-ceeEEEeeccCCccccccccccCC---------------CChHHHHHHHHHhHHHHHHHHHCCceecCCCC
Q 010091 308 IGACTRPP-RLFIVTEFMSGGSIYDYLHKQKCG---------------LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371 (518)
Q Consensus 308 ~~~~~~~~-~~~lV~Ey~~ggsL~~~l~~~~~~---------------l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp 371 (518)
++++...+ .+|+||||+++++|.+++...... +++..++.++.||+.||.|||++||+||||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 99987654 589999999999999999764432 78999999999999999999999999999999
Q ss_pred CcEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCH
Q 010091 372 ANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTP 447 (518)
Q Consensus 372 ~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~ 447 (518)
+||+++.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999976543322 122347889999999999999999999999999999998 9999988776
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 448 LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 448 ~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
.+.....+..+..+..+..+++.+.++|.+||+.||.+|||+.++++.|+.+++.-.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 666666666677777888899999999999999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=365.23 Aligned_cols=265 Identities=28% Similarity=0.483 Sum_probs=223.9
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEE------CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEee
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~ 309 (518)
..+...+....|++.++||+|+||.||++++ .++.||+|+++.... ......+.+|+.++++++||||+++++
T Consensus 12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (302)
T 4e5w_A 12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKG 90 (302)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeee
Confidence 3445566777788899999999999999995 367899999986542 233477899999999999999999999
Q ss_pred eeecC--CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeee
Q 010091 310 ACTRP--PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387 (518)
Q Consensus 310 ~~~~~--~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DF 387 (518)
++... ..+|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcc
Confidence 99776 6789999999999999999776778999999999999999999999999999999999999999999999999
Q ss_pred ccceeccccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC--------------CCHHH
Q 010091 388 GVARVQAQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDD--------------LTPLQ 449 (518)
Q Consensus 388 G~a~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~--------------~~~~~ 449 (518)
|++........ .....||..|+|||++.+..++.++||||||+++|+|++|..|+.. .....
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 99987554321 2234578889999999999999999999999999999999987642 22333
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 450 AAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 450 ~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
.....+..+.....+..+++.+.++|.+||+.||.+|||+.++++.|+.+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 4444555666777888899999999999999999999999999999998863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=362.47 Aligned_cols=259 Identities=33% Similarity=0.655 Sum_probs=219.5
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec-CC
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PP 315 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-~~ 315 (518)
...|.++.++|++.+.||+|+||.||++++.++.||||+++... ..+.|.+|+.++++++||||+++++++.. ..
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 45789999999999999999999999999999999999997643 34678999999999999999999998654 45
Q ss_pred ceeEEEeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..|+||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 78999999999999999976433 38899999999999999999999999999999999999999999999999997554
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ..+..+..+..+..+++.+.+
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ 245 (278)
T 1byg_A 169 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYKMDAPDGCPPAVYE 245 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-HHHTTTCCCCCCTTCCHHHHH
T ss_pred cc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcCCCCCCcccCCHHHHH
Confidence 32 223457889999999999999999999999999999998 99999887655444 334556677788889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+|.+||+.||.+|||+.++++.|+++.+.
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 99999999999999999999999998654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=378.95 Aligned_cols=265 Identities=30% Similarity=0.533 Sum_probs=228.1
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~ 310 (518)
+.+++...+|++.++||+|+||.||+|++. ++.||||+++... .......+.+|+.++++++||||++++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 446778888999999999999999999954 3579999997543 44455789999999999999999999999
Q ss_pred eecCCceeEEEeeccCCcccccccccc------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC---c
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG---V 381 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~---~ 381 (518)
+......|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 999999999999999999999997643 3588999999999999999999999999999999999999554 5
Q ss_pred EEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 010091 382 VKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQK 457 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~ 457 (518)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++ |..||......+.... +..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHc
Confidence 9999999997543322 1223457899999999999999999999999999999998 9999998877665544 445
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 458 GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 458 ~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
+..+..+..+++.+.++|.+||+.||.+|||+.++++.|+.+.+...
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 66677788899999999999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=374.11 Aligned_cols=262 Identities=28% Similarity=0.452 Sum_probs=216.9
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
....|.++..+|++.++||+|+||.||+|++.++.||||+++... .....+..|+.++++++||||+++++++....
T Consensus 15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 445788999999999999999999999999999999999997542 23345667999999999999999999987644
Q ss_pred ----ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC----------CceecCCCCCcEEeccCCc
Q 010091 316 ----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN----------NIIHRDLKAANLLMNENGV 381 (518)
Q Consensus 316 ----~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~----------gIiHrDLkp~NILl~~~~~ 381 (518)
.+|+||||+++++|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 369999999999999999763 489999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccceeccccCc---cccCCCCCcccChhhhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCC-------
Q 010091 382 VKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQ-----PYNHRADVFSFGIVLWELVTGKLPYDDLT------- 446 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~-----~~~~ksDV~SlGill~eLltG~~P~~~~~------- 446 (518)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999976544322 2335689999999999763 45678899999999999999999996531
Q ss_pred ---------HHHHHHHHHhcCCCCCCCCC-----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 447 ---------PLQAAVGVVQKGLRPTIPVH-----THPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 447 ---------~~~~~~~~~~~~~~p~~~~~-----~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
.............++.++.. .++.+.++|.+||+.||.+|||+.|+++.|+++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 12222222333344444432 245599999999999999999999999999998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=374.36 Aligned_cols=249 Identities=20% Similarity=0.366 Sum_probs=219.3
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|++.+.||+|+||.||++.+. ++.||+|++............+.+|+.++++++||||+++++++......|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45777999999999999999975 7899999999877777777889999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC---CcEEEeeeccceeccccCcc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN---GVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~---~~vkL~DFG~a~~~~~~~~~ 399 (518)
|++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.........
T Consensus 109 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 109 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 9999999999977 4578999999999999999999999999999999999999865 45999999999876654444
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~~ 477 (518)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....+....+ ..+++++.++|.+
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 267 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHH
T ss_pred ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 55679999999999999999999999999999999999999999887766665555544332222 3578999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||+.||.+|||+.++++
T Consensus 268 ~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 268 MLTVNPKKRITADQALK 284 (362)
T ss_dssp HSCSSGGGSCCHHHHTT
T ss_pred HcCCChhhCcCHHHHhc
Confidence 99999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=358.17 Aligned_cols=262 Identities=28% Similarity=0.530 Sum_probs=224.0
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
.|.+..++|++.+.||+|+||.||+|++.+ ..||+|++.... .......|.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 467788888999999999999999999653 249999998653 34456889999999999999999999999865
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
+..|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4579999999999999999876667999999999999999999999999999999999999999999999999999765
Q ss_pred cccCc--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 394 AQYGV--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 394 ~~~~~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
..... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+... .+..+..+..+..+++.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-VLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-HHHHTCCCCCCTTCCHH
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-HHhcCCCCCCCCCCCHH
Confidence 44321 223457889999999998999999999999999999998 999998776655443 34445566677788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
+.+++.+||+.||.+|||+.|+++.|+.+.+.-
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=374.04 Aligned_cols=249 Identities=22% Similarity=0.380 Sum_probs=217.0
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH----HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~----~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+.|++.+.||+|+||.||+++.. |+.||+|+++...... .....+.+|+.++++++||||+++++++.....+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 34666999999999999999975 7889999998754332 12467899999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC----cEEEeeeccceecc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG----VVKVADFGVARVQA 394 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~----~vkL~DFG~a~~~~ 394 (518)
+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999977 45799999999999999999999999999999999999998777 79999999998766
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILV 472 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~L~ 472 (518)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+....+. +.....+++.+.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 250 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence 544455567999999999999999999999999999999999999999988877766555543322 222356789999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|.+||..||.+|||+.|+++
T Consensus 251 ~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 251 DFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=372.62 Aligned_cols=249 Identities=22% Similarity=0.388 Sum_probs=217.1
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
..++|++.+.||+|+||.||+++.. ++.||+|+++.... .......+.+|+.++++++||||+++++++.....+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 4456777999999999999999975 78899999986432 11234678899999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-Cc
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GV 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~ 398 (518)
||||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ..
T Consensus 83 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 9999999999999976 457999999999999999999999999999999999999999999999999999764332 23
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
.....||+.|+|||++.+..++.++|+|||||++|||++|..||...+..+....+... ...+|..+++++.++|.+|
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHH
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHH
Confidence 34456999999999999999999999999999999999999999988776666555543 3456778899999999999
Q ss_pred hhhCCCCCC-----CHHHHHH
Q 010091 479 WQRDPSLRP-----DFSEITE 494 (518)
Q Consensus 479 L~~dP~~RP-----s~~eil~ 494 (518)
|+.||.+|| +++|+++
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHT
T ss_pred hhcCHHHhcCCCCCCHHHHHc
Confidence 999999998 8998876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=394.64 Aligned_cols=262 Identities=35% Similarity=0.684 Sum_probs=232.3
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
..+.|++..++|++.++||+|+||.||+|++. +..||||+++..... ...|.+|+.+|++++||||++++++|..
T Consensus 211 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp SSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 35789999999999999999999999999987 678999999875433 4689999999999999999999999999
Q ss_pred CCceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
...+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999999999999997633 4589999999999999999999999999999999999999999999999999987
Q ss_pred ccccCc--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010091 393 QAQYGV--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 393 ~~~~~~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
...... .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+.. ..+..+.+...+..+++
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 446 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCPE 446 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHHHTTCCCCCCTTCCH
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCCCCCCCH
Confidence 543221 222346789999999998999999999999999999999 99999988766544 44566778888889999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
.+.++|.+||+.||.+|||+.+|++.|+.+++
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999988753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=355.37 Aligned_cols=249 Identities=20% Similarity=0.347 Sum_probs=221.0
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.+.||+|+||.||+|.+. ++.||+|++.....+......+.+|+.++++++||||+++++++......|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45666999999999999999975 6889999999887777777889999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc---EEEeeeccceeccccCcc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV---VKVADFGVARVQAQYGVM 399 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~---vkL~DFG~a~~~~~~~~~ 399 (518)
|+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++.........
T Consensus 86 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 86 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 9999999999877 457999999999999999999999999999999999999986655 999999999876665555
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~L~~Li~~ 477 (518)
....||+.|+|||++.+..++.++||||||+++|+|++|..||......+.............. ...+++.+.++|.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHH
Confidence 5567999999999999999999999999999999999999999988877766665554443332 24678999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||+.||.+|||+.|+++
T Consensus 245 ~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 245 MLTVNPKKRITADQALK 261 (284)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcccChhhCCCHHHHhc
Confidence 99999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=363.66 Aligned_cols=268 Identities=27% Similarity=0.496 Sum_probs=222.9
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeee
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~ 310 (518)
..+.+.++.+.|++.+.||+|+||.||+|++.. +.||+|+++...........|.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 456788999999999999999999999998642 479999998877677777889999999999999999999999
Q ss_pred eecCC-----ceeEEEeeccCCcccccccc-----ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC
Q 010091 311 CTRPP-----RLFIVTEFMSGGSIYDYLHK-----QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (518)
Q Consensus 311 ~~~~~-----~~~lV~Ey~~ggsL~~~l~~-----~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~ 380 (518)
+.... ..|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 87654 45999999999999999842 235699999999999999999999999999999999999999999
Q ss_pred cEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 010091 381 VVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQ 456 (518)
Q Consensus 381 ~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~ 456 (518)
.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.... +.
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~ 263 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-LL 263 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-HH
Confidence 99999999997654322 1223447889999999999999999999999999999999 9999988776655544 34
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 457 KGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 457 ~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
.+..+..+..+++.+.++|.+||+.||.+|||+.++++.|+++++.+.
T Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 456677788899999999999999999999999999999999988763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=359.23 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=208.6
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH------------------------HHHHHHHHHHHH
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE------------------------NIRREFAQEVHI 295 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~------------------------~~~~~f~~E~~i 295 (518)
+..++|++.+.||+|+||.||+|+.. ++.||||++....... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 44567778999999999999999875 6889999998654221 123578899999
Q ss_pred HhhcCCCceeeEeeeeec--CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCc
Q 010091 296 MRKVRHMNVVQFIGACTR--PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (518)
Q Consensus 296 l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~N 373 (518)
+++++||||+++++++.. ....|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999876 5679999999999999998754 369999999999999999999999999999999999
Q ss_pred EEeccCCcEEEeeeccceeccccC-ccccCCCCCcccChhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 010091 374 LLMNENGVVKVADFGVARVQAQYG-VMTAETGTYRWMAPEVIEHQP---YNHRADVFSFGIVLWELVTGKLPYDDLTPLQ 449 (518)
Q Consensus 374 ILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~APE~l~~~~---~~~ksDV~SlGill~eLltG~~P~~~~~~~~ 449 (518)
||++.++.+||+|||+++...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 999999999999999998654432 234456999999999997665 3788999999999999999999999887666
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 450 AAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 450 ~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....+............+++.+.++|.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 555544444444444578899999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=368.27 Aligned_cols=247 Identities=18% Similarity=0.271 Sum_probs=217.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|++.+.||+|+||.||++++. ++.||+|+++.. ......+.+|+.++++++||||+++++++.....+|+|||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 45666999999999999999976 678999998754 2334678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc--CCcEEEeeeccceeccccCccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE--NGVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~ 400 (518)
|++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 161 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence 99999999999876667999999999999999999999999999999999999987 7899999999998765544444
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--IPVHTHPILVDLLERC 478 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~L~~Li~~c 478 (518)
...||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+........ ....+++++.++|.+|
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence 56699999999999988899999999999999999999999999887776666655443322 1246789999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||+.|+++
T Consensus 242 L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 242 LVKERKSRMTASEALQ 257 (321)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred cCCChhHCcCHHHHhc
Confidence 9999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=364.67 Aligned_cols=264 Identities=29% Similarity=0.539 Sum_probs=229.0
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEe
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~ 308 (518)
..+.|++..++|++.+.||+|+||.||+|++. ++.||+|++.... .......|.+|+.++++++||||++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 35689999999999999999999999999864 4679999997543 344457899999999999999999999
Q ss_pred eeeecCCceeEEEeeccCCcccccccccc---------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC
Q 010091 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQK---------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379 (518)
Q Consensus 309 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~ 379 (518)
+++......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 99999999999999999999999997532 356899999999999999999999999999999999999999
Q ss_pred CcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 010091 380 GVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVV 455 (518)
Q Consensus 380 ~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~ 455 (518)
+.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999999976543321 122346889999999999999999999999999999999 899999888766554444
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 456 QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 456 ~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
. +..+..+..+++.+.++|.+||+.||.+|||+.|+++.|++++.
T Consensus 255 ~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 E-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred c-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 3 44556677899999999999999999999999999999987754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=359.39 Aligned_cols=254 Identities=34% Similarity=0.651 Sum_probs=217.8
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHH--H---HHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENI--R---REFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~--~---~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
+..++|++.+.||+|+||.||+|++. ++.||+|++......... . ..|.+|+.++++++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44566777999999999999999984 788999999765433221 1 6889999999999999999999998765
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEeccCCc-----EEEeee
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGV-----VKVADF 387 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~~~~~-----vkL~DF 387 (518)
. ++||||+++++|.+++......+++..++.++.|++.||.|||++| |+||||||+||+++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 4 7999999999999999876778999999999999999999999999 999999999999988776 999999
Q ss_pred ccceeccccCccccCCCCCcccChhhh--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHhcCCCCCC
Q 010091 388 GVARVQAQYGVMTAETGTYRWMAPEVI--EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQA--AVGVVQKGLRPTI 463 (518)
Q Consensus 388 G~a~~~~~~~~~~~~~gt~~y~APE~l--~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~--~~~~~~~~~~p~~ 463 (518)
|+++.... ......||+.|+|||++ ....++.++||||||+++|+|++|..||......+. .......+..+..
T Consensus 174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251 (287)
T ss_dssp TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCC
T ss_pred Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCC
Confidence 99975433 23446799999999998 455678999999999999999999999987654333 4444556778888
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 464 ~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
+..+++.+.++|.+||+.||.+|||++++++.|+++
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 899999999999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=367.22 Aligned_cols=260 Identities=30% Similarity=0.560 Sum_probs=218.4
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--Cc----cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~----~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
.+..++|++.++||+|+||.||+|++. ++ +||+|.++... .......|.+|+.++++++||||++++++|...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 355667888999999999999999974 33 36888876543 223347899999999999999999999999875
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..++|+||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4889999999999999998877789999999999999999999999999999999999999999999999999998654
Q ss_pred ccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 395 QYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 395 ~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
.... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.. ..+..+.....+..++..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHHcCCCCCCCccCCHH
Confidence 4322 222346889999999999999999999999999999999 99999987765543 445556667778889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
+.+++.+||+.||.+||++.++++.|+.+.+..
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999987543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=393.03 Aligned_cols=263 Identities=35% Similarity=0.633 Sum_probs=231.2
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
..+.|+|..+.|++.++||+|+||.||+|++.+ +.||||+++..... .+.|.+|+.+|++++|+||+++++++..
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 357899999999999999999999999999875 67999999876543 3579999999999999999999999876
Q ss_pred CceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
...|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 67999999999999999998633 45899999999999999999999999999999999999999999999999999765
Q ss_pred cccC--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 394 AQYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 394 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
.... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+....+.... +..+.+...+..+++.
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~~~~ 492 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPES 492 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHH
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHH
Confidence 4321 1222346789999999998999999999999999999999 9999999887665544 4557777788899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
+.++|.+||+.||.+|||+.+|++.|+.++...
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 999999999999999999999999998876443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=356.42 Aligned_cols=260 Identities=28% Similarity=0.540 Sum_probs=220.8
Q ss_pred ceeeeEEeEecceEEEEEEEC--Cc---cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce-eEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQ---DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL-FIV 320 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~---~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~-~lV 320 (518)
|+..++||+|+||.||+|++. ++ .||+|++.... .....+.|.+|+.++++++||||+++++++...... ++|
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 445799999999999999963 22 69999987533 344568899999999999999999999999766555 999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC---
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG--- 397 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~--- 397 (518)
|||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 99999999999998867789999999999999999999999999999999999999999999999999997543321
Q ss_pred --ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 --VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 --~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+.. ..+..+.....+..+++.+.++
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l 260 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT-HFLAQGRRLPQPEYCPDSLYQV 260 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH-HHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH-HHhhcCCCCCCCccchHHHHHH
Confidence 1223457889999999999999999999999999999999 55556665554443 3444556667788899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhccc
Q 010091 475 LERCWQRDPSLRPDFSEITELLQHLAQRLQTKRG 508 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~~ 508 (518)
+.+||+.||.+|||+.++++.|+++++++.....
T Consensus 261 i~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 261 MQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 9999999999999999999999999998865543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=365.70 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=216.5
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH----HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~----~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+.|++.+.||+|+||.||+++.. ++.||+|+++...... .....+.+|+.++++++||||+++++++......|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 44666999999999999999975 7889999998654322 12467899999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC----cEEEeeeccceecc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG----VVKVADFGVARVQA 394 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~----~vkL~DFG~a~~~~ 394 (518)
+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999976 45799999999999999999999999999999999999999887 89999999998765
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--TIPVHTHPILV 472 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~L~ 472 (518)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+....... .....+++.+.
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence 5444455679999999999999999999999999999999999999999887766655544433221 12256788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|.+||+.||.+|||+.|+++
T Consensus 250 ~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 250 DFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=362.60 Aligned_cols=250 Identities=27% Similarity=0.361 Sum_probs=206.9
Q ss_pred cccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.++|++.++||+|+||.||+|++. ++.||+|+++....+......+.+|+.++++++||||+++++++......|+|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 455666999999999999999984 7889999998765555556788999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 178 (311)
T 3niz_A 100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178 (311)
T ss_dssp CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence 996 58888887766779999999999999999999999999999999999999999999999999998765332 3344
Q ss_pred CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC------------------
Q 010091 402 ETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT------------------ 462 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~------------------ 462 (518)
..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence 568999999999866 5689999999999999999999999987665554443332111000
Q ss_pred ----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 ----------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 ----------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....+++++.++|.+||+.||.+|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11346788999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=359.14 Aligned_cols=262 Identities=18% Similarity=0.240 Sum_probs=220.8
Q ss_pred eeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCce
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 317 (518)
.+..++|++.+.||+|+||.||+|+. .++.||||++...... ..+.+|+.+++++ +|+|++++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 34556777799999999999999995 4789999998765332 3577899999999 799999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc-----EEEeeecccee
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV-----VKVADFGVARV 392 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~-----vkL~DFG~a~~ 392 (518)
|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 99999999876667999999999999999999999999999999999999987765 99999999987
Q ss_pred ccccCc--------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcC---
Q 010091 393 QAQYGV--------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT---PLQAAVGVVQKG--- 458 (518)
Q Consensus 393 ~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~---~~~~~~~~~~~~--- 458 (518)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 554321 233458999999999999999999999999999999999999998743 333333222221
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 010091 459 LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKR 507 (518)
Q Consensus 459 ~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~ 507 (518)
..+.....+++.+.+++.+||+.||.+|||+++|++.|++++++++...
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 1222334678999999999999999999999999999999999886543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=358.42 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=208.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
++|++.++||+|+||.||+|++. ++.||+|++.....+......+.+|+.++++++||||+++++++......|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 35677999999999999999986 78899999987654444446788999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence 965 9999998766789999999999999999999999999999999999999999999999999997654322 23345
Q ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------------CCC----
Q 010091 403 TGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG----------------LRP---- 461 (518)
Q Consensus 403 ~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~----------------~~p---- 461 (518)
.||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+......... +.+
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence 68999999999965 458999999999999999999999999887766555443310 000
Q ss_pred -------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 -------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 -------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.....+++++.++|.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112357889999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=395.45 Aligned_cols=267 Identities=27% Similarity=0.513 Sum_probs=228.9
Q ss_pred Cceeeccccceeee-EEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 238 DVWEIDASLLKFEH-KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 238 d~~eI~~~~~~~~~-~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
..|.+....+.+.+ +||+|+||.||+|.+. +..||||+++.... ....+.|.+|+.+|++++||||+++++++.
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 35777777887777 8999999999999874 35699999987532 234578999999999999999999999987
Q ss_pred cCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
. +.+|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 6 569999999999999999987667799999999999999999999999999999999999999999999999999986
Q ss_pred ccccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010091 393 QAQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467 (518)
Q Consensus 393 ~~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~ 467 (518)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+... .+..+.++..+..+
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~ 564 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRMECPPEC 564 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-HHHTTCCCCCCTTC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCCcC
Confidence 543221 122345689999999999999999999999999999998 999999988766543 45557778888899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKR 507 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~ 507 (518)
++++.++|.+||+.||.+||++.++++.|+.++..+..+.
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 9999999999999999999999999999999998876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=379.17 Aligned_cols=249 Identities=20% Similarity=0.343 Sum_probs=217.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|++.++||+|+||.||++... ++.||+|++............+.+|+.++++++||||+++++++......|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 45677999999999999999874 7889999999877666666889999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec---cCCcEEEeeeccceeccccC-c
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN---ENGVVKVADFGVARVQAQYG-V 398 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~---~~~~vkL~DFG~a~~~~~~~-~ 398 (518)
|++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... .
T Consensus 91 ~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 91 LVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 9999999999987 45799999999999999999999999999999999999998 46789999999997654432 2
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVDLLE 476 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~ 476 (518)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.........+ ..+++++.++|.
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 249 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence 344579999999999999999999999999999999999999999888777666655544433222 467899999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
+||+.||.+|||+.|+++
T Consensus 250 ~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 250 KMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHSCSSTTTSCCHHHHHH
T ss_pred HHcCCChhHCCCHHHHhc
Confidence 999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=357.55 Aligned_cols=258 Identities=29% Similarity=0.548 Sum_probs=218.6
Q ss_pred cceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee-ecCCceeE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC-TRPPRLFI 319 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~-~~~~~~~l 319 (518)
.|++.++||+|+||.||+|++.+ ..||+|.+.... +......|.+|+.++++++||||+++++++ ......|+
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 46669999999999999999642 248999987633 444567899999999999999999999985 55668899
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC--
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-- 397 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-- 397 (518)
||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 999999999999998767779999999999999999999999999999999999999999999999999997654322
Q ss_pred ---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 398 ---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 398 ---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+.... +..+..+..+..+++.+.+
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~ 263 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLYE 263 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-HHTTCCCCCCTTCCHHHHH
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhcCCCCCCCccCCHHHHH
Confidence 1223446788999999999999999999999999999999 6778877665554433 3345566667788999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
++.+||+.||.+|||+.++++.|+.+++.+..
T Consensus 264 li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 264 VMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999887654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=363.67 Aligned_cols=263 Identities=26% Similarity=0.466 Sum_probs=222.4
Q ss_pred eccccceeeeEEeEecceEEEEEEE------CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee--c
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT--R 313 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~--~ 313 (518)
++..+|++.+.||+|+||.||++++ .++.||||++... .......+.+|+.++++++||||+++++++. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 5567788899999999999999995 3578999999765 3445578999999999999999999999875 5
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
....|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 56789999999999999999876667999999999999999999999999999999999999999999999999999875
Q ss_pred cccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------------HHHHHHHHH
Q 010091 394 AQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT--------------PLQAAVGVV 455 (518)
Q Consensus 394 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~--------------~~~~~~~~~ 455 (518)
..... .....||..|+|||++.+..++.++||||||+++|+|++|..||.... ........+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 44321 223457888999999999999999999999999999999999985432 223344455
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 456 QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 456 ~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
..+..+..+..+++.+.++|.+||+.||.+|||+.++++.|+.+.......
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 666777788899999999999999999999999999999999987765543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=364.32 Aligned_cols=263 Identities=33% Similarity=0.604 Sum_probs=222.8
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--Ccc--EEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCc
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQD--VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~--vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~ 316 (518)
++.++|++.+.||+|+||.||+|++. +.. +|+|.++... .......+.+|+.+++++ +||||+++++++...+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 44566777999999999999999964 443 5999987543 333456789999999999 89999999999999999
Q ss_pred eeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~ 381 (518)
.|+||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 999999999999999997643 36899999999999999999999999999999999999999999
Q ss_pred EEEeeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCC
Q 010091 382 VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR 460 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~ 460 (518)
+||+|||+++............+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +..+..
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~ 259 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYR 259 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGTCC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH-hhcCCC
Confidence 99999999975444333344557889999999998889999999999999999998 9999998877665443 445667
Q ss_pred CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 461 p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
+..+..+++.+.++|.+||+.||.+|||+.++++.|+.++.+....
T Consensus 260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 7778889999999999999999999999999999999998866533
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=360.34 Aligned_cols=257 Identities=35% Similarity=0.646 Sum_probs=214.5
Q ss_pred eeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
.|+.++|++.+.||+|+||.||++++.++.||+|++... .....|.+|+.++++++||||+++++++.. ..|+|
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 355667777999999999999999999999999998643 234789999999999999999999998874 48999
Q ss_pred EeeccCCccccccccccC--CCChHHHHHHHHHhHHHHHHHHH---CCceecCCCCCcEEeccCCc-EEEeeeccceecc
Q 010091 321 TEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHR---NNIIHRDLKAANLLMNENGV-VKVADFGVARVQA 394 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~ql~~gL~yLH~---~gIiHrDLkp~NILl~~~~~-vkL~DFG~a~~~~ 394 (518)
|||++|++|.+++..... .++...++.++.|++.||.|||+ +||+||||||+||+++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999976432 47889999999999999999999 89999999999999998886 7999999997544
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL-QAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .........+..+..+..+++.+.+
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence 32 23356999999999999999999999999999999999999999864322 2222334456677777889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
++.+||+.||.+|||+.++++.|+.+.+.+..
T Consensus 236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999776643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=380.97 Aligned_cols=253 Identities=22% Similarity=0.383 Sum_probs=211.4
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
.+.+..++|++.++||+|+||.||+++.. ++.||||+++.... .......+.+|+.++++++||||+++++++...+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 45667788999999999999999999975 68999999986533 2233467889999999999999999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
.+|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999999977 4579999999999999999999998 999999999999999999999999999997533
Q ss_pred cc-CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 395 QY-GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 395 ~~-~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... ..+|..+++++.+
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ 378 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLGPEAKS 378 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHH
Confidence 32 23344679999999999999999999999999999999999999999888777666655543 4467778999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHH
Q 010091 474 LLERCWQRDPSLRP-----DFSEITE 494 (518)
Q Consensus 474 Li~~cL~~dP~~RP-----s~~eil~ 494 (518)
+|.+||+.||.+|| +++|+++
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 99999999999999 9999876
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=354.35 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=208.5
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.++||+|+||.||+|++. ++.||+|++............+.+|+.++++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 35677999999999999999985 6889999999876666667889999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 9965 6666666656789999999999999999999999999999999999999999999999999998754332 3344
Q ss_pred CCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhcCCC-------------------
Q 010091 402 ETGTYRWMAPEVIEHQP-YNHRADVFSFGIVLWELVTGKLP-YDDLTPLQAAVGVVQKGLR------------------- 460 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~-~~~ksDV~SlGill~eLltG~~P-~~~~~~~~~~~~~~~~~~~------------------- 460 (518)
..||+.|+|||++.+.. ++.++||||||+++|+|++|..| |...+..+....+......
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 56899999999997665 89999999999999999998777 5555544444333321100
Q ss_pred --------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 --------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 --------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
......+++.+.++|.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0112346789999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=361.13 Aligned_cols=262 Identities=27% Similarity=0.513 Sum_probs=222.5
Q ss_pred eccccceeeeEEeEecceEEEEEEE------CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-- 313 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-- 313 (518)
++...|++.++||+|+||.||++.+ .++.||||+++... .......|.+|+.++++++||||+++++++..
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 3334447799999999999999876 46789999998653 44556789999999999999999999999976
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
...+|+||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 46789999999999999999764 4899999999999999999999999999999999999999999999999999876
Q ss_pred cccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------HHHHHHH
Q 010091 394 AQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL--------------QAAVGVV 455 (518)
Q Consensus 394 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~--------------~~~~~~~ 455 (518)
..... .....+|..|+|||++.+..++.++||||||+++|+|++|..||...... ......+
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 54321 22345788899999999989999999999999999999999999753211 1223344
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 456 QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 456 ~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
..+..+..+..+++.+.++|.+||+.||.+|||+.|+++.|+.+.+++...
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 556677788889999999999999999999999999999999999888654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.98 Aligned_cols=257 Identities=27% Similarity=0.468 Sum_probs=215.1
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--C-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--S-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~ 310 (518)
++|..++|++.+.||+|+||.||+|++. + ..||+|++.... ....+.|.+|+.++++++||||++++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 3567778888999999999999999865 2 459999997643 2334789999999999999999999999
Q ss_pred eecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc--------E
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV--------V 382 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~--------v 382 (518)
+......|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999886666999999999999999999999999999999999999998887 9
Q ss_pred EEeeeccceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCC
Q 010091 383 KVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLR 460 (518)
Q Consensus 383 kL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~ 460 (518)
||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++ |..||......... .... ..
T Consensus 161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~--~~ 234 (289)
T 4fvq_A 161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYE--DR 234 (289)
T ss_dssp EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHH--TT
T ss_pred eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhh--cc
Confidence 99999998654322 22347889999999987 778999999999999999999 55666665544433 2222 24
Q ss_pred CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 461 p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
+..+...++++.+++.+||+.||.+|||+.++++.|++++..-.
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 45566677889999999999999999999999999998876443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.38 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=208.4
Q ss_pred eeeccccceeeeEEeEecceEEEEEEE-----CCccEEEEEEeccccC--HHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~vAvKvl~~~~~~--~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
..+..+.|++.+.||+|+||.||+++. .++.||+|+++..... ......+.+|+.++++++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 456667788899999999999999997 4688999999875432 223467889999999999999999999999
Q ss_pred cCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
..+.+|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999976 45789999999999999999999999999999999999999999999999999975
Q ss_pred ccccC-ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 393 QAQYG-VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 393 ~~~~~-~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ...++..+++.+
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~ 248 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQEA 248 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTSCHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHH
Confidence 43322 233456999999999999999999999999999999999999999988877766555543 345667789999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHH
Q 010091 472 VDLLERCWQRDPSLRP-----DFSEITE 494 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RP-----s~~eil~ 494 (518)
.++|.+||+.||.+|| ++.|+++
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 9999999999999999 7777765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=374.12 Aligned_cols=265 Identities=18% Similarity=0.278 Sum_probs=214.1
Q ss_pred eccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHH---------HHHHHHHHHHHhhcCCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENI---------RREFAQEVHIMRKVRHMNVV 305 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~---------~~~f~~E~~il~~l~HpnIv 305 (518)
+....|++.++||+|+||.||+|.+. ++.||||++......... ...+.+|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 44567888999999999999999874 367999998865321100 12345566778888999999
Q ss_pred eEeeeeecC----CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec--cC
Q 010091 306 QFIGACTRP----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN--EN 379 (518)
Q Consensus 306 ~l~~~~~~~----~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~--~~ 379 (518)
++++++... ...|+||||+ |++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998664 4589999999 9999999988667899999999999999999999999999999999999999 88
Q ss_pred CcEEEeeeccceeccccCcc--------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 010091 380 GVVKVADFGVARVQAQYGVM--------TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA 451 (518)
Q Consensus 380 ~~vkL~DFG~a~~~~~~~~~--------~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~ 451 (518)
+.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 99999999999865443211 2234999999999999999999999999999999999999999864333222
Q ss_pred HHHHhcCCCCC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 010091 452 VGVVQKGLRPT---------IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKR 507 (518)
Q Consensus 452 ~~~~~~~~~p~---------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~ 507 (518)
.........+. ....+++++.+++.+||+.||.+||++.+|++.|+++++.++...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 22221111111 125678999999999999999999999999999999999887553
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=355.39 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=203.3
Q ss_pred eeeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
|++..++|++.++||+|+||.||++++ .++.||+|+++...........+.++...++.++||||+++++++......
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 567778888899999999999999998 478899999987654444445566666678889999999999999999999
Q ss_pred eEEEeeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 318 FIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
|+||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 588887753 345799999999999999999999998 9999999999999999999999999999876
Q ss_pred cccCccccCCCCCcccChhhh----cCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 394 AQYGVMTAETGTYRWMAPEVI----EHQPYNHRADVFSFGIVLWELVTGKLPYDD-LTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l----~~~~~~~ksDV~SlGill~eLltG~~P~~~-~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
..........||+.|+|||++ .+..++.++||||||+++|+|++|..||.. ..+................+..++
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 554444445799999999996 566789999999999999999999999987 445555555555444444456789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.++|.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 99999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=372.59 Aligned_cols=251 Identities=23% Similarity=0.387 Sum_probs=212.9
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCc
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~ 316 (518)
.+..++|++.++||+|+||.||+++.. ++.||||+++.... .......+.+|..+++.+ +||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 345567777999999999999999975 68899999986532 222346788899999988 79999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|+||||++|++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999999999977 457999999999999999999999999999999999999999999999999999753332
Q ss_pred C-ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010091 397 G-VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475 (518)
Q Consensus 397 ~-~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li 475 (518)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+... ...+|..+++.+.++|
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDATGIL 255 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence 2 233456999999999999889999999999999999999999999998887777666654 3456677899999999
Q ss_pred HHhhhhCCCCCCCH------HHHHH
Q 010091 476 ERCWQRDPSLRPDF------SEITE 494 (518)
Q Consensus 476 ~~cL~~dP~~RPs~------~eil~ 494 (518)
.+||+.||.+||++ ++++.
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHhhhCHHHccCCcccCCHHHHhh
Confidence 99999999999998 66654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=395.45 Aligned_cols=264 Identities=28% Similarity=0.532 Sum_probs=228.3
Q ss_pred Cceeeccccceeee-EEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 238 DVWEIDASLLKFEH-KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 238 d~~eI~~~~~~~~~-~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
..|.++...+.+.. +||+|+||.||+|.+. ++.||||+++....+.....+|.+|+.+|++++|||||++++++.
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 46778777777755 8999999999999763 467999999987666666789999999999999999999999986
Q ss_pred cCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
. +..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred c-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 5 468999999999999999976 45799999999999999999999999999999999999999999999999999986
Q ss_pred ccccC----ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 010091 393 QAQYG----VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467 (518)
Q Consensus 393 ~~~~~----~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~ 467 (518)
..... ..+...+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+... .+..+.++..+..+
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~ 597 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC 597 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCCCCCCTTC
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCC
Confidence 54322 1223346789999999999999999999999999999998 999999988766543 45556778888899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
++++.++|.+||+.||.+||++.++++.|++++.++.
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999999987763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=371.11 Aligned_cols=248 Identities=19% Similarity=0.351 Sum_probs=218.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|++.+.||+|+||.||+|+.. ++.||+|++.... ......+.+|+.++++++||||+++++++.....+|+|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 45777999999999999999975 6889999997653 2334678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc--CCcEEEeeeccceeccccCccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE--NGVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~ 400 (518)
|++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.........
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 99999999999876667999999999999999999999999999999999999974 4789999999998766554444
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHHHHHHh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--RPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~L~~Li~~c 478 (518)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....+ .+.....+++++.++|.+|
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 288 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 56799999999999999999999999999999999999999999887776665554433 3334457899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||+.|+++
T Consensus 289 L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 289 LQKEPRKRLTVHDALE 304 (387)
T ss_dssp SCSSGGGSCCHHHHHT
T ss_pred cCCChhHCcCHHHHhh
Confidence 9999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=370.55 Aligned_cols=257 Identities=21% Similarity=0.398 Sum_probs=214.6
Q ss_pred CceeeccccceeeeEEeEe--cceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 238 DVWEIDASLLKFEHKIVSG--SYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G--~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
..+..+..+|++.++||+| +||.||++++. ++.||||++............+.+|+.++++++||||+++++++..
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 3455566777789999999 99999999986 7899999999887777777889999999999999999999999999
Q ss_pred CCceeEEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999999999763 25699999999999999999999999999999999999999999999999999865
Q ss_pred ccccC--------ccccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---
Q 010091 393 QAQYG--------VMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--- 459 (518)
Q Consensus 393 ~~~~~--------~~~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~--- 459 (518)
..... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.....+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 33221 1122368999999999977 6799999999999999999999999987655444433222111
Q ss_pred -----------------------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 -----------------------------------------RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 -----------------------------------------~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....+..+++.+.+||.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11134457888999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=365.37 Aligned_cols=259 Identities=28% Similarity=0.548 Sum_probs=217.6
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--Ccc----EEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~----vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
+..++|++.+.||+|+||.||+|++. ++. ||+|++...... .....+.+|+.++++++||||+++++++. ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC-SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 44556777999999999999999975 343 788887644321 22356778999999999999999999886 45
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 79999999999999999987667899999999999999999999999999999999999999999999999999986543
Q ss_pred cC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 396 YG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 396 ~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
.. ......||..|+|||++.+..++.++||||||+++|+|++ |..||......+.. ..+..+..+..+..+++++
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 246 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLEKGERLAQPQICTIDV 246 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-HHHHTTCBCCCCTTBCTTT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-HHHHcCCCCCCCCcCcHHH
Confidence 32 1233457889999999999999999999999999999999 99999987765544 3344556667777888999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
.++|.+||+.||.+|||+.++++.|+.+.+.-
T Consensus 247 ~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 247 YMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp THHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 99999999999999999999999999986543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=368.19 Aligned_cols=267 Identities=30% Similarity=0.593 Sum_probs=222.3
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
....|+|..++|++.+.||+|+||.||+|++.+ .||+|+++....+......|.+|+.++++++||||+++++++....
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 457899999999999999999999999999876 5999999876544444466788999999999999999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999999999988666799999999999999999999999999999999999998 68999999999875432
Q ss_pred c------CccccCCCCCcccChhhhcC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Q 010091 396 Y------GVMTAETGTYRWMAPEVIEH---------QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR 460 (518)
Q Consensus 396 ~------~~~~~~~gt~~y~APE~l~~---------~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~ 460 (518)
. .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.............. +..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~ 260 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT-GMK 260 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT-TCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc-CCC
Confidence 1 12233458999999999864 4578999999999999999999999998887666555444 333
Q ss_pred CCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 461 PTI-PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 461 p~~-~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
+.. +..+++.+.+++.+||+.||.+|||+.++++.|+.+.+....
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 333 346788999999999999999999999999999998876544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=362.31 Aligned_cols=246 Identities=26% Similarity=0.448 Sum_probs=216.3
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
.++|++.+.||+|+||.||+++.. ++.||+|+++...... .....+.+|..+++.++||||+++++++.....+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 345666999999999999999975 7899999998643211 2246778899999999999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 400 (518)
|||++|++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ..
T Consensus 85 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~ 161 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TY 161 (318)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BC
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--cc
Confidence 999999999999987 457999999999999999999999999999999999999999999999999999865432 23
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
...||+.|+|||++.+..++.++|+|||||++|||++|..||...+..+....+.... ..+|..+++++.++|.+||+
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~ 239 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLIT 239 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHhc
Confidence 4579999999999999999999999999999999999999999888777776666543 45667889999999999999
Q ss_pred hCCCCCC-----CHHHHHH
Q 010091 481 RDPSLRP-----DFSEITE 494 (518)
Q Consensus 481 ~dP~~RP-----s~~eil~ 494 (518)
.||.+|| +++++++
T Consensus 240 ~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 240 RDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp SCTTTCTTSSTTTTHHHHT
T ss_pred cCHHHcCCCcCCCHHHHhc
Confidence 9999999 8888874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=375.69 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=216.9
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
..+.+..+.|++.+.||+|+||.||+++.. ++.||+|++...... ......+.+|+.++++++||||+++++++...
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 345777788888999999999999999976 578999999764321 12346788999999999999999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..+|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999999999987 5579999999999999999999999999999999999999999999999999998766
Q ss_pred ccCccccCCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCcH
Q 010091 395 QYGVMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTP--LQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~--~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
.........||+.|+|||++. +..++.++|||||||++|+|++|..||..... ......... ......+..+++
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~p~~~s~ 245 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-TTVVTYPSAWSQ 245 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-HCCCCCCTTSCH
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-hcccCCCCcCCH
Confidence 555556677999999999996 34589999999999999999999999975322 222222222 234566778899
Q ss_pred HHHHHHHHhhhhCCCCCCC-HHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPD-FSEITE 494 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs-~~eil~ 494 (518)
.+.++|.+||+.||.+||+ +++++.
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 9999999999999999998 776654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.92 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=206.0
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.+.||+|+||.||+|++. ++.||||++...... .....+.+|+.++++++||||+++++++......|+||||
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 3444999999999999999975 788999999765432 2336788999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC---ccc
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG---VMT 400 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~ 400 (518)
++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 999999999987 4569999999999999999999999999999999999999999999999999998654322 233
Q ss_pred cCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 401 AETGTYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQA-AVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
...||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ................+++.+.++|.+|
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHH
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHH
Confidence 4569999999999987765 7789999999999999999999987655422 2222222333333356789999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||+.|+++
T Consensus 246 L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 246 LVENPSARITIPDIKK 261 (323)
T ss_dssp SCSSTTTSCCHHHHTT
T ss_pred ccCChhhCcCHHHHhh
Confidence 9999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.12 Aligned_cols=264 Identities=26% Similarity=0.486 Sum_probs=223.3
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEE------CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
...+....|++.+.||+|+||.||++++ .++.||||++... .......|.+|+.++++++||||+++++++.
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 4456677788899999999999999985 3678999999764 3445678999999999999999999999886
Q ss_pred cC--CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 313 RP--PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 313 ~~--~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
.. ..+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 54 3789999999999999999886667999999999999999999999999999999999999999999999999999
Q ss_pred eeccccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---------------HHHH
Q 010091 391 RVQAQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP---------------LQAA 451 (518)
Q Consensus 391 ~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~---------------~~~~ 451 (518)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87654322 1223477889999999988899999999999999999999998864211 0112
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 452 VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 452 ~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
...+..+.++..+..+++.+.++|.+||+.||.+|||+.++++.|+.+.+++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 23344455666778899999999999999999999999999999999998875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=355.03 Aligned_cols=261 Identities=30% Similarity=0.551 Sum_probs=216.9
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC---Cc--cEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF---SQ--DVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~---~~--~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
..+..++|++.+.||+|+||.||+|++. ++ .||+|+++..... ......|.+|+.++++++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 4666778888999999999999999863 22 5899999876433 3456889999999999999999999999877
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
.. .++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 54 89999999999999999876667999999999999999999999999999999999999999999999999999875
Q ss_pred cccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 394 AQYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 394 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
..... .....+|..|+|||++.+..++.++||||||+++|+|++ |..||......+....+......+..+..++
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 44321 122347888999999998889999999999999999999 9999999888777766666666677778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
+.+.++|.+||+.||.+|||+.++++.|+++..
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 999999999999999999999999998887743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=360.87 Aligned_cols=248 Identities=23% Similarity=0.273 Sum_probs=207.6
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 318 (518)
+..+.|++.++||+|+||+||+|++. ++.||||++............+..|+..+.++ +||||++++++|.....+|
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34467888999999999999999985 78999999887666665556666777776666 8999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 999999 7799999987777899999999999999999999999999999999999999999999999999987665555
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
.....||+.|+|||++.+ .++.++||||||+++|||++|..|+......+ ........+.++..+++++.++|.+|
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccCCCcccccCCCHHHHHHHHHH
Confidence 555679999999999876 68999999999999999999976665433222 22222334445567889999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||+.|+++
T Consensus 289 L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 289 LEPDPKLRATAEALLA 304 (311)
T ss_dssp SCSSTTTSCCHHHHHT
T ss_pred cCCChhhCcCHHHHHh
Confidence 9999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=371.81 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=208.6
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhc-CCCceeeEeeeeecCC
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP 315 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~ 315 (518)
..+..++|++.++||+|+||.||+++.. ++.||+|+++...... .....+..|..+++++ +||||+++++++....
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 3455667888999999999999999976 5789999998765443 2335678899999887 8999999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.+|+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999999987 45799999999999999999999999999999999999999999999999999986332
Q ss_pred c-CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCC
Q 010091 396 Y-GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT--------PLQAAVGVVQKGLRPTIPVH 466 (518)
Q Consensus 396 ~-~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~--------~~~~~~~~~~~~~~p~~~~~ 466 (518)
. .......||+.|+|||++.+..++.++|+|||||++|||++|+.||.... ..+.....+. .....+|..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~ 284 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRS 284 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH-HCCCCCCTT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh-ccccCCCCc
Confidence 2 23444679999999999999999999999999999999999999996431 1111222222 335567788
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCH
Q 010091 467 THPILVDLLERCWQRDPSLRPDF 489 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~ 489 (518)
+++++.++|.+||+.||.+||++
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCHHHHHHHHHHhcCCHhHcCCC
Confidence 99999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=367.15 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=200.2
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
.+.++|++.++||+|+||.||+++.. ++.||||++....... ..+.+|+.++++++||||+++++++.....+|+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 44566777999999999999999975 7889999998654332 467899999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc--EEEeeeccceeccccC
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV--VKVADFGVARVQAQYG 397 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~--vkL~DFG~a~~~~~~~ 397 (518)
||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 94 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 94 IMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 9999999999999976 457999999999999999999999999999999999999987765 9999999997544444
Q ss_pred ccccCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCCcHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHR-ADVFSFGIVLWELVTGKLPYDDLTP----LQAAVGVVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~k-sDV~SlGill~eLltG~~P~~~~~~----~~~~~~~~~~~~~p~~~~~~~~~L~ 472 (518)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ...................+++.+.
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence 4445679999999999988888766 8999999999999999999987543 2222233333333333446789999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|.+||+.||.+|||+.|+++
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 253 HLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHHh
Confidence 9999999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=362.62 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=214.7
Q ss_pred cccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV 320 (518)
...|++.+.||+|+||.||+|+. .++.||||++...... ..+.+|+.+++++ +||||+++++++......|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 45677799999999999999996 4788999999865432 3578899999999 999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc-----EEEeeeccceeccc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV-----VKVADFGVARVQAQ 395 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~-----vkL~DFG~a~~~~~ 395 (518)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999 99999999876668999999999999999999999999999999999999998887 99999999986543
Q ss_pred cCc--------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCC--
Q 010091 396 YGV--------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGLRPT-- 462 (518)
Q Consensus 396 ~~~--------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~~p~-- 462 (518)
... .....||+.|+|||++.+..++.++||||||+++|||++|..||.+... .+....+........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 321 1345699999999999999999999999999999999999999987433 222222221111111
Q ss_pred -CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 463 -IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 463 -~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
....++ ++.+++.+||+.||.+||++.+|.+.|+++.+..+..
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 112344 9999999999999999999999999999998877543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=368.22 Aligned_cols=247 Identities=20% Similarity=0.333 Sum_probs=212.2
Q ss_pred eeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCC
Q 010091 250 EHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
.+.||+|+||.||+|+.. ++.||+|+++.... .....|.+|+.++++++||||+++++++......|+||||++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 678999999999999975 78999999987532 34578999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe--ccCCcEEEeeeccceeccccCccccCCCC
Q 010091 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM--NENGVVKVADFGVARVQAQYGVMTAETGT 405 (518)
Q Consensus 328 sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl--~~~~~vkL~DFG~a~~~~~~~~~~~~~gt 405 (518)
+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++............||
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt 251 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSS
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCC
Confidence 9999998766679999999999999999999999999999999999999 56679999999999876655545556799
Q ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHhhhhCC
Q 010091 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--IPVHTHPILVDLLERCWQRDP 483 (518)
Q Consensus 406 ~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~L~~Li~~cL~~dP 483 (518)
+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....+... ....+++++.++|.+||+.||
T Consensus 252 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 331 (373)
T 2x4f_A 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331 (373)
T ss_dssp CTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSG
T ss_pred CcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCCh
Confidence 999999999999999999999999999999999999999888777766665544322 225678999999999999999
Q ss_pred CCCCCHHHHHH--HHHH
Q 010091 484 SLRPDFSEITE--LLQH 498 (518)
Q Consensus 484 ~~RPs~~eil~--~L~~ 498 (518)
.+|||+.|+++ .+..
T Consensus 332 ~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 332 SWRISASEALKHPWLSD 348 (373)
T ss_dssp GGSCCHHHHHHSHHHHC
T ss_pred hhCCCHHHHhcCcCcCC
Confidence 99999999987 4443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=360.61 Aligned_cols=259 Identities=30% Similarity=0.570 Sum_probs=216.1
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--Ccc----EEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~----vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
.+...+|++.++||+|+||.||+|++. ++. ||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 345566777999999999999999975 444 5777775433 223347889999999999999999999999875
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
. .++|+||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4 889999999999999998877789999999999999999999999999999999999999999999999999998654
Q ss_pred ccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 395 QYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 395 ~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
.... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ..+..+.....+..++++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCCccCCHH
Confidence 4322 223346788999999999999999999999999999999 99999987765544 345556667778889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+.++|.+||+.||.+||++.|+++.|+.+.+.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=371.91 Aligned_cols=260 Identities=28% Similarity=0.541 Sum_probs=214.0
Q ss_pred cceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee-cCCceeE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT-RPPRLFI 319 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~-~~~~~~l 319 (518)
.|++.+.||+|+||.||+|++.+ ..||+|.++... +......|.+|+.++++++||||+++++++. ..+..|+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35678999999999999998642 358999987543 3345688999999999999999999999864 4567899
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC--
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-- 397 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-- 397 (518)
||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 999999999999998766778999999999999999999999999999999999999999999999999997543322
Q ss_pred ---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 398 ---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 398 ---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+.... +..+.++..+..+++.+.+
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-~~~~~~~~~p~~~~~~l~~ 327 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLYE 327 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-HHTTCCCCCCTTCCHHHHH
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHH
Confidence 1223447789999999999999999999999999999999 7889987665554433 3345566777889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHLAQRLQTKR 507 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~ 507 (518)
+|.+||+.||.+|||+.++++.|+.+++.+....
T Consensus 328 li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 328 VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 9999999999999999999999999998776543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=362.31 Aligned_cols=245 Identities=23% Similarity=0.388 Sum_probs=208.7
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCcee
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 318 (518)
..++|++.+.||+|+||.||+++.. ++.||+|+++..... ......+.+|..+++++ +||||+++++++.....+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 3456677999999999999999976 688999999876543 44557788999999988 8999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-C
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-G 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~ 397 (518)
+||||++|++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 87 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999999999976 457999999999999999999999999999999999999999999999999999863322 2
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCcH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT--------PLQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~--------~~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
......||+.|+|||++.+..++.++|+|||||++|||++|..||.... ........+. .....+|..+++
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~~s~ 244 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRSLSV 244 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH-HCCCCCCTTSCH
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH-cCCCCCCCCCCH
Confidence 3344579999999999999999999999999999999999999996521 1111222222 234557778999
Q ss_pred HHHHHHHHhhhhCCCCCCCH
Q 010091 470 ILVDLLERCWQRDPSLRPDF 489 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~ 489 (518)
++.++|.+||+.||.+||++
T Consensus 245 ~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 245 KAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHHHhcCCHhHCCCC
Confidence 99999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=363.08 Aligned_cols=246 Identities=31% Similarity=0.470 Sum_probs=215.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
..|+..+.||+|+||.||+|+.. ++.||||++....... .....|.+|+.++++++||||+++++++......|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 34777999999999999999964 7889999998764433 44578999999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
||+. |+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~ 209 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS 209 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---Cc
Confidence 9996 6888888766678999999999999999999999999999999999999999999999999999765432 33
Q ss_pred CCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 402 ETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 402 ~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
..||+.|+|||++. +..++.++||||||+++|||++|..||.....................+..+++.+.++|.+|
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 289 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 289 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 57999999999984 567899999999999999999999999988877766666655544455667899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||++++++
T Consensus 290 l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 290 LQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TCSSGGGSCCHHHHTT
T ss_pred cccChhhCcCHHHHhh
Confidence 9999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=358.38 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=210.5
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC--ce
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RL 317 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~--~~ 317 (518)
+...+|++.++||+|+||.||+|++. ++.||||+++...... ....+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34456777999999999999999986 7899999998644322 2467789999999999999999999987655 78
Q ss_pred eEEEeeccCCccccccccccC--CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe----ccCCcEEEeeeccce
Q 010091 318 FIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----NENGVVKVADFGVAR 391 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl----~~~~~vkL~DFG~a~ 391 (518)
|+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999986443 38999999999999999999999999999999999999 778889999999998
Q ss_pred eccccCccccCCCCCcccChhhhc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhcCC
Q 010091 392 VQAQYGVMTAETGTYRWMAPEVIE--------HQPYNHRADVFSFGIVLWELVTGKLPYDDLTP----LQAAVGVVQKGL 459 (518)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~ksDV~SlGill~eLltG~~P~~~~~~----~~~~~~~~~~~~ 459 (518)
............||+.|+|||++. +..++.++|||||||++|+|++|..||..... .+....+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 766655555567999999999986 57889999999999999999999999964332 222333332211
Q ss_pred C-----------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 460 R-----------------------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 460 ~-----------------------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
. ..++...++.+.++|.+||+.||.+|||++|+++...+-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0 011223456799999999999999999999998877653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=350.94 Aligned_cols=260 Identities=23% Similarity=0.430 Sum_probs=208.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccc-cCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~-~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
.+|++.+.||+|+||.||+|... ++.||+|+++... .+......+.+|+.++++++||||+++++++...+..|+||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 45667999999999999999964 7899999998643 34456688999999999999999999999999999999999
Q ss_pred eeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 322 EFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 322 Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 99999999999864 245689999999999999999999999999999999999999999999999999976544322
Q ss_pred -cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010091 399 -MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT--PLQAAVGVVQKGLRPTIPVHTHPILVDLL 475 (518)
Q Consensus 399 -~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~L~~Li 475 (518)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||.+.. ............+.+.....+++++.++|
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 271 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHH
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHH
Confidence 223468999999999999999999999999999999999999997543 22333333333344444467899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 476 ERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
.+||+.||.+|||+.++++.|+++.....
T Consensus 272 ~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 272 NMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 99999999999999999999999977654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=366.02 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=216.0
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
.++|++.+.||+|+||.||++++. ++.||||++....... .....+.+|+.++++++||||+++++++.....+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 345666999999999999999975 7899999997643211 2346788999999999999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 400 (518)
|||++|++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ..
T Consensus 120 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~ 196 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TW 196 (350)
T ss_dssp EECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BC
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--cc
Confidence 999999999999987 457999999999999999999999999999999999999999999999999999865432 23
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...+|..+++.+.++|.+||+
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~ 274 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHSC
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhh
Confidence 356999999999999999999999999999999999999999988877776665554 345677899999999999999
Q ss_pred hCCCCCCC-----HHHHHH
Q 010091 481 RDPSLRPD-----FSEITE 494 (518)
Q Consensus 481 ~dP~~RPs-----~~eil~ 494 (518)
.||.+||+ ++++++
T Consensus 275 ~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 275 VDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHT
T ss_pred cCHHhccCCccCCHHHHHh
Confidence 99999998 777764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=355.86 Aligned_cols=250 Identities=31% Similarity=0.608 Sum_probs=203.3
Q ss_pred ccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhh--cCCCceeeEeeeeec----CCc
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK--VRHMNVVQFIGACTR----PPR 316 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~--l~HpnIv~l~~~~~~----~~~ 316 (518)
-.++|++.+.||+|+||.||+|++.++.||||++.... ...+.+|..++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 34567779999999999999999999999999987542 2455566777666 799999999998643 345
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHH--------HCCceecCCCCCcEEeccCCcEEEeeec
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH--------RNNIIHRDLKAANLLMNENGVVKVADFG 388 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH--------~~gIiHrDLkp~NILl~~~~~vkL~DFG 388 (518)
.|+||||+++++|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||
T Consensus 81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 8999999999999999965 36899999999999999999999 9999999999999999999999999999
Q ss_pred cceeccccCc-----cccCCCCCcccChhhhcCC------CCCchhhHHHHHHHHHHHHcC----------CCCCCCCCH
Q 010091 389 VARVQAQYGV-----MTAETGTYRWMAPEVIEHQ------PYNHRADVFSFGIVLWELVTG----------KLPYDDLTP 447 (518)
Q Consensus 389 ~a~~~~~~~~-----~~~~~gt~~y~APE~l~~~------~~~~ksDV~SlGill~eLltG----------~~P~~~~~~ 447 (518)
+++....... .....||+.|+|||++.+. .++.++||||||+++|||++| ..||....+
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 9976544322 1224699999999999776 455799999999999999999 888865322
Q ss_pred ----HHHHHHHH-hcCCCCCCCCC-----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 448 ----LQAAVGVV-QKGLRPTIPVH-----THPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 448 ----~~~~~~~~-~~~~~p~~~~~-----~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
........ ....++.++.. +++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22222222 22334444432 457799999999999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=362.63 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=213.6
Q ss_pred ccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
..+.|++.+.||+|+||.||+|++. ++.||||++..... .....|.+|+.++++++||||+++++++...+..|+||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 4456777999999999999999975 78999999876533 34578999999999999999999999999999999999
Q ss_pred eeccCCcccccccccc---CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-
Q 010091 322 EFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG- 397 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~- 397 (518)
||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999997643 258999999999999999999999999999999999999999999999999998643322
Q ss_pred --ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHhc---------CCC
Q 010091 398 --VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQA------AVGVVQK---------GLR 460 (518)
Q Consensus 398 --~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~------~~~~~~~---------~~~ 460 (518)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+. ....... ...
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence 12233489999999999888999999999999999999999999976433211 1111111 111
Q ss_pred CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 461 p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
...+..++..+.+++.+||+.||.+|||+.|+++.|+.+++.
T Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 122233456799999999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=356.08 Aligned_cols=243 Identities=31% Similarity=0.484 Sum_probs=211.5
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|+..++||+|+||.||+|+.. |+.||||++...... ....+.+|+.++++++||||+++++++......|+||||+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 555789999999999999975 789999999865433 2467889999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 403 (518)
+|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ......
T Consensus 125 ~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 125 QGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp CSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence 99999999875 358999999999999999999999999999999999999999999999999997654432 233456
Q ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhh
Q 010091 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI--PVHTHPILVDLLERCWQR 481 (518)
Q Consensus 404 gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~L~~Li~~cL~~ 481 (518)
||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.. ...+.. +..+++.+.++|.+||+.
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~ 281 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKLKNSHKVSPVLRDFLERMLVR 281 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCcCccccCCHHHHHHHHHHccC
Confidence 99999999999999999999999999999999999999998887766554443 333332 345788999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
||.+|||+.++++
T Consensus 282 dp~~Rps~~ell~ 294 (321)
T 2c30_A 282 DPQERATAQELLD 294 (321)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999876
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=348.10 Aligned_cols=246 Identities=23% Similarity=0.388 Sum_probs=213.7
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
..|++.+.||+|+||.||+|++. +..||+|++......+ ...+.+|+.++++++||||+++++++......|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35666999999999999999986 4679999998754333 4678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe---ccCCcEEEeeeccceeccccCcc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl---~~~~~vkL~DFG~a~~~~~~~~~ 399 (518)
|+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 9999999999877 4568999999999999999999999999999999999999 78899999999999876655555
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~~ 477 (518)
....||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+.......... ..+++.+.++|.+
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence 556799999999998665 8999999999999999999999999988777666555443322111 2678999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||+.||.+|||+.++++
T Consensus 245 ~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 245 LLTKSPKQRITSLQALE 261 (277)
T ss_dssp HTCSSTTTSCCHHHHTT
T ss_pred HccCChhhCcCHHHHhc
Confidence 99999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=359.30 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=209.5
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc----
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR---- 316 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~---- 316 (518)
.++|++.+.||+|+||.||++++. ++.||||+++..... ......|.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 345666999999999999999964 688999999876543 3455789999999999999999999999866544
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 4999999999999999976 457999999999999999999999999999999999999999999999999999765433
Q ss_pred Cc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHH
Q 010091 397 GV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--IPVHTHPI 470 (518)
Q Consensus 397 ~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~ 470 (518)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+...........+. ....++++
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHH
Confidence 21 2224589999999999999999999999999999999999999999888777666665443322 23467899
Q ss_pred HHHHHHHhhhhCCCCCCCH-HHHHHHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDF-SEITELLQHLA 500 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~-~eil~~L~~l~ 500 (518)
+.++|.+||+.||.+||+. +++...|.++.
T Consensus 250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 9999999999999999854 45555555553
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=365.54 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=209.1
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc---CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~---~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
.+.|++.+.||+|+||.||++++. ++.||||++..... .......+.+|+.++++++||||+++++++.....+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 456788999999999999999975 78999999975321 1112467899999999999999999999999999999
Q ss_pred EEEeeccCCcccccccccc---CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc---EEEeeecccee
Q 010091 319 IVTEFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV---VKVADFGVARV 392 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~---vkL~DFG~a~~ 392 (518)
+||||++|++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 9999999999998886532 35899999999999999999999999999999999999986654 99999999987
Q ss_pred ccccCc-cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcH
Q 010091 393 QAQYGV-MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--IPVHTHP 469 (518)
Q Consensus 393 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~--~~~~~~~ 469 (518)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .+....+....+... ....+++
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~ 261 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISE 261 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCH
Confidence 655432 334569999999999999999999999999999999999999998753 333333333332211 1246789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++.++|.+||+.||.+|||+.|+++
T Consensus 262 ~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 262 SAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=357.19 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=215.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH----HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~----~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+.|++.+.||+|+||.||++++. ++.||+|+++...... .....+.+|+.++++++||||+++++++......|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44666999999999999999975 7889999998754322 12467899999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC----cEEEeeeccceecc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG----VVKVADFGVARVQA 394 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~----~vkL~DFG~a~~~~ 394 (518)
+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999976 45789999999999999999999999999999999999999888 79999999998766
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--RPTIPVHTHPILV 472 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~L~ 472 (518)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+..... .+......++.+.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHH
Confidence 54444556799999999999999999999999999999999999999998877666555443222 1122356789999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|.+||+.||.+|||+.|+++
T Consensus 251 ~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 251 DFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHhc
Confidence 9999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=358.17 Aligned_cols=264 Identities=30% Similarity=0.526 Sum_probs=223.3
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~ 310 (518)
+.+++...+|++.+.||+|+||.||+|++. ++.||||++.... .......+.+|+.++++++||||++++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 445788888999999999999999999842 4679999997543 44556789999999999999999999999
Q ss_pred eecCCceeEEEeeccCCcccccccccc------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---CCc
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGV 381 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~~~ 381 (518)
+......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. +..
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 999999999999999999999997643 34888999999999999999999999999999999999984 446
Q ss_pred EEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc
Q 010091 382 VKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQK 457 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~ 457 (518)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+... .+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-FVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-HHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH-HHhc
Confidence 9999999997543322 1223457889999999998999999999999999999998 999999877655443 3444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 458 GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 458 ~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
+..+..+..+++.+.++|.+||+.||.+||++.++++.|+.+.+.-
T Consensus 261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 5667778889999999999999999999999999999999887644
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=365.29 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=214.9
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCce
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 317 (518)
+..++|++.+.||+|+||.||+++.. ++.||||+++..... ......+..|..++..+ +||||+++++++.....+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 44566777999999999999999986 578999999865321 12346788899999988 799999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 97 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 999999999999999986 4579999999999999999999999999999999999999999999999999997643222
Q ss_pred -ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 398 -VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 398 -~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+....+... .+.+|..+++++.++|.
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~ 253 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICK 253 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHH
Confidence 233456999999999999999999999999999999999999999988877766666654 34567789999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHH
Q 010091 477 RCWQRDPSLRPD-----FSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs-----~~eil~ 494 (518)
+||+.||.+||+ ++++++
T Consensus 254 ~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 254 GLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHhhcCHHHcCCCCCCCHHHHhc
Confidence 999999999995 466654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=360.27 Aligned_cols=251 Identities=22% Similarity=0.376 Sum_probs=213.3
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC--CceeeEeeeeecCCce
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRPPRL 317 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H--pnIv~l~~~~~~~~~~ 317 (518)
++....|++.+.||+|+||.||++... ++.||||++.....+......|.+|+.++++++| +||+++++++.....+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 556677888999999999999999865 6789999999877777777899999999999986 9999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+|||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 85 ~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999995 58899999987 45789999999999999999999999999999999999997 6889999999998654332
Q ss_pred c---cccCCCCCcccChhhhcC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCCCCC
Q 010091 398 V---MTAETGTYRWMAPEVIEH-----------QPYNHRADVFSFGIVLWELVTGKLPYDDLTP-LQAAVGVVQKGLRPT 462 (518)
Q Consensus 398 ~---~~~~~gt~~y~APE~l~~-----------~~~~~ksDV~SlGill~eLltG~~P~~~~~~-~~~~~~~~~~~~~p~ 462 (518)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ...............
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 1 234569999999999864 6789999999999999999999999987543 344445555556677
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 ~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++...++.+.++|.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 78888899999999999999999999999976
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=370.24 Aligned_cols=246 Identities=28% Similarity=0.475 Sum_probs=209.6
Q ss_pred ccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
..|++.+.||+|+||.||+|++ .++.||+|++....... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3466699999999999999997 47899999997643222 12357889999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
||+ +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 89 E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 89 EYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp CCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred ECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 999 7899999876 45799999999999999999999999999999999999999999999999999987655554555
Q ss_pred CCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 402 ETGTYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
..||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+......... + ......+|..+++.+.++|.+||+
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-i-~~~~~~~p~~~s~~~~~li~~~L~ 244 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-V-NSCVYVMPDFLSPGAQSLIRRMIV 244 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-C-CSSCCCCCTTSCHHHHHHHHTTSC
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-H-HcCCCCCcccCCHHHHHHHHHHcC
Confidence 679999999999988776 7899999999999999999999986543221100 0 122445677789999999999999
Q ss_pred hCCCCCCCHHHHHH
Q 010091 481 RDPSLRPDFSEITE 494 (518)
Q Consensus 481 ~dP~~RPs~~eil~ 494 (518)
.||.+|||++|+++
T Consensus 245 ~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 245 ADPMQRITIQEIRR 258 (336)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred CChhHCcCHHHHHh
Confidence 99999999999976
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=350.25 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=214.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee--ecCCceeEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC--TRPPRLFIV 320 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~--~~~~~~~lV 320 (518)
++|++.+.||+|+||.||++++. ++.||+|++.....+......+.+|+.++++++||||+++++++ ......|+|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 34555999999999999999975 68899999998777777778999999999999999999999987 346789999
Q ss_pred EeeccCCcccccccccc---CCCChHHHHHHHHHhHHHHHHHHHCC-----ceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 321 TEFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNN-----IIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~ql~~gL~yLH~~g-----IiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999999997532 34899999999999999999999999 99999999999999999999999999976
Q ss_pred ccccCc-cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 393 QAQYGV-MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 393 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
...... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......+.... +..+..+.++..+++++
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l 244 (279)
T 2w5a_A 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-IREGKFRRIPYRYSDEL 244 (279)
T ss_dssp C---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHTCCCCCCTTSCHHH
T ss_pred eccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH-HhhcccccCCcccCHHH
Confidence 543321 1224589999999999999999999999999999999999999998876555443 44455667788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~ 495 (518)
.++|.+||+.||.+|||+.|+++.
T Consensus 245 ~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 245 NEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCcccCCCHHHHHhC
Confidence 999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=362.78 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=195.9
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
.+.|++.+.||+|+||.||+|++. ++.||||+++... ....+.+|+.++++++||||+++++++......|+||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 456777999999999999999986 5789999998653 2356888999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---CCcEEEeeeccceeccccCc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~~~vkL~DFG~a~~~~~~~~ 398 (518)
||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......
T Consensus 128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 99999999999977 456899999999999999999999999999999999999975 88999999999987655444
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCC--CCCCCCCcHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV-QKGLR--PTIPVHTHPILVDLL 475 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~-~~~~~--p~~~~~~~~~L~~Li 475 (518)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||......+.....+ ..... ......+++++.++|
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence 445679999999999999999999999999999999999999998766555333333 32222 223356789999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~ 494 (518)
.+||+.||.+|||+.|+++
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=352.85 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=206.9
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.++||+|+||.||+|++. ++.||+|++.....+......+.+|+.++++++||||+++++++......|+|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 35667999999999999999986 7889999998776666667889999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 9999999988766 4569999999999999999999999999999999999999999999999999998755332 2334
Q ss_pred CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------CCCC
Q 010091 402 ETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK-------------------GLRP 461 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~-------------------~~~p 461 (518)
..||..|+|||++.+ ..++.++||||||+++|+|++|..||.+....+........ +...
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence 568999999999965 67899999999999999999999999988766554433211 0000
Q ss_pred CC----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 TI----------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ~~----------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.. ...+++.+.++|.+||+.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0356788999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=349.42 Aligned_cols=247 Identities=25% Similarity=0.448 Sum_probs=211.9
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
++|++.+.||+|+||.||+|.+. ++.||+|++....... .....+.+|+.++++++||||+++++++......|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 45666999999999999999976 5679999997643322 22467889999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 89 e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~ 166 (279)
T 3fdn_A 89 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTD 166 (279)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-ccc
Confidence 99999999999976 4579999999999999999999999999999999999999999999999999986543322 234
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..||+.|+|||.+.+..++.++||||||+++|+|++|..||......+....... ....++..+++.+.++|.+||+.
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~ 244 (279)
T 3fdn_A 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKH 244 (279)
T ss_dssp -CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHHHCCS
T ss_pred cCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--CCCCCCCcCCHHHHHHHHHHhcc
Confidence 5689999999999999999999999999999999999999998877665544433 34556777899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 010091 482 DPSLRPDFSEITEL 495 (518)
Q Consensus 482 dP~~RPs~~eil~~ 495 (518)
||.+|||+.|+++.
T Consensus 245 ~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 245 NPSQRPMLREVLEH 258 (279)
T ss_dssp SGGGSCCHHHHHHC
T ss_pred ChhhCCCHHHHhhC
Confidence 99999999999873
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=362.06 Aligned_cols=266 Identities=27% Similarity=0.447 Sum_probs=205.4
Q ss_pred eeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHH--HhhcCCCceeeEeeeee-----
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHI--MRKVRHMNVVQFIGACT----- 312 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~i--l~~l~HpnIv~l~~~~~----- 312 (518)
+.++.++|++.+.||+|+||.||+|++.++.||||++..... ..+..|..+ +..++||||+++++.+.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 456667777899999999999999999999999999975431 334444444 55689999999997542
Q ss_pred cCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC---------CceecCCCCCcEEeccCCcEE
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN---------NIIHRDLKAANLLMNENGVVK 383 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~---------gIiHrDLkp~NILl~~~~~vk 383 (518)
....+|+||||+++++|.+++... ..++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 334678999999999999999764 358889999999999999999999 999999999999999999999
Q ss_pred EeeeccceeccccC---------ccccCCCCCcccChhhhcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCC-C
Q 010091 384 VADFGVARVQAQYG---------VMTAETGTYRWMAPEVIEH-------QPYNHRADVFSFGIVLWELVTGKLPYDDL-T 446 (518)
Q Consensus 384 L~DFG~a~~~~~~~---------~~~~~~gt~~y~APE~l~~-------~~~~~ksDV~SlGill~eLltG~~P~~~~-~ 446 (518)
|+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||... .
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997654321 1223469999999999976 45667899999999999999997665321 1
Q ss_pred ----------------HH-HHHHHHHhcCCCCCCCCCC------cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 447 ----------------PL-QAAVGVVQKGLRPTIPVHT------HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 447 ----------------~~-~~~~~~~~~~~~p~~~~~~------~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
.. ...........++.++..+ ++.+.++|.+||+.||.+|||+.|+++.|+.++..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 11 1111222334455555543 457999999999999999999999999999999999
Q ss_pred hhccccccc
Q 010091 504 QTKRGLAQG 512 (518)
Q Consensus 504 ~~~~~~~~~ 512 (518)
.++....++
T Consensus 321 ~~~~~~~~~ 329 (336)
T 3g2f_A 321 ERNKSVSPT 329 (336)
T ss_dssp CC-------
T ss_pred HhcccCCCc
Confidence 887766653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=366.69 Aligned_cols=250 Identities=24% Similarity=0.413 Sum_probs=214.1
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCc
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~ 316 (518)
.+..++|++.+.||+|+||.||+|++. ++.||||+++.... .+.....+..|..+++++ +||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 344566777999999999999999985 68899999986432 112235677899999887 89999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999999999977 457999999999999999999999999999999999999999999999999999754322
Q ss_pred -CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010091 397 -GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475 (518)
Q Consensus 397 -~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li 475 (518)
.......||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+....+... .+.++..+++++.++|
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL 249 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHHHHHH
Confidence 2234456999999999999999999999999999999999999999988877666555443 4566778899999999
Q ss_pred HHhhhhCCCCCCCHH-HHH
Q 010091 476 ERCWQRDPSLRPDFS-EIT 493 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~-eil 493 (518)
.+||+.||.+||++. +++
T Consensus 250 ~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGG
T ss_pred HHHhcCCHhHcCCChHHHH
Confidence 999999999999987 554
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=348.01 Aligned_cols=258 Identities=25% Similarity=0.333 Sum_probs=214.1
Q ss_pred cccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee-ecCCceeEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC-TRPPRLFIV 320 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~-~~~~~~~lV 320 (518)
.++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.++++++|++++..+..+ ......|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 34677799999999999999996 4789999998865433 3578899999999998877666555 667788999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe---ccCCcEEEeeeccceeccccC
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl---~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999 999999998666679999999999999999999999999999999999999 488999999999998755432
Q ss_pred c--------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCC---CCCC
Q 010091 398 V--------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGL---RPTI 463 (518)
Q Consensus 398 ~--------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~---~p~~ 463 (518)
. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .+....+..... .+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 2 2334689999999999999999999999999999999999999986432 122222222111 1223
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 464 ~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
+..+++.+.+++.+||+.||.+|||++++++.|+++.+..+..
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 3567899999999999999999999999999999999887654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=366.51 Aligned_cols=246 Identities=24% Similarity=0.396 Sum_probs=206.0
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHH-HhhcCCCceeeEeeeeecCCce
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHI-MRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~i-l~~l~HpnIv~l~~~~~~~~~~ 317 (518)
+..++|++.+.||+|+||.||+++.. ++.||||+++...... .....+.+|..+ ++.++||||+++++++.....+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 44566777999999999999999986 5789999998765433 334566777776 5778999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY- 396 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~- 396 (518)
|+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999999999977 457899999999999999999999999999999999999999999999999999753332
Q ss_pred CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
.......||+.|+|||++.+..++.++|+|||||++|||++|..||...+..+....++... ..++..+++.+.++|.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~ 271 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLE 271 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--CCCCSSSCHHHHHHHH
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHHHHH
Confidence 23344579999999999999999999999999999999999999999888777766666543 3456778999999999
Q ss_pred HhhhhCCCCCCCHH
Q 010091 477 RCWQRDPSLRPDFS 490 (518)
Q Consensus 477 ~cL~~dP~~RPs~~ 490 (518)
+||+.||.+||++.
T Consensus 272 ~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 272 GLLQKDRTKRLGAK 285 (373)
T ss_dssp HHTCSSGGGSTTTT
T ss_pred HHcccCHHhCCCCC
Confidence 99999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=358.58 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=210.5
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc---CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~---~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
..+|++.+.||+|+||.||+|++. ++.||+|++..... +......+.+|+.++++++||||+++++++......|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 456777999999999999999975 57899999976432 3344578999999999999999999999999999999
Q ss_pred EEEeeccCCccccccccc---------------------------------------cCCCChHHHHHHHHHhHHHHHHH
Q 010091 319 IVTEFMSGGSIYDYLHKQ---------------------------------------KCGLKLPLLLRVAIDVSKGMNYL 359 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~---------------------------------------~~~l~~~~i~~i~~ql~~gL~yL 359 (518)
+||||++|++|.+++... ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 11235677889999999999999
Q ss_pred HHCCceecCCCCCcEEeccCC--cEEEeeeccceeccccC-----ccccCCCCCcccChhhhcC--CCCCchhhHHHHHH
Q 010091 360 HRNNIIHRDLKAANLLMNENG--VVKVADFGVARVQAQYG-----VMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGI 430 (518)
Q Consensus 360 H~~gIiHrDLkp~NILl~~~~--~vkL~DFG~a~~~~~~~-----~~~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGi 430 (518)
|++||+||||||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 89999999998654322 1234569999999999965 67899999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 431 VLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 431 ll~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|+|++|..||......+..............+ ..+++.+.++|.+||+.||.+|||+.++++
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999998888777777655543333 247899999999999999999999999976
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=379.38 Aligned_cols=255 Identities=18% Similarity=0.303 Sum_probs=217.6
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
+++..++|++.++||+|+||.||+|++. ++.||+|+++...... .....+.+|..+++.++||||++++++|.....
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 4566677888999999999999999986 5789999997532211 112348889999999999999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|+||||++||+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 99999999999999999876678999999999999999999999999999999999999999999999999999765443
Q ss_pred Cc--cccCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---CCCCCCC
Q 010091 397 GV--MTAETGTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL---RPTIPVH 466 (518)
Q Consensus 397 ~~--~~~~~gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~---~p~~~~~ 466 (518)
.. .....||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....++.... .|.....
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 308 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence 32 23356999999999996 56789999999999999999999999999888777766654332 2333345
Q ss_pred CcHHHHHHHHHhhhhCCCC--CCCHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSL--RPDFSEITE 494 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~--RPs~~eil~ 494 (518)
+++++.+||.+||..+|.+ ||+++|+++
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 8999999999999888887 899999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=348.35 Aligned_cols=249 Identities=29% Similarity=0.532 Sum_probs=213.9
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec----CCc
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----PPR 316 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~----~~~ 316 (518)
+...|++.+.||+|+||.||+|.+. +..||+|++.....+......+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3445677999999999999999975 5779999999887777778899999999999999999999998754 456
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEec-cCCcEEEeeeccceec
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMN-ENGVVKVADFGVARVQ 393 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~-~~~~vkL~DFG~a~~~ 393 (518)
+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++...
T Consensus 104 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 8999999999999999976 457899999999999999999999999 99999999999997 7899999999999754
Q ss_pred cccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHH
Q 010091 394 AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILV 472 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~ 472 (518)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||............+..+. ....+...++++.
T Consensus 183 ~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 260 (290)
T 1t4h_A 183 RAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp CTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred ccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence 433 2334569999999998874 589999999999999999999999988666555555454443 3345566788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|.+||+.||.+|||+.++++
T Consensus 261 ~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 261 EIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhhCCCHHHHhh
Confidence 9999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=346.94 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=211.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHH----HHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN----IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~----~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+.|++.+.||+|+||.||++++. ++.||+|+++....... ....|.+|+.++++++||||+++++++......|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45667999999999999999986 78999999987543321 3478899999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC----cEEEeeeccceecc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG----VVKVADFGVARVQA 394 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~----~vkL~DFG~a~~~~ 394 (518)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||.+....
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999976 45799999999999999999999999999999999999998877 89999999998765
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILV 472 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~L~ 472 (518)
.........|++.|+|||++.+..++.++||||||+++|+|++|..||......+........... +......++.+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 243 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence 544444456999999999999999999999999999999999999999988776655444332221 122256788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.+||+.||.+|||+.++++
T Consensus 244 ~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 244 DFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHh
Confidence 9999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=345.78 Aligned_cols=243 Identities=21% Similarity=0.326 Sum_probs=210.1
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
++|++.+.||+|+||.||+|++. ++.||+|+++...........+.+|+.++.++ +||||+++++++...+..|+||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 45666999999999999999985 78999999998766666678889999999999 9999999999999999999999
Q ss_pred eeccCCcccccccccc---CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-------------------
Q 010091 322 EFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN------------------- 379 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~------------------- 379 (518)
||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 9999999999997632 568999999999999999999999999999999999999844
Q ss_pred CcEEEeeeccceeccccCccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Q 010091 380 GVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG 458 (518)
Q Consensus 380 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~ 458 (518)
..+||+|||.+...... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+....... .+..+
T Consensus 171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----~~~~~ 243 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH----EIRQG 243 (289)
T ss_dssp CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH----HHHTT
T ss_pred eEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH----HHHcC
Confidence 47999999999876543 234699999999999765 56789999999999999999998776543322 23445
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 ~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+.++..+++.+.++|.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 667788889999999999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=348.28 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=205.0
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|.+.++||+|+||.||+++.. ++.||+|++....... ....+.+|+.++++++||||+++++++......|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch-hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35666999999999999999975 6889999998764322 24678899999999999999999999999999999999
Q ss_pred eccCCccccccccc---cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe---ccCCcEEEeeeccceecccc
Q 010091 323 FMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 323 y~~ggsL~~~l~~~---~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl---~~~~~vkL~DFG~a~~~~~~ 396 (518)
|+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999998642 3569999999999999999999999999999999999999 45678999999999876554
Q ss_pred CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCcHHHHHHH
Q 010091 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT-IPVHTHPILVDLL 475 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~L~~Li 475 (518)
.......||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+............. .....++.+.++|
T Consensus 181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL 259 (285)
T ss_dssp ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHH
T ss_pred ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHH
Confidence 4445567999999999986 4689999999999999999999999998876665544443332222 2234789999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~ 494 (518)
.+||+.||.+|||+.|+++
T Consensus 260 ~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 260 KQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHTCSCTTTSCCHHHHHT
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=356.63 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=198.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC-------
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------- 315 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~------- 315 (518)
++|++.+.||+|+||.||+|++. ++.||||+++... .+...+.+.+|+.++++++||||++++++|....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 34666999999999999999985 7889999998654 3344578999999999999999999999885443
Q ss_pred --------------------------------------------------ceeEEEeeccCCccccccccccC--CCChH
Q 010091 316 --------------------------------------------------RLFIVTEFMSGGSIYDYLHKQKC--GLKLP 343 (518)
Q Consensus 316 --------------------------------------------------~~~lV~Ey~~ggsL~~~l~~~~~--~l~~~ 343 (518)
..|+||||++|++|.+++..... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999976432 34556
Q ss_pred HHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-------------ccccCCCCCcccC
Q 010091 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-------------VMTAETGTYRWMA 410 (518)
Q Consensus 344 ~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-------------~~~~~~gt~~y~A 410 (518)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998755432 1233469999999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 010091 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFS 490 (518)
Q Consensus 411 PE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~ 490 (518)
||++.+..++.++||||||+++|+|++|..|+... ............+......++.+.++|.+||+.||.+|||+.
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 321 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence 99999999999999999999999999987665321 112222222223333344567899999999999999999999
Q ss_pred HHHH
Q 010091 491 EITE 494 (518)
Q Consensus 491 eil~ 494 (518)
|+++
T Consensus 322 ~~l~ 325 (332)
T 3qd2_B 322 DIIE 325 (332)
T ss_dssp HHHH
T ss_pred HHhh
Confidence 9875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=355.66 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=202.3
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeee-
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACT- 312 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~- 312 (518)
...+++...+|++.++||+|+||.||++++ .++.||||++... .......+.+|+.+++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 457888889999999999999999999998 4789999998654 3444578899999999996 999999999983
Q ss_pred -------cCCceeEEEeeccCCcccccccc--ccCCCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEeccCCc
Q 010091 313 -------RPPRLFIVTEFMSGGSIYDYLHK--QKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGV 381 (518)
Q Consensus 313 -------~~~~~~lV~Ey~~ggsL~~~l~~--~~~~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~~~~~ 381 (518)
....+|+||||+. |+|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 3445899999995 799998865 3446999999999999999999999999 999999999999999999
Q ss_pred EEEeeeccceeccccCcc-------------ccCCCCCcccChhhh---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 010091 382 VKVADFGVARVQAQYGVM-------------TAETGTYRWMAPEVI---EHQPYNHRADVFSFGIVLWELVTGKLPYDDL 445 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~~~-------------~~~~gt~~y~APE~l---~~~~~~~ksDV~SlGill~eLltG~~P~~~~ 445 (518)
+||+|||+++........ ....||+.|+|||++ .+..++.++||||||+++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999765432211 134589999999998 5677899999999999999999999999875
Q ss_pred CHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 446 TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 446 ~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
..... .........+...++.+.++|.+||+.||.+|||+.|+++.|+.+.....
T Consensus 257 ~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 257 AKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 54332 22344444556677889999999999999999999999999999977654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=362.06 Aligned_cols=256 Identities=15% Similarity=0.239 Sum_probs=214.9
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEE-------ECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC---CCceee
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGA-------FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQ 306 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~-------~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~---HpnIv~ 306 (518)
...+++....|.+.++||+|+||.||+|+ ..++.||||+++... ..++..|+.++++++ |+||++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 45788889999999999999999999993 347899999997642 246777888888886 999999
Q ss_pred EeeeeecCCceeEEEeeccCCcccccccc----ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc----
Q 010091 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHK----QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---- 378 (518)
Q Consensus 307 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~----~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---- 378 (518)
+++++...+..|+||||++||+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 99999999999999999999999999974 2456999999999999999999999999999999999999998
Q ss_pred -------CCcEEEeeeccceeccc---cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 010091 379 -------NGVVKVADFGVARVQAQ---YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL 448 (518)
Q Consensus 379 -------~~~vkL~DFG~a~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~ 448 (518)
++.+||+|||+++.... ....+...||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999976432 22344567999999999999999999999999999999999999999643221
Q ss_pred HHHHHHHhcCCCCCCC-CCCcHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHHHHHhh
Q 010091 449 QAAVGVVQKGLRPTIP-VHTHPILVDLLERCWQRDPSLR-PDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 449 ~~~~~~~~~~~~p~~~-~~~~~~L~~Li~~cL~~dP~~R-Ps~~eil~~L~~l~~~~~ 504 (518)
.. .....+. ...++.+.+++.+||+.+|.+| |++.++.+.|++++.+-.
T Consensus 292 ~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 292 EC-------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp EE-------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ce-------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 10 0111111 1246779999999999999999 899999999999887643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=376.05 Aligned_cols=249 Identities=26% Similarity=0.493 Sum_probs=217.8
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
....|.+.+.||+|+||.||+|++. |+.||||++....... .....+.+|+.+++.++||||+++++++.....+|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3456777999999999999999975 7899999998653222 234678899999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcc
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 399 (518)
||||++|++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 94 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 94 VMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 9999999999999987 457999999999999999999999999999999999999999999999999999876654445
Q ss_pred ccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 400 TAETGTYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+... ....+..+++++.++|.+|
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~ 250 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQYLNPSVISLLKHM 250 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCCCCTTCCHHHHHHHHHH
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcCCCccCCHHHHHHHHHH
Confidence 55679999999999988765 68999999999999999999999987766555544432 3455677899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||+.|+++
T Consensus 251 L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 251 LQVDPMKRATIKDIRE 266 (476)
T ss_dssp TCSSTTTSCCHHHHHT
T ss_pred cCCCchhCcCHHHHHh
Confidence 9999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=374.95 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=215.8
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
+++..++|++.++||+|+||.||+++.. ++.||+|+++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 4556667777999999999999999985 6789999997532111 112457889999999999999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 99999999999999998753 5899999999999999999999999999999999999999999999999999876544
Q ss_pred Cc--cccCCCCCcccChhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCCc
Q 010091 397 GV--MTAETGTYRWMAPEVIEHQP----YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG--LRPTIPVHTH 468 (518)
Q Consensus 397 ~~--~~~~~gt~~y~APE~l~~~~----~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~--~~p~~~~~~~ 468 (518)
.. .....||+.|+|||++.+.. ++.++|||||||++|||++|..||...+..+....+.... +.......++
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 32 23456999999999997665 7899999999999999999999999988877776666543 2223334689
Q ss_pred HHHHHHHHHhhhhCCCC--CCCHHHHHH
Q 010091 469 PILVDLLERCWQRDPSL--RPDFSEITE 494 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~--RPs~~eil~ 494 (518)
+++.+||.+||+.+|.+ ||+++||++
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 99999999999999988 999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.64 Aligned_cols=253 Identities=21% Similarity=0.371 Sum_probs=214.3
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC--CCceeeEeeeeecCC
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR--HMNVVQFIGACTRPP 315 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~--HpnIv~l~~~~~~~~ 315 (518)
...+....|++.+.||+|+||.||++... ++.||||++.....+......|.+|+.++++++ ||||+++++++....
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 34566667888999999999999999865 788999999887767777789999999999996 599999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.+|+||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEEEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9999999 558899999987 44788999999999999999999999999999999999995 58999999999986543
Q ss_pred cC---ccccCCCCCcccChhhhcC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCCC
Q 010091 396 YG---VMTAETGTYRWMAPEVIEH-----------QPYNHRADVFSFGIVLWELVTGKLPYDDLTP-LQAAVGVVQKGLR 460 (518)
Q Consensus 396 ~~---~~~~~~gt~~y~APE~l~~-----------~~~~~ksDV~SlGill~eLltG~~P~~~~~~-~~~~~~~~~~~~~ 460 (518)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......++.....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 32 1234569999999999865 4689999999999999999999999987543 3444455555556
Q ss_pred CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..++...++++.++|.+||+.||.+|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 6677777899999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=356.33 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=195.9
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.++||+|+||.||+|++. ++.||+|+++.... ......+.+|+.++++++||||+++++++...+..|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45666999999999999999865 78899999986542 2223578899999999999999999999999999999999
Q ss_pred eccCCcccccccccc-----CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 323 FMSGGSIYDYLHKQK-----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 323 y~~ggsL~~~l~~~~-----~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|++ ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 997 59999986532 358999999999999999999999999999999999999999999999999998754332
Q ss_pred -ccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------
Q 010091 398 -VMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL---------------- 459 (518)
Q Consensus 398 -~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~---------------- 459 (518)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 2344568999999999976 4689999999999999999999999998877665544432100
Q ss_pred ----------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 ----------------RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ----------------~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+..+..+++++.++|.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 01112356789999999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=376.09 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=211.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
..|++.++||+|+||.||+|++. +..||+|++............+.+|+.++++++||||+++++++......|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45788999999999999999985 6789999998765444445788999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---CCcEEEeeeccceeccccCcc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~~~vkL~DFG~a~~~~~~~~~ 399 (518)
|++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.........
T Consensus 117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 9999999999876 457999999999999999999999999999999999999976 455999999999877665555
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~~ 477 (518)
....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+....+....+ ..+++.+.++|.+
T Consensus 196 ~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 274 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274 (494)
T ss_dssp CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence 5667999999999986 468999999999999999999999999988877766665544433332 4678999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||+.||.+|||+.|+++
T Consensus 275 ~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 275 MLQFDSQRRISAQQALE 291 (494)
T ss_dssp HTCSSTTTSCCHHHHHT
T ss_pred HCCCChhhCccHHHHhc
Confidence 99999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=354.31 Aligned_cols=253 Identities=20% Similarity=0.365 Sum_probs=215.2
Q ss_pred eccccceee-eEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCce
Q 010091 242 IDASLLKFE-HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRL 317 (518)
Q Consensus 242 I~~~~~~~~-~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 317 (518)
.-.+.|.+. +.||+|+||.||+++.. ++.||+|+++...........+.+|+.+++++. ||||+++++++......
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 334556666 88999999999999976 789999999876655555678999999999995 69999999999999999
Q ss_pred eEEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---CCcEEEeeeccceec
Q 010091 318 FIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVVKVADFGVARVQ 393 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~~~vkL~DFG~a~~~ 393 (518)
|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++..
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999999998653 356999999999999999999999999999999999999987 789999999999876
Q ss_pred cccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHH
Q 010091 394 AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--RPTIPVHTHPIL 471 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~L 471 (518)
..........||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+..... .......+++.+
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence 655444556799999999999999999999999999999999999999999887776655554333 334446788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.++|.+||+.||.+|||++++++
T Consensus 265 ~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcCCChhhCcCHHHHhC
Confidence 99999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=353.28 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=206.4
Q ss_pred eccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCH---HHHHHHHHHHHHHhhcC---CCceeeEeeeeec
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNE---NIRREFAQEVHIMRKVR---HMNVVQFIGACTR 313 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~---~~~~~f~~E~~il~~l~---HpnIv~l~~~~~~ 313 (518)
+..++|++.++||+|+||.||+|++ .++.||||++....... .....+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3355677799999999999999995 47889999997543211 11245667777777764 9999999999876
Q ss_pred CC-----ceeEEEeeccCCccccccccccC-CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeee
Q 010091 314 PP-----RLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387 (518)
Q Consensus 314 ~~-----~~~lV~Ey~~ggsL~~~l~~~~~-~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DF 387 (518)
.. ..|+||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 55 4899999996 599999977443 4899999999999999999999999999999999999999999999999
Q ss_pred ccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-----
Q 010091 388 GVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT----- 462 (518)
Q Consensus 388 G~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~----- 462 (518)
|+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+.
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 999876555445556799999999999999999999999999999999999999999887766655543211100
Q ss_pred --------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 --------------------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 --------------------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....+++.+.++|.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11356788999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=362.35 Aligned_cols=257 Identities=19% Similarity=0.288 Sum_probs=203.9
Q ss_pred eccccceeeeEEeEecceEEEEEEEC-----CccEEEEEEeccccCHH---------HHHHHHHHHHHHhhcCCCceeeE
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNEN---------IRREFAQEVHIMRKVRHMNVVQF 307 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~vAvKvl~~~~~~~~---------~~~~f~~E~~il~~l~HpnIv~l 307 (518)
+..++|++.+.||+|+||.||+|++. +..||+|++........ ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 44567888999999999999999984 47899999986532110 01346788899999999999999
Q ss_pred eeeeec----CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC--c
Q 010091 308 IGACTR----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG--V 381 (518)
Q Consensus 308 ~~~~~~----~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~--~ 381 (518)
++++.. ....|+||||+ |++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 999877 77899999999 999999998744 799999999999999999999999999999999999999887 9
Q ss_pred EEEeeeccceeccccCc--------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010091 382 VKVADFGVARVQAQYGV--------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVG 453 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~ 453 (518)
+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 99999999986543221 1334699999999999999999999999999999999999999965322222111
Q ss_pred HHhcCCCCCCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 454 VVQKGLRPTIP---------VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 454 ~~~~~~~p~~~---------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
.......+.++ ..+++++.++|.+||+.||.+|||+++|++.|+.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 12112222222 268889999999999999999999999999888753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.60 Aligned_cols=257 Identities=25% Similarity=0.342 Sum_probs=210.7
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee-ecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC-TRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~-~~~~~~~lV~ 321 (518)
++|++.+.||+|+||.||+|++. ++.||||++...... ..+.+|+.++++++|++++..+..+ ......|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45666999999999999999964 788999997765433 3577899999999988877766655 6677889999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe---ccCCcEEEeeeccceeccccCc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl---~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999 999999998666679999999999999999999999999999999999999 7889999999999987544321
Q ss_pred --------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCC---CCCC
Q 010091 399 --------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL---QAAVGVVQKGLR---PTIP 464 (518)
Q Consensus 399 --------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~---~~~~~~~~~~~~---p~~~ 464 (518)
.....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... +........... +...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh
Confidence 12346899999999999999999999999999999999999999764321 222222221111 1223
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 465 ~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
..+++.+.+++.+||+.||.+|||++++++.|++++++.+..
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 567899999999999999999999999999999999887644
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=376.79 Aligned_cols=248 Identities=25% Similarity=0.432 Sum_probs=214.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.++||+|+||.||++++. ++.||||++............+.+|+.++++++||||+++++++.....+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 45666999999999999999975 7899999997644333335788999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec---cCCcEEEeeeccceeccccCcc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN---ENGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~---~~~~vkL~DFG~a~~~~~~~~~ 399 (518)
|++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++........
T Consensus 102 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 9999999999877 45799999999999999999999999999999999999995 4567999999999876555555
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~~ 477 (518)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....+....+ ..+++++.++|.+
T Consensus 181 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 259 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259 (486)
T ss_dssp -CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHH
T ss_pred CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHH
Confidence 55679999999999976 58999999999999999999999999988877776666554443333 4578999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||+.||.+|||+.++++
T Consensus 260 ~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 260 MLTFHPSLRITATQCLE 276 (486)
T ss_dssp HTCSSTTTSCCHHHHHH
T ss_pred HcCCChhhCcCHHHHhc
Confidence 99999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=373.07 Aligned_cols=254 Identities=19% Similarity=0.301 Sum_probs=214.9
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
+++..++|++.++||+|+||.||+++.. ++.||||+++..... ......+.+|..++.+++||||+++++++.....
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 4556677788999999999999999975 789999999753221 1223457889999999999999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|+||||++||+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999999876567999999999999999999999999999999999999999999999999999876543
Q ss_pred Cc--cccCCCCCcccChhhhc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C-CCCCC
Q 010091 397 GV--MTAETGTYRWMAPEVIE-------HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG--L-RPTIP 464 (518)
Q Consensus 397 ~~--~~~~~gt~~y~APE~l~-------~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~--~-~p~~~ 464 (518)
.. .....||+.|+|||++. +..++.++|+|||||++|||++|+.||...+..+....++... + .|..+
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 32 22356999999999996 4578999999999999999999999999988877766665422 2 23344
Q ss_pred CCCcHHHHHHHHHhhhhCCCCC---CCHHHHHH
Q 010091 465 VHTHPILVDLLERCWQRDPSLR---PDFSEITE 494 (518)
Q Consensus 465 ~~~~~~L~~Li~~cL~~dP~~R---Ps~~eil~ 494 (518)
..+++++.++|.+||. +|.+| |+++|+++
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 6789999999999999 99998 68888864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=354.48 Aligned_cols=257 Identities=18% Similarity=0.300 Sum_probs=208.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
..|++.+.||+|+||.||++++. ++.||+|++..... +......+.+|+.++++++||||+++++++...+..|+||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 45666999999999999999975 68899999986544 3345588999999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC--cc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG--VM 399 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~--~~ 399 (518)
||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 114 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 114 RLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp ECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 99999999999986 4579999999999999999999999999999999999999999999999999997654432 12
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~L~~Li~~ 477 (518)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ....+..... ...+..+++.+.++|.+
T Consensus 193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 271 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPRPSTVRPGIPVAFDAVIAR 271 (309)
T ss_dssp ----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSCCCCGGGTSTTCCTHHHHHHHH
T ss_pred cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccCCCCccccCCCCCHHHHHHHHH
Confidence 33468999999999999999999999999999999999999998866543 2233332221 23456788999999999
Q ss_pred hhhhCCCCCC-CHHHHHHHHHHHHHHh
Q 010091 478 CWQRDPSLRP-DFSEITELLQHLAQRL 503 (518)
Q Consensus 478 cL~~dP~~RP-s~~eil~~L~~l~~~~ 503 (518)
||+.||.+|| +++++++.|+.++...
T Consensus 272 ~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 272 GMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred hccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 9999999998 9999999998876544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=358.27 Aligned_cols=249 Identities=24% Similarity=0.429 Sum_probs=214.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc--C----HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCC
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL--N----ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP 315 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~--~----~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~ 315 (518)
..|++.+.||+|+||.||+|++. |+.||||++..... . +.....+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 45777999999999999999975 78999999987542 1 12346788999999999 7999999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.+|.+||+|||++.....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999976 45799999999999999999999999999999999999999999999999999987665
Q ss_pred cCccccCCCCCcccChhhhc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCC
Q 010091 396 YGVMTAETGTYRWMAPEVIE------HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHT 467 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~------~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~ 467 (518)
........||+.|+|||++. ...++.++||||||+++|+|++|..||...........+.........+ ..+
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 332 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence 54455567999999999985 3368899999999999999999999999887766655555444333222 467
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++.+.++|.+||+.||.+|||+.++++
T Consensus 333 ~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 333 SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 888999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=346.74 Aligned_cols=249 Identities=22% Similarity=0.414 Sum_probs=215.8
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+..++|++.+.||+|+||.||+|+.. ++.||+|++....... .....+.+|+.++++++||||+++++++......|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 33456667999999999999999986 5779999997643221 22367889999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 99999999999999987 4578999999999999999999999999999999999999999999999999997654322
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.. ....++..+++.+.++|.+|
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 246 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPPFLSDGSKDLISKL 246 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--cccCCCCcCCHHHHHHHHHH
Confidence 2345689999999999999999999999999999999999999998876665544443 34456778899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||++++++
T Consensus 247 l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 247 LRYHPPQRLPLKGVME 262 (284)
T ss_dssp SCSSGGGSCCHHHHHT
T ss_pred hhcCHhhCCCHHHHhh
Confidence 9999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=350.06 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=190.1
Q ss_pred cceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|++.+.||+|+||.||+|+. .++.||+|++......+ .....+.+|+.++++++||||+++++++......|+|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 355599999999999999997 47899999997643221 224678999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 171 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCccee
Confidence 999999999998766789999999999999999999999999999999999999999999999999998654322 2223
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....... .....+..+++++.++|.+||+.
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~ 249 (278)
T 3cok_A 172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL--ADYEMPSFLSIEAKDLIHQLLRR 249 (278)
T ss_dssp --------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS--SCCCCCTTSCHHHHHHHHHHSCS
T ss_pred ccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh--cccCCccccCHHHHHHHHHHccc
Confidence 5689999999999988899999999999999999999999987654443322221 23345677899999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
||.+|||+.++++
T Consensus 250 dp~~Rps~~~~l~ 262 (278)
T 3cok_A 250 NPADRLSLSSVLD 262 (278)
T ss_dssp SGGGSCCHHHHTT
T ss_pred CHhhCCCHHHHhc
Confidence 9999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=345.85 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=216.5
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
.+|++.+.||+|+||.||++++. ++.||+|++..... .......+.+|+.++++++||||+++++++...+..|+||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 45666999999999999999986 67899999987643 3445678999999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMT 400 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 400 (518)
||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 95 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (294)
T 2rku_A 95 ELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173 (294)
T ss_dssp ECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccc
Confidence 99999999999876 4579999999999999999999999999999999999999999999999999998754332 233
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
...||+.|+|||.+.+..++.++||||||+++|+|++|..||......+....... .....+..+++.+.++|.+||+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~ 251 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--NEYSIPKHINPVAASLIQKMLQ 251 (294)
T ss_dssp CCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh--ccCCCccccCHHHHHHHHHHcc
Confidence 35689999999999999999999999999999999999999998876665544433 2345677889999999999999
Q ss_pred hCCCCCCCHHHHHH
Q 010091 481 RDPSLRPDFSEITE 494 (518)
Q Consensus 481 ~dP~~RPs~~eil~ 494 (518)
.||.+|||+.++++
T Consensus 252 ~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 252 TDPTARPTINELLN 265 (294)
T ss_dssp SSGGGSCCGGGGGG
T ss_pred cChhhCcCHHHHhh
Confidence 99999999999876
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=356.87 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=199.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.++||+|+||.||++++. ++.||||+++...........+.+|+.++++++||||+++++++.....+|+|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 45666999999999999999865 7889999998776555556788899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec-----cCCcEEEeeeccceecccc-
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-----ENGVVKVADFGVARVQAQY- 396 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~-----~~~~vkL~DFG~a~~~~~~- 396 (518)
|++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 114 ~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 114 YAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp CCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred cCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 996 599999977 44699999999999999999999999999999999999994 4556999999999765432
Q ss_pred CccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Q 010091 397 GVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT------------- 462 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~------------- 462 (518)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+......+.
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 223445689999999999764 589999999999999999999999998887776655543211111
Q ss_pred ---C------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 ---I------------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 ---~------------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. +..+++++.++|.+||+.||.+|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 0115788999999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=345.33 Aligned_cols=251 Identities=25% Similarity=0.478 Sum_probs=207.5
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
.+...+|++.+.||+|+||.||+|++. ++.||||++....... .....+.+|+.++++++||||+++++++......
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 344567777999999999999999975 7899999997643211 2346788999999999999999999999999999
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999999999976 4568999999999999999999999999999999999999999999999999998765544
Q ss_pred ccccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||......+....+.. + ....+..+++.+.++|.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~-~~~~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG-G-VFYIPEYLNRSVATLLM 243 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-C-CCCCCTTSCHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-C-cccCchhcCHHHHHHHH
Confidence 3444568999999999987765 6899999999999999999999988776555443332 2 34466778899999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
+||+.||.+|||+.++++
T Consensus 244 ~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHccCChhhCCCHHHHHh
Confidence 999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=375.59 Aligned_cols=251 Identities=23% Similarity=0.424 Sum_probs=219.7
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+-.+.|++.++||+|+||.||+++.. ++.||||++...... ......+.+|+.++++++||||+++++++......|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34556778999999999999999975 789999999765433 233578899999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe---ccCCcEEEeeeccceeccc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl---~~~~~vkL~DFG~a~~~~~ 395 (518)
+||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999999977 4579999999999999999999999999999999999999 5678999999999987655
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHH
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVD 473 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~ 473 (518)
........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....+....+ ..+++.+.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 544555679999999999976 68999999999999999999999999988887777666655544433 467899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~ 494 (518)
+|.+||+.||.+|||+.|+++
T Consensus 261 li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhh
Confidence 999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=348.68 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=210.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec---------
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--------- 313 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--------- 313 (518)
..|++.+.||+|+||.||+|++. ++.||+|+++... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 45677999999999999999986 7899999998653 356789999999999999999998754
Q ss_pred -------CCceeEEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEe
Q 010091 314 -------PPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVA 385 (518)
Q Consensus 314 -------~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~ 385 (518)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 44589999999999999999754 3568999999999999999999999999999999999999999999999
Q ss_pred eeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010091 386 DFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV 465 (518)
Q Consensus 386 DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~ 465 (518)
|||++.............||+.|+|||++.+..++.++||||||+++|+|++|..|+.... ....... ...++.
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~---~~~~~~ 238 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---KFFTDLR---DGIISD 238 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHHH---TTCCCT
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---HHHHHhh---cccccc
Confidence 9999987665544455679999999999999999999999999999999999998874321 1111122 233456
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhh
Q 010091 466 HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505 (518)
Q Consensus 466 ~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~ 505 (518)
.+++.+.++|.+||+.||.+|||+.|+++.|..+.+...+
T Consensus 239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 6789999999999999999999999999999988655443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=360.71 Aligned_cols=256 Identities=18% Similarity=0.248 Sum_probs=211.7
Q ss_pred cccceeeeEEeEecceEEEEEEEC----------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceee-------
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF----------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ------- 306 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~----------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~------- 306 (518)
...|++.+.||+|+||.||+|++. ++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 467777999999999999999974 578999999864 36788999999999999998
Q ss_pred --------Eeeeeec-CCceeEEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe
Q 010091 307 --------FIGACTR-PPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376 (518)
Q Consensus 307 --------l~~~~~~-~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl 376 (518)
+++++.. ....|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 5666654 67889999999 99999999864 3579999999999999999999999999999999999999
Q ss_pred ccCC--cEEEeeeccceeccccCc--------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 010091 377 NENG--VVKVADFGVARVQAQYGV--------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT 446 (518)
Q Consensus 377 ~~~~--~vkL~DFG~a~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~ 446 (518)
+.++ .+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 999999999976543221 123468999999999999999999999999999999999999998764
Q ss_pred -HHHHHHHHHh--cCCCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 010091 447 -PLQAAVGVVQ--KGLRPTIP------VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKR 507 (518)
Q Consensus 447 -~~~~~~~~~~--~~~~p~~~------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~ 507 (518)
.......... ....+.+. ..+++.+.++|.+||+.||.+|||++++++.|+.+++..+...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 2222222111 11112121 2468999999999999999999999999999999999887553
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.01 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=198.5
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCC--ceeE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPP--RLFI 319 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~--~~~l 319 (518)
.+|++.++||+|+||.||+|.+. ++.||||++............+.+|+.+++++. ||||+++++++.... .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 45677999999999999999875 789999999876666666788899999999997 999999999986543 7899
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc----
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ---- 395 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~---- 395 (518)
||||++ ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 89 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 999996 689988876 3689999999999999999999999999999999999999999999999999976432
Q ss_pred ------------------cCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 010091 396 ------------------YGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ 456 (518)
Q Consensus 396 ------------------~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~ 456 (518)
....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 112233569999999999976 6789999999999999999999999998877666554432
Q ss_pred cCCCCC---------------------------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 010091 457 KGLRPT---------------------------------------------IPVHTHPILVDLLERCWQRDPSLRPDFSE 491 (518)
Q Consensus 457 ~~~~p~---------------------------------------------~~~~~~~~L~~Li~~cL~~dP~~RPs~~e 491 (518)
....|. .+..+++++.+||.+||+.||.+|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 111110 12267889999999999999999999999
Q ss_pred HHH
Q 010091 492 ITE 494 (518)
Q Consensus 492 il~ 494 (518)
+++
T Consensus 326 ~l~ 328 (388)
T 3oz6_A 326 ALK 328 (388)
T ss_dssp HTT
T ss_pred HhC
Confidence 875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=354.55 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=213.2
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee--
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT-- 312 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~-- 312 (518)
.+.+.|+.++|++.+.||+|+||.||+++. .++.||||++... +......+.+|+.++++++||||+++++++.
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 356788899999999999999999999996 4789999998764 3445678999999999999999999999986
Q ss_pred --cCCceeEEEeeccCCcccccccc---ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeee
Q 010091 313 --RPPRLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387 (518)
Q Consensus 313 --~~~~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DF 387 (518)
.....|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence 34578999999999999999875 3457999999999999999999999999999999999999999999999999
Q ss_pred ccceeccccCc----------cccCCCCCcccChhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH
Q 010091 388 GVARVQAQYGV----------MTAETGTYRWMAPEVIEHQP---YNHRADVFSFGIVLWELVTGKLPYDDLTPL-QAAVG 453 (518)
Q Consensus 388 G~a~~~~~~~~----------~~~~~gt~~y~APE~l~~~~---~~~ksDV~SlGill~eLltG~~P~~~~~~~-~~~~~ 453 (518)
|++........ .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||...... .....
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 99875432110 11234799999999987554 689999999999999999999999542110 01112
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 454 VVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 454 ~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
..........+..+++.+.++|.+||+.||.+|||+.++++.|+.+
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 2233444445567889999999999999999999999999988765
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=373.84 Aligned_cols=249 Identities=22% Similarity=0.393 Sum_probs=213.1
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-----------HHHHHHHHHHHHHhhcCCCceeeEeee
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-----------NIRREFAQEVHIMRKVRHMNVVQFIGA 310 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-----------~~~~~f~~E~~il~~l~HpnIv~l~~~ 310 (518)
...|++.++||+|+||.||+|+.. ++.||+|++....... .....+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 356777999999999999999975 6789999998754332 234678999999999999999999999
Q ss_pred eecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC---cEEEeee
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG---VVKVADF 387 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~---~vkL~DF 387 (518)
+.....+|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999976 45799999999999999999999999999999999999998776 6999999
Q ss_pred ccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--C
Q 010091 388 GVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--V 465 (518)
Q Consensus 388 G~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~ 465 (518)
|++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+....+....+ .
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK 272 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence 9998776655555677999999999987 468999999999999999999999999988877666655544332222 5
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 466 HTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 466 ~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+++++.++|.+||+.||.+|||++|+++
T Consensus 273 ~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 273 NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 67899999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=352.47 Aligned_cols=254 Identities=31% Similarity=0.588 Sum_probs=206.2
Q ss_pred cccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhc--CCCceeeEeeeeecC----Cce
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV--RHMNVVQFIGACTRP----PRL 317 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l--~HpnIv~l~~~~~~~----~~~ 317 (518)
.++|++.++||+|+||.||+|++.++.||||++.... ...+..|..++..+ +||||+++++++... ...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3567779999999999999999999999999997542 13444555555544 899999999998776 678
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC--------CceecCCCCCcEEeccCCcEEEeeecc
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN--------NIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~--------gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
|+||||+++++|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 9999999999999999653 589999999999999999999999 999999999999999999999999999
Q ss_pred ceeccccCc-----cccCCCCCcccChhhhcCCCCCch------hhHHHHHHHHHHHHcC----------CCCCCCCCH-
Q 010091 390 ARVQAQYGV-----MTAETGTYRWMAPEVIEHQPYNHR------ADVFSFGIVLWELVTG----------KLPYDDLTP- 447 (518)
Q Consensus 390 a~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~~~k------sDV~SlGill~eLltG----------~~P~~~~~~- 447 (518)
+........ .....||+.|+|||++.+..++.+ +|||||||++|||++| ..||....+
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 976543321 123469999999999987766654 9999999999999999 777765322
Q ss_pred ---HHHHH-HHHhcCCCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 448 ---LQAAV-GVVQKGLRPTIPV-----HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 448 ---~~~~~-~~~~~~~~p~~~~-----~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
..... .......++.++. .+++.+.++|.+||+.||.+|||+.++++.|+.+.+..+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 22222 2223345555554 456779999999999999999999999999999987654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=356.03 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=212.0
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
++...+|++.+.||+|+||.||++++. ++.||+|++.... .......+.+|+.++++++||||+++++++......|
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 455566777999999999999999986 7889999998753 4555688999999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
+||||++|++|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999999999977 45789999999999999999999996 9999999999999999999999999999654332
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------------------------
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVG------------------------ 453 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~------------------------ 453 (518)
......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 22335799999999999999999999999999999999999999987654332111
Q ss_pred -----------------HHhcCCCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 454 -----------------VVQKGLRPTI-PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 454 -----------------~~~~~~~p~~-~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+.....+.. ...+++++.++|.+||+.||.+|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1111222222 2347889999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=344.90 Aligned_cols=246 Identities=33% Similarity=0.566 Sum_probs=217.3
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
..|++.+.||+|+||.||+|++. ++.||||++....... ....+.+|+.++++++||||+++++++......|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45777999999999999999975 6889999998764332 35788999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 9999999999875 468999999999999999999999999999999999999999999999999997654432 2234
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..||+.|+|||++.+..++.++||||||+++|+|++|..||......+.... +.....+..+..+++.+.++|.+||+.
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~ 257 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-IPKNNPPTLEGNYSKPLKEFVEACLNK 257 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHSCCCCCCSSCCHHHHHHHHHHCCS
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-hhcCCCCCCccccCHHHHHHHHHHcCC
Confidence 5689999999999999999999999999999999999999998877665543 334556777888999999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
||.+|||+.++++
T Consensus 258 dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 258 EPSFRPTAKELLK 270 (303)
T ss_dssp SGGGSCCHHHHTT
T ss_pred ChhhCcCHHHHhh
Confidence 9999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=353.04 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=217.4
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
..+|.+.+.||+|+||.||++++. ++.||+|++..... .......+.+|+.++++++||||+++++++......|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 345777999999999999999976 57899999986543 344567899999999999999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VM 399 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 399 (518)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 999999999999876 4579999999999999999999999999999999999999999999999999998754332 23
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
....||..|+|||++.+..++.++||||||+++|+|++|..||......+....+... ...++..+++.+.++|.+||
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKML 276 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHT
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHc
Confidence 3456899999999999999999999999999999999999999988766655544433 34566788999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
+.||.+|||+.|+++
T Consensus 277 ~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 277 QTDPTARPTINELLN 291 (335)
T ss_dssp CSSGGGSCCGGGGGG
T ss_pred cCChhHCcCHHHHhc
Confidence 999999999999976
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=340.13 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=208.3
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.+.||+|+||.||+|++. ++.||+|++...... .....+.+|+.++++++||||+++++++......|+||||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 4566999999999999999975 788999999865433 3457889999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC---ccc
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG---VMT 400 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~ 400 (518)
+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+....... ...
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 999999999976 4568999999999999999999999999999999999999999999999999997654322 233
Q ss_pred cCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 401 AETGTYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQA-AVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
...||..|+|||.+.+..+ +.++||||||+++|+|++|..||........ ................+++.+.++|.+|
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHH
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHH
Confidence 4568999999999987665 7789999999999999999999987654322 2222222222222346789999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||+.++++
T Consensus 246 l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 246 LVENPSARITIPDIKK 261 (276)
T ss_dssp SCSSTTTSCCHHHHTT
T ss_pred CCCCchhCCCHHHHhc
Confidence 9999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=350.37 Aligned_cols=251 Identities=29% Similarity=0.500 Sum_probs=208.2
Q ss_pred eeeEEeEecceEEEEEEECCccEEEEEEeccc--cCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccC
Q 010091 249 FEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEH--LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 249 ~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~--~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
..++||+|+||.||+|++.++.||+|++.... ..+.....|.+|+.++++++||||+++++++......|+||||+++
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 114 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114 (307)
T ss_dssp TCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred cCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence 36899999999999999999999999997643 2344567899999999999999999999999999999999999999
Q ss_pred Cccccccccc--cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---ccc
Q 010091 327 GSIYDYLHKQ--KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV---MTA 401 (518)
Q Consensus 327 gsL~~~l~~~--~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~ 401 (518)
++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ...
T Consensus 115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 194 (307)
T 2nru_A 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194 (307)
T ss_dssp CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSS
T ss_pred CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccc
Confidence 9999998743 24589999999999999999999999999999999999999999999999999986543221 223
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHhc----------CCCCCCCCCCc
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAV---GVVQK----------GLRPTIPVHTH 468 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~---~~~~~----------~~~p~~~~~~~ 468 (518)
..||+.|+|||.+.+ .++.++||||||+++|+|++|..||......+... ..... ...+..+...+
T Consensus 195 ~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (307)
T 2nru_A 195 IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV 273 (307)
T ss_dssp CCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHH
T ss_pred cCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHH
Confidence 468999999999865 47999999999999999999999998654322111 11110 11122233345
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 274 ~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 274 EAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 67999999999999999999999999998874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=383.54 Aligned_cols=264 Identities=30% Similarity=0.576 Sum_probs=228.1
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~ 311 (518)
...|++...+|++.+.||+|+||.||+|++.. ..||+|+++... .+.....|.+|+.++++++||||+++++++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35688999999999999999999999999752 459999987543 445568899999999999999999999998
Q ss_pred ecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 312 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
.. +..|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 461 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 461 TE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred ec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 54 56899999999999999998766679999999999999999999999999999999999999999999999999998
Q ss_pred eccccCc--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 392 VQAQYGV--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 392 ~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
....... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+ ..+.++..+..++
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~ 618 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 618 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HHTCCCCCCTTCC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCCCCCCcccc
Confidence 6544322 222346789999999999999999999999999999997 99999988876655443 4456677788899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
+.+.++|.+||+.||.+|||+.++++.|+.++++.
T Consensus 619 ~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 619 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=361.03 Aligned_cols=242 Identities=22% Similarity=0.374 Sum_probs=209.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHH------HHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN------IRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~------~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
.+|++.+.||+|+||.||+|++. ++.||||+++....... ....+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 45677999999999999999864 68899999987643221 23467789999999999999999999999999
Q ss_pred eeEEEeeccCC-ccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 317 LFIVTEFMSGG-SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 317 ~~lV~Ey~~gg-sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.|+||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 99999999766 99999977 45799999999999999999999999999999999999999999999999999987665
Q ss_pred cCccccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... . ......+..+++++.++
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~--~~~~~~~~~~~~~l~~l 254 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------V--EAAIHPPYLVSKELMSL 254 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------T--TTCCCCSSCCCHHHHHH
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------H--hhccCCCcccCHHHHHH
Confidence 554555679999999999988776 78999999999999999999999764321 1 22334556689999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 010091 475 LERCWQRDPSLRPDFSEITEL 495 (518)
Q Consensus 475 i~~cL~~dP~~RPs~~eil~~ 495 (518)
|.+||+.||.+|||+.++++.
T Consensus 255 i~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999873
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=348.01 Aligned_cols=252 Identities=29% Similarity=0.492 Sum_probs=208.8
Q ss_pred eeeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeec---
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR--- 313 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~--- 313 (518)
+......|++.+.||+|+||.||+|++ .++.||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 334456677799999999999999998 4789999999765432 35788999999999 79999999999865
Q ss_pred ---CCceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 314 ---PPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 314 ---~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
....|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 467899999999999999997643 4689999999999999999999999999999999999999999999999999
Q ss_pred ceeccccC-ccccCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010091 390 ARVQAQYG-VMTAETGTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI 463 (518)
Q Consensus 390 a~~~~~~~-~~~~~~gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~ 463 (518)
+....... ......||+.|+|||++. +..++.++||||||+++|+|++|..||.....................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 2x7f_A 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 255 (326)
T ss_dssp TC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred ceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCC
Confidence 97654322 223346899999999986 567899999999999999999999999988877766555554444445
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 464 ~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+..+++.+.++|.+||..||.+||++.++++
T Consensus 256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 5678999999999999999999999999977
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=357.37 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=208.7
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
..|++ ...|++.+.||+|+||.||+|++. |+.||||++.....+......+.+|+.++++++||||+++++++....
T Consensus 19 ~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 19 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 35666 467899999999999999999974 789999999876666666788999999999999999999999987653
Q ss_pred ------ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 316 ------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 316 ------~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899999876 3589999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--------
Q 010091 390 ARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR-------- 460 (518)
Q Consensus 390 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~-------- 460 (518)
++.... ..+...+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 175 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 175 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 987543 2444678999999999876 77999999999999999999999999988766555443321111
Q ss_pred ---------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 ---------------------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 ---------------------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.......++.+.+||.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 1122456889999999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=362.42 Aligned_cols=261 Identities=29% Similarity=0.466 Sum_probs=210.8
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
...+++..+.|++.+.||+|+||.||+|+.. ++.||||++....... ....|.+|+.++++++||||+++++++....
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 3456677778888999999999999999864 7889999998654322 1236889999999999999999999999999
Q ss_pred ceeEEEeeccCCcccccccccc---CCCChHHHHHHHHHhHHHHHHHHHC---CceecCCCCCcEEeccCCcEEEeeecc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRN---NIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~---~~l~~~~i~~i~~ql~~gL~yLH~~---gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
..|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 9999999999999999997643 2489999999999999999999999 999999999999999999999999999
Q ss_pred ceeccccC--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcC-----
Q 010091 390 ARVQAQYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT----PLQAAVGVVQKG----- 458 (518)
Q Consensus 390 a~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~----~~~~~~~~~~~~----- 458 (518)
++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ........+...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 98754332 2233459999999999988889999999999999999999999995210 000011111110
Q ss_pred --------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 010091 459 --------LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 459 --------~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~ 498 (518)
.....+...++.+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1111222234679999999999999999999999998875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=343.63 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=214.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc---C----HHHHHHHHHHHHHHhhcC-CCceeeEeeeeecC
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---N----ENIRREFAQEVHIMRKVR-HMNVVQFIGACTRP 314 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~---~----~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~ 314 (518)
..|++.+.||+|+||.||++++. ++.||||++..... . ......+.+|+.+++++. ||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 45556999999999999999985 68899999986532 1 233477889999999995 99999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
...|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 999999999999999999977 4579999999999999999999999999999999999999999999999999998765
Q ss_pred ccCccccCCCCCcccChhhhc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CC
Q 010091 395 QYGVMTAETGTYRWMAPEVIE------HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VH 466 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~------~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~ 466 (518)
.........|++.|+|||++. ...++.++||||||+++|+|++|..||...........+.........+ ..
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 1phk_A 176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255 (298)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccc
Confidence 544445567999999999984 5568899999999999999999999999887766665555544433322 45
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.+.++|.+||+.||.+|||+.++++
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 256 YSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 7899999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=353.43 Aligned_cols=254 Identities=30% Similarity=0.609 Sum_probs=212.3
Q ss_pred cccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhh--cCCCceeeEeeeeecCC----ce
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK--VRHMNVVQFIGACTRPP----RL 317 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~--l~HpnIv~l~~~~~~~~----~~ 317 (518)
...|++.+.||+|+||.||+|++.++.||||++.... ...+.+|+.+++. ++||||+++++++.... ..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 4567779999999999999999999999999997542 3567788888887 78999999999998775 78
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHH--------HCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH--------RNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH--------~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
|+||||+++++|.+++.+. .+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999999763 5899999999999999999999 89999999999999999999999999999
Q ss_pred ceeccccCc-----cccCCCCCcccChhhhcCCC------CCchhhHHHHHHHHHHHHcC----------CCCCCCCCH-
Q 010091 390 ARVQAQYGV-----MTAETGTYRWMAPEVIEHQP------YNHRADVFSFGIVLWELVTG----------KLPYDDLTP- 447 (518)
Q Consensus 390 a~~~~~~~~-----~~~~~gt~~y~APE~l~~~~------~~~ksDV~SlGill~eLltG----------~~P~~~~~~- 447 (518)
+........ .....||+.|+|||++.+.. ++.++||||||+++|+|++| ..||....+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 987554331 23346999999999997653 33689999999999999999 788876422
Q ss_pred ---HHHH-HHHHhcCCCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 448 ---LQAA-VGVVQKGLRPTIPV-----HTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 448 ---~~~~-~~~~~~~~~p~~~~-----~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
.+.. .......+++.++. .++..+.++|.+||+.||.+|||+.++++.|+++.++.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 2222 22334455666654 234679999999999999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=346.23 Aligned_cols=246 Identities=22% Similarity=0.398 Sum_probs=210.9
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|++.+.||+|+||.||+++.. ++.||+|+++..... ....+.+|+.++++++||||+++++++......|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 45666999999999999999975 789999999865322 23578899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe---ccCCcEEEeeeccceeccccCcc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl---~~~~~vkL~DFG~a~~~~~~~~~ 399 (518)
|+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...... ..
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~ 164 (304)
T 2jam_A 87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IM 164 (304)
T ss_dssp CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TT
T ss_pred cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cc
Confidence 9999999999976 4578999999999999999999999999999999999999 77889999999999764432 22
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--RPTIPVHTHPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~L~~Li~~ 477 (518)
....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+..... .......+++.+.++|.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 244 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHH
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence 334589999999999999999999999999999999999999998877666555554433 223345788999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||+.||.+|||+.++++
T Consensus 245 ~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 245 LLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHCSSTTTSCCHHHHHT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999976
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=371.16 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=203.4
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC------
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------ 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~------ 315 (518)
..+|++.++||+|+||.||+|.+. ++.||||++............+.+|+.++++++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467888999999999999999875 688999999887666677788999999999999999999999986553
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 56999999965 56666643 489999999999999999999999999999999999999999999999999987766
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP-------------- 461 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p-------------- 461 (518)
....+...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....++.....|
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 555566779999999999999999999999999999999999999999887766555443321110
Q ss_pred ------CCCC--------------C------CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 ------TIPV--------------H------THPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ------~~~~--------------~------~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.... . .++++.+||.+||+.||.+|||++|+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 0 0467999999999999999999999876
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=353.47 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=205.5
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH---HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE---NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~---~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
.+|++.+.||+|+||.||+|++. ++.||||++....... .....+.+|+.++++++||||+++++++......|+
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 45666999999999999999975 7889999998643322 223578899999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-c
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-V 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 398 (518)
||||+++ +|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...... .
T Consensus 90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168 (346)
T ss_dssp EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCccc
Confidence 9999975 8999988766679999999999999999999999999999999999999999999999999998654332 3
Q ss_pred cccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---------------
Q 010091 399 MTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--------------- 462 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~--------------- 462 (518)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+......+.
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccc
Confidence 344568999999999965 4589999999999999999999999999887776665554211110
Q ss_pred ------C-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 ------I-----PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 ------~-----~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. ....++++.++|.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 249 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 1345688999999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=368.26 Aligned_cols=259 Identities=23% Similarity=0.383 Sum_probs=212.2
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC--cee
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RLF 318 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~--~~~ 318 (518)
....|++.++||+|+||.||+|++. ++.||||+++...... ....+.+|+.++++++||||+++++++.... ..|
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 3455666999999999999999986 7899999998643322 2467789999999999999999999987655 789
Q ss_pred EEEeeccCCccccccccccC--CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe----ccCCcEEEeeecccee
Q 010091 319 IVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----NENGVVKVADFGVARV 392 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl----~~~~~vkL~DFG~a~~ 392 (518)
+||||++|++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999999987443 38999999999999999999999999999999999999 7778899999999987
Q ss_pred ccccCccccCCCCCcccChhhhcC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCCC
Q 010091 393 QAQYGVMTAETGTYRWMAPEVIEH--------QPYNHRADVFSFGIVLWELVTGKLPYDDLT----PLQAAVGVVQKGLR 460 (518)
Q Consensus 393 ~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~ksDV~SlGill~eLltG~~P~~~~~----~~~~~~~~~~~~~~ 460 (518)
...........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+....+......
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 665555555679999999999864 567889999999999999999999996422 23333333322110
Q ss_pred C-----------------C------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 461 P-----------------T------IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 461 p-----------------~------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
. . +...+++.+.++|.+||+.||.+||++.++++.++++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 1 1122356799999999999999999999999999888764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=354.80 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=201.7
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.++||+|+||.||+|++. ++.||+|+++..... .....+.+|+.++++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 35677999999999999999975 688999999765321 122345679999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
|++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 996 59999998766779999999999999999999999999999999999999999999999999997654332 2334
Q ss_pred CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC------------------
Q 010091 402 ETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT------------------ 462 (518)
Q Consensus 402 ~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~------------------ 462 (518)
..||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......+.
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 568999999999876 6689999999999999999999999999887665554433111110
Q ss_pred ----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 463 ----------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 463 ----------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....+++++.++|.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 01246788999999999999999999999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=361.96 Aligned_cols=242 Identities=21% Similarity=0.326 Sum_probs=193.7
Q ss_pred cceee-eEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHh-hcCCCceeeEeeeeec----CCce
Q 010091 246 LLKFE-HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMR-KVRHMNVVQFIGACTR----PPRL 317 (518)
Q Consensus 246 ~~~~~-~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~-~l~HpnIv~l~~~~~~----~~~~ 317 (518)
.|.+. ++||+|+||.||++.+. ++.||||++... ..+.+|+.++. ..+||||+++++++.. ...+
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 34445 68999999999999975 688999999743 35667888875 4589999999998864 5678
Q ss_pred eEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---CCcEEEeeeccceec
Q 010091 318 FIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVVKVADFGVARVQ 393 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~~~vkL~DFG~a~~~ 393 (518)
|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 99999999999999998743 36999999999999999999999999999999999999997 789999999999876
Q ss_pred cccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHhcCCCCC--CCCCC
Q 010091 394 AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQ----AAVGVVQKGLRPT--IPVHT 467 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~----~~~~~~~~~~~p~--~~~~~ 467 (518)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+....+... ....+
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 294 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294 (400)
T ss_dssp C-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTS
T ss_pred CCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccC
Confidence 55444555678999999999999999999999999999999999999997654321 1122222222222 22468
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++++.+||.+||+.||.+|||+.|+++
T Consensus 295 s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 295 SEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 899999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=343.90 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=213.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.+|++.+.||+|+||.||+++.. ++.||+|++............+.+|+.++++++||||+++++++......|+|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 45666999999999999999985 7899999998765554455789999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC---CcEEEeeeccceeccccCcc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN---GVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~---~~vkL~DFG~a~~~~~~~~~ 399 (518)
|+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.........
T Consensus 102 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 9999999999876 4478999999999999999999999999999999999999754 47999999999765544333
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VHTHPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~L~~Li~~ 477 (518)
....||+.|+|||.+.+. ++.++||||||+++|+|++|..||......+....+.........+ ..+++++.++|.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 259 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259 (287)
T ss_dssp SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHH
T ss_pred ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHH
Confidence 334588999999998764 8999999999999999999999999888776655555444433333 4678999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||+.||.+|||+.++++
T Consensus 260 ~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 260 MLTFHPSLRITATQCLE 276 (287)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcccChhhCcCHHHHhc
Confidence 99999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=353.36 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=208.8
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-----CCceeeEeeee
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-----HMNVVQFIGAC 311 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-----HpnIv~l~~~~ 311 (518)
...+-.+.|++.++||+|+||.||+|++ .++.||||+++.. ......+..|+.+++++. ||||+++++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 3455677899999999999999999998 4788999999752 344567788999999996 99999999999
Q ss_pred ecCCceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc------------
Q 010091 312 TRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE------------ 378 (518)
Q Consensus 312 ~~~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~------------ 378 (518)
......|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 9999999999999 999999997644 35899999999999999999999999999999999999975
Q ss_pred -------------CCcEEEeeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 010091 379 -------------NGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL 445 (518)
Q Consensus 379 -------------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~ 445 (518)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 789999999999864432 23456899999999999999999999999999999999999999887
Q ss_pred CHHHHHHHHHhcCCCC------------------------CCC--------------------CCCcHHHHHHHHHhhhh
Q 010091 446 TPLQAAVGVVQKGLRP------------------------TIP--------------------VHTHPILVDLLERCWQR 481 (518)
Q Consensus 446 ~~~~~~~~~~~~~~~p------------------------~~~--------------------~~~~~~L~~Li~~cL~~ 481 (518)
...+....+....... ..+ ...++.+.++|.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 7655443332211000 001 11236788999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
||.+|||+.|+++
T Consensus 343 dP~~Rpta~elL~ 355 (360)
T 3llt_A 343 DPTLRPSPAELLK 355 (360)
T ss_dssp SGGGSCCHHHHTT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=345.25 Aligned_cols=249 Identities=32% Similarity=0.494 Sum_probs=209.2
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
....+.|++.+.||+|+||.||+|++. ++.||+|++..... ...+.+|+.++++++||||+++++++......|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 344556777999999999999999986 78999999986532 257889999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG- 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~- 397 (518)
+||||+++++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999999998656689999999999999999999999999999999999999999999999999997654432
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--TIPVHTHPILVDLL 475 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~L~~Li 475 (518)
......||+.|+|||.+.+..++.++||||||+++|+|++|..||.............. ...+ ..+..+++.+.++|
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-NPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCSSGGGSCHHHHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-CCCcccCCcccCCHHHHHHH
Confidence 23345689999999999999999999999999999999999999998877665544333 2222 23455789999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~ 494 (518)
.+||+.||.+|||+.++++
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTT
T ss_pred HHHccCChhhCcCHHHHHh
Confidence 9999999999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=345.90 Aligned_cols=248 Identities=28% Similarity=0.490 Sum_probs=208.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
..|++.+.||+|+||.||+|++. ++.||+|++..... .....+.+|+.++++++||||+++++++...+..|+|||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45666999999999999999986 68899999876532 234688999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-Ccccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY-GVMTA 401 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~ 401 (518)
|+++++|.+++......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .....
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 99999999998876677999999999999999999999999999999999999999999999999997543221 12233
Q ss_pred CCCCCcccChhhh-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHHHHHHH
Q 010091 402 ETGTYRWMAPEVI-----EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR-PTIPVHTHPILVDLL 475 (518)
Q Consensus 402 ~~gt~~y~APE~l-----~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~L~~Li 475 (518)
..||+.|+|||++ .+..++.++||||||+++|+|++|..||.................. ...+..++..+.++|
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHH
Confidence 5689999999998 4677899999999999999999999999998877666555443322 223456789999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~ 494 (518)
.+||+.||.+|||+.++++
T Consensus 257 ~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 257 KIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHSCSCTTTSCCHHHHTT
T ss_pred HHHcccChhhCCCHHHHhc
Confidence 9999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=366.04 Aligned_cols=253 Identities=13% Similarity=0.139 Sum_probs=199.5
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHH---HHHhhcCCCceeeEe-----
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEV---HIMRKVRHMNVVQFI----- 308 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~---~il~~l~HpnIv~l~----- 308 (518)
|......|++.+.||+|+||.||+|++. ++.||||++..... .....+.|.+|+ .++++++||||++++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 3334567788999999999999999954 78999999986432 334557899999 555566899999998
Q ss_pred --eeeecCC-----------------ceeEEEeeccCCccccccccccCCCCh-------HHHHHHHHHhHHHHHHHHHC
Q 010091 309 --GACTRPP-----------------RLFIVTEFMSGGSIYDYLHKQKCGLKL-------PLLLRVAIDVSKGMNYLHRN 362 (518)
Q Consensus 309 --~~~~~~~-----------------~~~lV~Ey~~ggsL~~~l~~~~~~l~~-------~~i~~i~~ql~~gL~yLH~~ 362 (518)
+++...+ ..|+||||+ +|+|.+++.... .+++ ..++.++.||+.||.|||++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 5554443 389999999 689999998643 3444 78889999999999999999
Q ss_pred CceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCCcccChhhhcCC-----------CCCchhhHHHHHHH
Q 010091 363 NIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ-----------PYNHRADVFSFGIV 431 (518)
Q Consensus 363 gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~ksDV~SlGil 431 (518)
||+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999999986433 2334567 999999999877 89999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHHHHh
Q 010091 432 LWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE--LLQHLAQRL 503 (518)
Q Consensus 432 l~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~--~L~~l~~~~ 503 (518)
+|||++|+.||......+.... .......+++++.++|.+||+.||.+|||+.++++ .++.+.+.+
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEW------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 370 (377)
T ss_dssp HHHHHHSSCCC------CCSGG------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred HHHHHHCCCCCcccccccchhh------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence 9999999999976543322111 11123567899999999999999999999999986 556555444
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=349.40 Aligned_cols=256 Identities=31% Similarity=0.530 Sum_probs=196.0
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEE--CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
-.|.+..+.|++.+.||+|+||.||++++ .++.||||++..... ......+.+|+.++++++||||+++++++...+
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 35788889999999999999999999986 478999999876532 233467889999999999999999999999999
Q ss_pred ceeEEEeeccCCcccccccc-------ccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeec
Q 010091 316 RLFIVTEFMSGGSIYDYLHK-------QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~-------~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG 388 (518)
..|+||||++|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999999864 23458999999999999999999999999999999999999999999999999
Q ss_pred cceeccccC------ccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--
Q 010091 389 VARVQAQYG------VMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-- 459 (518)
Q Consensus 389 ~a~~~~~~~------~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-- 459 (518)
++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+..........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 987543321 1223458999999999865 5689999999999999999999999998777665544443221
Q ss_pred ------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 ------RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ------~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+.....+++.+.++|.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 12233567889999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=353.81 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=210.1
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
....++|++.+.||+|+||.||++++. ++.||+|++............+.+|+.++++++||||+++++++......|
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 334455666999999999999999986 788999999887767767788999999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG- 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~- 397 (518)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 101 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999998887665 4569999999999999999999999999999999999999999999999999997654432
Q ss_pred ccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------
Q 010091 398 VMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK------------------- 457 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~------------------- 457 (518)
......||+.|+|||++.+. .++.++||||||+++|+|++|..||......+........
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 23345689999999999765 7899999999999999999999999988776655443321
Q ss_pred CC-CCCC---------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 458 GL-RPTI---------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 458 ~~-~p~~---------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+. .+.. ...+++.+.++|.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0111 1256889999999999999999999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=341.20 Aligned_cols=255 Identities=27% Similarity=0.460 Sum_probs=213.0
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
..|.....++.....||+|+||.||+|++. ++.||||++.... ......+.+|+.++++++||||+++++++...+
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 345666666777779999999999999975 6789999998653 334578899999999999999999999999999
Q ss_pred ceeEEEeeccCCccccccccccC--CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-CCcEEEeeecccee
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVVKVADFGVARV 392 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-~~~vkL~DFG~a~~ 392 (518)
..++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 99999999999999999976433 4568889999999999999999999999999999999987 89999999999986
Q ss_pred ccccC-ccccCCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCCc
Q 010091 393 QAQYG-VMTAETGTYRWMAPEVIEHQP--YNHRADVFSFGIVLWELVTGKLPYDDLTPLQ-AAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 393 ~~~~~-~~~~~~gt~~y~APE~l~~~~--~~~ksDV~SlGill~eLltG~~P~~~~~~~~-~~~~~~~~~~~p~~~~~~~ 468 (518)
..... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||......+ ...........+.++..++
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (295)
T 2clq_A 173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252 (295)
T ss_dssp SCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC
T ss_pred cCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC
Confidence 54322 223456899999999996643 8899999999999999999999997654333 2223333456777888899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.++|.+||+.||.+||++.+++.
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=358.77 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=203.9
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
....|+| .++|++.+.||+|+||.||+|++. ++.||||+++....+......+.+|+.+|++++||||+++++++..
T Consensus 18 ~~~~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 18 GIKNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96 (432)
T ss_dssp CGGGCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCCccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEec
Confidence 3445666 457888999999999999999975 6789999998766666667889999999999999999999999876
Q ss_pred C-----CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeec
Q 010091 314 P-----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388 (518)
Q Consensus 314 ~-----~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG 388 (518)
. ..+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 5 57899999995 699999976 4579999999999999999999999999999999999999999999999999
Q ss_pred cceeccccC-----------------------ccccCCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHcCCCC---
Q 010091 389 VARVQAQYG-----------------------VMTAETGTYRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGKLP--- 441 (518)
Q Consensus 389 ~a~~~~~~~-----------------------~~~~~~gt~~y~APE~l-~~~~~~~ksDV~SlGill~eLltG~~P--- 441 (518)
+++...... ..+...||+.|+|||++ ....++.++|||||||++|||++|..|
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 998754322 13456799999999986 566799999999999999999985444
Q ss_pred --------CCCCCH-----------------HHHHHHHH----------------------hcCCCCCCC-------CCC
Q 010091 442 --------YDDLTP-----------------LQAAVGVV----------------------QKGLRPTIP-------VHT 467 (518)
Q Consensus 442 --------~~~~~~-----------------~~~~~~~~----------------------~~~~~p~~~-------~~~ 467 (518)
|.+... ......+. ...+....+ ..+
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 333221 01110000 001111111 357
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++++.+||.+||+.||.+|||++|+++
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 899999999999999999999999876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=364.32 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=193.6
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-- 313 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-- 313 (518)
..|++ .++|++.++||+|+||.||+|++. ++.||||++.....+......+.+|+.+|++++||||+++++++..
T Consensus 47 ~~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 47 SDWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp SSCCS-CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CcCcc-CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 34555 367888999999999999999865 7889999998766666667889999999999999999999999843
Q ss_pred ---CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 314 ---PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 314 ---~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
...+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccc
Confidence 35789999998 6799999876 457999999999999999999999999999999999999999999999999999
Q ss_pred eeccccC----------------------------ccccCCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHc----
Q 010091 391 RVQAQYG----------------------------VMTAETGTYRWMAPEVI-EHQPYNHRADVFSFGIVLWELVT---- 437 (518)
Q Consensus 391 ~~~~~~~----------------------------~~~~~~gt~~y~APE~l-~~~~~~~ksDV~SlGill~eLlt---- 437 (518)
+...... ..+...||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 8654221 12344689999999986 56779999999999999999998
Q ss_pred -------CCCCCCCCCHH--------------------HHHHHHHh----------------------cCCCC-------
Q 010091 438 -------GKLPYDDLTPL--------------------QAAVGVVQ----------------------KGLRP------- 461 (518)
Q Consensus 438 -------G~~P~~~~~~~--------------------~~~~~~~~----------------------~~~~p------- 461 (518)
|+.+|.+.... .....+.. ..+..
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 66777554311 10100000 00000
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
......++++.+||.+||..||.+|||++|+++
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 011345889999999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=377.63 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=212.0
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+..+.|.+.+.||+|+||.||+++.. |+.||+|++....... .....+.+|+.++++++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34455666999999999999999975 7899999997653322 22467889999999999999999999999999999
Q ss_pred EEEeeccCCccccccccc---cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 319 IVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999998653 23699999999999999999999999999999999999999999999999999987554
Q ss_pred cCcc-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 396 YGVM-TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLT----PLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 396 ~~~~-~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~----~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
.... ....||+.|+|||++.+..++.++|||||||++|||++|..||.... ..+....+.. ....+|..+++.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~~~s~~ 419 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPDKFSPA 419 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCcccCHH
Confidence 3322 33479999999999999999999999999999999999999997653 2333333332 244567788999
Q ss_pred HHHHHHHhhhhCCCCCCCH-----HHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDF-----SEITE 494 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~-----~eil~ 494 (518)
+.++|.+||+.||.+||++ ++++.
T Consensus 420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 9999999999999999975 56653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.05 Aligned_cols=247 Identities=25% Similarity=0.336 Sum_probs=199.4
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC------
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------ 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~------ 315 (518)
...|++.+.||+|+||.||+|... ++.||||++.....+......+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 356888999999999999999875 688999999877666666788999999999999999999999987654
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..|+||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 6899999996 578888753 489999999999999999999999999999999999999999999999999987655
Q ss_pred cCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 010091 396 YGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--------------- 460 (518)
Q Consensus 396 ~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--------------- 460 (518)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....++.....
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 44445567999999999999999999999999999999999999999988776655544432111
Q ss_pred -----CCC--------------CC------CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 -----PTI--------------PV------HTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 -----p~~--------------~~------~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+.. +. ..++.+.+||.+||+.||.+|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 110 00 01467999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=344.52 Aligned_cols=257 Identities=25% Similarity=0.419 Sum_probs=199.2
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
...|.+..++|++.+.||+|+||.||+|++. ++.||||++............+..+..+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 3568888889999999999999999999985 78999999987655444445566666778889999999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
...|+||||+ ++.+..+.......+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999999999 6566665555456799999999999999999999995 9999999999999999999999999999765
Q ss_pred cccCccccCCCCCcccChhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC--CC
Q 010091 394 AQYGVMTAETGTYRWMAPEVIE-----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP--VH 466 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~-----~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~--~~ 466 (518)
..........||+.|+|||++. +..++.++||||||+++|+|++|..||..................+..+ ..
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 5444444456999999999994 5678999999999999999999999998754333333333334444444 35
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.+.++|.+||+.||.+||++.++++
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 7899999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=353.17 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=206.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--------C
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--------P 314 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--------~ 314 (518)
++|++.++||+|+||.||+|++. ++.||+|++............+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 45666999999999999999974 7899999997765554445678899999999999999999999876 3
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
+.+|+||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 468999999964 8888877766779999999999999999999999999999999999999999999999999998654
Q ss_pred cc-----CccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCCCCCCCC
Q 010091 395 QY-----GVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK--GLRPTIPVH 466 (518)
Q Consensus 395 ~~-----~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~--~~~p~~~~~ 466 (518)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+... ...+.....
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 22 22334568999999999865 56899999999999999999999999988776655444321 111111111
Q ss_pred ----------------------------CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 467 ----------------------------THPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 467 ----------------------------~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.++.+.++|.+||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 2577999999999999999999999876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=352.34 Aligned_cols=252 Identities=22% Similarity=0.411 Sum_probs=213.1
Q ss_pred eeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHH---------------HHHHHHHHHHHHhhcCCCcee
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNEN---------------IRREFAQEVHIMRKVRHMNVV 305 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~---------------~~~~f~~E~~il~~l~HpnIv 305 (518)
.+..++|++.+.||+|+||.||+|++.++.||||++........ ....|.+|+.++++++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 34456788899999999999999999899999999986533211 126889999999999999999
Q ss_pred eEeeeeecCCceeEEEeeccCCccccc------cccc-cCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEec
Q 010091 306 QFIGACTRPPRLFIVTEFMSGGSIYDY------LHKQ-KCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMN 377 (518)
Q Consensus 306 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~------l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~ 377 (518)
++++++...+..|+||||+++++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+||+++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999999 6543 4579999999999999999999999 9999999999999999
Q ss_pred cCCcEEEeeeccceeccccCccccCCCCCcccChhhhcCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 010091 378 ENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ-PYNH-RADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV 455 (518)
Q Consensus 378 ~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~-ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~ 455 (518)
.++.+||+|||.+...... ......||..|+|||++.+. .++. ++||||||+++|+|++|..||............+
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i 265 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 9999999999999875443 33446799999999999877 6666 9999999999999999999998877633333333
Q ss_pred hcCCCCCCC-------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 456 QKGLRPTIP-------------------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 456 ~~~~~p~~~-------------------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+ ....+ ..+++.+.++|.+||+.||.+|||+.|+++
T Consensus 266 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 266 RTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp TSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 322 22233 567899999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=363.03 Aligned_cols=249 Identities=23% Similarity=0.385 Sum_probs=198.4
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC------HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN------ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~------~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
.+.|.+.++||+|+||.||+|.+. ++.||||++...... ......+.+|+.+|++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 456788999999999999999975 588999999865322 1222458899999999999999999999865 4
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC---cEEEeeecccee
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG---VVKVADFGVARV 392 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~---~vkL~DFG~a~~ 392 (518)
..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 58999999999999999977 45799999999999999999999999999999999999997544 599999999987
Q ss_pred ccccCccccCCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---CCCC
Q 010091 393 QAQYGVMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT---IPVH 466 (518)
Q Consensus 393 ~~~~~~~~~~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~---~~~~ 466 (518)
...........||+.|+|||++. ...++.++||||||+++|+|++|..||............+..+.... ....
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence 66555455567999999999985 46788999999999999999999999986544333333333332222 2246
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.+.++|.+||+.||.+|||+.|+++
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 7899999999999999999999999876
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=356.18 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=207.4
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec----
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR---- 313 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~---- 313 (518)
|++...+|++.++||+|+||.||+|++. ++.||||++..... .+.+|+.++++++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 4556677888999999999999999974 78999999876532 22369999999999999999998833
Q ss_pred ----------------------------------CCceeEEEeeccCCcccccccc---ccCCCChHHHHHHHHHhHHHH
Q 010091 314 ----------------------------------PPRLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGM 356 (518)
Q Consensus 314 ----------------------------------~~~~~lV~Ey~~ggsL~~~l~~---~~~~l~~~~i~~i~~ql~~gL 356 (518)
...+|+||||++ ++|.+.+.. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 334889999997 587777653 345799999999999999999
Q ss_pred HHHHHCCceecCCCCCcEEec-cCCcEEEeeeccceeccccCccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHH
Q 010091 357 NYLHRNNIIHRDLKAANLLMN-ENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWE 434 (518)
Q Consensus 357 ~yLH~~gIiHrDLkp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~e 434 (518)
.|||++||+||||||+|||++ .++.+||+|||+++............||+.|+|||++.+. .++.++|||||||++|+
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 999999999999999999998 6889999999999876655555566799999999998764 48999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHhcCC---------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 010091 435 LVTGKLPYDDLTPLQAAVGVVQKGL---------------------------RPTIPVHTHPILVDLLERCWQRDPSLRP 487 (518)
Q Consensus 435 LltG~~P~~~~~~~~~~~~~~~~~~---------------------------~p~~~~~~~~~L~~Li~~cL~~dP~~RP 487 (518)
|++|+.||.+.+..+....++.... ...++...++++.++|.+||+.||.+||
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 9999999999887776655543111 1113456788999999999999999999
Q ss_pred CHHHHHH--HHHHHH
Q 010091 488 DFSEITE--LLQHLA 500 (518)
Q Consensus 488 s~~eil~--~L~~l~ 500 (518)
|+.|+++ .++.+.
T Consensus 315 t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 315 NPYEAMAHPFFDHLR 329 (383)
T ss_dssp CHHHHHTSGGGHHHH
T ss_pred CHHHHhcCHHHHHHH
Confidence 9999985 445443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=349.50 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=201.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC------HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN------ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~------~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
+.|++.+.||+|+||.||+|++. ++.||||++...... ......+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 45666999999999999999975 578999999765321 122356889999999999999999999987654
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc---EEEeeeccceec
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV---VKVADFGVARVQ 393 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~---vkL~DFG~a~~~ 393 (518)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999876 457999999999999999999999999999999999999987654 999999999876
Q ss_pred cccCccccCCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCCCCCC
Q 010091 394 AQYGVMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR---PTIPVHT 467 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~---p~~~~~~ 467 (518)
..........||+.|+|||++. +..++.++||||||+++|+|++|..||............+..+.. +.....+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence 5443333456899999999973 567899999999999999999999999765433222222332222 2223567
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++.+.++|.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 899999999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=350.53 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=190.7
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHH-HHhhcCCCceeeEeeeee
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVH-IMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~-il~~l~HpnIv~l~~~~~ 312 (518)
....|++..++|++.+.||+|+||.||+|.+. ++.||||+++.... ......+..|+. +++.++||||+++++++.
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 34678999999999999999999999999986 78899999987643 333455556665 778889999999999999
Q ss_pred cCCceeEEEeeccCCcccccccc----ccCCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEeccCCcEEEeee
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHK----QKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVVKVADF 387 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~----~~~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~~~~vkL~DF 387 (518)
..+..|+||||+++ +|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence 99999999999965 88777753 245689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccccCccccCCCCCcccChhhh----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 010091 388 GVARVQAQYGVMTAETGTYRWMAPEVI----EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI 463 (518)
Q Consensus 388 G~a~~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~ 463 (518)
|+++............||+.|+|||++ .+..++.++||||||+++|+|++|..||...............+..+.+
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 999876554444445799999999998 5667899999999999999999999999875432222111112222222
Q ss_pred C----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 464 P----VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 464 ~----~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+ ..+++.+.++|.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 2 457899999999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=342.15 Aligned_cols=255 Identities=21% Similarity=0.368 Sum_probs=215.4
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC--CCceeeEeeeeec
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR--HMNVVQFIGACTR 313 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~--HpnIv~l~~~~~~ 313 (518)
.....+....|++.+.||+|+||.||++++. ++.||||++.....+......+.+|+.++++++ |+||+++++++..
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 4567888888999999999999999999875 688999999887777777789999999999997 5999999999999
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
....|+||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred CCEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 999999999 458899999987 45789999999999999999999999999999999999996 489999999999765
Q ss_pred cccCc---cccCCCCCcccChhhhcC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcC
Q 010091 394 AQYGV---MTAETGTYRWMAPEVIEH-----------QPYNHRADVFSFGIVLWELVTGKLPYDDLTP-LQAAVGVVQKG 458 (518)
Q Consensus 394 ~~~~~---~~~~~gt~~y~APE~l~~-----------~~~~~ksDV~SlGill~eLltG~~P~~~~~~-~~~~~~~~~~~ 458 (518)
..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ...........
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 43321 223468999999999865 4788999999999999999999999987643 33444445555
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 ~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.....+...++++.++|.+||+.||.+||++.|+++
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 566777778899999999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=376.91 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=215.1
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+..+.|++.+.||+|+||.||+++.. |+.||+|++....... .....+.+|+.+|++++||||+++++++.....+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 44556777999999999999999975 7899999997643211 22366889999999999999999999999999999
Q ss_pred EEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999999987643 349999999999999999999999999999999999999999999999999998765544
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGLRPTIPVHTHPILVDL 474 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~L~~L 474 (518)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... .......+. .....++..+++++.++
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVPEEYSERFSPQARSL 419 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-HCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-cccccCCccCCHHHHHH
Confidence 44556799999999999998999999999999999999999999987532 222222222 34556678899999999
Q ss_pred HHHhhhhCCCCCC-----CHHHHHH
Q 010091 475 LERCWQRDPSLRP-----DFSEITE 494 (518)
Q Consensus 475 i~~cL~~dP~~RP-----s~~eil~ 494 (518)
|.+||+.||.+|| +++|+++
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHh
Confidence 9999999999999 7888875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=345.72 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=208.8
Q ss_pred cccceeeeEEeEecceEEEEEEEC---CccEEEEEEeccccCHHHHHHHHHHHHHHhhc---CCCceeeEeeeee-----
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV---RHMNVVQFIGACT----- 312 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~---~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~~~~~----- 312 (518)
..+|++.+.||+|+||.||+|++. ++.||+|+++...........+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 356777999999999999999973 57899999986544333234566788777766 8999999999986
Q ss_pred cCCceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccce
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~ 391 (518)
.....|+||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 5667899999996 69999987643 348999999999999999999999999999999999999999999999999998
Q ss_pred eccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 010091 392 VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR----------- 460 (518)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~----------- 460 (518)
............||..|+|||++.+..++.++||||||+++|+|++|..||.+....+....++.....
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence 765544445567999999999999999999999999999999999999999988876655544421100
Q ss_pred --------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 --------------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 --------------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
......+++.+.++|.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0123457889999999999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=352.23 Aligned_cols=243 Identities=23% Similarity=0.393 Sum_probs=203.9
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+.|++.+.||+|+||.||++++. ++.||||++...... +.+|+.++.++ +||||+++++++......|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 45666999999999999999976 688999999875432 34688888888 7999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC----CcEEEeeeccceeccccC
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN----GVVKVADFGVARVQAQYG 397 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~----~~vkL~DFG~a~~~~~~~ 397 (518)
||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++.......
T Consensus 96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999999977 4579999999999999999999999999999999999998533 359999999998654432
Q ss_pred -ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCCC--CCCCCCCcHHH
Q 010091 398 -VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDL---TPLQAAVGVVQKGLR--PTIPVHTHPIL 471 (518)
Q Consensus 398 -~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~---~~~~~~~~~~~~~~~--p~~~~~~~~~L 471 (518)
......||+.|+|||++.+..++.++|||||||++|+|++|..||... +..+....+....+. ......+++++
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence 334457899999999998888999999999999999999999999763 333433333333322 22335688999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.++|.+||+.||.+||++.++++
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999999876
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.13 Aligned_cols=258 Identities=14% Similarity=0.122 Sum_probs=194.1
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhc--CCCceeeEe-------ee
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKV--RHMNVVQFI-------GA 310 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l--~HpnIv~l~-------~~ 310 (518)
....|++.++||+|+||.||+|++. ++.||||++....... .....+.+|+.+++.+ +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3445778999999999999999975 6889999999876533 3446777885555544 699988755 33
Q ss_pred eecC-----------------CceeEEEeeccCCccccccccccCCCChHHH------HHHHHHhHHHHHHHHHCCceec
Q 010091 311 CTRP-----------------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLL------LRVAIDVSKGMNYLHRNNIIHR 367 (518)
Q Consensus 311 ~~~~-----------------~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i------~~i~~ql~~gL~yLH~~gIiHr 367 (518)
+... ..+|+||||++ ++|.+++...+..+..... +.++.||+.||.|||++||+||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 3322 23799999997 8999999876555666666 7888999999999999999999
Q ss_pred CCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 010091 368 DLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDDL 445 (518)
Q Consensus 368 DLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~~~ 445 (518)
||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999998664322 13557799999999987 77999999999999999999999999876
Q ss_pred CHHHHHHH-----HH--hcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHHHHh
Q 010091 446 TPLQAAVG-----VV--QKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE--LLQHLAQRL 503 (518)
Q Consensus 446 ~~~~~~~~-----~~--~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~--~L~~l~~~~ 503 (518)
.+...... .. ...+.......+++.+.++|.+||+.||.+|||+.++++ .++.+..+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence 43211000 00 011122223477899999999999999999999999986 455554444
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=354.85 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=195.8
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC-
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP- 314 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~- 314 (518)
..|++. .+|++.+.||+|+||.||+|.+. |+.||||++.....+......+.+|+.++++++||||+++++++...
T Consensus 23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 467774 67999999999999999999865 78899999987666666678899999999999999999999998654
Q ss_pred -----CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 315 -----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 315 -----~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
...|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5689999999 7899999876 4699999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----------
Q 010091 390 ARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG---------- 458 (518)
Q Consensus 390 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~---------- 458 (518)
++..... .+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 179 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 179 ARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9765432 344679999999999876 678999999999999999999999999887665554433210
Q ss_pred ------------CC--CC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 ------------LR--PT-----IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 ------------~~--p~-----~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+. +. .....++.+.+||.+||+.||.+|||+.|++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 10 00 01346788999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.73 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=210.8
Q ss_pred CCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
...|++. .+|.+.+.||+|+||.||+|.+. ++.||||++......+.....+.+|+.++++++||||+++++++...
T Consensus 35 ~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 35 KTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp TEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 4567774 68999999999999999999975 78999999988776777778999999999999999999999999877
Q ss_pred Cce------eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeec
Q 010091 315 PRL------FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388 (518)
Q Consensus 315 ~~~------~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG 388 (518)
... |+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred CCcccceeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 655 99999996 688888744 48999999999999999999999999999999999999999999999999
Q ss_pred cceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC------
Q 010091 389 VARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP------ 461 (518)
Q Consensus 389 ~a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p------ 461 (518)
+++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......+
T Consensus 190 ~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 190 LARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp CC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 99865432 344678999999999976 788999999999999999999999999887766555443311110
Q ss_pred -----------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 -----------------------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 -----------------------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.....+++.+.++|.+||+.||.+|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 012356889999999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.98 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=200.7
Q ss_pred ccccceeeeEEeEecceEEEEEEEC-CccEEEEEEecccc---------CHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHL---------NENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~---------~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
..+.|++.+.||+|+||.||+|... ++.||||++..... +......+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 3455667999999999999999864 78899999875432 2334578999999999999999999999983
Q ss_pred c-----CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeee
Q 010091 313 R-----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADF 387 (518)
Q Consensus 313 ~-----~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DF 387 (518)
. ...+|+||||++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3 346899999996 6888888876678999999999999999999999999999999999999999999999999
Q ss_pred ccceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 010091 388 GVARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP----- 461 (518)
Q Consensus 388 G~a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p----- 461 (518)
|+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (362)
T 3pg1_A 179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258 (362)
T ss_dssp TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence 99986555444455678999999999876 678999999999999999999999999887666554443211111
Q ss_pred -----------------C--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 -----------------T--------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 -----------------~--------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. .....++.+.++|.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0 12345788999999999999999999999976
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=344.74 Aligned_cols=245 Identities=27% Similarity=0.443 Sum_probs=198.1
Q ss_pred cceee-eEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEE
Q 010091 246 LLKFE-HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 246 ~~~~~-~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
.|.+. +.||+|+||.||++++. ++.||||++..... .....+.+|+.+++++ +||||+++++++...+.+|+||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 34444 67999999999999864 78999999976532 2346788999999985 7999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc---EEEeeeccceeccccC-
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV---VKVADFGVARVQAQYG- 397 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~---vkL~DFG~a~~~~~~~- 397 (518)
||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 91 EKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 99999999999987 457899999999999999999999999999999999999988765 9999999987543221
Q ss_pred -------ccccCCCCCcccChhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------HHH
Q 010091 398 -------VMTAETGTYRWMAPEVIEH-----QPYNHRADVFSFGIVLWELVTGKLPYDDLTPL--------------QAA 451 (518)
Q Consensus 398 -------~~~~~~gt~~y~APE~l~~-----~~~~~ksDV~SlGill~eLltG~~P~~~~~~~--------------~~~ 451 (518)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ...
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 1123459999999999865 55889999999999999999999999765421 112
Q ss_pred HHHHhcCCCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 452 VGVVQKGLRPTIP----VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 452 ~~~~~~~~~p~~~----~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
...+..+. ..++ ..+++.+.++|.+||+.||.+|||+.|+++
T Consensus 250 ~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 250 FESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 22222222 2222 457889999999999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=351.07 Aligned_cols=238 Identities=21% Similarity=0.400 Sum_probs=181.9
Q ss_pred eeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEEeeccC
Q 010091 250 EHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
.+.||+|+||.||++++. ++.||||++... ....+.+|+.+++++. ||||+++++++......|+||||++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 478999999999999985 688999999754 2356778999999997 99999999999999999999999999
Q ss_pred CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC---cEEEeeeccceeccccC-ccccC
Q 010091 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG---VVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 327 gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~---~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... .....
T Consensus 91 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 169 (325)
T 3kn6_A 91 GELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169 (325)
T ss_dssp CBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccccc
Confidence 999999987 45799999999999999999999999999999999999998766 89999999998654432 23345
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCCCCC--CCCCcHHHHH
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP-------LQAAVGVVQKGLRPTI--PVHTHPILVD 473 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~-------~~~~~~~~~~~~~p~~--~~~~~~~L~~ 473 (518)
.||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+....+....+.... ...+++++.+
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 249 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHH
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHH
Confidence 689999999999999999999999999999999999999976432 2222222222111111 1357899999
Q ss_pred HHHHhhhhCCCCCCCHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEIT 493 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil 493 (518)
+|.+||+.||.+|||+++++
T Consensus 250 li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 250 LIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHHHHCCCTTTCCCTTTST
T ss_pred HHHHHCCCChhHCCCHHHHh
Confidence 99999999999999999876
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.30 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=207.7
Q ss_pred eeccccceeeeEEeEecceEEEEEEE-----CCccEEEEEEecccc--CHHHHHHHHHHHHHHhhc-CCCceeeEeeeee
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHL--NENIRREFAQEVHIMRKV-RHMNVVQFIGACT 312 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~vAvKvl~~~~~--~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~ 312 (518)
.+....|++.++||+|+||.||+++. .++.||||+++.... .......+.+|+.+++++ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 34456777799999999999999997 478899999875432 111224567899999999 6999999999999
Q ss_pred cCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
.....|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999987 45799999999999999999999999999999999999999999999999999986
Q ss_pred ccccC--ccccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCCCC
Q 010091 393 QAQYG--VMTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGLRPTIPV 465 (518)
Q Consensus 393 ~~~~~--~~~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~~p~~~~ 465 (518)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .......+. ...+..+.
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 287 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQ 287 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCCCCCCT
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-ccCCCCCc
Confidence 43322 2233469999999999975 4578999999999999999999999974321 122222122 23556777
Q ss_pred CCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 010091 466 HTHPILVDLLERCWQRDPSLRP-----DFSEITEL 495 (518)
Q Consensus 466 ~~~~~L~~Li~~cL~~dP~~RP-----s~~eil~~ 495 (518)
.+++.+.++|.+||+.||.+|| ++.|+++.
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 8899999999999999999999 89998763
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=344.61 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=209.0
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
..|++ ..+|.+.+.||+|+||.||+|++. |+.||||++.....++.....+.+|+.++++++||||+++++++....
T Consensus 18 ~~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 18 TAWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp EEEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred ccccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 45776 457888999999999999999975 789999999877666666788999999999999999999999987765
Q ss_pred c------eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 316 R------LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 316 ~------~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
. .|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred ccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 4 499999996 699888754 489999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------
Q 010091 390 ARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQK----------- 457 (518)
Q Consensus 390 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~----------- 457 (518)
++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9765432 334568999999999876 67899999999999999999999999987765544433221
Q ss_pred -----------CC----C---CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 458 -----------GL----R---PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 458 -----------~~----~---p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+ + ......+++.+.++|.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 1 1223467899999999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=337.56 Aligned_cols=247 Identities=22% Similarity=0.403 Sum_probs=205.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC--HHHHHHHHHHHHHHhhcCCCceeeEeeee--ecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKVRHMNVVQFIGAC--TRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~--~~~~~~f~~E~~il~~l~HpnIv~l~~~~--~~~~~~~ 318 (518)
.+|++.+.||+|+||.||++.+. ++.||+|+++..... ......+.+|+.++++++||||+++++++ ......|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 35666999999999999999974 678999999865321 23457899999999999999999999998 4556899
Q ss_pred EEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc-
Q 010091 319 IVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY- 396 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~- 396 (518)
+||||++++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+......
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999765 66766542 346899999999999999999999999999999999999999999999999999865432
Q ss_pred --CccccCCCCCcccChhhhcCCCC--CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 010091 397 --GVMTAETGTYRWMAPEVIEHQPY--NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV 472 (518)
Q Consensus 397 --~~~~~~~gt~~y~APE~l~~~~~--~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~ 472 (518)
.......||+.|+|||++.+... +.++||||||+++|+|++|..||......+....+... ...++..+++.+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPPLS 241 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHHHH
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHHHH
Confidence 12234568999999999976543 78999999999999999999999987766655443332 3456778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++|.+||+.||.+|||+.|+++
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=379.47 Aligned_cols=253 Identities=22% Similarity=0.376 Sum_probs=217.0
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecC
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRP 314 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~ 314 (518)
...+..++|++.++||+|+||.||++++. ++.||||+++.... .+.....+..|..++..+ +||||+++++++...
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 34566778999999999999999999976 57799999986432 112236778899999988 799999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999999987 4579999999999999999999999999999999999999999999999999998643
Q ss_pred ccC-ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 395 QYG-VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 395 ~~~-~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
... ......||+.|+|||++.+..++.++||||||+++|||++|..||.+.+..+....+... ...+|..+++++.+
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 571 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVA 571 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS--CCCCCTTSCHHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHH
Confidence 322 334456999999999999999999999999999999999999999998887777666643 45667789999999
Q ss_pred HHHHhhhhCCCCCCCH-----HHHHH
Q 010091 474 LLERCWQRDPSLRPDF-----SEITE 494 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~-----~eil~ 494 (518)
||.+||+.||.+||++ +||++
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 9999999999999987 66654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=341.25 Aligned_cols=242 Identities=18% Similarity=0.313 Sum_probs=201.8
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeec--CCcee
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTR--PPRLF 318 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~ 318 (518)
.++|++.++||+|+||.||+|++. ++.||||+++... ...+.+|+.++++++ ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 456888999999999999999864 7899999997542 357889999999997 9999999999987 66789
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-cEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-~vkL~DFG~a~~~~~~~ 397 (518)
+||||+++++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 110 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999998854 88999999999999999999999999999999999999776 89999999998766555
Q ss_pred ccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHH------------hcC-----
Q 010091 398 VMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLT-PLQAAVGVV------------QKG----- 458 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~-~~~~~~~~~------------~~~----- 458 (518)
......||..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+...... ...
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 5555679999999999976 678999999999999999999999995432 222211111 000
Q ss_pred ------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 ------------------LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 ------------------~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.....+..+++++.++|.+||+.||.+|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011112236899999999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=346.81 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=205.0
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC-----Cce
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PRL 317 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 317 (518)
.+|++.+.||+|+||.||++.+. ++.||||++.... .......+.+|+.++++++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 56777999999999999999975 6789999997543 444557899999999999999999999998654 468
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 99999996 599998865 359999999999999999999999999999999999999999999999999998765432
Q ss_pred c----cccCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----------
Q 010091 398 V----MTAETGTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP----------- 461 (518)
Q Consensus 398 ~----~~~~~gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p----------- 461 (518)
. .....||+.|+|||++. +..++.++||||||+++|+|++|+.||.+....+....+......+
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 2 23346899999999864 4558999999999999999999999998876655544433210000
Q ss_pred -------------C-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 -------------T-----IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 -------------~-----~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. ....+++++.++|.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 11456789999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=335.19 Aligned_cols=244 Identities=24% Similarity=0.427 Sum_probs=197.3
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec---------
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--------- 313 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--------- 313 (518)
++|++.+.||+|+||.||+|+.. ++.||||++... ......+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 35666999999999999999974 788999999653 3445789999999999999999999998754
Q ss_pred ----CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 314 ----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 314 ----~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
....|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 3568999999999999999987666788899999999999999999999999999999999999999999999999
Q ss_pred ceecccc---------------CccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 010091 390 ARVQAQY---------------GVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVG 453 (518)
Q Consensus 390 a~~~~~~---------------~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~ 453 (518)
+...... .......||+.|+|||++.+. .++.++||||||+++|+|++ ||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 9764321 112334589999999999754 78999999999999999998 5553322222222
Q ss_pred HHhc---CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 454 VVQK---GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 454 ~~~~---~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+.. .+.+..+...++.+.++|.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 2221 2344555667888999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=361.72 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=213.2
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC-CceeeEeeeeecCCceeEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV 320 (518)
.+.|++.++||+|+||.||+|++. ++.||||++...... ..+.+|+.+++.++| ++|..+..++......|+|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 345677999999999999999975 789999998865443 347789999999987 5555666666778889999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe---ccCCcEEEeeeccceeccccC
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl---~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9999 999999998766789999999999999999999999999999999999999 688999999999998755432
Q ss_pred c--------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCC---CCCC
Q 010091 398 V--------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQKGL---RPTI 463 (518)
Q Consensus 398 ~--------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~~~---~p~~ 463 (518)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||.+... .+....+..... ...+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 2 1145699999999999999999999999999999999999999987543 233322222221 1223
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 464 PVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 464 ~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
...+++++.++|.+||+.+|.+||++.+|++.|++++...+
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 35678999999999999999999999999999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.65 Aligned_cols=245 Identities=28% Similarity=0.436 Sum_probs=206.2
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc------CCCceeeEeeeeecCC
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV------RHMNVVQFIGACTRPP 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l------~HpnIv~l~~~~~~~~ 315 (518)
..+|++.++||+|+||.||+|.+. ++.||||+++.. ......+.+|+.+++.+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 456888999999999999999975 688999999763 33446778888888887 5779999999999999
Q ss_pred ceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc--EEEeeecccee
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV--VKVADFGVARV 392 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~--vkL~DFG~a~~ 392 (518)
.+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999999995 69999987644 35899999999999999999999999999999999999999887 99999999976
Q ss_pred ccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----------
Q 010091 393 QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP----------- 461 (518)
Q Consensus 393 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p----------- 461 (518)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 252 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~ 329 (429)
T 3kvw_A 252 EHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA 329 (429)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred cCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence 5432 334679999999999999999999999999999999999999999887766554433210000
Q ss_pred ----------------------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 ----------------------------------------------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ----------------------------------------------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.++...++.+.+||.+||+.||.+|||+.|+++
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 011234788999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.26 Aligned_cols=243 Identities=25% Similarity=0.318 Sum_probs=199.0
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec------CCc
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------PPR 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~------~~~ 316 (518)
..|++.+.||+|+||.||+|++. ++.||||++..... .+.+|+.++++++||||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 35777999999999999999985 78999999876432 23469999999999999999998743 224
Q ss_pred eeEEEeeccCCccccccc---cccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-CcEEEeeecccee
Q 010091 317 LFIVTEFMSGGSIYDYLH---KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVVKVADFGVARV 392 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~---~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-~~vkL~DFG~a~~ 392 (518)
+++||||+++ +|.+++. .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 6799999965 6666554 234579999999999999999999999999999999999999965 6789999999987
Q ss_pred ccccCccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Q 010091 393 QAQYGVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL------------ 459 (518)
Q Consensus 393 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~------------ 459 (518)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....++....
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 6554444556799999999998664 799999999999999999999999998877665555443100
Q ss_pred ------CCC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 ------RPT---------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ------~p~---------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+. ++...++++.+||.+||+.||.+|||+.|++.
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 011 23456789999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.12 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=204.9
Q ss_pred eccccceeeeEEeEecceEEEEEEE---CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc------eeeEeeeee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAF---FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN------VVQFIGACT 312 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~---~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn------Iv~l~~~~~ 312 (518)
+-.++|++.+.||+|+||.||++.+ .++.||||+++.. +.....+.+|+.++++++|++ ++++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 4456777799999999999999987 3678999999753 344578889999999997665 999999999
Q ss_pred cCCceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-------------
Q 010091 313 RPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE------------- 378 (518)
Q Consensus 313 ~~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~------------- 378 (518)
..+..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 889999997644 36889999999999999999999999999999999999987
Q ss_pred ------CCcEEEeeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 010091 379 ------NGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAV 452 (518)
Q Consensus 379 ------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~ 452 (518)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999865432 234578999999999999999999999999999999999999998877655433
Q ss_pred HHHhc-C-CC----------------------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 010091 453 GVVQK-G-LR----------------------------------------PTIPVHTHPILVDLLERCWQRDPSLRPDFS 490 (518)
Q Consensus 453 ~~~~~-~-~~----------------------------------------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~ 490 (518)
..... + .. ...+...++.+.++|.+||+.||.+|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 22110 0 00 001122356799999999999999999999
Q ss_pred HHHH
Q 010091 491 EITE 494 (518)
Q Consensus 491 eil~ 494 (518)
|+++
T Consensus 325 ell~ 328 (339)
T 1z57_A 325 EALK 328 (339)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.62 Aligned_cols=247 Identities=25% Similarity=0.324 Sum_probs=203.2
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC-----Cc
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PR 316 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~-----~~ 316 (518)
.+.|++.+.||+|+||.||+|++. ++.||||++.... .......+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 345666999999999999999986 7889999997542 344557888999999999999999999987654 67
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
.|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 899999996 689998876 35899999999999999999999999999999999999999999999999999865432
Q ss_pred Cc-----------cccCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---
Q 010091 397 GV-----------MTAETGTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--- 461 (518)
Q Consensus 397 ~~-----------~~~~~gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--- 461 (518)
.. .....||+.|+|||++. +..++.++||||||+++|+|++|+.||.+.+..+...........+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 11 12245899999999875 4778999999999999999999999999877655443322110000
Q ss_pred -------------------C--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 -------------------T--------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 -------------------~--------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. ....+++++.++|.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 11357889999999999999999999999876
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.86 Aligned_cols=246 Identities=26% Similarity=0.335 Sum_probs=200.0
Q ss_pred ccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC------
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------ 315 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~------ 315 (518)
...+|++.++||+|+||.||+|++. +..||+|.+..... ...+|+.++++++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3456888999999999999999985 45689988865432 1236999999999999999999984433
Q ss_pred ceeEEEeeccCCccccccc--cccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec-cCCcEEEeeecccee
Q 010091 316 RLFIVTEFMSGGSIYDYLH--KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVVKVADFGVARV 392 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~--~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~-~~~~vkL~DFG~a~~ 392 (518)
.+|+||||++++.+..... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 3889999997644333221 2245789999999999999999999999999999999999999 789999999999987
Q ss_pred ccccCccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 010091 393 QAQYGVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR----------- 460 (518)
Q Consensus 393 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~----------- 460 (518)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....++.....
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 6555555556799999999998654 5899999999999999999999999988876665554431100
Q ss_pred -------C---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 -------P---------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 -------p---------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+ .++...++++.+||.+||+.||.+|||+.|++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 123457889999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.61 Aligned_cols=246 Identities=23% Similarity=0.328 Sum_probs=198.9
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee---------
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT--------- 312 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~--------- 312 (518)
.++|++.+.||+|+||.||+|++. ++.||+|++... +......+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 467788999999999999999986 688999998754 3455678999999999999999999998873
Q ss_pred -----cCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec-cCCcEEEee
Q 010091 313 -----RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVVKVAD 386 (518)
Q Consensus 313 -----~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~-~~~~vkL~D 386 (518)
.....|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4467899999996 699999865 4589999999999999999999999999999999999997 567999999
Q ss_pred eccceeccccC----ccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--
Q 010091 387 FGVARVQAQYG----VMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-- 459 (518)
Q Consensus 387 FG~a~~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-- 459 (518)
||+++...... ......+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+.....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99998654321 1223457899999998865 6789999999999999999999999998877665544332210
Q ss_pred ---------------------CCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 ---------------------RPT-----IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 ---------------------~p~-----~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+. ....+++++.++|.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 011 12457899999999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=346.83 Aligned_cols=247 Identities=24% Similarity=0.344 Sum_probs=199.4
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC--------CCceeeEeeee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR--------HMNVVQFIGAC 311 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~--------HpnIv~l~~~~ 311 (518)
+-..+|++.++||+|+||.||+|++. ++.||||+++.. ......+.+|+.++++++ |+||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 33567778999999999999999875 688999999753 344578889999999995 78899999998
Q ss_pred e----cCCceeEEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEeccCC-----
Q 010091 312 T----RPPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENG----- 380 (518)
Q Consensus 312 ~----~~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~~~----- 380 (518)
. ....+|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 7 566899999999 56666666543 35699999999999999999999998 999999999999998775
Q ss_pred --------------------------------------------cEEEeeeccceeccccCccccCCCCCcccChhhhcC
Q 010091 381 --------------------------------------------VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH 416 (518)
Q Consensus 381 --------------------------------------------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~ 416 (518)
.+||+|||++...... .....||+.|+|||++.+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC
Confidence 7999999999876543 344679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc-CCC-----------------------------
Q 010091 417 QPYNHRADVFSFGIVLWELVTGKLPYDDLTP------LQAAVGVVQK-GLR----------------------------- 460 (518)
Q Consensus 417 ~~~~~ksDV~SlGill~eLltG~~P~~~~~~------~~~~~~~~~~-~~~----------------------------- 460 (518)
..++.++|||||||++|+|++|..||...+. .......... +..
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 9999999999999999999999999976442 1111111110 000
Q ss_pred ----------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 ----------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 ----------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
...+...++.+.+||.+||+.||.+|||+.|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0112233467899999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.78 Aligned_cols=250 Identities=21% Similarity=0.239 Sum_probs=193.3
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc--
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-- 316 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~-- 316 (518)
....++|++.+.||+|+||.||+|++. ++.||||++...... ...+.+++..++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 344456777999999999999999975 788999998764322 2356678888899999999999999854333
Q ss_pred -----eeEEEeeccCCccccccc---cccCCCChHHHHHHHHHhHHHHHHHH--HCCceecCCCCCcEEecc-CCcEEEe
Q 010091 317 -----LFIVTEFMSGGSIYDYLH---KQKCGLKLPLLLRVAIDVSKGMNYLH--RNNIIHRDLKAANLLMNE-NGVVKVA 385 (518)
Q Consensus 317 -----~~lV~Ey~~ggsL~~~l~---~~~~~l~~~~i~~i~~ql~~gL~yLH--~~gIiHrDLkp~NILl~~-~~~vkL~ 385 (518)
+|+||||+++ +|.+.+. .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 7899999976 5444433 23456889999999999999999999 999999999999999997 8999999
Q ss_pred eeccceeccccCccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----
Q 010091 386 DFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL----- 459 (518)
Q Consensus 386 DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~----- 459 (518)
|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.....
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 99999876655555556799999999998654 489999999999999999999999998877666555443110
Q ss_pred -------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 -------------------------RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 -------------------------~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+......++.+.++|.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11223346788999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=337.50 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=198.8
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH----HHHHHHHHHHHHHhhc----CCCceeeEe
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKV----RHMNVVQFI 308 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~----~~~~~f~~E~~il~~l----~HpnIv~l~ 308 (518)
..+.-.++|++.+.||+|+||.||+|++. ++.||||++....... .....+.+|+.+++++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34555678888999999999999999874 6889999997654332 1224566799999999 899999999
Q ss_pred eeeecCCceeEEEee-ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec-cCCcEEEee
Q 010091 309 GACTRPPRLFIVTEF-MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVVKVAD 386 (518)
Q Consensus 309 ~~~~~~~~~~lV~Ey-~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~-~~~~vkL~D 386 (518)
+++...+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 999999999999999 789999999987 45699999999999999999999999999999999999999 889999999
Q ss_pred eccceeccccCccccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 010091 387 FGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYN-HRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPV 465 (518)
Q Consensus 387 FG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~ 465 (518)
||++...... ......||..|+|||++.+..+. .++||||||+++|+|++|+.||..... .. .....++.
T Consensus 184 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~--~~~~~~~~ 254 (312)
T 2iwi_A 184 FGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------IL--EAELHFPA 254 (312)
T ss_dssp CSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--HTCCCCCT
T ss_pred cchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hh--hhccCCcc
Confidence 9999876543 23445689999999999776664 589999999999999999999976421 11 12345667
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 466 HTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 466 ~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+++.+.++|.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 78999999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=341.23 Aligned_cols=245 Identities=24% Similarity=0.420 Sum_probs=206.4
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH----HHHHHHHHHHHHHhhcC--CCceeeEeeee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVR--HMNVVQFIGAC 311 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~----~~~~~f~~E~~il~~l~--HpnIv~l~~~~ 311 (518)
++...++|++.+.||+|+||.||+|++. ++.||||++......+ .....+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 4555677888999999999999999974 6889999998764332 12245678999999996 59999999999
Q ss_pred ecCCceeEEEeeccC-CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec-cCCcEEEeeecc
Q 010091 312 TRPPRLFIVTEFMSG-GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVVKVADFGV 389 (518)
Q Consensus 312 ~~~~~~~lV~Ey~~g-gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~-~~~~vkL~DFG~ 389 (518)
......++||||+.+ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999999976 899999977 45789999999999999999999999999999999999999 789999999999
Q ss_pred ceeccccCccccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 390 ARVQAQYGVMTAETGTYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 390 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
++..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... ... .....+..++
T Consensus 197 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~~~~~~~~~ 267 (320)
T 3a99_A 197 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQVFFRQRVS 267 (320)
T ss_dssp CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCCCCSSCCC
T ss_pred ccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--ccccccccCC
Confidence 9876543 2334569999999999977665 6889999999999999999999976421 111 2234566789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.++|.+||+.||.+|||++++++
T Consensus 268 ~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 268 SECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.58 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=201.8
Q ss_pred cccceeeeEEeEecceEEEEEEEC--C-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc------eeeEeeeeecC
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--S-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN------VVQFIGACTRP 314 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn------Iv~l~~~~~~~ 314 (518)
..+|++.+.||+|+||.||++.+. + +.||+|+++.. ......+.+|+.++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 467777999999999999999975 3 67999999753 344577889999999998766 89999999999
Q ss_pred CceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe-----------------
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----------------- 376 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl----------------- 376 (518)
...|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999999 667777776533 469999999999999999999999999999999999999
Q ss_pred --ccCCcEEEeeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 010091 377 --NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGV 454 (518)
Q Consensus 377 --~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~ 454 (518)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+.....
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56789999999999864432 33457999999999999999999999999999999999999999987765544322
Q ss_pred HhcC-CCC-----------------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 010091 455 VQKG-LRP-----------------------------------------TIPVHTHPILVDLLERCWQRDPSLRPDFSEI 492 (518)
Q Consensus 455 ~~~~-~~p-----------------------------------------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~ei 492 (518)
.... ..| ......++.+.++|.+||+.||.+|||+.|+
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 2110 000 0011124579999999999999999999998
Q ss_pred HH
Q 010091 493 TE 494 (518)
Q Consensus 493 l~ 494 (518)
++
T Consensus 332 l~ 333 (355)
T 2eu9_A 332 LL 333 (355)
T ss_dssp TT
T ss_pred hc
Confidence 74
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=347.29 Aligned_cols=240 Identities=22% Similarity=0.387 Sum_probs=180.5
Q ss_pred eeEEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee--ecCCceeEEEee
Q 010091 250 EHKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC--TRPPRLFIVTEF 323 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~--~~~~~~~lV~Ey 323 (518)
.++||+|+||.||+|++. ++.||||++...... ..+.+|+.+|++++||||+++++++ .....+|+||||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~ 101 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence 457999999999999965 578999999865443 3677899999999999999999998 446789999999
Q ss_pred ccCCccccccccc--------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEe----ccCCcEEEeeeccce
Q 010091 324 MSGGSIYDYLHKQ--------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----NENGVVKVADFGVAR 391 (518)
Q Consensus 324 ~~ggsL~~~l~~~--------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl----~~~~~vkL~DFG~a~ 391 (518)
++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 102 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 102 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp CS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 95 5888877532 1248999999999999999999999999999999999999 677899999999998
Q ss_pred ecccc----CccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHHhc
Q 010091 392 VQAQY----GVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPL---------QAAVGVVQK 457 (518)
Q Consensus 392 ~~~~~----~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~---------~~~~~~~~~ 457 (518)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... +....++..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~ 260 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence 65432 12233568999999999977 45899999999999999999999999754431 112111111
Q ss_pred -CCCCC-----------------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 458 -GLRPT-----------------------------------IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 458 -~~~p~-----------------------------------~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+..+. .....++.+.+||.+||+.||.+|||++|+++
T Consensus 261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 10000 01122567899999999999999999999876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=335.55 Aligned_cols=244 Identities=21% Similarity=0.352 Sum_probs=174.9
Q ss_pred cccceeee-EEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec----CCc
Q 010091 244 ASLLKFEH-KIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----PPR 316 (518)
Q Consensus 244 ~~~~~~~~-~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~----~~~ 316 (518)
.++|.+.+ .||+|+||.||+|++. ++.||||++... ..... .....++.++||||+++++++.. ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 45566655 6999999999999986 789999999763 22222 22334566799999999999865 455
Q ss_pred eeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---CCcEEEeeecccee
Q 010091 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVVKVADFGVARV 392 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~~~vkL~DFG~a~~ 392 (518)
+|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 899999999999999998754 36999999999999999999999999999999999999976 45699999999986
Q ss_pred ccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh------cCCCCCCCCC
Q 010091 393 QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ------KGLRPTIPVH 466 (518)
Q Consensus 393 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~------~~~~p~~~~~ 466 (518)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............. ..........
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (336)
T 3fhr_A 181 TTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259 (336)
T ss_dssp C-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTT
T ss_pred cccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhcc
Confidence 5433 23345689999999999888899999999999999999999999976554332211111 1122222356
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.+.++|.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 260 VSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 7899999999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=349.83 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=198.3
Q ss_pred CCceeeccccceeeeEEeEecceE-EEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecC
Q 010091 237 IDVWEIDASLLKFEHKIVSGSYCD-LYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRP 314 (518)
Q Consensus 237 ~d~~eI~~~~~~~~~~Lg~G~~g~-Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~ 314 (518)
.+.+.+....|.+.+.||+|+||+ +|++...++.||||++...... .+.+|+.+++++ +||||+++++++...
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 456788888899999999999998 5566677899999999765332 355799999999 799999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---C--CcEEEeeecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---N--GVVKVADFGV 389 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~--~~vkL~DFG~ 389 (518)
...|+||||+. ++|.+++......+....++.++.||+.||.|||++||+||||||+|||++. + ..+||+|||+
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 99999999995 6999999876666677778899999999999999999999999999999953 2 3588999999
Q ss_pred ceeccccC----ccccCCCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCC
Q 010091 390 ARVQAQYG----VMTAETGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRP 461 (518)
Q Consensus 390 a~~~~~~~----~~~~~~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p 461 (518)
++...... ......||+.|+|||++. +..++.++|||||||++|+|++ |..||......+............
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 98654331 233456999999999997 4667889999999999999999 999997665444332211111111
Q ss_pred C-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 T-IPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ~-~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
. .+...+..+.++|.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 12233566899999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.89 Aligned_cols=249 Identities=20% Similarity=0.361 Sum_probs=200.3
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-----------CCceee
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-----------HMNVVQ 306 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-----------HpnIv~ 306 (518)
..+...+|++.+.||+|+||.||+|++. ++.||||++... ......+.+|+.++++++ |+||++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 3556677888999999999999999974 788999999753 334467889999999886 889999
Q ss_pred EeeeeecCC----ceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHC-CceecCCCCCcEEecc--
Q 010091 307 FIGACTRPP----RLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNE-- 378 (518)
Q Consensus 307 l~~~~~~~~----~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~-gIiHrDLkp~NILl~~-- 378 (518)
+++++.... .+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999987544 789999999 899999997633 4589999999999999999999998 9999999999999953
Q ss_pred ----CCcEEEeeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH------H
Q 010091 379 ----NGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP------L 448 (518)
Q Consensus 379 ----~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~------~ 448 (518)
.+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 348999999999876542 3345789999999999999999999999999999999999999986442 1
Q ss_pred HHHHHHHhc-C---------------------------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 010091 449 QAAVGVVQK-G---------------------------------------LRPTIPVHTHPILVDLLERCWQRDPSLRPD 488 (518)
Q Consensus 449 ~~~~~~~~~-~---------------------------------------~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs 488 (518)
+....+... + ....++...++++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111110 0 011223345677999999999999999999
Q ss_pred HHHHHH
Q 010091 489 FSEITE 494 (518)
Q Consensus 489 ~~eil~ 494 (518)
+.|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.13 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=202.2
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CC-----ceeeEeeeeecCC
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HM-----NVVQFIGACTRPP 315 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-Hp-----nIv~l~~~~~~~~ 315 (518)
.++|++.++||+|+||.||+|++. ++.||||+++.. ......+..|+.+++.++ |+ +|+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 467788999999999999999975 678999999753 334567788999988885 44 4999999999999
Q ss_pred ceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHH--HCCceecCCCCCcEEec--cCCcEEEeeeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLH--RNNIIHRDLKAANLLMN--ENGVVKVADFGVA 390 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH--~~gIiHrDLkp~NILl~--~~~~vkL~DFG~a 390 (518)
..|+||||++ ++|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||++
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999999995 59999997644 46899999999999999999999 57999999999999995 4778999999999
Q ss_pred eeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 010091 391 RVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT-------- 462 (518)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~-------- 462 (518)
+..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 209 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (382)
T 2vx3_A 209 CQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP 286 (382)
T ss_dssp EETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred eecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence 876432 3346799999999999999999999999999999999999999998877665554443110000
Q ss_pred --------CC------------------CC----------------------------CcHHHHHHHHHhhhhCCCCCCC
Q 010091 463 --------IP------------------VH----------------------------THPILVDLLERCWQRDPSLRPD 488 (518)
Q Consensus 463 --------~~------------------~~----------------------------~~~~L~~Li~~cL~~dP~~RPs 488 (518)
++ .. ..+.+.+||.+||+.||.+|||
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt 366 (382)
T 2vx3_A 287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366 (382)
T ss_dssp THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence 00 00 0147899999999999999999
Q ss_pred HHHHHH
Q 010091 489 FSEITE 494 (518)
Q Consensus 489 ~~eil~ 494 (518)
+.|+++
T Consensus 367 a~e~L~ 372 (382)
T 2vx3_A 367 PYYALQ 372 (382)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.56 Aligned_cols=232 Identities=13% Similarity=0.136 Sum_probs=192.1
Q ss_pred eccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+-..+|++.+.||+|+||.||+|++. ++.||||++...... ......|.+|+.++++++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44566777999999999999999986 789999999876544 455688999999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
+||||++|++|.+++... .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999999999652 4566788999999999999999999999999999999999999998443
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHhcCCCC--CCCCCCcHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAV---GVVQKGLRP--TIPVHTHPILVD 473 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~---~~~~~~~~p--~~~~~~~~~L~~ 473 (518)
|++ +++.++|||||||++|+|++|+.||.+.+..+... ........+ .....+++.+.+
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 333 37899999999999999999999998765422110 000111110 123568899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
+|.+||+.||.+| |+.|+++.|+++....
T Consensus 239 li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 9999999999999 9999999999986544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.63 Aligned_cols=240 Identities=23% Similarity=0.357 Sum_probs=186.3
Q ss_pred ceeeeEEeEecceEEEEE-EECCccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKG-AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~-~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|...+.||+|+||+||.+ ...|+.||||++.... ...+.+|+.+++++ +||||+++++++.....+|+||||+
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 444788999999999654 4568999999987642 24677899999986 8999999999999999999999999
Q ss_pred cCCccccccccccCC------CChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-------------CcEEEe
Q 010091 325 SGGSIYDYLHKQKCG------LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-------------GVVKVA 385 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~------l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-------------~~vkL~ 385 (518)
+ ++|.+++...... .++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 5 6999999764321 1333467899999999999999999999999999999754 489999
Q ss_pred eeccceeccccCc-----cccCCCCCcccChhhhcC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 010091 386 DFGVARVQAQYGV-----MTAETGTYRWMAPEVIEH-------QPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAV 452 (518)
Q Consensus 386 DFG~a~~~~~~~~-----~~~~~gt~~y~APE~l~~-------~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~ 452 (518)
|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++ |..||......+.
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-- 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-- 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--
Confidence 9999987544321 223469999999999965 678999999999999999999 9999987654432
Q ss_pred HHHhcCCCCC-CC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 453 GVVQKGLRPT-IP----VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 453 ~~~~~~~~p~-~~----~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.+........ .+ ..+++++.++|.+||+.||.+|||+.++++
T Consensus 249 ~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 2222222211 11 123578999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=351.60 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=201.6
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC---CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc-
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR- 316 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~---~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~- 316 (518)
++-..+|++.+.||+|+||.||++.+. ++.||||++.... +......|.+|+.++++++||||+++++++.....
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 344567888999999999999999974 6889999987542 44556789999999999999999999999977655
Q ss_pred ----eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 317 ----LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 317 ----~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999998765 68999999999999999999999999999999999999875 899999999987
Q ss_pred ccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCCcHHH
Q 010091 393 QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIP-VHTHPIL 471 (518)
Q Consensus 393 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~L 471 (518)
.... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+... .......+ ...++.+
T Consensus 231 ~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l 297 (681)
T 2pzi_A 231 INSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSY 297 (681)
T ss_dssp TTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHH
T ss_pred cccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHH
Confidence 5543 3456999999999997664 8999999999999999999988865211 01111000 1234679
Q ss_pred HHHHHHhhhhCCCCCC-CHHHHHHHHHHHHHHhh
Q 010091 472 VDLLERCWQRDPSLRP-DFSEITELLQHLAQRLQ 504 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RP-s~~eil~~L~~l~~~~~ 504 (518)
.++|.+||+.||.+|| +++++...|..++.++.
T Consensus 298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 331 (681)
T 2pzi_A 298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331 (681)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHHH
T ss_pred HHHHhhhccCChhhCCCHHHHHHHHHHHHHHHhh
Confidence 9999999999999998 67888888888876553
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=357.23 Aligned_cols=253 Identities=26% Similarity=0.361 Sum_probs=203.3
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec------CCcee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------PPRLF 318 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~------~~~~~ 318 (518)
|++.++||+|+||.||+|.+. ++.||||+++.. ........|.+|+.++++++||||+++++++.. ....|
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence 444999999999999999864 789999998765 345556889999999999999999999998755 67789
Q ss_pred EEEeeccCCccccccccccC--CCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc---EEEeeeccceec
Q 010091 319 IVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV---VKVADFGVARVQ 393 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~--~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~---vkL~DFG~a~~~ 393 (518)
+||||++|++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||.+...
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~ 174 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence 99999999999999976432 6899999999999999999999999999999999999997664 999999999876
Q ss_pred cccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----------Hhc------
Q 010091 394 AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGV----------VQK------ 457 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~----------~~~------ 457 (518)
..........||+.|+|||++.+..++.++||||||+++|+|++|..||............ ...
T Consensus 175 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~ 254 (676)
T 3qa8_A 175 DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254 (676)
T ss_dssp TSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSC
T ss_pred ccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccc
Confidence 6555455567999999999999999999999999999999999999999764322111000 000
Q ss_pred CC------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH-----HHHHHHHHH
Q 010091 458 GL------RPTIPVHTHPILVDLLERCWQRDPSLRPDFSE-----ITELLQHLA 500 (518)
Q Consensus 458 ~~------~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~e-----il~~L~~l~ 500 (518)
.+ ...+...+++.+.++|.+||+.||.+|||+.+ +...+++++
T Consensus 255 ~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred ccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00 01122235688999999999999999999988 455555554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=337.53 Aligned_cols=242 Identities=14% Similarity=0.144 Sum_probs=186.8
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCC-Ccee-------------
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRH-MNVV------------- 305 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~H-pnIv------------- 305 (518)
....|+..+.||+|+||.||+|++. |+.||||+++..... ....+.|.+|+.+++.++| +|..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3445777999999999999999986 899999999844322 2234789999999999987 2211
Q ss_pred --e------Eeeeeec-----CCceeEEEeeccCCccccccc------cccCCCChHHHHHHHHHhHHHHHHHHHCCcee
Q 010091 306 --Q------FIGACTR-----PPRLFIVTEFMSGGSIYDYLH------KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366 (518)
Q Consensus 306 --~------l~~~~~~-----~~~~~lV~Ey~~ggsL~~~l~------~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiH 366 (518)
. +..++.. ....|++|+++ +++|.+++. .....+++..++.++.||+.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1 1111111 23467788876 789999884 22345778889999999999999999999999
Q ss_pred cCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCCcccChhhh----------cCCCCCchhhHHHHHHHHHHHH
Q 010091 367 RDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVI----------EHQPYNHRADVFSFGIVLWELV 436 (518)
Q Consensus 367 rDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~~~ksDV~SlGill~eLl 436 (518)
|||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|+|+
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999875543 344567 999999999 5556889999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 437 TGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 437 tG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+|+.||......+.....+. ....+++.+.++|.+||+.||.+||++.++++
T Consensus 312 tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999987654332211111 12357799999999999999999999888765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.71 Aligned_cols=220 Identities=21% Similarity=0.373 Sum_probs=178.5
Q ss_pred ceee-eEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHH-hhcCCCceeeEeeeeec----CCcee
Q 010091 247 LKFE-HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIM-RKVRHMNVVQFIGACTR----PPRLF 318 (518)
Q Consensus 247 ~~~~-~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il-~~l~HpnIv~l~~~~~~----~~~~~ 318 (518)
|.+. +.||+|+||.||++.+. ++.||+|+++.. ..+.+|+.++ +.++||||+++++++.. ....|
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 4445 78999999999999974 688999999753 3566788888 56689999999999876 67789
Q ss_pred EEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---CCcEEEeeeccceecc
Q 010091 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVVKVADFGVARVQA 394 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~~~vkL~DFG~a~~~~ 394 (518)
+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999999999998643 36999999999999999999999999999999999999998 7899999999986432
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--CCCCCC----CCCc
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG--LRPTIP----VHTH 468 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~--~~p~~~----~~~~ 468 (518)
+..++.++||||||+++|+|++|..||................ .....+ ..++
T Consensus 172 ---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (299)
T 3m2w_A 172 ---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230 (299)
T ss_dssp ---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSC
T ss_pred ---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCC
Confidence 2456889999999999999999999997765433221111111 111222 4678
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++.++|.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 231 EEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.25 Aligned_cols=240 Identities=15% Similarity=0.179 Sum_probs=187.5
Q ss_pred eccccceeeeEEeEecceEEEEEEECCccEEEEEEecccc------CHHHHHHHHHHHHHHhhcC---------CCceee
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHL------NENIRREFAQEVHIMRKVR---------HMNVVQ 306 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~------~~~~~~~f~~E~~il~~l~---------HpnIv~ 306 (518)
+..++|++.++||+|+||.||+|++.++.||||+++.... .......+.+|+.++++++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4456777799999999999999999999999999987642 2223467888999999886 656655
Q ss_pred Eeee-----------------eec-------------CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHH
Q 010091 307 FIGA-----------------CTR-------------PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356 (518)
Q Consensus 307 l~~~-----------------~~~-------------~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL 356 (518)
+.+. +.. ...+|+||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 5554 332 6789999999999987777754 4589999999999999999
Q ss_pred HHHH-HCCceecCCCCCcEEeccCC--------------------cEEEeeeccceeccccCccccCCCCCcccChhhhc
Q 010091 357 NYLH-RNNIIHRDLKAANLLMNENG--------------------VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE 415 (518)
Q Consensus 357 ~yLH-~~gIiHrDLkp~NILl~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~ 415 (518)
.||| ++||+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 99999999999999999887 8999999999875532 246999999999998
Q ss_pred CCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCHHHHHH-HHHhc-CCCCCC----CCCCcHHHHHHHHHhhhhCCCCCCC
Q 010091 416 HQPYNHRADVFSFGIV-LWELVTGKLPYDDLTPLQAAV-GVVQK-GLRPTI----PVHTHPILVDLLERCWQRDPSLRPD 488 (518)
Q Consensus 416 ~~~~~~ksDV~SlGil-l~eLltG~~P~~~~~~~~~~~-~~~~~-~~~p~~----~~~~~~~L~~Li~~cL~~dP~~RPs 488 (518)
+.. +.++|||||+++ .+++++|..||.......... ..... ...... +..+++++.+||.+||+.| |
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 776 899999998777 777888999985432111121 11211 111111 2246788999999999976 8
Q ss_pred HHHHH
Q 010091 489 FSEIT 493 (518)
Q Consensus 489 ~~eil 493 (518)
+.|++
T Consensus 325 a~e~l 329 (336)
T 2vuw_A 325 ATDLL 329 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-31 Score=291.70 Aligned_cols=183 Identities=13% Similarity=0.168 Sum_probs=131.1
Q ss_pred EEeEecceEEEEEE--ECCccEEEEEEeccccC--------HHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCCceeEE
Q 010091 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLN--------ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 252 ~Lg~G~~g~Vy~~~--~~~~~vAvKvl~~~~~~--------~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV 320 (518)
..+.|++|....++ +.|+.|++|++...... +...++|.+|+.+|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777766655 56999999999865321 23347899999999999 799999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VM 399 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 399 (518)
|||++|++|.++|.. .+.++.. +|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+...... ..
T Consensus 321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 999999999999987 4566654 578999999999999999999999999999999999999999998654432 23
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCC
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK 439 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~ 439 (518)
....||+.|||||++.+. +..++|+||+|+++++|.++.
T Consensus 397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred cCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 345699999999999764 677899999999988775543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-28 Score=265.39 Aligned_cols=183 Identities=20% Similarity=0.273 Sum_probs=148.4
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCH------HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNE------NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~------~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.+.||+|+||.||++++.++.+++|......... ...+.|.+|+.++++++||||+++..++......|+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 6689999999999999889999999976644321 1235689999999999999999666666667778999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-----
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV----- 398 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 398 (518)
++|++|.+++.. ++.++.|++.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 421 ~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~ 489 (540)
T 3en9_A 421 INGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDL 489 (540)
T ss_dssp CCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHH
T ss_pred CCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccch
Confidence 999999999876 5689999999999999999999999999999998 999999999987654321
Q ss_pred ---cccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 010091 399 ---MTAETGTYRWMAPEVIEH--QPYNHRADVFSFGIVLWELVTGKLPYD 443 (518)
Q Consensus 399 ---~~~~~gt~~y~APE~l~~--~~~~~ksDV~SlGill~eLltG~~P~~ 443 (518)
.....||+.|||||++.. ..|+...|+||..+-..+.+.++-+|.
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 123458999999999976 567888999999988888877777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=218.31 Aligned_cols=155 Identities=12% Similarity=0.078 Sum_probs=123.0
Q ss_pred CCCceeeccc---------------cceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCH----------------
Q 010091 236 GIDVWEIDAS---------------LLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNE---------------- 283 (518)
Q Consensus 236 ~~d~~eI~~~---------------~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~---------------- 283 (518)
..++|++... .|.+.+.||+|+||.||+|++. |+.||||+++....+.
T Consensus 66 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~ 145 (282)
T 1zar_A 66 DYEGSTFTFIGLSLYSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV 145 (282)
T ss_dssp SSCEEEECHHHHHHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHH
T ss_pred CccceeeecCCccHHHHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHH
Confidence 4678888632 3456699999999999999984 7899999997543211
Q ss_pred HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCC
Q 010091 284 NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363 (518)
Q Consensus 284 ~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~g 363 (518)
.....+.+|+.++++++ | +++.+++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||++|
T Consensus 146 ~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g 213 (282)
T 1zar_A 146 LAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG 213 (282)
T ss_dssp HHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC
Confidence 13567899999999999 4 666665443 56799999999999998 422 234579999999999999999
Q ss_pred ceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCCCCcccChhhhc
Q 010091 364 IIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE 415 (518)
Q Consensus 364 IiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~ 415 (518)
|+||||||+|||++ ++.+||+|||+++. +..++|||++.
T Consensus 214 iiHrDlkp~NILl~-~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 214 IVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp EECSCCSTTSEEEE-TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred CEeCCCCHHHEEEE-CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 99999999999999 99999999999963 23468999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3e-20 Score=183.27 Aligned_cols=137 Identities=17% Similarity=0.175 Sum_probs=106.7
Q ss_pred ceeeeEEeEecceEEEEEEE--CCcc--EEEEEEeccccCH----------------------HHHHHHHHHHHHHhhcC
Q 010091 247 LKFEHKIVSGSYCDLYKGAF--FSQD--VAIKVLTNEHLNE----------------------NIRREFAQEVHIMRKVR 300 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~--~~~~--vAvKvl~~~~~~~----------------------~~~~~f~~E~~il~~l~ 300 (518)
|.+.+.||+|+||.||+|.+ .|+. ||||+++.....- .....+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45689999999999999997 6888 9999986542110 11246889999999998
Q ss_pred CCce--eeEeeeeecCCceeEEEeeccC-C----ccccccccccCCCChHHHHHHHHHhHHHHHHHH-HCCceecCCCCC
Q 010091 301 HMNV--VQFIGACTRPPRLFIVTEFMSG-G----SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH-RNNIIHRDLKAA 372 (518)
Q Consensus 301 HpnI--v~l~~~~~~~~~~~lV~Ey~~g-g----sL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH-~~gIiHrDLkp~ 372 (518)
|+++ +.++.. ...|+||||+.+ | +|.++... .++..+..++.|++.||.||| +.||+||||||+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 8764 444442 357899999942 4 45444322 335578899999999999999 999999999999
Q ss_pred cEEeccCCcEEEeeeccceec
Q 010091 373 NLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 373 NILl~~~~~vkL~DFG~a~~~ 393 (518)
|||++. .++|+|||+|...
T Consensus 201 NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS--SEEECCCTTCEET
T ss_pred HEEEcC--cEEEEECcccccC
Confidence 999998 9999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=6.5e-18 Score=175.70 Aligned_cols=135 Identities=16% Similarity=0.157 Sum_probs=98.7
Q ss_pred ceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccC------------H----H----HHHHHHHHHHHHhhcCCCcee
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN------------E----N----IRREFAQEVHIMRKVRHMNVV 305 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~------------~----~----~~~~f~~E~~il~~l~HpnIv 305 (518)
|.+.+.||+|++|.||+|... |+.||||+++....+ . . ......+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 566999999999999999964 789999998754221 0 0 001123466666666544432
Q ss_pred --eEeeeeecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC---
Q 010091 306 --QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG--- 380 (518)
Q Consensus 306 --~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~--- 380 (518)
..++. ...++||||++|++|.++... +....++.||+.+|.+||++|||||||||.|||++++|
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 22221 123799999999998776432 23457889999999999999999999999999998876
Q ss_pred -------cEEEeeecccee
Q 010091 381 -------VVKVADFGVARV 392 (518)
Q Consensus 381 -------~vkL~DFG~a~~ 392 (518)
.+.|+||+.+-.
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 389999998743
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=6.1e-13 Score=130.12 Aligned_cols=139 Identities=12% Similarity=0.077 Sum_probs=111.3
Q ss_pred ceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEEeecc
Q 010091 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMS 325 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 325 (518)
|++...++.|+.+.||+....++.+++|+........ ...+.+|+.+++.+. +..+.++++++...+..|+||||++
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 4457788888999999998778999999997642211 135788999999884 6778889999888889999999999
Q ss_pred CCccccccccccCCCChHHHHHHHHHhHHHHHHHHH--------------------------------------------
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-------------------------------------------- 361 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-------------------------------------------- 361 (518)
|.+|.+.+.. ......++.+++.+|..||+
T Consensus 94 G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 94 GVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9998876321 22334778899999999998
Q ss_pred ---------------CCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 362 ---------------NNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 362 ---------------~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
..++|||++|.|||+++++.+.|+||+.+...
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 45899999999999987666789999988543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.3e-11 Score=119.43 Aligned_cols=125 Identities=14% Similarity=0.151 Sum_probs=95.5
Q ss_pred eEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc--eeeEeeeeecCCceeEEEeeccCCccc
Q 010091 254 VSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--VVQFIGACTRPPRLFIVTEFMSGGSIY 330 (518)
Q Consensus 254 g~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~ggsL~ 330 (518)
+.|..+.||++... |+.+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..|+||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 45666999999754 5779999987542 135678999999886544 556888888778899999999999884
Q ss_pred cccccccCCCChHHHHHHHHHhHHHHHHHHHCC-----------------------------------------------
Q 010091 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN----------------------------------------------- 363 (518)
Q Consensus 331 ~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~g----------------------------------------------- 363 (518)
... .+ ...++.+++..|..||+..
T Consensus 104 --~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 --SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp --TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred --cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 221 11 1256677777888888643
Q ss_pred -----------ceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 364 -----------IIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 364 -----------IiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
++|+|++|.||++++++.+.|+|||.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998777778999999854
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=6e-11 Score=121.65 Aligned_cols=142 Identities=18% Similarity=0.295 Sum_probs=108.8
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEe--ccccCHHHHHHHHHHHHHHhhcCC--CceeeEeeeeecC---CceeEEEe
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLT--NEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRP---PRLFIVTE 322 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~--~~~~~~~~~~~f~~E~~il~~l~H--pnIv~l~~~~~~~---~~~~lV~E 322 (518)
.+.|+.|.++.||+.+..+..+++|+.. ..... .....+.+|..+++.+.. ..+++++.++... +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 5678999999999999888899999876 43211 123467789999999974 4578888888766 45899999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-----------------------------------------
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR----------------------------------------- 361 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~----------------------------------------- 361 (518)
|++|.++.+... ..++......++.+++..|..||+
T Consensus 122 ~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999988865321 236778888899999999999997
Q ss_pred -----------------CCceecCCCCCcEEeccCC--cEEEeeeccceeccc
Q 010091 362 -----------------NNIIHRDLKAANLLMNENG--VVKVADFGVARVQAQ 395 (518)
Q Consensus 362 -----------------~gIiHrDLkp~NILl~~~~--~vkL~DFG~a~~~~~ 395 (518)
..++|||+++.|||++.++ .+.|+||+.+.....
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~p 251 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGHP 251 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEECH
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCCH
Confidence 3589999999999998765 379999999976443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=8.4e-11 Score=117.82 Aligned_cols=183 Identities=16% Similarity=0.219 Sum_probs=124.3
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCc--eeeEeeeeecCC---ceeEEEee
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMN--VVQFIGACTRPP---RLFIVTEF 323 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~Ey 323 (518)
.+.++.|.+..||+. ++.+++|+.... .....+.+|..+++.+. +.. +.+++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v---~~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI---NRDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEES---TTSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEE---CCEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 345899999999986 378999997643 33467889999998883 333 445555443333 35899999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH------------------------------------------
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR------------------------------------------ 361 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~------------------------------------------ 361 (518)
++|.+|.+... ..++......++.+++..+..||+
T Consensus 98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99988875332 246777777888888888888886
Q ss_pred ----------------CCceecCCCCCcEEecc--CCcEEEeeeccceeccccCccccCCCCCcccChhhhc-----CCC
Q 010091 362 ----------------NNIIHRDLKAANLLMNE--NGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE-----HQP 418 (518)
Q Consensus 362 ----------------~gIiHrDLkp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~-----~~~ 418 (518)
..++|+|++|.||+++. ++.+.|+||+.+.................-..|+... .+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 13799999999999998 5678999999997654321111000000002333221 011
Q ss_pred C---------CchhhHHHHHHHHHHHHcCCCCC
Q 010091 419 Y---------NHRADVFSFGIVLWELVTGKLPY 442 (518)
Q Consensus 419 ~---------~~ksDV~SlGill~eLltG~~P~ 442 (518)
. ....+.|+++.++|.+.+|..+|
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 22368999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2.9e-07 Score=92.39 Aligned_cols=136 Identities=18% Similarity=0.157 Sum_probs=95.9
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCC---ceeeEeeeee-cCCceeEEEeecc
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM---NVVQFIGACT-RPPRLFIVTEFMS 325 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~Ey~~ 325 (518)
.+.++.|....||+. ++.+++|+... ......+.+|..+|+.+.+. .+.+.+.++. ..+..|+||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456788999999998 78999999532 23456788999999999752 3566666663 4556789999999
Q ss_pred CCccccccccccCCCChHHHHHHHHHhHHHHHHHHHC-------------------------------------------
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN------------------------------------------- 362 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~------------------------------------------- 362 (518)
|.+|.+..- ..++......++.++...|..||+.
T Consensus 97 G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 988865311 1234444444555555555555532
Q ss_pred -----------------CceecCCCCCcEEecc---CCc-EEEeeeccceeccc
Q 010091 363 -----------------NIIHRDLKAANLLMNE---NGV-VKVADFGVARVQAQ 395 (518)
Q Consensus 363 -----------------gIiHrDLkp~NILl~~---~~~-vkL~DFG~a~~~~~ 395 (518)
.++|+|++|.||+++. ++. +.|+||+.+.....
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~ 227 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP 227 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence 3599999999999987 344 58999999876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=6.1e-07 Score=87.50 Aligned_cols=131 Identities=14% Similarity=0.176 Sum_probs=94.2
Q ss_pred EeEecce-EEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEEeeccCCc
Q 010091 253 IVSGSYC-DLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSGGS 328 (518)
Q Consensus 253 Lg~G~~g-~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 328 (518)
+..|..+ .||+.... +..+++|+.... ....+.+|..+|+.+. +--+.+++.++...+..|+|||+++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 5556555 68987653 567999997654 2356778999998884 2236778888888889999999999988
Q ss_pred cccccccccCCCChHHHHHHHHHhHHHHHHHHHC----------------------------------------------
Q 010091 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN---------------------------------------------- 362 (518)
Q Consensus 329 L~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~---------------------------------------------- 362 (518)
+.+.... .......+..++...|..||+.
T Consensus 107 ~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 7665432 1122234455555555666531
Q ss_pred ------------CceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 363 ------------NIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 363 ------------gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
.++|+|+.+.|||++.++.+-|+||+.+...
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 2799999999999998877889999998654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=2.6e-07 Score=94.19 Aligned_cols=80 Identities=14% Similarity=0.132 Sum_probs=57.0
Q ss_pred eeEE-eEecceEEEEEEEC--------CccEEEEEEeccc---cCHHHHHHHHHHHHHHhhcCC---CceeeEeeeeecC
Q 010091 250 EHKI-VSGSYCDLYKGAFF--------SQDVAIKVLTNEH---LNENIRREFAQEVHIMRKVRH---MNVVQFIGACTRP 314 (518)
Q Consensus 250 ~~~L-g~G~~g~Vy~~~~~--------~~~vAvKvl~~~~---~~~~~~~~f~~E~~il~~l~H---pnIv~l~~~~~~~ 314 (518)
.+.| +.|....+|+.+.. ++.+++|+..... ... ...+.+|+.+++.+.. -.+.+++.++...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 5667 78889999998765 6789999876543 100 1345678888888743 3467788877654
Q ss_pred ---CceeEEEeeccCCcccc
Q 010091 315 ---PRLFIVTEFMSGGSIYD 331 (518)
Q Consensus 315 ---~~~~lV~Ey~~ggsL~~ 331 (518)
+..|+||||++|.++.+
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCB
T ss_pred CccCCceEEEEecCCCChhh
Confidence 35689999999988765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=4.2e-06 Score=83.97 Aligned_cols=137 Identities=20% Similarity=0.223 Sum_probs=80.5
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC--CceeeEeee------eecCCceeEEE
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGA------CTRPPRLFIVT 321 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H--pnIv~l~~~------~~~~~~~~lV~ 321 (518)
.+.|+.|..+.+|+....+..+++|+.... . ..+..|..+++.|.. -.+.+++.. ....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 345666788999999877777999998762 1 223345555555531 123444431 12355678999
Q ss_pred eeccCCcccc--------------ccccccCCC-------------ChHH------------------------------
Q 010091 322 EFMSGGSIYD--------------YLHKQKCGL-------------KLPL------------------------------ 344 (518)
Q Consensus 322 Ey~~ggsL~~--------------~l~~~~~~l-------------~~~~------------------------------ 344 (518)
+|++|.++.. .++.....+ .+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 9999876531 111111000 1100
Q ss_pred -HHHHHHHhHHHHHHHH-------------HCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 345 -LLRVAIDVSKGMNYLH-------------RNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 345 -i~~i~~ql~~gL~yLH-------------~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
+..+..++..++.+|+ ...+||||+++.|||++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111122344566665 25799999999999998888999999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=6.4e-06 Score=85.25 Aligned_cols=76 Identities=13% Similarity=-0.057 Sum_probs=49.6
Q ss_pred eeEEeEecceEEEEEEE--CCccEEEEEEecccc--CH---HHHHHHHHHHHHHhhcCC--C-ceeeEeeeeecCCceeE
Q 010091 250 EHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHL--NE---NIRREFAQEVHIMRKVRH--M-NVVQFIGACTRPPRLFI 319 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~--~~~~vAvKvl~~~~~--~~---~~~~~f~~E~~il~~l~H--p-nIv~l~~~~~~~~~~~l 319 (518)
.+.||.|.++.||+++. .++.++||...+... .+ ....++..|..+++.+.. + .+.+++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 45789999999999963 467899998764321 10 112456778888887742 3 344566543 345689
Q ss_pred EEeeccCC
Q 010091 320 VTEFMSGG 327 (518)
Q Consensus 320 V~Ey~~gg 327 (518)
||||++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.97 E-value=5.3e-05 Score=76.32 Aligned_cols=75 Identities=19% Similarity=0.204 Sum_probs=61.5
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC---CCceeeEeeeeecCCceeEEEeeccC
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~g 326 (518)
.+.|+.|....+|+.+..++.+++|+..... ...|..|...|+.|. ...+++++.++...+..|+||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 5678999999999998778899999987531 356888999998884 35688888888777889999999998
Q ss_pred Ccc
Q 010091 327 GSI 329 (518)
Q Consensus 327 gsL 329 (518)
.++
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.83 E-value=8.7e-05 Score=70.48 Aligned_cols=138 Identities=17% Similarity=0.163 Sum_probs=96.7
Q ss_pred CCccccccccccCCCChHHHHHHHHHhHHHHHHH-HHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCCC
Q 010091 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL-HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETG 404 (518)
Q Consensus 326 ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yL-H~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~g 404 (518)
..||.+.|...+.++++.++|.++.|.+.+|.-+ +++.-..+=+.|..|++..+|.|-+.+ +.+. ..
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 3489999998889999999999999999998776 222222344567899999999998764 2211 11
Q ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC--
Q 010091 405 TYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD-- 482 (518)
Q Consensus 405 t~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d-- 482 (518)
...+.+||... ...+.+.=|||||+++|..+-- ++.+.-+..+++.|..||..|...+
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy-------------------gL~e~eE~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY-------------------GLKENEERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTT-------------------TCCTTEEECCCHHHHHHHHHHTTCCC-
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc-------------------CCCcccchhhCHHHHHHHHHHHhcccc
Confidence 22456787753 3457889999999999998752 4455556678899999999998662
Q ss_pred -----------------------CCCCCCHHHHHHH
Q 010091 483 -----------------------PSLRPDFSEITEL 495 (518)
Q Consensus 483 -----------------------P~~RPs~~eil~~ 495 (518)
+..|+++++|++.
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~ 195 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL 195 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHH
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHH
Confidence 4577899888754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.74 E-value=5.2e-05 Score=79.16 Aligned_cols=78 Identities=14% Similarity=0.121 Sum_probs=49.5
Q ss_pred HHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccCC--CCCcccChhhhcCCC---CCchhhHHHHHHHHHH
Q 010091 360 HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET--GTYRWMAPEVIEHQP---YNHRADVFSFGIVLWE 434 (518)
Q Consensus 360 H~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~--gt~~y~APE~l~~~~---~~~ksDV~SlGill~e 434 (518)
+...++|||++|.|||++.++ ++|+||+.+............. -...|++|+...... .....++.+....+|+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 356799999999999998877 9999999997654321111000 123456665543111 1223556677788888
Q ss_pred HHcC
Q 010091 435 LVTG 438 (518)
Q Consensus 435 LltG 438 (518)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00016 Score=71.83 Aligned_cols=135 Identities=13% Similarity=0.151 Sum_probs=77.2
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCce-eeEeeeeecCCceeEEEeec-cCC
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFIVTEFM-SGG 327 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~-~gg 327 (518)
.+.|+.|....+|+. +.+++|+....... .....+|..+++.+...++ .++++.+ ...-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 567889999999998 78999998753211 1122457777777743333 4566543 33457899999 776
Q ss_pred ccccc------------------cccccCCCC-----hHHHHHHHHH--------------hHHHHHHHH--------HC
Q 010091 328 SIYDY------------------LHKQKCGLK-----LPLLLRVAID--------------VSKGMNYLH--------RN 362 (518)
Q Consensus 328 sL~~~------------------l~~~~~~l~-----~~~i~~i~~q--------------l~~gL~yLH--------~~ 362 (518)
+|..- ++.....+. ...+..+... +...+..+. ..
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 66421 111111010 0111111110 111111111 12
Q ss_pred CceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 363 NIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 363 gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
.++|+|+.+.||+ ..++.+.|+||..+....
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 3899999999999 556778999999887543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00022 Score=71.02 Aligned_cols=140 Identities=14% Similarity=0.135 Sum_probs=81.6
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc--eeeEeeee------ecCCceeEEE
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--VVQFIGAC------TRPPRLFIVT 321 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~~~~------~~~~~~~lV~ 321 (518)
.+.|+.|....+|+....+..+++|+....... ..+..|+.+++.+...+ +.+++... ...+..+++|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~----~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCCH----HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 556788888999999877778999998763111 23455777777664322 33444221 1234578999
Q ss_pred eeccCCccccc--------------cccccCC--------CChHHHHHH---------------HHHhHHHHHHHHH---
Q 010091 322 EFMSGGSIYDY--------------LHKQKCG--------LKLPLLLRV---------------AIDVSKGMNYLHR--- 361 (518)
Q Consensus 322 Ey~~ggsL~~~--------------l~~~~~~--------l~~~~i~~i---------------~~ql~~gL~yLH~--- 361 (518)
+|++|.++... ++..... ......... ...+...++.+.+
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 99998765321 1111000 111111110 0113344555542
Q ss_pred ----CCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 362 ----NNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 362 ----~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
.++||+|+.+.|||++.++.+.|+||+.+...
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g 218 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND 218 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhccCc
Confidence 36999999999999998777789999988643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00016 Score=72.69 Aligned_cols=137 Identities=13% Similarity=0.130 Sum_probs=73.4
Q ss_pred EEeEecceE-EEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC--CceeeEeeeeecCCceeEEEeeccCC
Q 010091 252 KIVSGSYCD-LYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRPPRLFIVTEFMSGG 327 (518)
Q Consensus 252 ~Lg~G~~g~-Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~gg 327 (518)
.|+.|.... +|+.+.. +..+++|...+... ..+..|+.+++.+.. -.+.+++.+....+ +++||++.+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 455554444 6677654 67788887554321 123346666666642 23556676544333 7899999776
Q ss_pred cccccccccc-------------------------CCCChHHHH-------H-H------------HHHhHHHHHHH---
Q 010091 328 SIYDYLHKQK-------------------------CGLKLPLLL-------R-V------------AIDVSKGMNYL--- 359 (518)
Q Consensus 328 sL~~~l~~~~-------------------------~~l~~~~i~-------~-i------------~~ql~~gL~yL--- 359 (518)
++.+++.... ..++..... . + ...+...+..+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6654432110 011111110 0 0 00111222233
Q ss_pred ---HHCCceecCCCCCcEEeccC----CcEEEeeeccceeccc
Q 010091 360 ---HRNNIIHRDLKAANLLMNEN----GVVKVADFGVARVQAQ 395 (518)
Q Consensus 360 ---H~~gIiHrDLkp~NILl~~~----~~vkL~DFG~a~~~~~ 395 (518)
+...++|||+.+.|||++.+ +.+.|+||+.+.....
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 23479999999999999874 6899999999976544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00073 Score=66.45 Aligned_cols=76 Identities=13% Similarity=0.050 Sum_probs=53.8
Q ss_pred eeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCC---ceeeEeeeeecCCceeEEEee
Q 010091 248 KFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM---NVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hp---nIv~l~~~~~~~~~~~lV~Ey 323 (518)
.-.+.+|.|..+.||+.+.. |+.|++|+........ ...|..|+..|+.|... -+.+++++. .-++||||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 33778999999999999975 7899999876543221 23577899999888422 345555542 24789999
Q ss_pred ccCCcc
Q 010091 324 MSGGSI 329 (518)
Q Consensus 324 ~~ggsL 329 (518)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987644
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00036 Score=73.26 Aligned_cols=73 Identities=14% Similarity=0.193 Sum_probs=50.9
Q ss_pred eeEEeEecceEEEEEEEC---------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCce-eeEeeeeecCCceeE
Q 010091 250 EHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFI 319 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~---------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~~~~~~~~~~~l 319 (518)
.+.|+.|-...+|+.... ++.+++|+..... . ...+..|..+++.+...++ .++++.+.. .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 457888999999999864 4679999985421 1 1344578888888854444 567776543 38
Q ss_pred EEeeccCCccc
Q 010091 320 VTEFMSGGSIY 330 (518)
Q Consensus 320 V~Ey~~ggsL~ 330 (518)
|+||++|.+|.
T Consensus 150 v~e~l~G~~l~ 160 (429)
T 1nw1_A 150 LEEYIPSRPLS 160 (429)
T ss_dssp EECCCCEEECC
T ss_pred EEEEeCCcccC
Confidence 99999876654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00048 Score=70.30 Aligned_cols=73 Identities=12% Similarity=0.194 Sum_probs=45.2
Q ss_pred eeEEeEecceEEEEEEECC----------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc-eeeEeeeeecCCcee
Q 010091 250 EHKIVSGSYCDLYKGAFFS----------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPPRLF 318 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~----------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~ 318 (518)
.+.|+.|....+|+....+ +.+++|+...... . ......|..+++.+...+ +.++++... -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--E-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--G-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--c-eecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4567888889999998654 6899998765321 1 112346888888775434 346665442 37
Q ss_pred EEEeeccCCcc
Q 010091 319 IVTEFMSGGSI 329 (518)
Q Consensus 319 lV~Ey~~ggsL 329 (518)
+||||++|.++
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999998655
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.001 Score=68.74 Aligned_cols=137 Identities=12% Similarity=0.165 Sum_probs=82.2
Q ss_pred eeEEeEecceEEEEEEEC---------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc-eeeEeeeeecCCceeE
Q 010091 250 EHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPPRLFI 319 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~---------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~l 319 (518)
.+.|..|-...+|+.+.. ++.+++|+...... ....+.+|..+++.+...+ ..++++.+.. .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 356777888889998863 36799998643211 1244558999998885333 3566766654 39
Q ss_pred EEeeccCCccccc-c----------------cccc----CCCC--hHHHHHHHHHhH-------------------HHHH
Q 010091 320 VTEFMSGGSIYDY-L----------------HKQK----CGLK--LPLLLRVAIDVS-------------------KGMN 357 (518)
Q Consensus 320 V~Ey~~ggsL~~~-l----------------~~~~----~~l~--~~~i~~i~~ql~-------------------~gL~ 357 (518)
||||++|.+|..- + +... .... +.++.++..++- ..+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998766421 1 1111 1111 234454544332 1233
Q ss_pred HHHH--------CCceecCCCCCcEEeccC----CcEEEeeeccceec
Q 010091 358 YLHR--------NNIIHRDLKAANLLMNEN----GVVKVADFGVARVQ 393 (518)
Q Consensus 358 yLH~--------~gIiHrDLkp~NILl~~~----~~vkL~DFG~a~~~ 393 (518)
.|.+ ..++|+|+.+.||+++.+ +.+.|+||..+...
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 3332 258999999999999876 78999999998653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0018 Score=65.60 Aligned_cols=34 Identities=18% Similarity=0.377 Sum_probs=29.5
Q ss_pred CCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 362 NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 362 ~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
..++|+|+.+.||+++.++.+.|+||+.+.....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~ 239 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK 239 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEECT
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCH
Confidence 4699999999999999888999999998876544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0042 Score=61.79 Aligned_cols=138 Identities=14% Similarity=0.098 Sum_probs=80.2
Q ss_pred eEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc--eeeEeee-----eecCCceeEEEe
Q 010091 251 HKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--VVQFIGA-----CTRPPRLFIVTE 322 (518)
Q Consensus 251 ~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~~~-----~~~~~~~~lV~E 322 (518)
..++ |....||+.... |+.+++|+..+...+. ..+..|..+++.+...+ +++++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3455 888899988754 5689999997654333 34556777777774322 3444443 112345678999
Q ss_pred eccCCccccc--------------ccccc--------CCCChHHH----------------------HHHHHHhHHHHHH
Q 010091 323 FMSGGSIYDY--------------LHKQK--------CGLKLPLL----------------------LRVAIDVSKGMNY 358 (518)
Q Consensus 323 y~~ggsL~~~--------------l~~~~--------~~l~~~~i----------------------~~i~~ql~~gL~y 358 (518)
|++|.++... ++... ...+.... ...+.+++..+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 9988665310 11100 01111111 0111111222221
Q ss_pred H----HHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 359 L----HRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 359 L----H~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
+ ....++|||+++.|||++ + .+.|+||+.+....
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~ 225 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGP 225 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence 1 234589999999999998 4 89999999886543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.004 Score=65.90 Aligned_cols=74 Identities=20% Similarity=0.089 Sum_probs=49.5
Q ss_pred eeEEeEecceEEEEEEECC--ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCce-eeEeeeeecCCceeEEEeeccC
Q 010091 250 EHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFIVTEFMSG 326 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~--~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~g 326 (518)
.+.|+.|-...+|+....+ ..+++|+....... . -...+|..+++.|...++ .++++.+.. .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--I-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--C-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--h-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 4578889999999999876 78999987543211 0 011468888998865555 467776632 369999998
Q ss_pred Cccc
Q 010091 327 GSIY 330 (518)
Q Consensus 327 gsL~ 330 (518)
.+|.
T Consensus 186 ~~l~ 189 (458)
T 2qg7_A 186 YALS 189 (458)
T ss_dssp EECC
T ss_pred ccCC
Confidence 6664
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0052 Score=64.36 Aligned_cols=74 Identities=15% Similarity=0.239 Sum_probs=48.8
Q ss_pred eeEEeEecceEEEEEEEC---------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCc-eeeEeeeeecCCceeE
Q 010091 250 EHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPPRLFI 319 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~---------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~l 319 (518)
.+.+..|-...+|+.... ++.+++|+..... +. .-...+|..+++.+...+ ..++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 456777888999999876 5789999975432 11 111246888888775333 345665432 378
Q ss_pred EEeeccCCccc
Q 010091 320 VTEFMSGGSIY 330 (518)
Q Consensus 320 V~Ey~~ggsL~ 330 (518)
||||++|.+|.
T Consensus 148 I~efI~G~~l~ 158 (424)
T 3mes_A 148 IEEFIDGEPLT 158 (424)
T ss_dssp EEECCCSEECC
T ss_pred EEEEeCCccCC
Confidence 99999997653
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 | Back alignment and structure |
|---|
Probab=95.98 E-value=0.0053 Score=56.91 Aligned_cols=63 Identities=17% Similarity=0.333 Sum_probs=51.2
Q ss_pred eeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcchHHHHHHHHHh
Q 010091 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAK 204 (518)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~~~~~l~~~l~~ 204 (518)
-+.|++++.|||+++++++..|++.|+||.++-.+.+.+++.+ .+.|+. +....+.+..++.+
T Consensus 6 ~~~itv~~~DrpGiva~vt~~La~~g~NI~d~~~~~~~~~f~~-~~~v~~-~~~~~~~l~~~L~~ 68 (192)
T 1u8s_A 6 HLVITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLISG-SPSNITRVETTLPL 68 (192)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEE-CHHHHHHHHHHHHH
T ss_pred EEEEEEEcCCCCcHHHHHHHHHHHCCCCEEeeeeeecCCceEE-EEEEec-CCCCHHHHHHHHHH
Confidence 4689999999999999999999999999999999998888777 555543 33456667666663
|
| >1zpv_A ACT domain protein; structural genomics, PSI, protein structure INIT midwest center for structural genomics, MCSG, unknown funct; 1.90A {Streptococcus pneumoniae} SCOP: d.58.18.7 | Back alignment and structure |
|---|
Probab=95.74 E-value=0.015 Score=46.73 Aligned_cols=64 Identities=25% Similarity=0.279 Sum_probs=50.9
Q ss_pred eeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcchHHHHHHHHHh
Q 010091 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAK 204 (518)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~~~~~l~~~l~~ 204 (518)
.+.|++.+.|+|++++.++..+++.|.||.....+... |.....+.++.-.....+++..++.+
T Consensus 5 ~~~l~v~~~DrpGila~vt~~la~~~~NI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~~ 68 (91)
T 1zpv_A 5 KAIITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLD-EYFTMMAVVSSDEKQDFTYLRNEFEA 68 (91)
T ss_dssp EEEEEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEESSCCCHHHHHHHHHH
T ss_pred eEEEEEEECCCCCHHHHHHHHHHHcCCCEEEEEeEEEc-CEEEEEEEEEeCCCCCHHHHHHHHHH
Confidence 46899999999999999999999999999887776554 76666666654334577888777763
|
| >2f1f_A Acetolactate synthase isozyme III small subunit; ferredoxin fold, ACT domain, transferase; HET: P33 1PE; 1.75A {Escherichia coli} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=95.60 E-value=0.018 Score=52.18 Aligned_cols=63 Identities=21% Similarity=0.171 Sum_probs=53.7
Q ss_pred eeEEEEecCCccchHHHHHhhhcccCCCcccccccccCC-CceeeEEEEcCCCcchHHHHHHHHH
Q 010091 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d-~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
-|.|++-..|+|++|++++.++++.|.||....+..|.| |++--.|+|+ ...+..+++.+++.
T Consensus 3 ~~~IsV~v~NrpGvLarIt~lfs~rg~NI~Sl~v~~t~d~~~sriti~V~-~d~~~leqI~kqL~ 66 (164)
T 2f1f_A 3 RRILSVLLENESGALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTV-GDEKVLEQIEKQLH 66 (164)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEE-SCHHHHHHHHHHHH
T ss_pred EEEEEEEEeCCCcHHHHHHHHHHHCCCCeeeceeeecCCCCEEEEEEEEe-ccHHHHHHHHHHHc
Confidence 388999999999999999999999999998877777775 8898888998 45667777777776
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.50 E-value=0.018 Score=59.62 Aligned_cols=31 Identities=23% Similarity=0.398 Sum_probs=26.3
Q ss_pred ceecCCCCCcEEe------ccCCcEEEeeeccceecc
Q 010091 364 IIHRDLKAANLLM------NENGVVKVADFGVARVQA 394 (518)
Q Consensus 364 IiHrDLkp~NILl------~~~~~vkL~DFG~a~~~~ 394 (518)
++|+|+.+.|||+ ++++.++++||..|....
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~ 282 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNY 282 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCC
Confidence 6899999999999 456789999999987543
|
| >2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria} | Back alignment and structure |
|---|
Probab=95.28 E-value=0.014 Score=54.38 Aligned_cols=47 Identities=13% Similarity=0.281 Sum_probs=42.9
Q ss_pred eeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEE
Q 010091 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFV 186 (518)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~ 186 (518)
-..|++++.|||+|.+.++..|.+.|+||.+|..|.+.++|++.+.+
T Consensus 5 ~~~ltv~~~DrpGiva~vs~~La~~g~NI~da~q~~~~~~f~m~~~v 51 (195)
T 2nyi_A 5 SFVVSVAGSDRVGIVHDFSWALKNISANVESSRMACLGGDFAMIVLV 51 (195)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEeCCCCcHHHHHHHHHHHCCCCEEEEEeEEECCeEEEEEEE
Confidence 35899999999999999999999999999999999999999984444
|
| >2ko1_A CTR148A, GTP pyrophosphokinase; homodimer, alpha+beta, transferase, structural genomics, PSI-2, protein structure initiative; NMR {Chlorobaculum tepidum} PDB: 3ibw_A | Back alignment and structure |
|---|
Probab=95.17 E-value=0.031 Score=44.24 Aligned_cols=64 Identities=19% Similarity=0.165 Sum_probs=46.9
Q ss_pred ceeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcchHHHHHHHHH
Q 010091 139 LMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 139 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
+...|.+...|+|++|+.++..+++.|.||......... +....++.++.-..+..+++..++.
T Consensus 4 ~~~~l~v~~~Dr~G~L~~I~~~la~~~inI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~ 67 (88)
T 2ko1_A 4 FLAGIRIVGEDKNGMTNQITGVISKFDTNIRTIVLNAKD-GIFTCNLMIFVKNTDKLTTLMDKLR 67 (88)
T ss_dssp EEEEEEEEEECCTTHHHHHHHHHTTSSSCEEEEEEEECS-SEEEEEEEEEESSHHHHHHHHHHHT
T ss_pred EEEEEEEEEECCCcHHHHHHHHHHHCCCCeEEEEEEEcC-CEEEEEEEEEECCHHHHHHHHHHHh
Confidence 456889999999999999999999999999877665443 4555555555544455566655554
|
| >2pc6_A Probable acetolactate synthase isozyme III (small; regulatory subunit, structural genomi protein structure initiative; HET: MSE; 2.50A {Nitrosomonas europaea atcc 19718} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=94.85 E-value=0.03 Score=50.67 Aligned_cols=62 Identities=26% Similarity=0.295 Sum_probs=52.3
Q ss_pred eEEEEecCCccchHHHHHhhhcccCCCcccccccccC-CCceeeEEEEcCCCcchHHHHHHHHH
Q 010091 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTV-DGYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~-d~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
|.|++-..|+|+.|++++.++++.|.||....+..|. +|.+--.++|+ .+....+++.+++.
T Consensus 5 ~~IsV~veNrpGvL~rI~~lfs~rg~NI~Sl~v~~t~d~g~sritivV~-~d~~~leql~kQL~ 67 (165)
T 2pc6_A 5 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTN-GPDEIVEQITKQLN 67 (165)
T ss_dssp EEEEEEEECSTTHHHHHHHHHHHHTCCCCEEEEEECSSTTEEEEEEEEE-ECHHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcHHHHHHHHHHHCCCcEEEEEEEecCCCCEEEEEEEEe-ccHHHHHHHHHHhc
Confidence 8899999999999999999999999999887777676 48888888887 34566777777766
|
| >2fgc_A Acetolactate synthase, small subunit; regulatory subunit, structural genomi protein structure initiative; 2.30A {Thermotoga maritima} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=92.38 E-value=0.16 Score=46.89 Aligned_cols=63 Identities=22% Similarity=0.319 Sum_probs=52.3
Q ss_pred eeEEEEecCCccchHHHHHhhhcccCCCcccccccccCC-CceeeEEEEcCCCcchHHHHHHHHH
Q 010091 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d-~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
-|-|++-..|+|+.|++++.++++-|+||..-.+..|.| |++--+++|++- ....+++.+++.
T Consensus 29 ~~~LsVlVeN~pGvLaRItglfsrRG~NI~SLtV~~ted~gisRitIvV~g~-e~~ieqL~kQL~ 92 (193)
T 2fgc_A 29 EHLVSMLVHNKPGVMRKVANLFARRGFNISSITVGESETPGLSRLVIMVKGD-DKTIEQIEKQAY 92 (193)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHHTTTCEEEEEEEEECSSTTEEEEEEEEEEC-TTHHHHHHHHHT
T ss_pred EEEEEEEECCCChHHHHHHHHHHHCCceEEEEEeeccCCCCEEEEEEEEECC-HHHHHHHHHHhc
Confidence 489999999999999999999999999997766665666 888888888753 557777777776
|
| >2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria} | Back alignment and structure |
|---|
Probab=88.83 E-value=0.28 Score=45.35 Aligned_cols=39 Identities=21% Similarity=0.243 Sum_probs=34.8
Q ss_pred ceeEEEEecCCccchHHHHHhhhcccCCCcccccccccC
Q 010091 139 LMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTV 177 (518)
Q Consensus 139 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~ 177 (518)
.-+-|++++.|+|+++..++..|++.|+||.++..+...
T Consensus 92 ~~~iltv~g~DrpGiva~Vt~~La~~g~nI~~~~~~t~~ 130 (195)
T 2nyi_A 92 REYELYVEGPDSEGIVEAVTAVLAKKGANIVELETETLP 130 (195)
T ss_dssp EEEEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEEE
T ss_pred cEEEEEEEeCCCcCHHHHHHHHHHHcCCCEEEceeeecc
Confidence 356799999999999999999999999999999888543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.63 E-value=0.04 Score=58.23 Aligned_cols=60 Identities=7% Similarity=0.046 Sum_probs=16.6
Q ss_pred eeEEeEecceEEEEEEECC--ccEEE------EEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeee
Q 010091 250 EHKIVSGSYCDLYKGAFFS--QDVAI------KVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~--~~vAv------Kvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~ 312 (518)
.++|| ||.||+|.+.+ .+||+ |..+......+....|.+|..+++.++|||+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 45565 99999999875 57888 777765555555578899999999999999999987643
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=87.36 E-value=11 Score=37.68 Aligned_cols=144 Identities=13% Similarity=0.084 Sum_probs=79.2
Q ss_pred eecccc---ceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeee-------
Q 010091 241 EIDASL---LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA------- 310 (518)
Q Consensus 241 eI~~~~---~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~------- 310 (518)
.|+.+. ++.++....|+.| ||.+.-++..|+||... .-..+-|..++...-.+.-|+..-+.-.
T Consensus 62 ~i~w~~l~~v~~I~~s~~Gstg-vff~~td~~~~VVK~s~-----~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~ 135 (342)
T 1cja_A 62 DINWKNLQQFKGIERSEKGTEG-LFFVETESGVFIVKRST-----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNM 135 (342)
T ss_dssp CCCTTCGGGEEEEEECCSTTSC-EEEEEESSCEEEEECCT-----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHH
T ss_pred ccccccccCeeEEEeccCCCCC-eEEEEeCCCEEEEeCcH-----HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHH
Confidence 455555 4555666666654 55554477889999541 1122445555555555666654332211
Q ss_pred ---------------eecCCceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCC-----ceecCC
Q 010091 311 ---------------CTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNN-----IIHRDL 369 (518)
Q Consensus 311 ---------------~~~~~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~g-----IiHrDL 369 (518)
....+..+++|+|.+|..|...-...- ..+.......++ + +-+++.+..++ +-+.--
T Consensus 136 ~~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG-~-Ii~FDi~InN~DR~Pl~W~n~G 213 (342)
T 1cja_A 136 LECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG-S-LMALDVIVNNSDRLPIAWTNEG 213 (342)
T ss_dssp HHHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH-H-HHHHHHHHTCCSSSCSSSCSCC
T ss_pred HHHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhc-h-hheehhhhcCCccCcccccCCC
Confidence 011224669999999877766533210 113222222211 1 33567777653 112235
Q ss_pred CCCcEEeccCCc-EEEeeecccee
Q 010091 370 KAANLLMNENGV-VKVADFGVARV 392 (518)
Q Consensus 370 kp~NILl~~~~~-vkL~DFG~a~~ 392 (518)
.++|||++.++. +.++|-+++..
T Consensus 214 N~~NIL~~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 214 NLDNIMLSERGATVVPIDSKIIPL 237 (342)
T ss_dssp CGGGEEEESBTTCEEECSCCCCCC
T ss_pred ChhheEEeCCCCeEEEEcCCcccc
Confidence 788999987554 88999988854
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 | Back alignment and structure |
|---|
Probab=85.36 E-value=1.2 Score=40.57 Aligned_cols=67 Identities=12% Similarity=0.050 Sum_probs=46.9
Q ss_pred ceeEEEEecCCccchHHHHHhhhcccCCCcccccccccC-------CCceeeEEEEcCCCcchHHHHHHHHHhh
Q 010091 139 LMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTV-------DGYSLDVFVVDGWPLQETEQLRNVLAKE 205 (518)
Q Consensus 139 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~-------d~~s~~v~~v~~w~~~~~~~l~~~l~~~ 205 (518)
..+-|++++.|+|+++..++..|++.|+||.++..+... .+.-...+.++.=...+.+.|+.++..-
T Consensus 92 ~~~~l~v~~~D~~Gil~~v~~~l~~~~~nI~~~~~~t~~~~~~~~~~~~F~~~~~~~~~~~~~~~~l~~~l~~~ 165 (192)
T 1u8s_A 92 YTVEVYVESDDKLGLTEKFTQFFAQRQIGMASLSAQTISKDKLHSEQNQFHIAISARVDSGCNLMQLQEEFDAL 165 (192)
T ss_dssp EEEEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEEEC--------CEEEEEEEEEECTTSCHHHHHHHHHHH
T ss_pred ceEEEEEEeCCCccHHHHHHHHHHHcCCcHHHhhhhcccCCccCCCCCEEEEEEEEeCCCCCCHHHHHHHHHHH
Confidence 456899999999999999999999999999998888542 2222222223221233667787777643
|
| >1y7p_A Hypothetical protein AF1403; structural genomics, protein structure initiative, PSI, alpha-beta-alpha sandwich; HET: RIP; 1.90A {Archaeoglobus fulgidus} SCOP: c.23.1.7 d.58.18.12 | Back alignment and structure |
|---|
Probab=85.16 E-value=1.3 Score=41.66 Aligned_cols=59 Identities=27% Similarity=0.394 Sum_probs=44.8
Q ss_pred EEEEecCCccchHHHHHhhhcccCCCcccccccccC----CCceeeEEEEcCCCcchHHHHHHHHH
Q 010091 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTV----DGYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 142 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~----d~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
.|.+...|||++|+.++..|++.+.||...+.+... +|.+.-.+-+++- +.+.+..++.
T Consensus 6 tL~I~a~DRpGLLsDIt~vLAe~kiNIltIn~~~~~kG~~ng~A~I~IEV~d~---~Le~LL~kLr 68 (223)
T 1y7p_A 6 GLRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEGG---DFEKILERVK 68 (223)
T ss_dssp EEEEEEECCTTHHHHHHHHCC----CEEEEEEEECCSSTTTTEEEEEEEECSS---CHHHHHHHHH
T ss_pred EEEEEEcCCCCHHHHHHHHHHHcCCCceEEEEEccccCCcCCEEEEEEEECCC---CHHHHHHHHh
Confidence 788999999999999999999999999999887777 7776666666554 6777766665
|
| >3p96_A Phosphoserine phosphatase SERB; ssgcid, structural genomics, structural genomics center for infectious disease, hydrolas; 2.05A {Mycobacterium avium} | Back alignment and structure |
|---|
Probab=81.71 E-value=0.73 Score=47.41 Aligned_cols=63 Identities=21% Similarity=0.265 Sum_probs=46.4
Q ss_pred eEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcchHHHHHHHHH
Q 010091 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
.=||+++.|||++.+.+|..|++.|.||-+.-.+...+-++..+.+--.+...+.++|..++.
T Consensus 13 ~~lt~~g~Dr~Giv~~vs~~l~~~~~nI~d~~q~~~~~~f~~~~~~~~~~~~~~~~~l~~~l~ 75 (415)
T 3p96_A 13 VLITVTGVDQPGVTATLFEVLSRHGVELLNVEQVVIRHRLTLGVLVCCPADVADGPALRHDVE 75 (415)
T ss_dssp EEEEEEEECCTTHHHHHHHHHTTTTCEEEEEEEEEETTEEEEEEEEEECHHHHTSHHHHHHHH
T ss_pred EEEEEEcCCCCCHHHHHHHHHHHCCCCEEEeeeEEECCEeEEEEEEEecCCcCCHHHHHHHHH
Confidence 459999999999999999999999999999988866655555554432221113466766665
|
| >3obi_A Formyltetrahydrofolate deformylase; structural genomics, joint center for structural genomics, J protein structure initiative; HET: MSE; 1.95A {Rhodopseudomonas palustris} | Back alignment and structure |
|---|
Probab=81.54 E-value=1.1 Score=43.99 Aligned_cols=62 Identities=23% Similarity=0.299 Sum_probs=46.6
Q ss_pred eEEEEecCCccchHHHHHhhhcccCCCcccccccccC-CCceeeEEEEcCCCc--chHHHHHHHHH
Q 010091 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTV-DGYSLDVFVVDGWPL--QETEQLRNVLA 203 (518)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~-d~~s~~v~~v~~w~~--~~~~~l~~~l~ 203 (518)
+-||+++.|||++...+|..|++.|.||.+...|.+. .|.-.....++ ++. .+.++|..++.
T Consensus 7 ~iLtv~g~DrpGIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~-~~~~~~~~~~L~~~f~ 71 (288)
T 3obi_A 7 YVLTLSCPDRAGIVSAVSTFLFENGQNILDAQQYNDTESGHFFMRVVFN-AAAKVIPLASLRTGFG 71 (288)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTEEEEEEEEEEETTTTEEEEEEEEE-ESSCCCCHHHHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHHHHHCCCcEEeeeeeecCCCCceEEEEEEE-cCCCCCCHHHHHHHHH
Confidence 4699999999999999999999999999999888543 44333333343 444 35677777775
|
| >3nrb_A Formyltetrahydrofolate deformylase; N-terminal ACT domain, structural genomics, joint center for structural genomics, JCSG; HET: MSE FLC; 2.05A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=80.57 E-value=1.4 Score=43.37 Aligned_cols=62 Identities=19% Similarity=0.356 Sum_probs=43.1
Q ss_pred eEEEEecCCccchHHHHHhhhcccCCCcccccccccC-CCceeeEEEEcCCCcchHHHHHHHHH
Q 010091 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTV-DGYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~-d~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
+=||+++.|||++...+|..|++.|.||.+...|++. .|.-.....++ ++..+.++|..++.
T Consensus 8 ~vLtv~c~Dr~GIVa~Vs~~La~~g~NI~d~~q~~d~~~g~Ffmr~~~~-~~~~~~~~L~~~f~ 70 (287)
T 3nrb_A 8 YVLSLACQDAPGIVSEVSTFLFNNGANIVEAEQFNDEDSSKFFMRVSVE-IPVAGVNDFNSAFG 70 (287)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTTTEEEEEEEEE-CCC---CHHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHHHHHCCCCEEeeeeeecCCCCeEEEEEEEE-cCCCCHHHHHHHHH
Confidence 4599999999999999999999999999999888533 34333333332 34333446666664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 518 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-85 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-76 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-71 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-70 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-69 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-69 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-69 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-68 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-66 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-66 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-65 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-65 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-65 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-62 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-62 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-61 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-60 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-60 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-58 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-56 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-56 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-52 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-49 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-46 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-43 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-40 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-12 | |
| d1ygya3 | 78 | d.58.18.1 (A:452-529) Phosphoglycerate dehydrogena | 2e-05 | |
| d1sc6a3 | 84 | d.58.18.1 (A:327-410) Phosphoglycerate dehydrogena | 3e-05 | |
| d1y7pa2 | 77 | d.58.18.12 (A:2-78) Hypothetical protein AF1403, N | 5e-04 | |
| d2pc6a2 | 77 | d.58.18.6 (A:1-77) Acetolactate synthase small sub | 0.002 | |
| d1zpva1 | 83 | d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Strepto | 0.004 | |
| d2fgca2 | 78 | d.58.18.6 (A:27-104) Acetolactate synthase small s | 0.004 | |
| d1u8sa1 | 86 | d.58.18.5 (A:2-87) putative transcriptional repres | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (669), Expect = 7e-85
Identities = 96/276 (34%), Positives = 158/276 (57%), Gaps = 12/276 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
D WEI + +I SGS+ +YKG + DVA+K+L + F EV ++R
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
K RH+N++ F+G T P L IVT++ G S+Y +LH + ++ L+ +A ++GM+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ---YGVMTAETGTYRWMAPEVI 414
YLH +IIHRDLK+ N+ ++E+ VK+ DFG+A V+++ +G+ WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 415 EHQ---PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR----PTIPVHT 467
Q PY+ ++DV++FGIVL+EL+TG+LPY ++ + +V +G + +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503
+ L+ C ++ RP F +I ++ LA+ L
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 3e-76
Identities = 85/262 (32%), Positives = 141/262 (53%), Gaps = 8/262 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
W ++ LK I G + D+ G + VA+K + N+ + F E +M ++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQL 57
Query: 300 RHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
RH N+VQ +G L+IVTE+M+ GS+ DYL + L LL+ ++DV + M
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ 417
YL NN +HRDL A N+L++E+ V KV+DFG+ + +W APE + +
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALREK 175
Query: 418 PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477
++ ++DV+SFGI+LWE+ + PL+ V V+KG + P P + ++++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235
Query: 478 CWQRDPSLRPDFSEITELLQHL 499
CW D ++RP F ++ E L+H+
Sbjct: 236 CWHLDAAMRPSFLQLREQLEHI 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 1e-71
Identities = 91/271 (33%), Positives = 140/271 (51%), Gaps = 8/271 (2%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIM 296
D WEI L+ E K+ G + +++ G + VAIK L F QE +M
Sbjct: 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVM 66
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLK-LPLLLRVAIDVSKG 355
+K+RH +VQ + P ++IVTE+MS GS+ D+L + LP L+ +A ++ G
Sbjct: 67 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWMAPEV 413
M Y+ R N +HRDL+AAN+L+ EN V KVADFG+AR+ +Y +W APE
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 414 IEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473
+ + ++DV+SFGI+L EL T + + V++G R P L D
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
Query: 474 LLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
L+ +CW+++P RP F + L+ +
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 6e-71
Identities = 77/266 (28%), Positives = 138/266 (51%), Gaps = 8/266 (3%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIM 296
D WE+ LK ++ +G + +++ G + VA+K L ++ F E ++M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLM 62
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKG 355
++++H +V+ T+ P ++I+TE+M GS+ D+L L + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWMAPEV 413
M ++ N IHRDL+AAN+L+++ K+ADFG+AR+ +Y +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 414 IEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473
I + + ++DV+SFGI+L E+VT + +++G R P + L
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241
Query: 474 LLERCWQRDPSLRPDFSEITELLQHL 499
L+ CW+ P RP F + +L+
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 6e-70
Identities = 76/267 (28%), Positives = 137/267 (51%), Gaps = 13/267 (4%)
Query: 242 IDASLLKFEHK-IVSGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIM 296
+D LL E K + SG++ + KG + + VA+K+L NE + ++ E E ++M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+++ + +V+ IG C +V E G + YL + + +K ++ + VS GM
Sbjct: 63 QQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGM 120
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV----QAQYGVMTAETGTYRWMAPE 412
YL +N +HRDL A N+L+ K++DFG+++ + Y T +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
I + ++ ++DV+SFG+++WE + G+ PY + + +++KG R P +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCPREM 239
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQH 498
DL+ CW D RP F+ + L++
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 3e-69
Identities = 74/271 (27%), Positives = 136/271 (50%), Gaps = 12/271 (4%)
Query: 245 SLLKFEHKIVSGSYCDLYKGAFFS----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
+LL + ++ G++ + +G + DVAIKVL + + E +E IM ++
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLD 67
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
+ +V+ IG C + L +V E GG ++ +L ++ + + + + VS GM YL
Sbjct: 68 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARV----QAQYGVMTAETGTYRWMAPEVIEH 416
N +HRDL A N+L+ K++DFG+++ + Y +A +W APE I
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 417 QPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475
+ ++ R+DV+S+G+ +WE ++ G+ PY + + + +++G R P P L L+
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPPELYALM 245
Query: 476 ERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506
CW RPDF + + ++ L +K
Sbjct: 246 SDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 221 bits (564), Expect = 3e-69
Identities = 91/269 (33%), Positives = 152/269 (56%), Gaps = 8/269 (2%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
D WE++ + + +HK+ G Y ++Y+G + +S VA+K L + EF +E +
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAV 66
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSK 354
M++++H N+VQ +G CTR P +I+TEFM+ G++ DYL + + +LL +A +S
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA--QYGVMTAETGTYRWMAPE 412
M YL + N IHRDL A N L+ EN +VKVADFG++R+ Y +W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 413 VIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV 472
+ + ++ ++DV++FG++LWE+ T + L +++K R P +
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 473 DLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+L+ CWQ +PS RP F+EI + + + Q
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 3e-69
Identities = 65/262 (24%), Positives = 123/262 (46%), Gaps = 12/262 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLN-ENIRREFAQEVHIM 296
W ++ + + G + ++Y +A+KVL L + + +EV I
Sbjct: 3 WALED--FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+RH N+++ G R++++ E+ G++Y L K +++ +
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANAL 119
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH 416
+Y H +IHRD+K NLL+ G +K+ADFG + A T GT ++ PE+IE
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 178
Query: 417 QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476
+ ++ + D++S G++ +E + GK P++ T + + + + T P DL+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLIS 236
Query: 477 RCWQRDPSLRPDFSEITELLQH 498
R + +PS RP E+ L+H
Sbjct: 237 RLLKHNPSQRPMLREV---LEH 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 8e-69
Identities = 86/263 (32%), Positives = 133/263 (50%), Gaps = 6/263 (2%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD-VAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
ID S L F +I SG + ++ G + ++D VAIK + ++E +F +E +M K+
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS 58
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H +VQ G C + +V EFM G + DYL Q+ LL + +DV +GM YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWMAPEVIEHQP 418
+IHRDL A N L+ EN V+KV+DFG+ R QY T +W +PEV
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 419 YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478
Y+ ++DV+SFG+++WE+ + + V + G R P + ++ C
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 479 WQRDPSLRPDFSEITELLQHLAQ 501
W+ P RP FS + L +A+
Sbjct: 239 WKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 1e-68
Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 35/292 (11%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKG-------AFFSQDVAIKVLTNEHLNENIRREFAQE 292
WE L+F + SG++ + S VA+K+L E + + R E
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSE 90
Query: 293 VHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-------------- 337
+ +M ++ H N+V +GACT ++++ E+ G + +YL ++
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 338 --------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389
L LL A V+KGM +L + +HRDL A N+L+ VVK+ DFG+
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 390 ARV---QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDL 445
AR + Y V +WMAPE + Y ++DV+S+GI+LWE+ + G PY +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 446 TPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
++Q G + P + + +++ CW D RP F +T L
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 2e-68
Identities = 75/267 (28%), Positives = 135/267 (50%), Gaps = 16/267 (5%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
D LKF+ +I GS+ +YKG + +VA L + L ++ R+ F +E +++ +
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 300 RHMNVVQFIGACTRPPR----LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
+H N+V+F + + + +VTE M+ G++ YL + K +K+ +L + KG
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKG 124
Query: 356 MNYLHRNN--IIHRDLKAAN-LLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPE 412
+ +LH IIHRDLK N + G VK+ D G+A ++ A GT +MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPE 183
Query: 413 VIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP-TIPVHTHPIL 471
+ E + Y+ DV++FG+ + E+ T + PY + V G++P + P +
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQH 498
+++E C +++ R ++ L H
Sbjct: 243 KEIIEGCIRQNKDERYSIKDL---LNH 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 3e-68
Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 11/262 (4%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
ID L F ++ +G + + G + DVAIK++ ++E EF +E +M +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLS 57
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H +VQ G CT+ +FI+TE+M+ G + +YL + + + LL + DV + M YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWMAPEVIEHQP 418
+HRDL A N L+N+ GVVKV+DFG++R +Y RW PEV+ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 419 YNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477
++ ++D+++FG+++WE+ + GK+PY+ T + A + +GLR P + ++
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYS 236
Query: 478 CWQRDPSLRPDFSEITELLQHL 499
CW RP F + L ++
Sbjct: 237 CWHEKADERPTFKIL---LSNI 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-67
Identities = 82/281 (29%), Positives = 139/281 (49%), Gaps = 11/281 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEV 293
EI S + + I +G + ++YKG + VAIK L E R +F E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEA 60
Query: 294 HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS 353
IM + H N+++ G ++ + I+TE+M G++ +L ++ + L+ + ++
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV----QAQYGVMTAETGTYRWM 409
GM YL N +HRDL A N+L+N N V KV+DFG++RV + RW
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 410 APEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469
APE I ++ + +DV+SFGIV+WE++T + + G R P+
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240
Query: 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKRGLA 510
+ L+ +CWQ++ + RP F++I +L L + + + LA
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (552), Expect = 3e-67
Identities = 90/274 (32%), Positives = 139/274 (50%), Gaps = 14/274 (5%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVH 294
EID S +K E I +G + ++ G VAIK L E RR+F E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEAS 79
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
IM + H NV+ G T+ + I+TEFM GS+ +L + + L+ + ++
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV------QAQYGVMTAETGTYRW 408
GM YL N +HRDL A N+L+N N V KV+DFG++R Y RW
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 409 MAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467
APE I+++ + +DV+S+GIV+WE+++ G+ PY D+T Q + +++ R P+
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDC 258
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
L L+ CWQ+D + RP F +I L + +
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 7e-67
Identities = 69/264 (26%), Positives = 125/264 (47%), Gaps = 17/264 (6%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ + I +GSY K S + + K L + E ++ EV+++R+++H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 306 QFIGACTRPP--RLFIVTEFMSGGSIYDYLH---KQKCGLKLPLLLRVAIDVSKGMNYLH 360
++ L+IV E+ GG + + K++ L +LRV ++ + H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 361 R-----NNIIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVI 414
R + ++HRDLK AN+ ++ VK+ DFG+AR + A GT +M+PE +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 415 EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDL 474
YN ++D++S G +L+EL P+ + + A G +++G IP L ++
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEI 245
Query: 475 LERCWQRDPSLRPDFSEITELLQH 498
+ R RP EI L++
Sbjct: 246 ITRMLNLKDYHRPSVEEI---LEN 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (547), Expect = 2e-66
Identities = 75/253 (29%), Positives = 121/253 (47%), Gaps = 13/253 (5%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNEN-IRREFAQEVHIMRKVRHMNVVQFI 308
+I GS+ +Y + VAIK ++ N ++ +EV ++K+RH N +Q+
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G R ++V E+ G + +K L+ + V +G+ YLH +N+IHRD
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 369 LKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE---HQPYNHRADV 425
+KA N+L++E G+VK+ DFG A + A + GT WMAPEVI Y+ + DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 426 FSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSL 485
+S GI EL K P ++ + A + Q H + ++ C Q+ P
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
Query: 486 RPDFSEITELLQH 498
RP + L+H
Sbjct: 258 RPTSEVL---LKH 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-66
Identities = 73/260 (28%), Positives = 130/260 (50%), Gaps = 14/260 (5%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ ++ G++ +YK A KV+ + +E ++ E+ I+ H N+V
Sbjct: 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIV 72
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ + A L+I+ EF +GG++ + + + L + V +NYLH N II
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 132
Query: 366 HRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTYRWMAPEVI-----EHQPY 419
HRDLKA N+L +G +K+ADFGV+ + + GT WMAPEV+ + +PY
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 420 NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ-KGLRPTIPVHTHPILVDLLERC 478
+++ADV+S GI L E+ + P+ +L P++ + + + + P D L++C
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 252
Query: 479 WQRDPSLRPDFSEITELLQH 498
+++ R S++ LQH
Sbjct: 253 LEKNVDARWTTSQL---LQH 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 4e-66
Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 12/264 (4%)
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLN-ENIRREFAQEVHIMRKVR 300
L+ K+ GS+ + +G + + VA+K L + L+ +F +EV+ M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H N+++ G PP + +VTE GS+ D L K + L L R A+ V++GM YL
Sbjct: 70 HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARV----QAQYGVMTAETGTYRWMAPEVIEH 416
IHRDL A NLL+ +VK+ DFG+ R Y + + W APE ++
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 417 QPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475
+ ++H +D + FG+ LWE+ T G+ P+ L Q + ++G R P + +++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 248
Query: 476 ERCWQRDPSLRPDFSEITELLQHL 499
+CW P RP F + + L
Sbjct: 249 VQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-65
Identities = 78/269 (28%), Positives = 137/269 (50%), Gaps = 9/269 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVH 294
+EI ++ I G + D+++G + S + VAIK ++++R +F QE
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEAL 60
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
MR+ H ++V+ IG T P ++I+ E + G + +L +K L L L+ A +S
Sbjct: 61 TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV--QAQYGVMTAETGTYRWMAPE 412
+ YL +HRD+ A N+L++ N VK+ DFG++R + Y + +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 413 VIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILV 472
I + + +DV+ FG+ +WE++ + +G ++ G R +P + P L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
Query: 473 DLLERCWQRDPSLRPDFSEITELLQHLAQ 501
L+ +CW DPS RP F+E+ L + +
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-65
Identities = 70/251 (27%), Positives = 124/251 (49%), Gaps = 11/251 (4%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+ +Y + Q+VAI+ + + + + E+ +MR+ ++ N+V ++
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLD 84
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+ L++V E+++GGS+ D + + + V + + + +LH N +IHRD+
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 370 KAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSF 428
K+ N+L+ +G VK+ DFG + + + GT WMAPEV+ + Y + D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 429 GIVLWELVTGKLPYDDLTPLQAAVGVVQKG-LRPTIPVHTHPILVDLLERCWQRDPSLRP 487
GI+ E++ G+ PY + PL+A + G P I D L RC D R
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG 262
Query: 488 DFSEITELLQH 498
E+ LQH
Sbjct: 263 SAKEL---LQH 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 7e-65
Identities = 89/286 (31%), Positives = 149/286 (52%), Gaps = 23/286 (8%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIM 296
+D + +KF+ I G++ + K D AIK + E+ +++ R+FA E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVL 64
Query: 297 RKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC---------------GL 340
K+ H N++ +GAC L++ E+ G++ D+L K + L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 341 KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMT 400
LL A DV++GM+YL + IHRDL A N+L+ EN V K+ADFG++R Q Y T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGL 459
RWMA E + + Y +DV+S+G++LWE+V+ G PY +T + + +G
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQGY 243
Query: 460 RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQT 505
R P++ + DL+ +CW+ P RP F++I L + + +T
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 5e-64
Identities = 84/304 (27%), Positives = 141/304 (46%), Gaps = 32/304 (10%)
Query: 227 INHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNE 279
I+ +P + WE + L F + +G++ + + + VA+K+L
Sbjct: 7 IDPTQLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 64
Query: 280 HLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK- 337
+ R E+ ++ + HMN+V +GACT ++TE+ G + ++L +++
Sbjct: 65 A-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 338 ----------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L L LL + V+KGM +L N IHRDL A N+L+ +
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
Query: 382 VKVADFGVARV---QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT- 437
K+ DFG+AR + Y V +WMAPE I + Y +DV+S+GI LWEL +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 438 GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497
G PY + ++++G R P H + D+++ CW DP RP F +I +L++
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 498 HLAQ 501
Sbjct: 304 KQIS 307
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 2e-63
Identities = 73/298 (24%), Positives = 132/298 (44%), Gaps = 34/298 (11%)
Query: 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREF 289
+ E + +++ I G++ +++ VA+K+L E + +++ +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADF 63
Query: 290 AQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ------------- 336
+E +M + + N+V+ +G C + ++ E+M+ G + ++L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 337 ----------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVAD 386
L L +A V+ GM YL +HRDL N L+ EN VVK+AD
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 387 FGVARV---QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYD 443
FG++R Y + RWM PE I + Y +DV+++G+VLWE+ + L
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 444 DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+ + V+ G P + L +L+ CW + P+ RP F I +LQ + +
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-62
Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 12/258 (4%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ G+Y ++ + VA+K++ + + +E+ I + + H NVV
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVV 66
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+F G ++ E+ SGG ++D + G+ P R + G+ YLH I
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 366 HRDLKAANLLMNENGVVKVADFGVARV---QAQYGVMTAETGTYRWMAPEVIEHQPYN-H 421
HRD+K NLL++E +K++DFG+A V + ++ GT ++APE+++ + ++
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 422 RADVFSFGIVLWELVTGKLPYDDLTP-LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480
DV+S GIVL ++ G+LP+D + Q +K + LL +
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245
Query: 481 RDPSLRPDFSEITELLQH 498
+PS R +I +
Sbjct: 246 ENPSARITIPDI---KKD 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 205 bits (522), Expect = 3e-62
Identities = 53/257 (20%), Positives = 110/257 (42%), Gaps = 11/257 (4%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
++ +G++ +++ + + A K + H ++ + +E+ M +RH +V
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLV 86
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
A + ++ EFMSGG +++ + + + + V KG+ ++H NN +
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146
Query: 366 HRDLKAANLLMN--ENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRA 423
H DLK N++ + +K+ DFG+ + TGT + APEV E +P +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 424 DVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH--PILVDLLERCWQR 481
D++S G++ + L++G P+ + V + D + +
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 266
Query: 482 DPSLRPDFSEITELLQH 498
DP+ R + L+H
Sbjct: 267 DPNTRMTIHQA---LEH 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-62
Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 12/276 (4%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEV 293
V + ++ F I G + +Y G D A+K L N + +F E
Sbjct: 21 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEG 79
Query: 294 HIMRKVRHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM+ H NV+ +G C R +V +M G + +++ + + L+ + V
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA-----QYGVMTAETGTYR 407
+KGM +L +HRDL A N +++E VKVADFG+AR T +
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 408 WMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHT 467
WMA E ++ Q + ++DV+SFG++LWEL+T P + +G R P +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 259
Query: 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503
L +++ +CW +RP FSE+ + +
Sbjct: 260 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 203 bits (518), Expect = 2e-61
Identities = 47/257 (18%), Positives = 114/257 (44%), Gaps = 11/257 (4%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
++ SG++ +++ + + K + + + + E+ IM ++ H ++
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 89
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
A + ++ EF+SGG ++D + + + ++ +G+ ++H ++I+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149
Query: 366 HRDLKAANLLM--NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRA 423
H D+K N++ + VK+ DFG+A ++ T T + APE+++ +P
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 424 DVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH--PILVDLLERCWQR 481
D+++ G++ + L++G P+ L+ V + + P D ++ Q+
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 269
Query: 482 DPSLRPDFSEITELLQH 498
+P R + L+H
Sbjct: 270 EPRKRLTVHDA---LEH 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-61
Identities = 66/296 (22%), Positives = 127/296 (42%), Gaps = 51/296 (17%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ ++ +G+ ++K + +A K++ + + IR + +E+ ++ + +V
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH-RNNI 364
F GA + I E M GGS+ L K + +L +V+I V KG+ YL ++ I
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 365 IHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRAD 424
+HRD+K +N+L+N G +K+ DFGV+ Q + + GT +M+PE ++ Y+ ++D
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 425 VFSFGIVLWELVTGKLPYD--DLTPLQAAVGVVQKGLRPTIPVHTH-------------- 468
++S G+ L E+ G+ P D L+ G +G P
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
Query: 469 --------------------------PILVDLLERCWQRDPSLRPDFSEITELLQH 498
D + +C ++P+ R D ++ + H
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL---MVH 298
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-61
Identities = 79/273 (28%), Positives = 136/273 (49%), Gaps = 13/273 (4%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHI 295
+ + K + SG++ +YKG + + VAIK L E + +E E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYV 64
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
M V + +V + +G C + ++T+ M G + DY+ + K + LL + ++KG
Sbjct: 65 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV---QAQYGVMTAETGTYRWMAPE 412
MNYL ++HRDL A N+L+ VK+ DFG+A++ + + +WMA E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 413 VIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471
I H+ Y H++DV+S+G+ +WEL+T G PYD + +++KG R P +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQPPICTIDV 242
Query: 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504
++ +CW D RP F E+ +A+ Q
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-60
Identities = 88/291 (30%), Positives = 138/291 (47%), Gaps = 27/291 (9%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFA 290
WE LK + G++ + + F D VA+K+L + R +
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQKCG---------- 339
+ ++ H+NVV +GACT+P L ++ EF G++ YL ++
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125
Query: 340 -----LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV-- 392
L L L+ + V+KGM +L IHRDL A N+L++E VVK+ DFG+AR
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 393 -QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTG-KLPYDDLTPLQA 450
Y +WMAPE I + Y ++DV+SFG++LWE+ + PY + +
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 451 AVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
+++G R P +T P + + CW +PS RP FSE+ E L +L Q
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 4e-60
Identities = 59/260 (22%), Positives = 113/260 (43%), Gaps = 12/260 (4%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNV 304
KF + GS+ + + ++ AIK+L H+ EN +E +M ++ H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
V+ +L+ + G + Y+ K ++ + YLH I
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 365 IHRDLKAANLLMNENGVVKVADFGVARVQA---QYGVMTAETGTYRWMAPEVIEHQPYNH 421
IHRDLK N+L+NE+ +++ DFG A+V + + + GT ++++PE++ +
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 422 RADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481
+D+++ G ++++LV G P+ +++ L P P DL+E+
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLVEKLLVL 247
Query: 482 DPSLRPDFSEI---TELLQH 498
D + R E+ L H
Sbjct: 248 DATKRLGCEEMEGYGPLKAH 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-59
Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 20/283 (7%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKG-------AFFSQDVAIKVLTNEHLNENIRREFA 290
D WE+ + ++ GS+ +Y+G VAIK + NE + R EF
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 71
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG---------LK 341
E +M++ +VV+ +G ++ ++ E M+ G + YL +
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 342 LPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV---QAQYGV 398
L ++++A +++ GM YL+ N +HRDL A N ++ E+ VK+ DFG+ R Y
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG 458
RWM+PE ++ + +DV+SFG+VLWE+ T + + V +G
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251
Query: 459 LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
P + +L +L+ CWQ +P +RP F EI ++ +
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 7e-59
Identities = 80/290 (27%), Positives = 136/290 (46%), Gaps = 29/290 (10%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKG---------AFFSQDVAIKVLTNEHLNENIRREFA 290
WE+ L + G++ + VA+K+L E +
Sbjct: 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI 66
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG---------- 339
E+ +M+ + +H N++ +GACT+ L+++ E+ S G++ +YL ++
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 340 -----LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV-- 392
L L+ A V++GM YL IHRDL A N+L+ E+ V+K+ADFG+AR
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 393 -QAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA 451
Y T +WMAPE + + Y H++DV+SFG++LWE+ T P++
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 452 VGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501
++++G R P + L ++ CW PS RP F ++ E L +
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-58
Identities = 49/257 (19%), Positives = 104/257 (40%), Gaps = 12/257 (4%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ G + +++ S + K + + ++ +E+ I+ RH N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRNIL 64
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ L ++ EF+SG I++ ++ L ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 366 HRDLKAANLLM--NENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRA 423
H D++ N++ + +K+ +FG AR + APEV +H +
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 424 DVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH--PILVDLLERCWQR 481
D++S G +++ L++G P+ T Q ++ +D ++R +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244
Query: 482 DPSLRPDFSEITELLQH 498
+ R SE LQH
Sbjct: 245 ERKSRMTASEA---LQH 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 3e-58
Identities = 60/258 (23%), Positives = 120/258 (46%), Gaps = 12/258 (4%)
Query: 248 KFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
F + +G++ ++ + VAIK + + L E E+ ++ K++H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-EGKEGSMENEIAVLHKIKHPNIV 70
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
L+++ + +SGG ++D + ++ R+ V + YLH I+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 366 HRDLKAANLL---MNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHR 422
HRDLK NLL ++E+ + ++DFG+++++ V++ GT ++APEV+ +PY+
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 423 ADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH--PILVDLLERCWQ 480
D +S G++ + L+ G P+ D + +++ P D + +
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249
Query: 481 RDPSLRPDFSEITELLQH 498
+DP R + LQH
Sbjct: 250 KDPEKRFTCEQA---LQH 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-57
Identities = 74/299 (24%), Positives = 140/299 (46%), Gaps = 48/299 (16%)
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
+ + I G + ++++G + ++VA+K+ ++ R E++ +RH N++
Sbjct: 5 IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILG 61
Query: 307 FIGACTRP----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH-- 360
FI A + +L++V+++ GS++DYL++ + + ++++A+ + G+ +LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHME 119
Query: 361 ------RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-----VMTAETGTYRWM 409
+ I HRDLK+ N+L+ +NG +AD G+A GT R+M
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 410 APEVIE------HQPYNHRADVFSFGIVLWELVTGKL----------PYDDLTPLQAAV- 452
APEV++ H RAD+++ G+V WE+ PY DL P +V
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 453 ----GVVQKGLRPTIPVHTHPI-----LVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502
V ++ LRP IP + ++ CW + + R I + L L+Q+
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 188 bits (478), Expect = 1e-56
Identities = 60/269 (22%), Positives = 115/269 (42%), Gaps = 22/269 (8%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLN-------ENIRREFAQEVHIMRK 298
+ + + G + + ++ A+K++ + +R +EV I+RK
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 299 VR-HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
V H N++Q F+V + M G ++DYL ++ L ++ + + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVIC 124
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIE-- 415
LH+ NI+HRDLK N+L++++ +K+ DFG + + GT ++APE+IE
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
Query: 416 ----HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH--P 469
H Y D++S G++++ L+ G P+ + ++ + P
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244
Query: 470 ILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ DL+ R P R E L H
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEA---LAH 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-56
Identities = 60/256 (23%), Positives = 114/256 (44%), Gaps = 10/256 (3%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHL--NENIRREFAQEVHIMRKVRHMN 303
+ GS+ ++ F Q AIK L + + ++++ ++ + H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363
+ LF V E+++GG + ++ L A ++ G+ +LH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG 123
Query: 364 IIHRDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVIEHQPYNHR 422
I++RDLK N+L++++G +K+ADFG+ + GT ++APE++ Q YNH
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183
Query: 423 ADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482
D +SFG++L+E++ G+ P+ + + P P DLL + + R+
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVRE 241
Query: 483 PSLRPDFSEITELLQH 498
P R ++ QH
Sbjct: 242 PEKRLGVRG--DIRQH 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 181 bits (461), Expect = 1e-53
Identities = 63/256 (24%), Positives = 120/256 (46%), Gaps = 10/256 (3%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNV 304
+ + +GS+ ++ + A+KVL E + E ++ V H +
Sbjct: 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
++ G ++F++ +++ GG ++ ++ P+ A +V + YLH +I
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 365 IHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRAD 424
I+RDLK N+L+++NG +K+ DFG A+ GT ++APEV+ +PYN D
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSID 183
Query: 425 VFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPS 484
+SFGI+++E++ G P+ D ++ ++ P + + DLL R RD S
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLS 241
Query: 485 LRPDFSEIT--ELLQH 498
R + ++ H
Sbjct: 242 QRLGNLQNGTEDVKNH 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 178 bits (453), Expect = 5e-53
Identities = 67/267 (25%), Positives = 123/267 (46%), Gaps = 16/267 (5%)
Query: 248 KFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNV 304
+ + G +++ +DVA+KVL + + + F +E + H +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 305 VQFIGAC----TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
V P +IV E++ G ++ D +H + + + V D + +N+ H
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH 128
Query: 361 RNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAET----GTYRWMAPEVIEH 416
+N IIHRD+K AN++++ VKV DFG+AR A G +T GT ++++PE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 417 QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH--PILVDL 474
+ R+DV+S G VL+E++TG+ P+ +P+ A V++ P H L +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248
Query: 475 LERCWQRDPSLRPDFSEITELLQHLAQ 501
+ + ++P R E+ L +
Sbjct: 249 VLKALAKNPENRY--QTAAEMRADLVR 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-53
Identities = 61/263 (23%), Positives = 115/263 (43%), Gaps = 16/263 (6%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNEN----IRREFAQEVHIMRKVRH 301
++ SG + + K S A K + + R + +EV I+++++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 302 MNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR 361
NV+ + ++ E ++GG ++D+L +++ L + G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS 131
Query: 362 NNIIHRDLKAANLLMNENGV----VKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQ 417
I H DLK N+++ + V +K+ DFG+A GT ++APE++ ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 418 PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQ--AAVGVVQKGLRPTIPVHTHPILVDLL 475
P AD++S G++ + L++G P+ T + A V V +T + D +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 476 ERCWQRDPSLRPDFSEITELLQH 498
R +DP R + LQH
Sbjct: 252 RRLLVKDPKKRMTIQDS---LQH 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 178 bits (453), Expect = 6e-52
Identities = 60/261 (22%), Positives = 115/261 (44%), Gaps = 12/261 (4%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLN----ENIRREFAQEVHIMRKVRH 301
I G + ++Y + A+K L + + E + + ++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 302 MNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR 361
+V A P +L + + M+GG ++ +L + + A ++ G+ ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHN 125
Query: 362 NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH-QPYN 420
+++RDLK AN+L++E+G V+++D G+A A GT+ +MAPEV++ Y+
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 421 HRADVFSFGIVLWELVTGKLPYDDLTPL-QAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479
AD FS G +L++L+ G P+ + + + + +P P L LLE
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 480 QRDPSLRPDFSE--ITELLQH 498
QRD + R E+ +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKES 265
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-50
Identities = 55/257 (21%), Positives = 115/257 (44%), Gaps = 9/257 (3%)
Query: 248 KFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNV 304
+ + G++ + + A+K+L E + ++ E +++ RH +
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
A RL V E+ +GG ++ +L + + ++ + YLH ++
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 365 IHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTYRWMAPEVIEHQPYNHRA 423
++RD+K NL+++++G +K+ DFG+ + G M GT ++APEV+E Y
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 424 DVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDP 483
D + G+V++E++ G+LP+ + + ++ + P P LL ++DP
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 484 SLRPDFSEIT--ELLQH 498
R E+++H
Sbjct: 245 KQRLGGGPSDAKEVMEH 261
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 3e-50
Identities = 61/275 (22%), Positives = 104/275 (37%), Gaps = 23/275 (8%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ KI SGS+ D+Y G + ++VAIK+ + + + E I + ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE----SKIYKMMQGGVGI 65
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
I C ++ + G S+ D + L +L +A + + Y+H N I
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 366 HRDLKAANLLMNENG---VVKVADFGVAR--------VQAQYGVMTAETGTYRWMAPEVI 414
HRD+K N LM +V + DFG+A+ Y TGT R+ +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 415 EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR------PTIPVHTH 468
+ R D+ S G VL G LP+ L + + +
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 469 PILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503
L C +PD+S + +L ++L R
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-49
Identities = 51/266 (19%), Positives = 106/266 (39%), Gaps = 27/266 (10%)
Query: 250 EHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQ 306
+ G + + + A+K+L + + +EV + + + ++V+
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVR 69
Query: 307 FIGAC----TRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHR 361
+ L IV E + GG ++ + + + + + + YLH
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 362 NNIIHRDLKAANLLMN---ENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQP 418
NI HRD+K NLL N ++K+ DFG A+ + +T T ++APEV+ +
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 189
Query: 419 YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTI------PVHTHPILV 472
Y+ D++S G++++ L+ G P+ L + G+ + +
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 249
Query: 473 DLLERCWQRDPSLRPDFSEITELLQH 498
L+ + +P+ R +E + H
Sbjct: 250 MLIRNLLKTEPTQRMTITEF---MNH 272
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (425), Expect = 8e-49
Identities = 47/280 (16%), Positives = 95/280 (33%), Gaps = 25/280 (8%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
K +I GS+ +++G Q VAIK +R E+ + + +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEY----RTYKLLAGCTGI 63
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ + ++ + G S+ D L + + A + + +H +++
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 366 HRDLKAANLLMNE-----NGVVKVADFGVARV--------QAQYGVMTAETGTYRWMAPE 412
+RD+K N L+ ++ V DFG+ + Y +GT R+M+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 413 VIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR------PTIPVH 466
+ + R D+ + G V + G LP+ L + G + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 467 THPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506
+ PD+ + L + +RL T
Sbjct: 244 FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-48
Identities = 60/287 (20%), Positives = 114/287 (39%), Gaps = 39/287 (13%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS---QDVAIKVLTNEHLNENIRREFAQEVHIMRK---VRH 301
+ +I G+Y ++K + VA+K + + E + +EV ++R H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 302 MNVVQFIGACTRPP-----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
NVV+ CT +L +V E + + G+ + + + +G+
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEH 416
++LH + ++HRDLK N+L+ +G +K+ADFG+AR+ + +T+ T + APEV+
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 417 QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT-------------- 462
Y D++S G + E+ K + + + ++ P
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 463 -----------IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ DLL +C +P+ R L H
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALSH 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-48
Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 22/261 (8%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENI----RREFAQEVHIMRKVR- 300
+ + SG + +Y G S VAIK + + +++ EV +++KV
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 301 -HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
V++ + RP ++ E ++ L+ L V + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 360 HRNNIIHRDLKAANLLMNEN-GVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQP 418
H ++HRD+K N+L++ N G +K+ DFG + V T GT + PE I +
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHR 185
Query: 419 Y-NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477
Y A V+S GI+L+++V G +P++ + + L+
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHLIRW 237
Query: 478 CWQRDPSLRPDFSEITELLQH 498
C PS RP F EI H
Sbjct: 238 CLALRPSDRPTFEEI---QNH 255
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-47
Identities = 65/280 (23%), Positives = 120/280 (42%), Gaps = 37/280 (13%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNEN---IRREFAQEVHIMRKVRHMNVVQ 306
+ G + +YK + Q VAIK + H +E I R +E+ +++++ H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+ A + +V +FM + + L + + +G+ YLH++ I+H
Sbjct: 65 LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 367 RDLKAANLLMNENGVVKVADFGVAR-VQAQYGVMTAETGTYRWMAPEVI-EHQPYNHRAD 424
RDLK NLL++ENGV+K+ADFG+A+ + T + T + APE++ + Y D
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183
Query: 425 VFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT---------------------- 462
+++ G +L EL+ + L + + PT
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243
Query: 463 ----IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
I L+DL++ + +P R T+ L+
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKM 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-46
Identities = 63/282 (22%), Positives = 114/282 (40%), Gaps = 34/282 (12%)
Query: 248 KFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ KI G+Y +YK + VA+K + + E + +E+ +++++ H N+V
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ + +L++V EF+ G+ LPL+ + +G+ + H + ++
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 366 HRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTYRWMAPEVIEHQPYNHRA- 423
HRDLK NLL+N G +K+ADFG+AR T E T + APE++ Y A
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 424 DVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--------------------- 462
D++S G + E+VT + + + + + + P
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 463 ------IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ LL + DP+ R L H
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS---AKAALAH 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 5e-45
Identities = 64/262 (24%), Positives = 116/262 (44%), Gaps = 12/262 (4%)
Query: 244 ASLLKFE--HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHL-NENIRREFAQEVHIMRK 298
A L +F+ + +GS+ + A+K+L + + E I++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNY 358
V +V+ + L++V E+++GG ++ +L + P A + Y
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 359 LHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQP 418
LH ++I+RDLK NLL+++ G ++V DFG A+ G GT +APE+I +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSKG 214
Query: 419 YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478
YN D ++ G++++E+ G P+ P+Q +V + P H L DLL
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNL 272
Query: 479 WQRDPSLRPDFSEIT--ELLQH 498
Q D + R + ++ H
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNH 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (395), Expect = 2e-44
Identities = 63/277 (22%), Positives = 112/277 (40%), Gaps = 34/277 (12%)
Query: 252 KIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
KI G+Y +YK + + A+K + E +E I +E+ I+++++H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
RL +V E + L + GL+ + + G+ Y H ++HRDLK
Sbjct: 69 IHTKKRLVLVFEHLDQDL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 371 AANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRW-MAPEVIE-HQPYNHRADVFSF 428
NLL+N G +K+ADFG+AR W AP+V+ + Y+ D++S
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 429 GIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT-------------------------- 462
G + E+V G + ++ + + + P
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247
Query: 463 -IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+DLL + + DP+ R + L+H
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQA---LEH 281
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-43
Identities = 69/297 (23%), Positives = 119/297 (40%), Gaps = 50/297 (16%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ KI G++ +++K Q VA+K + E+ E +E+ I++ ++H NVV
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 306 QFIGACTRPP--------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
I C +++V +F + L + RV + G+
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLY 131
Query: 358 YLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV-----QAQYGVMTAETGTYRWMAPE 412
Y+HRN I+HRD+KAAN+L+ +GV+K+ADFG+AR +Q T T + PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 413 VI-EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH--- 468
++ + Y D++ G ++ E+ T T + Q T V +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 469 ---------------------------PILVDLLERCWQRDPSLRPDFSEITELLQH 498
P +DL+++ DP+ R D + L H
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---SDDALNH 305
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 8e-43
Identities = 56/267 (20%), Positives = 119/267 (44%), Gaps = 17/267 (6%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHL--NENIRREFAQEVHIMRKVR 300
+ + +G+Y ++ S + A+KVL + E ++ +R
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 301 HM-NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
+V A +L ++ ++++GG ++ +L + + + ++ + +L
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHL 145
Query: 360 HRNNIIHRDLKAANLLMNENGVVKVADFGVAR--VQAQYGVMTAETGTYRWMAPEVIEHQ 417
H+ II+RD+K N+L++ NG V + DFG+++ V + GT +MAP+++
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 418 PYNH--RADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILVD 473
H D +S G++++EL+TG P+ + + ++ L+ P P + D
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 265
Query: 474 LLERCWQRDPSLRPDFSEIT--ELLQH 498
L++R +DP R E+ +H
Sbjct: 266 LIQRLLMKDPKKRLGCGPRDADEIKEH 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-42
Identities = 60/302 (19%), Positives = 119/302 (39%), Gaps = 51/302 (16%)
Query: 239 VWEIDASLLKFE--HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVH 294
V+++ ++ I G+Y + VAIK ++ ++ + +E+
Sbjct: 3 VFDVGP---RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIK 58
Query: 295 IMRKVRHMNVVQFIGACTRPP----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
I+ + RH N++ P + + + G +Y L Q L +
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLY 116
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV----QAQYGVMTAETGTY 406
+ +G+ Y+H N++HRDLK +NLL+N +K+ DFG+ARV G +T T
Sbjct: 117 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 407 RWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--- 462
+ APE++ + Y D++S G +L E+++ + + L ++ P+
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 463 --------------------------IPVHTHPILVDLLERCWQRDPSLRPDFSEITELL 496
+ + +DLL++ +P R + + + L
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQAL 293
Query: 497 QH 498
H
Sbjct: 294 AH 295
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 67/309 (21%), Positives = 118/309 (38%), Gaps = 52/309 (16%)
Query: 230 VNIPAEGID-VWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIR 286
V P +G D E+ + K I +GS+ +Y+ + VAIK + + +
Sbjct: 7 VATPGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------K 57
Query: 287 REFAQEVHIMRKVRHMNVVQFIGACTRP------PRLFIVTEFMSGGSIYDYLHKQKCGL 340
R +E+ IMRK+ H N+V+ L +V +++ H +
Sbjct: 58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117
Query: 341 KLPL--LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFGVARVQAQYG 397
LP+ + + + + Y+H I HRD+K NLL++ + V+K+ DFG A+ +
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 398 VMTAETGTYRWMAP-EVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ 456
+ + + AP + Y DV+S G VL EL+ G+ + + + V +++
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 457 KGLRPT---------------------------IPVHTHPILVDLLERCWQRDPSLRPDF 489
PT T P + L R + P+ R
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT- 296
Query: 490 SEITELLQH 498
E H
Sbjct: 297 --PLEACAH 303
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 75/299 (25%), Positives = 122/299 (40%), Gaps = 47/299 (15%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHI 295
WE+ ++ + + SG+Y + VAIK L +E + +E+ +
Sbjct: 12 TAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 296 MRKVRHMNVVQFIGACTRPPRL------FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVA 349
++ +RH NV+ + T L ++V FM G+ L K + L + +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGEDRIQFLV 127
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWM 409
+ KG+ Y+H IIHRDLK NL +NE+ +K+ DFG+AR MT T +
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYR 185
Query: 410 APEVI-EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP------- 461
APEVI Y D++S G ++ E++TGK + L +++ P
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 462 ----------------------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+I + P+ V+LLE+ D R E L H
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA---LAH 301
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-40
Identities = 60/279 (21%), Positives = 112/279 (40%), Gaps = 36/279 (12%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y ++K + VA+K + + +E + +E+ ++++++H N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+L +V EF + ++ + KG+ + H N++HRDL
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 370 KAANLLMNENGVVKVADFGVARVQAQYG-VMTAETGTYRWMAPEVIE-HQPYNHRADVFS 427
K NLL+N NG +K+A+FG+AR +AE T + P+V+ + Y+ D++S
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 428 FGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP-------------------------- 461
G + EL P + + + + L
Sbjct: 188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247
Query: 462 --TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ + DLL+ + +P R E LQH
Sbjct: 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA---LQH 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 59/297 (19%), Positives = 117/297 (39%), Gaps = 43/297 (14%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHI 295
+WE+ + + SG+Y + VA+K L+ + + +E+ +
Sbjct: 12 TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 296 MRKVRHMNVVQFIGACTRPPRL-----FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
++ ++H NV+ + T L + + G + + + QK L + +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIY 128
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGTYRWMA 410
+ +G+ Y+H +IIHRDLK +NL +NE+ +K+ DFG+AR + +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAP 187
Query: 411 PEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT-------- 462
++ YN D++S G ++ EL+TG+ + + +++ P
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 463 ---------------------IPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQH 498
+ + +P+ VDLLE+ D R + L H
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQALAH 301
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 66/313 (21%), Positives = 119/313 (38%), Gaps = 58/313 (18%)
Query: 237 IDVWEIDASLLK---FEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQ 291
++V + ++LK I SG+ + A ++VAIK L+ N+ + +
Sbjct: 6 VEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR 65
Query: 292 EVHIMRKVRHMNVVQFIGACTRPP------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLL 345
E+ +M+ V H N++ + T +++V E M + L +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERM 121
Query: 346 LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAETGT 405
+ + G+ +LH IIHRDLK +N+++ + +K+ DFG+AR +MT T
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 406 YRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--- 462
+ APEVI Y D++S G ++ E+V K+ + + V+++ P
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 463 -------------------------------------IPVHTHPILVDLLERCWQRDPSL 485
DLL + DP+
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 486 RPDFSEITELLQH 498
R + + LQH
Sbjct: 302 RIS---VDDALQH 311
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (322), Expect = 7e-34
Identities = 47/312 (15%), Positives = 115/312 (36%), Gaps = 63/312 (20%)
Query: 238 DVWEIDASLLKFEH--------KIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRR 287
+ W+ ++ ++++ + K+ G Y ++++ ++ V +K+L ++
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KK 74
Query: 288 EFAQEVHIMRKVR-HMNVVQFIGACTRPP--RLFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
+ +E+ I+ +R N++ P +V E ++ L
Sbjct: 75 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYD 130
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAAN-LLMNENGVVKVADFGVARVQAQYGVMTAET 403
+ ++ K ++Y H I+HRD+K N ++ +E+ +++ D+G+A
Sbjct: 131 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 190
Query: 404 GTYRWMAPEV-IEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--- 459
+ + PE+ +++Q Y++ D++S G +L ++ K P+ + + K L
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 460 ---------------------------------RPTIPVHTHPILVDLLERCWQRDPSLR 486
P +D L++ + D R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 487 PDFSEITELLQH 498
E ++H
Sbjct: 311 LT---AREAMEH 319
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 2e-24
Identities = 49/321 (15%), Positives = 102/321 (31%), Gaps = 78/321 (24%)
Query: 248 KFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
K+ G + ++ + VA+K++ ++ E+ ++++V +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 306 QFIGACTRPP---------------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
+ + +V E + + + G+ L + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 351 DVSKGMNYLH-RNNIIHRDLKAANLLMNENGV------VKVADFGVARVQAQYGVMTAET 403
+ G++Y+H R IIH D+K N+LM +K+AD G A ++ +
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--I 190
Query: 404 GTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL---- 459
T + +PEV+ P+ AD++S +++EL+TG ++
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 460 ------------------------------------------RPTIPVHTHPILVDLLER 477
+ + D L
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 478 CWQRDPSLRPDFSEITELLQH 498
Q DP R D L+ H
Sbjct: 311 MLQLDPRKRAD---AGGLVNH 328
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.4 bits (156), Expect = 1e-12
Identities = 20/157 (12%), Positives = 49/157 (31%), Gaps = 30/157 (19%)
Query: 252 KIVSGSYCDLYKGAFFS-QDVAIKVL----------------TNEHLNENIRREFAQEVH 294
+ G ++ + +K + H + R E
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
++K++ + V + ++ E + +Y + V + +
Sbjct: 67 ALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRVRVENP--------DEVLDMILE 114
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVAR 391
+ + I+H DL N+L++E G + + DF +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 78 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 40.6 bits (95), Expect = 2e-05
Identities = 12/63 (19%), Positives = 24/63 (38%), Gaps = 2/63 (3%)
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQET-EQL 198
+ I D+P L ++ +LL G+NIQ A + + + +D + +
Sbjct: 4 INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPDDVRTAI 63
Query: 199 RNV 201
Sbjct: 64 AAA 66
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} Length = 84 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Score = 40.5 bits (95), Expect = 3e-05
Identities = 10/63 (15%), Positives = 28/63 (44%), Gaps = 2/63 (3%)
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQET-EQL 198
+ ++P +L+ L + +E G+NI + ++ GY + D ++ + +
Sbjct: 12 RRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIEADEDVAEKALQAM 71
Query: 199 RNV 201
+ +
Sbjct: 72 KAI 74
|
| >d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]} Length = 77 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: AF1403 N-terminal domain-like domain: Hypothetical protein AF1403, N-terminal domain species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]
Score = 36.7 bits (85), Expect = 5e-04
Identities = 14/71 (19%), Positives = 26/71 (36%), Gaps = 4/71 (5%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVL 202
+ I +K +L LT++++E G NI A F G ++ E +L
Sbjct: 4 LRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIY--FEIEGGDFEKIL 61
Query: 203 AK--EIPKVEN 211
+ +
Sbjct: 62 ERVKTFDYIIE 72
|
| >d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]} Length = 77 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Nitrosomonas europaea [TaxId: 915]
Score = 35.0 bits (81), Expect = 0.002
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 4/74 (5%)
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQETEQLR 199
H I++ ++ LS++ L S G NI+ T D S V +G + EQ+
Sbjct: 3 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNGPD-EIVEQIT 61
Query: 200 NVLAKEIP--KVEN 211
L K I K+ +
Sbjct: 62 KQLNKLIEVVKLID 75
|
| >d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} Length = 83 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: SP0238-like domain: UPF0237 protein SP0238 species: Streptococcus pneumoniae [TaxId: 1313]
Score = 34.3 bits (79), Expect = 0.004
Identities = 14/62 (22%), Positives = 29/62 (46%), Gaps = 1/62 (1%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVL 202
IT+ DK +++ ++ ++E+GLNI + + +++ V Q+ LRN
Sbjct: 5 ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTMMAVVSSDEK-QDFTYLRNEF 63
Query: 203 AK 204
Sbjct: 64 EA 65
|
| >d2fgca2 d.58.18.6 (A:27-104) Acetolactate synthase small subunit, IlvH {Thermotoga maritima [TaxId: 2336]} Length = 78 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Thermotoga maritima [TaxId: 2336]
Score = 34.2 bits (79), Expect = 0.004
Identities = 17/74 (22%), Positives = 33/74 (44%), Gaps = 4/74 (5%)
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQETEQLR 199
H +++ ++KP ++ ++ +L + G NI + G S V +V G + EQ+
Sbjct: 4 HLVSMLVHNKPGVMRKVANLFARRGFNISSITVGESETPGLSRLVIMVKGDD-KTIEQIE 62
Query: 200 NVLAKEIP--KVEN 211
K + KV
Sbjct: 63 KQAYKLVEVVKVTP 76
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} Length = 86 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Score = 34.4 bits (79), Expect = 0.004
Identities = 10/62 (16%), Positives = 24/62 (38%), Gaps = 2/62 (3%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVL 202
IT D+P + +++ L+++ G NI + + ++ G ++ L
Sbjct: 8 ITAVGTDRPGICNEVVRLVTQAGCNI-IDSRIAMFGKEFTLLMLISG-SPSNITRVETTL 65
Query: 203 AK 204
Sbjct: 66 PL 67
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 518 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.52 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.99 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.88 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.86 | |
| d1zpva1 | 83 | UPF0237 protein SP0238 {Streptococcus pneumoniae [ | 95.84 | |
| d1u8sa1 | 86 | putative transcriptional repressor VC2159 {Vibrio | 95.68 | |
| d1ygya3 | 78 | Phosphoglycerate dehydrogenase, regulatory (C-term | 94.65 | |
| d1sc6a3 | 84 | Phosphoglycerate dehydrogenase, regulatory (C-term | 93.71 | |
| d2pc6a2 | 77 | Acetolactate synthase small subunit, IlvH {Nitroso | 93.49 | |
| d2f06a1 | 71 | Hypothetical protein BT0572 {Bacteroides thetaiota | 92.86 | |
| d2f06a2 | 70 | Hypothetical protein BT0572 {Bacteroides thetaiota | 92.84 | |
| d2f1fa1 | 76 | Acetolactate synthase small subunit, IlvH {Escheri | 92.16 | |
| d1u8sa2 | 93 | putative transcriptional repressor VC2159 {Vibrio | 92.0 | |
| d1y7pa2 | 77 | Hypothetical protein AF1403, N-terminal domain {Ar | 91.51 | |
| d2fgca2 | 78 | Acetolactate synthase small subunit, IlvH {Thermot | 91.04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-57 Score=449.97 Aligned_cols=264 Identities=36% Similarity=0.678 Sum_probs=229.9
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
|+|||+.++|++.++||+|+||.||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||++++++.. +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 6799999999999999999999999998665 59999998777667777899999999999999999999998765 568
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||++||+|.+++......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999999998767789999999999999999999999999999999999999999999999999998754322
Q ss_pred ---ccccCCCCCcccChhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC----CCCCCC
Q 010091 398 ---VMTAETGTYRWMAPEVIEH---QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP----TIPVHT 467 (518)
Q Consensus 398 ---~~~~~~gt~~y~APE~l~~---~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p----~~~~~~ 467 (518)
......||+.|||||++.+ ..++.++|||||||++|||+||+.||.+.++.......+..+..+ ..+..+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 2334569999999999954 458999999999999999999999999988777666666655432 345678
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
++++.++|.+||+.||.+|||++||++.|+.+.+.+
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 999999999999999999999999999999887644
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=432.14 Aligned_cols=262 Identities=30% Similarity=0.591 Sum_probs=229.6
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
..+.|||+.++|++.++||+|+||.||+|++. ++.||||+++..... .+.|.+|+.++++++|||||++++++..
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 46789999999999999999999999999987 467999999865444 3579999999999999999999998765
Q ss_pred CceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+|+..
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 56799999999999999886544 36999999999999999999999999999999999999999999999999999876
Q ss_pred cccC--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 394 AQYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTG-KLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 394 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG-~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
.... ......||+.|+|||++.+..++.++|||||||++|||+|| .+||...+..+ ....+..+.++..|..++++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCCCCCcccChHH
Confidence 5433 23345689999999999999999999999999999999995 45555555544 44556667888899999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
+.+++.+||+.||.+|||++++++.|++++..
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-55 Score=440.86 Aligned_cols=263 Identities=34% Similarity=0.652 Sum_probs=231.8
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
..+.|||+.++|++.++||+|+||.||+|++. ++.||||+++..... .++|.+|+.+|++++|||||+++++|..
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 56789999999999999999999999999985 678999999865443 3679999999999999999999999999
Q ss_pred CCceeEEEeeccCCccccccccc-cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~-~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
.+.+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999998753 45689999999999999999999999999999999999999999999999999987
Q ss_pred ccccCc--cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 393 QAQYGV--MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 393 ~~~~~~--~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
...... .+...|++.|+|||++.+..++.++|||||||++|||++|..||............+..+.++..+..++++
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHH
Confidence 544332 222347899999999999999999999999999999999766654444445555667778889999999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
+.+||.+||+.||.+|||+.|+++.|+.+++
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999998887643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=428.03 Aligned_cols=256 Identities=34% Similarity=0.631 Sum_probs=218.7
Q ss_pred eccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
|+.++|++.++||+|+||.||+|++. ++.||||+++...... ++|.+|+.++++++|||||+++++|...+.+|+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 56678888999999999999999986 5779999998755443 5799999999999999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-- 398 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 398 (518)
|||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999999999999988777899999999999999999999999999999999999999999999999999987554332
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
.....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+.. ..+..+.++..|..+++++.++|.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~-~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-HHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH-HHHHhcCCCCCccccCHHHHHHHHH
Confidence 223458999999999999999999999999999999999 56677766655544 4455678888889999999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
||+.||.+|||++|+++.|+++++
T Consensus 238 cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999998864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-54 Score=431.77 Aligned_cols=259 Identities=34% Similarity=0.599 Sum_probs=220.2
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--Cc---cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQ---DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~---~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
+++.+.|++.++||+|+||.||+|++. ++ .||||.+.... ++...+.|.+|+.+|++++|||||+++++|...+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 677788889999999999999999975 22 48888876543 4455678999999999999999999999999999
Q ss_pred ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccc
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQ 395 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~ 395 (518)
.+|+|||||+||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999999988777899999999999999999999999999999999999999999999999999986543
Q ss_pred cCc------cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCc
Q 010091 396 YGV------MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTH 468 (518)
Q Consensus 396 ~~~------~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~ 468 (518)
... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.+.+..+.... +..+.++..+..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-IEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCccch
Confidence 321 112347899999999999999999999999999999998 8999999887665544 55677888888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
+.+.++|.+||+.||.+|||+.||++.|+++++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 999999999999999999999999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=425.73 Aligned_cols=264 Identities=27% Similarity=0.531 Sum_probs=231.2
Q ss_pred eeeccccceeee-EEeEecceEEEEEEEC----CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 240 WEIDASLLKFEH-KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 240 ~eI~~~~~~~~~-~Lg~G~~g~Vy~~~~~----~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
|-|..+.+.+.+ +||+|+||.||+|++. +..||||+++... +....++|.+|+.+|++++|||||++++++..
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 456667777788 5999999999999864 3469999998653 45556889999999999999999999999865
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
+.+|+||||++||+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 46899999999999999987766789999999999999999999999999999999999999999999999999998765
Q ss_pred ccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010091 395 QYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 395 ~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
.... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.. ..+..+.++.+|..+++
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-~~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRMECPPECPP 239 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-HHHHTTCCCCCCTTCCH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCCCCcCCH
Confidence 4322 223458999999999999999999999999999999998 99999998866554 44566788889999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
++.++|.+||+.||.+||||.+|.+.|+.+...+..+
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 9999999999999999999999999999988776544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=423.35 Aligned_cols=260 Identities=32% Similarity=0.580 Sum_probs=222.6
Q ss_pred eeccccceeeeEEeEecceEEEEEEECC------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
||+.+.|++.++||+|+||.||+|.+.+ ..||||++.... ++.....|.+|+.++++++|||||+++|++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 6778889999999999999999999753 359999997653 445567899999999999999999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
...++||||+.++++.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999999999988777789999999999999999999999999999999999999999999999999998654
Q ss_pred ccC----ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010091 395 QYG----VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLP-YDDLTPLQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 395 ~~~----~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P-~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
... ......||+.|+|||++.+..++.++|||||||++|||++|..| |...+. ......+..+.++..+..+++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccCCCCCchhhHH
Confidence 322 12234589999999999999999999999999999999996555 555554 445556677888899999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
.+.++|.+||+.||.+|||+.||++.|+.+.+.
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999999999999999999999999988763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=435.60 Aligned_cols=259 Identities=29% Similarity=0.565 Sum_probs=227.9
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG 309 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~ 309 (518)
..|||+.++|++.++||+|+||.||+|++.+ ..||+|++.... +......|.+|+.+++++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4699999999999999999999999999753 259999987543 233447899999999998 8999999999
Q ss_pred eeecCCceeEEEeeccCCcccccccccc----------------------CCCChHHHHHHHHHhHHHHHHHHHCCceec
Q 010091 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQK----------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367 (518)
Q Consensus 310 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHr 367 (518)
++...+.+|+|||||+||+|.+++.... ..+++..++.++.||+.||+|||++||+||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999997543 247889999999999999999999999999
Q ss_pred CCCCCcEEeccCCcEEEeeeccceeccccCcc---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 010091 368 DLKAANLLMNENGVVKVADFGVARVQAQYGVM---TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYD 443 (518)
Q Consensus 368 DLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~ 443 (518)
||||+|||++.++.+||+|||+|+........ ....||+.|||||++.+..++.++|||||||++|||+| |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999875554322 23447999999999999999999999999999999998 899999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 010091 444 DLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQ 497 (518)
Q Consensus 444 ~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~ 497 (518)
+.+..+.....+..+.++..|..+++++.+||.+||+.||.+|||++||++.|.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 888777777888888899999999999999999999999999999999998875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=423.55 Aligned_cols=255 Identities=28% Similarity=0.543 Sum_probs=219.2
Q ss_pred ceee-eEEeEecceEEEEEEECC----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 247 LKFE-HKIVSGSYCDLYKGAFFS----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 247 ~~~~-~~Lg~G~~g~Vy~~~~~~----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+.+. ++||+|+||.||+|.+.+ +.||||+++....+....++|.+|+.+|++++|||||+++++|.. +..|+||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEE
Confidence 3444 479999999999998642 569999998766666667899999999999999999999999865 4679999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--- 398 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 398 (518)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 87 E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp ECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred EcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999999999976 55799999999999999999999999999999999999999999999999999986543321
Q ss_pred -cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 399 -MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 399 -~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.. ..+..+.++..|..+++++.++|.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-~~i~~~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-HHHHcCCCCCCCcccCHHHHHHHH
Confidence 223458999999999999999999999999999999998 89999998876654 445567788899999999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 477 RCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
+||+.||.+|||+++|.+.|++++.++-
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 9999999999999999999999876653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=421.47 Aligned_cols=263 Identities=30% Similarity=0.579 Sum_probs=222.7
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
+|||+.++|++.+.||+|+||.||+|++.+ ..||||+++... .+.....|.+|+.+|++++|||||++++++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 499999999999999999999999999753 347888876543 4555688999999999999999999999986
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
.+.+|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 46789999999999999998876778999999999999999999999999999999999999999999999999999865
Q ss_pred cccC--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHH
Q 010091 394 AQYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPI 470 (518)
Q Consensus 394 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 470 (518)
.... ..+...||+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+ ..+.++.++..++++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT 237 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTCCHH
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHH
Confidence 4332 2233458999999999999999999999999999999998 89999998877666544 456677888999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 471 LVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 471 L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
+.++|.+||+.||.+|||+.||++.|+.++++-+
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 9999999999999999999999999999987654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=418.56 Aligned_cols=253 Identities=31% Similarity=0.622 Sum_probs=227.7
Q ss_pred eccccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEE
Q 010091 242 IDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 242 I~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV 320 (518)
|+.++|++.++||+|+||.||+|++. ++.||||+++.....+ ++|.+|+.++++++||||++++++|...+.+|+|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 35678888999999999999999986 4689999999766554 5799999999999999999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc--
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-- 398 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 398 (518)
|||+++|+|.+++......+++..+++++.|+++||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999999887777899999999999999999999999999999999999999999999999999986544332
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLER 477 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~ 477 (518)
.....||+.|+|||.+.+..++.++||||||+++|||+| |+.||.+.+..+.... +..+.++..|..+++++.++|.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-HHhCCCCCCcccccHHHHHHHHH
Confidence 233568999999999999999999999999999999998 8999999987776554 45577888899999999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITELLQH 498 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~~L~~ 498 (518)
||+.||.+|||++++++.|.+
T Consensus 237 cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCSSGGGSCCHHHHHHHHHC
T ss_pred HccCCHhHCcCHHHHHHHhhC
Confidence 999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=420.68 Aligned_cols=249 Identities=25% Similarity=0.470 Sum_probs=220.0
Q ss_pred eeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCc
Q 010091 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (518)
Q Consensus 240 ~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~ 316 (518)
|.| ++|++.+.||+|+||.||+|++. ++.||+|++......+ .....+.+|+.++++++|||||++++++.....
T Consensus 3 ~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 3 WAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 80 (263)
T ss_dssp CCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE
Confidence 544 45777999999999999999985 6889999997643322 234678999999999999999999999999999
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|+||||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999999999987 457999999999999999999999999999999999999999999999999999765443
Q ss_pred CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ..+.+|..+++++.++|.
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLIS 236 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHHHHH
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCccCCHHHHHHHH
Confidence 23345799999999999999999999999999999999999999999887776655443 345677889999999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
+||+.||.+|||++|+++
T Consensus 237 ~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHTCSSGGGSCCHHHHHT
T ss_pred HHccCCHhHCcCHHHHHc
Confidence 999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=419.36 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=209.4
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--CCceeEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLFIV 320 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV 320 (518)
++|++.+.||+|+||.||+|++. |+.||+|++.....++...+.|.+|+.+|++++|||||++++++.+ ...+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 34666999999999999999975 7889999999887777777889999999999999999999998854 4568999
Q ss_pred EeeccCCccccccccc---cCCCChHHHHHHHHHhHHHHHHHHHCC-----ceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 321 TEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNN-----IIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~---~~~l~~~~i~~i~~ql~~gL~yLH~~g-----IiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
|||++||+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 356999999999999999999999976 99999999999999999999999999987
Q ss_pred ccccC-ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 393 QAQYG-VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 393 ~~~~~-~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
..... ......||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+....+.. +..+.++..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHH
Confidence 54433 23345699999999999999999999999999999999999999999887766655444 44556788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 010091 472 VDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.++|.+||+.||.+|||+.|+++
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHHh
Confidence 99999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=417.92 Aligned_cols=256 Identities=33% Similarity=0.668 Sum_probs=221.9
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec-CCce
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PPRL 317 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-~~~~ 317 (518)
+|+|+.++|++.++||+|+||.||+|++.|+.||||+++... ..+.|.+|+.++++++||||++++++|.+ .+.+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 599999999999999999999999999999999999997643 34678999999999999999999999854 4668
Q ss_pred eEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 318 FIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
|+||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999999999997643 35899999999999999999999999999999999999999999999999999865443
Q ss_pred CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 010091 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLL 475 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li 475 (518)
.....+|..|+|||++.+..++.++|||||||++|||+| |++||...+..+.... +..+.++.++..+++++.++|
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~li 233 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYEVM 233 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHHHHHHH
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCccCCHHHHHHH
Confidence 233568899999999999999999999999999999998 7899988877665544 556788999999999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 476 ERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 476 ~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
.+||+.||.+|||+.++++.|+++.+
T Consensus 234 ~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 234 KNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=419.19 Aligned_cols=264 Identities=34% Similarity=0.577 Sum_probs=224.5
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC-ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
..+.|+|+.++|++.+.||+|+||.||+|++.+ +.||||+++....+. +.|.+|+.+|++++|||||+++++|..
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 567899999999999999999999999999864 579999998765443 579999999999999999999999854
Q ss_pred CceeEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
+.+|+||||+++|+|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 56899999999999999887543 46999999999999999999999999999999999999999999999999999865
Q ss_pred cccC--ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHH
Q 010091 394 AQYG--VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPIL 471 (518)
Q Consensus 394 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L 471 (518)
.... ..+...||+.|+|||++.+..++.++|||||||++|||++|..||......+.....+..+.++..+..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 243 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHH
Confidence 4332 23335689999999999999999999999999999999996555544444454555566678888899999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 472 VDLLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
.++|.+||+.||.+|||+++|++.|++++...
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 99999999999999999999999888876543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=415.75 Aligned_cols=246 Identities=26% Similarity=0.426 Sum_probs=207.3
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
|++.++||+|+||.||+|++. |+.||||++...... ...+.|.+|+.+|++++|||||++++++...+.+|+||||+
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 444999999999999999975 789999999865432 23467899999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC---cccc
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG---VMTA 401 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~ 401 (518)
+||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ..+.
T Consensus 86 ~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 86 SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp TTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred CCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 99999999976 4579999999999999999999999999999999999999999999999999998754332 2344
Q ss_pred CCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 402 ETGTYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQAA-VGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
..||+.|||||++.+..+ +.++|||||||++|||++|+.||......... ...............+++++.+||.+||
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 244 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHc
Confidence 569999999999988876 57899999999999999999999775543333 2333333333334567899999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
+.||.+|||++|+++
T Consensus 245 ~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 245 VENPSARITIPDIKK 259 (271)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred CCChhHCcCHHHHhc
Confidence 999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=413.67 Aligned_cols=245 Identities=29% Similarity=0.536 Sum_probs=213.6
Q ss_pred ceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec----CCceeEE
Q 010091 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----PPRLFIV 320 (518)
Q Consensus 247 ~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV 320 (518)
|++.++||+|+||.||+|++. ++.||+|++.....++...+.|.+|+.+|++++|||||++++++.. ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 467889999999999999986 6789999999887777777889999999999999999999999854 4568999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCC--ceecCCCCCcEEec-cCCcEEEeeeccceeccccC
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMN-ENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~g--IiHrDLkp~NILl~-~~~~vkL~DFG~a~~~~~~~ 397 (518)
|||++||+|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+++.....
T Consensus 91 mE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 999999999999977 457999999999999999999999999 99999999999996 5789999999999864433
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCcHHHHHHHH
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR-PTIPVHTHPILVDLLE 476 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~L~~Li~ 476 (518)
......||+.|||||++.+ .++.++|||||||++|||++|+.||.+..........+..+.. +.++...++++.++|.
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 247 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHH
Confidence 2334679999999999876 5999999999999999999999999887666655555555543 3456678899999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
+||+.||.+|||++|+++
T Consensus 248 ~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 248 GCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HHccCCHhHCcCHHHHhC
Confidence 999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=420.17 Aligned_cols=247 Identities=29% Similarity=0.475 Sum_probs=216.3
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|++.++||+|+||.||+|++. ++.||||+++... ....+.|.+|+.+|++++|||||++++++...+.+|+||||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 3555999999999999999975 6789999998653 23346789999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
++||+|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... .....
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 99999999988766779999999999999999999999999999999999999999999999999997654432 23446
Q ss_pred CCCCcccChhhh-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHH
Q 010091 403 TGTYRWMAPEVI-----EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLE 476 (518)
Q Consensus 403 ~gt~~y~APE~l-----~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~ 476 (518)
.||+.|+|||++ .+..|+.++|||||||++|||+||+.||.+.++.+....+..... ....+..+++++.+||.
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~ 250 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 799999999998 356689999999999999999999999999888887766665432 23345678999999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 010091 477 RCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~ 494 (518)
+||+.||.+|||++|+++
T Consensus 251 ~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 251 KCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHSCSSTTTSCCHHHHTT
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=418.61 Aligned_cols=245 Identities=27% Similarity=0.488 Sum_probs=216.8
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.++||+|+||.||+|++. |+.||||+++...... .+.+.+|+.+|++++|||||++++++...+.+|+||||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4666999999999999999965 7899999998654332 36789999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
++||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...... .....
T Consensus 99 ~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred cCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 999999998765 369999999999999999999999999999999999999999999999999998754433 33445
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhhh
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-RPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+........+. ....+..+++++.++|.+||+.
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 256 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccC
Confidence 699999999999999999999999999999999999999999888777666555433 3455677899999999999999
Q ss_pred CCCCCCCHHHHHH
Q 010091 482 DPSLRPDFSEITE 494 (518)
Q Consensus 482 dP~~RPs~~eil~ 494 (518)
||.+|||+.|+++
T Consensus 257 dP~~R~s~~eil~ 269 (293)
T d1yhwa1 257 DVEKRGSAKELLQ 269 (293)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=417.06 Aligned_cols=265 Identities=33% Similarity=0.584 Sum_probs=222.7
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeE
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l 307 (518)
..+.|+|+.++|++.++||+|+||.||+|++.+ +.||||+++... .......|.+|..++.++ +|+||+.+
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 457899999999999999999999999999742 469999987544 334457788888888877 68999999
Q ss_pred eeeeec-CCceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCC
Q 010091 308 IGACTR-PPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371 (518)
Q Consensus 308 ~~~~~~-~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp 371 (518)
++++.. ...+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 998765 456899999999999999996532 2488999999999999999999999999999999
Q ss_pred CcEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCH
Q 010091 372 ANLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTG-KLPYDDLTP 447 (518)
Q Consensus 372 ~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG-~~P~~~~~~ 447 (518)
+|||++.++.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||+|| ..||.+...
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986543322 2334689999999999999999999999999999999996 578988777
Q ss_pred HHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 448 LQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 448 ~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
.+.....+..+.++..+..+++++.++|.+||+.||.+|||+.|+++.|+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 777777778888999999999999999999999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=417.31 Aligned_cols=245 Identities=30% Similarity=0.448 Sum_probs=217.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
.|+..++||+|+||.||+|++. ++.||||++......+ ...+.|.+|+.+|++++|||||++++++.....+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4677999999999999999975 6789999998765443 445789999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
||+||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~ 171 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSF 171 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCC
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCcc
Confidence 9999999766654 56799999999999999999999999999999999999999999999999999976543 2346
Q ss_pred CCCCcccChhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhh
Q 010091 403 TGTYRWMAPEVIE---HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 403 ~gt~~y~APE~l~---~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL 479 (518)
.||+.|||||++. ...|+.++|||||||++|||++|..||.+.+..+....+......+..+..+++++.+||.+||
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence 7999999999985 3568999999999999999999999999998888777777766655566778999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
+.||.+|||++|+++
T Consensus 252 ~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLK 266 (309)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred cCChhHCcCHHHHHh
Confidence 999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=417.72 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=215.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
++|++.+.||+|+||.||+|++. ++.||||++..... ++.....+.+|+.+|++++||||+++++++...+.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 44666999999999999999975 78899999976432 2233467899999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC---c
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG---V 398 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~---~ 398 (518)
||++||+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++++|.+||+|||+|+...... .
T Consensus 88 Ey~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 99999999999887 4579999999999999999999999999999999999999999999999999998754332 2
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... .+.+|..+++++.+||.+|
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKL 244 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCTTCCHHHHHHHHTT
T ss_pred cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHH
Confidence 33456999999999999999999999999999999999999999998877766655543 4567788999999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||++|++.
T Consensus 245 L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEG 260 (288)
T ss_dssp SCSSGGGSTTSGGGTC
T ss_pred ccCCHhHCcCHHHHcC
Confidence 9999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=412.86 Aligned_cols=258 Identities=30% Similarity=0.548 Sum_probs=218.7
Q ss_pred eeccccceeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecC
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~ 314 (518)
-|+..+|++.+.||+|+||.||+|++.+ ..||||+++.....+ ...+.|.+|+.+|++++||||+++++++..
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 3566788889999999999999999642 368999998765433 445789999999999999999999999965
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
+..++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 57899999999999999988877789999999999999999999999999999999999999999999999999998764
Q ss_pred ccCc----cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcH
Q 010091 395 QYGV----MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHP 469 (518)
Q Consensus 395 ~~~~----~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 469 (518)
.... .....|+..|+|||++.+..++.++||||||+++|||+| |..||.+.+..+....+...+.+++.+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence 4332 222347889999999999999999999999999999998 89999999988888888888888888999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 010091 470 ILVDLLERCWQRDPSLRPDFSEITELLQHL 499 (518)
Q Consensus 470 ~L~~Li~~cL~~dP~~RPs~~eil~~L~~l 499 (518)
++.++|.+||+.||.+|||+.||.+.|++.
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999999999999999999999888764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-52 Score=418.32 Aligned_cols=248 Identities=23% Similarity=0.414 Sum_probs=202.1
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+.|++.+.||+|+||.||+|++. ++.||||++....... ....+.+|+.+|++++|||||++++++...+.+|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 44777999999999999999975 7889999998765433 24678899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec---cCCcEEEeeeccceeccccCcc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN---ENGVVKVADFGVARVQAQYGVM 399 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~---~~~~vkL~DFG~a~~~~~~~~~ 399 (518)
||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+. +++.+||+|||+++........
T Consensus 88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 9999999999977 56799999999999999999999999999999999999995 5789999999999876655555
Q ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHH
Q 010091 400 TAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--TIPVHTHPILVDLLER 477 (518)
Q Consensus 400 ~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~L~~Li~~ 477 (518)
....||+.|||||++.+..++.++|||||||++|+|++|+.||.+....+....+....... ..+..+++++.++|.+
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 246 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence 55679999999999999999999999999999999999999999988877776666654433 3346789999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 010091 478 CWQRDPSLRPDFSEITE 494 (518)
Q Consensus 478 cL~~dP~~RPs~~eil~ 494 (518)
||+.||.+|||++|+++
T Consensus 247 ~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 247 LMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HSCSSGGGSCCHHHHHH
T ss_pred HccCCHhHCcCHHHHhc
Confidence 99999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-51 Score=413.24 Aligned_cols=260 Identities=28% Similarity=0.514 Sum_probs=227.6
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeee
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~ 311 (518)
.||+..++|++.++||+|+||.||+|++.+ +.||||+++... .+....+|.+|+.+|++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 478888899999999999999999999754 579999987543 455568899999999999999999999999
Q ss_pred ecCCceeEEEeeccCCcccccccccc-----------------------CCCChHHHHHHHHHhHHHHHHHHHCCceecC
Q 010091 312 TRPPRLFIVTEFMSGGSIYDYLHKQK-----------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368 (518)
Q Consensus 312 ~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrD 368 (518)
......++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999986422 2478899999999999999999999999999
Q ss_pred CCCCcEEeccCCcEEEeeeccceeccccC---ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCC-CCCCC
Q 010091 369 LKAANLLMNENGVVKVADFGVARVQAQYG---VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK-LPYDD 444 (518)
Q Consensus 369 Lkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~-~P~~~ 444 (518)
|||+|||++.++.+||+|||+++...... ..+...||+.|+|||.+.+..++.++|||||||++|||++|. .||.+
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999998653332 223355889999999999999999999999999999999985 68888
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 010091 445 LTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLA 500 (518)
Q Consensus 445 ~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~ 500 (518)
.+..+.... +..+.++.+|..+++++.+||.+||+.||.+||||.||++.|++|.
T Consensus 246 ~~~~e~~~~-v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 MAHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 887776655 5556678888999999999999999999999999999999998874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.8e-51 Score=419.99 Aligned_cols=247 Identities=21% Similarity=0.336 Sum_probs=220.3
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|++.+.||+|+||.||+|++. |+.||||++.... ....+.+.+|+.+|++++|||||++++++...+.+|+||||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5666999999999999999975 7899999997653 34457899999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc--CCcEEEeeeccceeccccCcccc
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE--NGVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
|+||+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..........
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~ 184 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 184 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence 9999999999776778999999999999999999999999999999999999964 57899999999988766555556
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHHHHHHHHhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--TIPVHTHPILVDLLERCW 479 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~L~~Li~~cL 479 (518)
..||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....+.. .....+++++.+||.+||
T Consensus 185 ~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 264 (350)
T d1koaa2 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 264 (350)
T ss_dssp ECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHC
T ss_pred ecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence 789999999999999999999999999999999999999999988877776666554432 233567899999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
+.||.+|||++|+++
T Consensus 265 ~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 265 LADPNTRMTIHQALE 279 (350)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCChhHCcCHHHHhc
Confidence 999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=418.52 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=211.3
Q ss_pred eeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+|..++|++.++||+|+||.||+|++. |+.||+|+++... +......+.+|+.+|++++|||||+++++|.....+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 455677888999999999999999975 7889999998653 3445578999999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
+||||++||+|.+++.+ .+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 99999999999999987 4579999999999999999999997 599999999999999999999999999998654432
Q ss_pred ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------------------------
Q 010091 398 VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAV------------------------- 452 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~------------------------- 452 (518)
.....||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..+...
T Consensus 160 -~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp -C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred -cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 334679999999999999999999999999999999999999997644322110
Q ss_pred ----------------HHHhcCCCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 453 ----------------GVVQKGLRPTIP-VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 453 ----------------~~~~~~~~p~~~-~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
........+..+ ...++++.++|.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001111222223 235789999999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8e-51 Score=418.60 Aligned_cols=247 Identities=19% Similarity=0.354 Sum_probs=220.9
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
.|++.++||+|+||.||+|++. |+.||||+++... ......+.+|+.+|++++|||||++++++.....+|+||||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4666999999999999999975 7899999998653 23346788999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec--cCCcEEEeeeccceeccccCcccc
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN--ENGVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~--~~~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
|+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+..........
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~ 187 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence 999999999887677899999999999999999999999999999999999997 578999999999988776655566
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHHHHHHHhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILVDLLERCW 479 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~L~~Li~~cL 479 (518)
..||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+...... ......+++++.+||.+||
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 267 (352)
T d1koba_ 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267 (352)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTS
T ss_pred ccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence 77999999999999999999999999999999999999999998888777666654443 3344678999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 010091 480 QRDPSLRPDFSEITE 494 (518)
Q Consensus 480 ~~dP~~RPs~~eil~ 494 (518)
+.||.+|||+.|+++
T Consensus 268 ~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 268 QKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhHCcCHHHHhc
Confidence 999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=409.09 Aligned_cols=249 Identities=22% Similarity=0.374 Sum_probs=219.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH----HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~----~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
+.|++.++||+|+||.||+|++. |+.||||+++...... ...+.|.+|+.+|++++|||||++++++.....+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35677999999999999999975 7899999998654322 23578999999999999999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC----cEEEeeeccceecc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG----VVKVADFGVARVQA 394 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~----~vkL~DFG~a~~~~ 394 (518)
+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999977 45799999999999999999999999999999999999998776 59999999998876
Q ss_pred ccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCcHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--PTIPVHTHPILV 472 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~L~ 472 (518)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...... +..+..+++++.
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 248 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHH
Confidence 655556677999999999999999999999999999999999999999998887776665544332 223367889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 010091 473 DLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 473 ~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+||.+||+.||.+|||++|+++
T Consensus 249 ~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 249 DFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=409.08 Aligned_cols=262 Identities=31% Similarity=0.608 Sum_probs=227.7
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEECC---------ccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeE
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~---------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l 307 (518)
..|+|+.++|.+.+.||+|+||.||+|++.+ ..||||+++... .+....++.+|+..+.++ +|||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 3599999999999999999999999998643 359999998654 444567889999999988 79999999
Q ss_pred eeeeecCCceeEEEeeccCCcccccccccc---------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCC
Q 010091 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (518)
Q Consensus 308 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~ 372 (518)
+++|......|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999999999999996543 35899999999999999999999999999999999
Q ss_pred cEEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 010091 373 NLLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPL 448 (518)
Q Consensus 373 NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~ 448 (518)
|||++.++.+||+|||+++....... .....||+.|+|||.+.++.|+.++||||||+++|||++ |..||.+.+..
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999987655432 233458999999999999999999999999999999998 79999888776
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 449 QAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 449 ~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
+. ...+..+.++..|..+++++.+||.+||+.||.+|||+.|+++.|++++.
T Consensus 245 ~~-~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 EL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH-HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 54 45566688899999999999999999999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=410.27 Aligned_cols=263 Identities=30% Similarity=0.600 Sum_probs=234.8
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEECC-------ccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeee
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGA 310 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~-------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~ 310 (518)
.|+|+.++|++.++||+|+||.||+|++.+ +.||||+++... ......+|.+|+.+++++ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 699999999999999999999999998632 579999998654 344567899999999999 69999999999
Q ss_pred eecCCceeEEEeeccCCcccccccccc-----------------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCc
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK-----------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~N 373 (518)
|......|+|||||++|+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999986532 258899999999999999999999999999999999
Q ss_pred EEeccCCcEEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 010091 374 LLMNENGVVKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQ 449 (518)
Q Consensus 374 ILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~ 449 (518)
|+++.++.+|++|||.++....... .+...||+.|+|||++.+..++.++||||||+++|||+| |.+||......+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987554322 223458999999999999999999999999999999999 677787777777
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 010091 450 AAVGVVQKGLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQR 502 (518)
Q Consensus 450 ~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~ 502 (518)
.....+..+.++..+..+++++.+||.+||+.||.+|||+++|++.|++++++
T Consensus 256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 77777888999999999999999999999999999999999999999988776
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=411.58 Aligned_cols=257 Identities=30% Similarity=0.563 Sum_probs=220.2
Q ss_pred cccceeeeEEeEecceEEEEEEEC--Cc----cEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCce
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~----~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~ 317 (518)
.++|+++++||+|+||.||+|++. |+ +||+|.++... +....++|.+|+.++++++|||||+++++|... ..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 345777999999999999999975 33 58899887543 333457899999999999999999999999764 57
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
++++||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 88899999999999998877789999999999999999999999999999999999999999999999999998754432
Q ss_pred c---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 398 V---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVT-GKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 398 ~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLlt-G~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
. .....||+.|+|||++.++.++.++|||||||++|||+| |..||.+.+..+. ...+..+.++..|..+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHcCCCCCCCcccCHHHHH
Confidence 2 222358999999999999999999999999999999998 8999998876654 4556667888888999999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHh
Q 010091 474 LLERCWQRDPSLRPDFSEITELLQHLAQRL 503 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~~L~~l~~~~ 503 (518)
++.+||+.||.+|||+.||+..|+.+.+..
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred HHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 999999999999999999999999887644
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-50 Score=400.29 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=216.3
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC----ce
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP----RL 317 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~----~~ 317 (518)
++|++.+.||+|+||.||+|++. ++.||||+++..... ......|.+|+.++++++||||+++++++.... .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 44666999999999999999975 789999999876553 455678999999999999999999999986543 37
Q ss_pred eEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC
Q 010091 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG 397 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~ 397 (518)
|+||||++|++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 999999999999999877 4579999999999999999999999999999999999999999999999999987543322
Q ss_pred ----ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCcHHH
Q 010091 398 ----VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--TIPVHTHPIL 471 (518)
Q Consensus 398 ----~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~L 471 (518)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.++.+.....+.....+ .....+++++
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l 245 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence 2333469999999999999999999999999999999999999999998888777777655433 2345789999
Q ss_pred HHHHHHhhhhCCCCCC-CHHHHHHHHHHHH
Q 010091 472 VDLLERCWQRDPSLRP-DFSEITELLQHLA 500 (518)
Q Consensus 472 ~~Li~~cL~~dP~~RP-s~~eil~~L~~l~ 500 (518)
.++|.+||++||.+|| |+++++..|.++.
T Consensus 246 ~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 246 DAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 9999999999999998 8999999988874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-51 Score=411.13 Aligned_cols=262 Identities=33% Similarity=0.591 Sum_probs=224.4
Q ss_pred eeccccceeeeEEeEecceEEEEEEECC--c--cEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeecCC
Q 010091 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS--Q--DVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP 315 (518)
Q Consensus 241 eI~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~--~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~~~ 315 (518)
.|+.++|++.++||+|+||.||+|++.+ . .||||.++... .+...+.|.+|+.+|+++ +|||||+++++|...+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4667888889999999999999999753 3 47788876443 233457899999999999 7999999999999999
Q ss_pred ceeEEEeeccCCccccccccc---------------cCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC
Q 010091 316 RLFIVTEFMSGGSIYDYLHKQ---------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (518)
Q Consensus 316 ~~~lV~Ey~~ggsL~~~l~~~---------------~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~ 380 (518)
.+|+||||++||+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999653 24689999999999999999999999999999999999999999
Q ss_pred cEEEeeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCHHHHHHHHHhcCC
Q 010091 381 VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGK-LPYDDLTPLQAAVGVVQKGL 459 (518)
Q Consensus 381 ~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~-~P~~~~~~~~~~~~~~~~~~ 459 (518)
.+||+|||+++............||..|+|||.+.+..++.++||||||+++|||++|. .||.+.+..+.... +..+.
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-i~~~~ 243 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGY 243 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGTC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH-HHhcC
Confidence 99999999998766554444556999999999999999999999999999999999965 67888776665544 45578
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 460 RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 460 ~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
++..+..+++++.+||.+||+.||++|||++|+++.|++++++.+
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 888999999999999999999999999999999999999987543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=410.59 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=219.3
Q ss_pred ccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeE
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 319 (518)
.-++|++++.||+|+||.||+|+.. |+.||||+++..... ......+.+|+.+|++++||||+++++++.....+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 3456777999999999999999975 789999999865322 2234778899999999999999999999999999999
Q ss_pred EEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-c
Q 010091 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-V 398 (518)
Q Consensus 320 V~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 398 (518)
|||||+||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... .
T Consensus 83 v~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred ceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 9999999999999987 5579999999999999999999999999999999999999999999999999998654432 3
Q ss_pred cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHh
Q 010091 399 MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERC 478 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~c 478 (518)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+... .+.+|..+++++.+||.+|
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHHhh
Confidence 34456999999999999999999999999999999999999999998877766555543 4567888999999999999
Q ss_pred hhhCCCCCCC-----HHHHHH
Q 010091 479 WQRDPSLRPD-----FSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs-----~~eil~ 494 (518)
|++||.+|++ ++|+++
T Consensus 240 L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCCchhhcccccccHHHHHc
Confidence 9999999984 788876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=404.82 Aligned_cols=262 Identities=29% Similarity=0.540 Sum_probs=230.0
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC-------CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeee
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~-------~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~ 310 (518)
|.|+|+.++|++.++||+|+||.||+|++. ++.||||+++... .......|.+|+.++++++||||++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 579999999999999999999999999874 3679999997543 44556789999999999999999999999
Q ss_pred eecCCceeEEEeeccCCcccccccccc---------CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCc
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK---------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~ 381 (518)
|......++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 999999999999999999999986422 24688899999999999999999999999999999999999999
Q ss_pred EEEeeeccceeccccCc---cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhc
Q 010091 382 VKVADFGVARVQAQYGV---MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTG-KLPYDDLTPLQAAVGVVQK 457 (518)
Q Consensus 382 vkL~DFG~a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG-~~P~~~~~~~~~~~~~~~~ 457 (518)
+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||+|| ..||.+.+..+....+ ..
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i-~~ 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-ME 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH-HT
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hh
Confidence 99999999986544322 2334589999999999999999999999999999999997 5889888877766554 45
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 010091 458 GLRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQ 501 (518)
Q Consensus 458 ~~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~ 501 (518)
+.++..+..+++.+.++|.+||+.||.+|||+++|++.|++.++
T Consensus 251 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 66788888999999999999999999999999999988876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-49 Score=395.43 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=218.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-------HHHHHHHHHHHHHHhhcC-CCceeeEeeeeecC
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-------ENIRREFAQEVHIMRKVR-HMNVVQFIGACTRP 314 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-------~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~ 314 (518)
++|++.+.||+|+||+||+|+.. ++.||||+++..... +...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 45667999999999999999974 689999999875432 223467899999999997 99999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
+.+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999999999999977 5579999999999999999999999999999999999999999999999999998876
Q ss_pred ccCccccCCCCCcccChhhhc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCC
Q 010091 395 QYGVMTAETGTYRWMAPEVIE------HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--IPVH 466 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~------~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~--~~~~ 466 (518)
.....+...||+.|+|||.+. ...++.++||||+||++|+|++|+.||.+.++......+......+. ....
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 655556677999999999984 34578899999999999999999999999888776666665544333 3347
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 467 THPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 467 ~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+++++.++|.+||+.||.+|||+.|+++
T Consensus 242 ~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 242 YSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 8999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-50 Score=405.68 Aligned_cols=245 Identities=26% Similarity=0.453 Sum_probs=217.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH-HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~-~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
++|++.++||+|+||.||+|++. |+.||||+++.....+ ...+.+.+|+.+|++++|||||++++++.....+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 35677999999999999999975 7899999998643222 23478899999999999999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCcccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTA 401 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 401 (518)
||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~ 160 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT 160 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence 99999999998877 557889999999999999999999999999999999999999999999999999876543 344
Q ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhh
Q 010091 402 ETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQR 481 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~ 481 (518)
..||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ...+|..+++++.++|.+||+.
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~ 238 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITR 238 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCS
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhh
Confidence 67999999999999999999999999999999999999999998888777666654 3456778899999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 010091 482 DPSLRP-----DFSEITE 494 (518)
Q Consensus 482 dP~~RP-----s~~eil~ 494 (518)
||.+|+ |++++++
T Consensus 239 dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 239 DLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CTTTCTTSSTTTTHHHHT
T ss_pred CHHhccccchhhHHHHHc
Confidence 999995 8999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=400.84 Aligned_cols=258 Identities=28% Similarity=0.490 Sum_probs=219.4
Q ss_pred eeeeEEeEecceEEEEEEECC-----ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec-CCceeEEE
Q 010091 248 KFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PPRLFIVT 321 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~~~-----~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lV~ 321 (518)
.+.++||+|+||+||+|++.. ..||||+++.. .+.....+|.+|+.+|++++||||++++|++.. ++.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 457889999999999999753 24899998753 355566889999999999999999999999764 56789999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc---
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV--- 398 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 398 (518)
|||++++|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999999999988777788999999999999999999999999999999999999999999999999986543321
Q ss_pred --cccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 399 --MTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 399 --~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
.....||..|+|||.+.+..++.++||||||+++|||+||..||............+..+.++..|..+++++.++|.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~ 268 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence 223458999999999999999999999999999999999777765544333344445567788889999999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHhhhc
Q 010091 477 RCWQRDPSLRPDFSEITELLQHLAQRLQTK 506 (518)
Q Consensus 477 ~cL~~dP~~RPs~~eil~~L~~l~~~~~~~ 506 (518)
+||+.||.+||++.||++.|+.+++.....
T Consensus 269 ~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 269 KCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 999999999999999999999998765543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=401.72 Aligned_cols=247 Identities=18% Similarity=0.267 Sum_probs=217.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
++|++.++||+|+||.||+|++. ++.||||+++.... ....+.+|+.+|++++|||||++++++.....+|+|||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34666999999999999999975 67899999986532 23568899999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC--CcEEEeeeccceeccccCccc
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN--GVVKVADFGVARVQAQYGVMT 400 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~--~~vkL~DFG~a~~~~~~~~~~ 400 (518)
||+||+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.........
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 999999999998766679999999999999999999999999999999999999854 589999999998765554445
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCcHHHHHHHHHh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPT--IPVHTHPILVDLLERC 478 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~L~~Li~~c 478 (518)
...+|+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+....+... ....+++++.+||.+|
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence 56689999999999999999999999999999999999999999888777766665444322 2246889999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 010091 479 WQRDPSLRPDFSEITE 494 (518)
Q Consensus 479 L~~dP~~RPs~~eil~ 494 (518)
|+.||.+|||+.|+++
T Consensus 242 L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 242 LVKERKSRMTASEALQ 257 (321)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-49 Score=405.23 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=216.2
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC-HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEe
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E 322 (518)
+|+++++||+|+||.||+|++. |+.||||++...... ......+.+|+.+|++++|||||++++++.....+|+|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 4555999999999999999975 789999999754322 2234678999999999999999999999999999999999
Q ss_pred eccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCccccC
Q 010091 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGVMTAE 402 (518)
Q Consensus 323 y~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 402 (518)
|+.||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..... ....
T Consensus 122 ~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~ 198 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTL 198 (350)
T ss_dssp CCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCC
T ss_pred cccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cccc
Confidence 9999999999977 457999999999999999999999999999999999999999999999999999875432 3346
Q ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhhC
Q 010091 403 TGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQRD 482 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~~d 482 (518)
.||+.|||||++.+..++.++|||||||++|+|+||+.||.+.+..+....+... .+.++..+++++.++|.+||+.|
T Consensus 199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~d 276 (350)
T d1rdqe_ 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHSCSC
T ss_pred cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHhhhC
Confidence 7999999999999999999999999999999999999999998887776666554 34567789999999999999999
Q ss_pred CCCC-----CCHHHHHH
Q 010091 483 PSLR-----PDFSEITE 494 (518)
Q Consensus 483 P~~R-----Ps~~eil~ 494 (518)
|.+| ||++++++
T Consensus 277 P~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 277 LTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTTCTTSSTTTTHHHHT
T ss_pred HHhccccccccHHHHHc
Confidence 9999 48999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=398.17 Aligned_cols=246 Identities=24% Similarity=0.414 Sum_probs=213.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEecccc-CHHHHHHHHHHHHHHh-hcCCCceeeEeeeeecCCceeEEE
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMR-KVRHMNVVQFIGACTRPPRLFIVT 321 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-~~~~~~~f~~E~~il~-~l~HpnIv~l~~~~~~~~~~~lV~ 321 (518)
+|.+.++||+|+||.||+|++. ++.||||+++.... .+.....+..|+.++. .++|||||++++++...+.+|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 4666999999999999999985 78899999975432 1222355666777665 689999999999999999999999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccc
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMT 400 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 400 (518)
||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..+
T Consensus 83 Ey~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~ 161 (320)
T d1xjda_ 83 EYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161 (320)
T ss_dssp ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred eecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence 99999999999987 5579999999999999999999999999999999999999999999999999998654332 344
Q ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhh
Q 010091 401 AETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVDLLERCWQ 480 (518)
Q Consensus 401 ~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~Li~~cL~ 480 (518)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... .+.+|..+++++.+||.+||+
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHSC
T ss_pred ccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHHHhcc
Confidence 467999999999999999999999999999999999999999998887766655543 567788899999999999999
Q ss_pred hCCCCCCCHH-HHHH
Q 010091 481 RDPSLRPDFS-EITE 494 (518)
Q Consensus 481 ~dP~~RPs~~-eil~ 494 (518)
.||.+||++. ++++
T Consensus 240 ~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQ 254 (320)
T ss_dssp SSGGGSBTTBSCGGG
T ss_pred cCCCCCcCHHHHHHh
Confidence 9999999985 6653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-48 Score=400.94 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=207.6
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccC----HHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCcee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~----~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 318 (518)
++|++.++||+|+||.||+|++. |+.||||++...... .........++.+++.++|||||++++++...+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 45666999999999999999975 789999999754322 122233344577788889999999999999999999
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV 398 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 398 (518)
+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus 84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~ 161 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-K 161 (364)
T ss_dssp EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-C
T ss_pred EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-c
Confidence 99999999999999987 457899999999999999999999999999999999999999999999999999866543 2
Q ss_pred cccCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCcHHHHHHHH
Q 010091 399 MTAETGTYRWMAPEVIE-HQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAA-VGVVQKGLRPTIPVHTHPILVDLLE 476 (518)
Q Consensus 399 ~~~~~gt~~y~APE~l~-~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~L~~Li~ 476 (518)
.....||+.|+|||++. +..++.++|||||||++|||+||+.||......... .........+.++..+++++.+||.
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence 34467999999999996 457899999999999999999999999875433222 1112234456677889999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHH
Q 010091 477 RCWQRDPSLRPD-----FSEITE 494 (518)
Q Consensus 477 ~cL~~dP~~RPs-----~~eil~ 494 (518)
+||+.||.+||| ++|+++
T Consensus 242 ~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 242 GLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHcccCHHHhCCCcccCHHHHHc
Confidence 999999999999 688875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=389.01 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=210.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC---CccEEEEEEeccccCHHHHHHHHHHHHHHhhc---CCCceeeEeeeee-----c
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV---RHMNVVQFIGACT-----R 313 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~---~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~~~~~-----~ 313 (518)
++|+++++||+|+||.||+|++. ++.||||+++.....+.....+.+|+.+|+.+ +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 46777999999999999999974 45699999987655444444566788887766 7999999999884 3
Q ss_pred CCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 314 ~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
...+|++|||++++++..........+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 35689999999888776666555667999999999999999999999999999999999999999999999999999876
Q ss_pred cccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------------
Q 010091 394 AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL-------------- 459 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~-------------- 459 (518)
..........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.++.+....+.....
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 246 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence 666566667899999999999999999999999999999999999999999887766655432100
Q ss_pred -----------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 -----------RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 -----------~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
...++...++.+.+||.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 01123457889999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=386.65 Aligned_cols=244 Identities=25% Similarity=0.343 Sum_probs=201.3
Q ss_pred eeEEeEecceEEEEEEEC--CccEEEEEEeccccCH---HHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEeec
Q 010091 250 EHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE---NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~---~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 324 (518)
+++||+|+||+||+|++. |+.||||+++...... .....+.+|+.+|++++|||||++++++...+.+|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 678999999999999964 7889999997654332 22367899999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccCC
Q 010091 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAET 403 (518)
Q Consensus 325 ~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 403 (518)
.|+++..+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ......
T Consensus 83 ~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 83 ETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp SEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred cchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 88777666554 5679999999999999999999999999999999999999999999999999997655433 233456
Q ss_pred CCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---------------------
Q 010091 404 GTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP--------------------- 461 (518)
Q Consensus 404 gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p--------------------- 461 (518)
||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence 9999999999864 568999999999999999999999999888777665544311000
Q ss_pred CC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 TI-----PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ~~-----~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.. ....++++.+||.+||+.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 1245788999999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=386.69 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=203.8
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|+++++||+|+||.||+|++. |+.||||+++.....+.....+.+|+.+|++++|||||++++++.....+|+||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 5666999999999999999975 78999999987655544557899999999999999999999999999999999999
Q ss_pred ccCCcccccc-ccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-cccc
Q 010091 324 MSGGSIYDYL-HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTA 401 (518)
Q Consensus 324 ~~ggsL~~~l-~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~ 401 (518)
+.+ ++.+++ ......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||.|+...... ....
T Consensus 83 ~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~ 161 (298)
T d1gz8a_ 83 LHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161 (298)
T ss_dssp CSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred cCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence 965 444444 3445579999999999999999999999999999999999999999999999999998765433 3344
Q ss_pred CCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------CCCC-
Q 010091 402 ETGTYRWMAPEVIEHQP-YNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL----------------RPTI- 463 (518)
Q Consensus 402 ~~gt~~y~APE~l~~~~-~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~----------------~p~~- 463 (518)
..||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+..+.......... ....
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence 56999999999986655 57899999999999999999999998877665544432110 0111
Q ss_pred ----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 464 ----------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 464 ----------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
....++++.+||.+||+.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1245688999999999999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=395.23 Aligned_cols=242 Identities=21% Similarity=0.358 Sum_probs=199.9
Q ss_pred cceeee-EEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhc-CCCceeeEeeeeec----CCce
Q 010091 246 LLKFEH-KIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR----PPRL 317 (518)
Q Consensus 246 ~~~~~~-~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~~~~~~----~~~~ 317 (518)
.|++.+ .||+|+||.||+|++. ++.||||+++.. ..+.+|+.++.++ +|||||++++++.. ...+
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 344465 5999999999999975 689999999753 3567899887655 89999999998854 4678
Q ss_pred eEEEeeccCCcccccccccc-CCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc---CCcEEEeeeccceec
Q 010091 318 FIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVVKVADFGVARVQ 393 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~~~~-~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~---~~~vkL~DFG~a~~~ 393 (518)
|+|||||+||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 99999999999999997643 46999999999999999999999999999999999999985 567999999999877
Q ss_pred cccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--CCCCCC----CCC
Q 010091 394 AQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG--LRPTIP----VHT 467 (518)
Q Consensus 394 ~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~--~~p~~~----~~~ 467 (518)
..........||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+..+........- ....+| ..+
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 66666666789999999999999999999999999999999999999997655433332222111 122222 246
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 468 HPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 468 ~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
++++.+||.+||+.||.+|||+.|++.
T Consensus 245 s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 889999999999999999999999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=387.60 Aligned_cols=255 Identities=26% Similarity=0.480 Sum_probs=205.9
Q ss_pred ccceeeeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC----ceeEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP----RLFIV 320 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~----~~~lV 320 (518)
.+|.+.++||+|+||.||+|++.|+.||||+++... .....+..|+..+.+++||||+++++++.... .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 467789999999999999999999999999997542 11122334666667889999999999986543 57999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHH--------CCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR--------NNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~--------~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
||||++|+|.+++++. .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999763 58999999999999999999996 6999999999999999999999999999987
Q ss_pred ccccCc-----cccCCCCCcccChhhhcCCC------CCchhhHHHHHHHHHHHHcCCCCCCCC---------------C
Q 010091 393 QAQYGV-----MTAETGTYRWMAPEVIEHQP------YNHRADVFSFGIVLWELVTGKLPYDDL---------------T 446 (518)
Q Consensus 393 ~~~~~~-----~~~~~gt~~y~APE~l~~~~------~~~ksDV~SlGill~eLltG~~P~~~~---------------~ 446 (518)
...... .....||+.|+|||++.+.. ++.++|||||||++|||+||..||... .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 644321 23356999999999986543 577899999999999999998876421 2
Q ss_pred HHHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 447 PLQAAVGVVQKGLRPTIPVHT-----HPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 447 ~~~~~~~~~~~~~~p~~~~~~-----~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
...........+++|.++... ...+.+++.+||+.||.+|||+.||++.|+++.++-+
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 222333334456677766543 2459999999999999999999999999999877654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-47 Score=380.74 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=207.9
Q ss_pred ccceeeeEEeEecceEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
++|++.++||+|+||+||+|++. |+.||||+++....++.....|.+|+.+|++++||||+++++++...+..|++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 36777999999999999999986 68999999987665555567899999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccCc-cccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYGV-MTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~ 402 (518)
+.++.+..+... .+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||.+........ ....
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred ehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 977666555544 66899999999999999999999999999999999999999999999999999987554332 2334
Q ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---------------------
Q 010091 403 TGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR--------------------- 460 (518)
Q Consensus 403 ~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~--------------------- 460 (518)
.|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence 58999999999864 55799999999999999999999999988776665544321000
Q ss_pred ------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 ------PTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 ------p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.......++++.++|.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123456789999999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=384.77 Aligned_cols=240 Identities=25% Similarity=0.437 Sum_probs=203.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCH----HHHHHHHHHHHHHhhcC--CCceeeEeeeeecCCc
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVR--HMNVVQFIGACTRPPR 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~----~~~~~f~~E~~il~~l~--HpnIv~l~~~~~~~~~ 316 (518)
++|++.+.||+|+||.||+|++. |+.||||++......+ ....++.+|+.+|++++ |||||++++++...+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 45667999999999999999975 7899999998654332 11244678999999996 8999999999999999
Q ss_pred eeEEEeeccC-CccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccC-CcEEEeeeccceecc
Q 010091 317 LFIVTEFMSG-GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVVKVADFGVARVQA 394 (518)
Q Consensus 317 ~~lV~Ey~~g-gsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~-~~vkL~DFG~a~~~~ 394 (518)
.|+||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 9999999976 577777766 5579999999999999999999999999999999999999854 799999999998654
Q ss_pred ccCccccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 010091 395 QYGVMTAETGTYRWMAPEVIEHQPY-NHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRPTIPVHTHPILVD 473 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~~~~-~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p~~~~~~~~~L~~ 473 (518)
.. ..+...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+. +.. ....++..+++++.+
T Consensus 163 ~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~--~~~~~~~~~s~~~~~ 233 (273)
T d1xwsa_ 163 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQVFFRQRVSSECQH 233 (273)
T ss_dssp SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCCCCSSCCCHHHHH
T ss_pred cc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh--cccCCCCCCCHHHHH
Confidence 43 3445679999999999977665 5678999999999999999999976321 122 234567788999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 010091 474 LLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 474 Li~~cL~~dP~~RPs~~eil~ 494 (518)
+|.+||+.||.+|||++|+++
T Consensus 234 li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHccCCHhHCcCHHHHhc
Confidence 999999999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-46 Score=379.70 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=208.6
Q ss_pred CceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC
Q 010091 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (518)
Q Consensus 238 d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~ 315 (518)
..|++ .++|+++++||+|+||.||+|++. |+.||||+++....++...+.+.+|+.+|++++|||||+++++|...+
T Consensus 12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 45888 678999999999999999999975 789999999877777777788999999999999999999999987654
Q ss_pred ------ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecc
Q 010091 316 ------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGV 389 (518)
Q Consensus 316 ------~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~ 389 (518)
.+|+||||+ +.+|..+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 579999999 6677777654 4699999999999999999999999999999999999999999999999999
Q ss_pred ceeccccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---------
Q 010091 390 ARVQAQYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGL--------- 459 (518)
Q Consensus 390 a~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~--------- 459 (518)
++.... ..+...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.............
T Consensus 168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 987544 3455779999999999865 5578999999999999999999999998776555433322110
Q ss_pred --------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 460 --------------------RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 460 --------------------~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
........++++.+||.+||..||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 01123456889999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=370.11 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=206.0
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceee-EeeeeecCCceeEEE
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ-FIGACTRPPRLFIVT 321 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~-l~~~~~~~~~~~lV~ 321 (518)
++|++.++||+|+||.||+|++. |+.||||++...... .++..|+.++++++|+|++. +..++......++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 35777999999999999999975 789999998875433 35778999999998776554 555567788899999
Q ss_pred eeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEec---cCCcEEEeeeccceeccccC-
Q 010091 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN---ENGVVKVADFGVARVQAQYG- 397 (518)
Q Consensus 322 Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~---~~~~vkL~DFG~a~~~~~~~- 397 (518)
||+ +++|.+.+......+++..++.++.|++.||+|||++||+||||||+|||++ .+..+||+|||+|+......
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999 6677777766667899999999999999999999999999999999999985 35579999999998754432
Q ss_pred -------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---hc---CCCCCCC
Q 010091 398 -------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVV---QK---GLRPTIP 464 (518)
Q Consensus 398 -------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~---~~---~~~p~~~ 464 (518)
......||+.|||||++.+..++.++|||||||++|||++|+.||......+...... .. ...+...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence 1223469999999999999999999999999999999999999998765543332211 11 1122334
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhh
Q 010091 465 VHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQ 504 (518)
Q Consensus 465 ~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~ 504 (518)
..+++++.++|.+||+.+|.+||+++++.+.|+++....+
T Consensus 242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 5788999999999999999999999999999999876544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-45 Score=367.61 Aligned_cols=259 Identities=18% Similarity=0.251 Sum_probs=215.4
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCC-CceeeEeeeeecCCceeEE
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNVVQFIGACTRPPRLFIV 320 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV 320 (518)
.++|++.++||+|+||.||+|++. |+.||||+++..... ..+.+|+.+++.++| +|++.+++++......|+|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 456777999999999999999975 688999998765332 346678888888875 8999999999999999999
Q ss_pred EeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEecc-----CCcEEEeeeccceeccc
Q 010091 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-----NGVVKVADFGVARVQAQ 395 (518)
Q Consensus 321 ~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~-----~~~vkL~DFG~a~~~~~ 395 (518)
|||+ +++|.+++......++...+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 78999999876778999999999999999999999999999999999999974 57899999999987543
Q ss_pred cC--------ccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhc---CCCC
Q 010091 396 YG--------VMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTP---LQAAVGVVQK---GLRP 461 (518)
Q Consensus 396 ~~--------~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~---~~~~~~~~~~---~~~p 461 (518)
.. ......||+.|||||++.+..++.++||||||+++|||+||..||.+... .+....+... ...+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 21 12234599999999999999999999999999999999999999976432 2222222221 1122
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 010091 462 TIPVHTHPILVDLLERCWQRDPSLRPDFSEITELLQHLAQRLQTKR 507 (518)
Q Consensus 462 ~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~~L~~l~~~~~~~~ 507 (518)
.+...+++++.+++..||..+|++||+++.+.+.|++++++.+.+.
T Consensus 239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~ 284 (293)
T d1csna_ 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284 (293)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence 3345688999999999999999999999999999999988776554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=369.93 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=200.2
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec--------C
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--------P 314 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~--------~ 314 (518)
++|++.++||+|+||+||+|++. |+.||||++......+.....+.+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 56777999999999999999975 7899999987765555556788999999999999999999998744 3
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..+|+||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 468999999977766555444 5679999999999999999999999999999999999999999999999999997644
Q ss_pred ccC-----ccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--CCCCCCC-
Q 010091 395 QYG-----VMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG--LRPTIPV- 465 (518)
Q Consensus 395 ~~~-----~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~--~~p~~~~- 465 (518)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.... ..+....
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 321 12234589999999998654 68999999999999999999999999887766554433211 1111100
Q ss_pred ---------------------------CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 466 ---------------------------HTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 466 ---------------------------~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..++++.+||.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 12567889999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=362.57 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=208.6
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCCceeEEEee
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 323 (518)
+|+++++||+|+||+||+|++. ++.||||+++.....+.....+.+|+.+|++++||||+++++++......++|+++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 5777999999999999999975 67899999988776777778999999999999999999999999999999999999
Q ss_pred ccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceeccccC-ccccC
Q 010091 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQYG-VMTAE 402 (518)
Q Consensus 324 ~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 402 (518)
+.+++|..++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... .....
T Consensus 83 ~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~ 161 (292)
T d1unla_ 83 CDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp CSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred cccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence 999988887765 5678999999999999999999999999999999999999999999999999998765543 23334
Q ss_pred CCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcC----------------------
Q 010091 403 TGTYRWMAPEVIEHQP-YNHRADVFSFGIVLWELVTGKLPYDDLTP-LQAAVGVVQKG---------------------- 458 (518)
Q Consensus 403 ~gt~~y~APE~l~~~~-~~~ksDV~SlGill~eLltG~~P~~~~~~-~~~~~~~~~~~---------------------- 458 (518)
.+++.|+|||.+.+.. ++.++|||||||++|||++|+.||..... .+....+....
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccc
Confidence 5788899999987654 68999999999999999999998654433 33322221100
Q ss_pred -----CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 -----LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 -----~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.........++.+.+||.+||+.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011123456788999999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=373.71 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=202.2
Q ss_pred ceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeecCC-
Q 010091 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP- 315 (518)
Q Consensus 239 ~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~~~- 315 (518)
.|+|. ++|+++++||+|+||+||+|++. |+.||||++.... .......+.+|+.+|++++||||+++++++....
T Consensus 3 ~~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 3 VFDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 35663 45888999999999999999975 7899999997543 3455678999999999999999999999986543
Q ss_pred ---ceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 316 ---RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 316 ---~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
..+++++|+.|++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 234455566799999999653 599999999999999999999999999999999999999999999999999986
Q ss_pred ccccCc----cccCCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---------
Q 010091 393 QAQYGV----MTAETGTYRWMAPEVI-EHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG--------- 458 (518)
Q Consensus 393 ~~~~~~----~~~~~gt~~y~APE~l-~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~--------- 458 (518)
...... .....||+.|+|||++ .+..++.++||||+||++|+|++|+.||...+............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 544322 2334589999999998 45567899999999999999999999998876554443322110
Q ss_pred -------------CCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 -------------LRP-------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 -------------~~p-------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
... ......++++.+||.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 012356788999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=373.33 Aligned_cols=243 Identities=25% Similarity=0.299 Sum_probs=199.5
Q ss_pred cceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec------CCce
Q 010091 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------PPRL 317 (518)
Q Consensus 246 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~------~~~~ 317 (518)
+|+..++||+|+||+||+|++. |+.||||+++.... .+.+|+.+|++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5788999999999999999985 78899999986542 23469999999999999999998843 3357
Q ss_pred eEEEeeccCCccccccc--cccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-cEEEeeeccceecc
Q 010091 318 FIVTEFMSGGSIYDYLH--KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFGVARVQA 394 (518)
Q Consensus 318 ~lV~Ey~~ggsL~~~l~--~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-~vkL~DFG~a~~~~ 394 (518)
|+||||++++.+..+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999997654333322 2345699999999999999999999999999999999999999775 89999999998776
Q ss_pred ccCccccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---------------
Q 010091 395 QYGVMTAETGTYRWMAPEVIEH-QPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKG--------------- 458 (518)
Q Consensus 395 ~~~~~~~~~gt~~y~APE~l~~-~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~--------------- 458 (518)
.........||..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+....
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 6555556779999999998764 578999999999999999999999998877666554433210
Q ss_pred ---CCC---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 ---LRP---------TIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 ---~~p---------~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
..+ ......++++.+||.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 112356889999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.7e-44 Score=362.88 Aligned_cols=242 Identities=18% Similarity=0.305 Sum_probs=198.9
Q ss_pred cccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeec--CCcee
Q 010091 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTR--PPRLF 318 (518)
Q Consensus 244 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~ 318 (518)
.++|+++++||+|+||+||+|++. ++.||||+++... ...+.+|+.+|++++ ||||+++++++.. ...+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 346777999999999999999975 7889999997643 357889999999995 9999999999864 45799
Q ss_pred EEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCC-cEEEeeeccceeccccC
Q 010091 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VVKVADFGVARVQAQYG 397 (518)
Q Consensus 319 lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~-~vkL~DFG~a~~~~~~~ 397 (518)
+||||+++++|.++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EEEeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999999987643 489999999999999999999999999999999999998654 69999999998766655
Q ss_pred ccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHh------------c-C----
Q 010091 398 VMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQ-AAVGVVQ------------K-G---- 458 (518)
Q Consensus 398 ~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~-~~~~~~~------------~-~---- 458 (518)
......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....... ....... . .
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 55566799999999998654 57999999999999999999999997654322 1111100 0 0
Q ss_pred ------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 459 ------------------LRPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 459 ------------------~~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
........+++++.+||.+||+.||.+|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011112336788999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=375.91 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=207.5
Q ss_pred ccccceeeeEEeEecceEEEEEEE-----CCccEEEEEEecccc--CHHHHHHHHHHHHHHhhcCC-CceeeEeeeeecC
Q 010091 243 DASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHL--NENIRREFAQEVHIMRKVRH-MNVVQFIGACTRP 314 (518)
Q Consensus 243 ~~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~vAvKvl~~~~~--~~~~~~~f~~E~~il~~l~H-pnIv~l~~~~~~~ 314 (518)
..++|++.++||+|+||.||+|+. .|+.||||+++.... +....+.+.+|+.++++++| |||+++++++...
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 345677799999999999999986 257899999875432 12223578889999999977 8999999999999
Q ss_pred CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecc
Q 010091 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQA 394 (518)
Q Consensus 315 ~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~ 394 (518)
..+|++|||+.|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999999999999999999987 4567889999999999999999999999999999999999999999999999997653
Q ss_pred ccC--ccccCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCc
Q 010091 395 QYG--VMTAETGTYRWMAPEVIEHQ--PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQ--KGLRPTIPVHTH 468 (518)
Q Consensus 395 ~~~--~~~~~~gt~~y~APE~l~~~--~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~--~~~~p~~~~~~~ 468 (518)
... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+.. ....+.++..++
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 322 23345699999999999654 478899999999999999999999976543332222222 134566778899
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 010091 469 PILVDLLERCWQRDPSLRP-----DFSEITE 494 (518)
Q Consensus 469 ~~L~~Li~~cL~~dP~~RP-----s~~eil~ 494 (518)
+++.++|.+||++||.+|| |++|+++
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 9999999999999999998 4788765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=371.06 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=210.2
Q ss_pred CCCceeeccccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec
Q 010091 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (518)
Q Consensus 236 ~~d~~eI~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~ 313 (518)
+.+.|+| .++|++.++||+|+||+||+|++. |+.||||+++....+......+.+|+.+|++++|||||++++++..
T Consensus 10 ~~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~ 88 (348)
T d2gfsa1 10 NKTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88 (348)
T ss_dssp SSSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3457998 578999999999999999999975 7899999998877676667889999999999999999999998853
Q ss_pred C-----CceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeec
Q 010091 314 P-----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFG 388 (518)
Q Consensus 314 ~-----~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG 388 (518)
. ...+++++|+.|++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||
T Consensus 89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 89 ARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccc
Confidence 3 344677778889999999865 359999999999999999999999999999999999999999999999999
Q ss_pred cceeccccCccccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC------
Q 010091 389 VARVQAQYGVMTAETGTYRWMAPEVIEHQ-PYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLRP------ 461 (518)
Q Consensus 389 ~a~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~p------ 461 (518)
.+...... .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 167 ~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 167 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp ---CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 99765432 3446689999999987654 56899999999999999999999998877665554443221111
Q ss_pred ---------------CC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 462 ---------------TI--------PVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 462 ---------------~~--------~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
.. ....++++.+||.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 11 1356888999999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=370.17 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=194.8
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCceeeEeeeeec------CCc
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------PPR 316 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~~~~~~------~~~ 316 (518)
.+|+++++||+|+||+||+|.+. |+.||||+++....+......+.+|+.++++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 45888999999999999999976 7899999999877777777889999999999999999999999853 367
Q ss_pred eeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccceecccc
Q 010091 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVARVQAQY 396 (518)
Q Consensus 317 ~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~~~~ 396 (518)
+|+||||+.++.+. .+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 97 ~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 89999999765554 433 35899999999999999999999999999999999999999999999999999877766
Q ss_pred CccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC----------------
Q 010091 397 GVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPLQAAVGVVQKGLR---------------- 460 (518)
Q Consensus 397 ~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~~~~~~~~~~~~~---------------- 460 (518)
...+...+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence 6666677999999999999999999999999999999999999999877655444333211000
Q ss_pred ----CCC--------------C------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 461 ----PTI--------------P------VHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 461 ----p~~--------------~------~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+.. + ...++++.+||.+||..||.+|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0 112467899999999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-38 Score=321.45 Aligned_cols=245 Identities=21% Similarity=0.369 Sum_probs=185.5
Q ss_pred ccceeeeEEeEecceEEEEEEEC--CccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-----------CCceeeEeeee
Q 010091 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-----------HMNVVQFIGAC 311 (518)
Q Consensus 245 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-----------HpnIv~l~~~~ 311 (518)
.+|+++++||+|+||+||+|++. |+.||||+++... .....+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 45788999999999999999974 7899999998642 33467788999998885 57899999887
Q ss_pred ec--CCceeEEEeeccCCccccc--cccccCCCChHHHHHHHHHhHHHHHHHHH-CCceecCCCCCcEEeccCC------
Q 010091 312 TR--PPRLFIVTEFMSGGSIYDY--LHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENG------ 380 (518)
Q Consensus 312 ~~--~~~~~lV~Ey~~ggsL~~~--l~~~~~~l~~~~i~~i~~ql~~gL~yLH~-~gIiHrDLkp~NILl~~~~------ 380 (518)
.. ....+++++++..+..... .......+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 54 3456667776655433222 22334578999999999999999999998 8999999999999998665
Q ss_pred cEEEeeeccceeccccCccccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH
Q 010091 381 VVKVADFGVARVQAQYGVMTAETGTYRWMAPEVIEHQPYNHRADVFSFGIVLWELVTGKLPYDDLTPL------QAAVGV 454 (518)
Q Consensus 381 ~vkL~DFG~a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ksDV~SlGill~eLltG~~P~~~~~~~------~~~~~~ 454 (518)
.++++|||.+...... .....||+.|+|||++....++.++|+||+||++++|++|+.||...... ......
T Consensus 170 ~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 3999999999765443 33467999999999999999999999999999999999999999753221 011000
Q ss_pred Hh-----------c-----------CC------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 010091 455 VQ-----------K-----------GL------------------RPTIPVHTHPILVDLLERCWQRDPSLRPDFSEITE 494 (518)
Q Consensus 455 ~~-----------~-----------~~------------------~p~~~~~~~~~L~~Li~~cL~~dP~~RPs~~eil~ 494 (518)
+. . .. ........++++.+||.+||..||.+|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 00 01111223567999999999999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=5.4e-24 Score=198.35 Aligned_cols=164 Identities=14% Similarity=0.139 Sum_probs=121.2
Q ss_pred eeeeEEeEecceEEEEEEEC-CccEEEEEEeccccC----------------HHHHHHHHHHHHHHhhcCCCceeeEeee
Q 010091 248 KFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN----------------ENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (518)
Q Consensus 248 ~~~~~Lg~G~~g~Vy~~~~~-~~~vAvKvl~~~~~~----------------~~~~~~f~~E~~il~~l~HpnIv~l~~~ 310 (518)
.+.++||+|+||+||+|++. |+.||||+++....+ ......+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45889999999999999964 789999998753221 1112445678899999999999998875
Q ss_pred eecCCceeEEEeeccCCccccccccccCCCChHHHHHHHHHhHHHHHHHHHCCceecCCCCCcEEeccCCcEEEeeeccc
Q 010091 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVVKVADFGVA 390 (518)
Q Consensus 311 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~~gIiHrDLkp~NILl~~~~~vkL~DFG~a 390 (518)
.. .+++|||+++..+.+ ++......++.|++.++.|||++||+||||||+|||++++ .++|+|||.|
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 32 379999998765543 3445567899999999999999999999999999999865 5889999999
Q ss_pred eeccccCccccCCCCCcccCh------hhhcCCCCCchhhHHHHHHHH
Q 010091 391 RVQAQYGVMTAETGTYRWMAP------EVIEHQPYNHRADVFSFGIVL 432 (518)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~AP------E~l~~~~~~~ksDV~SlGill 432 (518)
.....+.. ..|... +.+ ...|+.++|+||+.--+
T Consensus 150 ~~~~~~~~-------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 150 VEVGEEGW-------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EETTSTTH-------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ccCCCCCc-------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 75433211 111111 111 35678889999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=2.1e-07 Score=87.96 Aligned_cols=136 Identities=12% Similarity=0.074 Sum_probs=91.0
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcC-CCceeeEeeeeecCCceeEEEeeccCCc
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSGGS 328 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 328 (518)
.+..+-++.+.||+....++.++||+........ ...+.+|..+++.+. +--+.+++.++...+..|+||++++|.+
T Consensus 19 ~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~ 96 (263)
T d1j7la_ 19 VKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred EEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccc
Confidence 4443334457899998788889999887543222 134567888887774 3335677888888888999999999987
Q ss_pred cccccccccCCCChHHHHHHHHHhHHHHHHHHH-----------------------------------------------
Q 010091 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR----------------------------------------------- 361 (518)
Q Consensus 329 L~~~l~~~~~~l~~~~i~~i~~ql~~gL~yLH~----------------------------------------------- 361 (518)
+.+.... ......++.++...+..||+
T Consensus 97 ~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (263)
T d1j7la_ 97 CSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHH
T ss_pred ccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHH
Confidence 7543321 11112233333444444442
Q ss_pred ------------CCceecCCCCCcEEeccCCcEEEeeeccceec
Q 010091 362 ------------NNIIHRDLKAANLLMNENGVVKVADFGVARVQ 393 (518)
Q Consensus 362 ------------~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~~ 393 (518)
..++|+|+.|.|||+++++.+.|+||+.+...
T Consensus 171 ~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 12799999999999998777789999988653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=6.8e-06 Score=76.84 Aligned_cols=126 Identities=13% Similarity=0.129 Sum_probs=83.0
Q ss_pred EeEecc-eEEEEEEEC-CccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCC--ceeeEeeeeecCCceeEEEeeccCCc
Q 010091 253 IVSGSY-CDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM--NVVQFIGACTRPPRLFIVTEFMSGGS 328 (518)
Q Consensus 253 Lg~G~~-g~Vy~~~~~-~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~Hp--nIv~l~~~~~~~~~~~lV~Ey~~ggs 328 (518)
+..|.. +.||+.+.. +..+++|........ .+..|...++.+... .+.+++.++...+..++||+|++|.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 445543 689999865 456888987765432 355677777776433 35677888888888999999999877
Q ss_pred cccccccccCCCChHHHHHHHHHhHHH---------------------------------------------------HH
Q 010091 329 IYDYLHKQKCGLKLPLLLRVAIDVSKG---------------------------------------------------MN 357 (518)
Q Consensus 329 L~~~l~~~~~~l~~~~i~~i~~ql~~g---------------------------------------------------L~ 357 (518)
+.+... ... ..+.++... +.
T Consensus 93 ~~~~~~------~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 93 LLSSHL------APA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTTSCC------CHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccccc------cHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 654211 000 011111122 22
Q ss_pred HHHHC-------CceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 358 YLHRN-------NIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 358 yLH~~-------gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
.+.+. .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 22221 379999999999999877788999998854
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.52 E-value=8.8e-05 Score=74.47 Aligned_cols=78 Identities=14% Similarity=-0.055 Sum_probs=48.4
Q ss_pred eeEEeEecceEEEEEEEC--CccEEEEEEecccc-----CHHHHHHHHHHHHHHhhcC-C--CceeeEeeeeecCCceeE
Q 010091 250 EHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-----NENIRREFAQEVHIMRKVR-H--MNVVQFIGACTRPPRLFI 319 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~--~~~vAvKvl~~~~~-----~~~~~~~f~~E~~il~~l~-H--pnIv~l~~~~~~~~~~~l 319 (518)
.+.||.|....||+.+.. ++.++||...+... ......+...|...|+.+. + ..+++++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 456899999999999743 56799997654210 0011123445777777663 2 3466676653 345689
Q ss_pred EEeeccCCcc
Q 010091 320 VTEFMSGGSI 329 (518)
Q Consensus 320 V~Ey~~ggsL 329 (518)
|||++++.++
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.99 E-value=0.0011 Score=64.21 Aligned_cols=69 Identities=12% Similarity=0.070 Sum_probs=45.6
Q ss_pred ceEEEEEEE-CCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCcee--eEee-----eeecCCceeEEEeeccCCcc
Q 010091 258 YCDLYKGAF-FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV--QFIG-----ACTRPPRLFIVTEFMSGGSI 329 (518)
Q Consensus 258 ~g~Vy~~~~-~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnIv--~l~~-----~~~~~~~~~lV~Ey~~ggsL 329 (518)
--.||+++. .|+.|++|+.+++..+. +++..|...+..|...+|. ..+. .+...+..+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 368999986 47889999999876654 3456677777777433221 1111 22445667889999987544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.88 E-value=0.002 Score=64.06 Aligned_cols=73 Identities=14% Similarity=0.164 Sum_probs=50.0
Q ss_pred eeEEeEecceEEEEEEECC---------ccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCce-eeEeeeeecCCceeE
Q 010091 250 EHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFI 319 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~---------~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~~~~~~~~~~~l 319 (518)
++.|+-|-.-.+|+.+..+ +.|.+++.-.. .. . ....+|..+++.+.-.++ .++++++.. ++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET--E-SHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC--H-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch--h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 4578889999999998642 45777776532 12 1 234578889998854444 477777653 68
Q ss_pred EEeeccCCccc
Q 010091 320 VTEFMSGGSIY 330 (518)
Q Consensus 320 V~Ey~~ggsL~ 330 (518)
|+||++|.+|.
T Consensus 119 I~efi~g~~l~ 129 (395)
T d1nw1a_ 119 LEEYIPSRPLS 129 (395)
T ss_dssp EECCCCEEECC
T ss_pred EEEEeccccCC
Confidence 99999886654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.86 E-value=0.0015 Score=62.53 Aligned_cols=139 Identities=12% Similarity=0.032 Sum_probs=74.8
Q ss_pred eeEEeEecceEEEEEEECCccEEEEEEeccccCHHHHHHHHHHHHHHhhcCCCce--eeEee------eeecCCceeEEE
Q 010091 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV--VQFIG------ACTRPPRLFIVT 321 (518)
Q Consensus 250 ~~~Lg~G~~g~Vy~~~~~~~~vAvKvl~~~~~~~~~~~~f~~E~~il~~l~HpnI--v~l~~------~~~~~~~~~lV~ 321 (518)
.+.|..|.--+.|+.+..+..+++|+....... .+...|+.++..|...++ ...+. ........+.++
T Consensus 23 ~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~----~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~ 98 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 98 (316)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eecCCCCcccCeEEEEECCCcEEEEEcCCCCCH----HHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceee
Confidence 456777888889999988888999998654222 233346666776643322 11111 112233455666
Q ss_pred eeccCCccccccc----------------------cccCCC------------------ChHHHHHHHHHhHHHHHHHH-
Q 010091 322 EFMSGGSIYDYLH----------------------KQKCGL------------------KLPLLLRVAIDVSKGMNYLH- 360 (518)
Q Consensus 322 Ey~~ggsL~~~l~----------------------~~~~~l------------------~~~~i~~i~~ql~~gL~yLH- 360 (518)
.++.|......-. ...... ........+..+...+...+
T Consensus 99 ~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (316)
T d2ppqa1 99 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 178 (316)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred eecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCc
Confidence 7666643322110 000000 01111122222222222222
Q ss_pred ---HCCceecCCCCCcEEeccCCcEEEeeecccee
Q 010091 361 ---RNNIIHRDLKAANLLMNENGVVKVADFGVARV 392 (518)
Q Consensus 361 ---~~gIiHrDLkp~NILl~~~~~vkL~DFG~a~~ 392 (518)
..|+||+|+.++||+++.++..-|+||+.+..
T Consensus 179 ~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 179 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccccccCCcchhhhhcccccceeEeccccccc
Confidence 24799999999999999988889999998853
|
| >d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: SP0238-like domain: UPF0237 protein SP0238 species: Streptococcus pneumoniae [TaxId: 1313]
Probab=95.84 E-value=0.0052 Score=47.11 Aligned_cols=60 Identities=23% Similarity=0.367 Sum_probs=46.6
Q ss_pred EEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcc-hHHHHHHHHHh
Q 010091 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ-ETEQLRNVLAK 204 (518)
Q Consensus 143 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~-~~~~l~~~l~~ 204 (518)
||+++.|||++++.+|.+|++.|.||.+...+...+-++. .+.++ |+.. +.+++.+++.+
T Consensus 5 itv~g~DrpGiVa~vt~~l~~~g~NI~d~~q~~~~~~f~~-~~~v~-~~~~~~~~~l~~~l~~ 65 (83)
T d1zpva1 5 ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTM-MAVVS-SDEKQDFTYLRNEFEA 65 (83)
T ss_dssp EEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEE-ESSCCCHHHHHHHHHH
T ss_pred EEEEcCCCCCHHHHHHHHHHHCCCeEEEEEeEEeCCEEEE-EEEEE-EecCCCHHHHHHHHHH
Confidence 7999999999999999999999999999987765544444 44444 4443 57778877763
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Probab=95.68 E-value=0.0044 Score=47.93 Aligned_cols=60 Identities=15% Similarity=0.275 Sum_probs=46.0
Q ss_pred EEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcchHHHHHHHHH
Q 010091 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 142 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
=|++...|||++++.++..|++.|.||.+...+...+-++ -++.|+ |+..+.++|...|.
T Consensus 7 vitv~G~DrpGiva~vt~~l~~~g~NI~d~~~~~~~~~~~-~~~~v~-~~~~~~~~l~~~L~ 66 (86)
T d1u8sa1 7 VITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFT-LLMLIS-GSPSNITRVETTLP 66 (86)
T ss_dssp EEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEE-EEEEEE-ECHHHHHHHHHHHH
T ss_pred EEEEEeCCCChHHHHHHHHHHHCCCeEEEeEeEEECCeeE-EEEEEE-cCcccHHHHHHHHH
Confidence 3889999999999999999999999998887665544444 445554 46566777776665
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=94.65 E-value=0.043 Score=41.28 Aligned_cols=56 Identities=21% Similarity=0.217 Sum_probs=45.4
Q ss_pred eeEEEEecCCccchHHHHHhhhcccCCCccccccc-ccCCCceeeEEEEcCCCcchH
Q 010091 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAF-STVDGYSLDVFVVDGWPLQET 195 (518)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~-~t~d~~s~~v~~v~~w~~~~~ 195 (518)
.|=+.+...|+|+.+.+++++|++-|+||...+.. ....|.+..++.+|+-..++.
T Consensus 3 G~~L~i~~~D~PGvi~~I~~~l~~~~iNI~~m~~~~~~~g~~a~~vi~vD~~~~~~v 59 (78)
T d1ygya3 3 GINLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPDDV 59 (78)
T ss_dssp SEEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEECSSSSCEEEEEEESSCCCHHH
T ss_pred ceEEEEEeCCcCCHHHHHHHHHHhcCcChhhheeeecCCCCeEEEEEEcCCCccHHH
Confidence 36678888999999999999999999999887664 456778888999887555433
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Probab=93.71 E-value=0.029 Score=42.85 Aligned_cols=61 Identities=16% Similarity=0.337 Sum_probs=43.8
Q ss_pred eeEEEEecCCccchHHHHHhhhcccCCCcccccccccCC-CceeeEEEEcCCCcchHHHHHHHHH
Q 010091 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d-~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
-|-+++...|+|+.+.+++++|++-|+||..-...+..+ |+++ ..++. ..+..+++.+++.
T Consensus 11 ~~rl~i~~~d~PGvla~I~~~l~~~~iNI~~~~~~~~~~~~~a~--~~i~~-D~~~~~~v~~~i~ 72 (84)
T d1sc6a3 11 GRRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVV--IDIEA-DEDVAEKALQAMK 72 (84)
T ss_dssp SEEEEEEEESCTTHHHHHHHHHHHTTCEEEEEEEEECSSEEEEE--EEEEC-CHHHHHHHHHHHH
T ss_pred CeEEEEEeCCcCCHHHHHHHHHHHcCCCHHHhccccCCCCcEEE--EEEEC-CCCCHHHHHHHHH
Confidence 488999999999999999999999999998866555544 4443 33332 3344555555554
|
| >d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Nitrosomonas europaea [TaxId: 915]
Probab=93.49 E-value=0.06 Score=40.36 Aligned_cols=64 Identities=27% Similarity=0.330 Sum_probs=52.3
Q ss_pred eEEEEecCCccchHHHHHhhhcccCCCccccccc-ccCCCceeeEEEEcCCCcchHHHHHHHHHhh
Q 010091 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAF-STVDGYSLDVFVVDGWPLQETEQLRNVLAKE 205 (518)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~-~t~d~~s~~v~~v~~w~~~~~~~l~~~l~~~ 205 (518)
|-|++-..|+|+.|++.+.+.+.-|.||+.-.+- +..+|+|--.++++| ..+..+++.++|.+-
T Consensus 3 ~tisv~veN~pGvL~Ris~lF~rRg~NI~Sltv~~te~~~iSRmtivv~~-~~~~i~qi~kQL~Kl 67 (77)
T d2pc6a2 3 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNG-PDEIVEQITKQLNKL 67 (77)
T ss_dssp EEEEEEEECSTTHHHHHHHHHHHHTCCCCEEEEEECSSTTEEEEEEEEEE-CHHHHHHHHHHHHHS
T ss_pred EEEEEEEECCccHHHHHHHHHhccCcceEEEEEeccCCCCeEEEEEEEEC-CHHHHHHHHHHHhCC
Confidence 6788888999999999999999999999665444 356788888999988 556788888887743
|
| >d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=92.86 E-value=0.081 Score=38.96 Aligned_cols=55 Identities=22% Similarity=0.260 Sum_probs=45.3
Q ss_pred EEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEcCCCcchHHHHHHHHH
Q 010091 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLA 203 (518)
Q Consensus 143 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~~w~~~~~~~l~~~l~ 203 (518)
|.+...|+|+-|..+..+|++-|+||.-..+|.+. +.+..+|+|+ +.+.....|.
T Consensus 2 iaV~v~d~pG~L~~v~~~L~~~~InI~~~y~~~~~-~~~~~vl~vd-----d~~~a~~~L~ 56 (71)
T d2f06a1 2 VGISCPNVPGALAKVLGFLSAEGVFIEYMYSFANN-NVANVVIRPS-----NMDKCIEVLK 56 (71)
T ss_dssp EEEEEESSTTHHHHHHHHHHHTTCCEEEEEEEEET-TEEEEEEEES-----CHHHHHHHHH
T ss_pred EEEEecCCccHHHHHHHHHHHCCCCEEEEEEEcCC-CcEEEEEEEC-----CHHHHHHHHH
Confidence 45666899999999999999999999999999876 6889999986 4555555555
|
| >d2f06a2 d.58.18.11 (A:1-70) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=92.84 E-value=0.13 Score=37.67 Aligned_cols=48 Identities=15% Similarity=0.250 Sum_probs=39.3
Q ss_pred eeEEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEc
Q 010091 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVD 188 (518)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~ 188 (518)
+|.|++-..|||+.|.+++.++++-|.||..-.+ +.+.++..--++|+
T Consensus 3 ~~QisV~~eNkpG~L~~v~~~~~~~~inI~sl~v-~~t~~~~i~Riiv~ 50 (70)
T d2f06a2 3 AKQLSIFLENKSGRLTEVTEVLAKENINLSALCI-AENADFGILRGIVS 50 (70)
T ss_dssp EEEEEEEECSSSSHHHHHHHHHHHTTCCEEEEEE-EECSSCEEEEEEES
T ss_pred eEEEEEEEeCCCcHHHHHHHHHHHCCCCEEEEEE-eecCCCCEEEEEEC
Confidence 6788888999999999999999999999965444 55556677777775
|
| >d2f1fa1 d.58.18.6 (A:2-77) Acetolactate synthase small subunit, IlvH {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Escherichia coli [TaxId: 562]
Probab=92.16 E-value=0.16 Score=37.76 Aligned_cols=64 Identities=20% Similarity=0.199 Sum_probs=49.5
Q ss_pred eEEEEecCCccchHHHHHhhhcccCCCccccccc-ccCCCceeeEEEEcCCCcchHHHHHHHHHhh
Q 010091 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAF-STVDGYSLDVFVVDGWPLQETEQLRNVLAKE 205 (518)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~-~t~d~~s~~v~~v~~w~~~~~~~l~~~l~~~ 205 (518)
|=|++-..|+|+.|++++.+.+.-|.||..-.+- +...|+|-..+++.+ ..+..+++.+++.+-
T Consensus 2 htlsv~v~N~~GVL~RisglF~rRg~NI~Sl~v~~te~~~iSR~tivv~~-~~~~i~qi~kQL~Kl 66 (76)
T d2f1fa1 2 RILSVLLENESGALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTVG-DEKVLEQIEKQLHKL 66 (76)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEES-CHHHHHHHHHHHHHS
T ss_pred EEEEEEEECCCcHHHHHHHHHHhcCcceEEEEEcccCCCCeeEEEEEEEC-CHHHHHHHHHHHhCC
Confidence 4577778899999999999999999999654444 245677777788877 556788888877743
|
| >d1u8sa2 d.58.18.5 (A:88-180) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Probab=92.00 E-value=0.12 Score=39.90 Aligned_cols=35 Identities=17% Similarity=0.290 Sum_probs=31.1
Q ss_pred eeEEEEecCCccchHHHHHhhhcccCCCccccccc
Q 010091 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAF 174 (518)
Q Consensus 140 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~ 174 (518)
--||++.+.|||+++..+|..|++.|+||.+....
T Consensus 6 tv~v~v~g~DrpGIV~~it~~la~~~~nI~~l~t~ 40 (93)
T d1u8sa2 6 TVEVYVESDDKLGLTEKFTQFFAQRQIGMASLSAQ 40 (93)
T ss_dssp EEEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEE
T ss_pred EEEEEEEECCCCCHHHHHHHHHHHcCCCchhhhcc
Confidence 34899999999999999999999999999886543
|
| >d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: AF1403 N-terminal domain-like domain: Hypothetical protein AF1403, N-terminal domain species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]
Probab=91.51 E-value=0.063 Score=40.20 Aligned_cols=61 Identities=21% Similarity=0.203 Sum_probs=41.2
Q ss_pred EEEEecCCccchHHHHHhhhcccCCCcccccccccCCCceeeEEEEc--CCCcchHHHHHHHHH
Q 010091 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVD--GWPLQETEQLRNVLA 203 (518)
Q Consensus 142 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~t~d~~s~~v~~v~--~w~~~~~~~l~~~l~ 203 (518)
-|.+-+.|||++|+.++..+++.|.||...+.....+|.+-..|.++ .-. .+.+.+..++.
T Consensus 3 ~i~i~~~Dr~GlL~di~~~ia~~~~NI~~i~~~~~~~g~~~~~~~i~v~~~~-~~l~~ll~kL~ 65 (77)
T d1y7pa2 3 GLRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIYFEIEG-GDFEKILERVK 65 (77)
T ss_dssp EEEEEEECCTTHHHHHHHHCC----CEEEEEEEECCSSTTTTEEEEEEEECS-SCHHHHHHHHH
T ss_pred eEEEEEecCCChHHHHHHHHHHcCCCeEEEEeeccCCCeEEEEEEEEEEcCc-ccHHHHHHHHH
Confidence 47788899999999999999999999999988877777554333332 222 24666666655
|
| >d2fgca2 d.58.18.6 (A:27-104) Acetolactate synthase small subunit, IlvH {Thermotoga maritima [TaxId: 2336]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Thermotoga maritima [TaxId: 2336]
Probab=91.04 E-value=0.19 Score=37.65 Aligned_cols=63 Identities=24% Similarity=0.368 Sum_probs=50.0
Q ss_pred eEEEEecCCccchHHHHHhhhcccCCCcccccccc-cCCCceeeEEEEcCCCcchHHHHHHHHHh
Q 010091 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFS-TVDGYSLDVFVVDGWPLQETEQLRNVLAK 204 (518)
Q Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~a~~~~-t~d~~s~~v~~v~~w~~~~~~~l~~~l~~ 204 (518)
|-|.+-..|+|+.|++.+.+.+.-|.||..-.+-. ...|+|=-.++++| ..+..+++.+++.|
T Consensus 4 ~tisvlv~n~pGvL~Ri~~lF~rRg~NI~SL~v~~te~~~iSR~tivv~g-~~~~i~qi~kQl~K 67 (78)
T d2fgca2 4 HLVSMLVHNKPGVMRKVANLFARRGFNISSITVGESETPGLSRLVIMVKG-DDKTIEQIEKQAYK 67 (78)
T ss_dssp EEEEEEEECCTTHHHHHHHHHHTTTCEEEEEEEEECSSTTEEEEEEEEEE-CTTHHHHHHHHHTT
T ss_pred EEEEEEEeCCCcHHHHHHHHHhhCCcceEEEEEeecCCCCeEEEEEEEEc-CHHHHHHHHHHHhC
Confidence 66788889999999999999999999996654333 45577777888887 55678888777763
|